data_2kfp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kfp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -100.41 156.79 17.06 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.821 0.82 . . . . 0.0 110.367 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.0 mtp-105 -60.6 -46.58 89.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.64 -0.662 . . . . 0.0 110.171 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -47.73 -40.51 20.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.992 . . . . 0.0 109.677 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.77 -41.6 87.43 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.344 -0.848 . . . . 0.0 109.366 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -63.72 -45.43 89.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.458 -0.777 . . . . 0.0 110.095 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.2 mm -63.84 -46.02 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.79 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -67.38 -39.04 85.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 0.0 108.925 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -61.78 -46.14 90.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.456 -0.778 . . . . 0.0 109.936 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.28 86.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.477 -0.765 . . . . 0.0 109.914 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -65.95 -21.71 66.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -84.42 -53.22 5.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 109.914 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -88.87 -44.02 10.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.446 -0.784 . . . . 0.0 111.601 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 15' ' ' ASP . 45.6 m-85 -93.45 -6.16 47.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.785 -1.197 . . . . 0.0 110.071 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER 37.4 34.55 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.622 0.725 . . . . 0.0 109.796 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 14' ' ' TYR . 7.8 t -104.45 145.74 29.85 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.564 0.697 . . . . 0.0 110.085 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -98.47 151.28 37.4 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.66 149.35 73.51 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.712 2.275 . . . . 0.0 112.659 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -136.33 151.16 49.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.673 -0.642 . . . . 0.0 109.354 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -139.64 86.0 14.3 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -55.17 -38.1 93.8 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.566 2.178 . . . . 0.0 110.758 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -94.71 116.44 28.75 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.373 0.606 . . . . 0.0 109.509 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 25' ' ' PHE . 17.4 pt-20 -69.49 -31.31 69.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.493 -0.754 . . . . 0.0 109.405 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -64.78 -0.66 1.55 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.564 -0.71 . . . . 0.0 109.464 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' H ' ' C ' ' A' ' 23' ' ' GLU . 73.2 m-85 -137.05 71.75 54.95 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 109.333 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.7 -20.58 30.26 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.471 2.114 . . . . 0.0 111.615 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.18 -6.0 58.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.477 -0.764 . . . . 0.0 109.306 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.76 140.19 29.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.65 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.11 133.15 50.44 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.73 129.97 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.682 -0.636 . . . . 0.0 109.348 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -113.62 134.15 54.88 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -158.41 149.48 20.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.533 ' O ' ' NE1' ' A' ' 39' ' ' TRP . 81.2 m-70 -99.57 118.04 35.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.538 -0.726 . . . . 0.0 109.604 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 m -76.52 -15.09 59.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.534 -0.728 . . . . 0.0 109.149 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.59 -5.34 51.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.899 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 116' ' ' THR . 45.8 t-20 -115.24 -30.9 6.16 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.541 -0.724 . . . . 0.0 109.469 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 38' ' ' LYS . 65.1 t0 57.73 134.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.851 0.834 . . . . 0.0 111.018 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 6.3 tmtt? 82.41 102.2 0.05 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.515 0.674 . . . . 0.0 109.739 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -171.01 175.19 4.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.45 -0.781 . . . . 0.0 109.618 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.511 ' CG ' ' O ' ' A' ' 39' ' ' TRP . 80.3 m-85 -158.44 119.14 3.34 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.45 105.39 2.07 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.93 138.64 45.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 0.0 109.091 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 tt -116.4 124.76 50.83 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.8 ptt? -152.39 156.01 38.71 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.815 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.413 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 98.3 m-20 -94.4 114.49 26.53 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.6 pt -118.03 145.29 36.51 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.766 -0.583 . . . . 0.0 109.998 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -46.81 143.26 9.46 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.144 1.896 . . . . 0.0 112.431 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.09 -21.78 66.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.352 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -77.36 -14.23 59.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 109.783 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -84.57 -10.7 57.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 110.158 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 13.7 pt -105.08 1.45 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.2 -8.36 60.71 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.0 mt -79.72 139.2 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.848 -1.383 . . . . 0.0 110.14 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.37 -38.22 88.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.742 -0.599 . . . . 0.0 110.746 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -49.66 145.36 8.32 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.862 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -101.8 9.19 41.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.596 -0.943 . . . . 0.0 108.929 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -76.5 146.28 38.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 110.305 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.6 144.0 37.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.563 -0.711 . . . . 0.0 109.77 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.93 161.89 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.417 -0.802 . . . . 0.0 110.407 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.413 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 24.1 t70 -100.73 128.17 46.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.845 -0.534 . . . . 0.0 109.934 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.07 157.69 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.604 -0.685 . . . . 0.0 109.771 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 pt -132.61 150.15 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.48 0.657 . . . . 0.0 109.706 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 64.5 t0 -80.13 134.65 36.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.67 -0.644 . . . . 0.0 109.864 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.488 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.4 OUTLIER -125.82 124.0 39.98 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -89.91 129.47 36.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.943 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 m -138.64 164.68 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.895 0.855 . . . . 0.0 110.663 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.3 155.1 90.08 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.55 -24.62 75.3 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.752 2.302 . . . . 0.0 112.402 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -91.16 -23.59 20.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -0.968 . . . . 0.0 110.161 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.4 mt -92.68 1.18 57.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.03 -1.044 . . . . 0.0 109.469 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.98 -41.56 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 108.831 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.94 -40.52 98.98 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.2 t -65.34 -54.79 23.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -1.133 . . . . 0.0 110.281 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.25 -43.89 76.84 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 110.638 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -69.93 -18.29 63.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.457 -0.777 . . . . 0.0 110.214 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -71.66 -32.86 68.34 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.828 -1.17 . . . . 0.0 108.868 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -66.63 139.98 96.22 Favored Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.807 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.06 157.84 53.54 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.191 1.927 . . . . 0.0 112.562 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.44 -18.49 49.03 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.8 mt -103.23 117.11 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.971 . . . . 0.0 109.209 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 63.0 m-85 -105.82 151.2 39.89 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.694 -0.629 . . . . 0.0 109.445 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.631 ' CB ' ' HZ3' ' A' ' 88' ' ' LYS . 57.9 Cg_endo -68.75 153.17 73.61 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.608 2.205 . . . . 0.0 112.648 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.53 139.73 58.8 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.356 -0.84 . . . . 0.0 110.059 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.52 ' CZ ' ' CE1' ' A' ' 85' ' ' HIS . 54.2 p90 -90.13 2.76 54.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.557 -0.714 . . . . 0.0 109.207 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.52 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 78.5 m80 -79.9 -168.34 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.393 -0.817 . . . . 0.0 110.65 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.0 mtt -63.38 -40.37 97.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.518 -0.739 . . . . 0.0 109.574 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -81.31 -172.79 3.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.258 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.631 ' HZ3' ' CB ' ' A' ' 82' ' ' PRO . 48.8 tttp -165.31 -61.06 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -67.87 -38.7 83.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.567 -0.708 . . . . 0.0 109.455 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.86 -50.07 68.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.486 -0.759 . . . . 0.0 109.988 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -115.96 137.01 52.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.675 -0.64 . . . . 0.0 109.732 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.8 mm -129.16 133.39 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.569 0.699 . . . . 0.0 109.189 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.9 m -81.58 130.82 35.19 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.634 -0.666 . . . . 0.0 109.702 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.18 132.98 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.598 -0.689 . . . . 0.0 109.245 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.5 tp -87.54 103.84 15.93 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.509 0.671 . . . . 0.0 110.095 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 98' ' ' GLY . 72.2 mt -65.73 -40.08 91.82 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.607 0.717 . . . . 0.0 109.218 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -76.83 11.12 1.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -89.66 -164.5 40.13 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.89 0.41 10.02 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 123.226 2.617 . . . . 0.0 111.697 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 4.3 mm? -61.25 135.22 57.66 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.95 0.881 . . . . 0.0 110.985 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.68 157.43 28.7 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.08 97.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.561 -0.964 . . . . 0.0 109.538 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -70.26 -34.87 73.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.337 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.06 -43.25 92.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.457 -0.777 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.73 -42.91 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.511 -0.743 . . . . 0.0 109.37 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -56.49 -43.76 79.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 109.673 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.5 t -61.93 -44.82 95.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.395 -0.816 . . . . 0.0 109.963 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.65 -41.0 98.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.48 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.56 -42.64 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.018 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -51.7 -43.86 62.95 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -62.71 -43.23 99.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.618 -0.676 . . . . 0.0 109.324 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.2 p -70.02 -30.86 68.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 0.0 109.433 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.16 -43.91 87.63 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.441 -0.787 . . . . 0.0 109.179 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -49.84 -31.01 10.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.541 -0.724 . . . . 0.0 109.698 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 115' ' ' LEU . 10.2 mp -84.25 -17.43 39.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -0.857 . . . . 0.0 109.617 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.534 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 32.3 p -102.92 15.23 29.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.453 -0.78 . . . . 0.0 109.211 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 18.2 mmm180 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.973 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 tpp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.02 165.96 12.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.394 -0.817 . . . . 0.0 110.446 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -63.09 -42.52 99.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.75 -0.594 . . . . 0.0 109.731 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.52 HE22 ' CG ' ' A' ' 8' ' ' ASP . 2.2 tm0? -64.04 -38.59 91.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.146 -0.972 . . . . 0.0 109.471 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -63.57 -39.64 94.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.524 -0.735 . . . . 0.0 109.415 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -61.94 -46.86 87.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.438 -0.789 . . . . 0.0 109.83 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.66 -44.36 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.615 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.52 ' CG ' HE22 ' A' ' 4' ' ' GLN . 54.3 m-20 -65.87 -38.26 88.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.82 . . . . 0.0 109.023 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.501 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 91.6 t80 -61.58 -44.52 96.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.803 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' TYR . . . -64.13 -36.65 84.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 110.312 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 15' ' ' ASP . 58.3 mm-40 -61.88 -44.27 97.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.147 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -66.78 -38.44 86.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.893 -1.129 . . . . 0.0 109.552 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.501 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 29.9 mmtp -88.19 -11.73 45.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.491 -0.756 . . . . 0.0 111.302 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.411 ' CD1' ' NE2' ' A' ' 33' ' ' HIS . 80.7 m-85 -144.61 -21.68 0.52 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.821 -1.174 . . . . 0.0 110.818 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 11' ' ' GLN . 65.0 m-20 53.83 32.94 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 0.0 109.063 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.533 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 12.3 t -103.15 134.91 45.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.499 -0.75 . . . . 0.0 109.674 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -82.52 149.14 60.35 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.611 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.33 151.98 71.5 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.44 2.093 . . . . 0.0 112.346 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -132.77 130.21 39.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.646 -0.659 . . . . 0.0 109.288 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.424 ' O ' ' CD2' ' A' ' 20' ' ' HIS . 31.5 p-80 -132.4 86.33 45.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.72 -35.85 93.99 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.515 2.143 . . . . 0.0 111.381 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -81.35 104.06 11.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.588 -0.695 . . . . 0.0 109.977 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -68.07 -34.99 77.48 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.501 0.667 . . . . 0.0 109.359 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -67.24 -3.13 7.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.402 -0.811 . . . . 0.0 109.708 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -135.08 71.51 68.6 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.493 -0.754 . . . . 0.0 109.463 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.75 -17.54 42.25 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.323 2.015 . . . . 0.0 111.126 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -80.16 -5.92 56.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.495 -0.753 . . . . 0.0 109.221 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -104.68 135.91 45.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.505 -0.747 . . . . 0.0 109.471 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.67 147.87 47.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.583 -0.698 . . . . 0.0 109.318 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.86 126.4 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.759 -0.588 . . . . 0.0 109.682 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -108.92 117.75 35.0 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -149.45 153.17 36.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.066 -1.021 . . . . 0.0 109.792 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.652 ' N ' ' HE1' ' A' ' 39' ' ' TRP . 28.1 m80 -83.76 132.07 34.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 110.379 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -67.8 -40.19 83.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 109.828 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -92.68 -42.4 9.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.401 -0.812 . . . . 0.0 109.756 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' A' ' 38' ' ' LYS . 1.4 m-20 -95.01 31.76 1.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 37' ' ' ASP . 52.9 p-10 -48.38 83.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.541 0.686 . . . . 0.0 110.444 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 36' ' ' ASN . 6.1 tmtt? -147.32 -22.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.652 ' HE1' ' N ' ' A' ' 33' ' ' HIS . 4.4 p-90 -101.52 127.94 47.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.559 -0.713 . . . . 0.0 109.32 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -112.43 129.77 56.21 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.599 0.714 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.9 121.11 7.25 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.19 147.98 45.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.72 -0.612 . . . . 0.0 109.595 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.27 126.08 54.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.468 ' O ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -157.67 161.25 38.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.953 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' OD2' ' NH1' ' A' ' 58' ' ' ARG . 92.6 m-20 -99.67 142.57 30.98 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.9 pt -149.27 146.46 21.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.897 . . . . 0.0 109.306 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -49.74 144.02 21.27 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.869 1.713 . . . . 0.0 112.849 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.49 -21.81 66.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.594 -0.691 . . . . 0.0 109.802 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.18 -16.27 59.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.903 . . . . 0.0 110.103 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -84.87 -10.08 57.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.169 -0.957 . . . . 0.0 110.093 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 12.6 pt -103.57 3.32 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.285 -0.884 . . . . 0.0 109.206 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.15 -8.7 60.98 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.5 mt -83.93 129.98 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.81 -1.406 . . . . 0.0 110.334 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -65.77 87.0 0.09 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.622 -0.674 . . . . 0.0 109.335 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.29 136.32 3.21 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -95.81 11.94 31.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -1.078 . . . . 0.0 108.993 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -74.86 144.85 43.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 110.64 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.51 ' NH1' ' OD2' ' A' ' 45' ' ' ASP . 72.4 ttp85 -76.48 137.06 39.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.504 -0.747 . . . . 0.0 109.806 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.14 161.54 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -100.66 127.58 47.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.519 -0.738 . . . . 0.0 109.464 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -132.98 158.4 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.443 -0.785 . . . . 0.0 110.353 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 pt -135.02 152.8 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -116.14 145.27 43.2 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.437 0.637 . . . . 0.0 109.875 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.44 157.78 45.26 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -87.81 137.58 32.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.343 -0.848 . . . . 0.0 110.882 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.9 m -143.58 163.35 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.514 -0.741 . . . . 0.0 109.862 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -77.92 154.78 80.51 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.512 -0.743 . . . . 0.0 109.664 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -65.14 -21.5 62.57 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.411 2.074 . . . . 0.0 111.151 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -87.48 -26.92 22.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.131 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.3 mt -96.69 6.51 48.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.414 -0.803 . . . . 0.0 109.334 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.09 -36.49 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.513 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.72 -21.45 79.33 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.0 m -62.27 -59.07 5.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.18 -1.188 . . . . 0.0 110.914 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.516 ' H ' ' CD2' ' A' ' 74' ' ' LEU . 2.5 pt? -85.49 -29.25 24.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.057 -1.027 . . . . 0.0 110.698 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -67.73 -21.53 65.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.987 -1.07 . . . . 0.0 110.231 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.74 -8.14 55.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.051 -1.031 . . . . 0.0 109.229 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -75.92 149.09 82.55 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 110.081 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.5 140.87 49.03 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.435 2.09 . . . . 0.0 112.533 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.32 -21.1 18.56 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 2.7 mp -89.06 124.39 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.388 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 55.5 m-85 -123.84 151.14 64.06 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.751 -0.593 . . . . 0.0 109.588 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 84' ' ' TYR . 41.2 Cg_endo -67.95 158.57 56.77 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.412 2.075 . . . . 0.0 112.16 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 85' ' ' HIS . . . -66.17 65.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.451 -0.78 . . . . 0.0 109.423 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER 50.84 -83.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.696 -0.627 . . . . 0.0 109.719 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.574 ' N ' ' O ' ' A' ' 83' ' ' ALA . 60.8 t-80 -174.97 -7.66 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.2 mtt -63.92 -41.27 97.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.702 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 88' ' ' LYS . 36.0 m120 -119.61 -74.65 0.6 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.509 -0.744 . . . . 0.0 109.492 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 87' ' ' ASN . 84.9 tttt 57.9 150.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.611 0.72 . . . . 0.0 110.264 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 88' ' ' LYS . 31.7 tt0 75.51 -67.42 0.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -65.53 -52.61 51.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.468 -0.77 . . . . 0.0 109.825 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.401 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 7.3 m0 -119.0 132.94 56.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.698 -0.626 . . . . 0.0 109.858 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.19 133.95 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 6.8 p -87.42 143.14 27.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.773 -0.579 . . . . 0.0 110.152 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.4 t -122.29 134.91 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.6 tp -84.68 108.11 17.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.465 -0.772 . . . . 0.0 109.877 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.03 -39.58 93.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.656 -0.652 . . . . 0.0 109.353 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -75.25 1.18 14.21 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.092 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.0 177.14 20.26 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.71 -10.05 21.5 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.065 2.51 . . . . 0.0 111.844 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.61 143.32 57.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 110.403 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.78 170.52 48.04 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.153 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.67 78.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.727 -0.867 . . . . 0.0 109.13 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -62.21 -39.14 91.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -65.08 -37.61 88.07 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.336 -0.853 . . . . 0.0 108.904 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.42 -43.75 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 109.035 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -61.1 -45.46 94.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.426 -0.796 . . . . 0.0 109.762 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.9 m -61.39 -44.0 97.91 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.402 -0.811 . . . . 0.0 109.815 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.34 -44.52 91.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.58 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.16 -42.76 91.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.399 -0.813 . . . . 0.0 108.939 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -55.03 -40.63 70.44 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -63.64 -42.19 98.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.6 m -61.21 -41.94 97.73 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.11 -45.3 94.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.602 -0.686 . . . . 0.0 110.224 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -59.9 -29.03 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.493 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.1 mt -79.53 -15.7 57.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.723 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -120.43 14.45 11.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.492 -0.755 . . . . 0.0 109.081 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.878 . . . . 0.0 109.862 -179.362 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.297 0.57 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -93.78 168.13 11.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -0.794 . . . . 0.0 110.511 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -62.08 -43.38 98.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.692 -0.63 . . . . 0.0 109.8 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -65.72 -37.55 86.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 0.0 109.612 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.9 -42.38 97.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.543 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -61.93 -45.41 93.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.741 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 7' ' ' ILE . 96.5 mt -63.8 -43.78 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.391 -0.818 . . . . 0.0 109.448 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.495 ' OD2' ' NZ ' ' A' ' 12' ' ' LYS . 45.6 t0 -65.26 -37.64 87.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.381 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.472 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 83.4 t80 -59.97 -48.52 81.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.196 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.54 -30.69 71.06 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.478 -0.764 . . . . 0.0 109.115 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.56 ' O ' ' N ' ' A' ' 15' ' ' ASP . 36.0 tt0 -64.55 -42.26 95.8 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.46 -0.775 . . . . 0.0 109.404 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' NZ ' ' OD2' ' A' ' 8' ' ' ASP . 60.0 mttp -69.11 -36.8 77.93 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.882 -1.136 . . . . 0.0 109.814 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 30.3 mmtp -88.17 -12.37 44.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 111.292 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.496 ' CG ' ' CE1' ' A' ' 33' ' ' HIS . 94.2 m-85 -145.24 -22.11 0.49 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.869 -1.144 . . . . 0.0 110.46 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 11' ' ' GLN . 43.0 t0 54.82 34.58 22.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 109.011 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.7 m -102.01 130.1 48.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.404 -0.81 . . . . 0.0 109.402 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -87.02 156.71 54.82 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.445 -0.785 . . . . 0.0 109.985 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.54 140.16 45.49 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.188 1.925 . . . . 0.0 112.85 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -120.86 139.71 52.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -122.89 85.96 50.34 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.528 -0.732 . . . . 0.0 109.931 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.14 -39.55 90.5 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.65 2.233 . . . . 0.0 110.804 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -96.34 131.78 42.51 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.709 0.766 . . . . 0.0 110.137 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 1.1 pm0 -73.53 -36.06 65.64 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.695 -0.628 . . . . 0.0 109.772 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' C ' ' CD1' ' A' ' 25' ' ' PHE . 18.8 mtpp -67.95 10.45 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.439 -0.788 . . . . 0.0 111.16 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.434 ' H ' ' C ' ' A' ' 23' ' ' GLU . 81.2 m-85 -145.43 67.25 12.82 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.837 -1.164 . . . . 0.0 109.981 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.22 -20.37 32.74 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.571 2.18 . . . . 0.0 111.777 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -84.93 -4.11 58.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.068 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -88.42 150.8 22.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.788 . . . . 0.0 109.949 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.71 132.47 48.0 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.2 t -125.14 127.03 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.568 -0.707 . . . . 0.0 109.523 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -111.11 119.52 39.26 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -142.12 135.09 28.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.224 -0.922 . . . . 0.0 109.572 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.671 ' CD2' ' HE1' ' A' ' 39' ' ' TRP . 32.0 m-70 -100.1 127.52 46.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 109.818 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p -69.76 -25.06 63.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.49 -0.756 . . . . 0.0 109.506 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -78.15 -7.19 56.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 109.797 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 116' ' ' THR . 13.4 t-20 -117.43 30.19 7.44 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 38' ' ' LYS . 53.2 t0 60.97 29.19 18.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.34 0.59 . . . . 0.0 110.212 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 37' ' ' ASP . 57.4 mttp 53.17 106.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.357 -0.839 . . . . 0.0 110.053 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.671 ' HE1' ' CD2' ' A' ' 33' ' ' HIS . 7.9 p-90 -101.53 -177.47 3.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.523 -0.736 . . . . 0.0 110.202 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.31 129.21 46.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.572 -0.705 . . . . 0.0 110.252 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.03 105.75 3.28 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -111.43 125.72 54.18 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.577 0.703 . . . . 0.0 109.57 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 tt -129.66 112.91 14.15 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -162.88 174.13 12.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.41 -0.806 . . . . 0.0 109.568 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 87.7 m-20 -101.57 141.43 34.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.684 -0.635 . . . . 0.0 109.716 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.3 pt -143.34 145.54 32.56 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.565 -0.709 . . . . 0.0 109.464 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -48.5 144.28 14.18 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.989 1.792 . . . . 0.0 112.63 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.05 -24.06 67.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.6 -0.688 . . . . 0.0 110.191 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.86 -14.71 62.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 109.605 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -82.98 -12.58 57.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.399 -0.813 . . . . 0.0 110.501 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.471 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 11.2 pt -109.59 4.56 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.408 -0.808 . . . . 0.0 109.244 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.08 -17.19 59.06 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.75 130.82 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.864 -1.374 . . . . 0.0 110.39 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -86.05 99.18 11.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.534 -0.729 . . . . 0.0 109.362 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' LYS . . . -156.27 -8.17 0.07 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 41.79 20.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.995 -0.709 . . . . 0.0 109.647 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 55' ' ' GLY . 26.2 pttm -101.51 145.33 29.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.521 -0.737 . . . . 0.0 109.671 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -75.83 138.39 41.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.517 -0.739 . . . . 0.0 109.81 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.52 161.11 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.69 -0.631 . . . . 0.0 109.699 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 96.3 m-20 -88.79 132.42 34.64 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.559 -0.713 . . . . 0.0 109.433 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.01 149.23 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 109.836 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 pt -131.55 151.98 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.414 0.626 . . . . 0.0 109.823 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 67.9 t0 -86.05 142.54 28.66 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.456 -0.778 . . . . 0.0 109.457 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.529 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -133.01 126.71 32.51 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -88.96 126.72 35.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.642 -0.661 . . . . 0.0 110.038 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 m -137.91 163.88 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.541 -0.724 . . . . 0.0 109.588 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -80.74 157.31 72.11 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.083 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.88 -18.02 54.37 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.6 2.2 . . . . 0.0 110.987 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -95.44 -27.83 15.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.534 -0.729 . . . . 0.0 109.597 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.7 mt -89.89 -2.96 58.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.262 -0.898 . . . . 0.0 109.852 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.87 -38.87 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.867 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.79 97.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.0 m -68.58 -56.26 8.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.329 . . . . 0.0 110.639 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.56 -43.5 89.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 0.0 110.811 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -67.81 -17.15 64.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.022 -1.049 . . . . 0.0 110.033 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -78.59 -31.52 47.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.032 -1.043 . . . . 0.0 108.94 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -58.24 146.11 71.81 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.241 -0.912 . . . . 0.0 110.264 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.71 148.31 58.63 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.332 2.021 . . . . 0.0 112.612 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.53 -17.89 46.01 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 2.0 mp -87.72 123.15 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.353 -1.087 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 65.7 m-85 -116.79 149.38 43.9 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.82 -0.55 . . . . 0.0 109.696 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -67.8 144.52 65.58 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.575 2.183 . . . . 0.0 112.15 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.83 144.9 55.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 109.989 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.485 ' CE1' ' CE1' ' A' ' 85' ' ' HIS . 43.9 p90 -78.1 9.0 4.05 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.438 -0.789 . . . . 0.0 109.334 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.485 ' CE1' ' CE1' ' A' ' 84' ' ' TYR . 96.3 m-70 -88.03 165.64 15.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 110.043 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.8 mtp -68.55 -8.39 41.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.657 ' C ' ' H ' ' A' ' 89' ' ' GLU . 60.6 m-80 -77.73 -67.47 0.72 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.32 -0.862 . . . . 0.0 109.549 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 63.3 -26.76 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.95 -0.468 . . . . 0.0 109.77 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.657 ' H ' ' C ' ' A' ' 87' ' ' ASN . 97.6 mt-10 -98.67 -63.86 1.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -59.35 -46.52 88.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.318 -0.863 . . . . 0.0 110.338 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.609 ' CE3' ' ND2' ' A' ' 87' ' ' ASN . 9.3 m0 -116.41 138.55 51.27 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.618 0.723 . . . . 0.0 110.006 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.8 mt -138.56 153.51 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.6 m -97.56 138.4 35.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 110.036 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.6 t -120.34 133.44 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.4 tp -88.63 109.43 20.1 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.594 0.712 . . . . 0.0 110.408 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.63 -39.32 88.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -69.17 -8.65 47.55 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -57.25 178.26 0.96 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.29 -12.75 25.44 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.976 2.451 . . . . 0.0 111.686 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 pp -68.28 137.18 54.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.347 -0.846 . . . . 0.0 110.266 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.7 176.02 47.53 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.158 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.0 77.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.789 -0.83 . . . . 0.0 109.459 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -62.0 -40.49 95.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.406 -0.808 . . . . 0.0 108.82 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.9 -41.99 95.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.34 -0.85 . . . . 0.0 108.869 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.4 -43.06 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.441 -0.787 . . . . 0.0 109.482 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -56.15 -43.57 78.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.703 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.2 p -64.22 -41.92 96.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 109.719 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.81 -39.75 94.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.602 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.73 -42.6 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.385 -0.822 . . . . 0.0 109.182 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -57.95 -39.26 77.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 109.083 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.45 -42.91 98.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.303 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 99.6 p -63.94 -34.74 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 109.36 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 117' ' ' ARG . 88.9 t80 -60.14 -44.78 94.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.404 -0.81 . . . . 0.0 109.306 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.37 -43.54 96.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.5 -41.26 96.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.445 -0.784 . . . . 0.0 110.14 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.442 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 67.2 p -99.41 14.71 28.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.366 -0.834 . . . . 0.0 109.275 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 113' ' ' PHE . 38.6 ttp-105 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.166 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -93.57 -177.98 4.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 0.0 110.08 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.458 ' NH2' ' OD1' ' A' ' 60' ' ' ASP . 12.0 ptp85 -63.2 -32.9 74.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 109.541 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -56.44 -43.39 79.41 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.329 -0.857 . . . . 0.0 109.127 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.03 -42.44 84.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.067 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -62.05 -45.37 93.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.52 -0.737 . . . . 0.0 109.752 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.36 -43.09 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.408 -0.808 . . . . 0.0 109.36 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.72 -39.32 91.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.372 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -60.58 -44.46 96.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.818 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.06 86.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.521 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 16' ' ' THR . 98.9 mm-40 -65.19 -45.89 82.98 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 110.021 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.99 -37.27 83.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -63.71 -50.51 68.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.105 -0.997 . . . . 0.0 111.94 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -147.02 17.53 1.23 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.53 -1.357 . . . . 0.0 110.225 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 55.05 47.53 21.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.149 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.537 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 88.3 m -101.07 123.74 45.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.294 -0.879 . . . . 0.0 109.7 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.499 ' CB ' ' HZ3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -93.67 148.83 36.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 157.36 60.77 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.206 1.937 . . . . 0.0 112.672 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -108.71 155.15 21.06 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -136.85 86.56 21.15 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.478 -0.764 . . . . 0.0 110.047 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.78 -10.99 5.87 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.782 2.322 . . . . 0.0 110.393 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -102.04 98.66 8.83 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.5 0.667 . . . . 0.0 109.816 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 24' ' ' LYS . 14.9 pt-20 -68.55 -37.35 79.86 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.545 0.688 . . . . 0.0 109.658 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 23' ' ' GLU . 9.8 mtpm? -70.79 -3.54 19.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.479 -0.763 . . . . 0.0 110.788 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -142.95 77.38 16.25 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.078 -1.014 . . . . 0.0 110.018 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.66 -14.84 33.56 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.562 2.175 . . . . 0.0 112.099 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -78.72 -4.94 51.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.252 -0.905 . . . . 0.0 109.521 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -94.72 142.73 27.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.255 -0.903 . . . . 0.0 110.102 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.93 139.57 52.06 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -124.48 128.32 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.516 -0.74 . . . . 0.0 110.245 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.37 114.44 27.88 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 37' ' ' ASP . 77.8 ttt-85 -145.35 138.64 26.45 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.196 -0.94 . . . . 0.0 109.459 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.458 ' ND1' ' CD1' ' A' ' 39' ' ' TRP . 32.5 m170 -100.58 124.63 46.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.472 -0.767 . . . . 0.0 109.951 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.2 m -75.79 -22.71 56.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.428 -0.795 . . . . 0.0 109.983 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.64 -41.86 99.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.124 -0.985 . . . . 0.0 110.208 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 38' ' ' LYS . 12.3 m120 -93.49 4.07 54.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 0.0 108.531 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 98.8 m-20 47.56 11.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.77 . . . . 0.0 110.182 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 36' ' ' ASN . 8.4 mtmp? -139.99 -121.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.258 -0.901 . . . . 0.0 109.532 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.458 ' CD1' ' ND1' ' A' ' 33' ' ' HIS . 56.7 t-105 46.53 96.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.659 -0.651 . . . . 0.0 109.321 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -106.63 126.28 52.07 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.707 0.765 . . . . 0.0 109.981 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.06 128.53 10.68 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 140.55 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.943 -1.098 . . . . 0.0 109.812 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.6 130.74 55.49 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -157.19 157.88 35.2 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.943 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 33.6 p-10 -98.98 116.6 31.58 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 pt -125.74 145.8 52.85 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.688 -0.633 . . . . 0.0 109.722 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.2 139.05 22.02 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.811 1.674 . . . . 0.0 112.304 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.5 -22.03 65.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.191 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -62.67 -29.76 70.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.142 -0.974 . . . . 0.0 109.641 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.71 -40.55 95.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.802 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.2 pt -79.08 16.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.758 -1.214 . . . . 0.0 109.739 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.19 -8.24 58.36 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.443 -0.884 . . . . 0.0 110.927 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.9 mt -82.7 129.01 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.638 -1.507 . . . . 0.0 109.81 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -85.39 97.12 9.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.494 -0.754 . . . . 0.0 110.276 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.59 -16.96 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.516 -1.833 . . . . 0.0 108.516 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 57.6 t0 51.19 19.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -1.032 . . . . 0.0 109.069 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -107.9 146.3 32.55 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.583 -0.698 . . . . 0.0 110.138 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -73.91 139.3 44.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.493 -0.754 . . . . 0.0 109.7 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.44 157.88 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.424 -0.797 . . . . 0.0 109.464 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.458 ' OD1' ' NH2' ' A' ' 3' ' ' ARG . 90.2 m-20 -91.21 131.32 36.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.466 -0.771 . . . . 0.0 109.755 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.26 158.6 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.535 -0.728 . . . . 0.0 109.446 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.5 pt -134.53 146.49 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.421 0.629 . . . . 0.0 109.614 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 64.4 t0 -79.29 134.78 36.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.407 -0.808 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.488 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -127.14 121.82 32.45 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -83.89 134.83 34.67 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.418 -0.801 . . . . 0.0 110.114 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.0 m -143.84 164.28 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -93.32 155.34 41.04 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.521 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -48.75 -28.9 13.55 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.167 1.911 . . . . 0.0 111.26 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.02 -32.11 16.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.459 -0.776 . . . . 0.0 109.376 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.59 -5.25 58.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 109.466 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 72' ' ' GLY . 9.2 p -68.53 -40.44 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -0.909 . . . . 0.0 109.863 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.429 ' N ' ' CG1' ' A' ' 71' ' ' VAL . . . -63.87 -44.0 96.75 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.5 t -64.73 -26.32 68.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.938 -1.331 . . . . 0.0 110.21 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.98 -33.89 19.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.866 -1.146 . . . . 0.0 109.829 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -76.21 -7.49 54.97 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.375 -0.828 . . . . 0.0 109.105 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -7.33 59.68 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -94.14 113.76 61.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.634 -0.667 . . . . 0.0 109.474 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.94 147.05 19.95 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.303 2.002 . . . . 0.0 113.282 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.07 -13.28 67.31 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.4 mt -107.28 124.43 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.529 -0.983 . . . . 0.0 109.085 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.419 ' O ' ' OG1' ' A' ' 93' ' ' THR . 56.1 m-85 -119.47 150.07 49.04 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.76 -0.588 . . . . 0.0 110.01 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 83' ' ' ALA . 37.1 Cg_exo -56.13 149.45 53.66 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.124 1.882 . . . . 0.0 112.576 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 82' ' ' PRO . . . -45.99 174.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.825 0.822 . . . . 0.0 111.129 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.62 -71.73 0.28 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -137.97 140.95 40.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.551 -0.718 . . . . 0.0 109.934 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.0 mmm 57.59 154.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.738 0.78 . . . . 0.0 111.231 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.546 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 85.1 m-20 56.56 33.21 22.27 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.51 0.672 . . . . 0.0 109.388 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -63.27 -46.96 84.38 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.454 -0.779 . . . . 0.0 109.262 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -79.37 -35.87 40.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.122 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -66.35 -50.71 62.65 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.339 -0.851 . . . . 0.0 110.243 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.546 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 11.1 m0 -117.5 152.08 35.8 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.587 -0.696 . . . . 0.0 109.753 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 mm -136.22 157.68 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.567 -0.708 . . . . 0.0 109.451 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 7.6 p -105.85 123.68 48.35 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.8 t -108.46 131.06 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.5 tp -89.91 104.18 16.77 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.206 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.06 -39.49 86.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.539 -0.725 . . . . 0.0 109.264 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -69.28 -6.1 27.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.41 -0.806 . . . . 0.0 109.047 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -77.83 -162.26 18.12 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.72 6.26 5.89 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.348 2.699 . . . . 0.0 111.564 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.71 130.94 48.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 110.254 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.91 154.79 24.91 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.38 95.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.543 -0.975 . . . . 0.0 109.297 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.71 -42.08 95.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.943 . . . . 0.0 109.074 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -66.03 -43.95 86.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.446 -0.784 . . . . 0.0 109.198 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.58 -43.48 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.069 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -60.43 -43.57 96.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.462 -0.774 . . . . 0.0 109.654 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -62.77 -42.72 99.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.819 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.79 -41.92 95.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.931 . . . . 0.0 109.584 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.406 ' O ' ' OG ' ' A' ' 112' ' ' SER . 95.9 mt -63.79 -43.17 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.872 . . . . 0.0 108.919 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -61.19 -41.99 97.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -64.04 -41.58 97.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 109' ' ' ILE . 90.7 p -66.07 -33.91 76.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.79 . . . . 0.0 109.304 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.25 -47.93 83.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.633 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.49 -29.03 63.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.94 -42.23 97.39 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.185 -0.947 . . . . 0.0 109.511 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 117' ' ' ARG . 62.2 p -97.11 14.73 24.75 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.569 -0.707 . . . . 0.0 109.1 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.475 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 77.7 ttt-85 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.881 -0.512 . . . . 0.0 110.167 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpp . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -105.77 163.85 12.39 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.553 -0.717 . . . . 0.0 110.019 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -61.48 -43.25 99.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.585 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -64.26 -40.91 96.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.452 -0.78 . . . . 0.0 109.754 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.89 -42.27 94.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 109.572 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.42 -45.03 96.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.767 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.29 -44.67 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.26 -0.9 . . . . 0.0 109.153 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.63 -44.13 94.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.816 . . . . 0.0 109.487 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.618 ' HH ' ' HZ1' ' A' ' 13' ' ' LYS . 61.2 t80 -64.15 -42.1 96.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.483 -0.76 . . . . 0.0 109.872 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.5 -54.31 48.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.379 -0.826 . . . . 0.0 110.698 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -64.9 -33.1 75.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.244 -0.91 . . . . 0.0 109.756 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -60.57 -46.59 89.65 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 109.791 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.618 ' HZ1' ' HH ' ' A' ' 9' ' ' TYR . 38.1 ttmt -87.2 -37.61 17.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.348 -0.845 . . . . 0.0 111.416 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 77.2 m-85 -94.57 -0.73 54.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.924 -1.11 . . . . 0.0 111.115 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 14' ' ' TYR . 3.4 p30 40.97 35.61 0.36 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.379 -0.825 . . . . 0.0 109.907 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.6 t -118.64 143.88 46.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.566 -0.709 . . . . 0.0 109.359 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -96.23 151.81 38.4 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.308 -0.87 . . . . 0.0 109.564 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.22 149.55 85.32 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.469 2.112 . . . . 0.0 112.162 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 66.1 t0 -132.8 138.51 47.14 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.517 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 5.5 p80 -131.24 85.58 53.43 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -79.29 -10.52 14.87 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.943 1.762 . . . . 0.0 111.14 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -89.15 102.87 15.52 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.456 0.646 . . . . 0.0 109.555 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.86 -33.84 74.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -0.766 . . . . 0.0 109.592 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 25' ' ' PHE . 60.1 mttp -68.06 -5.75 19.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.348 -0.845 . . . . 0.0 109.849 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 24' ' ' LYS . 64.1 m-85 -153.29 83.84 4.49 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.202 -0.936 . . . . 0.0 109.463 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.4 -15.61 31.15 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.565 1.51 . . . . 0.0 111.209 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.63 -5.92 47.84 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.4 m-85 -86.08 141.68 29.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 109.106 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.98 135.93 38.08 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.44 126.01 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -110.26 122.66 48.2 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -134.3 155.22 50.6 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.051 -1.031 . . . . 0.0 109.267 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 37' ' ' ASP . 1.4 t-160 -85.42 113.84 22.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.317 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 t -65.35 -23.43 66.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.525 -0.735 . . . . 0.0 109.799 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.8 -44.57 92.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.377 -0.827 . . . . 0.0 110.639 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -122.48 -26.73 4.53 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.377 -0.827 . . . . 0.0 109.63 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 33' ' ' HIS . 54.4 m-20 58.49 -159.12 0.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.438 0.637 . . . . 0.0 109.938 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 59.9 24.51 13.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.934 -0.479 . . . . 0.0 110.274 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -112.25 149.02 32.91 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.396 -0.815 . . . . 0.0 109.553 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -113.71 131.53 56.14 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.676 0.75 . . . . 0.0 110.239 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.15 105.62 3.24 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.58 131.89 53.87 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.724 0.773 . . . . 0.0 110.417 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 tt -126.76 120.29 28.99 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.592 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 3.7 ptt? -160.41 164.19 32.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.01 . . . . 0.0 109.507 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 96.9 m-20 -98.38 118.78 35.81 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.2 pt -120.73 145.95 42.36 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.44 -0.788 . . . . 0.0 109.45 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.21 141.74 96.67 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.902 1.735 . . . . 0.0 112.719 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.19 -20.74 65.69 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.493 0.663 . . . . 0.0 109.263 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 56' ' ' ASP . 95.6 mt-10 -53.69 -36.0 61.72 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.625 -0.672 . . . . 0.0 109.899 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.05 -39.01 93.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 110.317 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 pt -92.94 -0.94 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.08 36.44 85.73 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.153 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' A' ' 55' ' ' GLY . 6.0 mt -104.46 133.63 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.182 -1.187 . . . . 0.0 109.713 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 52.77 -83.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.707 -0.621 . . . . 0.0 109.806 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . 143.46 114.65 1.0 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.6 OUTLIER 61.47 39.35 15.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.623 -0.928 . . . . 0.0 110.67 178.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -113.46 118.63 35.04 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -72.39 133.35 44.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.181 -0.949 . . . . 0.0 109.516 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.11 161.66 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 20.3 m-20 -99.43 138.07 37.03 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.29 -0.881 . . . . 0.0 109.444 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.75 156.59 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.304 -0.872 . . . . 0.0 109.344 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.8 pt -133.74 157.98 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.549 0.69 . . . . 0.0 109.702 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -90.48 122.07 32.99 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.85 120.47 39.36 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -84.23 135.55 34.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.321 -0.862 . . . . 0.0 109.849 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -143.29 169.65 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.287 -0.883 . . . . 0.0 109.63 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -78.11 153.59 79.86 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.583 -0.698 . . . . 0.0 109.489 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.77 -19.26 66.81 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.256 1.97 . . . . 0.0 111.313 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -91.42 -27.56 18.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.763 . . . . 0.0 109.395 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.21 7.62 44.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.322 -0.861 . . . . 0.0 109.221 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.26 -37.53 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.465 -0.772 . . . . 0.0 109.981 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.3 -15.1 81.47 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.522 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -71.25 -60.6 2.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.014 -1.286 . . . . 0.0 110.737 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.477 ' CD2' ' H ' ' A' ' 74' ' ' LEU . 2.5 pt? -75.49 -37.23 60.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.184 -0.947 . . . . 0.0 110.537 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.0 ttt-85 -60.61 -33.07 72.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.389 -0.819 . . . . 0.0 109.475 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -32.84 73.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.315 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -68.09 120.36 73.78 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.176 -0.952 . . . . 0.0 110.059 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.05 147.28 20.06 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.938 1.759 . . . . 0.0 112.61 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.88 -22.56 34.97 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.8 mt -105.85 120.89 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.535 -0.98 . . . . 0.0 109.279 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -107.08 150.76 40.27 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.497 -0.752 . . . . 0.0 109.923 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.41 159.15 54.8 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.223 1.949 . . . . 0.0 111.92 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.03 142.37 58.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 109.984 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -79.29 12.9 2.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 109.843 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -156.63 -161.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -0.919 . . . . 0.0 110.176 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 78.9 mtm -52.77 -175.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.571 0.701 . . . . 0.0 111.078 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.9 m120 59.1 33.19 22.74 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.514 0.673 . . . . 0.0 109.687 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -64.65 -39.22 93.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.556 -0.715 . . . . 0.0 109.605 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.28 -16.99 29.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.116 -0.99 . . . . 0.0 109.934 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -94.48 -53.33 3.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.24 -0.913 . . . . 0.0 110.358 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -111.19 131.32 55.21 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.389 -0.819 . . . . 0.0 109.781 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.98 141.12 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.4 m -86.77 129.46 34.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.218 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.1 t -114.16 133.17 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.1 tp -91.05 108.51 19.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.648 -0.657 . . . . 0.0 109.923 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.34 -39.46 92.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.53 -0.731 . . . . 0.0 109.086 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -76.03 5.56 6.48 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.5 -0.75 . . . . 0.0 109.034 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.51 -176.44 20.43 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.42 -6.59 14.7 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.113 2.542 . . . . 0.0 111.701 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.83 145.84 48.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.646 -0.659 . . . . 0.0 109.794 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.08 173.01 31.28 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.55 -29.1 70.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.653 -0.91 . . . . 0.0 109.332 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.18 -41.31 98.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.456 -0.778 . . . . 0.0 109.234 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 104' ' ' GLU . 58.2 mp0 -65.69 -41.61 92.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.19 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.38 -43.42 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.418 -0.801 . . . . 0.0 109.931 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -56.03 -45.75 79.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.83 . . . . 0.0 109.589 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.6 t -61.94 -44.27 97.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.4 -0.812 . . . . 0.0 109.935 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.9 -41.32 99.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.427 -0.796 . . . . 0.0 109.658 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.77 -43.18 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -56.29 -43.69 79.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 0.0 109.089 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -60.06 -44.75 94.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.365 -0.835 . . . . 0.0 109.09 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.7 p -70.38 -27.18 64.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.258 -0.902 . . . . 0.0 109.983 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.07 -44.85 91.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.331 -0.856 . . . . 0.0 109.382 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -58.46 -43.31 88.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.893 . . . . 0.0 109.653 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.33 -39.59 94.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.262 -0.899 . . . . 0.0 109.512 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.0 p -88.98 4.94 46.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.461 -0.774 . . . . 0.0 109.62 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.404 179.548 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.438 ' OD1' ' OE1' ' A' ' 5' ' ' GLN . 28.7 p30 -152.77 -179.03 7.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.22 -0.925 . . . . 0.0 109.536 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.472 ' NH2' ' O ' ' A' ' 27' ' ' ASP . 12.6 ptm180 -61.53 -33.0 73.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.456 -0.778 . . . . 0.0 109.369 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.547 HE22 ' CG ' ' A' ' 8' ' ' ASP . 4.5 tm0? -61.36 -44.12 97.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 110.001 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.438 ' OE1' ' OD1' ' A' ' 2' ' ' ASN . 4.3 mp0 -64.44 -38.42 90.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 108.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -60.2 -45.12 94.25 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.309 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 7' ' ' ILE . 96.6 mt -63.74 -44.83 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.3 -0.875 . . . . 0.0 109.547 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.547 ' CG ' HE22 ' A' ' 4' ' ' GLN . 54.4 m-20 -64.73 -46.11 83.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 108.727 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -63.48 -39.91 95.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.383 -0.823 . . . . 0.0 109.093 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.09 -43.56 70.47 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.461 -0.774 . . . . 0.0 109.679 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 86.0 mt-30 -67.21 -40.63 86.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.156 -0.965 . . . . 0.0 109.651 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -63.4 -38.17 90.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.852 -1.155 . . . . 0.0 109.265 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -86.76 -35.84 18.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 111.691 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -118.74 -20.8 8.12 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.134 -0.978 . . . . 0.0 111.032 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 44.2 t0 59.0 38.66 24.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.949 -1.094 . . . . 0.0 109.118 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -107.07 135.79 48.03 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.558 -0.714 . . . . 0.0 109.334 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -82.15 131.21 57.06 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.837 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.52 143.11 22.04 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.17 1.914 . . . . 0.0 112.982 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -127.72 121.89 31.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.634 -0.666 . . . . 0.0 109.276 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.624 ' HD1' ' H ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -119.62 86.83 35.64 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.2 -37.13 87.66 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.462 2.108 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.482 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -87.81 83.87 7.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 0.0 109.064 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -54.59 -14.43 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.458 -0.776 . . . . 0.0 109.564 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -76.18 -2.62 32.06 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -141.25 75.63 22.92 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.287 -0.883 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.65 -31.42 91.86 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.723 2.282 . . . . 0.0 111.327 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.472 ' O ' ' NH2' ' A' ' 3' ' ' ARG . 98.9 m-20 -68.22 -16.04 63.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.401 -0.812 . . . . 0.0 109.347 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -92.56 132.16 37.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 0.0 109.213 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.09 141.07 50.12 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.15 133.55 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 109.043 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -107.95 143.81 36.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.56 -0.712 . . . . 0.0 109.217 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -132.85 129.68 38.77 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.34 -0.85 . . . . 0.0 110.051 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -103.28 111.99 24.65 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.0 p -88.21 -16.66 32.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -94.39 -0.73 54.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.183 -0.948 . . . . 0.0 110.337 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 38' ' ' LYS . 20.3 t-20 -115.99 29.8 7.75 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.382 -0.823 . . . . 0.0 109.854 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 67.9 t0 46.68 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.575 -0.703 . . . . 0.0 110.511 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.1 tttt -79.98 136.15 36.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' A' ' 39' ' ' TRP . 7.8 p90 -141.96 141.38 32.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.281 -0.887 . . . . 0.0 110.607 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 39' ' ' TRP . 29.0 m-85 -159.51 119.96 3.1 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.83 105.4 2.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 108.769 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -113.09 125.01 53.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.537 -0.727 . . . . 0.0 109.286 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD22 ' HE ' ' A' ' 3' ' ' ARG . 8.8 tt -123.59 116.71 23.58 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -162.74 167.46 22.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.026 -1.046 . . . . 0.0 109.499 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.523 ' OD2' ' NH2' ' A' ' 58' ' ' ARG . 34.7 p-10 -106.95 116.75 32.47 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.6 pt -118.71 146.65 40.44 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.837 -0.539 . . . . 0.0 110.248 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.27 145.33 11.5 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.104 1.869 . . . . 0.0 112.846 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.44 -21.48 64.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.948 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 54' ' ' ASN . 61.9 mm-40 -70.31 -15.41 62.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.917 -1.114 . . . . 0.0 110.28 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -84.67 -10.99 56.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.982 -1.074 . . . . 0.0 110.605 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 pt -104.53 2.82 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.216 -0.927 . . . . 0.0 109.027 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.69 -5.0 69.53 Favored Glycine 0 N--CA 1.496 2.662 0 O-C-N 121.245 -0.91 . . . . 0.0 110.854 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.6 mt -81.47 138.09 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.912 -1.346 . . . . 0.0 110.235 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.425 ' O ' ' OE2' ' A' ' 49' ' ' GLU . 56.4 m-80 -61.58 -39.34 90.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.603 -0.686 . . . . 0.0 109.397 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -42.59 139.8 2.4 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 36.9 p-10 -103.33 14.0 32.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.973 . . . . 0.0 109.065 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -82.15 143.06 31.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 84.9 mtp180 -72.48 144.28 48.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.51 -0.744 . . . . 0.0 109.99 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.36 162.89 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.495 -0.753 . . . . 0.0 110.003 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -97.37 136.93 37.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.474 -0.766 . . . . 0.0 109.789 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.37 155.59 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.39 -0.819 . . . . 0.0 110.374 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.2 pt -138.32 150.51 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.98 152.38 26.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 110.065 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.1 125.06 17.13 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -84.84 131.06 34.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.94 . . . . 0.0 109.359 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.97 165.31 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.269 -0.894 . . . . 0.0 109.445 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -87.41 157.99 52.36 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 109.086 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.71 -21.03 68.19 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.577 2.185 . . . . 0.0 111.352 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -95.01 -29.39 14.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.063 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.47 -3.47 49.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 109.81 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.1 p -65.08 -36.14 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.058 -1.027 . . . . 0.0 109.591 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.45 99.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.5 m -61.7 -42.7 99.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.27 . . . . 0.0 110.47 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.0 -31.82 23.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.059 -1.026 . . . . 0.0 110.376 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -77.02 -21.87 53.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.114 -0.991 . . . . 0.0 110.401 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -85.61 -2.86 58.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 109.21 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -77.41 151.56 80.78 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.467 ' C ' ' H ' ' A' ' 80' ' ' ILE . 73.7 Cg_endo -72.28 151.64 54.67 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.864 2.376 . . . . 0.0 112.565 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.04 -20.12 2.59 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.467 ' H ' ' C ' ' A' ' 78' ' ' PRO . 72.2 mt -97.43 116.12 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -1.117 . . . . 0.0 108.363 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.446 ' O ' ' OG1' ' A' ' 93' ' ' THR . 18.1 m-85 -123.08 161.22 46.0 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.887 -0.508 . . . . 0.0 110.087 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.61 153.07 69.51 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.006 1.804 . . . . 0.0 111.961 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.33 140.37 33.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 110.585 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -74.77 7.62 2.97 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.473 -0.767 . . . . 0.0 109.125 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.406 ' O ' ' C ' ' A' ' 86' ' ' MET . 51.6 p-80 -157.7 -172.73 4.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 85' ' ' HIS . 79.0 mtm -38.06 158.92 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.457 0.646 . . . . 0.0 111.623 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 m120 72.96 79.96 0.14 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.426 0.631 . . . . 0.0 110.339 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -114.16 -36.3 4.76 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 109.547 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.81 -85.13 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.946 -1.096 . . . . 0.0 111.087 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -67.92 -33.38 74.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 110.677 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -93.93 130.62 39.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.014 . . . . 0.0 110.542 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.0 mm -134.89 143.8 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.437 -0.79 . . . . 0.0 109.021 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 1.1 p -91.51 134.57 34.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.485 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.82 133.82 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.6 tp -91.47 123.74 35.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.688 -0.633 . . . . 0.0 109.897 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.6 mt -87.64 -13.93 41.36 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -94.39 0.21 55.3 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 100' ' ' LEU . . . -89.14 -165.45 41.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.62 9.01 0.36 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 123.225 2.617 . . . . 0.0 111.259 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 3.7 mm? -70.35 124.86 25.2 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.16 161.47 20.8 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.28 89.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.567 -0.961 . . . . 0.0 109.364 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -64.72 -41.7 95.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -65.07 -44.93 87.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -0.806 . . . . 0.0 109.595 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.21 -43.4 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.276 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -58.98 -42.68 90.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -61.34 -44.02 97.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 109.95 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.99 -41.81 97.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.348 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.66 -42.77 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.388 -0.82 . . . . 0.0 109.187 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -55.54 -42.42 74.58 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.203 -0.935 . . . . 0.0 109.09 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -63.36 -40.65 97.85 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.343 -0.848 . . . . 0.0 109.19 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -63.24 -36.86 85.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.434 -0.791 . . . . 0.0 109.325 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -60.54 -47.27 86.92 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.426 -0.796 . . . . 0.0 110.409 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -77.0 -20.59 55.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 0.0 109.856 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.68 -42.01 98.35 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.16 -0.962 . . . . 0.0 109.951 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.487 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 6.2 p -101.21 16.77 24.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.453 -0.779 . . . . 0.0 109.364 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 . . . . . 0 N--CA 1.502 2.154 0 CA-C-O 121.726 0.774 . . . . 0.0 110.844 -179.222 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.317 0.579 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.72 165.34 12.35 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.301 -0.874 . . . . 0.0 110.189 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.63 -43.83 97.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.464 -0.773 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.528 HE22 ' CG ' ' A' ' 8' ' ' ASP . 9.6 tm0? -62.65 -39.47 93.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 109.909 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -63.34 -37.5 87.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.94 . . . . 0.0 109.545 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.52 -44.31 96.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.441 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.46 -45.06 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.158 -0.963 . . . . 0.0 109.43 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.528 ' CG ' HE22 ' A' ' 4' ' ' GLN . 95.8 m-20 -61.82 -44.29 97.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.968 . . . . 0.0 109.64 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.518 ' CD1' ' NE2' ' A' ' 106' ' ' HIS . 80.3 t80 -61.66 -47.18 86.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.837 . . . . 0.0 109.668 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.62 87.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 109.868 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.543 ' O ' ' N ' ' A' ' 15' ' ' ASP . 7.2 tp-100 -64.34 -48.59 74.97 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.453 -0.78 . . . . 0.0 109.932 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -65.44 -35.18 80.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.997 -1.064 . . . . 0.0 109.674 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -82.08 -35.8 28.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.349 -0.844 . . . . 0.0 111.737 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CG ' ' NE2' ' A' ' 33' ' ' HIS . 78.1 m-85 -124.2 -20.71 5.19 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.033 -1.042 . . . . 0.0 110.998 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 11' ' ' GLN . 56.2 t0 56.92 36.31 27.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 109.026 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -108.4 148.64 29.84 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.54 -0.725 . . . . 0.0 109.371 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.435 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 13.0 mptt -91.84 153.15 43.61 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.201 -0.937 . . . . 0.0 109.298 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.0 154.78 73.52 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.474 2.116 . . . . 0.0 111.66 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -139.72 142.05 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 109.118 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -127.54 86.14 59.2 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -55.56 -36.75 95.08 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.273 1.982 . . . . 0.0 110.708 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -81.24 106.31 13.12 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.466 0.65 . . . . 0.0 109.53 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -66.42 -21.26 66.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.417 -0.802 . . . . 0.0 109.613 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -78.6 -3.88 46.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.316 -0.865 . . . . 0.0 109.49 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -137.74 66.46 48.95 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.35 -19.25 49.92 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.301 2.001 . . . . 0.0 111.616 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -81.19 -5.79 58.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -90.18 147.58 23.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.24 -0.912 . . . . 0.0 109.215 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.03 131.65 53.58 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.53 -0.731 . . . . 0.0 109.363 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.78 132.04 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -111.97 137.53 49.85 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.356 -0.84 . . . . 0.0 109.488 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.456 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . 13.3 ptp180 -139.44 132.23 29.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.203 -0.936 . . . . 0.0 109.33 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.592 ' NE2' ' CG ' ' A' ' 14' ' ' TYR . 70.2 m80 -100.76 110.16 22.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.294 -0.879 . . . . 0.0 109.363 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -78.4 -12.29 60.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.83 -1.66 58.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 110.02 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' LYS . 33.8 m120 -119.79 19.57 12.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.506 -0.747 . . . . 0.0 109.217 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.403 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 67.0 t0 56.82 -76.84 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.814 -0.554 . . . . 0.0 109.879 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 54.0 mtmt -83.81 152.71 24.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.88 . . . . 0.0 109.958 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 39' ' ' TRP . 8.1 p90 -168.19 140.23 2.92 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.264 -0.897 . . . . 0.0 109.587 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -150.86 121.46 7.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.996 -1.065 . . . . 0.0 108.582 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.54 104.86 2.59 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.47 116.19 28.46 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tt -120.15 126.45 50.72 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -157.9 150.96 23.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.143 -0.973 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -97.75 117.21 31.55 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 23.3 pt -125.01 147.01 55.45 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.388 -0.82 . . . . 0.0 110.295 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -48.37 144.12 13.99 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.873 1.715 . . . . 0.0 112.262 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.84 -22.73 67.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -0.837 . . . . 0.0 110.258 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.99 -13.5 61.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.022 . . . . 0.0 109.94 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -84.61 -10.66 57.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.148 -0.97 . . . . 0.0 110.677 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.456 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 8.5 pt -104.89 5.17 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.101 -0.999 . . . . 0.0 109.56 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 -7.42 60.64 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 121.186 -0.946 . . . . 0.0 111.018 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.2 mt -79.04 142.05 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.874 -1.369 . . . . 0.0 110.448 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.88 -39.95 93.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 110.048 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.75 142.82 45.58 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.039 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -101.94 7.49 41.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.557 -0.966 . . . . 0.0 108.709 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -63.52 139.75 58.8 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 110.303 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -69.53 136.34 51.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.585 -0.697 . . . . 0.0 110.274 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.07 161.27 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.522 -0.736 . . . . 0.0 109.313 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -101.55 133.23 46.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 0.0 109.806 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 m -132.59 157.91 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.446 -0.783 . . . . 0.0 110.111 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 pt -136.66 153.4 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -118.45 126.98 53.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.451 -0.781 . . . . 0.0 109.656 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.4 160.31 30.83 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.851 0.834 . . . . 0.0 109.259 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -84.09 136.51 33.98 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.844 -0.535 . . . . 0.0 109.803 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 m -133.23 163.72 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -73.78 145.49 84.31 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.044 -1.035 . . . . 0.0 109.814 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -49.24 -30.23 18.95 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.268 1.979 . . . . 0.0 111.966 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -85.32 -28.0 25.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.416 -0.802 . . . . 0.0 110.238 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.58 0.94 55.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.108 -0.995 . . . . 0.0 109.968 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.45 -43.7 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.919 -1.113 . . . . 0.0 109.281 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.18 -48.46 64.55 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 t -61.33 -49.55 76.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.167 -1.196 . . . . 0.0 110.693 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.24 -42.7 83.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.813 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -75.29 -7.38 53.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.391 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -28.61 16.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -61.79 149.72 84.33 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.402 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.77 146.02 95.01 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 122.215 1.943 . . . . 0.0 113.058 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.06 -28.92 5.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 2.7 mp -83.65 128.41 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -1.215 . . . . 0.0 109.402 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 49.3 m-85 -124.07 153.03 67.86 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.801 -0.562 . . . . 0.0 109.773 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' O ' ' OG1' ' A' ' 93' ' ' THR . 53.9 Cg_exo -45.15 159.52 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.115 1.876 . . . . 0.0 112.089 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.72 144.05 56.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.144 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 88.0 t80 -89.28 4.27 49.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.805 . . . . 0.0 109.246 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.653 ' CG ' ' H ' ' A' ' 86' ' ' MET . 81.8 t60 -105.7 177.91 4.71 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.45 -0.781 . . . . 0.0 110.265 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.653 ' H ' ' CG ' ' A' ' 85' ' ' HIS . 91.7 mtp -64.69 -39.71 94.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.55 -0.719 . . . . 0.0 110.143 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -74.99 130.65 39.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.202 -0.936 . . . . 0.0 110.519 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -146.55 96.23 2.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -178.77 -43.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -111.9 -23.9 10.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 109.378 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -111.76 132.91 54.33 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.43 -0.794 . . . . 0.0 109.495 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -137.06 147.56 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.218 -0.926 . . . . 0.0 109.006 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 82' ' ' PRO . 3.2 p -87.49 147.6 25.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.602 -0.686 . . . . 0.0 110.051 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.43 134.72 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.4 tp -87.04 112.44 21.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 0.0 110.104 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.93 -38.68 83.19 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.44 -0.788 . . . . 0.0 108.996 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -73.81 -0.1 14.81 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.35 171.56 19.24 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.79 -16.03 33.23 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 123.365 2.71 . . . . 0.0 111.972 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.22 138.7 58.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.95 169.29 54.98 Favored Glycine 0 N--CA 1.493 2.439 0 CA-C-O 122.079 0.822 . . . . 0.0 111.222 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.63 -36.11 83.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.691 -0.887 . . . . 0.0 109.716 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -61.44 -38.75 88.29 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.356 -0.84 . . . . 0.0 108.986 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.09 -37.66 88.22 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.432 -0.792 . . . . 0.0 109.431 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.94 -43.87 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.968 . . . . 0.0 109.527 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.518 ' NE2' ' CD1' ' A' ' 9' ' ' TYR . 48.4 m170 -61.47 -42.76 99.27 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.153 -0.967 . . . . 0.0 109.659 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.567 ' HG ' ' N ' ' A' ' 108' ' ' LEU . 78.3 p -62.21 -44.66 96.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.7 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.567 ' N ' ' HG ' ' A' ' 107' ' ' SER . 94.4 mt -64.66 -44.05 91.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.706 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.39 -42.83 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.309 -0.869 . . . . 0.0 109.476 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -53.9 -41.33 67.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.273 -0.892 . . . . 0.0 109.137 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.97 -44.74 96.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.5 m -60.64 -37.54 81.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.57 -43.4 97.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.221 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -51.45 -40.05 58.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 110.049 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 115' ' ' LEU . 9.0 mp -63.49 -40.06 96.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.878 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 117' ' ' ARG . 5.6 p -92.19 6.53 46.3 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -0.964 . . . . 0.0 109.538 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 116' ' ' THR . 53.3 ptt85 . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.566 0.698 . . . . 0.0 110.922 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 ttm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -100.23 161.66 13.46 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.26 -0.9 . . . . 0.0 110.221 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -61.54 -42.99 99.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.771 . . . . 0.0 109.689 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -61.38 -39.22 89.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.791 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.46 -37.08 85.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.456 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -60.7 -44.23 96.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.72 -46.45 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.261 -0.899 . . . . 0.0 109.653 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.41 -41.34 98.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -60.64 -49.9 75.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 109.446 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.38 80.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 15' ' ' ASP . 35.3 tt0 -62.83 -50.39 71.15 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.271 -0.893 . . . . 0.0 109.979 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.48 -40.49 97.25 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.628 -1.295 . . . . 0.0 109.132 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -70.33 -46.42 64.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.864 . . . . 0.0 112.129 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CE1' ' CE1' ' A' ' 33' ' ' HIS . 86.4 m-85 -120.43 -17.97 8.02 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.026 -1.046 . . . . 0.0 111.547 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 11' ' ' GLN . 30.1 t0 60.94 42.38 12.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.927 -1.108 . . . . 0.0 109.457 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.4 t -108.41 136.4 48.11 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -92.9 157.34 39.53 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.094 -1.004 . . . . 0.0 109.779 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.88 143.7 90.64 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.761 1.641 . . . . 0.0 112.775 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -132.28 135.67 46.4 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -133.72 85.1 42.81 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.184 -0.948 . . . . 0.0 109.376 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.77 -34.94 97.51 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.499 2.133 . . . . 0.0 111.394 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -85.87 110.88 19.71 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.572 -0.705 . . . . 0.0 109.625 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -68.56 -31.09 70.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.838 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -67.2 -4.35 10.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.923 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -133.33 70.49 77.16 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.433 -0.792 . . . . 0.0 108.939 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.68 -16.34 33.68 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.229 1.952 . . . . 0.0 111.883 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 22.7 p-10 -88.68 0.27 56.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.336 -0.853 . . . . 0.0 109.258 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.0 m-85 -92.71 139.19 30.81 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.197 -0.939 . . . . 0.0 109.186 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.46 114.92 21.36 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.75 128.28 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.419 -0.801 . . . . 0.0 109.012 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -111.47 134.19 53.22 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.66 -0.65 . . . . 0.0 109.262 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -145.19 150.67 37.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.235 -0.916 . . . . 0.0 109.291 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 14' ' ' TYR . 64.1 m170 -100.08 160.99 13.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.339 -0.851 . . . . 0.0 109.926 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.3 t -102.91 -50.91 3.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.226 -0.921 . . . . 0.0 110.132 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -96.86 -0.82 47.2 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.097 -1.002 . . . . 0.0 110.83 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -104.99 31.82 4.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.162 -0.961 . . . . 0.0 109.129 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 38' ' ' LYS . 98.9 m-20 59.38 40.05 21.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.972 -0.455 . . . . 0.0 110.066 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 37' ' ' ASP . 6.3 ptpp? 31.23 76.22 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.676 0.75 . . . . 0.0 110.958 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -170.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.635 -0.666 . . . . 0.0 109.909 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CE2' ' OD2' ' A' ' 63' ' ' ASP . 63.0 t80 -115.04 122.69 46.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.611 -0.681 . . . . 0.0 109.167 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.79 129.99 9.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.503 -0.748 . . . . 0.0 109.209 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.2 tp -140.86 129.05 22.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 109.349 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tt -122.09 125.97 47.38 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.573 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.9 ptt? -159.05 157.35 30.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 59' ' ' VAL . 46.6 t0 -96.19 114.03 25.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.143 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 pt -116.67 144.79 33.97 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.616 -0.678 . . . . 0.0 109.206 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -48.3 143.77 14.37 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.58 1.52 . . . . 0.0 112.412 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.39 -22.08 64.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.394 -0.816 . . . . 0.0 109.458 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.62 -16.83 62.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.132 . . . . 0.0 110.278 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -84.72 -11.67 55.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.003 -1.061 . . . . 0.0 111.092 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.477 ' O ' ' CD2' ' A' ' 81' ' ' TYR . 11.4 pt -100.97 4.96 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 120.953 -1.092 . . . . 0.0 109.398 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.06 -11.07 65.91 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.556 ' C ' ' H ' ' A' ' 55' ' ' GLY . 61.6 mt -81.64 132.56 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.848 -1.383 . . . . 0.0 109.414 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -67.02 13.51 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.571 -0.706 . . . . 0.0 109.944 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -83.97 141.44 20.08 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 32.0 p-10 -101.04 8.9 42.71 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.452 -1.028 . . . . 0.0 109.019 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -84.03 141.39 31.21 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.494 -0.754 . . . . 0.0 109.556 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -72.52 145.44 47.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.867 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.432 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 31.6 m -136.13 161.3 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.486 -0.758 . . . . 0.0 109.721 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.67 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 95.7 m-20 -102.3 139.0 38.5 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.1 153.53 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.397 -0.815 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 pt -137.01 148.31 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.694 -0.629 . . . . 0.0 109.446 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.538 ' OD2' ' CE2' ' A' ' 40' ' ' TYR . 86.5 m-20 -74.61 144.63 43.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.305 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.11 131.92 41.08 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -97.73 130.3 44.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.223 -0.923 . . . . 0.0 109.912 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.11 165.6 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.369 -0.832 . . . . 0.0 110.316 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -70.61 152.9 95.23 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.512 -0.742 . . . . 0.0 109.129 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.57 -22.2 58.69 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.23 1.953 . . . . 0.0 111.353 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -86.47 -30.64 21.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.2 mt -97.38 10.62 39.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.244 -0.91 . . . . 0.0 109.291 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.531 ' O ' ' NH1' ' A' ' 75' ' ' ARG . 5.4 p -60.38 -46.74 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 110.1 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.92 -14.74 81.9 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.907 -1.139 . . . . 0.0 110.416 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 5.0 t -59.34 -55.46 34.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.015 -1.285 . . . . 0.0 110.898 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.595 ' CD1' HH22 ' A' ' 75' ' ' ARG . 1.9 pt? -86.3 -21.57 27.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.874 . . . . 0.0 110.864 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.603 HH21 ' CG2' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -57.77 -42.27 83.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.772 -1.205 . . . . 0.0 111.275 -177.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -79.91 0.43 31.35 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.465 -1.397 . . . . 0.0 110.594 -178.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -83.82 125.34 73.41 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.693 -1.254 . . . . 0.0 109.256 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.42 144.34 18.49 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 121.942 1.761 . . . . 0.0 113.141 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.57 -6.08 67.62 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.603 ' CG2' HH21 ' A' ' 75' ' ' ARG . 96.4 mt -122.47 128.77 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.208 -1.172 . . . . 0.0 109.805 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 31.7 m-85 -120.46 152.6 55.45 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.498 -0.751 . . . . 0.0 109.934 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.83 154.77 67.09 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.471 2.114 . . . . 0.0 111.895 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.81 147.22 53.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.204 -0.935 . . . . 0.0 110.127 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.547 ' C ' ' H ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -98.6 119.47 37.37 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 25.5 t60 66.74 -33.42 0.2 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.628 -0.67 . . . . 0.0 110.736 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.547 ' H ' ' C ' ' A' ' 84' ' ' TYR . 90.4 mmm -84.32 159.55 20.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.076 -1.015 . . . . 0.0 110.598 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 91' ' ' TRP . 57.9 t-20 -40.52 122.05 1.55 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.666 0.746 . . . . 0.0 110.939 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -94.41 -15.05 24.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.644 -0.66 . . . . 0.0 109.734 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.426 ' N ' ' OD1' ' A' ' 87' ' ' ASN . 98.1 mt-10 -80.87 -85.2 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.946 . . . . 0.0 110.66 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -60.6 -44.18 96.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -0.884 . . . . 0.0 110.739 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 91' ' ' TRP . 16.5 m0 -101.56 138.15 38.94 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.49 -0.756 . . . . 0.0 109.684 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 92' ' ' ILE . 9.3 mt -143.51 165.84 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.322 -0.861 . . . . 0.0 109.519 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 81' ' ' TYR . 6.3 p -107.77 138.58 43.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.9 t -121.1 133.97 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.0 tp -90.82 109.64 20.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 109.817 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.8 mt -64.95 -39.21 93.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 66.1 m-80 -74.41 5.76 4.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 109.66 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.85 165.18 15.33 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.52 -16.88 30.51 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.937 2.425 . . . . 0.0 111.293 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -60.22 169.3 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.648 -0.658 . . . . 0.0 110.46 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -99.99 169.13 21.71 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 121.231 -0.918 . . . . 0.0 110.913 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.88 82.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.629 -0.924 . . . . 0.0 109.365 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.497 ' NZ ' ' OE2' ' A' ' 104' ' ' GLU . 22.7 pttp -60.29 -37.05 79.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.329 -0.857 . . . . 0.0 108.973 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' A' ' 103' ' ' LYS . 72.9 mm-40 -65.33 -44.62 87.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.311 -0.868 . . . . 0.0 109.12 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.427 HG23 HD13 ' A' ' 105' ' ' ILE . 91.9 mt -64.05 -43.83 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.0 109.548 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -58.0 -44.29 87.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.273 -0.892 . . . . 0.0 109.911 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.0 p -61.15 -43.39 98.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 0.0 109.689 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.61 -42.05 98.24 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 109.034 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.68 -43.0 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.177 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -51.64 -44.83 63.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.109 -0.994 . . . . 0.0 108.879 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.21 -42.28 98.32 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.158 -0.964 . . . . 0.0 108.573 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 t -62.72 -38.75 91.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.2 -43.33 74.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.259 -0.901 . . . . 0.0 108.973 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -54.5 -31.81 56.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.773 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' A' ' 115' ' ' LEU . 9.0 mp -83.55 -13.48 54.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.084 -1.01 . . . . 0.0 109.974 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.472 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 45.0 p -102.04 13.87 33.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.297 -0.877 . . . . 0.0 109.306 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 110.168 -179.87 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 ttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.284 0.564 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -87.2 159.29 18.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.313 -0.867 . . . . 0.0 110.495 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.27 -42.89 96.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.646 -0.659 . . . . 0.0 109.588 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -59.24 -43.22 92.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.845 . . . . 0.0 109.497 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.86 -32.36 73.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.222 -0.923 . . . . 0.0 109.468 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -60.9 -47.66 85.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.664 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp -64.98 -46.77 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.207 -0.933 . . . . 0.0 109.184 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.75 -43.22 99.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 109.819 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.417 ' CE1' ' CE1' ' A' ' 106' ' ' HIS . 89.8 t80 -64.12 -44.15 93.09 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.868 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.86 -51.49 69.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.625 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 15' ' ' ASP . 3.5 pt20 -70.11 -38.17 75.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.033 -1.042 . . . . 0.0 110.255 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -60.01 -43.45 95.22 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.626 -1.296 . . . . 0.0 109.35 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.453 ' CE ' ' HH ' ' A' ' 14' ' ' TYR . 63.4 tttp -88.2 -32.06 18.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.145 -0.972 . . . . 0.0 111.698 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.525 ' CE1' ' CD1' ' A' ' 113' ' ' PHE . 73.5 m-85 -121.25 -8.56 9.21 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.065 -1.022 . . . . 0.0 111.654 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 11' ' ' GLN . 91.4 m-20 54.97 37.48 28.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 109.54 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.511 ' OG1' ' NE2' ' A' ' 33' ' ' HIS . 96.7 m -79.69 162.2 25.36 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.512 -0.742 . . . . 0.0 109.152 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -123.01 93.12 48.66 Favored Pre-proline 0 N--CA 1.497 1.895 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -56.49 146.5 74.24 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.405 2.07 . . . . 0.0 112.365 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 60.4 t0 -132.15 152.25 51.36 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.636 ' N ' ' HD1' ' A' ' 20' ' ' HIS . 0.8 OUTLIER -118.93 86.26 30.73 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 0.0 109.497 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.78 -36.84 83.73 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.235 1.956 . . . . 0.0 111.469 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -87.4 126.99 35.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.575 -0.703 . . . . 0.0 109.357 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -87.51 -28.84 21.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.371 -0.83 . . . . 0.0 109.715 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -81.84 -7.56 59.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.326 -0.859 . . . . 0.0 110.0 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -123.57 75.35 54.38 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.449 -0.782 . . . . 0.0 109.518 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.86 -17.66 41.63 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.985 1.79 . . . . 0.0 111.634 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -80.64 -5.04 56.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.472 -0.768 . . . . 0.0 109.573 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -100.39 135.09 42.36 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.414 -0.804 . . . . 0.0 109.333 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.91 147.54 44.47 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.16 129.47 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.47 -0.769 . . . . 0.0 109.394 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 43.6 m-85 -108.45 109.92 21.31 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -142.21 146.15 34.89 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.145 -0.972 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.511 ' NE2' ' OG1' ' A' ' 16' ' ' THR . 63.8 m170 -99.86 113.56 26.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.521 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.3 p -69.79 -17.89 63.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.307 -0.87 . . . . 0.0 109.585 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -62.74 -44.12 97.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.826 . . . . 0.0 109.808 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 38' ' ' LYS . 56.7 p30 -112.4 -1.49 15.02 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.425 -0.797 . . . . 0.0 109.133 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.4 t0 58.4 0.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.731 . . . . 0.0 109.925 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 36' ' ' ASN . 53.6 mtmt -101.3 -156.91 0.58 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 109.69 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 46.9 t-105 57.15 94.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.644 -0.66 . . . . 0.0 109.491 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.59 125.2 54.02 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.54 143.93 24.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.42 144.01 32.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.193 -0.942 . . . . 0.0 109.014 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.61 127.11 53.63 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -146.63 158.09 43.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.097 -1.002 . . . . 0.0 109.485 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 34.6 p-10 -95.59 115.6 27.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.366 -0.834 . . . . 0.0 109.265 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.2 pt -126.31 145.73 53.71 Favored Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.478 -0.764 . . . . 0.0 109.231 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.67 144.03 99.49 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.075 1.85 . . . . 0.0 112.78 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.82 -20.99 65.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.692 -0.63 . . . . 0.0 109.64 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.76 -36.54 76.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.051 -1.03 . . . . 0.0 110.465 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 52' ' ' GLY . 97.2 mttt -63.74 -43.49 96.33 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.97 -1.081 . . . . 0.0 111.239 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 pt -71.57 15.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.958 -1.089 . . . . 0.0 110.145 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . 80.75 -7.49 58.57 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.088 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.603 ' C ' ' H ' ' A' ' 55' ' ' GLY . 71.0 mt -79.4 133.06 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.775 -1.427 . . . . 0.0 109.335 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -68.91 26.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.374 -0.829 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -91.97 132.8 11.44 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 32.2 p-10 -101.79 8.86 41.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.333 -1.098 . . . . 0.0 108.962 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -83.89 154.92 23.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.388 -0.82 . . . . 0.0 109.767 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -82.28 130.38 35.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 108.667 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.401 ' HA ' HD21 ' A' ' 97' ' ' ASN . 16.3 m -125.79 143.61 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.535 -0.728 . . . . 0.0 109.615 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -89.57 141.62 28.42 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.265 -0.897 . . . . 0.0 109.927 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.8 158.96 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.416 -0.802 . . . . 0.0 109.468 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 pt -134.24 151.38 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -112.16 140.35 46.93 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.471 -0.768 . . . . 0.0 110.126 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.33 157.22 46.68 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.656 -0.653 . . . . 0.0 109.362 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -92.73 139.92 30.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 0.0 110.867 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 m -141.39 164.68 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.41 -0.806 . . . . 0.0 109.547 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -74.78 156.74 86.39 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.527 -0.733 . . . . 0.0 109.628 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.47 -23.39 64.77 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.327 2.018 . . . . 0.0 111.207 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -86.57 -25.8 24.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.38 -0.825 . . . . 0.0 109.429 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.22 5.67 49.69 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.21 -0.931 . . . . 0.0 109.38 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -63.28 -39.93 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.47 -15.42 81.44 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -68.17 -55.96 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.123 -1.222 . . . . 0.0 110.753 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 75' ' ' ARG . 2.0 pt? -86.48 -25.26 25.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.962 -1.086 . . . . 0.0 110.614 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.413 ' H ' HD23 ' A' ' 74' ' ' LEU . 78.6 ttt-85 -71.08 -21.63 62.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.947 -1.096 . . . . 0.0 109.627 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.22 -6.68 57.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 108.727 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -84.54 152.65 60.78 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.1 148.45 69.34 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.957 2.438 . . . . 0.0 113.19 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.47 -23.69 11.81 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 80' ' ' ILE . 98.2 mt -96.02 121.14 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -1.189 . . . . 0.0 110.066 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -117.56 157.28 48.05 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.793 -0.567 . . . . 0.0 109.979 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.34 152.55 66.18 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.848 1.698 . . . . 0.0 112.36 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.87 151.37 39.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.399 -0.813 . . . . 0.0 109.962 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -90.48 1.24 56.86 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.344 -0.847 . . . . 0.0 109.259 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.17 -174.02 2.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.405 -0.809 . . . . 0.0 110.047 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.4 ttm -63.82 -39.39 94.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.714 . . . . 0.0 110.148 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -67.9 153.55 43.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.532 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -148.59 -54.97 0.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.75 -17.6 59.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.364 -0.835 . . . . 0.0 109.257 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.41 ' CD2' ' N ' ' A' ' 90' ' ' HIS . 4.0 m170 -82.13 -62.84 1.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.949 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -109.79 148.08 32.1 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.658 -0.651 . . . . 0.0 109.903 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 mm -130.9 137.25 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.1 m -87.19 131.03 34.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.671 -0.643 . . . . 0.0 110.147 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.6 t -113.22 134.81 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.1 tp -89.22 108.73 19.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.941 . . . . 0.0 110.273 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.64 -41.06 96.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.401 HD21 ' HA ' ' A' ' 59' ' ' VAL . 97.0 m-20 -84.51 20.22 1.76 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 109.009 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.78 -176.43 39.76 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.26 -37.24 94.55 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.047 2.498 . . . . 0.0 112.774 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -57.97 138.22 56.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 0.0 110.418 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.92 -174.15 39.45 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.94 92.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.683 -0.892 . . . . 0.0 109.882 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -62.79 -40.93 98.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.27 -40.21 96.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.507 -0.746 . . . . 0.0 109.775 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.41 -43.61 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.771 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.417 ' CE1' ' CE1' ' A' ' 9' ' ' TYR . 55.9 m170 -59.59 -47.3 86.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.756 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.3 m -62.35 -43.93 97.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.957 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.31 -44.96 93.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.39 -0.819 . . . . 0.0 109.732 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.5 mt -65.32 -43.02 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -0.842 . . . . 0.0 109.337 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -52.2 -43.68 64.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.025 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -61.95 -44.18 97.3 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 109.273 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.0 p -67.34 -39.24 85.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.79 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 87.6 t80 -61.62 -45.52 93.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.911 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.24 -42.07 69.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.371 -0.83 . . . . 0.0 109.578 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.56 -39.83 92.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.378 -0.826 . . . . 0.0 110.113 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 p -99.99 14.54 30.2 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.157 -0.964 . . . . 0.0 109.835 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 113' ' ' PHE . 35.7 ptt180 . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 110.092 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.7 ttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.603 0.716 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -102.14 163.22 12.36 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.733 0.777 . . . . 0.0 110.183 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -61.29 -43.82 98.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.586 0.708 . . . . 0.0 109.6 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -58.89 -40.06 83.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.779 . . . . 0.0 109.842 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.14 -37.6 88.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.441 -0.787 . . . . 0.0 109.817 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -60.94 -43.8 98.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.317 -0.864 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.42 -44.26 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -0.783 . . . . 0.0 109.474 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.76 -44.32 96.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.634 ' CE1' ' CD2' ' A' ' 106' ' ' HIS . 63.9 t80 -63.46 -48.58 77.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.443 -0.786 . . . . 0.0 109.696 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.2 85.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.492 -0.755 . . . . 0.0 109.811 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 15' ' ' ASP . 40.6 tp60 -68.53 -49.91 56.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.824 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.84 -31.67 73.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.957 -1.089 . . . . 0.0 109.087 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.521 ' NZ ' ' CZ ' ' A' ' 14' ' ' TYR . 65.8 tttm -83.44 -38.36 21.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 111.74 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.621 ' CD1' ' NE2' ' A' ' 33' ' ' HIS . 74.9 m-85 -116.63 -21.41 9.14 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.824 -1.173 . . . . 0.0 111.148 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 49.7 t0 62.8 36.79 12.83 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.27 -0.894 . . . . 0.0 109.466 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.513 ' C ' HE22 ' A' ' 11' ' ' GLN . 14.5 t -114.88 134.75 54.89 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.593 0.711 . . . . 0.0 109.707 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -84.69 151.66 58.7 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.613 -0.679 . . . . 0.0 109.332 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.54 146.44 79.69 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.786 2.324 . . . . 0.0 112.477 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -115.38 155.17 27.87 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.693 0.759 . . . . 0.0 109.3 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -143.41 88.2 8.1 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 -15.28 21.12 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.339 2.026 . . . . 0.0 110.617 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -100.72 110.5 22.61 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.498 0.666 . . . . 0.0 109.335 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -68.32 -33.61 74.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.797 0.808 . . . . 0.0 109.186 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -67.76 -2.41 7.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.404 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -143.68 74.72 16.63 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.296 -0.878 . . . . 0.0 109.372 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.86 -15.8 29.63 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.605 2.203 . . . . 0.0 111.301 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -86.46 -4.96 59.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.494 -0.754 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -84.57 142.38 30.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.373 -0.829 . . . . 0.0 109.611 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.07 140.77 50.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.589 -0.694 . . . . 0.0 109.69 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.78 132.66 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -109.07 136.47 48.52 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.394 0.616 . . . . 0.0 109.699 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -156.12 149.23 24.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.342 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.621 ' NE2' ' CD1' ' A' ' 14' ' ' TYR . 80.3 m80 -100.75 128.95 46.6 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.611 0.719 . . . . 0.0 109.443 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.4 p -75.92 -6.89 53.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.471 -0.768 . . . . 0.0 109.518 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -94.33 -9.84 34.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.262 -0.899 . . . . 0.0 109.815 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -109.78 -30.23 7.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.147 -0.971 . . . . 0.0 108.783 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.8 t0 54.18 28.04 8.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.468 -0.77 . . . . 0.0 109.699 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 50.8 tptt -170.11 112.03 0.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.143 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.614 ' CD2' ' N ' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -173.22 -174.48 1.05 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.207 1.003 . . . . 0.0 109.75 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.432 ' CE2' ' CD2' ' A' ' 42' ' ' LEU . 9.7 t80 -160.18 118.93 2.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.199 -0.938 . . . . 0.0 109.137 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.12 121.72 4.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.432 ' CD2' ' CE2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -138.34 149.28 45.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.462 -0.774 . . . . 0.0 109.163 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.426 ' C ' ' CD2' ' A' ' 43' ' ' LEU . 7.4 tt -129.31 122.56 29.81 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.465 ' SD ' ' CG2' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -152.43 162.23 41.48 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.688 0.756 . . . . 0.0 109.928 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 42.5 p-10 -97.25 114.82 26.61 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.289 0.566 . . . . 0.0 109.518 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.7 pt -117.56 146.19 38.01 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.38 143.6 99.66 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.692 2.262 . . . . 0.0 112.495 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.77 -19.89 64.45 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.578 0.704 . . . . 0.0 109.794 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.91 -38.85 87.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.235 -0.915 . . . . 0.0 110.238 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 52' ' ' GLY . 97.0 mttt -63.87 -43.76 95.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.23 -0.918 . . . . 0.0 111.174 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 pt -76.95 12.17 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.036 -1.04 . . . . 0.0 109.834 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . 62.1 31.16 77.83 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.365 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' GLY . 47.9 mt -101.23 128.57 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.111 -1.229 . . . . 0.0 109.737 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -55.93 81.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.644 0.735 . . . . 0.0 110.458 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . -176.98 151.48 11.19 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.71 15.35 18.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.513 -0.992 . . . . 0.0 108.446 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -88.45 155.04 19.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.36 -0.838 . . . . 0.0 110.256 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -86.36 141.83 28.91 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.526 0.679 . . . . 0.0 110.095 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -134.04 153.32 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.548 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -90.47 139.4 30.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.696 -0.628 . . . . 0.0 110.167 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.465 ' CG2' ' SD ' ' A' ' 44' ' ' MET . 33.4 m -137.87 154.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.707 0.765 . . . . 0.0 109.987 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.6 pt -135.2 147.92 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.493 0.663 . . . . 0.0 109.871 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.76 143.37 34.54 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.419 0.628 . . . . 0.0 110.389 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.33 126.91 32.42 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -82.81 135.88 34.83 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.671 0.748 . . . . 0.0 110.569 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.76 158.35 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.597 0.713 . . . . 0.0 109.782 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -89.83 154.45 47.82 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.529 -0.732 . . . . 0.0 109.319 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -45.67 -28.86 4.84 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.252 1.968 . . . . 0.0 111.563 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -91.48 -29.11 17.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 0.0 109.54 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.2 mt -91.53 -8.33 47.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.269 -0.894 . . . . 0.0 109.668 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 72' ' ' GLY . 10.5 p -66.68 -40.01 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.652 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.42 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -62.88 -42.37 99.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.3 t -61.1 -48.76 80.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.353 -1.087 . . . . 0.0 110.073 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.07 -39.1 63.7 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.419 -0.8 . . . . 0.0 110.189 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.582 HH22 ' HZ2' ' A' ' 88' ' ' LYS . 72.9 ttt180 -72.17 -38.99 69.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.554 -0.716 . . . . 0.0 111.308 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -73.73 -5.06 38.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.909 -1.12 . . . . 0.0 110.051 -178.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -78.95 147.67 70.61 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.126 -0.984 . . . . 0.0 109.714 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.95 145.66 56.71 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.473 2.116 . . . . 0.0 112.542 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.31 -20.9 19.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.472 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 3.0 mp -91.83 122.59 43.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.323 -1.104 . . . . 0.0 109.449 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -115.06 154.94 47.17 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.23 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.44 146.81 96.04 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.841 2.361 . . . . 0.0 112.869 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.47 43.83 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.389 -0.819 . . . . 0.0 110.515 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 85' ' ' HIS . 45.7 p90 -96.13 3.86 52.93 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.63 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 71.9 m80 -87.93 -162.83 0.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.461 -0.774 . . . . 0.0 110.294 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' ASN . 42.0 ttp -55.32 160.86 2.08 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.56 0.695 . . . . 0.0 110.71 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 86' ' ' MET . 13.2 p30 42.32 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.864 0.84 . . . . 0.0 110.735 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.582 ' HZ2' HH22 ' A' ' 75' ' ' ARG . 81.9 tttt -151.83 -22.94 0.19 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 109.108 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 57.3 mp0 -96.02 -19.69 19.27 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.162 -0.962 . . . . 0.0 110.027 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -75.0 -69.82 0.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.633 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -110.39 138.81 46.29 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.392 -0.818 . . . . 0.0 110.026 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.5 mm -120.13 157.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 p -98.92 138.44 36.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.504 -0.747 . . . . 0.0 110.006 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.55 134.52 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.4 tp -86.3 105.89 16.98 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.585 0.707 . . . . 0.0 110.097 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.51 -39.67 88.79 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.805 0.812 . . . . 0.0 109.012 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -68.57 -7.55 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.77 -169.04 13.18 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.78 18.83 1.21 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.239 2.626 . . . . 0.0 111.425 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 3.9 mm? -66.06 132.9 49.62 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.95 0.881 . . . . 0.0 110.38 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.74 155.79 22.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.67 79.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.804 -0.821 . . . . 0.0 109.898 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.55 -40.06 92.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.386 -0.821 . . . . 0.0 109.207 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.99 -44.78 96.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.81 -43.4 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.243 -0.91 . . . . 0.0 109.583 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.634 ' CD2' ' CE1' ' A' ' 9' ' ' TYR . 54.2 m170 -58.94 -42.34 89.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 109.849 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -63.99 -42.14 97.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 109.853 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.8 -41.22 95.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.361 -0.837 . . . . 0.0 109.515 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 109' ' ' ILE . 95.1 mt -63.76 -42.88 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.75 -42.34 75.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.202 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.26 -41.03 98.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.23 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.4 t -60.19 -40.08 88.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.827 . . . . 0.0 109.649 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -58.36 -44.18 88.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 109.227 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -57.91 -46.1 85.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.359 -0.838 . . . . 0.0 109.844 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.29 -37.77 88.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 0.0 109.623 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.3 p -88.08 13.19 11.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.157 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.8 0.809 . . . . 0.0 109.022 179.703 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.6 ttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -104.62 155.08 19.16 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.67 -0.643 . . . . 0.0 109.884 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -61.6 -43.54 98.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.571 -0.706 . . . . 0.0 109.73 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -58.09 -41.79 84.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.596 -0.69 . . . . 0.0 110.019 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.36 -35.71 81.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.783 . . . . 0.0 110.122 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -60.16 -45.57 92.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.749 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.65 -45.46 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -62.82 -38.27 90.04 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.593 0.711 . . . . 0.0 109.506 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.587 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 59.9 t80 -69.5 -43.89 72.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 110.141 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.78 75.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.434 -0.791 . . . . 0.0 110.5 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 15' ' ' ASP . 4.8 pt20 -66.53 -30.41 70.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 109.984 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.4 -48.54 80.75 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 0.0 110.225 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.587 ' NZ ' ' CE2' ' A' ' 9' ' ' TYR . 63.3 mttp -90.34 -12.4 37.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.217 -0.927 . . . . 0.0 111.875 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -134.65 -20.38 1.79 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.981 -1.075 . . . . 0.0 111.012 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 11' ' ' GLN . 43.0 t0 58.42 39.45 25.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.119 -0.988 . . . . 0.0 109.263 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.5 m -106.93 127.1 53.14 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -89.34 156.04 48.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.715 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.66 141.3 43.98 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.981 1.787 . . . . 0.0 112.359 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -125.88 121.73 34.04 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 20' ' ' HIS . 25.2 p-80 -125.39 86.17 57.47 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.562 -0.711 . . . . 0.0 109.425 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.86 -32.3 91.62 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.537 2.158 . . . . 0.0 111.201 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -83.45 135.59 34.62 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.589 0.709 . . . . 0.0 110.161 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 1.4 pm0 -89.41 -24.26 21.95 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -78.11 -3.1 40.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.488 -0.757 . . . . 0.0 109.825 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -137.18 66.04 52.1 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.4 -0.812 . . . . 0.0 109.458 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.47 -20.2 36.51 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.433 2.088 . . . . 0.0 111.425 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -81.94 -5.61 58.44 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.53 -0.731 . . . . 0.0 109.063 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -90.96 140.35 29.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.497 -0.752 . . . . 0.0 109.117 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.72 121.52 34.87 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -109.44 125.49 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -108.76 116.55 32.19 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -145.07 135.31 24.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.092 -1.005 . . . . 0.0 109.285 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -99.95 115.0 28.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.486 -0.759 . . . . 0.0 109.716 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 m -63.69 -35.78 81.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.605 -0.684 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -71.68 -5.37 33.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.961 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 38' ' ' LYS . 10.7 t-20 -113.74 -30.8 6.66 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 42.66 18.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.766 -0.584 . . . . 0.0 109.96 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 36' ' ' ASN . 63.6 tttp -136.53 -19.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 39' ' ' TRP . 18.1 t-105 -78.01 117.99 19.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.491 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -115.26 125.72 53.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.614 -0.679 . . . . 0.0 109.274 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.42 129.01 11.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 108.739 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.3 tp -132.29 123.68 27.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.511 -0.743 . . . . 0.0 109.112 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.58 124.66 49.2 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -153.95 161.38 42.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 109.212 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 38.1 p-10 -98.05 114.53 26.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.267 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.9 pt -124.54 145.97 50.93 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.548 -0.72 . . . . 0.0 109.193 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.1 143.87 99.05 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.026 1.817 . . . . 0.0 112.573 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.81 -20.98 66.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.754 -0.591 . . . . 0.0 109.909 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.5 -35.51 74.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.993 . . . . 0.0 110.165 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -64.69 -41.85 95.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 0.0 110.94 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 pt -81.82 20.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 109.893 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.22 -4.89 53.29 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.282 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 79.4 mt -78.92 134.03 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.939 -1.33 . . . . 0.0 110.075 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 55' ' ' GLY . 92.6 m-20 -61.38 -39.35 90.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.74 -0.6 . . . . 0.0 110.101 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 54' ' ' ASN . . . -37.06 109.48 0.08 OUTLIER Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -80.81 4.35 19.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.517 -0.99 . . . . 0.0 109.007 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -84.12 161.55 20.59 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.654 0.74 . . . . 0.0 110.148 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.01 146.91 33.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.65 -0.656 . . . . 0.0 110.186 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 m -135.26 159.6 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.493 -0.754 . . . . 0.0 109.543 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.686 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 45.1 m-20 -102.05 135.77 43.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.362 -0.836 . . . . 0.0 109.681 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.45 155.94 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.395 -0.816 . . . . 0.0 110.057 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 62' ' ' ILE . 25.2 pt -133.83 146.71 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -84.39 142.56 30.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.842 . . . . 0.0 109.825 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.71 121.67 18.85 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -84.98 136.71 33.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 110.115 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 m -142.52 165.93 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.253 -0.904 . . . . 0.0 109.88 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -78.01 149.25 76.48 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 0.0 109.669 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.2 -39.31 52.14 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.963 1.776 . . . . 0.0 111.639 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.7 -33.79 71.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.726 -0.609 . . . . 0.0 110.037 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -84.67 2.66 40.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 0.0 109.837 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 72' ' ' GLY . 8.0 p -64.34 -42.56 95.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.434 ' N ' ' CG1' ' A' ' 71' ' ' VAL . . . -69.92 -40.22 74.28 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -62.36 -32.31 73.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.471 -1.017 . . . . 0.0 109.348 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 tt -84.85 -35.86 21.96 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.48 -0.762 . . . . 0.0 109.871 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.451 ' NH2' ' HZ2' ' A' ' 88' ' ' LYS . 75.4 mtp180 -73.49 -8.16 54.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 110.003 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -2.96 58.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.193 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -96.21 111.43 56.49 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.602 -0.686 . . . . 0.0 109.337 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.15 143.14 42.98 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.061 1.841 . . . . 0.0 113.551 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -19.97 52.02 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.2 mt -100.76 121.24 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.321 -1.105 . . . . 0.0 109.299 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.446 ' O ' ' OG1' ' A' ' 93' ' ' THR . 55.7 m-85 -108.78 151.07 41.58 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.468 -0.77 . . . . 0.0 109.765 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.56 163.66 37.29 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.466 2.11 . . . . 0.0 112.512 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -47.5 148.81 1.29 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.565 -0.71 . . . . 0.0 110.302 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -63.07 -43.86 97.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.613 -0.679 . . . . 0.0 109.882 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -160.13 -26.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 109.223 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.446 ' CG ' ' H ' ' A' ' 87' ' ' ASN . 5.8 tpt -61.61 -140.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.51 -0.744 . . . . 0.0 110.42 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.497 ' CG ' ' HD1' ' A' ' 90' ' ' HIS . 82.7 m-20 -72.75 131.3 42.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.631 -0.668 . . . . 0.0 110.009 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HZ2' ' NH2' ' A' ' 75' ' ' ARG . 88.7 tttt -94.53 -21.93 18.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.502 -0.749 . . . . 0.0 109.788 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -100.98 -43.49 6.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.477 -0.764 . . . . 0.0 109.678 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.497 ' HD1' ' CG ' ' A' ' 87' ' ' ASN . 3.4 m170 -63.21 -67.18 0.45 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 110.421 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -111.39 148.48 32.95 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.628 -0.67 . . . . 0.0 109.713 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mm -132.75 161.77 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 38.3 p -107.07 133.02 52.32 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.8 t -118.11 133.77 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.5 tp -90.75 108.45 19.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.508 -0.745 . . . . 0.0 109.957 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.58 -40.22 92.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.589 -0.694 . . . . 0.0 109.542 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.686 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 75.8 m-20 -78.32 6.2 8.82 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.475 -0.766 . . . . 0.0 109.164 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.83 178.84 53.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 100' ' ' LEU . 47.2 Cg_endo -68.02 -79.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.85 2.367 . . . . 0.0 112.079 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.495 ' C ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 22.92 -122.03 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.221 0.534 . . . . 0.0 111.085 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.412 ' H ' ' CG ' ' A' ' 100' ' ' LEU . . . 174.9 159.63 21.48 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.202 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.56 -37.23 86.84 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.64 -0.918 . . . . 0.0 109.489 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.68 -40.06 95.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.581 -0.699 . . . . 0.0 109.401 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.17 -42.72 99.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.537 -0.727 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.23 -43.24 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 109.638 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -56.33 -44.13 79.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.47 -0.769 . . . . 0.0 109.494 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 t -61.9 -43.96 97.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.577 -0.702 . . . . 0.0 109.621 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.3 -40.95 98.78 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.482 -0.761 . . . . 0.0 109.363 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.37 -43.18 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.49 -0.756 . . . . 0.0 109.24 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -60.42 -39.3 86.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.258 -0.902 . . . . 0.0 108.855 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.44 -41.14 98.52 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.8 t -62.73 -40.43 97.2 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.21 -44.5 83.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.545 -0.722 . . . . 0.0 109.209 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.83 -29.15 70.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.418 -0.801 . . . . 0.0 109.537 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.9 mt -86.1 -18.14 33.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.263 -0.898 . . . . 0.0 110.025 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.0 p -102.88 15.02 30.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.385 -0.822 . . . . 0.0 109.224 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 110.209 -179.766 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpp . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.474 0.654 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -95.23 162.33 13.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.356 -0.84 . . . . 0.0 110.489 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -61.52 -42.72 99.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 109.847 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -60.88 -39.04 87.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 109.756 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -63.59 -36.63 84.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.814 . . . . 0.0 109.059 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 56.5 t80 -60.98 -43.76 98.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 108.919 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.1 mm -61.1 -48.48 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.485 -0.76 . . . . 0.0 109.822 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -65.52 -41.47 93.1 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 109.452 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.508 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 47.3 t80 -61.54 -47.61 84.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -0.775 . . . . 0.0 109.849 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.66 -46.18 90.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.157 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ASP . 86.2 mt-30 -63.64 -32.28 73.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 110.465 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.39 -47.91 77.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.99 -1.069 . . . . 0.0 109.729 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.508 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 98.5 mttt -90.03 -12.21 39.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.302 -0.873 . . . . 0.0 111.844 -178.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 15' ' ' ASP . 97.7 m-85 -132.93 -18.04 2.39 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.839 -1.163 . . . . 0.0 110.915 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' GLN . 4.4 p-10 43.85 31.92 0.54 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.365 -0.834 . . . . 0.0 109.418 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.0 m -102.37 136.96 41.27 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.657 0.741 . . . . 0.0 110.069 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -83.04 148.79 57.57 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.58 -0.7 . . . . 0.0 109.275 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.2 145.39 72.45 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.403 2.069 . . . . 0.0 112.129 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -121.91 143.44 49.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.617 -0.677 . . . . 0.0 109.485 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.569 ' CD2' ' H ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER -122.18 86.44 47.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.62 -40.68 82.97 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.269 1.979 . . . . 0.0 111.068 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -90.3 136.54 32.99 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.61 0.719 . . . . 0.0 109.811 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -86.98 -22.02 25.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.62 -0.675 . . . . 0.0 109.516 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -75.85 -5.13 44.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.411 -0.806 . . . . 0.0 109.03 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -136.33 72.82 58.16 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.536 -0.728 . . . . 0.0 109.114 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.37 -12.08 24.99 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.499 2.133 . . . . 0.0 111.055 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 17.7 p-10 -87.53 -1.9 58.25 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.521 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.2 m-85 -87.15 142.09 28.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.511 -0.743 . . . . 0.0 109.892 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.93 129.18 47.66 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -132.03 131.14 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.532 -0.73 . . . . 0.0 109.888 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -109.4 139.08 44.81 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.496 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . 11.9 ptp180 -142.93 130.51 21.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.141 -0.974 . . . . 0.0 109.853 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -102.87 110.21 22.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.552 -0.718 . . . . 0.0 109.129 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.6 p -70.94 -16.31 62.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -0.812 . . . . 0.0 110.065 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -89.05 -5.14 58.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.124 -0.985 . . . . 0.0 109.644 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 38' ' ' LYS . 9.1 t-20 -107.45 -4.36 18.57 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.496 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 66.7 t0 59.35 -68.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.357 0.599 . . . . 0.0 110.231 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 36' ' ' ASN . 33.5 pttt -88.12 87.15 7.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.382 -0.824 . . . . 0.0 108.924 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.509 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 24.5 p90 -113.83 143.59 44.41 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.403 0.621 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.509 ' CG ' ' O ' ' A' ' 39' ' ' TRP . 99.4 m-85 -156.68 120.85 4.39 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.94 105.33 2.36 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.21 131.57 55.02 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.425 0.631 . . . . 0.0 109.694 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' CD1' ' CD2' ' A' ' 6' ' ' PHE . 7.8 tt -135.41 119.71 17.85 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.521 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.2 ptt? -162.5 163.29 27.56 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.082 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 33.0 p-10 -102.97 118.37 36.66 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.9 146.19 52.47 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.717 -0.614 . . . . 0.0 109.933 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -46.36 141.37 10.39 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.36 2.04 . . . . 0.0 112.765 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.45 -24.16 67.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.62 -0.675 . . . . 0.0 109.915 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.58 -29.29 69.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -0.863 . . . . 0.0 109.785 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -64.47 -35.63 81.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.244 -0.91 . . . . 0.0 110.379 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 pt -85.15 2.47 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.907 -1.12 . . . . 0.0 109.6 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.84 -7.43 62.94 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.27 126.61 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.775 -1.426 . . . . 0.0 110.072 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -61.71 86.35 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.705 0.764 . . . . 0.0 109.539 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.52 137.29 3.38 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -95.17 5.71 51.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.408 -1.054 . . . . 0.0 108.204 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -71.71 143.25 49.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 110.477 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -78.76 140.55 38.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.563 -0.711 . . . . 0.0 110.117 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.7 159.98 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.462 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 91.5 m-20 -88.19 134.06 33.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.463 -0.773 . . . . 0.0 109.929 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -137.49 153.44 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.496 -0.752 . . . . 0.0 109.714 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.7 pt -141.59 145.01 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.535 0.683 . . . . 0.0 110.151 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -79.82 142.23 35.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.543 -0.723 . . . . 0.0 109.84 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.31 127.81 44.93 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -82.11 130.39 35.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.639 -0.663 . . . . 0.0 109.937 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -139.13 163.59 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -0.785 . . . . 0.0 109.879 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -85.96 150.94 53.92 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.425 -0.797 . . . . 0.0 109.65 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -45.94 -26.7 3.6 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.271 1.981 . . . . 0.0 111.598 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 57.2 mp0 -94.31 -31.37 14.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.549 -0.719 . . . . 0.0 109.881 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.7 mt -87.12 -3.63 59.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 109.742 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 72' ' ' GLY . 9.0 p -67.51 -44.41 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.066 -1.021 . . . . 0.0 109.642 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.408 ' N ' ' CG1' ' A' ' 71' ' ' VAL . . . -63.63 -41.32 99.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -62.79 -53.63 51.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -1.19 . . . . 0.0 110.233 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.71 -44.5 77.51 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.813 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.51 -30.66 71.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.542 -0.724 . . . . 0.0 109.656 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -32.34 72.53 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -58.99 114.96 10.25 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.42 -0.8 . . . . 0.0 109.705 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.31 149.31 23.04 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.195 1.93 . . . . 0.0 113.186 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.92 -14.65 64.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.3 mt -106.57 120.09 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.599 -0.942 . . . . 0.0 109.345 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -105.15 150.36 38.72 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.593 -0.692 . . . . 0.0 109.668 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.6 149.32 79.4 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.436 2.091 . . . . 0.0 112.324 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.55 142.77 56.41 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.781 0.8 . . . . 0.0 110.502 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -86.52 -4.93 59.25 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.56 ' CG ' ' H ' ' A' ' 86' ' ' MET . 71.1 t60 -93.34 175.06 6.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.316 -0.865 . . . . 0.0 110.447 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.56 ' H ' ' CG ' ' A' ' 85' ' ' HIS . 79.1 mtm -52.11 -172.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.626 -0.671 . . . . 0.0 111.26 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 89' ' ' GLU . 99.1 m-20 56.26 -78.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 86' ' ' MET . 31.5 ttmt 69.76 -46.13 0.59 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.387 0.613 . . . . 0.0 109.786 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 87' ' ' ASN . 79.5 mm-40 -68.98 -44.39 72.98 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.39 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -69.62 -45.52 68.34 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.391 -0.818 . . . . 0.0 110.439 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -112.36 142.34 44.99 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.47 -0.769 . . . . 0.0 110.869 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 mm -132.09 139.88 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.6 m -83.76 129.53 34.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 109.594 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.1 t -115.01 132.01 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.7 tp -87.75 104.02 16.16 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.641 0.734 . . . . 0.0 110.019 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 98' ' ' GLY . 92.0 mt -66.36 -39.48 89.18 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.571 0.7 . . . . 0.0 109.123 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.462 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 98.6 m-20 -77.28 8.08 4.49 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -85.76 -161.39 34.85 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.49 -3.77 12.66 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.958 2.439 . . . . 0.0 111.874 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.6 132.31 53.58 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.926 0.87 . . . . 0.0 110.052 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.98 161.52 38.07 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.11 97.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.807 -0.819 . . . . 0.0 109.514 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -72.04 -35.4 69.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.436 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.23 -42.55 93.27 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.352 -0.843 . . . . 0.0 109.31 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 105' ' ' ILE . 93.0 mt -64.74 -43.02 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.683 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -56.67 -45.16 81.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 109.943 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.3 m -61.43 -43.73 98.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 109.715 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.97 -40.97 97.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 109.547 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.95 -42.43 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 108.78 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -52.09 -42.87 63.59 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.446 -0.784 . . . . 0.0 108.991 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -62.2 -40.98 97.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 108.969 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 t -64.31 -36.83 85.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 109.358 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' ARG . 80.4 t80 -58.18 -43.09 87.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.543 -0.723 . . . . 0.0 109.52 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -54.29 -45.13 72.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.234 -0.916 . . . . 0.0 109.924 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.75 -39.28 87.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.18 -0.95 . . . . 0.0 109.782 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.504 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 32.1 p -92.99 7.22 44.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.25 -0.906 . . . . 0.0 109.19 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 113' ' ' PHE . 42.2 ttm180 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.479 -0.763 . . . . 0.0 109.591 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 tpp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.358 0.599 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -101.1 162.84 12.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.435 -0.791 . . . . 0.0 110.17 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -61.53 -43.62 98.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.501 -0.75 . . . . 0.0 109.573 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.8 tp60 -65.9 -42.83 89.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.41 -41.87 96.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 0.0 109.482 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.405 ' CE1' ' CD1' ' A' ' 62' ' ' ILE . 87.3 t80 -62.26 -46.26 89.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 109.908 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 7' ' ' ILE . 96.6 mt -63.94 -43.71 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.252 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.01 -41.41 99.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.563 -0.71 . . . . 0.0 109.617 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -68.25 -36.61 79.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.49 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.44 73.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.433 -0.792 . . . . 0.0 110.344 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ASP . 2.8 pt20 -64.49 -37.53 87.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.601 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -61.42 -41.48 97.23 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.893 -1.129 . . . . 0.0 109.948 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -87.4 -33.8 18.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 111.503 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 16' ' ' THR . 88.3 m-85 -105.95 6.98 31.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.129 -0.982 . . . . 0.0 110.732 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 11' ' ' GLN . 2.1 p-10 39.91 29.74 0.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.427 -0.795 . . . . 0.0 109.643 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 14' ' ' TYR . 58.3 m -120.67 131.25 54.48 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.51 0.671 . . . . 0.0 109.915 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -87.35 156.82 53.84 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.556 -0.715 . . . . 0.0 109.374 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.66 133.29 26.66 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.077 1.851 . . . . 0.0 112.392 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -118.36 143.43 46.64 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.454 0.645 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.482 ' CG ' ' O ' ' A' ' 20' ' ' HIS . 20.0 p-80 -146.29 85.8 7.24 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.405 -0.809 . . . . 0.0 109.137 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.74 -10.71 9.41 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.737 2.291 . . . . 0.0 110.346 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -85.96 104.72 15.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.801 0.81 . . . . 0.0 109.647 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -68.08 -34.24 76.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.734 -0.604 . . . . 0.0 109.746 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -75.22 -6.08 47.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.857 . . . . 0.0 109.501 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.76 71.1 30.31 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.425 -0.797 . . . . 0.0 109.002 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.0 -17.59 40.97 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.458 2.106 . . . . 0.0 111.735 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -85.07 -4.41 59.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.386 -0.821 . . . . 0.0 109.328 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.3 m-85 -85.41 148.04 26.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 109.911 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.17 134.32 46.4 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.52 ' CG1' ' HE ' ' A' ' 32' ' ' ARG . 2.9 t -118.21 129.65 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.92 113.33 22.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.797 -0.565 . . . . 0.0 109.523 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.52 ' HE ' ' CG1' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -135.58 159.55 41.27 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.42 -0.8 . . . . 0.0 109.407 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.7 ' N ' ' HE1' ' A' ' 39' ' ' TRP . 0.5 OUTLIER -77.51 153.94 32.95 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.929 0.871 . . . . 0.0 110.516 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.8 p -88.37 -50.53 6.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -96.41 -25.66 15.62 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.326 -0.859 . . . . 0.0 111.247 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -105.07 30.02 5.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.096 -1.002 . . . . 0.0 110.037 -178.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 33' ' ' HIS . 10.4 m-20 -42.48 86.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.572 -0.705 . . . . 0.0 110.522 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.7 tttt -144.58 -29.02 0.48 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.7 ' HE1' ' N ' ' A' ' 33' ' ' HIS . 1.5 p-90 -95.89 159.27 15.06 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.384 -0.823 . . . . 0.0 109.368 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -138.58 126.2 22.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.617 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.75 150.48 31.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.495 -0.753 . . . . 0.0 109.421 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.51 152.85 33.53 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.494 -0.754 . . . . 0.0 109.089 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 tt -119.9 128.18 53.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.592 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 8.0 ptt? -148.21 156.32 42.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 109.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -95.89 114.54 26.27 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.18 147.27 41.2 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.589 . . . . 0.0 109.662 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.1 145.33 98.69 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.545 2.163 . . . . 0.0 112.453 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.17 63.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.602 -0.686 . . . . 0.0 109.904 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.419 ' OE2' ' OD1' ' A' ' 56' ' ' ASP . 96.0 mt-10 -71.23 -19.39 62.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 110.254 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -84.72 -12.24 54.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.015 -1.053 . . . . 0.0 110.271 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 pt -106.79 -0.32 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.287 -0.883 . . . . 0.0 109.245 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.11 -1.16 82.59 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.254 -0.974 . . . . 0.0 110.685 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.3 mt -81.9 132.17 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.823 -1.398 . . . . 0.0 110.162 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -85.44 96.99 9.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.553 -0.717 . . . . 0.0 109.858 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.9 -21.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.419 ' OD1' ' OE2' ' A' ' 49' ' ' GLU . 90.0 m-20 54.36 20.02 2.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.683 -0.893 . . . . 0.0 109.466 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -109.5 159.28 17.18 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.557 0.694 . . . . 0.0 110.082 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -84.38 142.26 30.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.648 -0.658 . . . . 0.0 109.662 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.56 159.18 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.494 -0.754 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.23 136.88 40.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.485 -0.759 . . . . 0.0 109.183 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.23 157.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.538 -0.726 . . . . 0.0 110.162 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.405 ' CD1' ' CE1' ' A' ' 6' ' ' PHE . 31.8 pt -137.0 145.24 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.48 0.657 . . . . 0.0 109.853 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -81.32 142.9 32.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.387 -0.82 . . . . 0.0 109.985 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.85 125.22 29.51 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -82.02 130.33 35.05 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.394 -0.816 . . . . 0.0 110.414 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.69 163.73 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.456 -0.777 . . . . 0.0 109.609 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -85.97 154.77 58.23 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 109.824 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -46.43 -35.0 15.45 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.511 2.141 . . . . 0.0 112.307 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -89.65 -21.72 22.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.171 -0.955 . . . . 0.0 110.157 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.1 mt -94.74 -6.06 43.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.096 -1.002 . . . . 0.0 109.334 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 72' ' ' GLY . 8.6 p -67.5 -41.46 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.339 -0.851 . . . . 0.0 109.544 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.44 ' N ' ' CG1' ' A' ' 71' ' ' VAL . . . -63.43 -39.54 97.84 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.7 t -61.2 -47.23 87.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -1.099 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -75.02 -42.16 57.91 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.445 -0.784 . . . . 0.0 109.809 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -69.91 -37.64 76.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.67 -0.644 . . . . 0.0 111.217 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -73.63 -3.41 27.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.922 -1.111 . . . . 0.0 109.762 -178.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -83.92 150.75 59.43 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.102 -0.999 . . . . 0.0 109.526 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.58 150.92 75.35 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.65 2.234 . . . . 0.0 113.1 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.96 2.89 79.46 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.0 127.74 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -1.049 . . . . 0.0 109.667 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -121.09 152.56 56.96 Favored Pre-proline 0 N--CA 1.494 1.733 0 CA-C-O 121.239 0.542 . . . . 0.0 109.786 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.423 ' O ' ' OG1' ' A' ' 93' ' ' THR . 43.4 Cg_endo -65.5 154.74 72.34 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.758 2.306 . . . . 0.0 112.322 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.2 147.14 10.45 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.379 -0.826 . . . . 0.0 110.464 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 54.9 t80 -85.64 12.86 7.92 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -154.43 -169.54 3.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 0.0 109.811 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.6 mmm -60.41 -176.6 0.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.432 -0.792 . . . . 0.0 110.893 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.7 m120 57.46 35.11 25.52 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.781 0.8 . . . . 0.0 109.186 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -63.13 -42.68 99.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.568 -0.708 . . . . 0.0 109.824 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.89 -44.02 81.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.348 -0.845 . . . . 0.0 110.081 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -70.05 -46.68 64.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 110.425 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -116.67 146.03 43.03 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.547 -0.72 . . . . 0.0 110.246 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 mm -130.16 146.25 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -91.36 137.78 32.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.755 . . . . 0.0 109.249 -179.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.7 t -118.05 133.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 tp -84.25 103.74 13.7 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.517 0.675 . . . . 0.0 110.122 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.04 -39.92 87.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.525 -0.734 . . . . 0.0 109.172 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -68.82 -4.8 17.58 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -76.44 -166.34 22.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -79.48 -3.14 12.78 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 123.106 2.538 . . . . 0.0 111.399 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.408 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 4.4 mm? -55.2 125.78 22.06 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.908 0.861 . . . . 0.0 109.912 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.61 161.34 35.12 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.91 95.92 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.642 -0.916 . . . . 0.0 109.173 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mtmm -64.42 -41.96 96.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 109.201 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.56 -43.58 89.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.402 -0.811 . . . . 0.0 109.21 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.22 -43.29 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 109.198 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -58.77 -41.64 87.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.828 . . . . 0.0 109.38 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.6 m -61.19 -43.38 98.98 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 109.229 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.47 -41.66 96.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 109.592 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.73 -42.97 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.121 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -59.47 -39.41 83.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.383 -0.823 . . . . 0.0 108.989 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -65.19 -37.83 88.56 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.3 t -61.51 -42.12 98.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.845 . . . . 0.0 109.179 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 117' ' ' ARG . 77.4 t80 -61.13 -44.24 97.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.07 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.62 -43.28 99.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 108.83 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.78 -39.98 94.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.561 -0.712 . . . . 0.0 109.372 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.1 p -99.14 14.97 27.47 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 113' ' ' PHE . 9.1 ptm180 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 121.796 0.808 . . . . 0.0 111.414 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.492 ' O ' ' NH2' ' A' ' 3' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.92 163.94 12.15 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.822 0.82 . . . . 0.0 110.24 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 1' ' ' MET . 13.8 mmp_? -59.91 -47.91 83.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.574 -0.704 . . . . 0.0 109.522 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -43.42 -43.15 5.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.558 -0.714 . . . . 0.0 109.962 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.03 -44.91 83.31 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 109.217 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -62.89 -46.03 89.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.35 -0.843 . . . . 0.0 109.635 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.7 mm -64.34 -45.0 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.361 -0.837 . . . . 0.0 109.722 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.08 -41.71 99.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.322 -0.862 . . . . 0.0 110.075 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -60.81 -44.56 96.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.531 -0.731 . . . . 0.0 109.988 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.41 84.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.485 -0.759 . . . . 0.0 110.117 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 15' ' ' ASP . 94.9 mt-30 -67.51 -35.92 80.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.844 -1.16 . . . . 0.0 109.603 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -64.9 -43.36 93.12 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.689 -1.257 . . . . 0.0 109.657 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -88.25 -11.84 45.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.378 -0.826 . . . . 0.0 111.346 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.606 ' CE1' ' NE2' ' A' ' 33' ' ' HIS . 91.4 m-85 -139.98 -20.34 0.89 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.837 -1.164 . . . . 0.0 111.139 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 11' ' ' GLN . 72.1 m-20 53.64 30.16 10.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.049 -1.032 . . . . 0.0 109.475 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -103.2 156.21 17.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.353 -0.842 . . . . 0.0 109.33 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -97.37 139.76 21.63 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.342 -0.849 . . . . 0.0 109.615 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -50.34 142.28 29.86 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.825 1.684 . . . . 0.0 112.906 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -125.97 121.68 33.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -89.55 146.44 35.75 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.184 -0.947 . . . . 0.0 109.867 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.32 -81.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.161 1.908 . . . . 0.0 111.561 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -87.2 137.03 32.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.448 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -61.51 -20.1 62.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.392 -0.817 . . . . 0.0 109.733 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -76.7 -5.19 46.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.0 109.629 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -129.8 70.12 81.87 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.469 -0.77 . . . . 0.0 109.286 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.92 -18.14 46.64 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.368 2.045 . . . . 0.0 112.015 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -79.78 -5.05 54.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.62 140.87 29.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.362 -0.836 . . . . 0.0 109.527 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.05 130.78 43.7 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.659 -0.65 . . . . 0.0 109.309 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 78.5 t -128.09 131.44 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -103.17 147.88 26.47 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.539 -0.726 . . . . 0.0 109.574 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -134.24 139.88 46.07 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.48 -0.762 . . . . 0.0 109.749 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.606 ' NE2' ' CE1' ' A' ' 14' ' ' TYR . 30.5 m170 -100.21 131.49 46.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.626 -0.671 . . . . 0.0 109.337 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -87.18 -32.11 19.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 0.0 110.59 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 31.4 p-10 -92.02 -1.6 57.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.092 -1.005 . . . . 0.0 111.491 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' LYS . 14.7 t-20 -118.66 29.1 7.92 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.027 -1.046 . . . . 0.0 110.16 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.412 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 98.7 m-20 37.23 -86.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.425 0.631 . . . . 0.0 111.215 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 17.9 ptpt -77.53 157.58 30.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.501 -0.749 . . . . 0.0 110.325 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.432 ' CE3' ' O ' ' A' ' 39' ' ' TRP . 12.0 p-90 -177.44 153.13 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.534 -0.729 . . . . 0.0 109.421 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -149.17 118.8 6.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.58 124.53 5.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.91 143.02 24.08 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.75 -1.219 . . . . 0.0 110.235 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.5 tt -121.03 125.45 47.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -156.99 162.11 39.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.04 114.89 26.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.582 -0.699 . . . . 0.0 109.157 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.7 pt -121.19 145.5 42.19 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.515 -0.741 . . . . 0.0 109.45 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -45.34 135.86 11.67 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.903 1.735 . . . . 0.0 112.787 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.25 -25.64 65.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.589 -0.695 . . . . 0.0 110.162 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -17.7 63.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.296 -0.877 . . . . 0.0 110.346 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -84.64 -12.84 53.15 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.971 -1.08 . . . . 0.0 110.991 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 pt -102.67 6.35 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.188 -0.945 . . . . 0.0 109.465 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.03 -4.61 67.98 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.2 mt -79.7 135.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.886 -1.361 . . . . 0.0 109.882 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -74.42 92.36 2.32 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.568 -0.707 . . . . 0.0 110.083 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.2 139.63 3.23 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 37.5 p-10 -88.99 4.55 47.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 108.394 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -80.62 152.94 28.27 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.642 -0.661 . . . . 0.0 110.023 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -97.6 150.01 21.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.563 -0.711 . . . . 0.0 109.814 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.33 163.05 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.715 -0.616 . . . . 0.0 109.642 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -91.57 128.81 37.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.583 -0.698 . . . . 0.0 109.39 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.83 160.18 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.0 110.348 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.15 150.97 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -84.96 127.27 34.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.466 -0.771 . . . . 0.0 109.975 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.99 121.31 39.61 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -82.93 132.2 35.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.855 . . . . 0.0 110.159 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 m -142.5 165.08 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.347 -0.846 . . . . 0.0 108.879 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -84.71 156.9 61.4 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 108.725 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.66 -22.84 74.26 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.382 2.055 . . . . 0.0 111.405 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -90.48 -29.64 17.81 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.441 -0.787 . . . . 0.0 109.352 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.9 mt -95.2 1.93 54.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.326 -0.859 . . . . 0.0 109.763 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.0 p -64.33 -34.47 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.0 109.52 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.56 -14.59 67.33 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.564 ' HG ' ' N ' ' A' ' 74' ' ' LEU . 55.9 p -68.27 -60.56 2.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -1.163 . . . . 0.0 111.101 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.564 ' N ' ' HG ' ' A' ' 73' ' ' SER . 1.7 pt? -88.24 -23.9 23.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.796 -1.19 . . . . 0.0 110.934 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.427 HH21 ' NZ ' ' A' ' 88' ' ' LYS . 78.9 ttt-85 -65.76 -22.8 66.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 110.097 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.453 ' CD ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -94.28 -9.34 36.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.205 -0.934 . . . . 0.0 108.833 179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -73.81 151.28 88.81 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.097 -1.002 . . . . 0.0 109.357 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.09 143.34 71.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.612 2.208 . . . . 0.0 112.53 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.15 -5.26 63.54 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.9 mm -98.41 125.18 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -1.157 . . . . 0.0 109.174 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.435 ' O ' ' OG1' ' A' ' 93' ' ' THR . 77.3 m-85 -119.87 147.91 45.29 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.733 -0.604 . . . . 0.0 109.598 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.403 ' CB ' ' NZ ' ' A' ' 88' ' ' LYS . 52.0 Cg_endo -69.95 153.68 67.8 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.054 1.836 . . . . 0.0 111.837 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.68 50.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 109.834 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 85' ' ' HIS . 32.1 p90 -66.2 179.31 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.261 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.509 ' CG ' ' O ' ' A' ' 85' ' ' HIS . 54.5 p-80 -40.85 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.471 0.653 . . . . 0.0 110.545 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.1 ttm -167.67 -78.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.526 -0.734 . . . . 0.0 109.193 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.622 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 98.9 m-20 -139.92 -31.84 0.64 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.427 ' NZ ' HH21 ' A' ' 75' ' ' ARG . 49.9 tttp 58.77 -68.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.238 0.542 . . . . 0.0 111.417 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 87' ' ' ASN . 74.2 mt-10 -60.92 -52.21 66.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.868 . . . . 0.0 112.001 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -66.54 -46.77 75.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.935 -1.103 . . . . 0.0 111.251 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.622 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 8.9 m0 -115.51 140.99 48.66 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.439 -0.788 . . . . 0.0 110.317 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mm -128.87 138.41 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 10.8 p -86.84 133.35 33.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.876 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.9 t -112.91 132.58 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.3 tp -87.02 104.07 15.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.518 0.675 . . . . 0.0 110.488 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.64 -39.75 84.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.567 -0.708 . . . . 0.0 109.482 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.87 1.78 6.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.529 -0.732 . . . . 0.0 109.386 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.83 -162.47 30.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.44 -3.39 11.4 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.892 2.394 . . . . 0.0 111.242 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -49.6 126.63 13.99 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.618 0.723 . . . . 0.0 110.0 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.21 169.29 34.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.84 94.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -1.133 . . . . 0.0 109.232 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -64.85 -42.02 95.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.692 . . . . 0.0 109.612 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.74 -42.69 94.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.28 -43.3 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -56.94 -43.84 81.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.387 -0.82 . . . . 0.0 109.564 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.3 m -61.16 -43.99 98.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.897 . . . . 0.0 109.654 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.87 -42.46 97.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.201 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -42.78 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 108.652 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -53.07 -40.9 64.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.475 -0.766 . . . . 0.0 108.936 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.64 -39.61 94.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 108.702 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 t -65.02 -40.34 94.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.836 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -57.99 -48.97 78.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.417 -0.802 . . . . 0.0 110.076 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -67.75 -32.12 72.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.087 -1.008 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -41.12 97.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.7 p -90.78 14.93 12.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.49 -0.756 . . . . 0.0 109.395 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.467 -0.771 . . . . 0.0 110.319 -179.533 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -104.56 156.23 18.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.458 -0.776 . . . . 0.0 110.001 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.493 ' NH1' ' OD2' ' A' ' 45' ' ' ASP . 61.6 ttp180 -61.29 -42.9 99.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.54 -0.725 . . . . 0.0 109.336 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -63.56 -39.77 95.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.368 -0.832 . . . . 0.0 109.773 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -62.75 -42.44 99.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.013 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -61.08 -45.55 94.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.526 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.35 -44.51 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.487 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.12 -45.79 90.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.185 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -62.61 -43.19 99.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.782 . . . . 0.0 109.258 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.94 97.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.414 -0.803 . . . . 0.0 110.002 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 81.0 mt-30 -65.65 -45.0 84.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 110.123 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.37 -35.8 80.27 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.09 -1.006 . . . . 0.0 109.514 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -85.07 -37.24 20.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.398 -0.814 . . . . 0.0 111.686 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.543 ' CZ ' ' CE2' ' A' ' 39' ' ' TRP . 93.2 m-85 -114.55 6.63 15.88 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.015 -1.053 . . . . 0.0 111.698 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 2.4 p-10 39.04 29.12 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.162 -0.961 . . . . 0.0 110.434 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 14' ' ' TYR . 33.0 m -109.94 126.17 53.61 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 109.147 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 157.68 63.21 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.0 109.221 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.59 135.74 33.79 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.842 1.695 . . . . 0.0 112.316 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.433 ' C ' ' CD2' ' A' ' 20' ' ' HIS . 97.1 m-20 -118.27 140.22 50.14 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 20' ' ' HIS . 2.1 m-70 -136.99 85.43 22.76 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.365 -0.834 . . . . 0.0 109.165 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -54.83 -40.31 85.75 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.241 1.961 . . . . 0.0 111.626 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -91.92 130.7 37.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.677 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -84.44 -17.13 40.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.468 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -81.78 -5.16 57.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 109.391 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -128.81 62.04 59.18 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.57 -0.706 . . . . 0.0 109.405 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.93 -19.38 52.29 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.348 2.032 . . . . 0.0 111.828 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.35 -5.11 57.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.116 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.475 ' O ' ' ND1' ' A' ' 20' ' ' HIS . 21.8 m-85 -99.27 134.01 42.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.472 -0.768 . . . . 0.0 109.602 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.72 132.94 54.9 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.61 127.46 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -112.77 122.78 48.67 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.367 0.603 . . . . 0.0 109.862 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -151.57 143.98 24.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 109.106 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.82 124.11 42.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.266 -0.896 . . . . 0.0 109.769 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -80.0 -12.08 59.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.516 -0.74 . . . . 0.0 109.811 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -62.88 -45.23 93.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.095 -1.003 . . . . 0.0 110.528 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 54.3 p30 -123.6 -13.15 7.58 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.29 -0.881 . . . . 0.0 109.919 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 36' ' ' ASN . 45.8 t0 59.24 5.05 0.53 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.446 -0.784 . . . . 0.0 109.799 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 36' ' ' ASN . 28.6 mmtp -94.21 -8.95 37.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.055 -1.028 . . . . 0.0 109.086 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.543 ' CE2' ' CZ ' ' A' ' 14' ' ' TYR . 63.0 t-105 -90.35 108.36 19.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.461 -0.775 . . . . 0.0 109.298 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -107.88 128.62 54.78 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.554 -0.716 . . . . 0.0 109.171 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.33 123.92 8.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.495 -0.753 . . . . 0.0 108.98 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.8 tp -124.34 130.36 52.35 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.64 -0.663 . . . . 0.0 109.274 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.82 128.38 46.47 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.2 ptt? -160.39 162.78 33.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 110.025 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.493 ' OD2' ' NH1' ' A' ' 3' ' ' ARG . 99.3 m-20 -100.28 117.37 34.35 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.7 pt -134.44 145.57 55.75 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.85 151.32 85.7 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.538 2.158 . . . . 0.0 112.917 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.82 64.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.593 -0.692 . . . . 0.0 109.761 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -66.22 -17.94 65.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.121 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -84.28 -14.67 49.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.064 -1.023 . . . . 0.0 111.253 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.64 10.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.174 -0.954 . . . . 0.0 109.885 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.34 -9.26 72.08 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.105 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.5 mt -79.96 135.12 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.802 -1.41 . . . . 0.0 109.722 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -74.61 95.67 2.85 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.14 133.52 1.75 Allowed Glycine 0 N--CA 1.482 1.717 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -91.1 11.72 22.23 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -64.96 157.63 27.64 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.1 mtp85 -100.35 135.98 40.95 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.3 m -137.55 157.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.705 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 96.6 m-20 -99.07 140.3 33.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.95 151.01 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.399 -0.813 . . . . 0.0 110.109 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 62' ' ' ILE . 17.8 pt -131.32 161.07 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 66.8 t0 -133.73 140.76 47.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.236 -0.915 . . . . 0.0 109.732 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.519 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -132.9 159.19 40.62 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.444 0.64 . . . . 0.0 109.336 -179.718 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -88.36 138.93 31.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.491 -0.755 . . . . 0.0 110.629 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.1 161.92 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.56 -0.712 . . . . 0.0 109.298 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -80.72 157.96 71.38 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.411 -0.805 . . . . 0.0 109.344 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.92 -23.85 76.35 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.532 2.155 . . . . 0.0 111.592 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -88.88 -30.81 18.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.279 -0.888 . . . . 0.0 109.574 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.5 mt -93.13 -0.16 57.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -0.84 . . . . 0.0 109.415 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.95 -31.54 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.464 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.51 -15.44 78.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 p -69.01 -54.32 15.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 110.527 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.45 ' H ' ' CD2' ' A' ' 74' ' ' LEU . 2.2 pt? -85.38 -28.04 25.43 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.0 -1.062 . . . . 0.0 110.499 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.3 ttt-85 -69.51 -21.96 63.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.192 -0.942 . . . . 0.0 110.585 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.25 -7.94 52.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.939 -1.101 . . . . 0.0 109.502 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -82.22 150.26 63.96 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.894 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.05 144.32 63.29 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.549 2.166 . . . . 0.0 112.293 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.78 -16.36 54.81 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.524 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 2.0 mp -90.16 127.14 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.044 -1.268 . . . . 0.0 108.905 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -115.55 126.16 28.03 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.394 -0.816 . . . . 0.0 110.212 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -52.28 146.51 31.47 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.41 1.406 . . . . 0.0 111.79 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.24 140.26 57.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.375 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -98.03 1.45 47.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.384 -0.823 . . . . 0.0 108.933 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -65.77 -176.91 0.41 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.458 -0.776 . . . . 0.0 110.374 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 74.4 mtm -64.29 -41.17 97.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.531 -0.731 . . . . 0.0 109.938 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -97.62 138.02 35.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.263 -0.898 . . . . 0.0 109.784 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -141.32 70.27 1.34 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.409 -0.807 . . . . 0.0 109.342 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -143.83 -54.29 0.36 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.46 -0.775 . . . . 0.0 109.07 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -99.31 -15.68 18.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -108.26 122.41 46.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.368 -0.833 . . . . 0.0 110.011 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.7 mm -125.9 137.04 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.5 m -95.01 144.22 25.86 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -120.59 136.67 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.1 tp -87.22 113.63 23.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.975 . . . . 0.0 110.276 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.448 ' C ' ' H ' ' A' ' 98' ' ' GLY . 12.8 mt -64.62 -40.72 95.97 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.705 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 58.8 m-80 -70.78 4.29 2.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.416 -0.802 . . . . 0.0 109.063 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -68.06 171.99 34.44 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.96 -4.97 15.5 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 123.445 2.763 . . . . 0.0 112.327 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.42 ' H ' HD23 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -72.14 150.06 44.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.144 -179.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.09 171.53 42.62 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 120.489 -0.863 . . . . 0.0 111.04 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.42 83.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.95 . . . . 0.0 109.715 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.9 pttm -61.11 -36.32 79.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.219 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -65.87 -38.84 89.86 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.415 -0.803 . . . . 0.0 109.126 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.92 -44.18 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -58.94 -42.54 90.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.388 -0.82 . . . . 0.0 109.786 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.7 m -60.71 -45.09 95.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 110.172 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.78 -44.1 94.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.752 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.03 -43.12 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.501 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -51.9 -42.06 62.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 108.875 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.37 -43.92 97.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.226 -0.921 . . . . 0.0 109.061 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 t -63.67 -41.76 98.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.0 110.69 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -58.96 -45.3 90.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.257 -0.902 . . . . 0.0 110.893 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -60.8 -38.83 86.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.028 -1.045 . . . . 0.0 110.418 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.01 -40.71 98.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.695 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.4 p -93.78 14.32 19.67 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.437 -0.789 . . . . 0.0 109.693 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.7 ttm . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.509 0.671 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -93.48 166.05 12.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.361 -0.837 . . . . 0.0 110.727 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -63.22 -42.76 99.31 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.348 0.594 . . . . 0.0 109.76 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -65.48 -39.45 91.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.3 -0.875 . . . . 0.0 109.673 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.02 -38.75 92.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.327 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.75 -45.53 93.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -0.815 . . . . 0.0 109.439 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 7' ' ' ILE . 95.1 mt -63.59 -43.77 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.409 -0.807 . . . . 0.0 109.412 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.14 -41.61 97.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.446 -0.784 . . . . 0.0 109.794 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -62.2 -42.66 99.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.415 -0.803 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.38 82.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.432 -0.793 . . . . 0.0 109.719 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 15' ' ' ASP . 25.9 mt-30 -63.45 -48.42 77.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.062 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -64.48 -37.45 87.59 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.721 -1.237 . . . . 0.0 109.466 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -68.79 -46.3 69.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.522 -0.736 . . . . 0.0 111.942 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.17 -20.43 4.13 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.0 110.677 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 25.4 t0 65.31 42.1 4.07 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.266 -0.896 . . . . 0.0 108.855 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.7 m -104.19 133.35 49.27 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.609 0.718 . . . . 0.0 109.595 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -83.75 151.4 61.23 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.725 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.21 153.55 71.3 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.818 2.345 . . . . 0.0 112.533 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 61.6 t0 -140.76 138.92 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 108.96 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.467 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 13.7 p-80 -132.64 86.94 42.99 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.505 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -54.54 -37.92 90.28 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.502 2.135 . . . . 0.0 110.653 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -87.51 82.06 7.59 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.443 ' C ' ' H ' ' A' ' 25' ' ' PHE . 22.3 pt-20 -55.2 -14.45 1.71 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -65.18 -2.33 2.84 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.503 -0.748 . . . . 0.0 109.073 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.443 ' H ' ' C ' ' A' ' 23' ' ' GLU . 87.0 m-85 -147.95 76.15 10.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.394 -0.817 . . . . 0.0 109.325 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.08 -19.22 65.61 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.635 2.224 . . . . 0.0 110.764 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 12.5 p-10 -81.19 -2.48 48.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -100.38 139.48 36.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.435 -0.791 . . . . 0.0 109.255 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.0 128.17 45.94 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -113.66 124.51 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.657 -0.652 . . . . 0.0 109.561 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.88 136.5 51.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.688 -0.632 . . . . 0.0 109.295 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -157.18 139.37 14.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -101.0 126.65 47.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.528 -0.733 . . . . 0.0 109.635 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 m -80.79 -10.62 59.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.473 -0.767 . . . . 0.0 109.168 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -64.03 -40.84 97.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.396 -0.815 . . . . 0.0 109.95 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 38' ' ' LYS . 2.1 m120 -113.16 -24.6 9.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.324 -0.86 . . . . 0.0 109.252 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.8 t0 63.36 -8.88 0.13 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.589 -0.694 . . . . 0.0 109.855 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.557 ' H ' ' C ' ' A' ' 36' ' ' ASN . 64.5 mttp -97.64 -6.29 33.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.205 -0.934 . . . . 0.0 108.863 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -84.82 109.88 18.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 109.683 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -109.3 125.92 52.82 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.82 136.72 35.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.5 tp -145.1 122.95 11.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.404 ' C ' ' CD2' ' A' ' 43' ' ' LEU . 7.4 tt -120.23 124.48 45.78 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.401 ' C ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -162.68 164.76 26.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 0.0 109.689 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 88.9 m-20 -96.42 114.05 25.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.565 -0.71 . . . . 0.0 109.721 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.2 pt -116.83 144.99 34.48 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -48.78 141.38 21.19 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.985 1.79 . . . . 0.0 112.421 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.08 -21.09 65.94 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.382 0.61 . . . . 0.0 109.972 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.29 -13.99 59.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.123 -0.986 . . . . 0.0 109.608 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -84.32 -10.85 57.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.3 pt -103.19 1.73 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.301 -0.874 . . . . 0.0 109.345 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.43 -14.39 59.43 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 55' ' ' GLY . 76.4 mt -78.55 130.55 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.956 -1.32 . . . . 0.0 109.498 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -63.28 14.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.585 -0.697 . . . . 0.0 110.539 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -86.11 140.78 17.96 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -101.27 5.77 42.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.503 -0.998 . . . . 0.0 109.628 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -88.44 144.81 26.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -71.73 145.8 48.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.63 -0.669 . . . . 0.0 110.359 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.46 157.46 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.528 -0.732 . . . . 0.0 109.633 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 12.9 m-20 -93.81 131.63 39.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.495 -0.753 . . . . 0.0 109.355 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.95 156.89 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.42 -0.8 . . . . 0.0 110.292 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 pt -134.96 149.88 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.474 0.654 . . . . 0.0 109.739 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -81.68 146.64 29.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.11 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.95 127.08 33.46 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -82.21 131.69 35.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.556 -0.715 . . . . 0.0 110.147 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.37 161.32 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 109.677 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -85.62 158.71 56.64 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.87 -19.79 56.44 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.61 2.207 . . . . 0.0 111.544 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -95.88 -28.24 14.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.346 -0.846 . . . . 0.0 109.116 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.04 -2.56 56.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.415 -0.803 . . . . 0.0 109.493 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.7 -41.08 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.946 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.12 -40.66 99.44 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.7 m -62.13 -36.03 80.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.208 -1.172 . . . . 0.0 110.419 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -39.07 43.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.079 . . . . 0.0 111.011 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.562 HH21 ' CD1' ' A' ' 92' ' ' ILE . 95.9 mtt180 -76.71 -6.54 52.57 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.069 -1.019 . . . . 0.0 110.125 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -11.41 58.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.084 -1.01 . . . . 0.0 109.171 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -90.83 148.07 37.46 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 109.266 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.07 144.73 58.74 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.716 2.278 . . . . 0.0 113.09 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.15 -5.0 85.92 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.81 122.87 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -1.109 . . . . 0.0 109.782 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -124.6 145.52 49.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.26 150.08 81.45 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.454 2.103 . . . . 0.0 112.387 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.1 138.88 58.06 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.708 0.766 . . . . 0.0 110.257 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 13.0 p90 -95.32 1.02 54.27 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 86' ' ' MET . 8.9 m170 -148.47 159.36 44.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.112 -0.993 . . . . 0.0 110.793 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.443 ' O ' ' O ' ' A' ' 87' ' ' ASN . 79.5 mtp 48.61 105.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.892 0.853 . . . . 0.0 111.023 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 86' ' ' MET . 99.2 m-20 44.01 -171.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.642 0.734 . . . . 0.0 110.751 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -144.92 -57.78 0.35 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.49 -0.756 . . . . 0.0 109.308 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.0 -37.75 84.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.212 -0.93 . . . . 0.0 109.125 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -57.01 -67.13 0.34 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.44 -0.788 . . . . 0.0 109.801 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -105.04 144.53 31.71 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.525 0.679 . . . . 0.0 110.094 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.562 ' CD1' HH21 ' A' ' 75' ' ' ARG . 7.1 mm -130.54 144.07 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.8 m -87.48 131.18 34.43 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.394 -0.816 . . . . 0.0 109.82 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.1 t -118.52 132.39 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.5 tp -87.9 101.98 14.26 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.622 0.725 . . . . 0.0 110.24 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 98' ' ' GLY . 84.1 mt -66.04 -40.39 90.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -71.96 5.49 2.63 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -84.63 -166.33 41.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.8 7.86 4.34 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.023 2.482 . . . . 0.0 111.611 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 4.3 mm? -62.24 130.55 45.9 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.973 0.892 . . . . 0.0 110.578 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.5 158.43 31.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.463 ' O ' ' ND1' ' A' ' 106' ' ' HIS . . . -60.16 -47.02 87.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.695 -0.885 . . . . 0.0 109.552 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -65.18 -40.52 94.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.511 -0.743 . . . . 0.0 109.447 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.0 -44.89 96.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.509 -0.744 . . . . 0.0 109.522 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -64.43 -43.32 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.554 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 102' ' ' ALA . 31.8 m80 -58.74 -42.62 89.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.368 -0.833 . . . . 0.0 109.888 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.9 m -61.43 -43.6 98.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.54 -40.7 96.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.454 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.408 ' O ' ' OG ' ' A' ' 112' ' ' SER . 94.9 mt -63.92 -43.2 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.215 -0.928 . . . . 0.0 109.337 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -60.48 -37.8 82.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.66 -42.04 99.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.493 -0.754 . . . . 0.0 108.987 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 109' ' ' ILE . 96.6 p -62.61 -36.24 82.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.363 -0.836 . . . . 0.0 109.155 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.69 -45.21 95.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.385 -0.822 . . . . 0.0 109.594 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -65.65 -27.63 68.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.009 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.2 mt -82.37 -13.15 57.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.536 -0.727 . . . . 0.0 109.317 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 79.4 p -110.64 14.66 22.32 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.863 0.84 . . . . 0.0 110.308 -179.322 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.6 ttp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.155 0.503 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -94.96 155.64 16.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.176 -0.952 . . . . 0.0 110.373 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.512 ' NH2' ' OD1' ' A' ' 45' ' ' ASP . 40.8 ttm180 -62.09 -42.63 99.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.549 -0.719 . . . . 0.0 109.546 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -53.99 -42.32 68.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 109.817 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.65 -35.54 80.4 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.129 -0.982 . . . . 0.0 109.49 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -60.89 -44.65 96.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.123 -0.985 . . . . 0.0 109.161 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.9 mm -64.0 -44.66 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.288 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.15 -41.13 99.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.519 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -60.32 -49.86 75.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.3 -35.25 75.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 17.4 tt0 -59.34 -49.91 76.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.385 -0.822 . . . . 0.0 110.28 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -64.26 -40.21 95.51 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.637 -1.289 . . . . 0.0 109.465 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -68.34 -44.29 75.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 112.259 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.526 ' OH ' ' CD1' ' A' ' 113' ' ' PHE . 97.0 m-85 -127.64 -18.49 4.34 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.993 -1.067 . . . . 0.0 110.902 -178.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 24.9 t0 63.68 45.81 4.39 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.0 . . . . 0.0 109.084 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.0 m -113.72 127.9 56.21 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -83.95 155.19 64.51 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.12 -0.987 . . . . 0.0 109.759 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.55 140.54 64.79 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.77 1.647 . . . . 0.0 112.607 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -116.28 121.31 41.63 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 20' ' ' HIS . 11.8 m-70 -114.87 85.32 11.61 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.499 -0.751 . . . . 0.0 109.19 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.43 -12.82 16.91 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.928 1.752 . . . . 0.0 110.878 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -100.7 93.97 5.85 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -63.34 -17.57 62.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 0.0 109.848 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -83.87 -3.07 57.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.681 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -143.43 69.35 17.5 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.128 -0.983 . . . . 0.0 109.792 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.98 -29.53 89.55 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.55 2.167 . . . . 0.0 111.191 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.91 -6.94 45.53 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.429 -0.795 . . . . 0.0 109.366 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -102.72 135.41 44.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.457 -0.777 . . . . 0.0 109.13 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -123.35 146.78 47.67 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.6 t -125.62 130.49 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.559 -0.713 . . . . 0.0 109.209 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.48 112.03 22.91 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.69 -0.631 . . . . 0.0 109.319 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -134.24 138.45 45.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.306 -0.871 . . . . 0.0 108.665 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.594 ' ND1' ' CD1' ' A' ' 39' ' ' TRP . 35.9 m170 -100.87 118.2 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -0.852 . . . . 0.0 109.765 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.1 m -63.28 -36.73 84.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.351 -0.843 . . . . 0.0 109.342 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.03 -43.42 98.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 110.134 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 38' ' ' LYS . 15.9 m120 -91.99 5.45 50.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.067 -1.021 . . . . 0.0 108.882 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' LYS . 66.9 t0 51.25 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.778 -0.576 . . . . 0.0 110.712 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' ASN . 60.3 mttp -55.88 -110.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 110.582 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.594 ' CD1' ' ND1' ' A' ' 33' ' ' HIS . 48.5 t-105 40.8 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.756 -0.59 . . . . 0.0 109.831 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -107.97 125.77 51.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.459 -0.776 . . . . 0.0 109.325 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.89 128.25 10.61 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.95 146.0 40.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 109.388 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 tt -116.84 128.26 55.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -152.08 163.17 39.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.994 . . . . 0.0 109.392 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.512 ' OD1' ' NH2' ' A' ' 3' ' ' ARG . 98.5 m-20 -98.89 136.56 38.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -0.795 . . . . 0.0 108.858 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -139.95 145.73 43.68 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.208 -0.932 . . . . 0.0 109.767 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.17 135.73 30.65 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.844 1.696 . . . . 0.0 113.089 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -29.52 70.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 109.902 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 55' ' ' GLY . 15.7 pt-20 -55.57 -29.89 59.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.076 -1.015 . . . . 0.0 110.22 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -63.79 -34.94 79.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.977 -1.077 . . . . 0.0 110.322 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.6 pt -96.41 -1.55 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.16 -0.963 . . . . 0.0 109.708 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.96 34.75 32.92 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.874 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.566 ' O ' ' N ' ' A' ' 55' ' ' GLY . 35.0 mt -110.16 136.51 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.349 -1.089 . . . . 0.0 110.059 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.401 ' C ' ' OD1' ' A' ' 54' ' ' ASN . 49.1 t-20 43.03 -89.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.396 0.617 . . . . 0.0 110.252 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . -158.73 -110.87 0.29 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -108.76 47.82 0.89 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.628 -0.925 . . . . 0.0 109.517 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -91.8 129.67 37.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.224 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -71.87 136.4 46.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.58 164.22 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.346 -0.846 . . . . 0.0 109.233 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.682 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 83.4 m-20 -92.01 134.34 34.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.189 -0.945 . . . . 0.0 110.04 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -137.02 158.93 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.234 -0.916 . . . . 0.0 109.69 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.3 pt -135.04 146.74 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -110.59 140.15 45.17 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.553 -0.717 . . . . 0.0 109.621 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.27 164.28 28.45 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 132.08 52.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.483 -0.761 . . . . 0.0 109.877 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.22 162.78 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.342 -0.848 . . . . 0.0 110.144 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -72.03 133.96 83.51 Favored Pre-proline 0 C--N 1.298 -1.643 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.46 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -44.69 -38.18 12.27 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.962 1.775 . . . . 0.0 112.302 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.43 -32.21 66.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.054 -1.029 . . . . 0.0 110.442 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.406 ' O ' ' OG ' ' A' ' 73' ' ' SER . 83.7 mt -92.1 5.02 51.86 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.085 -1.01 . . . . 0.0 110.111 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.47 -28.21 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.047 -1.033 . . . . 0.0 109.015 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.461 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -58.46 -39.46 93.0 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 70' ' ' LEU . 78.2 p -59.5 -41.11 89.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.15 -1.206 . . . . 0.0 109.668 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 2.5 mm? -68.99 -44.9 71.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 110.781 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -78.2 -36.92 46.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.0 111.299 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.461 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -72.98 -1.72 18.2 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.066 -1.053 . . . . 0.0 109.654 -178.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.49 139.99 21.96 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 109.157 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.99 143.69 45.56 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.124 1.883 . . . . 0.0 112.969 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.09 -17.42 56.98 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.92 127.44 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -1.178 . . . . 0.0 109.401 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -114.35 133.55 22.43 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.699 -0.625 . . . . 0.0 110.133 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -54.32 149.26 38.11 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.278 1.319 . . . . 0.0 111.352 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.23 143.42 55.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.832 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -92.45 21.96 4.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 109.404 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' MET . 7.5 p80 -148.0 167.89 23.73 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.017 -1.052 . . . . 0.0 110.409 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' HIS . 65.5 mtt -43.68 173.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.539 0.685 . . . . 0.0 111.497 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 57.83 34.12 24.01 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.618 0.723 . . . . 0.0 109.459 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.7 -43.0 99.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.458 -0.776 . . . . 0.0 109.832 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.05 -44.52 84.34 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.102 -0.999 . . . . 0.0 109.858 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -68.78 -46.7 68.05 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.114 -0.991 . . . . 0.0 110.857 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -115.7 145.78 42.45 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.419 -0.801 . . . . 0.0 110.291 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.0 mm -130.61 152.32 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.9 m -101.92 135.49 43.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.406 -0.809 . . . . 0.0 109.508 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.37 136.41 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 63.2 tp -90.66 116.26 28.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 110.085 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' ' 98' ' ' GLY . 13.6 mt -65.96 -40.22 91.12 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 65.3 m-80 -72.28 3.58 4.52 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -56.56 164.94 5.22 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.74 -8.5 18.07 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.109 2.539 . . . . 0.0 111.576 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.93 162.29 28.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.217 -0.927 . . . . 0.0 110.66 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.58 163.59 50.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.47 80.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.509 -0.995 . . . . 0.0 109.089 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.11 -39.55 92.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -0.858 . . . . 0.0 109.419 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -62.48 -42.12 99.27 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.114 -0.991 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.58 -43.89 96.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.213 -0.93 . . . . 0.0 109.354 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -66.03 -38.51 88.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.297 -0.877 . . . . 0.0 109.577 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.7 m -59.48 -44.57 93.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.116 -0.99 . . . . 0.0 109.809 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.37 -42.13 96.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 109.261 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.61 -42.94 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.061 -1.024 . . . . 0.0 109.058 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -53.09 -40.63 64.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.225 -0.922 . . . . 0.0 108.637 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.75 -40.89 98.66 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.3 -0.875 . . . . 0.0 108.724 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -60.2 -38.91 84.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.454 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 14' ' ' TYR . 74.8 t80 -61.39 -43.52 98.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.68 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -47.81 -39.55 18.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.194 -0.941 . . . . 0.0 109.68 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.01 -39.19 93.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 109.684 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.5 p -90.94 9.68 29.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.149 -0.969 . . . . 0.0 109.172 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.864 -179.541 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.408 ' N ' ' CD1' ' A' ' 105' ' ' ILE . 21.4 ptp . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.271 0.558 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -94.17 165.45 12.6 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.411 -0.806 . . . . 0.0 109.993 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 42.6 ttm180 -62.31 -44.72 95.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.506 -0.746 . . . . 0.0 109.433 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -63.68 -39.72 95.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.843 . . . . 0.0 109.095 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -63.63 -37.26 86.67 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.399 -0.813 . . . . 0.0 109.264 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.63 -46.94 88.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.488 -0.757 . . . . 0.0 109.74 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.59 -45.41 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.262 -0.899 . . . . 0.0 108.605 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -62.32 -41.8 98.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 0.0 109.558 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.72 -49.6 76.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.201 -0.937 . . . . 0.0 109.074 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.25 -36.1 78.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.729 . . . . 0.0 109.608 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -61.8 -42.6 99.21 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.501 -0.75 . . . . 0.0 110.006 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -83.98 -20.87 32.1 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.096 -1.003 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.4 tptt -87.2 -51.31 6.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.256 -0.902 . . . . 0.0 111.321 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -118.05 -15.05 9.94 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.204 -0.935 . . . . 0.0 110.312 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.0 t0 58.11 41.71 23.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.359 -0.838 . . . . 0.0 109.933 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.6 m -99.85 134.22 43.07 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.174 -0.954 . . . . 0.0 108.704 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -84.4 132.69 46.48 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.031 -1.043 . . . . 0.0 109.244 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.86 151.07 56.54 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.832 1.688 . . . . 0.0 112.295 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -132.94 149.26 52.26 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.542 -0.724 . . . . 0.0 109.352 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.49 ' CG ' ' O ' ' A' ' 20' ' ' HIS . 13.9 p-80 -132.6 85.38 47.89 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.39 -0.819 . . . . 0.0 109.222 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -55.7 -37.05 95.9 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.312 2.008 . . . . 0.0 111.233 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -79.76 98.67 7.11 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.651 0.739 . . . . 0.0 109.43 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.95 -23.32 65.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.438 -0.789 . . . . 0.0 109.744 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -74.49 -3.9 33.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.675 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -145.16 76.56 13.41 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.23 -0.918 . . . . 0.0 109.705 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.77 -20.0 63.94 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.617 2.211 . . . . 0.0 110.768 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 12.8 p-10 -76.5 -2.4 32.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.722 -0.611 . . . . 0.0 109.65 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 6.6 m-85 -99.54 134.87 41.78 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.45 129.86 29.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.288 -0.882 . . . . 0.0 109.405 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.78 128.37 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -100.34 124.06 45.34 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.366 -0.834 . . . . 0.0 109.849 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.7 mtm-85 -137.02 135.68 37.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.297 -0.877 . . . . 0.0 109.284 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.98 112.77 25.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.458 -0.776 . . . . 0.0 109.725 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.2 t -69.72 -26.56 64.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.437 -0.79 . . . . 0.0 109.406 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -64.25 -39.34 93.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.51 -0.744 . . . . 0.0 109.559 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.71 -11.03 22.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.323 -0.86 . . . . 0.0 108.887 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 61.41 38.41 16.07 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.426 0.631 . . . . 0.0 109.626 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -167.65 -120.33 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.453 -0.779 . . . . 0.0 109.55 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 56.16 91.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.489 -0.757 . . . . 0.0 109.318 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -105.21 126.64 52.31 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.945 0.879 . . . . 0.0 110.041 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.5 146.71 27.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.4 tp -140.53 120.55 13.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.951 -1.093 . . . . 0.0 110.268 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.1 tt -113.08 126.43 55.47 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.51 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.3 ptt? -153.27 165.18 36.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.997 -1.064 . . . . 0.0 109.843 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 92.9 m-20 -97.03 116.17 28.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 pt -127.55 145.55 55.1 Favored Pre-proline 0 N--CA 1.504 2.257 0 O-C-N 121.385 -0.822 . . . . 0.0 109.368 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.31 145.53 88.59 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.095 1.864 . . . . 0.0 112.116 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.43 -21.78 66.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.613 -0.679 . . . . 0.0 109.998 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HB3' ' H ' ' A' ' 56' ' ' ASP . 9.8 pt-20 -56.62 -20.42 21.11 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 110.232 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.81 -13.0 59.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.107 -0.995 . . . . 0.0 110.705 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 pt -116.43 -5.7 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.302 -0.874 . . . . 0.0 109.79 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.22 -2.29 81.05 Favored Glycine 0 N--CA 1.499 2.874 0 O-C-N 121.184 -0.947 . . . . 0.0 111.12 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 55' ' ' GLY . 39.3 mt -79.36 146.51 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.902 -1.352 . . . . 0.0 110.066 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 53' ' ' ILE . 18.2 m120 37.16 -88.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.493 0.664 . . . . 0.0 110.603 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . 143.94 116.43 1.11 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.405 ' H ' ' HB3' ' A' ' 49' ' ' GLU . 47.3 t0 60.26 41.44 16.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.946 . . . . 0.0 110.569 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -112.42 124.76 53.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.41 -0.806 . . . . 0.0 108.988 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -71.27 127.84 33.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 109.953 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 m -137.97 161.06 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.338 -0.851 . . . . 0.0 109.017 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -98.86 130.95 45.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.404 -0.81 . . . . 0.0 109.226 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.25 158.28 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.481 -0.762 . . . . 0.0 109.531 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.5 pt -131.66 146.83 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -110.83 136.62 49.61 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 pp -137.88 156.79 47.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.287 -0.883 . . . . 0.0 109.48 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -90.65 144.72 25.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.815 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.07 162.1 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 0.0 109.621 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -70.25 155.64 93.12 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.17 -18.28 62.84 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.075 1.85 . . . . 0.0 110.953 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -94.28 -28.76 15.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.544 -0.722 . . . . 0.0 109.226 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.1 mt -94.32 -3.03 51.2 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.177 -0.952 . . . . 0.0 110.039 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.45 -31.72 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.137 -0.977 . . . . 0.0 109.919 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.53 -14.72 81.83 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.44 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 34.7 t -70.41 -55.44 9.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -1.099 . . . . 0.0 111.483 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.449 ' H ' ' CD2' ' A' ' 74' ' ' LEU . 1.8 pt? -84.28 -23.09 30.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.119 -0.988 . . . . 0.0 111.106 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' H ' HD22 ' A' ' 74' ' ' LEU . 79.9 ttt-85 -66.38 -41.42 89.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.106 -0.997 . . . . 0.0 111.264 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CD ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -76.29 -7.57 55.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.869 -1.145 . . . . 0.0 110.108 -178.502 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.578 ' CB ' ' HZ2' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -77.69 149.22 77.5 Favored Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.799 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 80' ' ' ILE . 40.2 Cg_endo -66.34 155.37 70.3 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.12 2.547 . . . . 0.0 112.462 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.47 -25.77 0.9 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' A' ' 78' ' ' PRO . 78.9 mt -93.7 115.35 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -1.216 . . . . 0.0 108.951 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.8 150.34 42.63 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.619 -0.675 . . . . 0.0 110.036 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.04 150.94 85.01 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.156 1.904 . . . . 0.0 111.809 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.4 143.88 56.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.345 -0.847 . . . . 0.0 109.625 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 52.4 p90 -92.08 126.9 37.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.119 -0.988 . . . . 0.0 109.899 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 85' ' ' HIS . 85.5 t60 41.53 43.51 2.28 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.561 -0.712 . . . . 0.0 110.405 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.0 mmm -143.46 65.32 1.32 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.234 -0.916 . . . . 0.0 109.044 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.612 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 22.2 m-20 68.39 -50.14 0.56 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.166 -0.334 . . . . 0.0 110.42 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 63.91 -37.63 0.19 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 120.979 0.419 . . . . 0.0 110.24 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 87' ' ' ASN . 83.1 tt0 -88.66 -20.19 25.23 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.903 -1.123 . . . . 0.0 109.817 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -96.88 -59.84 1.72 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.266 -0.896 . . . . 0.0 110.336 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . 0.612 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 5.4 m0 -105.96 140.96 38.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.494 -0.754 . . . . 0.0 109.912 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.0 mm -121.14 138.55 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.1 m -85.43 134.46 34.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.707 -0.62 . . . . 0.0 109.834 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.4 t -119.63 134.82 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.596 -0.69 . . . . 0.0 109.157 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.2 tp -89.55 107.2 18.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.199 -0.938 . . . . 0.0 110.058 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.23 -39.33 89.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.497 -0.752 . . . . 0.0 109.71 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -74.28 2.88 8.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.477 -0.765 . . . . 0.0 109.61 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.93 -166.05 30.28 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 100' ' ' LEU . 83.8 Cg_endo -85.34 10.63 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.396 2.731 . . . . 0.0 111.54 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 99' ' ' PRO . 3.8 mm? -52.55 -107.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.629 0.728 . . . . 0.0 109.63 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.11 154.38 6.15 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.48 -46.3 86.93 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.303 -1.116 . . . . 0.0 109.357 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.65 -42.67 98.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.501 -0.749 . . . . 0.0 109.84 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -66.06 -42.73 89.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.397 -0.814 . . . . 0.0 109.743 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.408 ' CD1' ' N ' ' A' ' 1' ' ' MET . 94.9 mt -64.15 -43.25 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -55.16 -43.98 74.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.318 -0.864 . . . . 0.0 109.263 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 56.0 m -60.83 -42.37 97.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.855 . . . . 0.0 109.46 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.07 -42.95 99.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.432 -0.793 . . . . 0.0 109.323 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.06 -43.08 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.369 -0.832 . . . . 0.0 109.097 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -58.52 -37.71 76.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 108.593 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.446 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 92.4 m-20 -62.57 -35.77 80.56 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.8 p -81.51 -23.55 37.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 109.306 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -61.65 -44.43 96.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.427 -0.796 . . . . 0.0 109.885 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.462 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 5.4 pt20 -50.9 -41.25 58.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.337 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.462 ' N ' ' CG ' ' A' ' 114' ' ' GLN . 84.6 mt -64.77 -39.71 94.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.526 -0.733 . . . . 0.0 109.745 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.3 p -92.99 14.83 16.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.135 -0.978 . . . . 0.0 109.522 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.145 -0.972 . . . . 0.0 109.58 -179.569 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.511 ' O ' ' ND2' ' A' ' 2' ' ' ASN . 6.3 ttt . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 1' ' ' MET . 15.2 m120 -146.73 -178.33 6.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.104 -0.998 . . . . 0.0 110.116 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.53 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 40.8 ttm180 -62.25 -44.61 96.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.593 -0.692 . . . . 0.0 109.81 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -61.83 -37.33 84.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.898 . . . . 0.0 109.521 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -59.98 -40.44 89.13 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.346 -0.846 . . . . 0.0 109.04 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -62.65 -41.63 99.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.696 -0.628 . . . . 0.0 110.363 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.5 mm -59.24 -47.7 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.059 -1.025 . . . . 0.0 110.018 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 9' ' ' TYR . 0.6 OUTLIER -63.8 -43.86 95.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.914 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.622 ' CE2' ' CD2' ' A' ' 106' ' ' HIS . 43.4 t80 -62.53 -48.29 80.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.562 -0.711 . . . . 0.0 109.872 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.01 86.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.4 -0.813 . . . . 0.0 110.102 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 15' ' ' ASP . 11.6 tp-100 -64.75 -48.95 72.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.384 -0.822 . . . . 0.0 109.896 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -66.71 -33.63 76.07 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.931 -1.106 . . . . 0.0 110.599 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -87.05 -12.09 48.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.118 -0.989 . . . . 0.0 111.83 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.609 ' CD1' ' NE2' ' A' ' 33' ' ' HIS . 95.8 m-85 -141.62 -0.22 1.39 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.653 -1.279 . . . . 0.0 110.446 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER 41.06 35.18 0.34 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -109.76 138.06 46.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.507 0.67 . . . . 0.0 109.653 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -91.1 151.13 42.81 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.504 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.65 149.05 73.32 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.596 2.198 . . . . 0.0 112.186 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -123.83 134.36 53.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.623 -0.673 . . . . 0.0 109.343 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 20' ' ' HIS . 18.6 p80 -128.78 85.4 60.33 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.37 -12.76 11.36 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.452 2.101 . . . . 0.0 110.973 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -92.38 97.52 10.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -70.15 -18.59 63.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.507 -0.746 . . . . 0.0 109.934 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 10.0 mtpm? -76.56 -4.65 43.93 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.142 -0.974 . . . . 0.0 109.14 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 24' ' ' LYS . 53.3 m-85 -156.85 79.47 3.71 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.433 -0.792 . . . . 0.0 108.903 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.3 -19.48 50.71 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.723 2.282 . . . . 0.0 111.294 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -73.13 -5.96 42.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.521 -0.737 . . . . 0.0 109.183 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.586 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 4.9 m-85 -87.55 137.95 31.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.573 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.88 141.38 34.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 0.0 109.156 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.09 126.44 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -106.66 120.08 41.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.54 -0.725 . . . . 0.0 109.5 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.449 ' NH2' ' O ' ' A' ' 37' ' ' ASP . 17.5 ptm180 -150.61 158.3 43.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.135 -0.978 . . . . 0.0 109.61 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.609 ' NE2' ' CD1' ' A' ' 14' ' ' TYR . 4.4 m170 -97.94 126.52 43.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 109.713 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.4 p -66.45 -34.26 77.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.469 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.76 -39.54 94.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.36 -0.838 . . . . 0.0 109.86 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 38' ' ' LYS . 53.0 t-20 -93.23 -12.26 30.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.409 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.449 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 37.7 t70 57.93 -71.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.695 -0.628 . . . . 0.0 110.713 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.6 tttt -63.61 124.66 21.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 110.506 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.434 ' HE1' ' HG1' ' A' ' 116' ' ' THR . 0.0 OUTLIER -178.86 126.46 0.1 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.345 -0.847 . . . . 0.0 108.975 179.075 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -115.09 123.29 48.61 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.553 0.692 . . . . 0.0 109.524 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.8 106.23 2.85 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.59 128.25 54.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.524 -0.735 . . . . 0.0 109.788 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tt -122.61 118.19 27.59 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.586 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -162.82 166.67 23.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.968 . . . . 0.0 109.92 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.53 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 91.5 m-20 -93.6 143.5 26.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.56 -0.713 . . . . 0.0 109.33 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.9 pt -150.67 146.23 19.31 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.254 -0.904 . . . . 0.0 109.435 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.62 145.82 6.02 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.127 1.885 . . . . 0.0 112.697 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.6 -20.98 62.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.48 -0.763 . . . . 0.0 109.959 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.61 -17.59 63.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.887 . . . . 0.0 110.135 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.95 -10.45 57.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.05 -1.031 . . . . 0.0 111.042 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.2 pt -105.82 7.12 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.142 -0.974 . . . . 0.0 109.428 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 -13.83 63.24 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.59 129.01 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.845 -1.386 . . . . 0.0 110.028 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -88.52 100.84 13.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.454 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.06 -22.48 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 56.76 31.53 19.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.795 -0.827 . . . . 0.0 109.708 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -102.8 144.98 30.44 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.323 -0.861 . . . . 0.0 109.775 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -74.15 128.19 34.88 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.326 -0.858 . . . . 0.0 109.278 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.25 161.19 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.482 -0.761 . . . . 0.0 109.769 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.418 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 28.3 m-20 -93.28 132.32 37.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.795 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.11 155.95 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.39 -0.818 . . . . 0.0 110.249 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.0 pt -130.93 155.3 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -92.86 119.74 32.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 110.2 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.632 ' CD1' ' HG ' ' A' ' 112' ' ' SER . 0.3 OUTLIER -115.7 119.81 37.31 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -86.71 135.86 33.23 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.461 -0.774 . . . . 0.0 110.588 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.66 165.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.426 -0.796 . . . . 0.0 109.946 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -75.31 152.78 85.98 Favored Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 121.362 -0.836 . . . . 0.0 110.176 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -48.93 -34.01 27.54 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.13 1.887 . . . . 0.0 111.77 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -85.51 -29.21 24.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.393 -0.817 . . . . 0.0 110.087 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.0 mt -88.25 1.03 55.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.985 -1.072 . . . . 0.0 109.847 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.423 ' CG1' ' N ' ' A' ' 72' ' ' GLY . 14.8 p -66.13 -42.5 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.136 -0.977 . . . . 0.0 109.516 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.423 ' N ' ' CG1' ' A' ' 71' ' ' VAL . . . -66.05 -40.61 95.23 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -60.75 -36.75 79.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -1.217 . . . . 0.0 109.524 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.75 -37.39 19.37 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.553 -0.717 . . . . 0.0 109.825 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 ttp85 -73.92 -16.98 61.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.794 . . . . 0.0 110.644 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -7.65 58.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.95 -1.094 . . . . 0.0 109.081 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.476 ' HZ3' ' CD2' ' A' ' 108' ' ' LEU . 40.9 mtmt -85.32 122.83 73.68 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.181 -0.95 . . . . 0.0 109.397 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.24 146.28 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.216 1.944 . . . . 0.0 113.137 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.71 -21.29 39.76 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.4 mt -104.45 122.97 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.296 -1.12 . . . . 0.0 109.307 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -118.8 149.3 46.25 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.69 -0.631 . . . . 0.0 109.858 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -40.56 165.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.564 2.176 . . . . 0.0 112.619 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.07 147.08 50.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.353 -0.842 . . . . 0.0 110.603 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.453 ' OH ' ' CE ' ' A' ' 44' ' ' MET . 5.9 p90 -76.64 167.39 21.92 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.731 0.777 . . . . 0.0 110.759 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 73.8 m80 53.29 -94.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.622 -0.674 . . . . 0.0 110.147 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 93.7 mtp -138.48 -151.79 0.4 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.389 -0.819 . . . . 0.0 109.747 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 59.35 34.96 23.04 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -88.62 62.47 6.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.471 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -146.16 -67.01 0.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 108.889 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -96.36 -19.13 19.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.391 -0.818 . . . . 0.0 109.668 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 -110.51 138.15 47.27 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.461 -0.775 . . . . 0.0 110.085 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.8 mm -136.27 154.31 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.462 -0.774 . . . . 0.0 108.938 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.4 m -98.85 131.28 45.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.853 . . . . 0.0 110.814 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.5 t -113.16 133.84 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.6 tp -93.71 112.76 24.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.432 -0.793 . . . . 0.0 110.256 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.03 -39.54 90.28 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.637 0.732 . . . . 0.0 109.432 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -71.89 -6.21 40.15 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.285 -0.884 . . . . 0.0 109.245 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.02 177.65 1.52 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.72 -12.73 24.46 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 123.038 2.492 . . . . 0.0 111.404 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.82 136.9 54.86 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.562 0.696 . . . . 0.0 110.684 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.96 -178.73 46.03 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.49 81.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.618 -0.931 . . . . 0.0 109.671 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -56.55 -42.07 77.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.887 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.423 ' OE2' ' NZ ' ' A' ' 77' ' ' LYS . 46.0 tp10 -69.09 -40.05 78.66 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.013 -1.054 . . . . 0.0 109.443 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.424 HD13 HG22 ' A' ' 105' ' ' ILE . 97.2 mt -64.77 -43.13 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.351 -0.843 . . . . 0.0 109.484 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.622 ' CD2' ' CE2' ' A' ' 9' ' ' TYR . 62.7 m170 -56.89 -44.33 82.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 109.487 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.5 t -62.72 -43.45 98.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.37 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.476 ' CD2' ' HZ3' ' A' ' 77' ' ' LYS . 88.9 mt -63.39 -41.02 98.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.362 -0.836 . . . . 0.0 109.209 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 109' ' ' ILE . 86.6 mt -63.0 -42.45 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -56.3 -42.26 77.28 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.256 -0.903 . . . . 0.0 108.781 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.23 -37.69 88.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' SER . . . . . 0.632 ' HG ' ' CD1' ' A' ' 64' ' ' LEU . 2.4 m -60.75 -39.66 89.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.46 -0.775 . . . . 0.0 109.29 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -59.89 -42.9 94.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.573 -0.704 . . . . 0.0 109.688 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -52.62 -46.36 67.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 110.091 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 115' ' ' LEU . 4.1 mm? -65.9 -40.11 91.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.413 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.434 ' HG1' ' HE1' ' A' ' 39' ' ' TRP . 15.9 p -93.94 15.46 16.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.978 . . . . 0.0 109.147 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 121.687 0.756 . . . . 0.0 110.673 -179.724 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.9 ttp . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.711 0.767 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.8 p30 -92.17 170.32 9.91 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.997 0.903 . . . . 0.0 110.408 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -63.5 -42.07 98.51 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.567 0.699 . . . . 0.0 109.607 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -51.33 -43.02 61.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.759 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -66.83 -37.78 85.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 109.457 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -61.21 -44.22 97.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.337 -0.852 . . . . 0.0 109.889 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.44 -46.66 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.184 -0.947 . . . . 0.0 109.726 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -63.9 -45.62 88.52 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 110.001 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.448 ' CD2' ' NE2' ' A' ' 106' ' ' HIS . 56.0 t80 -66.25 -42.16 88.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 110.195 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.41 98.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.208 -0.932 . . . . 0.0 109.99 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ASP . 84.6 mt-30 -65.75 -41.72 91.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.287 -0.883 . . . . 0.0 110.031 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -62.76 -31.49 72.45 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.889 -1.132 . . . . 0.0 109.185 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -87.93 -45.29 10.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 111.69 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -107.4 -13.85 15.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.013 -1.054 . . . . 0.0 111.251 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 11' ' ' GLN . 99.3 m-20 54.52 34.16 20.52 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.08 -1.012 . . . . 0.0 108.776 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.9 m -121.64 132.09 54.47 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.857 0.836 . . . . 0.0 110.273 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -83.04 152.25 65.05 Favored Pre-proline 0 N--CA 1.486 1.367 0 O-C-N 121.595 -0.69 . . . . 0.0 109.166 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.61 134.58 27.15 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.172 1.915 . . . . 0.0 112.481 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -106.03 121.61 44.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.478 -0.763 . . . . 0.0 109.232 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -85.37 116.88 67.4 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.42 -0.8 . . . . 0.0 109.825 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HG2' ' H ' ' A' ' 22' ' ' TRP . 72.4 Cg_endo -80.19 -90.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.52 2.147 . . . . 0.0 111.999 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.414 ' H ' ' HG2' ' A' ' 21' ' ' PRO . 5.5 m-90 -81.18 137.5 35.89 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.855 0.836 . . . . 0.0 110.055 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -65.77 -30.69 71.38 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.542 0.686 . . . . 0.0 110.066 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -67.84 -0.56 4.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.808 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -143.77 73.02 17.04 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.039 -1.038 . . . . 0.0 109.61 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.61 -19.0 25.01 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.363 2.042 . . . . 0.0 110.881 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -81.18 -4.23 54.77 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.631 0.729 . . . . 0.0 109.209 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -96.11 139.1 32.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.468 -0.77 . . . . 0.0 109.222 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.97 146.37 47.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.697 . . . . 0.0 109.398 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.4 t -127.87 129.58 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.396 0.617 . . . . 0.0 109.395 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -118.24 113.87 22.14 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -146.49 161.36 40.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.15 -0.969 . . . . 0.0 110.086 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.524 ' O ' ' N ' ' A' ' 37' ' ' ASP . 53.1 m170 -96.68 129.34 44.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.527 -0.733 . . . . 0.0 109.784 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.6 m -69.6 -20.66 63.63 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.58 0.705 . . . . 0.0 109.673 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.39 -45.64 90.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.09 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 37' ' ' ASP . 93.8 m-20 -125.58 -30.73 3.05 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.403 -0.81 . . . . 0.0 109.838 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 33' ' ' HIS . 1.2 p30 50.68 25.19 1.96 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.564 0.697 . . . . 0.0 110.04 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.24 -8.53 45.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.138 -0.977 . . . . 0.0 108.777 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -91.19 146.52 23.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.378 -0.826 . . . . 0.0 110.02 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.8 124.35 43.1 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.698 0.761 . . . . 0.0 109.493 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.61 105.71 2.84 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.86 149.36 52.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.267 -0.895 . . . . 0.0 109.457 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 tt -118.91 128.04 54.05 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.98 163.97 39.55 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.875 0.845 . . . . 0.0 110.211 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 51.9 p-10 -93.52 145.61 24.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.537 0.684 . . . . 0.0 110.016 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.6 pt -155.75 146.96 16.63 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.606 -0.684 . . . . 0.0 109.467 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.44 141.67 97.83 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.099 1.866 . . . . 0.0 111.619 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.53 -20.26 66.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.484 -0.76 . . . . 0.0 109.902 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -54.76 -16.59 2.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.431 -0.793 . . . . 0.0 110.214 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -85.5 -23.72 27.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.253 -0.905 . . . . 0.0 111.171 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 pt -95.64 10.69 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.892 -1.13 . . . . 0.0 109.726 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.13 -8.27 75.82 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.3 mt -78.77 129.98 36.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.806 -1.408 . . . . 0.0 109.996 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -62.23 -39.9 94.34 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.591 0.71 . . . . 0.0 109.34 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -42.07 133.23 4.12 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.8 p30 -89.6 3.08 53.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.462 -1.022 . . . . 0.0 108.93 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.8 144.65 56.18 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.731 0.777 . . . . 0.0 110.485 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -87.11 145.57 26.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.52 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.51 160.42 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.658 0.742 . . . . 0.0 110.321 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.77 132.89 34.99 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.305 0.574 . . . . 0.0 110.019 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.41 156.16 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.659 0.743 . . . . 0.0 110.017 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.8 pt -136.09 146.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.596 0.713 . . . . 0.0 109.963 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -81.87 143.34 31.77 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.524 0.678 . . . . 0.0 110.308 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.26 125.97 30.48 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -82.95 131.28 35.19 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.689 0.757 . . . . 0.0 110.67 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.83 161.8 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.739 0.78 . . . . 0.0 109.726 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -87.11 153.14 54.03 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.529 -0.732 . . . . 0.0 109.464 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -47.5 -26.18 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.159 1.906 . . . . 0.0 111.577 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -94.78 -29.17 14.89 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.708 0.766 . . . . 0.0 109.345 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.5 mt -86.77 -6.51 58.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 0.0 109.644 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.29 -39.58 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 109.553 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -61.32 -47.04 93.03 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.6 m -59.59 -42.49 92.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.295 -1.121 . . . . 0.0 110.532 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.2 tt -84.65 -24.37 29.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 110.576 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.605 ' NH1' ' NZ ' ' A' ' 88' ' ' LYS . 69.7 ttt180 -82.72 -40.56 20.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.868 -1.145 . . . . 0.0 109.173 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -69.02 1.22 3.66 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 75' ' ' ARG . 34.8 mmtt -88.01 116.03 64.94 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.473 -0.767 . . . . 0.0 109.459 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.26 144.92 37.3 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.331 2.02 . . . . 0.0 113.045 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.61 -20.76 46.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.01 125.67 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.477 -1.013 . . . . 0.0 109.396 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.422 ' O ' ' OG1' ' A' ' 93' ' ' THR . 57.8 m-85 -106.0 151.65 40.11 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.593 -0.692 . . . . 0.0 109.996 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.22 146.62 81.87 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.5 2.133 . . . . 0.0 112.194 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.09 153.23 44.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.546 -0.721 . . . . 0.0 110.592 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.09 -143.02 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.916 0.865 . . . . 0.0 110.52 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 46.16 -113.54 0.44 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.443 0.639 . . . . 0.0 109.954 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 98.2 mmm -141.07 0.89 1.59 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 89' ' ' GLU . 81.8 m-20 -59.64 -85.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 109.691 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.605 ' NZ ' ' NH1' ' A' ' 75' ' ' ARG . 62.7 tttm 56.86 -76.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.648 -0.657 . . . . 0.0 110.222 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' ASN . 97.5 mt-10 -65.35 -38.7 90.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 0.0 109.673 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -68.51 -68.12 0.42 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.584 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -120.57 159.4 25.33 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.525 -0.734 . . . . 0.0 109.634 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 mm -129.6 147.69 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.919 0.866 . . . . 0.0 109.826 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 6.1 p -90.59 134.6 34.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.683 -0.636 . . . . 0.0 110.076 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -115.48 129.87 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 34.0 tp -86.77 104.84 16.53 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.669 0.747 . . . . 0.0 109.976 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.76 -38.4 88.96 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.788 0.804 . . . . 0.0 109.237 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.39 -5.88 44.97 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.897 0.856 . . . . 0.0 109.113 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.92 -175.41 8.96 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.514 ' O ' ' C ' ' A' ' 100' ' ' LEU . 44.5 Cg_endo -71.63 -81.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.633 2.222 . . . . 0.0 112.226 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.514 ' C ' ' O ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER 19.2 -120.7 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 121.158 0.504 . . . . 0.0 111.689 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.95 165.61 30.19 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.22 -39.07 86.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.528 -0.984 . . . . 0.0 109.461 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -64.91 -35.5 81.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.447 -0.783 . . . . 0.0 109.611 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -67.09 -40.7 87.01 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.201 -0.937 . . . . 0.0 109.411 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.71 -43.3 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 109.273 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' HIS . . . . . 0.448 ' NE2' ' CD2' ' A' ' 9' ' ' TYR . 52.1 m170 -56.65 -44.95 81.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 109.76 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.2 m -62.25 -42.44 99.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.744 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.52 -41.03 96.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 109.194 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 109' ' ' ILE . 86.7 mt -63.1 -42.7 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.339 -0.85 . . . . 0.0 108.988 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -53.77 -46.55 71.0 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.502 -0.749 . . . . 0.0 109.438 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -64.43 -38.53 91.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.075 -1.016 . . . . 0.0 108.851 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.6 p -62.18 -36.24 81.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 0.0 109.226 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -61.75 -44.6 96.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.413 -0.805 . . . . 0.0 109.664 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.16 -41.86 89.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.296 -0.877 . . . . 0.0 109.612 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.8 mt -66.53 -38.7 87.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.341 -0.849 . . . . 0.0 109.798 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.8 p -89.09 5.84 42.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.216 -0.927 . . . . 0.0 109.372 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 108.903 179.624 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -100.41 156.79 17.06 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.821 0.82 . . . . 0.0 110.367 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.0 mtp-105 -60.6 -46.58 89.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.64 -0.662 . . . . 0.0 110.171 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -47.73 -40.51 20.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.992 . . . . 0.0 109.677 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.77 -41.6 87.43 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.344 -0.848 . . . . 0.0 109.366 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -63.72 -45.43 89.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.458 -0.777 . . . . 0.0 110.095 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.2 mm -63.84 -46.02 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.79 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -67.38 -39.04 85.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 0.0 108.925 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -61.78 -46.14 90.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.456 -0.778 . . . . 0.0 109.936 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.28 86.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.477 -0.765 . . . . 0.0 109.914 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -65.95 -21.71 66.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -84.42 -53.22 5.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 109.914 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -88.87 -44.02 10.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.446 -0.784 . . . . 0.0 111.601 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 15' ' ' ASP . 45.6 m-85 -93.45 -6.16 47.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.785 -1.197 . . . . 0.0 110.071 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER 37.4 34.55 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.622 0.725 . . . . 0.0 109.796 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 14' ' ' TYR . 7.8 t -104.45 145.74 29.85 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.564 0.697 . . . . 0.0 110.085 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -98.47 151.28 37.4 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.66 149.35 73.51 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.712 2.275 . . . . 0.0 112.659 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -136.33 151.16 49.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.673 -0.642 . . . . 0.0 109.354 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -139.64 86.0 14.3 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -55.17 -38.1 93.8 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.566 2.178 . . . . 0.0 110.758 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -94.71 116.44 28.75 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.373 0.606 . . . . 0.0 109.509 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 25' ' ' PHE . 17.4 pt-20 -69.49 -31.31 69.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.493 -0.754 . . . . 0.0 109.405 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -64.78 -0.66 1.55 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.564 -0.71 . . . . 0.0 109.464 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' H ' ' C ' ' A' ' 23' ' ' GLU . 73.2 m-85 -137.05 71.75 54.95 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 109.333 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.7 -20.58 30.26 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.471 2.114 . . . . 0.0 111.615 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.18 -6.0 58.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.477 -0.764 . . . . 0.0 109.306 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.76 140.19 29.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.65 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.11 133.15 50.44 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.73 129.97 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.682 -0.636 . . . . 0.0 109.348 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -113.62 134.15 54.88 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -158.41 149.48 20.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.533 ' O ' ' NE1' ' A' ' 39' ' ' TRP . 81.2 m-70 -99.57 118.04 35.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.538 -0.726 . . . . 0.0 109.604 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 m -76.52 -15.09 59.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.534 -0.728 . . . . 0.0 109.149 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.59 -5.34 51.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.899 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 116' ' ' THR . 45.8 t-20 -115.24 -30.9 6.16 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.541 -0.724 . . . . 0.0 109.469 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 38' ' ' LYS . 65.1 t0 57.73 134.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.851 0.834 . . . . 0.0 111.018 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 6.3 tmtt? 82.41 102.2 0.05 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.515 0.674 . . . . 0.0 109.739 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -171.01 175.19 4.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.45 -0.781 . . . . 0.0 109.618 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.511 ' CG ' ' O ' ' A' ' 39' ' ' TRP . 80.3 m-85 -158.44 119.14 3.34 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.45 105.39 2.07 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.93 138.64 45.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 0.0 109.091 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 tt -116.4 124.76 50.83 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.8 ptt? -152.39 156.01 38.71 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.815 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.413 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 98.3 m-20 -94.4 114.49 26.53 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.6 pt -118.03 145.29 36.51 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.766 -0.583 . . . . 0.0 109.998 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -46.81 143.26 9.46 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.144 1.896 . . . . 0.0 112.431 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.09 -21.78 66.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.352 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -77.36 -14.23 59.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 109.783 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -84.57 -10.7 57.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 110.158 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 13.7 pt -105.08 1.45 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.2 -8.36 60.71 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.0 mt -79.72 139.2 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.848 -1.383 . . . . 0.0 110.14 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.37 -38.22 88.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.742 -0.599 . . . . 0.0 110.746 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -49.66 145.36 8.32 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.862 -178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -101.8 9.19 41.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.596 -0.943 . . . . 0.0 108.929 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -76.5 146.28 38.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 110.305 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.6 144.0 37.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.563 -0.711 . . . . 0.0 109.77 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.93 161.89 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.417 -0.802 . . . . 0.0 110.407 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.413 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 24.1 t70 -100.73 128.17 46.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.845 -0.534 . . . . 0.0 109.934 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.07 157.69 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.604 -0.685 . . . . 0.0 109.771 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 pt -132.61 150.15 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.48 0.657 . . . . 0.0 109.706 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 64.5 t0 -80.13 134.65 36.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.67 -0.644 . . . . 0.0 109.864 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.488 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.4 OUTLIER -125.82 124.0 39.98 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -89.91 129.47 36.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.943 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.0 m -138.64 164.68 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.895 0.855 . . . . 0.0 110.663 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.3 155.1 90.08 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.55 -24.62 75.3 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.752 2.302 . . . . 0.0 112.402 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -91.16 -23.59 20.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -0.968 . . . . 0.0 110.161 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.4 mt -92.68 1.18 57.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.03 -1.044 . . . . 0.0 109.469 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.6 p -63.98 -41.56 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 108.831 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.94 -40.52 98.98 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.2 t -65.34 -54.79 23.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -1.133 . . . . 0.0 110.281 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.25 -43.89 76.84 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 110.638 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -69.93 -18.29 63.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.457 -0.777 . . . . 0.0 110.214 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -71.66 -32.86 68.34 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.828 -1.17 . . . . 0.0 108.868 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -66.63 139.98 96.22 Favored Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.807 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.06 157.84 53.54 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.191 1.927 . . . . 0.0 112.562 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.44 -18.49 49.03 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.8 mt -103.23 117.11 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.971 . . . . 0.0 109.209 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 63.0 m-85 -105.82 151.2 39.89 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.694 -0.629 . . . . 0.0 109.445 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.631 ' CB ' ' HZ3' ' A' ' 88' ' ' LYS . 57.9 Cg_endo -68.75 153.17 73.61 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.608 2.205 . . . . 0.0 112.648 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.53 139.73 58.8 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.356 -0.84 . . . . 0.0 110.059 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.52 ' CZ ' ' CE1' ' A' ' 85' ' ' HIS . 54.2 p90 -90.13 2.76 54.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.557 -0.714 . . . . 0.0 109.207 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.52 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 78.5 m80 -79.9 -168.34 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.393 -0.817 . . . . 0.0 110.65 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.0 mtt -63.38 -40.37 97.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.518 -0.739 . . . . 0.0 109.574 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -81.31 -172.79 3.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.258 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.631 ' HZ3' ' CB ' ' A' ' 82' ' ' PRO . 48.8 tttp -165.31 -61.06 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -67.87 -38.7 83.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.567 -0.708 . . . . 0.0 109.455 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.86 -50.07 68.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.486 -0.759 . . . . 0.0 109.988 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -115.96 137.01 52.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.675 -0.64 . . . . 0.0 109.732 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.8 mm -129.16 133.39 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.569 0.699 . . . . 0.0 109.189 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.9 m -81.58 130.82 35.19 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.634 -0.666 . . . . 0.0 109.702 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.18 132.98 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.598 -0.689 . . . . 0.0 109.245 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.5 tp -87.54 103.84 15.93 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.509 0.671 . . . . 0.0 110.095 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.434 ' C ' ' H ' ' A' ' 98' ' ' GLY . 72.2 mt -65.73 -40.08 91.82 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.607 0.717 . . . . 0.0 109.218 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -76.83 11.12 1.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -89.66 -164.5 40.13 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.89 0.41 10.02 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 123.226 2.617 . . . . 0.0 111.697 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 4.3 mm? -61.25 135.22 57.66 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.95 0.881 . . . . 0.0 110.985 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.68 157.43 28.7 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.08 97.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.561 -0.964 . . . . 0.0 109.538 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -70.26 -34.87 73.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.337 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.06 -43.25 92.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.457 -0.777 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.73 -42.91 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.511 -0.743 . . . . 0.0 109.37 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -56.49 -43.76 79.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 109.673 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.5 t -61.93 -44.82 95.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.395 -0.816 . . . . 0.0 109.963 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.65 -41.0 98.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.48 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.56 -42.64 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.018 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -51.7 -43.86 62.95 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -62.71 -43.23 99.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.618 -0.676 . . . . 0.0 109.324 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.2 p -70.02 -30.86 68.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 0.0 109.433 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.16 -43.91 87.63 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.441 -0.787 . . . . 0.0 109.179 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -49.84 -31.01 10.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.541 -0.724 . . . . 0.0 109.698 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 115' ' ' LEU . 10.2 mp -84.25 -17.43 39.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -0.857 . . . . 0.0 109.617 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.534 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 32.3 p -102.92 15.23 29.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.453 -0.78 . . . . 0.0 109.211 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 18.2 mmm180 -63.77 141.51 58.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.973 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.428 ' CD1' ' N ' ' A' ' 118' ' ' LEU . 10.6 mp -77.31 152.1 34.7 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.564 0.697 . . . . 0.0 110.821 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 56.99 75.69 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.654 0.74 . . . . 0.0 110.118 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.766 ' HD1' ' H ' ' A' ' 121' ' ' HIS . 0.0 OUTLIER -66.51 -39.69 88.8 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.629 -0.669 . . . . 0.0 109.404 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.766 ' H ' ' HD1' ' A' ' 120' ' ' HIS . 19.3 p80 -154.54 146.4 23.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 110.23 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -174.37 83.78 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -157.51 123.76 4.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.407 -0.808 . . . . 0.0 109.466 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -66.77 -39.98 88.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.49 -0.756 . . . . 0.0 109.617 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.191 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 tpp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.02 165.96 12.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.394 -0.817 . . . . 0.0 110.446 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -63.09 -42.52 99.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.75 -0.594 . . . . 0.0 109.731 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.52 HE22 ' CG ' ' A' ' 8' ' ' ASP . 2.2 tm0? -64.04 -38.59 91.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.146 -0.972 . . . . 0.0 109.471 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -63.57 -39.64 94.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.524 -0.735 . . . . 0.0 109.415 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -61.94 -46.86 87.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.438 -0.789 . . . . 0.0 109.83 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.66 -44.36 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.615 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.52 ' CG ' HE22 ' A' ' 4' ' ' GLN . 54.3 m-20 -65.87 -38.26 88.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.82 . . . . 0.0 109.023 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.501 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 91.6 t80 -61.58 -44.52 96.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.803 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' TYR . . . -64.13 -36.65 84.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 110.312 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.576 ' O ' ' N ' ' A' ' 15' ' ' ASP . 58.3 mm-40 -61.88 -44.27 97.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.147 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -66.78 -38.44 86.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.893 -1.129 . . . . 0.0 109.552 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 29.9 mmtp -88.19 -11.73 45.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.491 -0.756 . . . . 0.0 111.302 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.411 ' CD1' ' NE2' ' A' ' 33' ' ' HIS . 80.7 m-85 -144.61 -21.68 0.52 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.821 -1.174 . . . . 0.0 110.818 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.576 ' N ' ' O ' ' A' ' 11' ' ' GLN . 65.0 m-20 53.83 32.94 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 0.0 109.063 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.533 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 12.3 t -103.15 134.91 45.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.499 -0.75 . . . . 0.0 109.674 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -82.52 149.14 60.35 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.611 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.33 151.98 71.5 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.44 2.093 . . . . 0.0 112.346 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -132.77 130.21 39.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.646 -0.659 . . . . 0.0 109.288 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.424 ' O ' ' CD2' ' A' ' 20' ' ' HIS . 31.5 p-80 -132.4 86.33 45.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.72 -35.85 93.99 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.515 2.143 . . . . 0.0 111.381 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -81.35 104.06 11.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.588 -0.695 . . . . 0.0 109.977 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -68.07 -34.99 77.48 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.501 0.667 . . . . 0.0 109.359 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -67.24 -3.13 7.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.402 -0.811 . . . . 0.0 109.708 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -135.08 71.51 68.6 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.493 -0.754 . . . . 0.0 109.463 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.75 -17.54 42.25 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.323 2.015 . . . . 0.0 111.126 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -80.16 -5.92 56.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.495 -0.753 . . . . 0.0 109.221 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -104.68 135.91 45.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.505 -0.747 . . . . 0.0 109.471 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.67 147.87 47.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.583 -0.698 . . . . 0.0 109.318 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.86 126.4 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.759 -0.588 . . . . 0.0 109.682 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -108.92 117.75 35.0 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -149.45 153.17 36.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.066 -1.021 . . . . 0.0 109.792 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.652 ' N ' ' HE1' ' A' ' 39' ' ' TRP . 28.1 m80 -83.76 132.07 34.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 110.379 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -67.8 -40.19 83.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 109.828 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -92.68 -42.4 9.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.401 -0.812 . . . . 0.0 109.756 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' A' ' 38' ' ' LYS . 1.4 m-20 -95.01 31.76 1.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 37' ' ' ASP . 52.9 p-10 -48.38 83.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.541 0.686 . . . . 0.0 110.444 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 36' ' ' ASN . 6.1 tmtt? -147.32 -22.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.652 ' HE1' ' N ' ' A' ' 33' ' ' HIS . 4.4 p-90 -101.52 127.94 47.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.559 -0.713 . . . . 0.0 109.32 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -112.43 129.77 56.21 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.599 0.714 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.9 121.11 7.25 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.19 147.98 45.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.72 -0.612 . . . . 0.0 109.595 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.27 126.08 54.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.468 ' O ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -157.67 161.25 38.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.953 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' OD2' ' NH1' ' A' ' 58' ' ' ARG . 92.6 m-20 -99.67 142.57 30.98 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.9 pt -149.27 146.46 21.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.897 . . . . 0.0 109.306 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -49.74 144.02 21.27 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.869 1.713 . . . . 0.0 112.849 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.49 -21.81 66.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.594 -0.691 . . . . 0.0 109.802 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.18 -16.27 59.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.903 . . . . 0.0 110.103 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -84.87 -10.08 57.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.169 -0.957 . . . . 0.0 110.093 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 12.6 pt -103.57 3.32 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.285 -0.884 . . . . 0.0 109.206 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.15 -8.7 60.98 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.5 mt -83.93 129.98 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.81 -1.406 . . . . 0.0 110.334 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -65.77 87.0 0.09 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.622 -0.674 . . . . 0.0 109.335 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -176.29 136.32 3.21 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -95.81 11.94 31.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -1.078 . . . . 0.0 108.993 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -74.86 144.85 43.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 110.64 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.51 ' NH1' ' OD2' ' A' ' 45' ' ' ASP . 72.4 ttp85 -76.48 137.06 39.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.504 -0.747 . . . . 0.0 109.806 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.14 161.54 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -100.66 127.58 47.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.519 -0.738 . . . . 0.0 109.464 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -132.98 158.4 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.443 -0.785 . . . . 0.0 110.353 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 pt -135.02 152.8 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -116.14 145.27 43.2 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.437 0.637 . . . . 0.0 109.875 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.44 157.78 45.26 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -87.81 137.58 32.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.343 -0.848 . . . . 0.0 110.882 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.9 m -143.58 163.35 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.514 -0.741 . . . . 0.0 109.862 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -77.92 154.78 80.51 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.512 -0.743 . . . . 0.0 109.664 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -65.14 -21.5 62.57 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.411 2.074 . . . . 0.0 111.151 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -87.48 -26.92 22.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.131 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.3 mt -96.69 6.51 48.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.414 -0.803 . . . . 0.0 109.334 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.09 -36.49 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.513 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.72 -21.45 79.33 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.0 m -62.27 -59.07 5.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.18 -1.188 . . . . 0.0 110.914 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.516 ' H ' ' CD2' ' A' ' 74' ' ' LEU . 2.5 pt? -85.49 -29.25 24.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.057 -1.027 . . . . 0.0 110.698 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -67.73 -21.53 65.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.987 -1.07 . . . . 0.0 110.231 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.74 -8.14 55.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.051 -1.031 . . . . 0.0 109.229 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -75.92 149.09 82.55 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 110.081 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.5 140.87 49.03 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.435 2.09 . . . . 0.0 112.533 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.32 -21.1 18.56 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.506 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 2.7 mp -89.06 124.39 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.388 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 55.5 m-85 -123.84 151.14 64.06 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.751 -0.593 . . . . 0.0 109.588 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 84' ' ' TYR . 41.2 Cg_endo -67.95 158.57 56.77 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.412 2.075 . . . . 0.0 112.16 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 85' ' ' HIS . . . -66.17 65.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.451 -0.78 . . . . 0.0 109.423 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER 50.84 -83.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.696 -0.627 . . . . 0.0 109.719 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.574 ' N ' ' O ' ' A' ' 83' ' ' ALA . 60.8 t-80 -174.97 -7.66 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 65.2 mtt -63.92 -41.27 97.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.702 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 88' ' ' LYS . 36.0 m120 -119.61 -74.65 0.6 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.509 -0.744 . . . . 0.0 109.492 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.434 ' O ' ' O ' ' A' ' 87' ' ' ASN . 84.9 tttt 57.9 150.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.611 0.72 . . . . 0.0 110.264 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 88' ' ' LYS . 31.7 tt0 75.51 -67.42 0.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -65.53 -52.61 51.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.468 -0.77 . . . . 0.0 109.825 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.401 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 7.3 m0 -119.0 132.94 56.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.698 -0.626 . . . . 0.0 109.858 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.19 133.95 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 6.8 p -87.42 143.14 27.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.773 -0.579 . . . . 0.0 110.152 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.4 t -122.29 134.91 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.6 tp -84.68 108.11 17.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.465 -0.772 . . . . 0.0 109.877 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.03 -39.58 93.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.656 -0.652 . . . . 0.0 109.353 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -75.25 1.18 14.21 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.092 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.0 177.14 20.26 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.71 -10.05 21.5 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.065 2.51 . . . . 0.0 111.844 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.61 143.32 57.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 110.403 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.78 170.52 48.04 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.153 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.67 78.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.727 -0.867 . . . . 0.0 109.13 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -62.21 -39.14 91.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -65.08 -37.61 88.07 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.336 -0.853 . . . . 0.0 108.904 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.42 -43.75 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 109.035 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -61.1 -45.46 94.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.426 -0.796 . . . . 0.0 109.762 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.9 m -61.39 -44.0 97.91 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.402 -0.811 . . . . 0.0 109.815 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.34 -44.52 91.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.58 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.16 -42.76 91.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.399 -0.813 . . . . 0.0 108.939 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -55.03 -40.63 70.44 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -63.64 -42.19 98.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.6 m -61.21 -41.94 97.73 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.11 -45.3 94.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.602 -0.686 . . . . 0.0 110.224 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -59.9 -29.03 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.493 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.1 mt -79.53 -15.7 57.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.723 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -120.43 14.45 11.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.492 -0.755 . . . . 0.0 109.081 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -56.78 138.85 52.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.878 . . . . 0.0 109.862 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.1 tp -90.88 136.71 32.89 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.428 -0.795 . . . . 0.0 110.507 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -112.92 76.52 0.98 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.706 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -67.67 -37.97 83.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.536 -0.727 . . . . 0.0 109.719 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.656 ' HD1' ' CD2' ' A' ' 120' ' ' HIS . 73.7 m80 -135.0 149.54 50.2 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.629 0.728 . . . . 0.0 110.221 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -67.01 -39.22 87.02 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.794 -0.566 . . . . 0.0 109.853 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -147.68 155.4 41.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.083 -1.011 . . . . 0.0 109.944 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.423 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 6.5 p80 -152.27 165.7 34.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.423 ' CG ' ' O ' ' A' ' 124' ' ' HIS . 77.9 m80 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.858 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.297 0.57 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -93.78 168.13 11.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -0.794 . . . . 0.0 110.511 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -62.08 -43.38 98.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.692 -0.63 . . . . 0.0 109.8 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -65.72 -37.55 86.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 0.0 109.612 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.9 -42.38 97.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.543 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -61.93 -45.41 93.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.741 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.407 HG22 HD11 ' A' ' 7' ' ' ILE . 96.5 mt -63.8 -43.78 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.391 -0.818 . . . . 0.0 109.448 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.495 ' OD2' ' NZ ' ' A' ' 12' ' ' LYS . 45.6 t0 -65.26 -37.64 87.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.381 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.472 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 83.4 t80 -59.97 -48.52 81.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.196 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.54 -30.69 71.06 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.478 -0.764 . . . . 0.0 109.115 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.56 ' O ' ' N ' ' A' ' 15' ' ' ASP . 36.0 tt0 -64.55 -42.26 95.8 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.46 -0.775 . . . . 0.0 109.404 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' NZ ' ' OD2' ' A' ' 8' ' ' ASP . 60.0 mttp -69.11 -36.8 77.93 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.882 -1.136 . . . . 0.0 109.814 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.472 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 30.3 mmtp -88.17 -12.37 44.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 111.292 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.496 ' CG ' ' CE1' ' A' ' 33' ' ' HIS . 94.2 m-85 -145.24 -22.11 0.49 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.869 -1.144 . . . . 0.0 110.46 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 11' ' ' GLN . 43.0 t0 54.82 34.58 22.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 109.011 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.7 m -102.01 130.1 48.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.404 -0.81 . . . . 0.0 109.402 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -87.02 156.71 54.82 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.445 -0.785 . . . . 0.0 109.985 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.54 140.16 45.49 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.188 1.925 . . . . 0.0 112.85 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -120.86 139.71 52.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -122.89 85.96 50.34 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.528 -0.732 . . . . 0.0 109.931 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.14 -39.55 90.5 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.65 2.233 . . . . 0.0 110.804 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -96.34 131.78 42.51 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.709 0.766 . . . . 0.0 110.137 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.573 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 1.1 pm0 -73.53 -36.06 65.64 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.695 -0.628 . . . . 0.0 109.772 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' C ' ' CD1' ' A' ' 25' ' ' PHE . 18.8 mtpp -67.95 10.45 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.439 -0.788 . . . . 0.0 111.16 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.434 ' H ' ' C ' ' A' ' 23' ' ' GLU . 81.2 m-85 -145.43 67.25 12.82 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.837 -1.164 . . . . 0.0 109.981 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.22 -20.37 32.74 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.571 2.18 . . . . 0.0 111.777 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -84.93 -4.11 58.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.068 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -88.42 150.8 22.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.788 . . . . 0.0 109.949 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.71 132.47 48.0 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.2 t -125.14 127.03 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.568 -0.707 . . . . 0.0 109.523 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -111.11 119.52 39.26 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -142.12 135.09 28.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.224 -0.922 . . . . 0.0 109.572 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.671 ' CD2' ' HE1' ' A' ' 39' ' ' TRP . 32.0 m-70 -100.1 127.52 46.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 109.818 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p -69.76 -25.06 63.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.49 -0.756 . . . . 0.0 109.506 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -78.15 -7.19 56.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 109.797 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 116' ' ' THR . 13.4 t-20 -117.43 30.19 7.44 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 38' ' ' LYS . 53.2 t0 60.97 29.19 18.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.34 0.59 . . . . 0.0 110.212 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 37' ' ' ASP . 57.4 mttp 53.17 106.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.357 -0.839 . . . . 0.0 110.053 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.671 ' HE1' ' CD2' ' A' ' 33' ' ' HIS . 7.9 p-90 -101.53 -177.47 3.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.523 -0.736 . . . . 0.0 110.202 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.31 129.21 46.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.572 -0.705 . . . . 0.0 110.252 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.03 105.75 3.28 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -111.43 125.72 54.18 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.577 0.703 . . . . 0.0 109.57 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 tt -129.66 112.91 14.15 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -162.88 174.13 12.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.41 -0.806 . . . . 0.0 109.568 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 87.7 m-20 -101.57 141.43 34.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.684 -0.635 . . . . 0.0 109.716 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.3 pt -143.34 145.54 32.56 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.565 -0.709 . . . . 0.0 109.464 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -48.5 144.28 14.18 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.989 1.792 . . . . 0.0 112.63 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.05 -24.06 67.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.6 -0.688 . . . . 0.0 110.191 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.86 -14.71 62.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 109.605 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -82.98 -12.58 57.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.399 -0.813 . . . . 0.0 110.501 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.471 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 11.2 pt -109.59 4.56 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.408 -0.808 . . . . 0.0 109.244 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.08 -17.19 59.06 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.75 130.82 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.864 -1.374 . . . . 0.0 110.39 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -86.05 99.18 11.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.534 -0.729 . . . . 0.0 109.362 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' LYS . . . -156.27 -8.17 0.07 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 41.79 20.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.995 -0.709 . . . . 0.0 109.647 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 55' ' ' GLY . 26.2 pttm -101.51 145.33 29.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.521 -0.737 . . . . 0.0 109.671 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -75.83 138.39 41.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.517 -0.739 . . . . 0.0 109.81 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.52 161.11 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.69 -0.631 . . . . 0.0 109.699 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 96.3 m-20 -88.79 132.42 34.64 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.559 -0.713 . . . . 0.0 109.433 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.01 149.23 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 109.836 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 pt -131.55 151.98 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.414 0.626 . . . . 0.0 109.823 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 67.9 t0 -86.05 142.54 28.66 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.456 -0.778 . . . . 0.0 109.457 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.529 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -133.01 126.71 32.51 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -88.96 126.72 35.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.642 -0.661 . . . . 0.0 110.038 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 m -137.91 163.88 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.541 -0.724 . . . . 0.0 109.588 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -80.74 157.31 72.11 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.083 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.88 -18.02 54.37 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.6 2.2 . . . . 0.0 110.987 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -95.44 -27.83 15.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.534 -0.729 . . . . 0.0 109.597 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.7 mt -89.89 -2.96 58.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.262 -0.898 . . . . 0.0 109.852 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.87 -38.87 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.867 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.32 -42.79 97.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.0 m -68.58 -56.26 8.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.329 . . . . 0.0 110.639 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.9 tt -65.56 -43.5 89.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 0.0 110.811 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.0 ttt-85 -67.81 -17.15 64.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.022 -1.049 . . . . 0.0 110.033 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -78.59 -31.52 47.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.032 -1.043 . . . . 0.0 108.94 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -58.24 146.11 71.81 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.241 -0.912 . . . . 0.0 110.264 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.71 148.31 58.63 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.332 2.021 . . . . 0.0 112.612 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.53 -17.89 46.01 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.536 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 2.0 mp -87.72 123.15 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.353 -1.087 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 65.7 m-85 -116.79 149.38 43.9 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.82 -0.55 . . . . 0.0 109.696 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -67.8 144.52 65.58 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.575 2.183 . . . . 0.0 112.15 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.83 144.9 55.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 109.989 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.485 ' CE1' ' CE1' ' A' ' 85' ' ' HIS . 43.9 p90 -78.1 9.0 4.05 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.438 -0.789 . . . . 0.0 109.334 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.485 ' CE1' ' CE1' ' A' ' 84' ' ' TYR . 96.3 m-70 -88.03 165.64 15.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 110.043 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.8 mtp -68.55 -8.39 41.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.657 ' C ' ' H ' ' A' ' 89' ' ' GLU . 60.6 m-80 -77.73 -67.47 0.72 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.32 -0.862 . . . . 0.0 109.549 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 63.3 -26.76 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.95 -0.468 . . . . 0.0 109.77 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.657 ' H ' ' C ' ' A' ' 87' ' ' ASN . 97.6 mt-10 -98.67 -63.86 1.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -59.35 -46.52 88.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.318 -0.863 . . . . 0.0 110.338 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.609 ' CE3' ' ND2' ' A' ' 87' ' ' ASN . 9.3 m0 -116.41 138.55 51.27 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.618 0.723 . . . . 0.0 110.006 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.8 mt -138.56 153.51 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.6 m -97.56 138.4 35.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 110.036 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.6 t -120.34 133.44 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.4 tp -88.63 109.43 20.1 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.594 0.712 . . . . 0.0 110.408 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.63 -39.32 88.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -69.17 -8.65 47.55 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -57.25 178.26 0.96 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.29 -12.75 25.44 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.976 2.451 . . . . 0.0 111.686 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 pp -68.28 137.18 54.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.347 -0.846 . . . . 0.0 110.266 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.7 176.02 47.53 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.158 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.0 77.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.789 -0.83 . . . . 0.0 109.459 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -62.0 -40.49 95.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.406 -0.808 . . . . 0.0 108.82 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.9 -41.99 95.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.34 -0.85 . . . . 0.0 108.869 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.4 -43.06 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.441 -0.787 . . . . 0.0 109.482 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -56.15 -43.57 78.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.703 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.2 p -64.22 -41.92 96.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 109.719 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.7 mt -64.81 -39.75 94.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.602 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.73 -42.6 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.385 -0.822 . . . . 0.0 109.182 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -57.95 -39.26 77.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 109.083 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.45 -42.91 98.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.303 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 99.6 p -63.94 -34.74 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 109.36 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 117' ' ' ARG . 88.9 t80 -60.14 -44.78 94.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.404 -0.81 . . . . 0.0 109.306 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.37 -43.54 96.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.5 -41.26 96.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.445 -0.784 . . . . 0.0 110.14 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.442 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 67.2 p -99.41 14.71 28.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.366 -0.834 . . . . 0.0 109.275 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 113' ' ' PHE . 38.6 ttp-105 -43.06 122.8 2.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.166 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.1 11.42 39.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.521 -0.737 . . . . 0.0 109.088 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.65 140.6 58.89 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.466 -0.771 . . . . 0.0 109.755 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.562 ' ND1' ' N ' ' A' ' 121' ' ' HIS . 60.4 t-80 -153.85 173.53 15.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.922 . . . . 0.0 109.981 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.562 ' N ' ' ND1' ' A' ' 120' ' ' HIS . 58.5 m170 -67.77 8.1 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.508 -0.745 . . . . 0.0 109.621 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.548 ' H ' ' C ' ' A' ' 120' ' ' HIS . 99.5 m-70 56.26 109.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.64 0.733 . . . . 0.0 110.382 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -66.95 -38.66 86.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.489 -0.757 . . . . 0.0 109.443 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -148.79 159.44 44.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.023 -179.509 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -93.57 -177.98 4.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 0.0 110.08 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.458 ' NH2' ' OD1' ' A' ' 60' ' ' ASP . 12.0 ptp85 -63.2 -32.9 74.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 109.541 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -56.44 -43.39 79.41 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.329 -0.857 . . . . 0.0 109.127 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.03 -42.44 84.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.067 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -62.05 -45.37 93.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.52 -0.737 . . . . 0.0 109.752 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.36 -43.09 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.408 -0.808 . . . . 0.0 109.36 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.72 -39.32 91.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.372 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -60.58 -44.46 96.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.818 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.06 86.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.521 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 16' ' ' THR . 98.9 mm-40 -65.19 -45.89 82.98 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 110.021 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.99 -37.27 83.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -63.71 -50.51 68.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.105 -0.997 . . . . 0.0 111.94 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -147.02 17.53 1.23 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.53 -1.357 . . . . 0.0 110.225 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 55.05 47.53 21.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.149 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.537 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 88.3 m -101.07 123.74 45.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.294 -0.879 . . . . 0.0 109.7 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.499 ' CB ' ' HZ3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -93.67 148.83 36.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 157.36 60.77 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.206 1.937 . . . . 0.0 112.672 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -108.71 155.15 21.06 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -136.85 86.56 21.15 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.478 -0.764 . . . . 0.0 110.047 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.78 -10.99 5.87 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.782 2.322 . . . . 0.0 110.393 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -102.04 98.66 8.83 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.5 0.667 . . . . 0.0 109.816 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 24' ' ' LYS . 14.9 pt-20 -68.55 -37.35 79.86 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.545 0.688 . . . . 0.0 109.658 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 23' ' ' GLU . 9.8 mtpm? -70.79 -3.54 19.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.479 -0.763 . . . . 0.0 110.788 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -142.95 77.38 16.25 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.078 -1.014 . . . . 0.0 110.018 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.66 -14.84 33.56 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.562 2.175 . . . . 0.0 112.099 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -78.72 -4.94 51.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.252 -0.905 . . . . 0.0 109.521 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -94.72 142.73 27.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.255 -0.903 . . . . 0.0 110.102 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.93 139.57 52.06 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -124.48 128.32 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.516 -0.74 . . . . 0.0 110.245 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.37 114.44 27.88 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 37' ' ' ASP . 77.8 ttt-85 -145.35 138.64 26.45 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.196 -0.94 . . . . 0.0 109.459 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.458 ' ND1' ' CD1' ' A' ' 39' ' ' TRP . 32.5 m170 -100.58 124.63 46.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.472 -0.767 . . . . 0.0 109.951 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.2 m -75.79 -22.71 56.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.428 -0.795 . . . . 0.0 109.983 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.64 -41.86 99.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.124 -0.985 . . . . 0.0 110.208 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 38' ' ' LYS . 12.3 m120 -93.49 4.07 54.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 0.0 108.531 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 98.8 m-20 47.56 11.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.77 . . . . 0.0 110.182 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 36' ' ' ASN . 8.4 mtmp? -139.99 -121.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.258 -0.901 . . . . 0.0 109.532 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.458 ' CD1' ' ND1' ' A' ' 33' ' ' HIS . 56.7 t-105 46.53 96.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.659 -0.651 . . . . 0.0 109.321 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -106.63 126.28 52.07 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.707 0.765 . . . . 0.0 109.981 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.06 128.53 10.68 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 140.55 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.943 -1.098 . . . . 0.0 109.812 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.6 130.74 55.49 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -157.19 157.88 35.2 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.943 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 33.6 p-10 -98.98 116.6 31.58 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 pt -125.74 145.8 52.85 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.688 -0.633 . . . . 0.0 109.722 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.2 139.05 22.02 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.811 1.674 . . . . 0.0 112.304 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.5 -22.03 65.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.191 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -62.67 -29.76 70.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.142 -0.974 . . . . 0.0 109.641 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.71 -40.55 95.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.802 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 12.2 pt -79.08 16.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.758 -1.214 . . . . 0.0 109.739 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.19 -8.24 58.36 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.443 -0.884 . . . . 0.0 110.927 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.9 mt -82.7 129.01 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.638 -1.507 . . . . 0.0 109.81 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -85.39 97.12 9.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.494 -0.754 . . . . 0.0 110.276 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.59 -16.96 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.516 -1.833 . . . . 0.0 108.516 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 57.6 t0 51.19 19.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -1.032 . . . . 0.0 109.069 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -107.9 146.3 32.55 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.583 -0.698 . . . . 0.0 110.138 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -73.91 139.3 44.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.493 -0.754 . . . . 0.0 109.7 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.44 157.88 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.424 -0.797 . . . . 0.0 109.464 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.458 ' OD1' ' NH2' ' A' ' 3' ' ' ARG . 90.2 m-20 -91.21 131.32 36.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.466 -0.771 . . . . 0.0 109.755 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.26 158.6 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.535 -0.728 . . . . 0.0 109.446 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.5 pt -134.53 146.49 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.421 0.629 . . . . 0.0 109.614 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 64.4 t0 -79.29 134.78 36.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.407 -0.808 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.488 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -127.14 121.82 32.45 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.3 tmtm? -83.89 134.83 34.67 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.418 -0.801 . . . . 0.0 110.114 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.0 m -143.84 164.28 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -93.32 155.34 41.04 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.521 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -48.75 -28.9 13.55 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.167 1.911 . . . . 0.0 111.26 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.02 -32.11 16.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.459 -0.776 . . . . 0.0 109.376 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.59 -5.25 58.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 109.466 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.429 ' CG1' ' N ' ' A' ' 72' ' ' GLY . 9.2 p -68.53 -40.44 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -0.909 . . . . 0.0 109.863 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.429 ' N ' ' CG1' ' A' ' 71' ' ' VAL . . . -63.87 -44.0 96.75 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.5 t -64.73 -26.32 68.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.938 -1.331 . . . . 0.0 110.21 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.98 -33.89 19.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.866 -1.146 . . . . 0.0 109.829 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -76.21 -7.49 54.97 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.375 -0.828 . . . . 0.0 109.105 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -7.33 59.68 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -94.14 113.76 61.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.634 -0.667 . . . . 0.0 109.474 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.94 147.05 19.95 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.303 2.002 . . . . 0.0 113.282 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.07 -13.28 67.31 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 15.4 mt -107.28 124.43 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.529 -0.983 . . . . 0.0 109.085 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.419 ' O ' ' OG1' ' A' ' 93' ' ' THR . 56.1 m-85 -119.47 150.07 49.04 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.76 -0.588 . . . . 0.0 110.01 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 83' ' ' ALA . 37.1 Cg_exo -56.13 149.45 53.66 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.124 1.882 . . . . 0.0 112.576 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 82' ' ' PRO . . . -45.99 174.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.825 0.822 . . . . 0.0 111.129 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.62 -71.73 0.28 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -137.97 140.95 40.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.551 -0.718 . . . . 0.0 109.934 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.0 mmm 57.59 154.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.738 0.78 . . . . 0.0 111.231 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.546 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 85.1 m-20 56.56 33.21 22.27 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.51 0.672 . . . . 0.0 109.388 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -63.27 -46.96 84.38 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.454 -0.779 . . . . 0.0 109.262 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -79.37 -35.87 40.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.122 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -66.35 -50.71 62.65 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.339 -0.851 . . . . 0.0 110.243 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.546 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 11.1 m0 -117.5 152.08 35.8 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.587 -0.696 . . . . 0.0 109.753 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.4 mm -136.22 157.68 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.567 -0.708 . . . . 0.0 109.451 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 7.6 p -105.85 123.68 48.35 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.8 t -108.46 131.06 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.5 tp -89.91 104.18 16.77 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.206 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.06 -39.49 86.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.539 -0.725 . . . . 0.0 109.264 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -69.28 -6.1 27.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.41 -0.806 . . . . 0.0 109.047 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -77.83 -162.26 18.12 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.72 6.26 5.89 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.348 2.699 . . . . 0.0 111.564 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.71 130.94 48.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 110.254 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.91 154.79 24.91 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.38 95.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.543 -0.975 . . . . 0.0 109.297 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.71 -42.08 95.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.943 . . . . 0.0 109.074 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -66.03 -43.95 86.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.446 -0.784 . . . . 0.0 109.198 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.58 -43.48 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.069 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -60.43 -43.57 96.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.462 -0.774 . . . . 0.0 109.654 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -62.77 -42.72 99.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.819 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.79 -41.92 95.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.931 . . . . 0.0 109.584 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.406 ' O ' ' OG ' ' A' ' 112' ' ' SER . 95.9 mt -63.79 -43.17 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.872 . . . . 0.0 108.919 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -61.19 -41.99 97.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -64.04 -41.58 97.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 109' ' ' ILE . 90.7 p -66.07 -33.91 76.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.79 . . . . 0.0 109.304 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.25 -47.93 83.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.633 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.49 -29.03 63.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.94 -42.23 97.39 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.185 -0.947 . . . . 0.0 109.511 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 117' ' ' ARG . 62.2 p -97.11 14.73 24.75 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.569 -0.707 . . . . 0.0 109.1 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.475 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 77.7 ttt-85 -40.78 -95.57 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.881 -0.512 . . . . 0.0 110.167 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.51 93.04 1.17 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.86 82.86 1.94 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -152.59 -59.99 0.15 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -84.08 138.69 32.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.649 -0.657 . . . . 0.0 110.22 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -148.55 -25.81 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -67.37 -39.35 85.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.476 -0.765 . . . . 0.0 109.664 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -65.79 -41.7 91.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.838 . . . . 0.0 109.705 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.531 ' N ' ' HD1' ' A' ' 125' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.326 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpp . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -105.77 163.85 12.39 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.553 -0.717 . . . . 0.0 110.019 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -61.48 -43.25 99.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.585 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -64.26 -40.91 96.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.452 -0.78 . . . . 0.0 109.754 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.89 -42.27 94.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 109.572 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.42 -45.03 96.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.767 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.29 -44.67 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.26 -0.9 . . . . 0.0 109.153 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.63 -44.13 94.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.816 . . . . 0.0 109.487 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.618 ' HH ' ' HZ1' ' A' ' 13' ' ' LYS . 61.2 t80 -64.15 -42.1 96.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.483 -0.76 . . . . 0.0 109.872 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.5 -54.31 48.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.379 -0.826 . . . . 0.0 110.698 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -64.9 -33.1 75.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.244 -0.91 . . . . 0.0 109.756 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -60.57 -46.59 89.65 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 109.791 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.618 ' HZ1' ' HH ' ' A' ' 9' ' ' TYR . 38.1 ttmt -87.2 -37.61 17.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.348 -0.845 . . . . 0.0 111.416 -178.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 77.2 m-85 -94.57 -0.73 54.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.924 -1.11 . . . . 0.0 111.115 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 14' ' ' TYR . 3.4 p30 40.97 35.61 0.36 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.379 -0.825 . . . . 0.0 109.907 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.6 t -118.64 143.88 46.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.566 -0.709 . . . . 0.0 109.359 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -96.23 151.81 38.4 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.308 -0.87 . . . . 0.0 109.564 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.22 149.55 85.32 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.469 2.112 . . . . 0.0 112.162 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 66.1 t0 -132.8 138.51 47.14 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.517 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 5.5 p80 -131.24 85.58 53.43 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -79.29 -10.52 14.87 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.943 1.762 . . . . 0.0 111.14 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -89.15 102.87 15.52 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.456 0.646 . . . . 0.0 109.555 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.86 -33.84 74.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -0.766 . . . . 0.0 109.592 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 25' ' ' PHE . 60.1 mttp -68.06 -5.75 19.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.348 -0.845 . . . . 0.0 109.849 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 24' ' ' LYS . 64.1 m-85 -153.29 83.84 4.49 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.202 -0.936 . . . . 0.0 109.463 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.4 -15.61 31.15 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.565 1.51 . . . . 0.0 111.209 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.63 -5.92 47.84 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.4 m-85 -86.08 141.68 29.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 109.106 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.98 135.93 38.08 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.44 126.01 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -110.26 122.66 48.2 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 95.6 mtm-85 -134.3 155.22 50.6 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.051 -1.031 . . . . 0.0 109.267 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 37' ' ' ASP . 1.4 t-160 -85.42 113.84 22.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.317 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 t -65.35 -23.43 66.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.525 -0.735 . . . . 0.0 109.799 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.8 -44.57 92.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.377 -0.827 . . . . 0.0 110.639 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -122.48 -26.73 4.53 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.377 -0.827 . . . . 0.0 109.63 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 33' ' ' HIS . 54.4 m-20 58.49 -159.12 0.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.438 0.637 . . . . 0.0 109.938 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 59.9 24.51 13.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.934 -0.479 . . . . 0.0 110.274 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 44.0 m95 -112.25 149.02 32.91 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.396 -0.815 . . . . 0.0 109.553 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -113.71 131.53 56.14 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.676 0.75 . . . . 0.0 110.239 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.15 105.62 3.24 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.58 131.89 53.87 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.724 0.773 . . . . 0.0 110.417 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 tt -126.76 120.29 28.99 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.592 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 3.7 ptt? -160.41 164.19 32.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.01 . . . . 0.0 109.507 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 96.9 m-20 -98.38 118.78 35.81 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.2 pt -120.73 145.95 42.36 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.44 -0.788 . . . . 0.0 109.45 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.21 141.74 96.67 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.902 1.735 . . . . 0.0 112.719 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.19 -20.74 65.69 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.493 0.663 . . . . 0.0 109.263 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 56' ' ' ASP . 95.6 mt-10 -53.69 -36.0 61.72 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.625 -0.672 . . . . 0.0 109.899 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.05 -39.01 93.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 110.317 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 pt -92.94 -0.94 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.08 36.44 85.73 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.153 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' A' ' 55' ' ' GLY . 6.0 mt -104.46 133.63 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.182 -1.187 . . . . 0.0 109.713 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 52.77 -83.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.707 -0.621 . . . . 0.0 109.806 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . 143.46 114.65 1.0 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.6 OUTLIER 61.47 39.35 15.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.623 -0.928 . . . . 0.0 110.67 178.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -113.46 118.63 35.04 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -72.39 133.35 44.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.181 -0.949 . . . . 0.0 109.516 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.11 161.66 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 20.3 m-20 -99.43 138.07 37.03 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.29 -0.881 . . . . 0.0 109.444 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.75 156.59 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.304 -0.872 . . . . 0.0 109.344 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.8 pt -133.74 157.98 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.549 0.69 . . . . 0.0 109.702 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -90.48 122.07 32.99 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.85 120.47 39.36 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -84.23 135.55 34.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.321 -0.862 . . . . 0.0 109.849 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 30.0 m -143.29 169.65 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.287 -0.883 . . . . 0.0 109.63 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -78.11 153.59 79.86 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.583 -0.698 . . . . 0.0 109.489 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.77 -19.26 66.81 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.256 1.97 . . . . 0.0 111.313 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -91.42 -27.56 18.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.763 . . . . 0.0 109.395 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.21 7.62 44.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.322 -0.861 . . . . 0.0 109.221 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.26 -37.53 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.465 -0.772 . . . . 0.0 109.981 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.3 -15.1 81.47 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.522 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -71.25 -60.6 2.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.014 -1.286 . . . . 0.0 110.737 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.477 ' H ' ' CD2' ' A' ' 74' ' ' LEU . 2.5 pt? -75.49 -37.23 60.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.184 -0.947 . . . . 0.0 110.537 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.0 ttt-85 -60.61 -33.07 72.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.389 -0.819 . . . . 0.0 109.475 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -32.84 73.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.315 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -68.09 120.36 73.78 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.176 -0.952 . . . . 0.0 110.059 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.05 147.28 20.06 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.938 1.759 . . . . 0.0 112.61 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.88 -22.56 34.97 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.8 mt -105.85 120.89 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.535 -0.98 . . . . 0.0 109.279 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -107.08 150.76 40.27 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.497 -0.752 . . . . 0.0 109.923 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.41 159.15 54.8 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.223 1.949 . . . . 0.0 111.92 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.03 142.37 58.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 109.984 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -79.29 12.9 2.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 109.843 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -156.63 -161.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -0.919 . . . . 0.0 110.176 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 78.9 mtm -52.77 -175.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.571 0.701 . . . . 0.0 111.078 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.9 m120 59.1 33.19 22.74 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.514 0.673 . . . . 0.0 109.687 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -64.65 -39.22 93.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.556 -0.715 . . . . 0.0 109.605 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.28 -16.99 29.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.116 -0.99 . . . . 0.0 109.934 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -94.48 -53.33 3.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.24 -0.913 . . . . 0.0 110.358 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -111.19 131.32 55.21 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.389 -0.819 . . . . 0.0 109.781 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.98 141.12 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.4 m -86.77 129.46 34.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.218 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.1 t -114.16 133.17 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.1 tp -91.05 108.51 19.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.648 -0.657 . . . . 0.0 109.923 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.34 -39.46 92.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.53 -0.731 . . . . 0.0 109.086 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -76.03 5.56 6.48 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.5 -0.75 . . . . 0.0 109.034 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.51 -176.44 20.43 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.42 -6.59 14.7 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.113 2.542 . . . . 0.0 111.701 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.83 145.84 48.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.646 -0.659 . . . . 0.0 109.794 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.08 173.01 31.28 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.55 -29.1 70.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.653 -0.91 . . . . 0.0 109.332 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.18 -41.31 98.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.456 -0.778 . . . . 0.0 109.234 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 104' ' ' GLU . 58.2 mp0 -65.69 -41.61 92.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.19 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.38 -43.42 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.418 -0.801 . . . . 0.0 109.931 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -56.03 -45.75 79.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.83 . . . . 0.0 109.589 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.6 t -61.94 -44.27 97.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.4 -0.812 . . . . 0.0 109.935 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.9 -41.32 99.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.427 -0.796 . . . . 0.0 109.658 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.77 -43.18 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -56.29 -43.69 79.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 0.0 109.089 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -60.06 -44.75 94.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.365 -0.835 . . . . 0.0 109.09 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.7 p -70.38 -27.18 64.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.258 -0.902 . . . . 0.0 109.983 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.07 -44.85 91.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.331 -0.856 . . . . 0.0 109.382 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -58.46 -43.31 88.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.893 . . . . 0.0 109.653 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.9 mp -63.33 -39.59 94.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.262 -0.899 . . . . 0.0 109.512 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.0 p -88.98 4.94 46.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.461 -0.774 . . . . 0.0 109.62 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -74.06 145.77 44.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.404 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.2 tp -67.11 136.07 54.57 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -77.75 110.37 12.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 109.709 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.429 ' CG ' ' O ' ' A' ' 120' ' ' HIS . 85.8 t60 -96.52 10.33 38.7 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.427 -0.796 . . . . 0.0 108.898 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 50.3 m80 54.5 175.44 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.367 0.603 . . . . 0.0 110.524 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -144.49 141.11 29.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.388 -0.82 . . . . 0.0 109.783 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.445 ' CD2' ' O ' ' A' ' 124' ' ' HIS . 80.3 t60 -79.01 144.52 34.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.394 -0.816 . . . . 0.0 110.192 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.445 ' O ' ' CD2' ' A' ' 123' ' ' HIS . 63.4 t-80 -65.05 145.77 55.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.494 -0.754 . . . . 0.0 110.024 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.526 ' OXT' ' CG ' ' A' ' 125' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.413 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.438 ' OD1' ' OE1' ' A' ' 5' ' ' GLN . 28.7 p30 -152.77 -179.03 7.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.22 -0.925 . . . . 0.0 109.536 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.472 ' NH2' ' O ' ' A' ' 27' ' ' ASP . 12.6 ptm180 -61.53 -33.0 73.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.456 -0.778 . . . . 0.0 109.369 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.547 HE22 ' CG ' ' A' ' 8' ' ' ASP . 4.5 tm0? -61.36 -44.12 97.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 110.001 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.438 ' OE1' ' OD1' ' A' ' 2' ' ' ASN . 4.3 mp0 -64.44 -38.42 90.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 108.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -60.2 -45.12 94.25 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.309 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.418 HG21 HD13 ' A' ' 7' ' ' ILE . 96.6 mt -63.74 -44.83 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.3 -0.875 . . . . 0.0 109.547 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.547 ' CG ' HE22 ' A' ' 4' ' ' GLN . 54.4 m-20 -64.73 -46.11 83.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 108.727 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -63.48 -39.91 95.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.383 -0.823 . . . . 0.0 109.093 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.09 -43.56 70.47 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.461 -0.774 . . . . 0.0 109.679 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 86.0 mt-30 -67.21 -40.63 86.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.156 -0.965 . . . . 0.0 109.651 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -63.4 -38.17 90.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.852 -1.155 . . . . 0.0 109.265 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -86.76 -35.84 18.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 111.691 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -118.74 -20.8 8.12 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.134 -0.978 . . . . 0.0 111.032 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 44.2 t0 59.0 38.66 24.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.949 -1.094 . . . . 0.0 109.118 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -107.07 135.79 48.03 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.558 -0.714 . . . . 0.0 109.334 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -82.15 131.21 57.06 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.837 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.52 143.11 22.04 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.17 1.914 . . . . 0.0 112.982 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -127.72 121.89 31.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.634 -0.666 . . . . 0.0 109.276 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.624 ' HD1' ' H ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -119.62 86.83 35.64 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.2 -37.13 87.66 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.462 2.108 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.482 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -87.81 83.87 7.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 0.0 109.064 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -54.59 -14.43 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.458 -0.776 . . . . 0.0 109.564 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -76.18 -2.62 32.06 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -141.25 75.63 22.92 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.287 -0.883 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.65 -31.42 91.86 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.723 2.282 . . . . 0.0 111.327 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.472 ' O ' ' NH2' ' A' ' 3' ' ' ARG . 98.9 m-20 -68.22 -16.04 63.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.401 -0.812 . . . . 0.0 109.347 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -92.56 132.16 37.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 0.0 109.213 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.09 141.07 50.12 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.15 133.55 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 109.043 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -107.95 143.81 36.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.56 -0.712 . . . . 0.0 109.217 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -132.85 129.68 38.77 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.34 -0.85 . . . . 0.0 110.051 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -103.28 111.99 24.65 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.0 p -88.21 -16.66 32.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -94.39 -0.73 54.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.183 -0.948 . . . . 0.0 110.337 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 38' ' ' LYS . 20.3 t-20 -115.99 29.8 7.75 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.382 -0.823 . . . . 0.0 109.854 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 67.9 t0 46.68 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.575 -0.703 . . . . 0.0 110.511 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.1 tttt -79.98 136.15 36.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' A' ' 39' ' ' TRP . 7.8 p90 -141.96 141.38 32.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.281 -0.887 . . . . 0.0 110.607 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 39' ' ' TRP . 29.0 m-85 -159.51 119.96 3.1 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -156.83 105.4 2.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 108.769 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -113.09 125.01 53.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.537 -0.727 . . . . 0.0 109.286 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD22 ' HE ' ' A' ' 3' ' ' ARG . 8.8 tt -123.59 116.71 23.58 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -162.74 167.46 22.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.026 -1.046 . . . . 0.0 109.499 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.523 ' OD2' ' NH2' ' A' ' 58' ' ' ARG . 34.7 p-10 -106.95 116.75 32.47 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.6 pt -118.71 146.65 40.44 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.837 -0.539 . . . . 0.0 110.248 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.27 145.33 11.5 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.104 1.869 . . . . 0.0 112.846 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.44 -21.48 64.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.948 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 54' ' ' ASN . 61.9 mm-40 -70.31 -15.41 62.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.917 -1.114 . . . . 0.0 110.28 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -84.67 -10.99 56.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.982 -1.074 . . . . 0.0 110.605 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 pt -104.53 2.82 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.216 -0.927 . . . . 0.0 109.027 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.69 -5.0 69.53 Favored Glycine 0 N--CA 1.496 2.662 0 O-C-N 121.245 -0.91 . . . . 0.0 110.854 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.6 mt -81.47 138.09 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.912 -1.346 . . . . 0.0 110.235 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.425 ' O ' ' OE2' ' A' ' 49' ' ' GLU . 56.4 m-80 -61.58 -39.34 90.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.603 -0.686 . . . . 0.0 109.397 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -42.59 139.8 2.4 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.416 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 36.9 p-10 -103.33 14.0 32.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.973 . . . . 0.0 109.065 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -82.15 143.06 31.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 84.9 mtp180 -72.48 144.28 48.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.51 -0.744 . . . . 0.0 109.99 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.36 162.89 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.495 -0.753 . . . . 0.0 110.003 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -97.37 136.93 37.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.474 -0.766 . . . . 0.0 109.789 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.37 155.59 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.39 -0.819 . . . . 0.0 110.374 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.2 pt -138.32 150.51 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.98 152.38 26.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 110.065 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.1 125.06 17.13 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 pttm -84.84 131.06 34.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.94 . . . . 0.0 109.359 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.97 165.31 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.269 -0.894 . . . . 0.0 109.445 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -87.41 157.99 52.36 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 109.086 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.71 -21.03 68.19 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.577 2.185 . . . . 0.0 111.352 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -95.01 -29.39 14.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.063 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.47 -3.47 49.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 109.81 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.1 p -65.08 -36.14 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.058 -1.027 . . . . 0.0 109.591 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.45 99.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.5 m -61.7 -42.7 99.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.27 . . . . 0.0 110.47 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.5 tt -85.0 -31.82 23.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.059 -1.026 . . . . 0.0 110.376 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -77.02 -21.87 53.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.114 -0.991 . . . . 0.0 110.401 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -85.61 -2.86 58.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 109.21 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -77.41 151.56 80.78 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.467 ' C ' ' H ' ' A' ' 80' ' ' ILE . 73.7 Cg_endo -72.28 151.64 54.67 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.864 2.376 . . . . 0.0 112.565 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.04 -20.12 2.59 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.467 ' H ' ' C ' ' A' ' 78' ' ' PRO . 72.2 mt -97.43 116.12 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -1.117 . . . . 0.0 108.363 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.446 ' O ' ' OG1' ' A' ' 93' ' ' THR . 18.1 m-85 -123.08 161.22 46.0 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.887 -0.508 . . . . 0.0 110.087 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.61 153.07 69.51 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.006 1.804 . . . . 0.0 111.961 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.33 140.37 33.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 110.585 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -74.77 7.62 2.97 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.473 -0.767 . . . . 0.0 109.125 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.406 ' O ' ' C ' ' A' ' 86' ' ' MET . 51.6 p-80 -157.7 -172.73 4.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 85' ' ' HIS . 79.0 mtm -38.06 158.92 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.457 0.646 . . . . 0.0 111.623 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 m120 72.96 79.96 0.14 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.426 0.631 . . . . 0.0 110.339 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -114.16 -36.3 4.76 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 109.547 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.81 -85.13 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.946 -1.096 . . . . 0.0 111.087 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -67.92 -33.38 74.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 110.677 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -93.93 130.62 39.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.014 . . . . 0.0 110.542 -178.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.0 mm -134.89 143.8 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.437 -0.79 . . . . 0.0 109.021 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 1.1 p -91.51 134.57 34.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.485 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.82 133.82 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.6 tp -91.47 123.74 35.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.688 -0.633 . . . . 0.0 109.897 -179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.6 mt -87.64 -13.93 41.36 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -94.39 0.21 55.3 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 100' ' ' LEU . . . -89.14 -165.45 41.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.62 9.01 0.36 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 123.225 2.617 . . . . 0.0 111.259 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 3.7 mm? -70.35 124.86 25.2 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.16 161.47 20.8 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.28 89.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.567 -0.961 . . . . 0.0 109.364 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -64.72 -41.7 95.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -65.07 -44.93 87.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -0.806 . . . . 0.0 109.595 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.21 -43.4 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.276 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -58.98 -42.68 90.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -61.34 -44.02 97.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 109.95 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.2 mt -63.99 -41.81 97.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.348 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.66 -42.77 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.388 -0.82 . . . . 0.0 109.187 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -55.54 -42.42 74.58 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.203 -0.935 . . . . 0.0 109.09 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -63.36 -40.65 97.85 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.343 -0.848 . . . . 0.0 109.19 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.4 m -63.24 -36.86 85.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.434 -0.791 . . . . 0.0 109.325 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -60.54 -47.27 86.92 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.426 -0.796 . . . . 0.0 110.409 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -77.0 -20.59 55.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 0.0 109.856 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.68 -42.01 98.35 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.16 -0.962 . . . . 0.0 109.951 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.487 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 6.2 p -101.21 16.77 24.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.453 -0.779 . . . . 0.0 109.364 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -37.84 138.94 0.35 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.726 0.774 . . . . 0.0 110.844 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 67.7 mt -73.98 150.49 40.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.631 -0.668 . . . . 0.0 110.569 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 56.15 27.95 12.32 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.579 0.704 . . . . 0.0 109.769 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -67.18 -40.14 86.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.403 -0.811 . . . . 0.0 109.68 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -68.44 119.4 12.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -84.77 136.12 33.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 109.945 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.519 ' HD1' ' H ' ' A' ' 125' ' ' HIS . 48.8 t-80 -144.95 143.37 30.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.168 -0.957 . . . . 0.0 109.424 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -60.14 -40.96 91.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.38 -0.825 . . . . 0.0 109.823 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 85.7 t60 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.196 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.317 0.579 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.72 165.34 12.35 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.301 -0.874 . . . . 0.0 110.189 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.63 -43.83 97.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.464 -0.773 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.528 HE22 ' CG ' ' A' ' 8' ' ' ASP . 9.6 tm0? -62.65 -39.47 93.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 109.909 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -63.34 -37.5 87.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.94 . . . . 0.0 109.545 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.52 -44.31 96.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.441 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.46 -45.06 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.158 -0.963 . . . . 0.0 109.43 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.528 ' CG ' HE22 ' A' ' 4' ' ' GLN . 95.8 m-20 -61.82 -44.29 97.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.968 . . . . 0.0 109.64 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.518 ' CD1' ' NE2' ' A' ' 106' ' ' HIS . 80.3 t80 -61.66 -47.18 86.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.837 . . . . 0.0 109.668 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.62 87.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 109.868 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.543 ' O ' ' N ' ' A' ' 15' ' ' ASP . 7.2 tp-100 -64.34 -48.59 74.97 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.453 -0.78 . . . . 0.0 109.932 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -65.44 -35.18 80.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.997 -1.064 . . . . 0.0 109.674 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -82.08 -35.8 28.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.349 -0.844 . . . . 0.0 111.737 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CG ' ' NE2' ' A' ' 33' ' ' HIS . 78.1 m-85 -124.2 -20.71 5.19 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.033 -1.042 . . . . 0.0 110.998 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 11' ' ' GLN . 56.2 t0 56.92 36.31 27.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 109.026 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -108.4 148.64 29.84 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.54 -0.725 . . . . 0.0 109.371 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.435 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 13.0 mptt -91.84 153.15 43.61 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.201 -0.937 . . . . 0.0 109.298 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.0 154.78 73.52 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.474 2.116 . . . . 0.0 111.66 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -139.72 142.05 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 109.118 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -127.54 86.14 59.2 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -55.56 -36.75 95.08 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.273 1.982 . . . . 0.0 110.708 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -81.24 106.31 13.12 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.466 0.65 . . . . 0.0 109.53 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -66.42 -21.26 66.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.417 -0.802 . . . . 0.0 109.613 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -78.6 -3.88 46.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.316 -0.865 . . . . 0.0 109.49 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -137.74 66.46 48.95 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.35 -19.25 49.92 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.301 2.001 . . . . 0.0 111.616 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -81.19 -5.79 58.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -90.18 147.58 23.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.24 -0.912 . . . . 0.0 109.215 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.03 131.65 53.58 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.53 -0.731 . . . . 0.0 109.363 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.78 132.04 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -111.97 137.53 49.85 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.356 -0.84 . . . . 0.0 109.488 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.456 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . 13.3 ptp180 -139.44 132.23 29.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.203 -0.936 . . . . 0.0 109.33 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.592 ' NE2' ' CG ' ' A' ' 14' ' ' TYR . 70.2 m80 -100.76 110.16 22.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.294 -0.879 . . . . 0.0 109.363 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -78.4 -12.29 60.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.83 -1.66 58.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 110.02 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' LYS . 33.8 m120 -119.79 19.57 12.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.506 -0.747 . . . . 0.0 109.217 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.403 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 67.0 t0 56.82 -76.84 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.814 -0.554 . . . . 0.0 109.879 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 54.0 mtmt -83.81 152.71 24.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.88 . . . . 0.0 109.958 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 39' ' ' TRP . 8.1 p90 -168.19 140.23 2.92 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.264 -0.897 . . . . 0.0 109.587 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -150.86 121.46 7.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.996 -1.065 . . . . 0.0 108.582 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.54 104.86 2.59 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.47 116.19 28.46 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tt -120.15 126.45 50.72 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -157.9 150.96 23.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.143 -0.973 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -97.75 117.21 31.55 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 23.3 pt -125.01 147.01 55.45 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.388 -0.82 . . . . 0.0 110.295 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -48.37 144.12 13.99 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.873 1.715 . . . . 0.0 112.262 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.84 -22.73 67.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -0.837 . . . . 0.0 110.258 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.99 -13.5 61.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.022 . . . . 0.0 109.94 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -84.61 -10.66 57.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.148 -0.97 . . . . 0.0 110.677 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.456 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 8.5 pt -104.89 5.17 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.101 -0.999 . . . . 0.0 109.56 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 -7.42 60.64 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 121.186 -0.946 . . . . 0.0 111.018 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.2 mt -79.04 142.05 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.874 -1.369 . . . . 0.0 110.448 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.88 -39.95 93.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 110.048 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -58.75 142.82 45.58 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.039 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -101.94 7.49 41.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.557 -0.966 . . . . 0.0 108.709 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -63.52 139.75 58.8 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 110.303 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -69.53 136.34 51.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.585 -0.697 . . . . 0.0 110.274 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.07 161.27 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.522 -0.736 . . . . 0.0 109.313 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -101.55 133.23 46.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 0.0 109.806 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 m -132.59 157.91 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.446 -0.783 . . . . 0.0 110.111 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 pt -136.66 153.4 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -118.45 126.98 53.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.451 -0.781 . . . . 0.0 109.656 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.4 160.31 30.83 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.851 0.834 . . . . 0.0 109.259 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -84.09 136.51 33.98 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.844 -0.535 . . . . 0.0 109.803 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.2 m -133.23 163.72 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -73.78 145.49 84.31 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.044 -1.035 . . . . 0.0 109.814 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -49.24 -30.23 18.95 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.268 1.979 . . . . 0.0 111.966 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -85.32 -28.0 25.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.416 -0.802 . . . . 0.0 110.238 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.58 0.94 55.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.108 -0.995 . . . . 0.0 109.968 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.45 -43.7 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.919 -1.113 . . . . 0.0 109.281 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.18 -48.46 64.55 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 t -61.33 -49.55 76.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.167 -1.196 . . . . 0.0 110.693 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.24 -42.7 83.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.813 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -75.29 -7.38 53.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.391 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -28.61 16.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -61.79 149.72 84.33 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.402 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.77 146.02 95.01 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 122.215 1.943 . . . . 0.0 113.058 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.06 -28.92 5.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 2.7 mp -83.65 128.41 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -1.215 . . . . 0.0 109.402 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 49.3 m-85 -124.07 153.03 67.86 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.801 -0.562 . . . . 0.0 109.773 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' O ' ' OG1' ' A' ' 93' ' ' THR . 53.9 Cg_exo -45.15 159.52 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.115 1.876 . . . . 0.0 112.089 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.72 144.05 56.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.144 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 88.0 t80 -89.28 4.27 49.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.805 . . . . 0.0 109.246 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.653 ' CG ' ' H ' ' A' ' 86' ' ' MET . 81.8 t60 -105.7 177.91 4.71 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.45 -0.781 . . . . 0.0 110.265 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.653 ' H ' ' CG ' ' A' ' 85' ' ' HIS . 91.7 mtp -64.69 -39.71 94.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.55 -0.719 . . . . 0.0 110.143 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -74.99 130.65 39.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.202 -0.936 . . . . 0.0 110.519 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -146.55 96.23 2.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -178.77 -43.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -111.9 -23.9 10.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 109.378 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 2.0 m-90 -111.76 132.91 54.33 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.43 -0.794 . . . . 0.0 109.495 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mp -137.06 147.56 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.218 -0.926 . . . . 0.0 109.006 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 82' ' ' PRO . 3.2 p -87.49 147.6 25.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.602 -0.686 . . . . 0.0 110.051 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.43 134.72 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.4 tp -87.04 112.44 21.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 0.0 110.104 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.93 -38.68 83.19 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.44 -0.788 . . . . 0.0 108.996 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -73.81 -0.1 14.81 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.35 171.56 19.24 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.79 -16.03 33.23 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 123.365 2.71 . . . . 0.0 111.972 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.22 138.7 58.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.95 169.29 54.98 Favored Glycine 0 N--CA 1.493 2.439 0 CA-C-O 122.079 0.822 . . . . 0.0 111.222 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.63 -36.11 83.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.691 -0.887 . . . . 0.0 109.716 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -61.44 -38.75 88.29 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.356 -0.84 . . . . 0.0 108.986 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.09 -37.66 88.22 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.432 -0.792 . . . . 0.0 109.431 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.94 -43.87 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.968 . . . . 0.0 109.527 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.518 ' NE2' ' CD1' ' A' ' 9' ' ' TYR . 48.4 m170 -61.47 -42.76 99.27 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.153 -0.967 . . . . 0.0 109.659 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.567 ' HG ' ' N ' ' A' ' 108' ' ' LEU . 78.3 p -62.21 -44.66 96.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.7 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.567 ' N ' ' HG ' ' A' ' 107' ' ' SER . 94.4 mt -64.66 -44.05 91.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.706 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.39 -42.83 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.309 -0.869 . . . . 0.0 109.476 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -53.9 -41.33 67.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.273 -0.892 . . . . 0.0 109.137 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.97 -44.74 96.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.5 m -60.64 -37.54 81.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.57 -43.4 97.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.221 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -51.45 -40.05 58.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 110.049 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' A' ' 115' ' ' LEU . 9.0 mp -63.49 -40.06 96.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.878 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 117' ' ' ARG . 5.6 p -92.19 6.53 46.3 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -0.964 . . . . 0.0 109.538 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 116' ' ' THR . 53.3 ptt85 -40.16 162.14 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.566 0.698 . . . . 0.0 110.922 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.475 ' CD2' HD21 ' A' ' 36' ' ' ASN . 26.0 mt -83.75 136.14 34.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.467 -0.771 . . . . 0.0 110.327 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -78.44 163.61 25.48 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.613 0.721 . . . . 0.0 110.283 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 54.25 -92.74 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.546 -0.721 . . . . 0.0 110.632 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -75.32 119.13 19.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.389 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -96.5 -7.28 35.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.5 m170 53.18 84.82 0.05 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.596 -0.69 . . . . 0.0 109.92 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -75.28 141.54 43.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.53 -0.731 . . . . 0.0 109.993 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.841 179.833 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 ttm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -100.23 161.66 13.46 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.26 -0.9 . . . . 0.0 110.221 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -61.54 -42.99 99.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.771 . . . . 0.0 109.689 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -61.38 -39.22 89.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.791 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.46 -37.08 85.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.456 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -60.7 -44.23 96.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.72 -46.45 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.261 -0.899 . . . . 0.0 109.653 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.41 -41.34 98.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -60.64 -49.9 75.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 109.446 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.38 80.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 15' ' ' ASP . 35.3 tt0 -62.83 -50.39 71.15 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.271 -0.893 . . . . 0.0 109.979 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.48 -40.49 97.25 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.628 -1.295 . . . . 0.0 109.132 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -70.33 -46.42 64.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.864 . . . . 0.0 112.129 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CE1' ' CE1' ' A' ' 33' ' ' HIS . 86.4 m-85 -120.43 -17.97 8.02 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.026 -1.046 . . . . 0.0 111.547 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 11' ' ' GLN . 30.1 t0 60.94 42.38 12.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.927 -1.108 . . . . 0.0 109.457 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.4 t -108.41 136.4 48.11 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -92.9 157.34 39.53 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.094 -1.004 . . . . 0.0 109.779 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.88 143.7 90.64 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.761 1.641 . . . . 0.0 112.775 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -132.28 135.67 46.4 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -133.72 85.1 42.81 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.184 -0.948 . . . . 0.0 109.376 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.77 -34.94 97.51 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.499 2.133 . . . . 0.0 111.394 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -85.87 110.88 19.71 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.572 -0.705 . . . . 0.0 109.625 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -68.56 -31.09 70.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.838 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -67.2 -4.35 10.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.923 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -133.33 70.49 77.16 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.433 -0.792 . . . . 0.0 108.939 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.68 -16.34 33.68 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.229 1.952 . . . . 0.0 111.883 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 22.7 p-10 -88.68 0.27 56.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.336 -0.853 . . . . 0.0 109.258 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.0 m-85 -92.71 139.19 30.81 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.197 -0.939 . . . . 0.0 109.186 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.46 114.92 21.36 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.75 128.28 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.419 -0.801 . . . . 0.0 109.012 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -111.47 134.19 53.22 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.66 -0.65 . . . . 0.0 109.262 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -145.19 150.67 37.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.235 -0.916 . . . . 0.0 109.291 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 14' ' ' TYR . 64.1 m170 -100.08 160.99 13.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.339 -0.851 . . . . 0.0 109.926 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.3 t -102.91 -50.91 3.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.226 -0.921 . . . . 0.0 110.132 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -96.86 -0.82 47.2 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.097 -1.002 . . . . 0.0 110.83 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -104.99 31.82 4.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.162 -0.961 . . . . 0.0 109.129 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 38' ' ' LYS . 98.9 m-20 59.38 40.05 21.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.972 -0.455 . . . . 0.0 110.066 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 37' ' ' ASP . 6.3 ptpp? 31.23 76.22 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.676 0.75 . . . . 0.0 110.958 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -55.59 -170.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.635 -0.666 . . . . 0.0 109.909 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CE2' ' OD2' ' A' ' 63' ' ' ASP . 63.0 t80 -115.04 122.69 46.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.611 -0.681 . . . . 0.0 109.167 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.79 129.99 9.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.503 -0.748 . . . . 0.0 109.209 179.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.2 tp -140.86 129.05 22.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 109.349 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.7 tt -122.09 125.97 47.38 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.573 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.9 ptt? -159.05 157.35 30.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 59' ' ' VAL . 46.6 t0 -96.19 114.03 25.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.143 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 pt -116.67 144.79 33.97 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.616 -0.678 . . . . 0.0 109.206 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -48.3 143.77 14.37 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.58 1.52 . . . . 0.0 112.412 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.39 -22.08 64.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.394 -0.816 . . . . 0.0 109.458 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.62 -16.83 62.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.132 . . . . 0.0 110.278 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -84.72 -11.67 55.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.003 -1.061 . . . . 0.0 111.092 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.477 ' O ' ' CD2' ' A' ' 81' ' ' TYR . 11.4 pt -100.97 4.96 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 120.953 -1.092 . . . . 0.0 109.398 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.06 -11.07 65.91 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.556 ' C ' ' H ' ' A' ' 55' ' ' GLY . 61.6 mt -81.64 132.56 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.848 -1.383 . . . . 0.0 109.414 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -67.02 13.51 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.571 -0.706 . . . . 0.0 109.944 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -83.97 141.44 20.08 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 32.0 p-10 -101.04 8.9 42.71 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.452 -1.028 . . . . 0.0 109.019 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -84.03 141.39 31.21 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.494 -0.754 . . . . 0.0 109.556 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -72.52 145.44 47.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.867 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.432 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 31.6 m -136.13 161.3 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.486 -0.758 . . . . 0.0 109.721 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.67 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 95.7 m-20 -102.3 139.0 38.5 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.1 153.53 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.397 -0.815 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 pt -137.01 148.31 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.694 -0.629 . . . . 0.0 109.446 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.538 ' OD2' ' CE2' ' A' ' 40' ' ' TYR . 86.5 m-20 -74.61 144.63 43.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.305 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.11 131.92 41.08 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -97.73 130.3 44.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.223 -0.923 . . . . 0.0 109.912 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.11 165.6 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.369 -0.832 . . . . 0.0 110.316 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -70.61 152.9 95.23 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.512 -0.742 . . . . 0.0 109.129 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -65.57 -22.2 58.69 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.23 1.953 . . . . 0.0 111.353 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -86.47 -30.64 21.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.2 mt -97.38 10.62 39.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.244 -0.91 . . . . 0.0 109.291 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.531 ' O ' ' NH1' ' A' ' 75' ' ' ARG . 5.4 p -60.38 -46.74 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 110.1 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.92 -14.74 81.9 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.907 -1.139 . . . . 0.0 110.416 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 5.0 t -59.34 -55.46 34.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.015 -1.285 . . . . 0.0 110.898 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.595 ' CD1' HH22 ' A' ' 75' ' ' ARG . 1.9 pt? -86.3 -21.57 27.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.874 . . . . 0.0 110.864 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.603 HH21 ' CG2' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -57.77 -42.27 83.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.772 -1.205 . . . . 0.0 111.275 -177.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -79.91 0.43 31.35 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.465 -1.397 . . . . 0.0 110.594 -178.525 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -83.82 125.34 73.41 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.693 -1.254 . . . . 0.0 109.256 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.42 144.34 18.49 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 121.942 1.761 . . . . 0.0 113.141 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.57 -6.08 67.62 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.603 ' CG2' HH21 ' A' ' 75' ' ' ARG . 96.4 mt -122.47 128.77 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.208 -1.172 . . . . 0.0 109.805 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 31.7 m-85 -120.46 152.6 55.45 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.498 -0.751 . . . . 0.0 109.934 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.83 154.77 67.09 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.471 2.114 . . . . 0.0 111.895 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.81 147.22 53.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.204 -0.935 . . . . 0.0 110.127 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.547 ' C ' ' H ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -98.6 119.47 37.37 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 25.5 t60 66.74 -33.42 0.2 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.628 -0.67 . . . . 0.0 110.736 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.547 ' H ' ' C ' ' A' ' 84' ' ' TYR . 90.4 mmm -84.32 159.55 20.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.076 -1.015 . . . . 0.0 110.598 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 91' ' ' TRP . 57.9 t-20 -40.52 122.05 1.55 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.666 0.746 . . . . 0.0 110.939 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -94.41 -15.05 24.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.644 -0.66 . . . . 0.0 109.734 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' N ' ' OD1' ' A' ' 87' ' ' ASN . 98.1 mt-10 -80.87 -85.2 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.946 . . . . 0.0 110.66 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -60.6 -44.18 96.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -0.884 . . . . 0.0 110.739 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 91' ' ' TRP . 16.5 m0 -101.56 138.15 38.94 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.49 -0.756 . . . . 0.0 109.684 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.406 HD11 HG22 ' A' ' 92' ' ' ILE . 9.3 mt -143.51 165.84 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.322 -0.861 . . . . 0.0 109.519 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 81' ' ' TYR . 6.3 p -107.77 138.58 43.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.9 t -121.1 133.97 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.0 tp -90.82 109.64 20.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 109.817 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.8 mt -64.95 -39.21 93.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 66.1 m-80 -74.41 5.76 4.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 109.66 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.85 165.18 15.33 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.52 -16.88 30.51 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.937 2.425 . . . . 0.0 111.293 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -60.22 169.3 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.648 -0.658 . . . . 0.0 110.46 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -99.99 169.13 21.71 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 121.231 -0.918 . . . . 0.0 110.913 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.88 82.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.629 -0.924 . . . . 0.0 109.365 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.497 ' NZ ' ' OE2' ' A' ' 104' ' ' GLU . 22.7 pttp -60.29 -37.05 79.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.329 -0.857 . . . . 0.0 108.973 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' A' ' 103' ' ' LYS . 72.9 mm-40 -65.33 -44.62 87.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.311 -0.868 . . . . 0.0 109.12 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.427 HG23 HD13 ' A' ' 105' ' ' ILE . 91.9 mt -64.05 -43.83 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.0 109.548 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -58.0 -44.29 87.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.273 -0.892 . . . . 0.0 109.911 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.0 p -61.15 -43.39 98.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 0.0 109.689 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.61 -42.05 98.24 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 109.034 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.68 -43.0 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.177 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -51.64 -44.83 63.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.109 -0.994 . . . . 0.0 108.879 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.21 -42.28 98.32 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.158 -0.964 . . . . 0.0 108.573 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 t -62.72 -38.75 91.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.2 -43.33 74.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.259 -0.901 . . . . 0.0 108.973 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -54.5 -31.81 56.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.773 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.475 ' CD1' ' N ' ' A' ' 115' ' ' LEU . 9.0 mp -83.55 -13.48 54.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.084 -1.01 . . . . 0.0 109.974 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.472 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 45.0 p -102.04 13.87 33.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.297 -0.877 . . . . 0.0 109.306 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.34 148.51 51.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 110.168 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 68.8 mt -71.42 145.82 49.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.535 -0.728 . . . . 0.0 110.109 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -71.56 146.24 48.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.53 -0.731 . . . . 0.0 110.293 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -154.1 150.62 28.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.433 -0.792 . . . . 0.0 109.264 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -100.72 3.14 42.05 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -99.36 120.5 39.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.547 -0.72 . . . . 0.0 109.393 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -80.36 128.74 33.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.32 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.65 146.47 42.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.545 ' OXT' ' CG ' ' A' ' 125' ' ' HIS . 51.5 p-80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.79 -1.1 . . . . 0.0 109.845 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 ttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.284 0.564 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -87.2 159.29 18.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.313 -0.867 . . . . 0.0 110.495 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.27 -42.89 96.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.646 -0.659 . . . . 0.0 109.588 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -59.24 -43.22 92.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.845 . . . . 0.0 109.497 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.86 -32.36 73.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.222 -0.923 . . . . 0.0 109.468 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -60.9 -47.66 85.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.664 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mp -64.98 -46.77 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.207 -0.933 . . . . 0.0 109.184 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.75 -43.22 99.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 109.819 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.417 ' CE1' ' CE1' ' A' ' 106' ' ' HIS . 89.8 t80 -64.12 -44.15 93.09 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.868 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.86 -51.49 69.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.625 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 15' ' ' ASP . 3.5 pt20 -70.11 -38.17 75.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.033 -1.042 . . . . 0.0 110.255 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -60.01 -43.45 95.22 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.626 -1.296 . . . . 0.0 109.35 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.453 ' CE ' ' HH ' ' A' ' 14' ' ' TYR . 63.4 tttp -88.2 -32.06 18.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.145 -0.972 . . . . 0.0 111.698 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.525 ' CE1' ' CD1' ' A' ' 113' ' ' PHE . 73.5 m-85 -121.25 -8.56 9.21 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.065 -1.022 . . . . 0.0 111.654 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 11' ' ' GLN . 91.4 m-20 54.97 37.48 28.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 109.54 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.511 ' OG1' ' NE2' ' A' ' 33' ' ' HIS . 96.7 m -79.69 162.2 25.36 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.512 -0.742 . . . . 0.0 109.152 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 tptt -123.01 93.12 48.66 Favored Pre-proline 0 N--CA 1.497 1.895 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -56.49 146.5 74.24 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.405 2.07 . . . . 0.0 112.365 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 60.4 t0 -132.15 152.25 51.36 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.636 ' N ' ' HD1' ' A' ' 20' ' ' HIS . 0.8 OUTLIER -118.93 86.26 30.73 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 0.0 109.497 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.78 -36.84 83.73 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.235 1.956 . . . . 0.0 111.469 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -87.4 126.99 35.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.575 -0.703 . . . . 0.0 109.357 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -87.51 -28.84 21.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.371 -0.83 . . . . 0.0 109.715 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -81.84 -7.56 59.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.326 -0.859 . . . . 0.0 110.0 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -123.57 75.35 54.38 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.449 -0.782 . . . . 0.0 109.518 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.86 -17.66 41.63 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.985 1.79 . . . . 0.0 111.634 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -80.64 -5.04 56.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.472 -0.768 . . . . 0.0 109.573 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -100.39 135.09 42.36 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.414 -0.804 . . . . 0.0 109.333 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.91 147.54 44.47 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.16 129.47 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.47 -0.769 . . . . 0.0 109.394 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 43.6 m-85 -108.45 109.92 21.31 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -142.21 146.15 34.89 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.145 -0.972 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.511 ' NE2' ' OG1' ' A' ' 16' ' ' THR . 63.8 m170 -99.86 113.56 26.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.521 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.3 p -69.79 -17.89 63.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.307 -0.87 . . . . 0.0 109.585 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -62.74 -44.12 97.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.826 . . . . 0.0 109.808 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' A' ' 38' ' ' LYS . 56.7 p30 -112.4 -1.49 15.02 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.425 -0.797 . . . . 0.0 109.133 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.4 t0 58.4 0.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.731 . . . . 0.0 109.925 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 36' ' ' ASN . 53.6 mtmt -101.3 -156.91 0.58 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 109.69 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 46.9 t-105 57.15 94.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.644 -0.66 . . . . 0.0 109.491 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.59 125.2 54.02 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.54 143.93 24.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.42 144.01 32.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.193 -0.942 . . . . 0.0 109.014 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.1 tt -117.61 127.11 53.63 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.6 ptt? -146.63 158.09 43.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.097 -1.002 . . . . 0.0 109.485 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 34.6 p-10 -95.59 115.6 27.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.366 -0.834 . . . . 0.0 109.265 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.2 pt -126.31 145.73 53.71 Favored Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.478 -0.764 . . . . 0.0 109.231 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.67 144.03 99.49 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.075 1.85 . . . . 0.0 112.78 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.82 -20.99 65.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.692 -0.63 . . . . 0.0 109.64 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.76 -36.54 76.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.051 -1.03 . . . . 0.0 110.465 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 52' ' ' GLY . 97.2 mttt -63.74 -43.49 96.33 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.97 -1.081 . . . . 0.0 111.239 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.4 pt -71.57 15.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.958 -1.089 . . . . 0.0 110.145 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.503 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . 80.75 -7.49 58.57 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.088 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.603 ' C ' ' H ' ' A' ' 55' ' ' GLY . 71.0 mt -79.4 133.06 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.775 -1.427 . . . . 0.0 109.335 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -68.91 26.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.374 -0.829 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.603 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -91.97 132.8 11.44 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 32.2 p-10 -101.79 8.86 41.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.333 -1.098 . . . . 0.0 108.962 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -83.89 154.92 23.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.388 -0.82 . . . . 0.0 109.767 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -82.28 130.38 35.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 108.667 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.401 ' HA ' HD21 ' A' ' 97' ' ' ASN . 16.3 m -125.79 143.61 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.535 -0.728 . . . . 0.0 109.615 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -89.57 141.62 28.42 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.265 -0.897 . . . . 0.0 109.927 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 m -135.8 158.96 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.416 -0.802 . . . . 0.0 109.468 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 pt -134.24 151.38 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -112.16 140.35 46.93 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.471 -0.768 . . . . 0.0 110.126 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -138.33 157.22 46.68 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.656 -0.653 . . . . 0.0 109.362 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -92.73 139.92 30.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 0.0 110.867 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 m -141.39 164.68 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.41 -0.806 . . . . 0.0 109.547 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -74.78 156.74 86.39 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.527 -0.733 . . . . 0.0 109.628 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -64.47 -23.39 64.77 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.327 2.018 . . . . 0.0 111.207 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -86.57 -25.8 24.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.38 -0.825 . . . . 0.0 109.429 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.22 5.67 49.69 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.21 -0.931 . . . . 0.0 109.38 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.6 p -63.28 -39.93 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.47 -15.42 81.44 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -68.17 -55.96 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.123 -1.222 . . . . 0.0 110.753 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.413 HD23 ' H ' ' A' ' 75' ' ' ARG . 2.0 pt? -86.48 -25.26 25.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.962 -1.086 . . . . 0.0 110.614 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.413 ' H ' HD23 ' A' ' 74' ' ' LEU . 78.6 ttt-85 -71.08 -21.63 62.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.947 -1.096 . . . . 0.0 109.627 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.22 -6.68 57.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 108.727 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -84.54 152.65 60.78 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.1 148.45 69.34 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.957 2.438 . . . . 0.0 113.19 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.47 -23.69 11.81 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.427 HD13 HG23 ' A' ' 80' ' ' ILE . 98.2 mt -96.02 121.14 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -1.189 . . . . 0.0 110.066 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -117.56 157.28 48.05 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.793 -0.567 . . . . 0.0 109.979 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.34 152.55 66.18 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.848 1.698 . . . . 0.0 112.36 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.87 151.37 39.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.399 -0.813 . . . . 0.0 109.962 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -90.48 1.24 56.86 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.344 -0.847 . . . . 0.0 109.259 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.17 -174.02 2.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.405 -0.809 . . . . 0.0 110.047 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.4 ttm -63.82 -39.39 94.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.714 . . . . 0.0 110.148 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -67.9 153.55 43.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.532 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -148.59 -54.97 0.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.75 -17.6 59.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.364 -0.835 . . . . 0.0 109.257 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.41 ' CD2' ' N ' ' A' ' 90' ' ' HIS . 4.0 m170 -82.13 -62.84 1.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.949 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -109.79 148.08 32.1 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.658 -0.651 . . . . 0.0 109.903 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 mm -130.9 137.25 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.1 m -87.19 131.03 34.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.671 -0.643 . . . . 0.0 110.147 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.6 t -113.22 134.81 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.1 tp -89.22 108.73 19.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.941 . . . . 0.0 110.273 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.64 -41.06 96.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.401 HD21 ' HA ' ' A' ' 59' ' ' VAL . 97.0 m-20 -84.51 20.22 1.76 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 109.009 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.78 -176.43 39.76 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.26 -37.24 94.55 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.047 2.498 . . . . 0.0 112.774 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -57.97 138.22 56.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 0.0 110.418 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.92 -174.15 39.45 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.94 92.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.683 -0.892 . . . . 0.0 109.882 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -62.79 -40.93 98.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.27 -40.21 96.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.507 -0.746 . . . . 0.0 109.775 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.41 -43.61 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.771 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.417 ' CE1' ' CE1' ' A' ' 9' ' ' TYR . 55.9 m170 -59.59 -47.3 86.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.756 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.3 m -62.35 -43.93 97.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.957 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.31 -44.96 93.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.39 -0.819 . . . . 0.0 109.732 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.5 mt -65.32 -43.02 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -0.842 . . . . 0.0 109.337 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -52.2 -43.68 64.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.025 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -61.95 -44.18 97.3 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 109.273 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.0 p -67.34 -39.24 85.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.79 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 87.6 t80 -61.62 -45.52 93.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.911 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.24 -42.07 69.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.371 -0.83 . . . . 0.0 109.578 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.56 -39.83 92.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.378 -0.826 . . . . 0.0 110.113 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 p -99.99 14.54 30.2 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.157 -0.964 . . . . 0.0 109.835 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 113' ' ' PHE . 35.7 ptt180 -50.58 156.86 0.83 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 110.092 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.7 mp -92.26 -145.88 0.21 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.595 -0.691 . . . . 0.0 109.728 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 58.15 -148.81 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.73 -0.606 . . . . 0.0 110.215 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.0 t60 54.75 78.17 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.609 -0.682 . . . . 0.0 109.384 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -79.74 155.15 28.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.599 -0.688 . . . . 0.0 109.628 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -61.85 -40.58 95.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.547 -0.72 . . . . 0.0 110.152 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.5 130.78 42.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.266 -0.896 . . . . 0.0 110.159 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -83.81 144.87 29.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.388 -0.82 . . . . 0.0 110.138 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.406 ' CD2' ' N ' ' A' ' 125' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.641 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.7 ttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.603 0.716 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -102.14 163.22 12.36 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.733 0.777 . . . . 0.0 110.183 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -61.29 -43.82 98.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.586 0.708 . . . . 0.0 109.6 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -58.89 -40.06 83.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.779 . . . . 0.0 109.842 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.14 -37.6 88.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.441 -0.787 . . . . 0.0 109.817 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -60.94 -43.8 98.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.317 -0.864 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.42 -44.26 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -0.783 . . . . 0.0 109.474 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.76 -44.32 96.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.634 ' CE1' ' CD2' ' A' ' 106' ' ' HIS . 63.9 t80 -63.46 -48.58 77.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.443 -0.786 . . . . 0.0 109.696 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.2 85.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.492 -0.755 . . . . 0.0 109.811 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 15' ' ' ASP . 40.6 tp60 -68.53 -49.91 56.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.824 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.84 -31.67 73.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.957 -1.089 . . . . 0.0 109.087 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.521 ' NZ ' ' CZ ' ' A' ' 14' ' ' TYR . 65.8 tttm -83.44 -38.36 21.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 111.74 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.621 ' CD1' ' NE2' ' A' ' 33' ' ' HIS . 74.9 m-85 -116.63 -21.41 9.14 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.824 -1.173 . . . . 0.0 111.148 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 49.7 t0 62.8 36.79 12.83 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.27 -0.894 . . . . 0.0 109.466 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.513 ' C ' HE22 ' A' ' 11' ' ' GLN . 14.5 t -114.88 134.75 54.89 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.593 0.711 . . . . 0.0 109.707 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -84.69 151.66 58.7 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.613 -0.679 . . . . 0.0 109.332 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.54 146.44 79.69 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.786 2.324 . . . . 0.0 112.477 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -115.38 155.17 27.87 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.693 0.759 . . . . 0.0 109.3 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -143.41 88.2 8.1 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 -15.28 21.12 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.339 2.026 . . . . 0.0 110.617 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -100.72 110.5 22.61 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.498 0.666 . . . . 0.0 109.335 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -68.32 -33.61 74.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.797 0.808 . . . . 0.0 109.186 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -67.76 -2.41 7.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.404 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -143.68 74.72 16.63 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.296 -0.878 . . . . 0.0 109.372 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.86 -15.8 29.63 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.605 2.203 . . . . 0.0 111.301 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -86.46 -4.96 59.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.494 -0.754 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -84.57 142.38 30.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.373 -0.829 . . . . 0.0 109.611 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.07 140.77 50.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.589 -0.694 . . . . 0.0 109.69 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.78 132.66 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -109.07 136.47 48.52 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.394 0.616 . . . . 0.0 109.699 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -156.12 149.23 24.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.342 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.621 ' NE2' ' CD1' ' A' ' 14' ' ' TYR . 80.3 m80 -100.75 128.95 46.6 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.611 0.719 . . . . 0.0 109.443 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.4 p -75.92 -6.89 53.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.471 -0.768 . . . . 0.0 109.518 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -94.33 -9.84 34.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.262 -0.899 . . . . 0.0 109.815 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -109.78 -30.23 7.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.147 -0.971 . . . . 0.0 108.783 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.8 t0 54.18 28.04 8.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.468 -0.77 . . . . 0.0 109.699 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 50.8 tptt -170.11 112.03 0.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.143 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.614 ' CD2' ' N ' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -173.22 -174.48 1.05 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.207 1.003 . . . . 0.0 109.75 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.432 ' CE2' ' CD2' ' A' ' 42' ' ' LEU . 9.7 t80 -160.18 118.93 2.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.199 -0.938 . . . . 0.0 109.137 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.12 121.72 4.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.432 ' CD2' ' CE2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -138.34 149.28 45.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.462 -0.774 . . . . 0.0 109.163 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.426 ' C ' ' CD2' ' A' ' 43' ' ' LEU . 7.4 tt -129.31 122.56 29.81 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.465 ' SD ' ' CG2' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -152.43 162.23 41.48 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.688 0.756 . . . . 0.0 109.928 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 42.5 p-10 -97.25 114.82 26.61 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.289 0.566 . . . . 0.0 109.518 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.7 pt -117.56 146.19 38.01 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.38 143.6 99.66 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.692 2.262 . . . . 0.0 112.495 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.77 -19.89 64.45 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.578 0.704 . . . . 0.0 109.794 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.91 -38.85 87.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.235 -0.915 . . . . 0.0 110.238 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 52' ' ' GLY . 97.0 mttt -63.87 -43.76 95.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.23 -0.918 . . . . 0.0 111.174 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.8 pt -76.95 12.17 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.036 -1.04 . . . . 0.0 109.834 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . 62.1 31.16 77.83 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.365 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 55' ' ' GLY . 47.9 mt -101.23 128.57 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.111 -1.229 . . . . 0.0 109.737 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -55.93 81.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.644 0.735 . . . . 0.0 110.458 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . -176.98 151.48 11.19 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.71 15.35 18.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.513 -0.992 . . . . 0.0 108.446 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -88.45 155.04 19.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.36 -0.838 . . . . 0.0 110.256 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -86.36 141.83 28.91 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.526 0.679 . . . . 0.0 110.095 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -134.04 153.32 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.548 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -90.47 139.4 30.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.696 -0.628 . . . . 0.0 110.167 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.465 ' CG2' ' SD ' ' A' ' 44' ' ' MET . 33.4 m -137.87 154.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.707 0.765 . . . . 0.0 109.987 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.6 pt -135.2 147.92 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.493 0.663 . . . . 0.0 109.871 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.76 143.37 34.54 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.419 0.628 . . . . 0.0 110.389 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.33 126.91 32.42 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -82.81 135.88 34.83 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.671 0.748 . . . . 0.0 110.569 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.76 158.35 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.597 0.713 . . . . 0.0 109.782 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -89.83 154.45 47.82 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.529 -0.732 . . . . 0.0 109.319 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -45.67 -28.86 4.84 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.252 1.968 . . . . 0.0 111.563 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -91.48 -29.11 17.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 0.0 109.54 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.2 mt -91.53 -8.33 47.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.269 -0.894 . . . . 0.0 109.668 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 72' ' ' GLY . 10.5 p -66.68 -40.01 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.652 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.42 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -62.88 -42.37 99.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.3 t -61.1 -48.76 80.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.353 -1.087 . . . . 0.0 110.073 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.07 -39.1 63.7 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.419 -0.8 . . . . 0.0 110.189 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.582 HH22 ' HZ2' ' A' ' 88' ' ' LYS . 72.9 ttt180 -72.17 -38.99 69.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.554 -0.716 . . . . 0.0 111.308 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -73.73 -5.06 38.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.909 -1.12 . . . . 0.0 110.051 -178.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -78.95 147.67 70.61 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.126 -0.984 . . . . 0.0 109.714 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.95 145.66 56.71 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.473 2.116 . . . . 0.0 112.542 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.31 -20.9 19.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.472 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 3.0 mp -91.83 122.59 43.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.323 -1.104 . . . . 0.0 109.449 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -115.06 154.94 47.17 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.23 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.44 146.81 96.04 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.841 2.361 . . . . 0.0 112.869 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.47 43.83 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.389 -0.819 . . . . 0.0 110.515 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 85' ' ' HIS . 45.7 p90 -96.13 3.86 52.93 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.63 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 71.9 m80 -87.93 -162.83 0.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.461 -0.774 . . . . 0.0 110.294 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' ASN . 42.0 ttp -55.32 160.86 2.08 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.56 0.695 . . . . 0.0 110.71 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 86' ' ' MET . 13.2 p30 42.32 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.864 0.84 . . . . 0.0 110.735 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.582 ' HZ2' HH22 ' A' ' 75' ' ' ARG . 81.9 tttt -151.83 -22.94 0.19 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 109.108 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 57.3 mp0 -96.02 -19.69 19.27 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.162 -0.962 . . . . 0.0 110.027 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -75.0 -69.82 0.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.633 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -110.39 138.81 46.29 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.392 -0.818 . . . . 0.0 110.026 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.5 mm -120.13 157.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 p -98.92 138.44 36.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.504 -0.747 . . . . 0.0 110.006 -179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.55 134.52 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 38.4 tp -86.3 105.89 16.98 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.585 0.707 . . . . 0.0 110.097 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.51 -39.67 88.79 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.805 0.812 . . . . 0.0 109.012 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -68.57 -7.55 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.77 -169.04 13.18 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.78 18.83 1.21 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.239 2.626 . . . . 0.0 111.425 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 3.9 mm? -66.06 132.9 49.62 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.95 0.881 . . . . 0.0 110.38 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.74 155.79 22.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.67 79.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.804 -0.821 . . . . 0.0 109.898 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.55 -40.06 92.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.386 -0.821 . . . . 0.0 109.207 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.99 -44.78 96.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.81 -43.4 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.243 -0.91 . . . . 0.0 109.583 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.634 ' CD2' ' CE1' ' A' ' 9' ' ' TYR . 54.2 m170 -58.94 -42.34 89.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 109.849 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -63.99 -42.14 97.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 109.853 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.8 -41.22 95.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.361 -0.837 . . . . 0.0 109.515 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.407 HD13 HG22 ' A' ' 109' ' ' ILE . 95.1 mt -63.76 -42.88 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.75 -42.34 75.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.202 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.26 -41.03 98.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.23 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.4 t -60.19 -40.08 88.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.827 . . . . 0.0 109.649 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -58.36 -44.18 88.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 109.227 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -57.91 -46.1 85.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.359 -0.838 . . . . 0.0 109.844 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.29 -37.77 88.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 0.0 109.623 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.416 ' C ' ' H ' ' A' ' 118' ' ' LEU . 81.3 p -88.08 13.19 11.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.157 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -72.37 48.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.8 0.809 . . . . 0.0 109.022 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.416 ' H ' ' C ' ' A' ' 116' ' ' THR . 10.3 mp 52.67 173.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.868 0.842 . . . . 0.0 110.543 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -96.75 -151.6 0.36 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.748 0.785 . . . . 0.0 109.924 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.3 t60 53.3 92.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.89 0.852 . . . . 0.0 109.618 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -79.83 138.85 37.32 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.591 0.71 . . . . 0.0 109.965 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' A' ' 122' ' ' HIS . 4.4 p80 -51.45 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.61 0.719 . . . . 0.0 110.287 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -152.56 142.79 22.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.379 -0.825 . . . . 0.0 109.751 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.445 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 85.4 t60 42.89 -101.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.411 0.624 . . . . 0.0 110.361 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 124' ' ' HIS . 80.3 m80 . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.277 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.6 ttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -104.62 155.08 19.16 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.67 -0.643 . . . . 0.0 109.884 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -61.6 -43.54 98.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.571 -0.706 . . . . 0.0 109.73 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -58.09 -41.79 84.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.596 -0.69 . . . . 0.0 110.019 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.36 -35.71 81.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.783 . . . . 0.0 110.122 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -60.16 -45.57 92.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.749 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.65 -45.46 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -62.82 -38.27 90.04 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.593 0.711 . . . . 0.0 109.506 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.587 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 59.9 t80 -69.5 -43.89 72.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 110.141 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.78 75.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.434 -0.791 . . . . 0.0 110.5 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 15' ' ' ASP . 4.8 pt20 -66.53 -30.41 70.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 109.984 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.4 -48.54 80.75 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 0.0 110.225 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.587 ' NZ ' ' CE2' ' A' ' 9' ' ' TYR . 63.3 mttp -90.34 -12.4 37.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.217 -0.927 . . . . 0.0 111.875 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -134.65 -20.38 1.79 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.981 -1.075 . . . . 0.0 111.012 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 11' ' ' GLN . 43.0 t0 58.42 39.45 25.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.119 -0.988 . . . . 0.0 109.263 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.5 m -106.93 127.1 53.14 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -89.34 156.04 48.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.715 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.66 141.3 43.98 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.981 1.787 . . . . 0.0 112.359 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -125.88 121.73 34.04 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 20' ' ' HIS . 25.2 p-80 -125.39 86.17 57.47 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.562 -0.711 . . . . 0.0 109.425 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.86 -32.3 91.62 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.537 2.158 . . . . 0.0 111.201 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -83.45 135.59 34.62 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.589 0.709 . . . . 0.0 110.161 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.572 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 1.4 pm0 -89.41 -24.26 21.95 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -78.11 -3.1 40.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.488 -0.757 . . . . 0.0 109.825 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -137.18 66.04 52.1 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.4 -0.812 . . . . 0.0 109.458 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.47 -20.2 36.51 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.433 2.088 . . . . 0.0 111.425 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -81.94 -5.61 58.44 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.53 -0.731 . . . . 0.0 109.063 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -90.96 140.35 29.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.497 -0.752 . . . . 0.0 109.117 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.72 121.52 34.87 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -109.44 125.49 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -108.76 116.55 32.19 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -145.07 135.31 24.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.092 -1.005 . . . . 0.0 109.285 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -99.95 115.0 28.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.486 -0.759 . . . . 0.0 109.716 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 m -63.69 -35.78 81.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.605 -0.684 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -71.68 -5.37 33.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.961 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 38' ' ' LYS . 10.7 t-20 -113.74 -30.8 6.66 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 42.66 18.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.766 -0.584 . . . . 0.0 109.96 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 36' ' ' ASN . 63.6 tttp -136.53 -19.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 39' ' ' TRP . 18.1 t-105 -78.01 117.99 19.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.491 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -115.26 125.72 53.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.614 -0.679 . . . . 0.0 109.274 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.42 129.01 11.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 108.739 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.3 tp -132.29 123.68 27.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.511 -0.743 . . . . 0.0 109.112 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tt -117.58 124.66 49.2 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.5 ptt? -153.95 161.38 42.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 109.212 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 38.1 p-10 -98.05 114.53 26.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.267 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.9 pt -124.54 145.97 50.93 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.548 -0.72 . . . . 0.0 109.193 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.1 143.87 99.05 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.026 1.817 . . . . 0.0 112.573 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.81 -20.98 66.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.754 -0.591 . . . . 0.0 109.909 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.5 -35.51 74.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.993 . . . . 0.0 110.165 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -64.69 -41.85 95.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 0.0 110.94 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 pt -81.82 20.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 109.893 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.22 -4.89 53.29 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.282 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 79.4 mt -78.92 134.03 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.939 -1.33 . . . . 0.0 110.075 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 55' ' ' GLY . 92.6 m-20 -61.38 -39.35 90.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.74 -0.6 . . . . 0.0 110.101 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 54' ' ' ASN . . . -37.06 109.48 0.08 OUTLIER Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -80.81 4.35 19.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.517 -0.99 . . . . 0.0 109.007 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -84.12 161.55 20.59 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.654 0.74 . . . . 0.0 110.148 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.01 146.91 33.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.65 -0.656 . . . . 0.0 110.186 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 m -135.26 159.6 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.493 -0.754 . . . . 0.0 109.543 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.686 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 45.1 m-20 -102.05 135.77 43.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.362 -0.836 . . . . 0.0 109.681 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.45 155.94 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.395 -0.816 . . . . 0.0 110.057 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.422 HG23 HD11 ' A' ' 62' ' ' ILE . 25.2 pt -133.83 146.71 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -84.39 142.56 30.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.842 . . . . 0.0 109.825 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.71 121.67 18.85 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -84.98 136.71 33.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 110.115 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.6 m -142.52 165.93 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.253 -0.904 . . . . 0.0 109.88 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -78.01 149.25 76.48 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 0.0 109.669 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -50.2 -39.31 52.14 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.963 1.776 . . . . 0.0 111.639 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.7 -33.79 71.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.726 -0.609 . . . . 0.0 110.037 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -84.67 2.66 40.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 0.0 109.837 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.434 ' CG1' ' N ' ' A' ' 72' ' ' GLY . 8.0 p -64.34 -42.56 95.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.434 ' N ' ' CG1' ' A' ' 71' ' ' VAL . . . -69.92 -40.22 74.28 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -62.36 -32.31 73.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.471 -1.017 . . . . 0.0 109.348 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 tt -84.85 -35.86 21.96 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.48 -0.762 . . . . 0.0 109.871 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.451 ' NH2' ' HZ2' ' A' ' 88' ' ' LYS . 75.4 mtp180 -73.49 -8.16 54.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 110.003 -179.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -2.96 58.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.193 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -96.21 111.43 56.49 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.602 -0.686 . . . . 0.0 109.337 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.15 143.14 42.98 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.061 1.841 . . . . 0.0 113.551 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -19.97 52.02 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.2 mt -100.76 121.24 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.321 -1.105 . . . . 0.0 109.299 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.446 ' O ' ' OG1' ' A' ' 93' ' ' THR . 55.7 m-85 -108.78 151.07 41.58 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.468 -0.77 . . . . 0.0 109.765 -179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.56 163.66 37.29 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.466 2.11 . . . . 0.0 112.512 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -47.5 148.81 1.29 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.565 -0.71 . . . . 0.0 110.302 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -63.07 -43.86 97.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.613 -0.679 . . . . 0.0 109.882 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -160.13 -26.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 109.223 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.446 ' CG ' ' H ' ' A' ' 87' ' ' ASN . 5.8 tpt -61.61 -140.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.51 -0.744 . . . . 0.0 110.42 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.497 ' CG ' ' HD1' ' A' ' 90' ' ' HIS . 82.7 m-20 -72.75 131.3 42.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.631 -0.668 . . . . 0.0 110.009 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.451 ' HZ2' ' NH2' ' A' ' 75' ' ' ARG . 88.7 tttt -94.53 -21.93 18.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.502 -0.749 . . . . 0.0 109.788 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -100.98 -43.49 6.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.477 -0.764 . . . . 0.0 109.678 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.497 ' HD1' ' CG ' ' A' ' 87' ' ' ASN . 3.4 m170 -63.21 -67.18 0.45 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 110.421 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.3 m0 -111.39 148.48 32.95 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.628 -0.67 . . . . 0.0 109.713 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mm -132.75 161.77 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 38.3 p -107.07 133.02 52.32 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 48.8 t -118.11 133.77 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.5 tp -90.75 108.45 19.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.508 -0.745 . . . . 0.0 109.957 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 88.6 mt -65.58 -40.22 92.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.589 -0.694 . . . . 0.0 109.542 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.686 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 75.8 m-20 -78.32 6.2 8.82 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.475 -0.766 . . . . 0.0 109.164 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.83 178.84 53.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 100' ' ' LEU . 47.2 Cg_endo -68.02 -79.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.85 2.367 . . . . 0.0 112.079 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.495 ' C ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 22.92 -122.03 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.221 0.534 . . . . 0.0 111.085 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.412 ' H ' ' CG ' ' A' ' 100' ' ' LEU . . . 174.9 159.63 21.48 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.202 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.56 -37.23 86.84 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.64 -0.918 . . . . 0.0 109.489 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.68 -40.06 95.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.581 -0.699 . . . . 0.0 109.401 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.17 -42.72 99.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.537 -0.727 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.23 -43.24 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 109.638 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -56.33 -44.13 79.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.47 -0.769 . . . . 0.0 109.494 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 t -61.9 -43.96 97.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.577 -0.702 . . . . 0.0 109.621 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.7 mt -63.3 -40.95 98.78 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.482 -0.761 . . . . 0.0 109.363 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.37 -43.18 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.49 -0.756 . . . . 0.0 109.24 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -60.42 -39.3 86.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.258 -0.902 . . . . 0.0 108.855 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.44 -41.14 98.52 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.8 t -62.73 -40.43 97.2 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.21 -44.5 83.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.545 -0.722 . . . . 0.0 109.209 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.83 -29.15 70.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.418 -0.801 . . . . 0.0 109.537 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.9 mt -86.1 -18.14 33.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.263 -0.898 . . . . 0.0 110.025 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.0 p -102.88 15.02 30.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.385 -0.822 . . . . 0.0 109.224 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -48.67 143.87 4.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 110.209 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.0 mt -78.06 142.96 37.82 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.53 0.681 . . . . 0.0 110.668 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 57.58 68.12 0.88 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.393 0.616 . . . . 0.0 109.632 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -82.63 -72.26 0.45 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.453 -0.78 . . . . 0.0 110.027 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -87.58 5.12 40.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -0.751 . . . . 0.0 109.226 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -80.57 142.27 34.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.654 -0.654 . . . . 0.0 110.054 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -82.83 136.7 34.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -0.771 . . . . 0.0 110.37 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.681 ' N ' ' HD1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -67.75 -40.98 84.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.683 . . . . 0.0 109.73 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 124' ' ' HIS . 3.1 p80 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpp . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.474 0.654 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -95.23 162.33 13.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.356 -0.84 . . . . 0.0 110.489 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -61.52 -42.72 99.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 109.847 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -60.88 -39.04 87.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 109.756 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -63.59 -36.63 84.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.814 . . . . 0.0 109.059 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 56.5 t80 -60.98 -43.76 98.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 108.919 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.1 mm -61.1 -48.48 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.485 -0.76 . . . . 0.0 109.822 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -65.52 -41.47 93.1 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 109.452 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.508 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 47.3 t80 -61.54 -47.61 84.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -0.775 . . . . 0.0 109.849 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.66 -46.18 90.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.157 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ASP . 86.2 mt-30 -63.64 -32.28 73.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 110.465 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.39 -47.91 77.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.99 -1.069 . . . . 0.0 109.729 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.508 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 98.5 mttt -90.03 -12.21 39.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.302 -0.873 . . . . 0.0 111.844 -178.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 15' ' ' ASP . 97.7 m-85 -132.93 -18.04 2.39 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.839 -1.163 . . . . 0.0 110.915 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' GLN . 4.4 p-10 43.85 31.92 0.54 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.365 -0.834 . . . . 0.0 109.418 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.0 m -102.37 136.96 41.27 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.657 0.741 . . . . 0.0 110.069 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -83.04 148.79 57.57 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.58 -0.7 . . . . 0.0 109.275 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.2 145.39 72.45 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.403 2.069 . . . . 0.0 112.129 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -121.91 143.44 49.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.617 -0.677 . . . . 0.0 109.485 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.569 ' CD2' ' H ' ' A' ' 20' ' ' HIS . 0.3 OUTLIER -122.18 86.44 47.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.589 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.62 -40.68 82.97 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.269 1.979 . . . . 0.0 111.068 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -90.3 136.54 32.99 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.61 0.719 . . . . 0.0 109.811 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -86.98 -22.02 25.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.62 -0.675 . . . . 0.0 109.516 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -75.85 -5.13 44.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.411 -0.806 . . . . 0.0 109.03 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -136.33 72.82 58.16 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.536 -0.728 . . . . 0.0 109.114 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.37 -12.08 24.99 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.499 2.133 . . . . 0.0 111.055 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 17.7 p-10 -87.53 -1.9 58.25 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.521 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.2 m-85 -87.15 142.09 28.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.511 -0.743 . . . . 0.0 109.892 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.93 129.18 47.66 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t -132.03 131.14 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.532 -0.73 . . . . 0.0 109.888 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -109.4 139.08 44.81 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.496 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . 11.9 ptp180 -142.93 130.51 21.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.141 -0.974 . . . . 0.0 109.853 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -102.87 110.21 22.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.552 -0.718 . . . . 0.0 109.129 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.6 p -70.94 -16.31 62.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -0.812 . . . . 0.0 110.065 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -89.05 -5.14 58.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.124 -0.985 . . . . 0.0 109.644 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 38' ' ' LYS . 9.1 t-20 -107.45 -4.36 18.57 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.496 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 66.7 t0 59.35 -68.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.357 0.599 . . . . 0.0 110.231 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 36' ' ' ASN . 33.5 pttt -88.12 87.15 7.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.382 -0.824 . . . . 0.0 108.924 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.509 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 24.5 p90 -113.83 143.59 44.41 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.403 0.621 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.509 ' CG ' ' O ' ' A' ' 39' ' ' TRP . 99.4 m-85 -156.68 120.85 4.39 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -155.94 105.33 2.36 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -111.21 131.57 55.02 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.425 0.631 . . . . 0.0 109.694 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' CD1' ' CD2' ' A' ' 6' ' ' PHE . 7.8 tt -135.41 119.71 17.85 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.521 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.2 ptt? -162.5 163.29 27.56 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.082 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.406 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 33.0 p-10 -102.97 118.37 36.66 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.9 146.19 52.47 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.717 -0.614 . . . . 0.0 109.933 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -46.36 141.37 10.39 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.36 2.04 . . . . 0.0 112.765 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.45 -24.16 67.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.62 -0.675 . . . . 0.0 109.915 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.58 -29.29 69.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -0.863 . . . . 0.0 109.785 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -64.47 -35.63 81.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.244 -0.91 . . . . 0.0 110.379 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 pt -85.15 2.47 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.907 -1.12 . . . . 0.0 109.6 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.84 -7.43 62.94 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.1 mt -78.27 126.61 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.775 -1.426 . . . . 0.0 110.072 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -61.71 86.35 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.705 0.764 . . . . 0.0 109.539 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.52 137.29 3.38 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -95.17 5.71 51.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.408 -1.054 . . . . 0.0 108.204 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -71.71 143.25 49.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 110.477 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -78.76 140.55 38.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.563 -0.711 . . . . 0.0 110.117 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.7 159.98 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.462 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 91.5 m-20 -88.19 134.06 33.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.463 -0.773 . . . . 0.0 109.929 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -137.49 153.44 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.496 -0.752 . . . . 0.0 109.714 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.7 pt -141.59 145.01 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.535 0.683 . . . . 0.0 110.151 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -79.82 142.23 35.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.543 -0.723 . . . . 0.0 109.84 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.31 127.81 44.93 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm -82.11 130.39 35.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.639 -0.663 . . . . 0.0 109.937 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -139.13 163.59 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -0.785 . . . . 0.0 109.879 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -85.96 150.94 53.92 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.425 -0.797 . . . . 0.0 109.65 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -45.94 -26.7 3.6 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.271 1.981 . . . . 0.0 111.598 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 57.2 mp0 -94.31 -31.37 14.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.549 -0.719 . . . . 0.0 109.881 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.7 mt -87.12 -3.63 59.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 109.742 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 72' ' ' GLY . 9.0 p -67.51 -44.41 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.066 -1.021 . . . . 0.0 109.642 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.408 ' N ' ' CG1' ' A' ' 71' ' ' VAL . . . -63.63 -41.32 99.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -62.79 -53.63 51.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -1.19 . . . . 0.0 110.233 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tt -67.71 -44.5 77.51 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.813 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.51 -30.66 71.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.542 -0.724 . . . . 0.0 109.656 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -32.34 72.53 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -58.99 114.96 10.25 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.42 -0.8 . . . . 0.0 109.705 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.31 149.31 23.04 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.195 1.93 . . . . 0.0 113.186 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.92 -14.65 64.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.3 mt -106.57 120.09 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.599 -0.942 . . . . 0.0 109.345 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -105.15 150.36 38.72 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.593 -0.692 . . . . 0.0 109.668 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.6 149.32 79.4 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.436 2.091 . . . . 0.0 112.324 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.55 142.77 56.41 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.781 0.8 . . . . 0.0 110.502 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -86.52 -4.93 59.25 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.56 ' CG ' ' H ' ' A' ' 86' ' ' MET . 71.1 t60 -93.34 175.06 6.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.316 -0.865 . . . . 0.0 110.447 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.56 ' H ' ' CG ' ' A' ' 85' ' ' HIS . 79.1 mtm -52.11 -172.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.626 -0.671 . . . . 0.0 111.26 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.435 ' C ' ' H ' ' A' ' 89' ' ' GLU . 99.1 m-20 56.26 -78.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 86' ' ' MET . 31.5 ttmt 69.76 -46.13 0.59 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.387 0.613 . . . . 0.0 109.786 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 87' ' ' ASN . 79.5 mm-40 -68.98 -44.39 72.98 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.39 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -69.62 -45.52 68.34 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.391 -0.818 . . . . 0.0 110.439 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -112.36 142.34 44.99 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.47 -0.769 . . . . 0.0 110.869 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 mm -132.09 139.88 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.6 m -83.76 129.53 34.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 109.594 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.1 t -115.01 132.01 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.7 tp -87.75 104.02 16.16 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.641 0.734 . . . . 0.0 110.019 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 98' ' ' GLY . 92.0 mt -66.36 -39.48 89.18 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.571 0.7 . . . . 0.0 109.123 179.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.462 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 98.6 m-20 -77.28 8.08 4.49 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.403 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -85.76 -161.39 34.85 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.49 -3.77 12.66 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.958 2.439 . . . . 0.0 111.874 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.6 132.31 53.58 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.926 0.87 . . . . 0.0 110.052 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.98 161.52 38.07 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.11 97.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.807 -0.819 . . . . 0.0 109.514 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -72.04 -35.4 69.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.436 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.23 -42.55 93.27 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.352 -0.843 . . . . 0.0 109.31 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.419 HG23 HD13 ' A' ' 105' ' ' ILE . 93.0 mt -64.74 -43.02 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.683 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -56.67 -45.16 81.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 109.943 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.3 m -61.43 -43.73 98.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 109.715 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.2 mt -63.97 -40.97 97.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 109.547 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.95 -42.43 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 108.78 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -52.09 -42.87 63.59 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.446 -0.784 . . . . 0.0 108.991 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -62.2 -40.98 97.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 108.969 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 t -64.31 -36.83 85.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 109.358 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' ARG . 80.4 t80 -58.18 -43.09 87.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.543 -0.723 . . . . 0.0 109.52 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -54.29 -45.13 72.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.234 -0.916 . . . . 0.0 109.924 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.7 mp -66.75 -39.28 87.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.18 -0.95 . . . . 0.0 109.782 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.504 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 32.1 p -92.99 7.22 44.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.25 -0.906 . . . . 0.0 109.19 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 113' ' ' PHE . 42.2 ttm180 -59.85 144.53 48.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.479 -0.763 . . . . 0.0 109.591 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mt -73.26 144.48 46.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.363 -0.836 . . . . 0.0 110.736 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -171.77 96.76 0.17 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -137.87 145.08 41.75 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.308 -0.87 . . . . 0.0 109.514 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -121.79 156.64 32.75 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.603 0.716 . . . . 0.0 110.084 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -61.61 -45.16 95.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.553 -0.717 . . . . 0.0 109.787 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.53 ' HD1' ' CD2' ' A' ' 124' ' ' HIS . 56.1 t-80 -67.22 -44.55 79.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.278 -0.888 . . . . 0.0 109.711 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.53 ' CD2' ' HD1' ' A' ' 123' ' ' HIS . 32.6 m170 -109.35 117.57 34.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.536 -0.728 . . . . 0.0 109.885 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.542 ' OXT' ' CG ' ' A' ' 125' ' ' HIS . 49.3 p-80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.894 -1.05 . . . . 0.0 108.95 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 tpp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.358 0.599 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -101.1 162.84 12.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.435 -0.791 . . . . 0.0 110.17 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -61.53 -43.62 98.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.501 -0.75 . . . . 0.0 109.573 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.8 tp60 -65.9 -42.83 89.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.41 -41.87 96.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 0.0 109.482 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.405 ' CE1' ' CD1' ' A' ' 62' ' ' ILE . 87.3 t80 -62.26 -46.26 89.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 109.908 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 7' ' ' ILE . 96.6 mt -63.94 -43.71 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.252 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.01 -41.41 99.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.563 -0.71 . . . . 0.0 109.617 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -68.25 -36.61 79.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.49 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.44 73.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.433 -0.792 . . . . 0.0 110.344 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ASP . 2.8 pt20 -64.49 -37.53 87.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.601 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -61.42 -41.48 97.23 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.893 -1.129 . . . . 0.0 109.948 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -87.4 -33.8 18.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 111.503 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 16' ' ' THR . 88.3 m-85 -105.95 6.98 31.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.129 -0.982 . . . . 0.0 110.732 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 11' ' ' GLN . 2.1 p-10 39.91 29.74 0.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.427 -0.795 . . . . 0.0 109.643 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 14' ' ' TYR . 58.3 m -120.67 131.25 54.48 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.51 0.671 . . . . 0.0 109.915 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -87.35 156.82 53.84 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.556 -0.715 . . . . 0.0 109.374 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.66 133.29 26.66 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.077 1.851 . . . . 0.0 112.392 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -118.36 143.43 46.64 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.454 0.645 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.482 ' CG ' ' O ' ' A' ' 20' ' ' HIS . 20.0 p-80 -146.29 85.8 7.24 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.405 -0.809 . . . . 0.0 109.137 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.74 -10.71 9.41 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.737 2.291 . . . . 0.0 110.346 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -85.96 104.72 15.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.801 0.81 . . . . 0.0 109.647 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -68.08 -34.24 76.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.734 -0.604 . . . . 0.0 109.746 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -75.22 -6.08 47.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.857 . . . . 0.0 109.501 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.76 71.1 30.31 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.425 -0.797 . . . . 0.0 109.002 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.0 -17.59 40.97 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.458 2.106 . . . . 0.0 111.735 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -85.07 -4.41 59.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.386 -0.821 . . . . 0.0 109.328 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.3 m-85 -85.41 148.04 26.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 109.911 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.17 134.32 46.4 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.52 ' CG1' ' HE ' ' A' ' 32' ' ' ARG . 2.9 t -118.21 129.65 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.92 113.33 22.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.797 -0.565 . . . . 0.0 109.523 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.52 ' HE ' ' CG1' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -135.58 159.55 41.27 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.42 -0.8 . . . . 0.0 109.407 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.7 ' N ' ' HE1' ' A' ' 39' ' ' TRP . 0.5 OUTLIER -77.51 153.94 32.95 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.929 0.871 . . . . 0.0 110.516 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.8 p -88.37 -50.53 6.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -96.41 -25.66 15.62 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.326 -0.859 . . . . 0.0 111.247 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -105.07 30.02 5.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.096 -1.002 . . . . 0.0 110.037 -178.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 33' ' ' HIS . 10.4 m-20 -42.48 86.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.572 -0.705 . . . . 0.0 110.522 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.7 tttt -144.58 -29.02 0.48 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.7 ' HE1' ' N ' ' A' ' 33' ' ' HIS . 1.5 p-90 -95.89 159.27 15.06 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.384 -0.823 . . . . 0.0 109.368 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -138.58 126.2 22.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.617 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.75 150.48 31.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.495 -0.753 . . . . 0.0 109.421 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.51 152.85 33.53 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.494 -0.754 . . . . 0.0 109.089 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 tt -119.9 128.18 53.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.592 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 8.0 ptt? -148.21 156.32 42.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 109.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -95.89 114.54 26.27 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.18 147.27 41.2 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.589 . . . . 0.0 109.662 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.1 145.33 98.69 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.545 2.163 . . . . 0.0 112.453 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.17 63.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.602 -0.686 . . . . 0.0 109.904 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' OE2' ' OD1' ' A' ' 56' ' ' ASP . 96.0 mt-10 -71.23 -19.39 62.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 110.254 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -84.72 -12.24 54.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.015 -1.053 . . . . 0.0 110.271 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 pt -106.79 -0.32 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.287 -0.883 . . . . 0.0 109.245 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.11 -1.16 82.59 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.254 -0.974 . . . . 0.0 110.685 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.3 mt -81.9 132.17 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.823 -1.398 . . . . 0.0 110.162 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -85.44 96.99 9.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.553 -0.717 . . . . 0.0 109.858 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.9 -21.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.419 ' OD1' ' OE2' ' A' ' 49' ' ' GLU . 90.0 m-20 54.36 20.02 2.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.683 -0.893 . . . . 0.0 109.466 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -109.5 159.28 17.18 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.557 0.694 . . . . 0.0 110.082 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -84.38 142.26 30.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.648 -0.658 . . . . 0.0 109.662 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.56 159.18 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.494 -0.754 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.23 136.88 40.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.485 -0.759 . . . . 0.0 109.183 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.23 157.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.538 -0.726 . . . . 0.0 110.162 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.405 ' CD1' ' CE1' ' A' ' 6' ' ' PHE . 31.8 pt -137.0 145.24 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.48 0.657 . . . . 0.0 109.853 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -81.32 142.9 32.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.387 -0.82 . . . . 0.0 109.985 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.85 125.22 29.51 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -82.02 130.33 35.05 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.394 -0.816 . . . . 0.0 110.414 -179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.69 163.73 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.456 -0.777 . . . . 0.0 109.609 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -85.97 154.77 58.23 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 109.824 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -46.43 -35.0 15.45 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.511 2.141 . . . . 0.0 112.307 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -89.65 -21.72 22.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.171 -0.955 . . . . 0.0 110.157 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.1 mt -94.74 -6.06 43.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.096 -1.002 . . . . 0.0 109.334 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 72' ' ' GLY . 8.6 p -67.5 -41.46 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.339 -0.851 . . . . 0.0 109.544 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.44 ' N ' ' CG1' ' A' ' 71' ' ' VAL . . . -63.43 -39.54 97.84 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.7 t -61.2 -47.23 87.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -1.099 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.2 tt -75.02 -42.16 57.91 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.445 -0.784 . . . . 0.0 109.809 179.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -69.91 -37.64 76.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.67 -0.644 . . . . 0.0 111.217 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -73.63 -3.41 27.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.922 -1.111 . . . . 0.0 109.762 -178.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -83.92 150.75 59.43 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.102 -0.999 . . . . 0.0 109.526 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.58 150.92 75.35 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.65 2.234 . . . . 0.0 113.1 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.96 2.89 79.46 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.0 127.74 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -1.049 . . . . 0.0 109.667 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -121.09 152.56 56.96 Favored Pre-proline 0 N--CA 1.494 1.733 0 CA-C-O 121.239 0.542 . . . . 0.0 109.786 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.423 ' O ' ' OG1' ' A' ' 93' ' ' THR . 43.4 Cg_endo -65.5 154.74 72.34 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.758 2.306 . . . . 0.0 112.322 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.2 147.14 10.45 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.379 -0.826 . . . . 0.0 110.464 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 54.9 t80 -85.64 12.86 7.92 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -154.43 -169.54 3.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 0.0 109.811 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.6 mmm -60.41 -176.6 0.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.432 -0.792 . . . . 0.0 110.893 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.7 m120 57.46 35.11 25.52 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.781 0.8 . . . . 0.0 109.186 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -63.13 -42.68 99.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.568 -0.708 . . . . 0.0 109.824 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.89 -44.02 81.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.348 -0.845 . . . . 0.0 110.081 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -70.05 -46.68 64.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 110.425 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -116.67 146.03 43.03 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.547 -0.72 . . . . 0.0 110.246 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.4 mm -130.16 146.25 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -91.36 137.78 32.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.755 . . . . 0.0 109.249 -179.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.7 t -118.05 133.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 tp -84.25 103.74 13.7 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.517 0.675 . . . . 0.0 110.122 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.04 -39.92 87.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.525 -0.734 . . . . 0.0 109.172 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -68.82 -4.8 17.58 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -76.44 -166.34 22.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -79.48 -3.14 12.78 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 123.106 2.538 . . . . 0.0 111.399 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.408 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 4.4 mm? -55.2 125.78 22.06 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.908 0.861 . . . . 0.0 109.912 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.61 161.34 35.12 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.91 95.92 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.642 -0.916 . . . . 0.0 109.173 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mtmm -64.42 -41.96 96.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 109.201 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.56 -43.58 89.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.402 -0.811 . . . . 0.0 109.21 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.22 -43.29 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 109.198 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -58.77 -41.64 87.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.828 . . . . 0.0 109.38 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.6 m -61.19 -43.38 98.98 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 109.229 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.8 mt -64.47 -41.66 96.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 109.592 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.73 -42.97 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.121 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -59.47 -39.41 83.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.383 -0.823 . . . . 0.0 108.989 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -65.19 -37.83 88.56 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.3 t -61.51 -42.12 98.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.845 . . . . 0.0 109.179 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 117' ' ' ARG . 77.4 t80 -61.13 -44.24 97.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.07 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.62 -43.28 99.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 108.83 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.78 -39.98 94.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.561 -0.712 . . . . 0.0 109.372 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.1 p -99.14 14.97 27.47 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 113' ' ' PHE . 9.1 ptm180 -38.57 144.27 0.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.796 0.808 . . . . 0.0 111.414 -178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 63.3 tp -74.72 142.86 44.35 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 121.567 -0.708 . . . . 0.0 109.813 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.78 22.52 2.88 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -150.35 97.25 2.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.433 -0.792 . . . . 0.0 109.257 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -86.57 112.93 22.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.412 -0.805 . . . . 0.0 109.846 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -69.93 -35.95 74.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.533 -0.729 . . . . 0.0 109.583 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 57.59 68.19 0.88 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.608 0.718 . . . . 0.0 109.845 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.96 -42.89 84.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.595 -0.691 . . . . 0.0 109.589 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 56.5 p-80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.298 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.492 ' O ' ' NH2' ' A' ' 3' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.92 163.94 12.15 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.822 0.82 . . . . 0.0 110.24 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 1' ' ' MET . 13.8 mmp_? -59.91 -47.91 83.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.574 -0.704 . . . . 0.0 109.522 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -43.42 -43.15 5.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.558 -0.714 . . . . 0.0 109.962 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.03 -44.91 83.31 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 109.217 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -62.89 -46.03 89.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.35 -0.843 . . . . 0.0 109.635 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.7 mm -64.34 -45.0 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.361 -0.837 . . . . 0.0 109.722 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.08 -41.71 99.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.322 -0.862 . . . . 0.0 110.075 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -60.81 -44.56 96.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.531 -0.731 . . . . 0.0 109.988 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.41 84.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.485 -0.759 . . . . 0.0 110.117 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 15' ' ' ASP . 94.9 mt-30 -67.51 -35.92 80.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.844 -1.16 . . . . 0.0 109.603 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -64.9 -43.36 93.12 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.689 -1.257 . . . . 0.0 109.657 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -88.25 -11.84 45.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.378 -0.826 . . . . 0.0 111.346 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.606 ' CE1' ' NE2' ' A' ' 33' ' ' HIS . 91.4 m-85 -139.98 -20.34 0.89 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.837 -1.164 . . . . 0.0 111.139 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 11' ' ' GLN . 72.1 m-20 53.64 30.16 10.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.049 -1.032 . . . . 0.0 109.475 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -103.2 156.21 17.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.353 -0.842 . . . . 0.0 109.33 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -97.37 139.76 21.63 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.342 -0.849 . . . . 0.0 109.615 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -50.34 142.28 29.86 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.825 1.684 . . . . 0.0 112.906 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -125.97 121.68 33.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -89.55 146.44 35.75 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.184 -0.947 . . . . 0.0 109.867 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.32 -81.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.161 1.908 . . . . 0.0 111.561 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -87.2 137.03 32.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.448 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -61.51 -20.1 62.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.392 -0.817 . . . . 0.0 109.733 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -76.7 -5.19 46.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.0 109.629 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -129.8 70.12 81.87 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.469 -0.77 . . . . 0.0 109.286 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.92 -18.14 46.64 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.368 2.045 . . . . 0.0 112.015 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -79.78 -5.05 54.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.62 140.87 29.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.362 -0.836 . . . . 0.0 109.527 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.05 130.78 43.7 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.659 -0.65 . . . . 0.0 109.309 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 78.5 t -128.09 131.44 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -103.17 147.88 26.47 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.539 -0.726 . . . . 0.0 109.574 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -134.24 139.88 46.07 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.48 -0.762 . . . . 0.0 109.749 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.606 ' NE2' ' CE1' ' A' ' 14' ' ' TYR . 30.5 m170 -100.21 131.49 46.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.626 -0.671 . . . . 0.0 109.337 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -87.18 -32.11 19.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 0.0 110.59 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 31.4 p-10 -92.02 -1.6 57.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.092 -1.005 . . . . 0.0 111.491 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' LYS . 14.7 t-20 -118.66 29.1 7.92 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.027 -1.046 . . . . 0.0 110.16 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.412 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 98.7 m-20 37.23 -86.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.425 0.631 . . . . 0.0 111.215 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 17.9 ptpt -77.53 157.58 30.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.501 -0.749 . . . . 0.0 110.325 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.432 ' CE3' ' O ' ' A' ' 39' ' ' TRP . 12.0 p-90 -177.44 153.13 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.534 -0.729 . . . . 0.0 109.421 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -149.17 118.8 6.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.58 124.53 5.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.91 143.02 24.08 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.75 -1.219 . . . . 0.0 110.235 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.5 tt -121.03 125.45 47.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -156.99 162.11 39.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.04 114.89 26.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.582 -0.699 . . . . 0.0 109.157 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.7 pt -121.19 145.5 42.19 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.515 -0.741 . . . . 0.0 109.45 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -45.34 135.86 11.67 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.903 1.735 . . . . 0.0 112.787 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.25 -25.64 65.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.589 -0.695 . . . . 0.0 110.162 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -17.7 63.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.296 -0.877 . . . . 0.0 110.346 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -84.64 -12.84 53.15 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.971 -1.08 . . . . 0.0 110.991 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 pt -102.67 6.35 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.188 -0.945 . . . . 0.0 109.465 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.03 -4.61 67.98 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.2 mt -79.7 135.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.886 -1.361 . . . . 0.0 109.882 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -74.42 92.36 2.32 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.568 -0.707 . . . . 0.0 110.083 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.2 139.63 3.23 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 37.5 p-10 -88.99 4.55 47.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 108.394 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -80.62 152.94 28.27 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.642 -0.661 . . . . 0.0 110.023 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -97.6 150.01 21.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.563 -0.711 . . . . 0.0 109.814 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.33 163.05 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.715 -0.616 . . . . 0.0 109.642 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -91.57 128.81 37.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.583 -0.698 . . . . 0.0 109.39 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.83 160.18 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.0 110.348 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.15 150.97 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -84.96 127.27 34.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.466 -0.771 . . . . 0.0 109.975 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.99 121.31 39.61 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -82.93 132.2 35.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.855 . . . . 0.0 110.159 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 m -142.5 165.08 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.347 -0.846 . . . . 0.0 108.879 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -84.71 156.9 61.4 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 108.725 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.66 -22.84 74.26 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.382 2.055 . . . . 0.0 111.405 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -90.48 -29.64 17.81 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.441 -0.787 . . . . 0.0 109.352 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.9 mt -95.2 1.93 54.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.326 -0.859 . . . . 0.0 109.763 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.0 p -64.33 -34.47 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.0 109.52 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.56 -14.59 67.33 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.564 ' HG ' ' N ' ' A' ' 74' ' ' LEU . 55.9 p -68.27 -60.56 2.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -1.163 . . . . 0.0 111.101 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.564 ' N ' ' HG ' ' A' ' 73' ' ' SER . 1.7 pt? -88.24 -23.9 23.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.796 -1.19 . . . . 0.0 110.934 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.427 HH21 ' NZ ' ' A' ' 88' ' ' LYS . 78.9 ttt-85 -65.76 -22.8 66.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 110.097 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.453 ' CD ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -94.28 -9.34 36.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.205 -0.934 . . . . 0.0 108.833 179.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -73.81 151.28 88.81 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.097 -1.002 . . . . 0.0 109.357 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.09 143.34 71.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.612 2.208 . . . . 0.0 112.53 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.15 -5.26 63.54 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.9 mm -98.41 125.18 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -1.157 . . . . 0.0 109.174 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.435 ' O ' ' OG1' ' A' ' 93' ' ' THR . 77.3 m-85 -119.87 147.91 45.29 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.733 -0.604 . . . . 0.0 109.598 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.403 ' CB ' ' NZ ' ' A' ' 88' ' ' LYS . 52.0 Cg_endo -69.95 153.68 67.8 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.054 1.836 . . . . 0.0 111.837 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.68 50.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 109.834 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 85' ' ' HIS . 32.1 p90 -66.2 179.31 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.261 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.509 ' CG ' ' O ' ' A' ' 85' ' ' HIS . 54.5 p-80 -40.85 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.471 0.653 . . . . 0.0 110.545 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.1 ttm -167.67 -78.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.526 -0.734 . . . . 0.0 109.193 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.622 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 98.9 m-20 -139.92 -31.84 0.64 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.427 ' NZ ' HH21 ' A' ' 75' ' ' ARG . 49.9 tttp 58.77 -68.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.238 0.542 . . . . 0.0 111.417 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 87' ' ' ASN . 74.2 mt-10 -60.92 -52.21 66.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.868 . . . . 0.0 112.001 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -66.54 -46.77 75.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.935 -1.103 . . . . 0.0 111.251 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.622 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 8.9 m0 -115.51 140.99 48.66 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.439 -0.788 . . . . 0.0 110.317 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mm -128.87 138.41 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 10.8 p -86.84 133.35 33.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.876 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.9 t -112.91 132.58 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.3 tp -87.02 104.07 15.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.518 0.675 . . . . 0.0 110.488 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.64 -39.75 84.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.567 -0.708 . . . . 0.0 109.482 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.87 1.78 6.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.529 -0.732 . . . . 0.0 109.386 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.83 -162.47 30.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.44 -3.39 11.4 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.892 2.394 . . . . 0.0 111.242 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -49.6 126.63 13.99 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.618 0.723 . . . . 0.0 110.0 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.21 169.29 34.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.84 94.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -1.133 . . . . 0.0 109.232 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -64.85 -42.02 95.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.692 . . . . 0.0 109.612 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.74 -42.69 94.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.28 -43.3 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -56.94 -43.84 81.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.387 -0.82 . . . . 0.0 109.564 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.3 m -61.16 -43.99 98.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.897 . . . . 0.0 109.654 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.87 -42.46 97.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.201 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.0 mt -63.8 -42.78 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 108.652 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -53.07 -40.9 64.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.475 -0.766 . . . . 0.0 108.936 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.64 -39.61 94.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 108.702 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 t -65.02 -40.34 94.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.836 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -57.99 -48.97 78.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.417 -0.802 . . . . 0.0 110.076 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -67.75 -32.12 72.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.087 -1.008 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.88 -41.12 97.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.7 p -90.78 14.93 12.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.49 -0.756 . . . . 0.0 109.395 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -53.93 145.69 15.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.467 -0.771 . . . . 0.0 110.319 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.2 mt -71.51 141.19 50.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.642 0.734 . . . . 0.0 110.547 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -97.09 21.95 9.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.649 . . . . 0.0 109.551 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -150.04 162.93 39.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.937 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -80.5 155.63 26.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.545 -0.722 . . . . 0.0 110.175 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -60.44 -41.28 93.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.553 -0.717 . . . . 0.0 109.678 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -73.92 129.12 37.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.582 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -76.32 135.12 39.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.469 -0.769 . . . . 0.0 110.261 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.501 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 86.8 t60 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.346 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -104.56 156.23 18.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.458 -0.776 . . . . 0.0 110.001 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.493 ' NH1' ' OD2' ' A' ' 45' ' ' ASP . 61.6 ttp180 -61.29 -42.9 99.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.54 -0.725 . . . . 0.0 109.336 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -63.56 -39.77 95.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.368 -0.832 . . . . 0.0 109.773 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -62.75 -42.44 99.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.013 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -61.08 -45.55 94.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.526 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.35 -44.51 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.487 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.12 -45.79 90.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.185 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -62.61 -43.19 99.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.782 . . . . 0.0 109.258 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.94 97.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.414 -0.803 . . . . 0.0 110.002 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 81.0 mt-30 -65.65 -45.0 84.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 110.123 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.37 -35.8 80.27 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.09 -1.006 . . . . 0.0 109.514 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -85.07 -37.24 20.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.398 -0.814 . . . . 0.0 111.686 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.543 ' CZ ' ' CE2' ' A' ' 39' ' ' TRP . 93.2 m-85 -114.55 6.63 15.88 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.015 -1.053 . . . . 0.0 111.698 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 2.4 p-10 39.04 29.12 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.162 -0.961 . . . . 0.0 110.434 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 14' ' ' TYR . 33.0 m -109.94 126.17 53.61 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 109.147 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 157.68 63.21 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.0 109.221 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.59 135.74 33.79 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.842 1.695 . . . . 0.0 112.316 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.433 ' C ' ' CD2' ' A' ' 20' ' ' HIS . 97.1 m-20 -118.27 140.22 50.14 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 20' ' ' HIS . 2.1 m-70 -136.99 85.43 22.76 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.365 -0.834 . . . . 0.0 109.165 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -54.83 -40.31 85.75 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.241 1.961 . . . . 0.0 111.626 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -91.92 130.7 37.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.677 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -84.44 -17.13 40.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.468 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -81.78 -5.16 57.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 109.391 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -128.81 62.04 59.18 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.57 -0.706 . . . . 0.0 109.405 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.93 -19.38 52.29 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.348 2.032 . . . . 0.0 111.828 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.35 -5.11 57.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.116 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.475 ' O ' ' ND1' ' A' ' 20' ' ' HIS . 21.8 m-85 -99.27 134.01 42.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.472 -0.768 . . . . 0.0 109.602 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.72 132.94 54.9 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.61 127.46 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -112.77 122.78 48.67 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.367 0.603 . . . . 0.0 109.862 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -151.57 143.98 24.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 109.106 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.82 124.11 42.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.266 -0.896 . . . . 0.0 109.769 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -80.0 -12.08 59.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.516 -0.74 . . . . 0.0 109.811 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -62.88 -45.23 93.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.095 -1.003 . . . . 0.0 110.528 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 54.3 p30 -123.6 -13.15 7.58 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.29 -0.881 . . . . 0.0 109.919 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 36' ' ' ASN . 45.8 t0 59.24 5.05 0.53 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.446 -0.784 . . . . 0.0 109.799 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' A' ' 36' ' ' ASN . 28.6 mmtp -94.21 -8.95 37.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.055 -1.028 . . . . 0.0 109.086 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.543 ' CE2' ' CZ ' ' A' ' 14' ' ' TYR . 63.0 t-105 -90.35 108.36 19.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.461 -0.775 . . . . 0.0 109.298 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -107.88 128.62 54.78 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.554 -0.716 . . . . 0.0 109.171 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.33 123.92 8.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.495 -0.753 . . . . 0.0 108.98 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.8 tp -124.34 130.36 52.35 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.64 -0.663 . . . . 0.0 109.274 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.4 tt -126.82 128.38 46.47 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 6.2 ptt? -160.39 162.78 33.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 110.025 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.493 ' OD2' ' NH1' ' A' ' 3' ' ' ARG . 99.3 m-20 -100.28 117.37 34.35 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.7 pt -134.44 145.57 55.75 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.85 151.32 85.7 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.538 2.158 . . . . 0.0 112.917 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.82 64.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.593 -0.692 . . . . 0.0 109.761 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -66.22 -17.94 65.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.121 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -84.28 -14.67 49.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.064 -1.023 . . . . 0.0 111.253 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.64 10.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.174 -0.954 . . . . 0.0 109.885 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.34 -9.26 72.08 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.105 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.5 mt -79.96 135.12 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.802 -1.41 . . . . 0.0 109.722 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -74.61 95.67 2.85 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.14 133.52 1.75 Allowed Glycine 0 N--CA 1.482 1.717 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -91.1 11.72 22.23 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -64.96 157.63 27.64 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.1 mtp85 -100.35 135.98 40.95 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.3 m -137.55 157.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.705 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 96.6 m-20 -99.07 140.3 33.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.95 151.01 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.399 -0.813 . . . . 0.0 110.109 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.426 HD12 HG21 ' A' ' 62' ' ' ILE . 17.8 pt -131.32 161.07 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 66.8 t0 -133.73 140.76 47.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.236 -0.915 . . . . 0.0 109.732 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.519 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -132.9 159.19 40.62 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.444 0.64 . . . . 0.0 109.336 -179.718 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -88.36 138.93 31.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.491 -0.755 . . . . 0.0 110.629 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.1 161.92 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.56 -0.712 . . . . 0.0 109.298 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -80.72 157.96 71.38 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.411 -0.805 . . . . 0.0 109.344 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -61.92 -23.85 76.35 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.532 2.155 . . . . 0.0 111.592 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -88.88 -30.81 18.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.279 -0.888 . . . . 0.0 109.574 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.5 mt -93.13 -0.16 57.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -0.84 . . . . 0.0 109.415 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.3 p -63.95 -31.54 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.464 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.51 -15.44 78.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 p -69.01 -54.32 15.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 110.527 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.45 ' H ' ' CD2' ' A' ' 74' ' ' LEU . 2.2 pt? -85.38 -28.04 25.43 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.0 -1.062 . . . . 0.0 110.499 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.3 ttt-85 -69.51 -21.96 63.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.192 -0.942 . . . . 0.0 110.585 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.25 -7.94 52.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.939 -1.101 . . . . 0.0 109.502 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -82.22 150.26 63.96 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.894 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.05 144.32 63.29 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.549 2.166 . . . . 0.0 112.293 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.78 -16.36 54.81 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.524 ' CD1' ' N ' ' A' ' 80' ' ' ILE . 2.0 mp -90.16 127.14 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.044 -1.268 . . . . 0.0 108.905 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -115.55 126.16 28.03 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.394 -0.816 . . . . 0.0 110.212 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -52.28 146.51 31.47 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.41 1.406 . . . . 0.0 111.79 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.24 140.26 57.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.375 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -98.03 1.45 47.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.384 -0.823 . . . . 0.0 108.933 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -65.77 -176.91 0.41 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.458 -0.776 . . . . 0.0 110.374 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 74.4 mtm -64.29 -41.17 97.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.531 -0.731 . . . . 0.0 109.938 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -97.62 138.02 35.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.263 -0.898 . . . . 0.0 109.784 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -141.32 70.27 1.34 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.409 -0.807 . . . . 0.0 109.342 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -143.83 -54.29 0.36 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.46 -0.775 . . . . 0.0 109.07 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -99.31 -15.68 18.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -108.26 122.41 46.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.368 -0.833 . . . . 0.0 110.011 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.7 mm -125.9 137.04 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.5 m -95.01 144.22 25.86 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -120.59 136.67 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.1 tp -87.22 113.63 23.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.975 . . . . 0.0 110.276 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.448 ' C ' ' H ' ' A' ' 98' ' ' GLY . 12.8 mt -64.62 -40.72 95.97 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.705 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 58.8 m-80 -70.78 4.29 2.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.416 -0.802 . . . . 0.0 109.063 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -68.06 171.99 34.44 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.96 -4.97 15.5 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 123.445 2.763 . . . . 0.0 112.327 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.42 ' H ' HD23 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -72.14 150.06 44.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.144 -179.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.09 171.53 42.62 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 120.489 -0.863 . . . . 0.0 111.04 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.42 83.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.95 . . . . 0.0 109.715 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.9 pttm -61.11 -36.32 79.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.219 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -65.87 -38.84 89.86 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.415 -0.803 . . . . 0.0 109.126 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.92 -44.18 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -58.94 -42.54 90.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.388 -0.82 . . . . 0.0 109.786 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.7 m -60.71 -45.09 95.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 110.172 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.78 -44.1 94.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.752 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.03 -43.12 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.501 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -51.9 -42.06 62.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 108.875 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.37 -43.92 97.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.226 -0.921 . . . . 0.0 109.061 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 t -63.67 -41.76 98.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.0 110.69 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -58.96 -45.3 90.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.257 -0.902 . . . . 0.0 110.893 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -60.8 -38.83 86.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.028 -1.045 . . . . 0.0 110.418 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 96.7 mt -63.01 -40.71 98.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.695 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.4 p -93.78 14.32 19.67 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -45.71 142.48 2.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.437 -0.789 . . . . 0.0 109.693 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 120' ' ' HIS . 76.1 mt -68.69 147.57 51.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.33 -0.857 . . . . 0.0 109.941 -179.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.591 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 1.3 pm0 -74.66 43.98 0.2 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.537 -0.727 . . . . 0.0 109.756 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.539 ' ND1' ' N ' ' A' ' 121' ' ' HIS . 63.3 t-80 60.35 167.14 0.08 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.536 0.684 . . . . 0.0 110.636 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.539 ' N ' ' ND1' ' A' ' 120' ' ' HIS . 75.7 m80 -82.31 150.59 27.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.555 -0.716 . . . . 0.0 110.058 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -84.44 167.56 16.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 109.965 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -76.34 123.41 25.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 110.425 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -68.29 -37.99 81.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.572 -0.705 . . . . 0.0 109.946 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.564 -179.421 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.7 ttm . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.509 0.671 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -93.48 166.05 12.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.361 -0.837 . . . . 0.0 110.727 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -63.22 -42.76 99.31 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.348 0.594 . . . . 0.0 109.76 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -65.48 -39.45 91.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.3 -0.875 . . . . 0.0 109.673 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.02 -38.75 92.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.327 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.75 -45.53 93.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -0.815 . . . . 0.0 109.439 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 7' ' ' ILE . 95.1 mt -63.59 -43.77 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.409 -0.807 . . . . 0.0 109.412 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.14 -41.61 97.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.446 -0.784 . . . . 0.0 109.794 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -62.2 -42.66 99.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.415 -0.803 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.38 82.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.432 -0.793 . . . . 0.0 109.719 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 15' ' ' ASP . 25.9 mt-30 -63.45 -48.42 77.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.062 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -64.48 -37.45 87.59 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.721 -1.237 . . . . 0.0 109.466 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -68.79 -46.3 69.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.522 -0.736 . . . . 0.0 111.942 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.17 -20.43 4.13 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.0 110.677 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 25.4 t0 65.31 42.1 4.07 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.266 -0.896 . . . . 0.0 108.855 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.7 m -104.19 133.35 49.27 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.609 0.718 . . . . 0.0 109.595 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -83.75 151.4 61.23 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.725 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.21 153.55 71.3 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.818 2.345 . . . . 0.0 112.533 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 61.6 t0 -140.76 138.92 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 108.96 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.467 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 13.7 p-80 -132.64 86.94 42.99 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.505 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -54.54 -37.92 90.28 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.502 2.135 . . . . 0.0 110.653 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -87.51 82.06 7.59 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.443 ' C ' ' H ' ' A' ' 25' ' ' PHE . 22.3 pt-20 -55.2 -14.45 1.71 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -65.18 -2.33 2.84 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.503 -0.748 . . . . 0.0 109.073 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.443 ' H ' ' C ' ' A' ' 23' ' ' GLU . 87.0 m-85 -147.95 76.15 10.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.394 -0.817 . . . . 0.0 109.325 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.08 -19.22 65.61 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.635 2.224 . . . . 0.0 110.764 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 12.5 p-10 -81.19 -2.48 48.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -100.38 139.48 36.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.435 -0.791 . . . . 0.0 109.255 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.0 128.17 45.94 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -113.66 124.51 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.657 -0.652 . . . . 0.0 109.561 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.88 136.5 51.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.688 -0.632 . . . . 0.0 109.295 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -157.18 139.37 14.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -101.0 126.65 47.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.528 -0.733 . . . . 0.0 109.635 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 m -80.79 -10.62 59.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.473 -0.767 . . . . 0.0 109.168 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -64.03 -40.84 97.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.396 -0.815 . . . . 0.0 109.95 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 38' ' ' LYS . 2.1 m120 -113.16 -24.6 9.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.324 -0.86 . . . . 0.0 109.252 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.8 t0 63.36 -8.88 0.13 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.589 -0.694 . . . . 0.0 109.855 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.557 ' H ' ' C ' ' A' ' 36' ' ' ASN . 64.5 mttp -97.64 -6.29 33.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.205 -0.934 . . . . 0.0 108.863 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 15.0 t-105 -84.82 109.88 18.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 109.683 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -109.3 125.92 52.82 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -138.82 136.72 35.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.5 tp -145.1 122.95 11.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.404 ' C ' ' CD2' ' A' ' 43' ' ' LEU . 7.4 tt -120.23 124.48 45.78 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.401 ' C ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -162.68 164.76 26.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 0.0 109.689 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 88.9 m-20 -96.42 114.05 25.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.565 -0.71 . . . . 0.0 109.721 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.2 pt -116.83 144.99 34.48 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -48.78 141.38 21.19 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.985 1.79 . . . . 0.0 112.421 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.08 -21.09 65.94 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.382 0.61 . . . . 0.0 109.972 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.29 -13.99 59.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.123 -0.986 . . . . 0.0 109.608 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -84.32 -10.85 57.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.3 pt -103.19 1.73 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.301 -0.874 . . . . 0.0 109.345 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.43 -14.39 59.43 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.593 ' C ' ' H ' ' A' ' 55' ' ' GLY . 76.4 mt -78.55 130.55 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.956 -1.32 . . . . 0.0 109.498 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -63.28 14.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.585 -0.697 . . . . 0.0 110.539 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -86.11 140.78 17.96 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -101.27 5.77 42.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.503 -0.998 . . . . 0.0 109.628 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -88.44 144.81 26.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -71.73 145.8 48.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.63 -0.669 . . . . 0.0 110.359 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.46 157.46 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.528 -0.732 . . . . 0.0 109.633 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 12.9 m-20 -93.81 131.63 39.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.495 -0.753 . . . . 0.0 109.355 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.95 156.89 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.42 -0.8 . . . . 0.0 110.292 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 pt -134.96 149.88 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.474 0.654 . . . . 0.0 109.739 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -81.68 146.64 29.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.11 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.95 127.08 33.46 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -82.21 131.69 35.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.556 -0.715 . . . . 0.0 110.147 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.37 161.32 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 109.677 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -85.62 158.71 56.64 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.87 -19.79 56.44 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.61 2.207 . . . . 0.0 111.544 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -95.88 -28.24 14.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.346 -0.846 . . . . 0.0 109.116 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.04 -2.56 56.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.415 -0.803 . . . . 0.0 109.493 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.7 -41.08 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.946 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.12 -40.66 99.44 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.7 m -62.13 -36.03 80.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.208 -1.172 . . . . 0.0 110.419 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 -39.07 43.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.079 . . . . 0.0 111.011 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.562 HH21 ' CD1' ' A' ' 92' ' ' ILE . 95.9 mtt180 -76.71 -6.54 52.57 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.069 -1.019 . . . . 0.0 110.125 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -11.41 58.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.084 -1.01 . . . . 0.0 109.171 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -90.83 148.07 37.46 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 109.266 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.07 144.73 58.74 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.716 2.278 . . . . 0.0 113.09 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.15 -5.0 85.92 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.81 122.87 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -1.109 . . . . 0.0 109.782 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -124.6 145.52 49.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.26 150.08 81.45 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.454 2.103 . . . . 0.0 112.387 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.1 138.88 58.06 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.708 0.766 . . . . 0.0 110.257 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 13.0 p90 -95.32 1.02 54.27 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 86' ' ' MET . 8.9 m170 -148.47 159.36 44.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.112 -0.993 . . . . 0.0 110.793 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.443 ' O ' ' O ' ' A' ' 87' ' ' ASN . 79.5 mtp 48.61 105.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.892 0.853 . . . . 0.0 111.023 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 86' ' ' MET . 99.2 m-20 44.01 -171.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.642 0.734 . . . . 0.0 110.751 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -144.92 -57.78 0.35 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.49 -0.756 . . . . 0.0 109.308 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.0 -37.75 84.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.212 -0.93 . . . . 0.0 109.125 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -57.01 -67.13 0.34 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.44 -0.788 . . . . 0.0 109.801 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -105.04 144.53 31.71 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.525 0.679 . . . . 0.0 110.094 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.562 ' CD1' HH21 ' A' ' 75' ' ' ARG . 7.1 mm -130.54 144.07 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.8 m -87.48 131.18 34.43 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.394 -0.816 . . . . 0.0 109.82 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.1 t -118.52 132.39 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.5 tp -87.9 101.98 14.26 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.622 0.725 . . . . 0.0 110.24 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.472 ' C ' ' H ' ' A' ' 98' ' ' GLY . 84.1 mt -66.04 -40.39 90.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -71.96 5.49 2.63 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -84.63 -166.33 41.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.8 7.86 4.34 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.023 2.482 . . . . 0.0 111.611 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' A' ' 100' ' ' LEU . 4.3 mm? -62.24 130.55 45.9 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.973 0.892 . . . . 0.0 110.578 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.5 158.43 31.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.463 ' O ' ' ND1' ' A' ' 106' ' ' HIS . . . -60.16 -47.02 87.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.695 -0.885 . . . . 0.0 109.552 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -65.18 -40.52 94.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.511 -0.743 . . . . 0.0 109.447 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.0 -44.89 96.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.509 -0.744 . . . . 0.0 109.522 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 105' ' ' ILE . 97.0 mt -64.43 -43.32 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.554 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 102' ' ' ALA . 31.8 m80 -58.74 -42.62 89.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.368 -0.833 . . . . 0.0 109.888 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.9 m -61.43 -43.6 98.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.54 -40.7 96.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.454 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.408 ' O ' ' OG ' ' A' ' 112' ' ' SER . 94.9 mt -63.92 -43.2 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.215 -0.928 . . . . 0.0 109.337 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -60.48 -37.8 82.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.66 -42.04 99.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.493 -0.754 . . . . 0.0 108.987 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 109' ' ' ILE . 96.6 p -62.61 -36.24 82.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.363 -0.836 . . . . 0.0 109.155 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.69 -45.21 95.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.385 -0.822 . . . . 0.0 109.594 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -65.65 -27.63 68.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.009 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.2 mt -82.37 -13.15 57.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.536 -0.727 . . . . 0.0 109.317 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 79.4 p -110.64 14.66 22.32 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -68.15 140.06 56.14 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.863 0.84 . . . . 0.0 110.308 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.522 ' CD2' ' ND2' ' A' ' 36' ' ' ASN . 88.3 mt -81.9 177.02 9.09 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.668 0.747 . . . . 0.0 110.912 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 56.94 108.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.64 0.734 . . . . 0.0 109.984 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 122' ' ' HIS . 54.7 t-80 -84.47 90.37 7.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.436 -0.79 . . . . 0.0 109.681 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 74.6 m80 46.61 13.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 120' ' ' HIS . 61.8 m170 -110.98 149.93 29.98 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.906 0.86 . . . . 0.0 109.988 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 53.18 90.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.74 0.781 . . . . 0.0 110.187 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.9 m80 46.87 83.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.717 0.77 . . . . 0.0 110.021 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.937 179.638 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.6 ttp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.155 0.503 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -94.96 155.64 16.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.176 -0.952 . . . . 0.0 110.373 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.512 ' NH2' ' OD1' ' A' ' 45' ' ' ASP . 40.8 ttm180 -62.09 -42.63 99.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.549 -0.719 . . . . 0.0 109.546 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -53.99 -42.32 68.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 109.817 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.65 -35.54 80.4 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.129 -0.982 . . . . 0.0 109.49 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -60.89 -44.65 96.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.123 -0.985 . . . . 0.0 109.161 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.9 mm -64.0 -44.66 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.288 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.15 -41.13 99.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.519 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -60.32 -49.86 75.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.3 -35.25 75.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 17.4 tt0 -59.34 -49.91 76.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.385 -0.822 . . . . 0.0 110.28 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -64.26 -40.21 95.51 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.637 -1.289 . . . . 0.0 109.465 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -68.34 -44.29 75.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 112.259 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.526 ' OH ' ' CD1' ' A' ' 113' ' ' PHE . 97.0 m-85 -127.64 -18.49 4.34 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.993 -1.067 . . . . 0.0 110.902 -178.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 24.9 t0 63.68 45.81 4.39 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.0 . . . . 0.0 109.084 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.0 m -113.72 127.9 56.21 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -83.95 155.19 64.51 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.12 -0.987 . . . . 0.0 109.759 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.55 140.54 64.79 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.77 1.647 . . . . 0.0 112.607 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -116.28 121.31 41.63 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 20' ' ' HIS . 11.8 m-70 -114.87 85.32 11.61 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.499 -0.751 . . . . 0.0 109.19 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.43 -12.82 16.91 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.928 1.752 . . . . 0.0 110.878 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -100.7 93.97 5.85 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -63.34 -17.57 62.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 0.0 109.848 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -83.87 -3.07 57.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.681 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -143.43 69.35 17.5 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.128 -0.983 . . . . 0.0 109.792 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.98 -29.53 89.55 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.55 2.167 . . . . 0.0 111.191 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.91 -6.94 45.53 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.429 -0.795 . . . . 0.0 109.366 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -102.72 135.41 44.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.457 -0.777 . . . . 0.0 109.13 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -123.35 146.78 47.67 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.6 t -125.62 130.49 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.559 -0.713 . . . . 0.0 109.209 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.48 112.03 22.91 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.69 -0.631 . . . . 0.0 109.319 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -134.24 138.45 45.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.306 -0.871 . . . . 0.0 108.665 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.594 ' ND1' ' CD1' ' A' ' 39' ' ' TRP . 35.9 m170 -100.87 118.2 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -0.852 . . . . 0.0 109.765 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.1 m -63.28 -36.73 84.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.351 -0.843 . . . . 0.0 109.342 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.03 -43.42 98.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 110.134 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 38' ' ' LYS . 15.9 m120 -91.99 5.45 50.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.067 -1.021 . . . . 0.0 108.882 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' LYS . 66.9 t0 51.25 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.778 -0.576 . . . . 0.0 110.712 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' ASN . 60.3 mttp -55.88 -110.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 110.582 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.594 ' CD1' ' ND1' ' A' ' 33' ' ' HIS . 48.5 t-105 40.8 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.756 -0.59 . . . . 0.0 109.831 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -107.97 125.77 51.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.459 -0.776 . . . . 0.0 109.325 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.89 128.25 10.61 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.95 146.0 40.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 109.388 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 tt -116.84 128.26 55.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -152.08 163.17 39.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.994 . . . . 0.0 109.392 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.512 ' OD1' ' NH2' ' A' ' 3' ' ' ARG . 98.5 m-20 -98.89 136.56 38.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -0.795 . . . . 0.0 108.858 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -139.95 145.73 43.68 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.208 -0.932 . . . . 0.0 109.767 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.17 135.73 30.65 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.844 1.696 . . . . 0.0 113.089 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.83 -29.52 70.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 109.902 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 55' ' ' GLY . 15.7 pt-20 -55.57 -29.89 59.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.076 -1.015 . . . . 0.0 110.22 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -63.79 -34.94 79.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.977 -1.077 . . . . 0.0 110.322 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.6 pt -96.41 -1.55 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.16 -0.963 . . . . 0.0 109.708 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.96 34.75 32.92 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.874 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.566 ' O ' ' N ' ' A' ' 55' ' ' GLY . 35.0 mt -110.16 136.51 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.349 -1.089 . . . . 0.0 110.059 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.401 ' C ' ' OD1' ' A' ' 54' ' ' ASN . 49.1 t-20 43.03 -89.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.396 0.617 . . . . 0.0 110.252 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . -158.73 -110.87 0.29 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -108.76 47.82 0.89 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.628 -0.925 . . . . 0.0 109.517 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -91.8 129.67 37.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.224 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -71.87 136.4 46.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.58 164.22 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.346 -0.846 . . . . 0.0 109.233 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.682 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 83.4 m-20 -92.01 134.34 34.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.189 -0.945 . . . . 0.0 110.04 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -137.02 158.93 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.234 -0.916 . . . . 0.0 109.69 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.3 pt -135.04 146.74 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -110.59 140.15 45.17 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.553 -0.717 . . . . 0.0 109.621 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.27 164.28 28.45 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 132.08 52.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.483 -0.761 . . . . 0.0 109.877 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.22 162.78 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.342 -0.848 . . . . 0.0 110.144 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -72.03 133.96 83.51 Favored Pre-proline 0 C--N 1.298 -1.643 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.46 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -44.69 -38.18 12.27 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.962 1.775 . . . . 0.0 112.302 178.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.43 -32.21 66.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.054 -1.029 . . . . 0.0 110.442 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.406 ' O ' ' OG ' ' A' ' 73' ' ' SER . 83.7 mt -92.1 5.02 51.86 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.085 -1.01 . . . . 0.0 110.111 -178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.7 p -61.47 -28.21 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.047 -1.033 . . . . 0.0 109.015 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.461 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -58.46 -39.46 93.0 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 70' ' ' LEU . 78.2 p -59.5 -41.11 89.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.15 -1.206 . . . . 0.0 109.668 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 2.5 mm? -68.99 -44.9 71.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 110.781 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -78.2 -36.92 46.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.0 111.299 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.461 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -72.98 -1.72 18.2 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.066 -1.053 . . . . 0.0 109.654 -178.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.49 139.99 21.96 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 109.157 179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.99 143.69 45.56 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.124 1.883 . . . . 0.0 112.969 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.09 -17.42 56.98 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.92 127.44 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -1.178 . . . . 0.0 109.401 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -114.35 133.55 22.43 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.699 -0.625 . . . . 0.0 110.133 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -54.32 149.26 38.11 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.278 1.319 . . . . 0.0 111.352 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.23 143.42 55.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.832 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -92.45 21.96 4.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 109.404 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' MET . 7.5 p80 -148.0 167.89 23.73 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.017 -1.052 . . . . 0.0 110.409 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' HIS . 65.5 mtt -43.68 173.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.539 0.685 . . . . 0.0 111.497 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 57.83 34.12 24.01 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.618 0.723 . . . . 0.0 109.459 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.7 -43.0 99.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.458 -0.776 . . . . 0.0 109.832 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.05 -44.52 84.34 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.102 -0.999 . . . . 0.0 109.858 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -68.78 -46.7 68.05 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.114 -0.991 . . . . 0.0 110.857 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -115.7 145.78 42.45 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.419 -0.801 . . . . 0.0 110.291 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.0 mm -130.61 152.32 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.9 m -101.92 135.49 43.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.406 -0.809 . . . . 0.0 109.508 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.37 136.41 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 63.2 tp -90.66 116.26 28.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 110.085 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.412 ' C ' ' H ' ' A' ' 98' ' ' GLY . 13.6 mt -65.96 -40.22 91.12 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 65.3 m-80 -72.28 3.58 4.52 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -56.56 164.94 5.22 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.74 -8.5 18.07 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.109 2.539 . . . . 0.0 111.576 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.93 162.29 28.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.217 -0.927 . . . . 0.0 110.66 -178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.58 163.59 50.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.47 80.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.509 -0.995 . . . . 0.0 109.089 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.11 -39.55 92.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -0.858 . . . . 0.0 109.419 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -62.48 -42.12 99.27 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.114 -0.991 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.58 -43.89 96.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.213 -0.93 . . . . 0.0 109.354 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -66.03 -38.51 88.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.297 -0.877 . . . . 0.0 109.577 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.7 m -59.48 -44.57 93.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.116 -0.99 . . . . 0.0 109.809 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.37 -42.13 96.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 109.261 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.61 -42.94 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.061 -1.024 . . . . 0.0 109.058 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -53.09 -40.63 64.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.225 -0.922 . . . . 0.0 108.637 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.75 -40.89 98.66 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.3 -0.875 . . . . 0.0 108.724 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -60.2 -38.91 84.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.454 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 14' ' ' TYR . 74.8 t80 -61.39 -43.52 98.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.68 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -47.81 -39.55 18.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.194 -0.941 . . . . 0.0 109.68 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 10.9 mp -65.01 -39.19 93.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 109.684 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.5 p -90.94 9.68 29.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.149 -0.969 . . . . 0.0 109.172 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -49.57 136.68 16.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.864 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 119' ' ' GLU . 92.9 mt -80.81 -133.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.0 109.881 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 118' ' ' LEU . 16.1 pt-20 38.84 -160.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.376 0.608 . . . . 0.0 110.942 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.568 ' CD2' ' H ' ' A' ' 121' ' ' HIS . 13.9 t-80 -156.81 170.57 22.16 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.265 -0.897 . . . . 0.0 109.541 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.568 ' H ' ' CD2' ' A' ' 120' ' ' HIS . 45.9 p-80 -148.54 167.18 26.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 0.0 109.462 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -69.83 142.08 53.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.282 -0.887 . . . . 0.0 110.448 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.86 164.19 14.14 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.284 -0.885 . . . . 0.0 110.302 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -113.31 145.54 40.9 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.0 110.124 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 117.716 -1.135 . . . . 0.0 108.704 179.539 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' N ' ' CD1' ' A' ' 105' ' ' ILE . 21.4 ptp . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.271 0.558 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -94.17 165.45 12.6 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.411 -0.806 . . . . 0.0 109.993 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 42.6 ttm180 -62.31 -44.72 95.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.506 -0.746 . . . . 0.0 109.433 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -63.68 -39.72 95.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.843 . . . . 0.0 109.095 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -63.63 -37.26 86.67 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.399 -0.813 . . . . 0.0 109.264 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.63 -46.94 88.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.488 -0.757 . . . . 0.0 109.74 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.59 -45.41 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.262 -0.899 . . . . 0.0 108.605 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -62.32 -41.8 98.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 0.0 109.558 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.72 -49.6 76.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.201 -0.937 . . . . 0.0 109.074 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.25 -36.1 78.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.729 . . . . 0.0 109.608 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -61.8 -42.6 99.21 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.501 -0.75 . . . . 0.0 110.006 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -83.98 -20.87 32.1 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.096 -1.003 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.4 tptt -87.2 -51.31 6.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.256 -0.902 . . . . 0.0 111.321 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -118.05 -15.05 9.94 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.204 -0.935 . . . . 0.0 110.312 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.0 t0 58.11 41.71 23.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.359 -0.838 . . . . 0.0 109.933 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.6 m -99.85 134.22 43.07 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.174 -0.954 . . . . 0.0 108.704 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -84.4 132.69 46.48 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.031 -1.043 . . . . 0.0 109.244 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.86 151.07 56.54 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.832 1.688 . . . . 0.0 112.295 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -132.94 149.26 52.26 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.542 -0.724 . . . . 0.0 109.352 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.49 ' CG ' ' O ' ' A' ' 20' ' ' HIS . 13.9 p-80 -132.6 85.38 47.89 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.39 -0.819 . . . . 0.0 109.222 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -55.7 -37.05 95.9 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.312 2.008 . . . . 0.0 111.233 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -79.76 98.67 7.11 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.651 0.739 . . . . 0.0 109.43 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.95 -23.32 65.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.438 -0.789 . . . . 0.0 109.744 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -74.49 -3.9 33.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.675 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -145.16 76.56 13.41 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.23 -0.918 . . . . 0.0 109.705 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.77 -20.0 63.94 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.617 2.211 . . . . 0.0 110.768 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 12.8 p-10 -76.5 -2.4 32.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.722 -0.611 . . . . 0.0 109.65 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 6.6 m-85 -99.54 134.87 41.78 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.45 129.86 29.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.288 -0.882 . . . . 0.0 109.405 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.78 128.37 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -100.34 124.06 45.34 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.366 -0.834 . . . . 0.0 109.849 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.7 mtm-85 -137.02 135.68 37.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.297 -0.877 . . . . 0.0 109.284 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.98 112.77 25.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.458 -0.776 . . . . 0.0 109.725 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.2 t -69.72 -26.56 64.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.437 -0.79 . . . . 0.0 109.406 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -64.25 -39.34 93.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.51 -0.744 . . . . 0.0 109.559 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.71 -11.03 22.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.323 -0.86 . . . . 0.0 108.887 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 61.41 38.41 16.07 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.426 0.631 . . . . 0.0 109.626 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -167.65 -120.33 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.453 -0.779 . . . . 0.0 109.55 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 56.16 91.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.489 -0.757 . . . . 0.0 109.318 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -105.21 126.64 52.31 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.945 0.879 . . . . 0.0 110.041 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.5 146.71 27.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.4 tp -140.53 120.55 13.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.951 -1.093 . . . . 0.0 110.268 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.1 tt -113.08 126.43 55.47 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.51 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.3 ptt? -153.27 165.18 36.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.997 -1.064 . . . . 0.0 109.843 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 92.9 m-20 -97.03 116.17 28.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 pt -127.55 145.55 55.1 Favored Pre-proline 0 N--CA 1.504 2.257 0 O-C-N 121.385 -0.822 . . . . 0.0 109.368 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.31 145.53 88.59 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.095 1.864 . . . . 0.0 112.116 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.43 -21.78 66.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.613 -0.679 . . . . 0.0 109.998 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.405 ' HB3' ' H ' ' A' ' 56' ' ' ASP . 9.8 pt-20 -56.62 -20.42 21.11 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 110.232 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.81 -13.0 59.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.107 -0.995 . . . . 0.0 110.705 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 pt -116.43 -5.7 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.302 -0.874 . . . . 0.0 109.79 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.22 -2.29 81.05 Favored Glycine 0 N--CA 1.499 2.874 0 O-C-N 121.184 -0.947 . . . . 0.0 111.12 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.561 ' O ' ' N ' ' A' ' 55' ' ' GLY . 39.3 mt -79.36 146.51 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.902 -1.352 . . . . 0.0 110.066 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 53' ' ' ILE . 18.2 m120 37.16 -88.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.493 0.664 . . . . 0.0 110.603 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . 143.94 116.43 1.11 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.405 ' H ' ' HB3' ' A' ' 49' ' ' GLU . 47.3 t0 60.26 41.44 16.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.946 . . . . 0.0 110.569 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -112.42 124.76 53.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.41 -0.806 . . . . 0.0 108.988 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -71.27 127.84 33.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 109.953 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 m -137.97 161.06 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.338 -0.851 . . . . 0.0 109.017 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -98.86 130.95 45.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.404 -0.81 . . . . 0.0 109.226 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.25 158.28 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.481 -0.762 . . . . 0.0 109.531 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 37.5 pt -131.66 146.83 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -110.83 136.62 49.61 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 pp -137.88 156.79 47.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.287 -0.883 . . . . 0.0 109.48 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -90.65 144.72 25.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.815 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.07 162.1 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 0.0 109.621 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -70.25 155.64 93.12 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.17 -18.28 62.84 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.075 1.85 . . . . 0.0 110.953 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -94.28 -28.76 15.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.544 -0.722 . . . . 0.0 109.226 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.1 mt -94.32 -3.03 51.2 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.177 -0.952 . . . . 0.0 110.039 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 7.6 p -63.45 -31.72 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.137 -0.977 . . . . 0.0 109.919 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.53 -14.72 81.83 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.44 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 34.7 t -70.41 -55.44 9.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -1.099 . . . . 0.0 111.483 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.449 ' H ' ' CD2' ' A' ' 74' ' ' LEU . 1.8 pt? -84.28 -23.09 30.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.119 -0.988 . . . . 0.0 111.106 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' H ' HD22 ' A' ' 74' ' ' LEU . 79.9 ttt-85 -66.38 -41.42 89.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.106 -0.997 . . . . 0.0 111.264 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CD ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -76.29 -7.57 55.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.869 -1.145 . . . . 0.0 110.108 -178.502 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.578 ' CB ' ' HZ2' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -77.69 149.22 77.5 Favored Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.799 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.523 ' C ' ' H ' ' A' ' 80' ' ' ILE . 40.2 Cg_endo -66.34 155.37 70.3 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.12 2.547 . . . . 0.0 112.462 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.47 -25.77 0.9 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.523 ' H ' ' C ' ' A' ' 78' ' ' PRO . 78.9 mt -93.7 115.35 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -1.216 . . . . 0.0 108.951 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.8 150.34 42.63 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.619 -0.675 . . . . 0.0 110.036 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.04 150.94 85.01 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.156 1.904 . . . . 0.0 111.809 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.4 143.88 56.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.345 -0.847 . . . . 0.0 109.625 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 52.4 p90 -92.08 126.9 37.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.119 -0.988 . . . . 0.0 109.899 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 85' ' ' HIS . 85.5 t60 41.53 43.51 2.28 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.561 -0.712 . . . . 0.0 110.405 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.0 mmm -143.46 65.32 1.32 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.234 -0.916 . . . . 0.0 109.044 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.612 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 22.2 m-20 68.39 -50.14 0.56 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.166 -0.334 . . . . 0.0 110.42 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 63.91 -37.63 0.19 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 120.979 0.419 . . . . 0.0 110.24 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 87' ' ' ASN . 83.1 tt0 -88.66 -20.19 25.23 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.903 -1.123 . . . . 0.0 109.817 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -96.88 -59.84 1.72 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.266 -0.896 . . . . 0.0 110.336 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.612 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 5.4 m0 -105.96 140.96 38.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.494 -0.754 . . . . 0.0 109.912 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.0 mm -121.14 138.55 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.1 m -85.43 134.46 34.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.707 -0.62 . . . . 0.0 109.834 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.4 t -119.63 134.82 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.596 -0.69 . . . . 0.0 109.157 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.2 tp -89.55 107.2 18.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.199 -0.938 . . . . 0.0 110.058 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.23 -39.33 89.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.497 -0.752 . . . . 0.0 109.71 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -74.28 2.88 8.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.477 -0.765 . . . . 0.0 109.61 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.93 -166.05 30.28 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 100' ' ' LEU . 83.8 Cg_endo -85.34 10.63 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.396 2.731 . . . . 0.0 111.54 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 99' ' ' PRO . 3.8 mm? -52.55 -107.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.629 0.728 . . . . 0.0 109.63 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.11 154.38 6.15 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.48 -46.3 86.93 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.303 -1.116 . . . . 0.0 109.357 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.65 -42.67 98.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.501 -0.749 . . . . 0.0 109.84 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -66.06 -42.73 89.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.397 -0.814 . . . . 0.0 109.743 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.408 ' CD1' ' N ' ' A' ' 1' ' ' MET . 94.9 mt -64.15 -43.25 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -55.16 -43.98 74.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.318 -0.864 . . . . 0.0 109.263 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 56.0 m -60.83 -42.37 97.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.855 . . . . 0.0 109.46 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.07 -42.95 99.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.432 -0.793 . . . . 0.0 109.323 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.06 -43.08 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.369 -0.832 . . . . 0.0 109.097 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -58.52 -37.71 76.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 108.593 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.446 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 92.4 m-20 -62.57 -35.77 80.56 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.8 p -81.51 -23.55 37.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 109.306 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -61.65 -44.43 96.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.427 -0.796 . . . . 0.0 109.885 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.462 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 5.4 pt20 -50.9 -41.25 58.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.337 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.462 ' N ' ' CG ' ' A' ' 114' ' ' GLN . 84.6 mt -64.77 -39.71 94.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.526 -0.733 . . . . 0.0 109.745 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.3 p -92.99 14.83 16.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.135 -0.978 . . . . 0.0 109.522 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -58.09 141.22 50.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.145 -0.972 . . . . 0.0 109.58 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mt -75.83 147.92 38.77 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.739 0.781 . . . . 0.0 110.409 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.09 136.47 56.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.619 -0.676 . . . . 0.0 109.816 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -154.01 137.95 16.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.395 -0.816 . . . . 0.0 108.966 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -82.38 146.02 29.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.0 110.639 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -61.36 -42.89 99.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.699 -0.626 . . . . 0.0 110.025 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' A' ' 123' ' ' HIS . 56.8 p-80 -98.28 108.04 20.65 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.364 -0.835 . . . . 0.0 109.874 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -133.0 124.01 26.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.485 -0.759 . . . . 0.0 108.998 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.436 -179.963 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.511 ' O ' ' ND2' ' A' ' 2' ' ' ASN . 6.3 ttt . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 1' ' ' MET . 15.2 m120 -146.73 -178.33 6.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.104 -0.998 . . . . 0.0 110.116 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.53 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 40.8 ttm180 -62.25 -44.61 96.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.593 -0.692 . . . . 0.0 109.81 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -61.83 -37.33 84.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.898 . . . . 0.0 109.521 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -59.98 -40.44 89.13 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.346 -0.846 . . . . 0.0 109.04 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -62.65 -41.63 99.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.696 -0.628 . . . . 0.0 110.363 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.5 mm -59.24 -47.7 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.059 -1.025 . . . . 0.0 110.018 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 9' ' ' TYR . 0.6 OUTLIER -63.8 -43.86 95.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.914 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.622 ' CE2' ' CD2' ' A' ' 106' ' ' HIS . 43.4 t80 -62.53 -48.29 80.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.562 -0.711 . . . . 0.0 109.872 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.01 86.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.4 -0.813 . . . . 0.0 110.102 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 15' ' ' ASP . 11.6 tp-100 -64.75 -48.95 72.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.384 -0.822 . . . . 0.0 109.896 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -66.71 -33.63 76.07 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.931 -1.106 . . . . 0.0 110.599 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -87.05 -12.09 48.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.118 -0.989 . . . . 0.0 111.83 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.609 ' CD1' ' NE2' ' A' ' 33' ' ' HIS . 95.8 m-85 -141.62 -0.22 1.39 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.653 -1.279 . . . . 0.0 110.446 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER 41.06 35.18 0.34 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -109.76 138.06 46.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.507 0.67 . . . . 0.0 109.653 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -91.1 151.13 42.81 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.504 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.65 149.05 73.32 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.596 2.198 . . . . 0.0 112.186 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -123.83 134.36 53.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.623 -0.673 . . . . 0.0 109.343 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 20' ' ' HIS . 18.6 p80 -128.78 85.4 60.33 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.37 -12.76 11.36 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.452 2.101 . . . . 0.0 110.973 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -92.38 97.52 10.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -70.15 -18.59 63.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.507 -0.746 . . . . 0.0 109.934 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 10.0 mtpm? -76.56 -4.65 43.93 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.142 -0.974 . . . . 0.0 109.14 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 24' ' ' LYS . 53.3 m-85 -156.85 79.47 3.71 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.433 -0.792 . . . . 0.0 108.903 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.3 -19.48 50.71 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.723 2.282 . . . . 0.0 111.294 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -73.13 -5.96 42.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.521 -0.737 . . . . 0.0 109.183 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.586 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 4.9 m-85 -87.55 137.95 31.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.573 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.88 141.38 34.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 0.0 109.156 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.09 126.44 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -106.66 120.08 41.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.54 -0.725 . . . . 0.0 109.5 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.449 ' NH2' ' O ' ' A' ' 37' ' ' ASP . 17.5 ptm180 -150.61 158.3 43.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.135 -0.978 . . . . 0.0 109.61 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.609 ' NE2' ' CD1' ' A' ' 14' ' ' TYR . 4.4 m170 -97.94 126.52 43.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 109.713 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.4 p -66.45 -34.26 77.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.469 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.76 -39.54 94.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.36 -0.838 . . . . 0.0 109.86 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 38' ' ' LYS . 53.0 t-20 -93.23 -12.26 30.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.409 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.449 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 37.7 t70 57.93 -71.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.695 -0.628 . . . . 0.0 110.713 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.6 tttt -63.61 124.66 21.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 110.506 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.434 ' HE1' ' HG1' ' A' ' 116' ' ' THR . 0.0 OUTLIER -178.86 126.46 0.1 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.345 -0.847 . . . . 0.0 108.975 179.075 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -115.09 123.29 48.61 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.553 0.692 . . . . 0.0 109.524 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.8 106.23 2.85 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -107.59 128.25 54.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.524 -0.735 . . . . 0.0 109.788 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tt -122.61 118.19 27.59 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.586 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -162.82 166.67 23.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.968 . . . . 0.0 109.92 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.53 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 91.5 m-20 -93.6 143.5 26.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.56 -0.713 . . . . 0.0 109.33 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.9 pt -150.67 146.23 19.31 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.254 -0.904 . . . . 0.0 109.435 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.62 145.82 6.02 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.127 1.885 . . . . 0.0 112.697 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.6 -20.98 62.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.48 -0.763 . . . . 0.0 109.959 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.61 -17.59 63.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.887 . . . . 0.0 110.135 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.95 -10.45 57.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.05 -1.031 . . . . 0.0 111.042 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.2 pt -105.82 7.12 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.142 -0.974 . . . . 0.0 109.428 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 -13.83 63.24 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.59 129.01 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.845 -1.386 . . . . 0.0 110.028 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -88.52 100.84 13.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.454 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.06 -22.48 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 56.76 31.53 19.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.795 -0.827 . . . . 0.0 109.708 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -102.8 144.98 30.44 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.323 -0.861 . . . . 0.0 109.775 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -74.15 128.19 34.88 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.326 -0.858 . . . . 0.0 109.278 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.25 161.19 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.482 -0.761 . . . . 0.0 109.769 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.418 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 28.3 m-20 -93.28 132.32 37.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.795 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.11 155.95 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.39 -0.818 . . . . 0.0 110.249 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.0 pt -130.93 155.3 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -92.86 119.74 32.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 110.2 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.632 ' CD1' ' HG ' ' A' ' 112' ' ' SER . 0.3 OUTLIER -115.7 119.81 37.31 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.279 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.9 ptmm? -86.71 135.86 33.23 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.461 -0.774 . . . . 0.0 110.588 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.66 165.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.426 -0.796 . . . . 0.0 109.946 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -75.31 152.78 85.98 Favored Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 121.362 -0.836 . . . . 0.0 110.176 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -48.93 -34.01 27.54 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.13 1.887 . . . . 0.0 111.77 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -85.51 -29.21 24.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.393 -0.817 . . . . 0.0 110.087 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.0 mt -88.25 1.03 55.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.985 -1.072 . . . . 0.0 109.847 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.423 ' CG1' ' N ' ' A' ' 72' ' ' GLY . 14.8 p -66.13 -42.5 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.136 -0.977 . . . . 0.0 109.516 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.423 ' N ' ' CG1' ' A' ' 71' ' ' VAL . . . -66.05 -40.61 95.23 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -60.75 -36.75 79.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -1.217 . . . . 0.0 109.524 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.6 tt -85.75 -37.39 19.37 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.553 -0.717 . . . . 0.0 109.825 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 ttp85 -73.92 -16.98 61.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.794 . . . . 0.0 110.644 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -7.65 58.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.95 -1.094 . . . . 0.0 109.081 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.476 ' HZ3' ' CD2' ' A' ' 108' ' ' LEU . 40.9 mtmt -85.32 122.83 73.68 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.181 -0.95 . . . . 0.0 109.397 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.24 146.28 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.216 1.944 . . . . 0.0 113.137 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.71 -21.29 39.76 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.4 mt -104.45 122.97 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.296 -1.12 . . . . 0.0 109.307 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -118.8 149.3 46.25 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.69 -0.631 . . . . 0.0 109.858 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -40.56 165.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.564 2.176 . . . . 0.0 112.619 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.07 147.08 50.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.353 -0.842 . . . . 0.0 110.603 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.453 ' OH ' ' CE ' ' A' ' 44' ' ' MET . 5.9 p90 -76.64 167.39 21.92 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.731 0.777 . . . . 0.0 110.759 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 73.8 m80 53.29 -94.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.622 -0.674 . . . . 0.0 110.147 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 93.7 mtp -138.48 -151.79 0.4 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.389 -0.819 . . . . 0.0 109.747 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 59.35 34.96 23.04 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -88.62 62.47 6.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.471 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -146.16 -67.01 0.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 108.889 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -96.36 -19.13 19.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.391 -0.818 . . . . 0.0 109.668 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 -110.51 138.15 47.27 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.461 -0.775 . . . . 0.0 110.085 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.8 mm -136.27 154.31 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.462 -0.774 . . . . 0.0 108.938 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.4 m -98.85 131.28 45.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.853 . . . . 0.0 110.814 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.5 t -113.16 133.84 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.6 tp -93.71 112.76 24.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.432 -0.793 . . . . 0.0 110.256 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.03 -39.54 90.28 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.637 0.732 . . . . 0.0 109.432 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -71.89 -6.21 40.15 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.285 -0.884 . . . . 0.0 109.245 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.02 177.65 1.52 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.72 -12.73 24.46 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 123.038 2.492 . . . . 0.0 111.404 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.82 136.9 54.86 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.562 0.696 . . . . 0.0 110.684 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.96 -178.73 46.03 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.49 81.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.618 -0.931 . . . . 0.0 109.671 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -56.55 -42.07 77.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.887 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.423 ' OE2' ' NZ ' ' A' ' 77' ' ' LYS . 46.0 tp10 -69.09 -40.05 78.66 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.013 -1.054 . . . . 0.0 109.443 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.424 HD13 HG22 ' A' ' 105' ' ' ILE . 97.2 mt -64.77 -43.13 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.351 -0.843 . . . . 0.0 109.484 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.622 ' CD2' ' CE2' ' A' ' 9' ' ' TYR . 62.7 m170 -56.89 -44.33 82.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 109.487 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.5 t -62.72 -43.45 98.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.37 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.476 ' CD2' ' HZ3' ' A' ' 77' ' ' LYS . 88.9 mt -63.39 -41.02 98.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.362 -0.836 . . . . 0.0 109.209 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.402 HD11 HG22 ' A' ' 109' ' ' ILE . 86.6 mt -63.0 -42.45 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -56.3 -42.26 77.28 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.256 -0.903 . . . . 0.0 108.781 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.23 -37.69 88.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.632 ' HG ' ' CD1' ' A' ' 64' ' ' LEU . 2.4 m -60.75 -39.66 89.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.46 -0.775 . . . . 0.0 109.29 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -59.89 -42.9 94.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.573 -0.704 . . . . 0.0 109.688 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -52.62 -46.36 67.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 110.091 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 115' ' ' LEU . 4.1 mm? -65.9 -40.11 91.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.413 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.434 ' HG1' ' HE1' ' A' ' 39' ' ' TRP . 15.9 p -93.94 15.46 16.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.978 . . . . 0.0 109.147 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.96 143.0 56.02 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.687 0.756 . . . . 0.0 110.673 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.07 157.98 32.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.54 -0.725 . . . . 0.0 110.702 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 57.23 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.55 0.691 . . . . 0.0 110.031 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -87.22 138.1 31.78 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.559 0.695 . . . . 0.0 109.937 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -70.3 149.72 47.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 124' ' ' HIS . 23.9 p80 -144.48 161.83 38.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.247 -0.908 . . . . 0.0 109.922 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -88.64 -13.24 40.32 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.507 ' HD1' ' C ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -151.81 164.52 36.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 0.0 109.868 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 76.0 m80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.859 -1.067 . . . . 0.0 109.996 -179.682 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.9 ttp . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.711 0.767 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.8 p30 -92.17 170.32 9.91 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.997 0.903 . . . . 0.0 110.408 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -63.5 -42.07 98.51 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.567 0.699 . . . . 0.0 109.607 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -51.33 -43.02 61.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.759 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -66.83 -37.78 85.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 109.457 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -61.21 -44.22 97.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.337 -0.852 . . . . 0.0 109.889 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.44 -46.66 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.184 -0.947 . . . . 0.0 109.726 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -63.9 -45.62 88.52 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 110.001 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.448 ' CD2' ' NE2' ' A' ' 106' ' ' HIS . 56.0 t80 -66.25 -42.16 88.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 110.195 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.41 98.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.208 -0.932 . . . . 0.0 109.99 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ASP . 84.6 mt-30 -65.75 -41.72 91.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.287 -0.883 . . . . 0.0 110.031 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -62.76 -31.49 72.45 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.889 -1.132 . . . . 0.0 109.185 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -87.93 -45.29 10.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 111.69 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -107.4 -13.85 15.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.013 -1.054 . . . . 0.0 111.251 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 11' ' ' GLN . 99.3 m-20 54.52 34.16 20.52 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.08 -1.012 . . . . 0.0 108.776 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.9 m -121.64 132.09 54.47 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.857 0.836 . . . . 0.0 110.273 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -83.04 152.25 65.05 Favored Pre-proline 0 N--CA 1.486 1.367 0 O-C-N 121.595 -0.69 . . . . 0.0 109.166 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.61 134.58 27.15 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.172 1.915 . . . . 0.0 112.481 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -106.03 121.61 44.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.478 -0.763 . . . . 0.0 109.232 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -85.37 116.88 67.4 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.42 -0.8 . . . . 0.0 109.825 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.414 ' HG2' ' H ' ' A' ' 22' ' ' TRP . 72.4 Cg_endo -80.19 -90.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.52 2.147 . . . . 0.0 111.999 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.414 ' H ' ' HG2' ' A' ' 21' ' ' PRO . 5.5 m-90 -81.18 137.5 35.89 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.855 0.836 . . . . 0.0 110.055 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -65.77 -30.69 71.38 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.542 0.686 . . . . 0.0 110.066 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -67.84 -0.56 4.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.808 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -143.77 73.02 17.04 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.039 -1.038 . . . . 0.0 109.61 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.61 -19.0 25.01 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.363 2.042 . . . . 0.0 110.881 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -81.18 -4.23 54.77 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.631 0.729 . . . . 0.0 109.209 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -96.11 139.1 32.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.468 -0.77 . . . . 0.0 109.222 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.97 146.37 47.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.697 . . . . 0.0 109.398 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.4 t -127.87 129.58 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.396 0.617 . . . . 0.0 109.395 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -118.24 113.87 22.14 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -146.49 161.36 40.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.15 -0.969 . . . . 0.0 110.086 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.524 ' O ' ' N ' ' A' ' 37' ' ' ASP . 53.1 m170 -96.68 129.34 44.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.527 -0.733 . . . . 0.0 109.784 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.6 m -69.6 -20.66 63.63 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.58 0.705 . . . . 0.0 109.673 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.39 -45.64 90.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.09 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 37' ' ' ASP . 93.8 m-20 -125.58 -30.73 3.05 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.403 -0.81 . . . . 0.0 109.838 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.524 ' N ' ' O ' ' A' ' 33' ' ' HIS . 1.2 p30 50.68 25.19 1.96 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.564 0.697 . . . . 0.0 110.04 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.24 -8.53 45.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.138 -0.977 . . . . 0.0 108.777 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -91.19 146.52 23.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.378 -0.826 . . . . 0.0 110.02 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.8 124.35 43.1 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.698 0.761 . . . . 0.0 109.493 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.61 105.71 2.84 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.86 149.36 52.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.267 -0.895 . . . . 0.0 109.457 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.6 tt -118.91 128.04 54.05 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.98 163.97 39.55 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.875 0.845 . . . . 0.0 110.211 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.419 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 51.9 p-10 -93.52 145.61 24.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.537 0.684 . . . . 0.0 110.016 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.6 pt -155.75 146.96 16.63 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.606 -0.684 . . . . 0.0 109.467 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.44 141.67 97.83 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.099 1.866 . . . . 0.0 111.619 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.53 -20.26 66.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.484 -0.76 . . . . 0.0 109.902 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -54.76 -16.59 2.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.431 -0.793 . . . . 0.0 110.214 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -85.5 -23.72 27.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.253 -0.905 . . . . 0.0 111.171 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 pt -95.64 10.69 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.892 -1.13 . . . . 0.0 109.726 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.13 -8.27 75.82 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.3 mt -78.77 129.98 36.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.806 -1.408 . . . . 0.0 109.996 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -62.23 -39.9 94.34 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.591 0.71 . . . . 0.0 109.34 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -42.07 133.23 4.12 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.8 p30 -89.6 3.08 53.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.462 -1.022 . . . . 0.0 108.93 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.8 144.65 56.18 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.731 0.777 . . . . 0.0 110.485 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -87.11 145.57 26.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.52 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.51 160.42 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.658 0.742 . . . . 0.0 110.321 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.77 132.89 34.99 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.305 0.574 . . . . 0.0 110.019 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.41 156.16 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.659 0.743 . . . . 0.0 110.017 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.8 pt -136.09 146.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.596 0.713 . . . . 0.0 109.963 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -81.87 143.34 31.77 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.524 0.678 . . . . 0.0 110.308 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.26 125.97 30.48 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -82.95 131.28 35.19 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.689 0.757 . . . . 0.0 110.67 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.83 161.8 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.739 0.78 . . . . 0.0 109.726 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -87.11 153.14 54.03 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.529 -0.732 . . . . 0.0 109.464 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -47.5 -26.18 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.159 1.906 . . . . 0.0 111.577 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -94.78 -29.17 14.89 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.708 0.766 . . . . 0.0 109.345 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.5 mt -86.77 -6.51 58.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 0.0 109.644 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.1 p -67.29 -39.58 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 109.553 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -61.32 -47.04 93.03 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.6 m -59.59 -42.49 92.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.295 -1.121 . . . . 0.0 110.532 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.2 tt -84.65 -24.37 29.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 110.576 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.605 ' NH1' ' NZ ' ' A' ' 88' ' ' LYS . 69.7 ttt180 -82.72 -40.56 20.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.868 -1.145 . . . . 0.0 109.173 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -69.02 1.22 3.66 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 75' ' ' ARG . 34.8 mmtt -88.01 116.03 64.94 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.473 -0.767 . . . . 0.0 109.459 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.26 144.92 37.3 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.331 2.02 . . . . 0.0 113.045 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.61 -20.76 46.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.01 125.67 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.477 -1.013 . . . . 0.0 109.396 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.422 ' O ' ' OG1' ' A' ' 93' ' ' THR . 57.8 m-85 -106.0 151.65 40.11 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.593 -0.692 . . . . 0.0 109.996 -179.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.22 146.62 81.87 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.5 2.133 . . . . 0.0 112.194 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.09 153.23 44.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.546 -0.721 . . . . 0.0 110.592 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.09 -143.02 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.916 0.865 . . . . 0.0 110.52 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 46.16 -113.54 0.44 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.443 0.639 . . . . 0.0 109.954 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 98.2 mmm -141.07 0.89 1.59 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 89' ' ' GLU . 81.8 m-20 -59.64 -85.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 109.691 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.605 ' NZ ' ' NH1' ' A' ' 75' ' ' ARG . 62.7 tttm 56.86 -76.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.648 -0.657 . . . . 0.0 110.222 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' ASN . 97.5 mt-10 -65.35 -38.7 90.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 0.0 109.673 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -68.51 -68.12 0.42 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.584 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -120.57 159.4 25.33 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.525 -0.734 . . . . 0.0 109.634 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 mm -129.6 147.69 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.919 0.866 . . . . 0.0 109.826 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 6.1 p -90.59 134.6 34.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.683 -0.636 . . . . 0.0 110.076 -179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -115.48 129.87 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 34.0 tp -86.77 104.84 16.53 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.669 0.747 . . . . 0.0 109.976 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.76 -38.4 88.96 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.788 0.804 . . . . 0.0 109.237 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.39 -5.88 44.97 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.897 0.856 . . . . 0.0 109.113 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.92 -175.41 8.96 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.514 ' O ' ' C ' ' A' ' 100' ' ' LEU . 44.5 Cg_endo -71.63 -81.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.633 2.222 . . . . 0.0 112.226 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.514 ' C ' ' O ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER 19.2 -120.7 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 121.158 0.504 . . . . 0.0 111.689 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.95 165.61 30.19 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.22 -39.07 86.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.528 -0.984 . . . . 0.0 109.461 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -64.91 -35.5 81.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.447 -0.783 . . . . 0.0 109.611 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -67.09 -40.7 87.01 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.201 -0.937 . . . . 0.0 109.411 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.71 -43.3 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 109.273 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.448 ' NE2' ' CD2' ' A' ' 9' ' ' TYR . 52.1 m170 -56.65 -44.95 81.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 109.76 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.2 m -62.25 -42.44 99.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.744 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.52 -41.03 96.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 109.194 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 109' ' ' ILE . 86.7 mt -63.1 -42.7 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.339 -0.85 . . . . 0.0 108.988 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -53.77 -46.55 71.0 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.502 -0.749 . . . . 0.0 109.438 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -64.43 -38.53 91.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.075 -1.016 . . . . 0.0 108.851 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.6 p -62.18 -36.24 81.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 0.0 109.226 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -61.75 -44.6 96.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.413 -0.805 . . . . 0.0 109.664 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.16 -41.86 89.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.296 -0.877 . . . . 0.0 109.612 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.8 mt -66.53 -38.7 87.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.341 -0.849 . . . . 0.0 109.798 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.8 p -89.09 5.84 42.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.216 -0.927 . . . . 0.0 109.372 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 118' ' ' LEU . 34.4 ttm180 -73.86 51.47 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 108.903 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 117' ' ' ARG . 5.3 mp 40.03 -161.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.532 0.682 . . . . 0.0 110.833 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -94.14 -122.25 0.1 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.247 -0.908 . . . . 0.0 109.813 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 120' ' ' HIS . 52.5 p-80 -146.55 59.9 1.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.579 -0.701 . . . . 0.0 109.537 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' HIS . . . . . 0.409 ' C ' ' H ' ' A' ' 123' ' ' HIS . 97.3 m-70 -84.76 156.98 21.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.451 -0.781 . . . . 0.0 110.633 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 86.3 t60 56.03 10.76 0.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.556 0.693 . . . . 0.0 109.439 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.409 ' H ' ' C ' ' A' ' 121' ' ' HIS . 62.6 t-80 -81.48 62.24 5.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.799 . . . . 0.0 109.209 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -67.33 -39.87 85.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 0.0 109.425 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 80.7 m80 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.935 -179.425 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -100.41 156.79 17.06 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.821 0.82 . . . . 0.0 110.367 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.0 mtp-105 -60.6 -46.58 89.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.64 -0.662 . . . . 0.0 110.171 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -47.73 -40.51 20.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.992 . . . . 0.0 109.677 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.77 -41.6 87.43 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.344 -0.848 . . . . 0.0 109.366 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -63.72 -45.43 89.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.458 -0.777 . . . . 0.0 110.095 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.2 mm -63.84 -46.02 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.79 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -67.38 -39.04 85.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 0.0 108.925 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -61.78 -46.14 90.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.456 -0.778 . . . . 0.0 109.936 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.28 86.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.477 -0.765 . . . . 0.0 109.914 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -65.95 -21.71 66.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -84.42 -53.22 5.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 109.914 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -88.87 -44.02 10.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.446 -0.784 . . . . 0.0 111.601 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 15' ' ' ASP . 45.6 m-85 -93.45 -6.16 47.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.785 -1.197 . . . . 0.0 110.071 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER 37.4 34.55 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.622 0.725 . . . . 0.0 109.796 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 14' ' ' TYR . 7.8 t -104.45 145.74 29.85 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.564 0.697 . . . . 0.0 110.085 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -98.47 151.28 37.4 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.66 149.35 73.51 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.712 2.275 . . . . 0.0 112.659 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -136.33 151.16 49.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.673 -0.642 . . . . 0.0 109.354 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -139.64 86.0 14.3 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -55.17 -38.1 93.8 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.566 2.178 . . . . 0.0 110.758 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -94.71 116.44 28.75 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.373 0.606 . . . . 0.0 109.509 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 25' ' ' PHE . 17.4 pt-20 -69.49 -31.31 69.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.493 -0.754 . . . . 0.0 109.405 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -64.78 -0.66 1.55 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.564 -0.71 . . . . 0.0 109.464 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 23' ' ' GLU . 73.2 m-85 -137.05 71.75 54.95 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 109.333 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.7 -20.58 30.26 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.471 2.114 . . . . 0.0 111.615 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.18 -6.0 58.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.477 -0.764 . . . . 0.0 109.306 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.76 140.19 29.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.65 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.11 133.15 50.44 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.73 129.97 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.682 -0.636 . . . . 0.0 109.348 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -113.62 134.15 54.88 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -158.41 149.48 20.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.533 ' O ' ' NE1' ' A' ' 39' ' ' TRP . 81.2 m-70 -99.57 118.04 35.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.538 -0.726 . . . . 0.0 109.604 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 m -76.52 -15.09 59.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.534 -0.728 . . . . 0.0 109.149 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.59 -5.34 51.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.899 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 116' ' ' THR . 45.8 t-20 -115.24 -30.9 6.16 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.541 -0.724 . . . . 0.0 109.469 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 38' ' ' LYS . 65.1 t0 57.73 134.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.851 0.834 . . . . 0.0 111.018 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 6.3 tmtt? 82.41 102.2 0.05 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.515 0.674 . . . . 0.0 109.739 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -171.01 175.19 4.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.45 -0.781 . . . . 0.0 109.618 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.511 ' CG ' ' O ' ' A' ' 39' ' ' TRP . 80.3 m-85 -158.44 119.14 3.34 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.45 105.39 2.07 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -133.93 138.64 45.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 0.0 109.091 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.629 HD21 ' OD1' ' A' ' 60' ' ' ASP . 9.1 tt -116.4 124.76 50.83 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.8 ptt? -152.39 156.01 38.71 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.815 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.413 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 98.3 m-20 -94.4 114.49 26.53 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.6 pt -118.03 145.29 36.51 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.766 -0.583 . . . . 0.0 109.998 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -46.81 143.26 9.46 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.144 1.896 . . . . 0.0 112.431 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 57' ' ' LYS . . . -64.09 -21.78 66.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -77.36 -14.23 59.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 109.783 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -84.57 -10.7 57.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 110.158 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 13.7 pt -105.08 1.45 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.2 -8.36 60.71 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 55' ' ' GLY . 77.0 mt -79.72 139.2 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.848 -1.383 . . . . 0.0 110.14 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.37 -38.22 88.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.742 -0.599 . . . . 0.0 110.746 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -49.66 145.36 8.32 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.862 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -101.8 9.19 41.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.596 -0.943 . . . . 0.0 108.929 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 62.5 pttt -76.5 146.28 38.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 110.305 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.6 144.0 37.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.563 -0.711 . . . . 0.0 109.77 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.93 161.89 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.417 -0.802 . . . . 0.0 110.407 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.629 ' OD1' HD21 ' A' ' 43' ' ' LEU . 24.1 t70 -100.73 128.17 46.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.845 -0.534 . . . . 0.0 109.934 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.07 157.69 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.604 -0.685 . . . . 0.0 109.771 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 pt -132.61 150.15 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.48 0.657 . . . . 0.0 109.706 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 64.5 t0 -80.13 134.65 36.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.67 -0.644 . . . . 0.0 109.864 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.654 HD12 HG13 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -125.82 124.0 39.98 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.643 ' N ' HD13 ' A' ' 64' ' ' LEU . 36.2 ttmt -89.91 129.47 36.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.943 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.654 HG13 HD12 ' A' ' 64' ' ' LEU . 15.0 m -138.64 164.68 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.895 0.855 . . . . 0.0 110.663 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.3 155.1 90.08 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.433 ' O ' HG12 ' A' ' 71' ' ' VAL . 31.3 Cg_endo -62.55 -24.62 75.3 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.752 2.302 . . . . 0.0 112.402 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -91.16 -23.59 20.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -0.968 . . . . 0.0 110.161 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.4 mt -92.68 1.18 57.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.03 -1.044 . . . . 0.0 109.469 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 72' ' ' GLY . 10.6 p -63.98 -41.56 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 108.831 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.511 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -61.94 -40.52 98.98 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.2 t -65.34 -54.79 23.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -1.133 . . . . 0.0 110.281 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.533 HD13 HG11 ' A' ' 66' ' ' VAL . 2.3 tt -68.25 -43.89 76.84 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 110.638 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -69.93 -18.29 63.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.457 -0.777 . . . . 0.0 110.214 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -71.66 -32.86 68.34 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.828 -1.17 . . . . 0.0 108.868 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -66.63 139.98 96.22 Favored Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.807 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.06 157.84 53.54 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.191 1.927 . . . . 0.0 112.562 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.44 -18.49 49.03 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.8 mt -103.23 117.11 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.971 . . . . 0.0 109.209 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 63.0 m-85 -105.82 151.2 39.89 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.694 -0.629 . . . . 0.0 109.445 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.583 ' CB ' ' HZ1' ' A' ' 88' ' ' LYS . 57.9 Cg_endo -68.75 153.17 73.61 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.608 2.205 . . . . 0.0 112.648 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.53 139.73 58.8 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.356 -0.84 . . . . 0.0 110.059 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -90.13 2.76 54.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.557 -0.714 . . . . 0.0 109.207 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -79.9 -168.34 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.393 -0.817 . . . . 0.0 110.65 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.0 mtt -63.38 -40.37 97.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.518 -0.739 . . . . 0.0 109.574 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.504 ' ND2' ' CH2' ' A' ' 91' ' ' TRP . 94.1 m-20 -81.31 -172.79 3.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.258 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.583 ' HZ1' ' CB ' ' A' ' 82' ' ' PRO . 48.8 tttp -165.31 -61.06 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -67.87 -38.7 83.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.567 -0.708 . . . . 0.0 109.455 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.86 -50.07 68.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.486 -0.759 . . . . 0.0 109.988 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.504 ' CH2' ' ND2' ' A' ' 87' ' ' ASN . 6.8 m0 -115.96 137.01 52.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.675 -0.64 . . . . 0.0 109.732 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.46 HG21 ' CD2' ' A' ' 74' ' ' LEU . 6.8 mm -129.16 133.39 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.569 0.699 . . . . 0.0 109.189 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.9 m -81.58 130.82 35.19 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.634 -0.666 . . . . 0.0 109.702 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.18 132.98 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.598 -0.689 . . . . 0.0 109.245 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.5 tp -87.54 103.84 15.93 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.509 0.671 . . . . 0.0 110.095 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 98' ' ' GLY . 72.2 mt -65.73 -40.08 91.82 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.607 0.717 . . . . 0.0 109.218 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -76.83 11.12 1.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -89.66 -164.5 40.13 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.89 0.41 10.02 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 123.226 2.617 . . . . 0.0 111.697 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.3 mm? -61.25 135.22 57.66 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.95 0.881 . . . . 0.0 110.985 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.68 157.43 28.7 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.08 97.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.561 -0.964 . . . . 0.0 109.538 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -70.26 -34.87 73.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.337 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.06 -43.25 92.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.457 -0.777 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.73 -42.91 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.511 -0.743 . . . . 0.0 109.37 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -56.49 -43.76 79.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 109.673 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.5 t -61.93 -44.82 95.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.395 -0.816 . . . . 0.0 109.963 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.65 -41.0 98.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.48 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.56 -42.64 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.018 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -51.7 -43.86 62.95 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -62.71 -43.23 99.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.618 -0.676 . . . . 0.0 109.324 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.2 p -70.02 -30.86 68.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 0.0 109.433 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.16 -43.91 87.63 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.441 -0.787 . . . . 0.0 109.179 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -49.84 -31.01 10.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.541 -0.724 . . . . 0.0 109.698 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.2 mp -84.25 -17.43 39.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -0.857 . . . . 0.0 109.617 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.534 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 32.3 p -102.92 15.23 29.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.453 -0.78 . . . . 0.0 109.211 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 18.2 mmm180 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.973 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 tpp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -95.02 165.96 12.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.394 -0.817 . . . . 0.0 110.446 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -63.09 -42.52 99.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.75 -0.594 . . . . 0.0 109.731 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.549 HE22 ' CG ' ' A' ' 8' ' ' ASP . 2.2 tm0? -64.04 -38.59 91.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.146 -0.972 . . . . 0.0 109.471 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -63.57 -39.64 94.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.524 -0.735 . . . . 0.0 109.415 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -61.94 -46.86 87.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.438 -0.789 . . . . 0.0 109.83 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.66 -44.36 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.615 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.549 ' CG ' HE22 ' A' ' 4' ' ' GLN . 54.3 m-20 -65.87 -38.26 88.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.82 . . . . 0.0 109.023 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.462 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 91.6 t80 -61.58 -44.52 96.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.803 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' TYR . . . -64.13 -36.65 84.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 110.312 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.567 ' O ' ' N ' ' A' ' 15' ' ' ASP . 58.3 mm-40 -61.88 -44.27 97.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.147 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -66.78 -38.44 86.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.893 -1.129 . . . . 0.0 109.552 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 29.9 mmtp -88.19 -11.73 45.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.491 -0.756 . . . . 0.0 111.302 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' ALA . 80.7 m-85 -144.61 -21.68 0.52 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.821 -1.174 . . . . 0.0 110.818 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 11' ' ' GLN . 65.0 m-20 53.83 32.94 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 0.0 109.063 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.533 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 12.3 t -103.15 134.91 45.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.499 -0.75 . . . . 0.0 109.674 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -82.52 149.14 60.35 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.611 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.33 151.98 71.5 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.44 2.093 . . . . 0.0 112.346 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -132.77 130.21 39.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.646 -0.659 . . . . 0.0 109.288 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.424 ' O ' ' CD2' ' A' ' 20' ' ' HIS . 31.5 p-80 -132.4 86.33 45.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.72 -35.85 93.99 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.515 2.143 . . . . 0.0 111.381 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -81.35 104.06 11.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.588 -0.695 . . . . 0.0 109.977 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -68.07 -34.99 77.48 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.501 0.667 . . . . 0.0 109.359 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -67.24 -3.13 7.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.402 -0.811 . . . . 0.0 109.708 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -135.08 71.51 68.6 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.493 -0.754 . . . . 0.0 109.463 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.75 -17.54 42.25 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.323 2.015 . . . . 0.0 111.126 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -80.16 -5.92 56.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.495 -0.753 . . . . 0.0 109.221 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -104.68 135.91 45.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.505 -0.747 . . . . 0.0 109.471 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.67 147.87 47.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.583 -0.698 . . . . 0.0 109.318 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.86 126.4 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.759 -0.588 . . . . 0.0 109.682 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -108.92 117.75 35.0 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -149.45 153.17 36.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.066 -1.021 . . . . 0.0 109.792 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.689 ' N ' ' HE1' ' A' ' 39' ' ' TRP . 28.1 m80 -83.76 132.07 34.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 110.379 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -67.8 -40.19 83.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 109.828 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -92.68 -42.4 9.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.401 -0.812 . . . . 0.0 109.756 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' A' ' 38' ' ' LYS . 1.4 m-20 -95.01 31.76 1.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 37' ' ' ASP . 52.9 p-10 -48.38 83.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.541 0.686 . . . . 0.0 110.444 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 36' ' ' ASN . 6.1 tmtt? -147.32 -22.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.689 ' HE1' ' N ' ' A' ' 33' ' ' HIS . 4.4 p-90 -101.52 127.94 47.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.559 -0.713 . . . . 0.0 109.32 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -112.43 129.77 56.21 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.599 0.714 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.9 121.11 7.25 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.19 147.98 45.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.72 -0.612 . . . . 0.0 109.595 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.27 126.08 54.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.468 ' O ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -157.67 161.25 38.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.953 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' OD2' ' NH1' ' A' ' 58' ' ' ARG . 92.6 m-20 -99.67 142.57 30.98 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.9 pt -149.27 146.46 21.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.897 . . . . 0.0 109.306 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -49.74 144.02 21.27 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.869 1.713 . . . . 0.0 112.849 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -64.49 -21.81 66.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.594 -0.691 . . . . 0.0 109.802 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.18 -16.27 59.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.903 . . . . 0.0 110.103 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -84.87 -10.08 57.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.169 -0.957 . . . . 0.0 110.093 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 12.6 pt -103.57 3.32 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.285 -0.884 . . . . 0.0 109.206 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.15 -8.7 60.98 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.5 mt -83.93 129.98 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.81 -1.406 . . . . 0.0 110.334 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -65.77 87.0 0.09 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.622 -0.674 . . . . 0.0 109.335 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -176.29 136.32 3.21 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -95.81 11.94 31.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -1.078 . . . . 0.0 108.993 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -74.86 144.85 43.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 110.64 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.51 ' NH1' ' OD2' ' A' ' 45' ' ' ASP . 72.4 ttp85 -76.48 137.06 39.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.504 -0.747 . . . . 0.0 109.806 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.14 161.54 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -100.66 127.58 47.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.519 -0.738 . . . . 0.0 109.464 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -132.98 158.4 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.443 -0.785 . . . . 0.0 110.353 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 pt -135.02 152.8 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -116.14 145.27 43.2 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.437 0.637 . . . . 0.0 109.875 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.44 157.78 45.26 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -87.81 137.58 32.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.343 -0.848 . . . . 0.0 110.882 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.9 m -143.58 163.35 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.514 -0.741 . . . . 0.0 109.862 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.444 ' CD ' HD22 ' A' ' 115' ' ' LEU . 57.7 mt-30 -77.92 154.78 80.51 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.512 -0.743 . . . . 0.0 109.664 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.507 ' O ' HG12 ' A' ' 71' ' ' VAL . 27.9 Cg_endo -65.14 -21.5 62.57 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.411 2.074 . . . . 0.0 111.151 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -87.48 -26.92 22.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.131 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.3 mt -96.69 6.51 48.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.414 -0.803 . . . . 0.0 109.334 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 68' ' ' PRO . 7.5 p -63.09 -36.49 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.513 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.72 -21.45 79.33 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.0 m -62.27 -59.07 5.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.18 -1.188 . . . . 0.0 110.914 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.835 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -85.49 -29.25 24.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.057 -1.027 . . . . 0.0 110.698 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.405 ' HE ' ' HB3' ' A' ' 82' ' ' PRO . 78.1 ttt-85 -67.73 -21.53 65.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.987 -1.07 . . . . 0.0 110.231 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.74 -8.14 55.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.051 -1.031 . . . . 0.0 109.229 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -75.92 149.09 82.55 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 110.081 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.402 ' O ' HD12 ' A' ' 80' ' ' ILE . 47.7 Cg_endo -68.5 140.87 49.03 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.435 2.09 . . . . 0.0 112.533 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.32 -21.1 18.56 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.746 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.7 mp -89.06 124.39 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.388 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 55.5 m-85 -123.84 151.14 64.06 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.751 -0.593 . . . . 0.0 109.588 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 84' ' ' TYR . 41.2 Cg_endo -67.95 158.57 56.77 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.412 2.075 . . . . 0.0 112.16 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 85' ' ' HIS . . . -66.17 65.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.451 -0.78 . . . . 0.0 109.423 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER 50.84 -83.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.696 -0.627 . . . . 0.0 109.719 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.574 ' N ' ' O ' ' A' ' 83' ' ' ALA . 60.8 t-80 -174.97 -7.66 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.406 ' H ' ' H ' ' A' ' 85' ' ' HIS . 65.2 mtt -63.92 -41.27 97.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.702 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 88' ' ' LYS . 36.0 m120 -119.61 -74.65 0.6 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.509 -0.744 . . . . 0.0 109.492 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.509 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 84.9 tttt 57.9 150.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.611 0.72 . . . . 0.0 110.264 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 88' ' ' LYS . 31.7 tt0 75.51 -67.42 0.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -65.53 -52.61 51.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.468 -0.77 . . . . 0.0 109.825 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.401 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 7.3 m0 -119.0 132.94 56.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.698 -0.626 . . . . 0.0 109.858 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.19 133.95 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.8 p -87.42 143.14 27.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.773 -0.579 . . . . 0.0 110.152 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.4 t -122.29 134.91 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.6 tp -84.68 108.11 17.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.465 -0.772 . . . . 0.0 109.877 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.03 -39.58 93.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.656 -0.652 . . . . 0.0 109.353 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -75.25 1.18 14.21 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.092 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.0 177.14 20.26 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.71 -10.05 21.5 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.065 2.51 . . . . 0.0 111.844 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.61 143.32 57.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 110.403 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.78 170.52 48.04 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.153 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.67 78.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.727 -0.867 . . . . 0.0 109.13 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -62.21 -39.14 91.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -65.08 -37.61 88.07 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.336 -0.853 . . . . 0.0 108.904 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.42 -43.75 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 109.035 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -61.1 -45.46 94.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.426 -0.796 . . . . 0.0 109.762 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.9 m -61.39 -44.0 97.91 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.402 -0.811 . . . . 0.0 109.815 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.34 -44.52 91.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.58 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.16 -42.76 91.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.399 -0.813 . . . . 0.0 108.939 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -55.03 -40.63 70.44 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -63.64 -42.19 98.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.6 m -61.21 -41.94 97.73 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.11 -45.3 94.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.602 -0.686 . . . . 0.0 110.224 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -59.9 -29.03 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.493 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.444 HD22 ' CD ' ' A' ' 67' ' ' GLN . 88.1 mt -79.53 -15.7 57.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.723 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -120.43 14.45 11.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.492 -0.755 . . . . 0.0 109.081 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.878 . . . . 0.0 109.862 -179.362 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.297 0.57 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -93.78 168.13 11.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -0.794 . . . . 0.0 110.511 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -62.08 -43.38 98.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.692 -0.63 . . . . 0.0 109.8 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -65.72 -37.55 86.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 0.0 109.612 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.9 -42.38 97.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.543 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -61.93 -45.41 93.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.741 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.8 -43.78 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.391 -0.818 . . . . 0.0 109.448 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.495 ' OD2' ' NZ ' ' A' ' 12' ' ' LYS . 45.6 t0 -65.26 -37.64 87.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.381 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.472 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 83.4 t80 -59.97 -48.52 81.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.196 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.54 -30.69 71.06 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.478 -0.764 . . . . 0.0 109.115 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.56 ' O ' ' N ' ' A' ' 15' ' ' ASP . 36.0 tt0 -64.55 -42.26 95.8 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.46 -0.775 . . . . 0.0 109.404 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' NZ ' ' OD2' ' A' ' 8' ' ' ASP . 60.0 mttp -69.11 -36.8 77.93 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.882 -1.136 . . . . 0.0 109.814 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 30.3 mmtp -88.17 -12.37 44.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 111.292 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -145.24 -22.11 0.49 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.869 -1.144 . . . . 0.0 110.46 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 11' ' ' GLN . 43.0 t0 54.82 34.58 22.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 109.011 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.7 m -102.01 130.1 48.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.404 -0.81 . . . . 0.0 109.402 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -87.02 156.71 54.82 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.445 -0.785 . . . . 0.0 109.985 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.54 140.16 45.49 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.188 1.925 . . . . 0.0 112.85 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -120.86 139.71 52.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -122.89 85.96 50.34 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.528 -0.732 . . . . 0.0 109.931 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.14 -39.55 90.5 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.65 2.233 . . . . 0.0 110.804 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -96.34 131.78 42.51 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.709 0.766 . . . . 0.0 110.137 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.657 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 1.1 pm0 -73.53 -36.06 65.64 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.695 -0.628 . . . . 0.0 109.772 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' C ' ' CD1' ' A' ' 25' ' ' PHE . 18.8 mtpp -67.95 10.45 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.439 -0.788 . . . . 0.0 111.16 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 24' ' ' LYS . 81.2 m-85 -145.43 67.25 12.82 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.837 -1.164 . . . . 0.0 109.981 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.22 -20.37 32.74 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.571 2.18 . . . . 0.0 111.777 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -84.93 -4.11 58.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.068 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -88.42 150.8 22.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.788 . . . . 0.0 109.949 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.71 132.47 48.0 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.2 t -125.14 127.03 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.568 -0.707 . . . . 0.0 109.523 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.534 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 97.7 m-85 -111.11 119.52 39.26 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -142.12 135.09 28.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.224 -0.922 . . . . 0.0 109.572 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.419 ' ND1' ' NE1' ' A' ' 39' ' ' TRP . 15.1 m80 -100.1 127.52 46.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 109.818 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p -69.76 -25.06 63.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.49 -0.756 . . . . 0.0 109.506 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -78.15 -7.19 56.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 109.797 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 116' ' ' THR . 13.4 t-20 -117.43 30.19 7.44 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 38' ' ' LYS . 53.2 t0 60.97 29.19 18.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.34 0.59 . . . . 0.0 110.212 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 37' ' ' ASP . 57.4 mttp 53.17 106.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.357 -0.839 . . . . 0.0 110.053 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.668 ' CZ3' ' HB2' ' A' ' 41' ' ' ALA . 7.9 p-90 -101.53 -177.47 3.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.523 -0.736 . . . . 0.0 110.202 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.31 129.21 46.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.572 -0.705 . . . . 0.0 110.252 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.668 ' HB2' ' CZ3' ' A' ' 39' ' ' TRP . . . -151.03 105.75 3.28 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 63' ' ' ASP . 1.3 mm? -111.43 125.72 54.18 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.577 0.703 . . . . 0.0 109.57 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.642 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.6 tt -129.66 112.91 14.15 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -162.88 174.13 12.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.41 -0.806 . . . . 0.0 109.568 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 87.7 m-20 -101.57 141.43 34.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.684 -0.635 . . . . 0.0 109.716 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.3 pt -143.34 145.54 32.56 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.565 -0.709 . . . . 0.0 109.464 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -48.5 144.28 14.18 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.989 1.792 . . . . 0.0 112.63 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.05 -24.06 67.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.6 -0.688 . . . . 0.0 110.191 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.86 -14.71 62.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 109.605 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -82.98 -12.58 57.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.399 -0.813 . . . . 0.0 110.501 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.471 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 11.2 pt -109.59 4.56 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.408 -0.808 . . . . 0.0 109.244 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.08 -17.19 59.06 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.75 130.82 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.864 -1.374 . . . . 0.0 110.39 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -86.05 99.18 11.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.534 -0.729 . . . . 0.0 109.362 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' LYS . . . -156.27 -8.17 0.07 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 55' ' ' GLY . 7.5 p-10 41.79 20.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.995 -0.709 . . . . 0.0 109.647 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 55' ' ' GLY . 26.2 pttm -101.51 145.33 29.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.521 -0.737 . . . . 0.0 109.671 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -75.83 138.39 41.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.517 -0.739 . . . . 0.0 109.81 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.52 161.11 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.69 -0.631 . . . . 0.0 109.699 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 96.3 m-20 -88.79 132.42 34.64 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.559 -0.713 . . . . 0.0 109.433 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.01 149.23 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 109.836 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 pt -131.55 151.98 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.414 0.626 . . . . 0.0 109.823 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 67.9 t0 -86.05 142.54 28.66 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.456 -0.778 . . . . 0.0 109.457 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.63 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -133.01 126.71 32.51 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.63 ' N ' HD13 ' A' ' 64' ' ' LEU . 65.6 tttm -88.96 126.72 35.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.642 -0.661 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 m -137.91 163.88 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.541 -0.724 . . . . 0.0 109.588 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -80.74 157.31 72.11 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.083 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' O ' HG12 ' A' ' 71' ' ' VAL . 17.7 Cg_endo -60.88 -18.02 54.37 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.6 2.2 . . . . 0.0 110.987 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -95.44 -27.83 15.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.534 -0.729 . . . . 0.0 109.597 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.7 mt -89.89 -2.96 58.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.262 -0.898 . . . . 0.0 109.852 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.559 HG23 HD11 ' A' ' 92' ' ' ILE . 7.5 p -64.87 -38.87 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.867 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.45 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -59.32 -42.79 97.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.0 m -68.58 -56.26 8.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.329 . . . . 0.0 110.639 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.56 HD12 HD22 ' A' ' 108' ' ' LEU . 2.9 tt -65.56 -43.5 89.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 0.0 110.811 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 82' ' ' PRO . 69.0 ttt-85 -67.81 -17.15 64.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.022 -1.049 . . . . 0.0 110.033 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -78.59 -31.52 47.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.032 -1.043 . . . . 0.0 108.94 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -58.24 146.11 71.81 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.241 -0.912 . . . . 0.0 110.264 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.71 148.31 58.63 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.332 2.021 . . . . 0.0 112.612 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.53 -17.89 46.01 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.726 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.0 mp -87.72 123.15 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.353 -1.087 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 65.7 m-85 -116.79 149.38 43.9 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.82 -0.55 . . . . 0.0 109.696 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HB3' ' HE ' ' A' ' 75' ' ' ARG . 51.7 Cg_endo -67.8 144.52 65.58 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.575 2.183 . . . . 0.0 112.15 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.83 144.9 55.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 109.989 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.485 ' CE1' ' CE1' ' A' ' 85' ' ' HIS . 43.9 p90 -78.1 9.0 4.05 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.438 -0.789 . . . . 0.0 109.334 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.485 ' CE1' ' CE1' ' A' ' 84' ' ' TYR . 96.3 m-70 -88.03 165.64 15.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 110.043 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.8 mtp -68.55 -8.39 41.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.621 ' C ' ' H ' ' A' ' 89' ' ' GLU . 32.7 m120 -77.73 -67.47 0.72 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.32 -0.862 . . . . 0.0 109.549 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 63.3 -26.76 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.95 -0.468 . . . . 0.0 109.77 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 87' ' ' ASN . 97.6 mt-10 -98.67 -63.86 1.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -59.35 -46.52 88.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.318 -0.863 . . . . 0.0 110.338 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.453 ' CE3' ' OD1' ' A' ' 87' ' ' ASN . 9.3 m0 -116.41 138.55 51.27 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.618 0.723 . . . . 0.0 110.006 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.559 HD11 HG23 ' A' ' 71' ' ' VAL . 88.8 mt -138.56 153.51 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.6 m -97.56 138.4 35.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 110.036 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.6 t -120.34 133.44 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.4 tp -88.63 109.43 20.1 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.594 0.712 . . . . 0.0 110.408 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.63 -39.32 88.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -69.17 -8.65 47.55 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -57.25 178.26 0.96 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.29 -12.75 25.44 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.976 2.451 . . . . 0.0 111.686 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 pp -68.28 137.18 54.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.347 -0.846 . . . . 0.0 110.266 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.7 176.02 47.53 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.158 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.0 77.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.789 -0.83 . . . . 0.0 109.459 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 103' ' ' LYS . 13.5 mptt -62.0 -40.49 95.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.406 -0.808 . . . . 0.0 108.82 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.9 -41.99 95.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.34 -0.85 . . . . 0.0 108.869 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.4 -43.06 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.441 -0.787 . . . . 0.0 109.482 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -56.15 -43.57 78.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.703 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.2 p -64.22 -41.92 96.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 109.719 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.56 HD22 HD12 ' A' ' 74' ' ' LEU . 94.7 mt -64.81 -39.75 94.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.602 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.73 -42.6 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.385 -0.822 . . . . 0.0 109.182 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -57.95 -39.26 77.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 109.083 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.45 -42.91 98.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.303 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 99.6 p -63.94 -34.74 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 109.36 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 117' ' ' ARG . 88.9 t80 -60.14 -44.78 94.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.404 -0.81 . . . . 0.0 109.306 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.37 -43.54 96.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.5 -41.26 96.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.445 -0.784 . . . . 0.0 110.14 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.442 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 67.2 p -99.41 14.71 28.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.366 -0.834 . . . . 0.0 109.275 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 113' ' ' PHE . 38.6 ttp-105 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.166 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -93.57 -177.98 4.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 0.0 110.08 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.458 ' NH2' ' OD1' ' A' ' 60' ' ' ASP . 12.0 ptp85 -63.2 -32.9 74.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 109.541 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -56.44 -43.39 79.41 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.329 -0.857 . . . . 0.0 109.127 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.03 -42.44 84.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.067 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -62.05 -45.37 93.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.52 -0.737 . . . . 0.0 109.752 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.36 -43.09 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.408 -0.808 . . . . 0.0 109.36 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.72 -39.32 91.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.372 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -60.58 -44.46 96.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.818 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.06 86.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.521 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -65.19 -45.89 82.98 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 110.021 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.99 -37.27 83.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -63.71 -50.51 68.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.105 -0.997 . . . . 0.0 111.94 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -147.02 17.53 1.23 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.53 -1.357 . . . . 0.0 110.225 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 55.05 47.53 21.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.149 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.3 m -101.07 123.74 45.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.294 -0.879 . . . . 0.0 109.7 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' HB3' ' HZ3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -93.67 148.83 36.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 157.36 60.77 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.206 1.937 . . . . 0.0 112.672 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -108.71 155.15 21.06 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -136.85 86.56 21.15 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.478 -0.764 . . . . 0.0 110.047 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.78 -10.99 5.87 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.782 2.322 . . . . 0.0 110.393 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -102.04 98.66 8.83 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.5 0.667 . . . . 0.0 109.816 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 24' ' ' LYS . 14.9 pt-20 -68.55 -37.35 79.86 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.545 0.688 . . . . 0.0 109.658 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 23' ' ' GLU . 9.8 mtpm? -70.79 -3.54 19.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.479 -0.763 . . . . 0.0 110.788 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -142.95 77.38 16.25 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.078 -1.014 . . . . 0.0 110.018 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.66 -14.84 33.56 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.562 2.175 . . . . 0.0 112.099 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -78.72 -4.94 51.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.252 -0.905 . . . . 0.0 109.521 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -94.72 142.73 27.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.255 -0.903 . . . . 0.0 110.102 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.93 139.57 52.06 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -124.48 128.32 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.516 -0.74 . . . . 0.0 110.245 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.37 114.44 27.88 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 37' ' ' ASP . 77.8 ttt-85 -145.35 138.64 26.45 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.196 -0.94 . . . . 0.0 109.459 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.458 ' ND1' ' CD1' ' A' ' 39' ' ' TRP . 32.5 m170 -100.58 124.63 46.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.472 -0.767 . . . . 0.0 109.951 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.2 m -75.79 -22.71 56.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.428 -0.795 . . . . 0.0 109.983 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.64 -41.86 99.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.124 -0.985 . . . . 0.0 110.208 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 38' ' ' LYS . 12.3 m120 -93.49 4.07 54.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 0.0 108.531 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 98.8 m-20 47.56 11.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.77 . . . . 0.0 110.182 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 36' ' ' ASN . 8.4 mtmp? -139.99 -121.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.258 -0.901 . . . . 0.0 109.532 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.458 ' CD1' ' ND1' ' A' ' 33' ' ' HIS . 56.7 t-105 46.53 96.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.659 -0.651 . . . . 0.0 109.321 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -106.63 126.28 52.07 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.707 0.765 . . . . 0.0 109.981 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.06 128.53 10.68 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 140.55 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.943 -1.098 . . . . 0.0 109.812 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.6 130.74 55.49 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -157.19 157.88 35.2 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.943 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 33.6 p-10 -98.98 116.6 31.58 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 pt -125.74 145.8 52.85 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.688 -0.633 . . . . 0.0 109.722 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.2 139.05 22.02 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.811 1.674 . . . . 0.0 112.304 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.5 -22.03 65.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.191 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -62.67 -29.76 70.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.142 -0.974 . . . . 0.0 109.641 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.71 -40.55 95.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.802 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.472 HD12 HD12 ' A' ' 53' ' ' ILE . 12.2 pt -79.08 16.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.758 -1.214 . . . . 0.0 109.739 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.19 -8.24 58.36 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.443 -0.884 . . . . 0.0 110.927 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.472 HD12 HD12 ' A' ' 51' ' ' ILE . 80.9 mt -82.7 129.01 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.638 -1.507 . . . . 0.0 109.81 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -85.39 97.12 9.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.494 -0.754 . . . . 0.0 110.276 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.59 -16.96 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.516 -1.833 . . . . 0.0 108.516 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 57.6 t0 51.19 19.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -1.032 . . . . 0.0 109.069 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -107.9 146.3 32.55 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.583 -0.698 . . . . 0.0 110.138 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -73.91 139.3 44.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.493 -0.754 . . . . 0.0 109.7 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.44 157.88 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.424 -0.797 . . . . 0.0 109.464 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.458 ' OD1' ' NH2' ' A' ' 3' ' ' ARG . 90.2 m-20 -91.21 131.32 36.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.466 -0.771 . . . . 0.0 109.755 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.26 158.6 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.535 -0.728 . . . . 0.0 109.446 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.5 pt -134.53 146.49 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.421 0.629 . . . . 0.0 109.614 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 64.4 t0 -79.29 134.78 36.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.407 -0.808 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -127.14 121.82 32.45 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.589 ' N ' HD13 ' A' ' 64' ' ' LEU . 7.3 tmtm? -83.89 134.83 34.67 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.418 -0.801 . . . . 0.0 110.114 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.0 m -143.84 164.28 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -93.32 155.34 41.04 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.521 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.507 ' O ' HG12 ' A' ' 71' ' ' VAL . 47.6 Cg_exo -48.75 -28.9 13.55 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.167 1.911 . . . . 0.0 111.26 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.02 -32.11 16.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.459 -0.776 . . . . 0.0 109.376 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.59 -5.25 58.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 109.466 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 68' ' ' PRO . 9.2 p -68.53 -40.44 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -0.909 . . . . 0.0 109.863 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.482 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.87 -44.0 96.75 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.5 t -64.73 -26.32 68.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.938 -1.331 . . . . 0.0 110.21 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.537 HD12 HD22 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -86.98 -33.89 19.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.866 -1.146 . . . . 0.0 109.829 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -76.21 -7.49 54.97 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.375 -0.828 . . . . 0.0 109.105 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -7.33 59.68 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.476 ' HB2' HD12 ' A' ' 80' ' ' ILE . 61.2 mttm -94.14 113.76 61.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.634 -0.667 . . . . 0.0 109.474 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.94 147.05 19.95 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.303 2.002 . . . . 0.0 113.282 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.07 -13.28 67.31 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 77' ' ' LYS . 15.4 mt -107.28 124.43 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.529 -0.983 . . . . 0.0 109.085 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.404 ' O ' ' OG1' ' A' ' 93' ' ' THR . 56.1 m-85 -119.47 150.07 49.04 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.76 -0.588 . . . . 0.0 110.01 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 83' ' ' ALA . 37.1 Cg_exo -56.13 149.45 53.66 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.124 1.882 . . . . 0.0 112.576 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . . . -45.99 174.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.825 0.822 . . . . 0.0 111.129 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.62 -71.73 0.28 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -137.97 140.95 40.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.551 -0.718 . . . . 0.0 109.934 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.0 mmm 57.59 154.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.738 0.78 . . . . 0.0 111.231 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.546 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 85.1 m-20 56.56 33.21 22.27 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.51 0.672 . . . . 0.0 109.388 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.463 ' O ' HD13 ' A' ' 92' ' ' ILE . 37.8 ttpt -63.27 -46.96 84.38 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.454 -0.779 . . . . 0.0 109.262 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -79.37 -35.87 40.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.122 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -66.35 -50.71 62.65 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.339 -0.851 . . . . 0.0 110.243 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.546 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 11.1 m0 -117.5 152.08 35.8 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.587 -0.696 . . . . 0.0 109.753 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 88' ' ' LYS . 6.4 mm -136.22 157.68 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.567 -0.708 . . . . 0.0 109.451 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 7.6 p -105.85 123.68 48.35 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.8 t -108.46 131.06 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.5 tp -89.91 104.18 16.77 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.206 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.06 -39.49 86.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.539 -0.725 . . . . 0.0 109.264 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -69.28 -6.1 27.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.41 -0.806 . . . . 0.0 109.047 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -77.83 -162.26 18.12 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.72 6.26 5.89 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.348 2.699 . . . . 0.0 111.564 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.71 130.94 48.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 110.254 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.91 154.79 24.91 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.38 95.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.543 -0.975 . . . . 0.0 109.297 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.71 -42.08 95.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.943 . . . . 0.0 109.074 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -66.03 -43.95 86.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.446 -0.784 . . . . 0.0 109.198 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.58 -43.48 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.069 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -60.43 -43.57 96.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.462 -0.774 . . . . 0.0 109.654 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -62.77 -42.72 99.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.819 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.537 HD22 HD12 ' A' ' 74' ' ' LEU . 95.1 mt -64.79 -41.92 95.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.931 . . . . 0.0 109.584 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.79 -43.17 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.872 . . . . 0.0 108.919 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -61.19 -41.99 97.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -64.04 -41.58 97.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.7 p -66.07 -33.91 76.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.79 . . . . 0.0 109.304 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.25 -47.93 83.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.633 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.49 -29.03 63.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.94 -42.23 97.39 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.185 -0.947 . . . . 0.0 109.511 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 117' ' ' ARG . 62.2 p -97.11 14.73 24.75 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.569 -0.707 . . . . 0.0 109.1 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.475 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 77.7 ttt-85 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.881 -0.512 . . . . 0.0 110.167 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpp . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -105.77 163.85 12.39 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.553 -0.717 . . . . 0.0 110.019 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -61.48 -43.25 99.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.585 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -64.26 -40.91 96.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.452 -0.78 . . . . 0.0 109.754 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.89 -42.27 94.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 109.572 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.42 -45.03 96.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.767 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.29 -44.67 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.26 -0.9 . . . . 0.0 109.153 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.63 -44.13 94.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.816 . . . . 0.0 109.487 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -64.15 -42.1 96.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.483 -0.76 . . . . 0.0 109.872 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.5 -54.31 48.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.379 -0.826 . . . . 0.0 110.698 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -64.9 -33.1 75.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.244 -0.91 . . . . 0.0 109.756 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -60.57 -46.59 89.65 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 109.791 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -87.2 -37.61 17.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.348 -0.845 . . . . 0.0 111.416 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 77.2 m-85 -94.57 -0.73 54.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.924 -1.11 . . . . 0.0 111.115 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 14' ' ' TYR . 3.4 p30 40.97 35.61 0.36 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.379 -0.825 . . . . 0.0 109.907 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.6 t -118.64 143.88 46.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.566 -0.709 . . . . 0.0 109.359 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -96.23 151.81 38.4 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.308 -0.87 . . . . 0.0 109.564 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.22 149.55 85.32 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.469 2.112 . . . . 0.0 112.162 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 66.1 t0 -132.8 138.51 47.14 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.517 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 14.8 p-80 -131.24 85.58 53.43 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -79.29 -10.52 14.87 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.943 1.762 . . . . 0.0 111.14 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -89.15 102.87 15.52 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.456 0.646 . . . . 0.0 109.555 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.86 -33.84 74.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -0.766 . . . . 0.0 109.592 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 25' ' ' PHE . 60.1 mttp -68.06 -5.75 19.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.348 -0.845 . . . . 0.0 109.849 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 24' ' ' LYS . 64.1 m-85 -153.29 83.84 4.49 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.202 -0.936 . . . . 0.0 109.463 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.4 -15.61 31.15 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.565 1.51 . . . . 0.0 111.209 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.63 -5.92 47.84 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.4 m-85 -86.08 141.68 29.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 109.106 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.98 135.93 38.08 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.4 HG11 ' NH1' ' A' ' 32' ' ' ARG . 3.1 t -117.44 126.01 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 93.9 m-85 -110.26 122.66 48.2 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.4 ' NH1' HG11 ' A' ' 30' ' ' VAL . 95.6 mtm-85 -134.3 155.22 50.6 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.051 -1.031 . . . . 0.0 109.267 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 37' ' ' ASP . 1.4 t-160 -85.42 113.84 22.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.317 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 t -65.35 -23.43 66.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.525 -0.735 . . . . 0.0 109.799 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.8 -44.57 92.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.377 -0.827 . . . . 0.0 110.639 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -122.48 -26.73 4.53 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.377 -0.827 . . . . 0.0 109.63 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 33' ' ' HIS . 54.4 m-20 58.49 -159.12 0.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.438 0.637 . . . . 0.0 109.938 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 59.9 24.51 13.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.934 -0.479 . . . . 0.0 110.274 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.405 ' HE1' ' HB2' ' A' ' 36' ' ' ASN . 44.0 m95 -112.25 149.02 32.91 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.396 -0.815 . . . . 0.0 109.553 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -113.71 131.53 56.14 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.676 0.75 . . . . 0.0 110.239 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 31' ' ' PHE . . . -151.15 105.62 3.24 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.2 mm? -107.58 131.89 53.87 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.724 0.773 . . . . 0.0 110.417 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 tt -126.76 120.29 28.99 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.592 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 3.7 ptt? -160.41 164.19 32.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.01 . . . . 0.0 109.507 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 96.9 m-20 -98.38 118.78 35.81 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.2 pt -120.73 145.95 42.36 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.44 -0.788 . . . . 0.0 109.45 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.21 141.74 96.67 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.902 1.735 . . . . 0.0 112.719 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.19 -20.74 65.69 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.493 0.663 . . . . 0.0 109.263 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 56' ' ' ASP . 95.6 mt-10 -53.69 -36.0 61.72 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.625 -0.672 . . . . 0.0 109.899 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.05 -39.01 93.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 110.317 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.9 HD12 HD12 ' A' ' 53' ' ' ILE . 5.2 pt -92.94 -0.94 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.08 36.44 85.73 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.153 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.9 HD12 HD12 ' A' ' 51' ' ' ILE . 6.0 mt -104.46 133.63 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.182 -1.187 . . . . 0.0 109.713 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 52.77 -83.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.707 -0.621 . . . . 0.0 109.806 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . 143.46 114.65 1.0 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.6 OUTLIER 61.47 39.35 15.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.623 -0.928 . . . . 0.0 110.67 178.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -113.46 118.63 35.04 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -72.39 133.35 44.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.181 -0.949 . . . . 0.0 109.516 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.11 161.66 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 20.3 m-20 -99.43 138.07 37.03 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.29 -0.881 . . . . 0.0 109.444 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.75 156.59 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.304 -0.872 . . . . 0.0 109.344 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.8 pt -133.74 157.98 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.549 0.69 . . . . 0.0 109.702 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 42' ' ' LEU . 44.5 t0 -90.48 122.07 32.99 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.539 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -115.85 120.47 39.36 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.539 ' N ' HD13 ' A' ' 64' ' ' LEU . 37.9 ttmt -84.23 135.55 34.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.321 -0.862 . . . . 0.0 109.849 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.604 HG11 HD13 ' A' ' 74' ' ' LEU . 30.0 m -143.29 169.65 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.287 -0.883 . . . . 0.0 109.63 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -78.11 153.59 79.86 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.583 -0.698 . . . . 0.0 109.489 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' O ' HG12 ' A' ' 71' ' ' VAL . 28.8 Cg_endo -63.77 -19.26 66.81 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.256 1.97 . . . . 0.0 111.313 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -91.42 -27.56 18.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.763 . . . . 0.0 109.395 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.21 7.62 44.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.322 -0.861 . . . . 0.0 109.221 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 72' ' ' GLY . 7.1 p -63.26 -37.53 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.465 -0.772 . . . . 0.0 109.981 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -78.3 -15.1 81.47 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.522 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -71.25 -60.6 2.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.014 -1.286 . . . . 0.0 110.737 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.737 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -75.49 -37.23 60.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.184 -0.947 . . . . 0.0 110.537 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.432 ' HE ' ' HB3' ' A' ' 82' ' ' PRO . 79.0 ttt-85 -60.61 -33.07 72.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.389 -0.819 . . . . 0.0 109.475 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -32.84 73.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.315 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -68.09 120.36 73.78 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.176 -0.952 . . . . 0.0 110.059 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.05 147.28 20.06 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.938 1.759 . . . . 0.0 112.61 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.88 -22.56 34.97 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.8 mt -105.85 120.89 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.535 -0.98 . . . . 0.0 109.279 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -107.08 150.76 40.27 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.497 -0.752 . . . . 0.0 109.923 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.502 ' CB ' ' HZ2' ' A' ' 88' ' ' LYS . 53.6 Cg_endo -69.41 159.15 54.8 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.223 1.949 . . . . 0.0 111.92 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.03 142.37 58.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 109.984 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -79.29 12.9 2.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 109.843 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -156.63 -161.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -0.919 . . . . 0.0 110.176 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 78.9 mtm -52.77 -175.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.571 0.701 . . . . 0.0 111.078 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.9 m120 59.1 33.19 22.74 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.514 0.673 . . . . 0.0 109.687 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.502 ' HZ2' ' CB ' ' A' ' 82' ' ' PRO . 64.4 tttp -64.65 -39.22 93.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.556 -0.715 . . . . 0.0 109.605 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.28 -16.99 29.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.116 -0.99 . . . . 0.0 109.934 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -94.48 -53.33 3.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.24 -0.913 . . . . 0.0 110.358 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -111.19 131.32 55.21 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.389 -0.819 . . . . 0.0 109.781 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.98 141.12 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.4 m -86.77 129.46 34.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.218 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.1 t -114.16 133.17 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.1 tp -91.05 108.51 19.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.648 -0.657 . . . . 0.0 109.923 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.34 -39.46 92.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.53 -0.731 . . . . 0.0 109.086 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -76.03 5.56 6.48 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.5 -0.75 . . . . 0.0 109.034 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.51 -176.44 20.43 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.42 -6.59 14.7 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.113 2.542 . . . . 0.0 111.701 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.83 145.84 48.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.646 -0.659 . . . . 0.0 109.794 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.08 173.01 31.28 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.55 -29.1 70.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.653 -0.91 . . . . 0.0 109.332 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.18 -41.31 98.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.456 -0.778 . . . . 0.0 109.234 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 104' ' ' GLU . 58.2 mp0 -65.69 -41.61 92.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.19 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.38 -43.42 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.418 -0.801 . . . . 0.0 109.931 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -56.03 -45.75 79.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.83 . . . . 0.0 109.589 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.6 t -61.94 -44.27 97.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.4 -0.812 . . . . 0.0 109.935 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.9 -41.32 99.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.427 -0.796 . . . . 0.0 109.658 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.77 -43.18 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -56.29 -43.69 79.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 0.0 109.089 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -60.06 -44.75 94.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.365 -0.835 . . . . 0.0 109.09 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.7 p -70.38 -27.18 64.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.258 -0.902 . . . . 0.0 109.983 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.07 -44.85 91.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.331 -0.856 . . . . 0.0 109.382 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -58.46 -43.31 88.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.893 . . . . 0.0 109.653 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.9 mp -63.33 -39.59 94.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.262 -0.899 . . . . 0.0 109.512 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.0 p -88.98 4.94 46.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.461 -0.774 . . . . 0.0 109.62 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.404 179.548 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.438 ' OD1' ' OE1' ' A' ' 5' ' ' GLN . 28.7 p30 -152.77 -179.03 7.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.22 -0.925 . . . . 0.0 109.536 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.615 ' HE ' HD21 ' A' ' 43' ' ' LEU . 12.6 ptm180 -61.53 -33.0 73.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.456 -0.778 . . . . 0.0 109.369 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.587 HE22 ' CG ' ' A' ' 8' ' ' ASP . 4.5 tm0? -61.36 -44.12 97.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 110.001 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.438 ' OE1' ' OD1' ' A' ' 2' ' ' ASN . 4.3 mp0 -64.44 -38.42 90.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 108.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -60.2 -45.12 94.25 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.309 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.74 -44.83 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.3 -0.875 . . . . 0.0 109.547 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.587 ' CG ' HE22 ' A' ' 4' ' ' GLN . 54.4 m-20 -64.73 -46.11 83.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 108.727 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -63.48 -39.91 95.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.383 -0.823 . . . . 0.0 109.093 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.09 -43.56 70.47 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.461 -0.774 . . . . 0.0 109.679 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 86.0 mt-30 -67.21 -40.63 86.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.156 -0.965 . . . . 0.0 109.651 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -63.4 -38.17 90.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.852 -1.155 . . . . 0.0 109.265 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -86.76 -35.84 18.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 111.691 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -118.74 -20.8 8.12 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.134 -0.978 . . . . 0.0 111.032 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 44.2 t0 59.0 38.66 24.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.949 -1.094 . . . . 0.0 109.118 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -107.07 135.79 48.03 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.558 -0.714 . . . . 0.0 109.334 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -82.15 131.21 57.06 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.837 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.52 143.11 22.04 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.17 1.914 . . . . 0.0 112.982 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -127.72 121.89 31.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.634 -0.666 . . . . 0.0 109.276 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.48 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -119.62 86.83 35.64 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.2 -37.13 87.66 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.462 2.108 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.476 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -87.81 83.87 7.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 0.0 109.064 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -54.59 -14.43 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.458 -0.776 . . . . 0.0 109.564 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -76.18 -2.62 32.06 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -141.25 75.63 22.92 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.287 -0.883 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.65 -31.42 91.86 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.723 2.282 . . . . 0.0 111.327 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.472 ' O ' ' NH2' ' A' ' 3' ' ' ARG . 98.9 m-20 -68.22 -16.04 63.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.401 -0.812 . . . . 0.0 109.347 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -92.56 132.16 37.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 0.0 109.213 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.09 141.07 50.12 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.15 133.55 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 109.043 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -107.95 143.81 36.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.56 -0.712 . . . . 0.0 109.217 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -132.85 129.68 38.77 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.34 -0.85 . . . . 0.0 110.051 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.467 ' H ' ' HB2' ' A' ' 39' ' ' TRP . 80.2 m80 -103.28 111.99 24.65 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.0 p -88.21 -16.66 32.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -94.39 -0.73 54.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.183 -0.948 . . . . 0.0 110.337 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 38' ' ' LYS . 20.3 t-20 -115.99 29.8 7.75 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.382 -0.823 . . . . 0.0 109.854 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 67.9 t0 46.68 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.575 -0.703 . . . . 0.0 110.511 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.1 tttt -79.98 136.15 36.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' A' ' 39' ' ' TRP . 7.8 p90 -141.96 141.38 32.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.281 -0.887 . . . . 0.0 110.607 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 39' ' ' TRP . 29.0 m-85 -159.51 119.96 3.1 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.517 ' C ' HD22 ' A' ' 42' ' ' LEU . . . -156.83 105.4 2.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 108.769 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.2 mm? -113.09 125.01 53.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.537 -0.727 . . . . 0.0 109.286 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.634 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.8 tt -123.59 116.71 23.58 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -162.74 167.46 22.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.026 -1.046 . . . . 0.0 109.499 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.523 ' OD2' ' NH2' ' A' ' 58' ' ' ARG . 34.7 p-10 -106.95 116.75 32.47 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.6 pt -118.71 146.65 40.44 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.837 -0.539 . . . . 0.0 110.248 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.27 145.33 11.5 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.104 1.869 . . . . 0.0 112.846 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -61.44 -21.48 64.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.948 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 54' ' ' ASN . 61.9 mm-40 -70.31 -15.41 62.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.917 -1.114 . . . . 0.0 110.28 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -84.67 -10.99 56.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.982 -1.074 . . . . 0.0 110.605 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.445 ' CD1' HD12 ' A' ' 53' ' ' ILE . 4.7 pt -104.53 2.82 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.216 -0.927 . . . . 0.0 109.027 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.69 -5.0 69.53 Favored Glycine 0 N--CA 1.496 2.662 0 O-C-N 121.245 -0.91 . . . . 0.0 110.854 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 55' ' ' GLY . 86.6 mt -81.47 138.09 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.912 -1.346 . . . . 0.0 110.235 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.425 ' O ' ' OE2' ' A' ' 49' ' ' GLU . 56.4 m-80 -61.58 -39.34 90.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.603 -0.686 . . . . 0.0 109.397 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 53' ' ' ILE . . . -42.59 139.8 2.4 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 36.9 p-10 -103.33 14.0 32.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.973 . . . . 0.0 109.065 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 78.5 tttt -82.15 143.06 31.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.366 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 84.9 mtp180 -72.48 144.28 48.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.51 -0.744 . . . . 0.0 109.99 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HB ' HD11 ' A' ' 95' ' ' LEU . 27.3 m -136.36 162.89 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.495 -0.753 . . . . 0.0 110.003 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -97.37 136.93 37.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.474 -0.766 . . . . 0.0 109.789 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.37 155.59 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.39 -0.819 . . . . 0.0 110.374 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.2 pt -138.32 150.51 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.98 152.38 26.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 110.065 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.622 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -141.1 125.06 17.13 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.35 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.622 ' N ' HD13 ' A' ' 64' ' ' LEU . 3.5 pttm -84.84 131.06 34.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.94 . . . . 0.0 109.359 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.97 165.31 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.269 -0.894 . . . . 0.0 109.445 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -87.41 157.99 52.36 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 109.086 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.71 -21.03 68.19 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.577 2.185 . . . . 0.0 111.352 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -95.01 -29.39 14.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.063 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.47 -3.47 49.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 109.81 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.1 p -65.08 -36.14 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.058 -1.027 . . . . 0.0 109.591 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.45 99.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.5 m -61.7 -42.7 99.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.27 . . . . 0.0 110.47 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.484 HD12 HD22 ' A' ' 108' ' ' LEU . 3.5 tt -85.0 -31.82 23.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.059 -1.026 . . . . 0.0 110.376 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -77.02 -21.87 53.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.114 -0.991 . . . . 0.0 110.401 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -85.61 -2.86 58.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 109.21 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HB2' HD12 ' A' ' 80' ' ' ILE . 50.3 mttm -77.41 151.56 80.78 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 80' ' ' ILE . 73.7 Cg_endo -72.28 151.64 54.67 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.864 2.376 . . . . 0.0 112.565 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.04 -20.12 2.59 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 77' ' ' LYS . 72.2 mt -97.43 116.12 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -1.117 . . . . 0.0 108.363 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.408 ' O ' ' OG1' ' A' ' 93' ' ' THR . 18.1 m-85 -123.08 161.22 46.0 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.887 -0.508 . . . . 0.0 110.087 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.61 153.07 69.51 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.006 1.804 . . . . 0.0 111.961 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.33 140.37 33.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 110.585 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -74.77 7.62 2.97 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.473 -0.767 . . . . 0.0 109.125 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.406 ' O ' ' C ' ' A' ' 86' ' ' MET . 51.6 p-80 -157.7 -172.73 4.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 85' ' ' HIS . 79.0 mtm -38.06 158.92 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.457 0.646 . . . . 0.0 111.623 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 m120 72.96 79.96 0.14 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.426 0.631 . . . . 0.0 110.339 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -114.16 -36.3 4.76 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 109.547 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.81 -85.13 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.946 -1.096 . . . . 0.0 111.087 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -67.92 -33.38 74.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 110.677 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.439 ' HE1' ' CB ' ' A' ' 40' ' ' TYR . 24.8 m-90 -93.93 130.62 39.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.014 . . . . 0.0 110.542 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.0 mm -134.89 143.8 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.437 -0.79 . . . . 0.0 109.021 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 1.1 p -91.51 134.57 34.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.485 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.82 133.82 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.411 HD11 ' HB ' ' A' ' 59' ' ' VAL . 46.6 tp -91.47 123.74 35.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.688 -0.633 . . . . 0.0 109.897 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.6 mt -87.64 -13.93 41.36 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -94.39 0.21 55.3 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 100' ' ' LEU . . . -89.14 -165.45 41.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.62 9.01 0.36 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 123.225 2.617 . . . . 0.0 111.259 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.7 mm? -70.35 124.86 25.2 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.16 161.47 20.8 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.28 89.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.567 -0.961 . . . . 0.0 109.364 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -64.72 -41.7 95.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -65.07 -44.93 87.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -0.806 . . . . 0.0 109.595 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.21 -43.4 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.276 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -58.98 -42.68 90.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -61.34 -44.02 97.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 109.95 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.484 HD22 HD12 ' A' ' 74' ' ' LEU . 96.2 mt -63.99 -41.81 97.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.348 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.66 -42.77 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.388 -0.82 . . . . 0.0 109.187 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -55.54 -42.42 74.58 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.203 -0.935 . . . . 0.0 109.09 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -63.36 -40.65 97.85 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.343 -0.848 . . . . 0.0 109.19 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.454 ' OG ' HD11 ' A' ' 64' ' ' LEU . 1.4 m -63.24 -36.86 85.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.434 -0.791 . . . . 0.0 109.325 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -60.54 -47.27 86.92 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.426 -0.796 . . . . 0.0 110.409 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 114' ' ' GLN . 4.6 pt20 -77.0 -20.59 55.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 0.0 109.856 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.68 -42.01 98.35 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.16 -0.962 . . . . 0.0 109.951 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.487 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 6.2 p -101.21 16.77 24.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.453 -0.779 . . . . 0.0 109.364 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 . . . . . 0 N--CA 1.502 2.154 0 CA-C-O 121.726 0.774 . . . . 0.0 110.844 -179.222 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.317 0.579 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.72 165.34 12.35 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.301 -0.874 . . . . 0.0 110.189 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.63 -43.83 97.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.464 -0.773 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -39.47 93.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 109.909 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -63.34 -37.5 87.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.94 . . . . 0.0 109.545 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.52 -44.31 96.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.441 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.46 -45.06 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.158 -0.963 . . . . 0.0 109.43 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -61.82 -44.29 97.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.968 . . . . 0.0 109.64 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.518 ' CD1' ' NE2' ' A' ' 106' ' ' HIS . 80.3 t80 -61.66 -47.18 86.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.837 . . . . 0.0 109.668 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.62 87.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 109.868 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.543 ' O ' ' N ' ' A' ' 15' ' ' ASP . 7.2 tp-100 -64.34 -48.59 74.97 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.453 -0.78 . . . . 0.0 109.932 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -65.44 -35.18 80.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.997 -1.064 . . . . 0.0 109.674 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -82.08 -35.8 28.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.349 -0.844 . . . . 0.0 111.737 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CG ' ' NE2' ' A' ' 33' ' ' HIS . 78.1 m-85 -124.2 -20.71 5.19 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.033 -1.042 . . . . 0.0 110.998 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 11' ' ' GLN . 56.2 t0 56.92 36.31 27.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 109.026 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -108.4 148.64 29.84 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.54 -0.725 . . . . 0.0 109.371 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.435 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 13.0 mptt -91.84 153.15 43.61 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.201 -0.937 . . . . 0.0 109.298 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.0 154.78 73.52 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.474 2.116 . . . . 0.0 111.66 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -139.72 142.05 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 109.118 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -127.54 86.14 59.2 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -55.56 -36.75 95.08 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.273 1.982 . . . . 0.0 110.708 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -81.24 106.31 13.12 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.466 0.65 . . . . 0.0 109.53 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -66.42 -21.26 66.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.417 -0.802 . . . . 0.0 109.613 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -78.6 -3.88 46.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.316 -0.865 . . . . 0.0 109.49 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -137.74 66.46 48.95 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.35 -19.25 49.92 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.301 2.001 . . . . 0.0 111.616 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -81.19 -5.79 58.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -90.18 147.58 23.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.24 -0.912 . . . . 0.0 109.215 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.03 131.65 53.58 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.53 -0.731 . . . . 0.0 109.363 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.78 132.04 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -111.97 137.53 49.85 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.356 -0.84 . . . . 0.0 109.488 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.456 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . 13.3 ptp180 -139.44 132.23 29.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.203 -0.936 . . . . 0.0 109.33 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.592 ' NE2' ' CG ' ' A' ' 14' ' ' TYR . 70.2 m80 -100.76 110.16 22.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.294 -0.879 . . . . 0.0 109.363 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -78.4 -12.29 60.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.83 -1.66 58.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 110.02 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' LYS . 33.8 m120 -119.79 19.57 12.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.506 -0.747 . . . . 0.0 109.217 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.403 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 67.0 t0 56.82 -76.84 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.814 -0.554 . . . . 0.0 109.879 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 54.0 mtmt -83.81 152.71 24.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.88 . . . . 0.0 109.958 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 39' ' ' TRP . 8.1 p90 -168.19 140.23 2.92 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.264 -0.897 . . . . 0.0 109.587 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -150.86 121.46 7.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.996 -1.065 . . . . 0.0 108.582 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.54 104.86 2.59 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -114.47 116.19 28.46 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.546 ' N ' HD13 ' A' ' 42' ' ' LEU . 7.4 tt -120.15 126.45 50.72 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -157.9 150.96 23.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.143 -0.973 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -97.75 117.21 31.55 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 23.3 pt -125.01 147.01 55.45 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.388 -0.82 . . . . 0.0 110.295 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -48.37 144.12 13.99 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.873 1.715 . . . . 0.0 112.262 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -63.84 -22.73 67.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -0.837 . . . . 0.0 110.258 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 10.7 pt-20 -71.99 -13.5 61.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.022 . . . . 0.0 109.94 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -84.61 -10.66 57.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.148 -0.97 . . . . 0.0 110.677 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.456 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 8.5 pt -104.89 5.17 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.101 -0.999 . . . . 0.0 109.56 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 -7.42 60.64 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 121.186 -0.946 . . . . 0.0 111.018 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 55' ' ' GLY . 88.2 mt -79.04 142.05 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.874 -1.369 . . . . 0.0 110.448 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.88 -39.95 93.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 110.048 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.564 ' H ' HG22 ' A' ' 53' ' ' ILE . . . -58.75 142.82 45.58 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.039 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -101.94 7.49 41.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.557 -0.966 . . . . 0.0 108.709 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -63.52 139.75 58.8 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 110.303 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -69.53 136.34 51.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.585 -0.697 . . . . 0.0 110.274 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.07 161.27 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.522 -0.736 . . . . 0.0 109.313 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -101.55 133.23 46.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 0.0 109.806 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 m -132.59 157.91 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.446 -0.783 . . . . 0.0 110.111 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 pt -136.66 153.4 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -118.45 126.98 53.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.451 -0.781 . . . . 0.0 109.656 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.4 160.31 30.83 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.851 0.834 . . . . 0.0 109.259 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -84.09 136.51 33.98 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.844 -0.535 . . . . 0.0 109.803 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.654 HG11 HD13 ' A' ' 74' ' ' LEU . 4.2 m -133.23 163.72 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -73.78 145.49 84.31 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.044 -1.035 . . . . 0.0 109.814 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.61 ' O ' HG12 ' A' ' 71' ' ' VAL . 49.7 Cg_exo -49.24 -30.23 18.95 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.268 1.979 . . . . 0.0 111.966 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -85.32 -28.0 25.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.416 -0.802 . . . . 0.0 110.238 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.58 0.94 55.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.108 -0.995 . . . . 0.0 109.968 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 68' ' ' PRO . 7.4 p -63.45 -43.7 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.919 -1.113 . . . . 0.0 109.281 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.548 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -66.18 -48.46 64.55 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 t -61.33 -49.55 76.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.167 -1.196 . . . . 0.0 110.693 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.654 HD13 HG11 ' A' ' 66' ' ' VAL . 2.0 tt -67.24 -42.7 83.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.813 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -75.29 -7.38 53.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.391 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -28.61 16.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -61.79 149.72 84.33 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.402 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' O ' HD12 ' A' ' 80' ' ' ILE . 24.7 Cg_exo -62.77 146.02 95.01 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 122.215 1.943 . . . . 0.0 113.058 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.06 -28.92 5.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.774 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.7 mp -83.65 128.41 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -1.215 . . . . 0.0 109.402 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 49.3 m-85 -124.07 153.03 67.86 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.801 -0.562 . . . . 0.0 109.773 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' O ' ' OG1' ' A' ' 93' ' ' THR . 53.9 Cg_exo -45.15 159.52 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.115 1.876 . . . . 0.0 112.089 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.72 144.05 56.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.144 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 88.0 t80 -89.28 4.27 49.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.805 . . . . 0.0 109.246 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 86' ' ' MET . 33.0 t-80 -105.7 177.91 4.71 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.45 -0.781 . . . . 0.0 110.265 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.613 ' H ' ' CG ' ' A' ' 85' ' ' HIS . 91.7 mtp -64.69 -39.71 94.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.55 -0.719 . . . . 0.0 110.143 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.99 130.65 39.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.202 -0.936 . . . . 0.0 110.519 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -146.55 96.23 2.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -178.77 -43.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -111.9 -23.9 10.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 109.378 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.85 ' C ' HD12 ' A' ' 92' ' ' ILE . 2.0 m-90 -111.76 132.91 54.33 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.43 -0.794 . . . . 0.0 109.495 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.85 HD12 ' C ' ' A' ' 91' ' ' TRP . 3.0 mp -137.06 147.56 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.218 -0.926 . . . . 0.0 109.006 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 82' ' ' PRO . 3.2 p -87.49 147.6 25.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.602 -0.686 . . . . 0.0 110.051 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.43 134.72 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.4 tp -87.04 112.44 21.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 0.0 110.104 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.93 -38.68 83.19 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.44 -0.788 . . . . 0.0 108.996 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -73.81 -0.1 14.81 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.35 171.56 19.24 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.79 -16.03 33.23 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 123.365 2.71 . . . . 0.0 111.972 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.22 138.7 58.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.95 169.29 54.98 Favored Glycine 0 N--CA 1.493 2.439 0 CA-C-O 122.079 0.822 . . . . 0.0 111.222 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.63 -36.11 83.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.691 -0.887 . . . . 0.0 109.716 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -61.44 -38.75 88.29 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.356 -0.84 . . . . 0.0 108.986 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.09 -37.66 88.22 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.432 -0.792 . . . . 0.0 109.431 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.94 -43.87 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.968 . . . . 0.0 109.527 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.518 ' NE2' ' CD1' ' A' ' 9' ' ' TYR . 48.4 m170 -61.47 -42.76 99.27 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.153 -0.967 . . . . 0.0 109.659 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -62.21 -44.66 96.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.7 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.66 -44.05 91.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.706 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.39 -42.83 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.309 -0.869 . . . . 0.0 109.476 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -53.9 -41.33 67.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.273 -0.892 . . . . 0.0 109.137 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.97 -44.74 96.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.5 m -60.64 -37.54 81.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.57 -43.4 97.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.221 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -51.45 -40.05 58.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 110.049 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 115' ' ' LEU . 9.0 mp -63.49 -40.06 96.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.878 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 117' ' ' ARG . 5.6 p -92.19 6.53 46.3 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -0.964 . . . . 0.0 109.538 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 116' ' ' THR . 53.3 ptt85 . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.566 0.698 . . . . 0.0 110.922 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 ttm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -100.23 161.66 13.46 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.26 -0.9 . . . . 0.0 110.221 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -61.54 -42.99 99.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.771 . . . . 0.0 109.689 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -61.38 -39.22 89.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.791 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.46 -37.08 85.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.456 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -60.7 -44.23 96.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.72 -46.45 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.261 -0.899 . . . . 0.0 109.653 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.41 -41.34 98.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -60.64 -49.9 75.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 109.446 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.38 80.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 15' ' ' ASP . 35.3 tt0 -62.83 -50.39 71.15 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.271 -0.893 . . . . 0.0 109.979 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.48 -40.49 97.25 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.628 -1.295 . . . . 0.0 109.132 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -70.33 -46.42 64.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.864 . . . . 0.0 112.129 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CE1' ' CE1' ' A' ' 33' ' ' HIS . 86.4 m-85 -120.43 -17.97 8.02 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.026 -1.046 . . . . 0.0 111.547 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 11' ' ' GLN . 30.1 t0 60.94 42.38 12.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.927 -1.108 . . . . 0.0 109.457 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.4 t -108.41 136.4 48.11 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -92.9 157.34 39.53 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.094 -1.004 . . . . 0.0 109.779 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.88 143.7 90.64 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.761 1.641 . . . . 0.0 112.775 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -132.28 135.67 46.4 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -133.72 85.1 42.81 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.184 -0.948 . . . . 0.0 109.376 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.77 -34.94 97.51 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.499 2.133 . . . . 0.0 111.394 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -85.87 110.88 19.71 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.572 -0.705 . . . . 0.0 109.625 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -68.56 -31.09 70.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.838 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -67.2 -4.35 10.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.923 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -133.33 70.49 77.16 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.433 -0.792 . . . . 0.0 108.939 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.68 -16.34 33.68 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.229 1.952 . . . . 0.0 111.883 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 22.7 p-10 -88.68 0.27 56.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.336 -0.853 . . . . 0.0 109.258 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.0 m-85 -92.71 139.19 30.81 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.197 -0.939 . . . . 0.0 109.186 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.46 114.92 21.36 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.75 128.28 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.419 -0.801 . . . . 0.0 109.012 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -111.47 134.19 53.22 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.66 -0.65 . . . . 0.0 109.262 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -145.19 150.67 37.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.235 -0.916 . . . . 0.0 109.291 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 14' ' ' TYR . 64.1 m170 -100.08 160.99 13.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.339 -0.851 . . . . 0.0 109.926 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.3 t -102.91 -50.91 3.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.226 -0.921 . . . . 0.0 110.132 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -96.86 -0.82 47.2 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.097 -1.002 . . . . 0.0 110.83 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 116' ' ' THR . 14.2 t-20 -104.99 31.82 4.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.162 -0.961 . . . . 0.0 109.129 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 38' ' ' LYS . 98.9 m-20 59.38 40.05 21.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.972 -0.455 . . . . 0.0 110.066 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.471 ' HA ' ' H ' ' A' ' 33' ' ' HIS . 6.3 ptpp? 31.23 76.22 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.676 0.75 . . . . 0.0 110.958 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -55.59 -170.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.635 -0.666 . . . . 0.0 109.909 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CE2' ' OD2' ' A' ' 63' ' ' ASP . 63.0 t80 -115.04 122.69 46.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.611 -0.681 . . . . 0.0 109.167 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . . . -154.79 129.99 9.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.503 -0.748 . . . . 0.0 109.209 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.2 tp -140.86 129.05 22.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 109.349 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.576 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.7 tt -122.09 125.97 47.38 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.573 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.9 ptt? -159.05 157.35 30.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 59' ' ' VAL . 46.6 t0 -96.19 114.03 25.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.143 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 pt -116.67 144.79 33.97 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.616 -0.678 . . . . 0.0 109.206 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -48.3 143.77 14.37 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.58 1.52 . . . . 0.0 112.412 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -61.39 -22.08 64.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.394 -0.816 . . . . 0.0 109.458 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.62 -16.83 62.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.132 . . . . 0.0 110.278 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -84.72 -11.67 55.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.003 -1.061 . . . . 0.0 111.092 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.477 ' O ' ' CD2' ' A' ' 81' ' ' TYR . 11.4 pt -100.97 4.96 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 120.953 -1.092 . . . . 0.0 109.398 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.06 -11.07 65.91 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.515 ' C ' ' H ' ' A' ' 55' ' ' GLY . 61.6 mt -81.64 132.56 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.848 -1.383 . . . . 0.0 109.414 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -67.02 13.51 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.571 -0.706 . . . . 0.0 109.944 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -83.97 141.44 20.08 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 32.0 p-10 -101.04 8.9 42.71 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.452 -1.028 . . . . 0.0 109.019 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 64.1 tttp -84.03 141.39 31.21 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.494 -0.754 . . . . 0.0 109.556 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -72.52 145.44 47.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.867 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.435 ' HB ' HD11 ' A' ' 95' ' ' LEU . 31.6 m -136.13 161.3 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.486 -0.758 . . . . 0.0 109.721 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -102.3 139.0 38.5 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.1 153.53 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.397 -0.815 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 pt -137.01 148.31 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.694 -0.629 . . . . 0.0 109.446 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.538 ' OD2' ' CE2' ' A' ' 40' ' ' TYR . 86.5 m-20 -74.61 144.63 43.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.305 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.666 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -133.11 131.92 41.08 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.666 ' N ' HD13 ' A' ' 64' ' ' LEU . 10.0 mtpm? -97.73 130.3 44.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.223 -0.923 . . . . 0.0 109.912 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.11 165.6 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.369 -0.832 . . . . 0.0 110.316 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -70.61 152.9 95.23 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.512 -0.742 . . . . 0.0 109.129 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.461 ' O ' HG12 ' A' ' 71' ' ' VAL . 37.3 Cg_endo -65.57 -22.2 58.69 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.23 1.953 . . . . 0.0 111.353 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -86.47 -30.64 21.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.2 mt -97.38 10.62 39.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.244 -0.91 . . . . 0.0 109.291 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.532 HG13 ' N ' ' A' ' 72' ' ' GLY . 5.4 p -60.38 -46.74 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 110.1 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.532 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -75.92 -14.74 81.9 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.907 -1.139 . . . . 0.0 110.416 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 5.0 t -59.34 -55.46 34.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.015 -1.285 . . . . 0.0 110.898 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.004 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.9 pt? -86.3 -21.57 27.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.874 . . . . 0.0 110.864 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.847 ' CZ ' HG21 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -57.77 -42.27 83.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.772 -1.205 . . . . 0.0 111.275 -177.365 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -79.91 0.43 31.35 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.465 -1.397 . . . . 0.0 110.594 -178.525 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -83.82 125.34 73.41 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.693 -1.254 . . . . 0.0 109.256 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.42 144.34 18.49 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 121.942 1.761 . . . . 0.0 113.141 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.57 -6.08 67.62 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.62 ' CG2' HH21 ' A' ' 75' ' ' ARG . 96.4 mt -122.47 128.77 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.208 -1.172 . . . . 0.0 109.805 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 31.7 m-85 -120.46 152.6 55.45 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.498 -0.751 . . . . 0.0 109.934 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.83 154.77 67.09 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.471 2.114 . . . . 0.0 111.895 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.81 147.22 53.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.204 -0.935 . . . . 0.0 110.127 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.511 ' C ' ' H ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -98.6 119.47 37.37 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 25.5 t60 66.74 -33.42 0.2 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.628 -0.67 . . . . 0.0 110.736 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.511 ' H ' ' C ' ' A' ' 84' ' ' TYR . 90.4 mmm -84.32 159.55 20.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.076 -1.015 . . . . 0.0 110.598 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 91' ' ' TRP . 57.9 t-20 -40.52 122.05 1.55 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.666 0.746 . . . . 0.0 110.939 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -94.41 -15.05 24.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.644 -0.66 . . . . 0.0 109.734 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.426 ' N ' ' OD1' ' A' ' 87' ' ' ASN . 98.1 mt-10 -80.87 -85.2 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.946 . . . . 0.0 110.66 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -60.6 -44.18 96.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -0.884 . . . . 0.0 110.739 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 91' ' ' TRP . 16.5 m0 -101.56 138.15 38.94 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.49 -0.756 . . . . 0.0 109.684 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.847 HG21 ' CZ ' ' A' ' 75' ' ' ARG . 9.3 mt -143.51 165.84 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.322 -0.861 . . . . 0.0 109.519 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 81' ' ' TYR . 6.3 p -107.77 138.58 43.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.9 t -121.1 133.97 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.435 HD11 ' HB ' ' A' ' 59' ' ' VAL . 31.0 tp -90.82 109.64 20.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 109.817 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.8 mt -64.95 -39.21 93.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -74.41 5.76 4.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 109.66 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.85 165.18 15.33 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.52 -16.88 30.51 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.937 2.425 . . . . 0.0 111.293 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 100' ' ' LEU . 1.9 pp -60.22 169.3 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.648 -0.658 . . . . 0.0 110.46 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -99.99 169.13 21.71 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 121.231 -0.918 . . . . 0.0 110.913 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.88 82.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.629 -0.924 . . . . 0.0 109.365 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.497 ' NZ ' ' OE2' ' A' ' 104' ' ' GLU . 22.7 pttp -60.29 -37.05 79.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.329 -0.857 . . . . 0.0 108.973 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' A' ' 103' ' ' LYS . 72.9 mm-40 -65.33 -44.62 87.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.311 -0.868 . . . . 0.0 109.12 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.05 -43.83 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.0 109.548 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -58.0 -44.29 87.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.273 -0.892 . . . . 0.0 109.911 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.0 p -61.15 -43.39 98.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 0.0 109.689 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.61 -42.05 98.24 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 109.034 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.68 -43.0 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.177 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -51.64 -44.83 63.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.109 -0.994 . . . . 0.0 108.879 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.21 -42.28 98.32 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.158 -0.964 . . . . 0.0 108.573 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 t -62.72 -38.75 91.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.2 -43.33 74.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.259 -0.901 . . . . 0.0 108.973 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -54.5 -31.81 56.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.773 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 115' ' ' LEU . 9.0 mp -83.55 -13.48 54.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.084 -1.01 . . . . 0.0 109.974 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.513 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 45.0 p -102.04 13.87 33.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.297 -0.877 . . . . 0.0 109.306 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 110.168 -179.87 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 ttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.284 0.564 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -87.2 159.29 18.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.313 -0.867 . . . . 0.0 110.495 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.27 -42.89 96.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.646 -0.659 . . . . 0.0 109.588 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -59.24 -43.22 92.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.845 . . . . 0.0 109.497 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.86 -32.36 73.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.222 -0.923 . . . . 0.0 109.468 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -60.9 -47.66 85.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.664 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.0 mp -64.98 -46.77 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.207 -0.933 . . . . 0.0 109.184 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.75 -43.22 99.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 109.819 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.417 ' CE1' ' CE1' ' A' ' 106' ' ' HIS . 89.8 t80 -64.12 -44.15 93.09 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.868 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.86 -51.49 69.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.625 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 15' ' ' ASP . 3.5 pt20 -70.11 -38.17 75.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.033 -1.042 . . . . 0.0 110.255 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -60.01 -43.45 95.22 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.626 -1.296 . . . . 0.0 109.35 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -88.2 -32.06 18.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.145 -0.972 . . . . 0.0 111.698 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.525 ' CE1' ' CD1' ' A' ' 113' ' ' PHE . 73.5 m-85 -121.25 -8.56 9.21 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.065 -1.022 . . . . 0.0 111.654 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 11' ' ' GLN . 91.4 m-20 54.97 37.48 28.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 109.54 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 17' ' ' LYS . 96.7 m -79.69 162.2 25.36 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.512 -0.742 . . . . 0.0 109.152 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' N ' HG22 ' A' ' 16' ' ' THR . 37.1 tptt -123.01 93.12 48.66 Favored Pre-proline 0 N--CA 1.497 1.895 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -56.49 146.5 74.24 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.405 2.07 . . . . 0.0 112.365 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 60.4 t0 -132.15 152.25 51.36 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.8 OUTLIER -118.93 86.26 30.73 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 0.0 109.497 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.78 -36.84 83.73 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.235 1.956 . . . . 0.0 111.469 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -87.4 126.99 35.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.575 -0.703 . . . . 0.0 109.357 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -87.51 -28.84 21.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.371 -0.83 . . . . 0.0 109.715 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -81.84 -7.56 59.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.326 -0.859 . . . . 0.0 110.0 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -123.57 75.35 54.38 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.449 -0.782 . . . . 0.0 109.518 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.86 -17.66 41.63 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.985 1.79 . . . . 0.0 111.634 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -80.64 -5.04 56.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.472 -0.768 . . . . 0.0 109.573 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -100.39 135.09 42.36 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.414 -0.804 . . . . 0.0 109.333 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.91 147.54 44.47 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.16 129.47 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.47 -0.769 . . . . 0.0 109.394 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 43.6 m-85 -108.45 109.92 21.31 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -142.21 146.15 34.89 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.145 -0.972 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.505 ' NE2' ' OG1' ' A' ' 16' ' ' THR . 63.8 m170 -99.86 113.56 26.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.521 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.3 p -69.79 -17.89 63.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.307 -0.87 . . . . 0.0 109.585 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -62.74 -44.12 97.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.826 . . . . 0.0 109.808 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 38' ' ' LYS . 56.7 p30 -112.4 -1.49 15.02 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.425 -0.797 . . . . 0.0 109.133 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.4 t0 58.4 0.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.731 . . . . 0.0 109.925 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 36' ' ' ASN . 53.6 mtmt -101.3 -156.91 0.58 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 109.69 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 46.9 t-105 57.15 94.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.644 -0.66 . . . . 0.0 109.491 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.59 125.2 54.02 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.54 143.93 24.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.42 144.01 32.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.193 -0.942 . . . . 0.0 109.014 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.615 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.1 tt -117.61 127.11 53.63 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.528 ' N ' HD23 ' A' ' 43' ' ' LEU . 6.6 ptt? -146.63 158.09 43.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.097 -1.002 . . . . 0.0 109.485 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 34.6 p-10 -95.59 115.6 27.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.366 -0.834 . . . . 0.0 109.265 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.2 pt -126.31 145.73 53.71 Favored Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.478 -0.764 . . . . 0.0 109.231 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.67 144.03 99.49 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.075 1.85 . . . . 0.0 112.78 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -62.82 -20.99 65.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.692 -0.63 . . . . 0.0 109.64 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.76 -36.54 76.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.051 -1.03 . . . . 0.0 110.465 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 52' ' ' GLY . 97.2 mttt -63.74 -43.49 96.33 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.97 -1.081 . . . . 0.0 111.239 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.456 ' CD1' HD12 ' A' ' 53' ' ' ILE . 9.4 pt -71.57 15.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.958 -1.089 . . . . 0.0 110.145 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . 80.75 -7.49 58.57 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.088 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 55' ' ' GLY . 71.0 mt -79.4 133.06 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.775 -1.427 . . . . 0.0 109.335 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -68.91 26.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.374 -0.829 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -91.97 132.8 11.44 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 32.2 p-10 -101.79 8.86 41.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.333 -1.098 . . . . 0.0 108.962 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -83.89 154.92 23.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.388 -0.82 . . . . 0.0 109.767 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -82.28 130.38 35.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 108.667 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.446 ' HA ' HD22 ' A' ' 97' ' ' ASN . 16.3 m -125.79 143.61 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.535 -0.728 . . . . 0.0 109.615 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -89.57 141.62 28.42 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.265 -0.897 . . . . 0.0 109.927 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.401 HG12 HD12 ' A' ' 95' ' ' LEU . 3.8 m -135.8 158.96 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.416 -0.802 . . . . 0.0 109.468 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 pt -134.24 151.38 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -112.16 140.35 46.93 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.471 -0.768 . . . . 0.0 110.126 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -138.33 157.22 46.68 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.656 -0.653 . . . . 0.0 109.362 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -92.73 139.92 30.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 0.0 110.867 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 m -141.39 164.68 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.41 -0.806 . . . . 0.0 109.547 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.78 156.74 86.39 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.527 -0.733 . . . . 0.0 109.628 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 71' ' ' VAL . 31.2 Cg_endo -64.47 -23.39 64.77 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.327 2.018 . . . . 0.0 111.207 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -86.57 -25.8 24.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.38 -0.825 . . . . 0.0 109.429 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.22 5.67 49.69 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.21 -0.931 . . . . 0.0 109.38 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 72' ' ' GLY . 11.6 p -63.28 -39.93 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.499 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -77.47 -15.42 81.44 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -68.17 -55.96 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.123 -1.222 . . . . 0.0 110.753 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.0 pt? -86.48 -25.26 25.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.962 -1.086 . . . . 0.0 110.614 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -71.08 -21.63 62.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.947 -1.096 . . . . 0.0 109.627 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.22 -6.68 57.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 108.727 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.42 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 9.0 mtpm? -84.54 152.65 60.78 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.1 148.45 69.34 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.957 2.438 . . . . 0.0 113.19 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.47 -23.69 11.81 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.2 mt -96.02 121.14 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -1.189 . . . . 0.0 110.066 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -117.56 157.28 48.05 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.793 -0.567 . . . . 0.0 109.979 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.34 152.55 66.18 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.848 1.698 . . . . 0.0 112.36 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.87 151.37 39.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.399 -0.813 . . . . 0.0 109.962 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -90.48 1.24 56.86 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.344 -0.847 . . . . 0.0 109.259 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.17 -174.02 2.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.405 -0.809 . . . . 0.0 110.047 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.4 ttm -63.82 -39.39 94.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.714 . . . . 0.0 110.148 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.9 153.55 43.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.532 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -148.59 -54.97 0.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.75 -17.6 59.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.364 -0.835 . . . . 0.0 109.257 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.41 ' CD2' ' N ' ' A' ' 90' ' ' HIS . 4.0 m170 -82.13 -62.84 1.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.949 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -109.79 148.08 32.1 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.658 -0.651 . . . . 0.0 109.903 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 mm -130.9 137.25 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.1 m -87.19 131.03 34.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.671 -0.643 . . . . 0.0 110.147 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 64' ' ' LEU . 72.6 t -113.22 134.81 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.435 HD11 ' HB ' ' A' ' 59' ' ' VAL . 46.1 tp -89.22 108.73 19.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.941 . . . . 0.0 110.273 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.64 -41.06 96.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 59' ' ' VAL . 97.0 m-20 -84.51 20.22 1.76 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 109.009 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.78 -176.43 39.76 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.26 -37.24 94.55 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.047 2.498 . . . . 0.0 112.774 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -57.97 138.22 56.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 0.0 110.418 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.92 -174.15 39.45 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.94 92.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.683 -0.892 . . . . 0.0 109.882 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -62.79 -40.93 98.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.27 -40.21 96.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.507 -0.746 . . . . 0.0 109.775 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.41 -43.61 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.771 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.417 ' CE1' ' CE1' ' A' ' 9' ' ' TYR . 55.9 m170 -59.59 -47.3 86.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.756 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.3 m -62.35 -43.93 97.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.957 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.31 -44.96 93.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.39 -0.819 . . . . 0.0 109.732 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.5 mt -65.32 -43.02 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -0.842 . . . . 0.0 109.337 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -52.2 -43.68 64.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.025 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -61.95 -44.18 97.3 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 109.273 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.0 p -67.34 -39.24 85.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.79 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 87.6 t80 -61.62 -45.52 93.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.911 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.24 -42.07 69.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.371 -0.83 . . . . 0.0 109.578 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.56 -39.83 92.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.378 -0.826 . . . . 0.0 110.113 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 p -99.99 14.54 30.2 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.157 -0.964 . . . . 0.0 109.835 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 113' ' ' PHE . 35.7 ptt180 . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 110.092 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.7 ttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.603 0.716 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -102.14 163.22 12.36 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.733 0.777 . . . . 0.0 110.183 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.408 HH21 ' CG ' ' A' ' 60' ' ' ASP . 41.3 ttm180 -61.29 -43.82 98.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.586 0.708 . . . . 0.0 109.6 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -58.89 -40.06 83.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.779 . . . . 0.0 109.842 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.14 -37.6 88.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.441 -0.787 . . . . 0.0 109.817 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -60.94 -43.8 98.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.317 -0.864 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.42 -44.26 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -0.783 . . . . 0.0 109.474 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.76 -44.32 96.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.634 ' CE1' ' CD2' ' A' ' 106' ' ' HIS . 63.9 t80 -63.46 -48.58 77.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.443 -0.786 . . . . 0.0 109.696 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.2 85.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.492 -0.755 . . . . 0.0 109.811 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 15' ' ' ASP . 5.5 tp-100 -68.53 -49.91 56.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.824 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.84 -31.67 73.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.957 -1.089 . . . . 0.0 109.087 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' NZ ' ' CZ ' ' A' ' 14' ' ' TYR . 65.8 tttm -83.44 -38.36 21.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 111.74 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.484 ' CZ ' ' NZ ' ' A' ' 13' ' ' LYS . 74.9 m-85 -116.63 -21.41 9.14 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.824 -1.173 . . . . 0.0 111.148 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 49.7 t0 62.8 36.79 12.83 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.27 -0.894 . . . . 0.0 109.466 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -114.88 134.75 54.89 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.593 0.711 . . . . 0.0 109.707 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -84.69 151.66 58.7 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.613 -0.679 . . . . 0.0 109.332 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.54 146.44 79.69 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.786 2.324 . . . . 0.0 112.477 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -115.38 155.17 27.87 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.693 0.759 . . . . 0.0 109.3 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -143.41 88.2 8.1 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 -15.28 21.12 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.339 2.026 . . . . 0.0 110.617 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -100.72 110.5 22.61 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.498 0.666 . . . . 0.0 109.335 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -68.32 -33.61 74.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.797 0.808 . . . . 0.0 109.186 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -67.76 -2.41 7.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.404 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -143.68 74.72 16.63 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.296 -0.878 . . . . 0.0 109.372 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.86 -15.8 29.63 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.605 2.203 . . . . 0.0 111.301 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -86.46 -4.96 59.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.494 -0.754 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -84.57 142.38 30.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.373 -0.829 . . . . 0.0 109.611 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.07 140.77 50.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.589 -0.694 . . . . 0.0 109.69 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.78 132.66 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -109.07 136.47 48.52 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.394 0.616 . . . . 0.0 109.699 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -156.12 149.23 24.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.342 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.5 ' O ' ' NE1' ' A' ' 39' ' ' TRP . 80.3 m80 -100.75 128.95 46.6 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.611 0.719 . . . . 0.0 109.443 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.4 p -75.92 -6.89 53.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.471 -0.768 . . . . 0.0 109.518 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -94.33 -9.84 34.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.262 -0.899 . . . . 0.0 109.815 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -109.78 -30.23 7.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.147 -0.971 . . . . 0.0 108.783 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.8 t0 54.18 28.04 8.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.468 -0.77 . . . . 0.0 109.699 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 50.8 tptt -170.11 112.03 0.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.143 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.614 ' CD2' ' N ' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -173.22 -174.48 1.05 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.207 1.003 . . . . 0.0 109.75 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.432 ' CE2' ' CD2' ' A' ' 42' ' ' LEU . 9.7 t80 -160.18 118.93 2.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.199 -0.938 . . . . 0.0 109.137 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.12 121.72 4.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.432 ' CD2' ' CE2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -138.34 149.28 45.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.462 -0.774 . . . . 0.0 109.163 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.663 ' C ' HD23 ' A' ' 43' ' ' LEU . 7.4 tt -129.31 122.56 29.81 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.547 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.43 162.23 41.48 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.688 0.756 . . . . 0.0 109.928 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 42.5 p-10 -97.25 114.82 26.61 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.289 0.566 . . . . 0.0 109.518 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.7 pt -117.56 146.19 38.01 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.38 143.6 99.66 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.692 2.262 . . . . 0.0 112.495 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.77 -19.89 64.45 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.578 0.704 . . . . 0.0 109.794 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.91 -38.85 87.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.235 -0.915 . . . . 0.0 110.238 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.87 -43.76 95.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.23 -0.918 . . . . 0.0 111.174 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.669 HD12 HD12 ' A' ' 53' ' ' ILE . 2.8 pt -76.95 12.17 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.036 -1.04 . . . . 0.0 109.834 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.1 31.16 77.83 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.365 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.669 HD12 HD12 ' A' ' 51' ' ' ILE . 47.9 mt -101.23 128.57 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.111 -1.229 . . . . 0.0 109.737 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -55.93 81.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.644 0.735 . . . . 0.0 110.458 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . -176.98 151.48 11.19 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.71 15.35 18.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.513 -0.992 . . . . 0.0 108.446 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -88.45 155.04 19.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.36 -0.838 . . . . 0.0 110.256 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -86.36 141.83 28.91 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.526 0.679 . . . . 0.0 110.095 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 95' ' ' LEU . 29.6 m -134.04 153.32 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.548 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.408 ' CG ' HH21 ' A' ' 3' ' ' ARG . 96.4 m-20 -90.47 139.4 30.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.696 -0.628 . . . . 0.0 110.167 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.465 ' CG2' ' SD ' ' A' ' 44' ' ' MET . 33.4 m -137.87 154.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.707 0.765 . . . . 0.0 109.987 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.6 pt -135.2 147.92 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.493 0.663 . . . . 0.0 109.871 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.76 143.37 34.54 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.419 0.628 . . . . 0.0 110.389 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.667 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -133.33 126.91 32.42 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.667 ' N ' HD13 ' A' ' 64' ' ' LEU . 64.8 tttm -82.81 135.88 34.83 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.671 0.748 . . . . 0.0 110.569 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.76 158.35 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.597 0.713 . . . . 0.0 109.782 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' H ' ' HB2' ' A' ' 70' ' ' LEU . 61.7 mt-30 -89.83 154.45 47.82 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.529 -0.732 . . . . 0.0 109.319 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.485 ' O ' HG12 ' A' ' 71' ' ' VAL . 52.6 Cg_exo -45.67 -28.86 4.84 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.252 1.968 . . . . 0.0 111.563 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -91.48 -29.11 17.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 0.0 109.54 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.433 ' HB2' ' H ' ' A' ' 67' ' ' GLN . 89.2 mt -91.53 -8.33 47.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.269 -0.894 . . . . 0.0 109.668 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 68' ' ' PRO . 10.5 p -66.68 -40.01 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.652 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -62.88 -42.37 99.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.3 t -61.1 -48.76 80.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.353 -1.087 . . . . 0.0 110.073 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.07 -39.1 63.7 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.419 -0.8 . . . . 0.0 110.189 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.426 ' HE ' ' HG3' ' A' ' 82' ' ' PRO . 72.9 ttt180 -72.17 -38.99 69.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.554 -0.716 . . . . 0.0 111.308 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -73.73 -5.06 38.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.909 -1.12 . . . . 0.0 110.051 -178.565 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -78.95 147.67 70.61 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.126 -0.984 . . . . 0.0 109.714 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.416 ' O ' HD12 ' A' ' 80' ' ' ILE . 55.2 Cg_endo -69.95 145.66 56.71 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.473 2.116 . . . . 0.0 112.542 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.31 -20.9 19.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.701 HD12 ' N ' ' A' ' 80' ' ' ILE . 3.0 mp -91.83 122.59 43.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.323 -1.104 . . . . 0.0 109.449 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.533 ' CZ ' HD11 ' A' ' 53' ' ' ILE . 82.8 m-85 -115.06 154.94 47.17 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.23 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HG3' ' HE ' ' A' ' 75' ' ' ARG . 31.4 Cg_exo -60.44 146.81 96.04 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.841 2.361 . . . . 0.0 112.869 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.47 43.83 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.389 -0.819 . . . . 0.0 110.515 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 85' ' ' HIS . 45.7 p90 -96.13 3.86 52.93 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.63 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 71.9 m80 -87.93 -162.83 0.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.461 -0.774 . . . . 0.0 110.294 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' ASN . 42.0 ttp -55.32 160.86 2.08 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.56 0.695 . . . . 0.0 110.71 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 86' ' ' MET . 13.2 p30 42.32 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.864 0.84 . . . . 0.0 110.735 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.454 ' O ' HD11 ' A' ' 92' ' ' ILE . 81.9 tttt -151.83 -22.94 0.19 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 109.108 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 57.3 mp0 -96.02 -19.69 19.27 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.162 -0.962 . . . . 0.0 110.027 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -75.0 -69.82 0.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.633 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -110.39 138.81 46.29 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.392 -0.818 . . . . 0.0 110.026 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.454 HD11 ' O ' ' A' ' 88' ' ' LYS . 49.5 mm -120.13 157.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.429 ' N ' HG22 ' A' ' 92' ' ' ILE . 2.0 p -98.92 138.44 36.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.504 -0.747 . . . . 0.0 110.006 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.55 134.52 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.415 HD11 ' HB ' ' A' ' 59' ' ' VAL . 38.4 tp -86.3 105.89 16.98 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.585 0.707 . . . . 0.0 110.097 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.51 -39.67 88.79 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.805 0.812 . . . . 0.0 109.012 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -68.57 -7.55 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.77 -169.04 13.18 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.78 18.83 1.21 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.239 2.626 . . . . 0.0 111.425 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 80' ' ' ILE . 3.9 mm? -66.06 132.9 49.62 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.95 0.881 . . . . 0.0 110.38 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.74 155.79 22.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.67 79.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.804 -0.821 . . . . 0.0 109.898 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.55 -40.06 92.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.386 -0.821 . . . . 0.0 109.207 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.99 -44.78 96.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.81 -43.4 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.243 -0.91 . . . . 0.0 109.583 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.634 ' CD2' ' CE1' ' A' ' 9' ' ' TYR . 54.2 m170 -58.94 -42.34 89.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 109.849 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -63.99 -42.14 97.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 109.853 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.8 -41.22 95.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.361 -0.837 . . . . 0.0 109.515 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.76 -42.88 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.75 -42.34 75.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.202 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.26 -41.03 98.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.23 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.4 t -60.19 -40.08 88.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.827 . . . . 0.0 109.649 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -58.36 -44.18 88.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 109.227 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -57.91 -46.1 85.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.359 -0.838 . . . . 0.0 109.844 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.29 -37.77 88.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 0.0 109.623 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.3 p -88.08 13.19 11.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.157 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.8 0.809 . . . . 0.0 109.022 179.703 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.6 ttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -104.62 155.08 19.16 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.67 -0.643 . . . . 0.0 109.884 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -61.6 -43.54 98.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.571 -0.706 . . . . 0.0 109.73 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -58.09 -41.79 84.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.596 -0.69 . . . . 0.0 110.019 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.36 -35.71 81.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.783 . . . . 0.0 110.122 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -60.16 -45.57 92.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.749 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.65 -45.46 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -62.82 -38.27 90.04 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.593 0.711 . . . . 0.0 109.506 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.516 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 59.9 t80 -69.5 -43.89 72.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 110.141 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.78 75.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.434 -0.791 . . . . 0.0 110.5 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 15' ' ' ASP . 4.8 pt20 -66.53 -30.41 70.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 109.984 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.4 -48.54 80.75 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 0.0 110.225 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.516 ' NZ ' ' CE2' ' A' ' 9' ' ' TYR . 63.3 mttp -90.34 -12.4 37.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.217 -0.927 . . . . 0.0 111.875 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -134.65 -20.38 1.79 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.981 -1.075 . . . . 0.0 111.012 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 11' ' ' GLN . 43.0 t0 58.42 39.45 25.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.119 -0.988 . . . . 0.0 109.263 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.5 m -106.93 127.1 53.14 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -89.34 156.04 48.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.715 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.66 141.3 43.98 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.981 1.787 . . . . 0.0 112.359 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -125.88 121.73 34.04 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 20' ' ' HIS . 25.2 p-80 -125.39 86.17 57.47 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.562 -0.711 . . . . 0.0 109.425 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.86 -32.3 91.62 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.537 2.158 . . . . 0.0 111.201 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -83.45 135.59 34.62 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.589 0.709 . . . . 0.0 110.161 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.661 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 1.4 pm0 -89.41 -24.26 21.95 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -78.11 -3.1 40.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.488 -0.757 . . . . 0.0 109.825 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -137.18 66.04 52.1 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.4 -0.812 . . . . 0.0 109.458 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.47 -20.2 36.51 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.433 2.088 . . . . 0.0 111.425 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -81.94 -5.61 58.44 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.53 -0.731 . . . . 0.0 109.063 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -90.96 140.35 29.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.497 -0.752 . . . . 0.0 109.117 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.72 121.52 34.87 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -109.44 125.49 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -108.76 116.55 32.19 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -145.07 135.31 24.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.092 -1.005 . . . . 0.0 109.285 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -99.95 115.0 28.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.486 -0.759 . . . . 0.0 109.716 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 m -63.69 -35.78 81.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.605 -0.684 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -71.68 -5.37 33.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.961 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 38' ' ' LYS . 10.7 t-20 -113.74 -30.8 6.66 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 42.66 18.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.766 -0.584 . . . . 0.0 109.96 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 36' ' ' ASN . 63.6 tttp -136.53 -19.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 39' ' ' TRP . 18.1 t-105 -78.01 117.99 19.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.491 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -115.26 125.72 53.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.614 -0.679 . . . . 0.0 109.274 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.42 129.01 11.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 108.739 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.3 tp -132.29 123.68 27.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.511 -0.743 . . . . 0.0 109.112 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.588 ' C ' HD23 ' A' ' 43' ' ' LEU . 7.4 tt -117.58 124.66 49.2 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.52 ' N ' HD23 ' A' ' 43' ' ' LEU . 7.5 ptt? -153.95 161.38 42.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 109.212 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 38.1 p-10 -98.05 114.53 26.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.267 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.9 pt -124.54 145.97 50.93 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.548 -0.72 . . . . 0.0 109.193 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.1 143.87 99.05 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.026 1.817 . . . . 0.0 112.573 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -63.81 -20.98 66.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.754 -0.591 . . . . 0.0 109.909 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.5 -35.51 74.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.993 . . . . 0.0 110.165 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -64.69 -41.85 95.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 0.0 110.94 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.463 ' CD1' HD12 ' A' ' 53' ' ' ILE . 5.0 pt -81.82 20.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 109.893 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.22 -4.89 53.29 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.282 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.617 ' HB ' ' HB1' ' A' ' 48' ' ' ALA . 79.4 mt -78.92 134.03 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.939 -1.33 . . . . 0.0 110.075 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 55' ' ' GLY . 92.6 m-20 -61.38 -39.35 90.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.74 -0.6 . . . . 0.0 110.101 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.828 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -37.06 109.48 0.08 OUTLIER Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -80.81 4.35 19.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.517 -0.99 . . . . 0.0 109.007 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -84.12 161.55 20.59 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.654 0.74 . . . . 0.0 110.148 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.01 146.91 33.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.65 -0.656 . . . . 0.0 110.186 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 m -135.26 159.6 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.493 -0.754 . . . . 0.0 109.543 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -102.05 135.77 43.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.362 -0.836 . . . . 0.0 109.681 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.45 155.94 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.395 -0.816 . . . . 0.0 110.057 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.498 HG23 HD11 ' A' ' 96' ' ' LEU . 25.2 pt -133.83 146.71 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -84.39 142.56 30.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.842 . . . . 0.0 109.825 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -136.71 121.67 18.85 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.592 ' N ' HD13 ' A' ' 64' ' ' LEU . 21.5 ptmt -84.98 136.71 33.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 110.115 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.442 HG11 HD13 ' A' ' 74' ' ' LEU . 28.6 m -142.52 165.93 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.253 -0.904 . . . . 0.0 109.88 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -78.01 149.25 76.48 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 0.0 109.669 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.639 ' O ' HG12 ' A' ' 71' ' ' VAL . 51.3 Cg_exo -50.2 -39.31 52.14 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.963 1.776 . . . . 0.0 111.639 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 69' ' ' GLU . 2.4 pt-20 -70.7 -33.79 71.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.726 -0.609 . . . . 0.0 110.037 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -84.67 2.66 40.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 0.0 109.837 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 68' ' ' PRO . 8.0 p -64.34 -42.56 95.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.506 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -69.92 -40.22 74.28 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -62.36 -32.31 73.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.471 -1.017 . . . . 0.0 109.348 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.478 HD12 HD22 ' A' ' 108' ' ' LEU . 2.2 tt -84.85 -35.86 21.96 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.48 -0.762 . . . . 0.0 109.871 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -73.49 -8.16 54.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 110.003 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -2.96 58.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.193 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.573 ' HB2' HD12 ' A' ' 80' ' ' ILE . 31.0 mtpt -96.21 111.43 56.49 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.602 -0.686 . . . . 0.0 109.337 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.15 143.14 42.98 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.061 1.841 . . . . 0.0 113.551 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -19.97 52.02 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.573 HD12 ' HB2' ' A' ' 77' ' ' LYS . 69.2 mt -100.76 121.24 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.321 -1.105 . . . . 0.0 109.299 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -108.78 151.07 41.58 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.468 -0.77 . . . . 0.0 109.765 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.56 163.66 37.29 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.466 2.11 . . . . 0.0 112.512 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -47.5 148.81 1.29 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.565 -0.71 . . . . 0.0 110.302 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.575 ' CZ ' HG21 ' A' ' 93' ' ' THR . 12.1 m-85 -63.07 -43.86 97.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.613 -0.679 . . . . 0.0 109.882 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -160.13 -26.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 109.223 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.407 ' CG ' ' H ' ' A' ' 87' ' ' ASN . 5.8 tpt -61.61 -140.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.51 -0.744 . . . . 0.0 110.42 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.464 ' CG ' ' ND1' ' A' ' 90' ' ' HIS . 82.7 m-20 -72.75 131.3 42.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.631 -0.668 . . . . 0.0 110.009 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -94.53 -21.93 18.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.502 -0.749 . . . . 0.0 109.788 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -100.98 -43.49 6.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.477 -0.764 . . . . 0.0 109.678 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.491 ' CD2' ' N ' ' A' ' 90' ' ' HIS . 3.4 m170 -63.21 -67.18 0.45 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 110.421 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.823 ' O ' HD13 ' A' ' 92' ' ' ILE . 8.3 m0 -111.39 148.48 32.95 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.628 -0.67 . . . . 0.0 109.713 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.823 HD13 ' O ' ' A' ' 91' ' ' TRP . 3.0 mm -132.75 161.77 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.575 HG21 ' CZ ' ' A' ' 84' ' ' TYR . 38.3 p -107.07 133.02 52.32 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.533 HG22 HG23 ' A' ' 80' ' ' ILE . 48.8 t -118.11 133.77 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.5 tp -90.75 108.45 19.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.508 -0.745 . . . . 0.0 109.957 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 62' ' ' ILE . 88.6 mt -65.58 -40.22 92.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.589 -0.694 . . . . 0.0 109.542 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -78.32 6.2 8.82 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.475 -0.766 . . . . 0.0 109.164 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.83 178.84 53.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 100' ' ' LEU . 47.2 Cg_endo -68.02 -79.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.85 2.367 . . . . 0.0 112.079 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.495 ' C ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 22.92 -122.03 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.221 0.534 . . . . 0.0 111.085 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.9 159.63 21.48 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.202 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.56 -37.23 86.84 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.64 -0.918 . . . . 0.0 109.489 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.68 -40.06 95.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.581 -0.699 . . . . 0.0 109.401 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.17 -42.72 99.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.537 -0.727 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.23 -43.24 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 109.638 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -56.33 -44.13 79.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.47 -0.769 . . . . 0.0 109.494 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 t -61.9 -43.96 97.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.577 -0.702 . . . . 0.0 109.621 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.478 HD22 HD12 ' A' ' 74' ' ' LEU . 95.7 mt -63.3 -40.95 98.78 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.482 -0.761 . . . . 0.0 109.363 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.37 -43.18 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.49 -0.756 . . . . 0.0 109.24 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -60.42 -39.3 86.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.258 -0.902 . . . . 0.0 108.855 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.44 -41.14 98.52 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 116' ' ' THR . 38.8 t -62.73 -40.43 97.2 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.21 -44.5 83.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.545 -0.722 . . . . 0.0 109.209 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.83 -29.15 70.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.418 -0.801 . . . . 0.0 109.537 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.9 mt -86.1 -18.14 33.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.263 -0.898 . . . . 0.0 110.025 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 112' ' ' SER . 68.0 p -102.88 15.02 30.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.385 -0.822 . . . . 0.0 109.224 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 110.209 -179.766 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpp . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.474 0.654 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -95.23 162.33 13.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.356 -0.84 . . . . 0.0 110.489 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -61.52 -42.72 99.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 109.847 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -60.88 -39.04 87.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 109.756 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -63.59 -36.63 84.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.814 . . . . 0.0 109.059 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 56.5 t80 -60.98 -43.76 98.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 108.919 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.1 mm -61.1 -48.48 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.485 -0.76 . . . . 0.0 109.822 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -65.52 -41.47 93.1 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 109.452 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -61.54 -47.61 84.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -0.775 . . . . 0.0 109.849 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.66 -46.18 90.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.157 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ASP . 86.2 mt-30 -63.64 -32.28 73.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 110.465 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.39 -47.91 77.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.99 -1.069 . . . . 0.0 109.729 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -90.03 -12.21 39.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.302 -0.873 . . . . 0.0 111.844 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 15' ' ' ASP . 97.7 m-85 -132.93 -18.04 2.39 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.839 -1.163 . . . . 0.0 110.915 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' GLN . 4.4 p-10 43.85 31.92 0.54 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.365 -0.834 . . . . 0.0 109.418 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.0 m -102.37 136.96 41.27 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.657 0.741 . . . . 0.0 110.069 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -83.04 148.79 57.57 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.58 -0.7 . . . . 0.0 109.275 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.2 145.39 72.45 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.403 2.069 . . . . 0.0 112.129 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -121.91 143.44 49.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.617 -0.677 . . . . 0.0 109.485 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 86.44 47.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.62 -40.68 82.97 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.269 1.979 . . . . 0.0 111.068 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -90.3 136.54 32.99 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.61 0.719 . . . . 0.0 109.811 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 16.4 pt-20 -86.98 -22.02 25.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.62 -0.675 . . . . 0.0 109.516 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -75.85 -5.13 44.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.411 -0.806 . . . . 0.0 109.03 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -136.33 72.82 58.16 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.536 -0.728 . . . . 0.0 109.114 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.37 -12.08 24.99 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.499 2.133 . . . . 0.0 111.055 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 17.7 p-10 -87.53 -1.9 58.25 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.521 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.2 m-85 -87.15 142.09 28.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.511 -0.743 . . . . 0.0 109.892 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.93 129.18 47.66 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.411 HG22 HD13 ' A' ' 42' ' ' LEU . 48.2 t -132.03 131.14 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.532 -0.73 . . . . 0.0 109.888 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -109.4 139.08 44.81 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.496 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . 11.9 ptp180 -142.93 130.51 21.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.141 -0.974 . . . . 0.0 109.853 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.405 ' H ' ' CB ' ' A' ' 39' ' ' TRP . 1.0 OUTLIER -102.87 110.21 22.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.552 -0.718 . . . . 0.0 109.129 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.6 p -70.94 -16.31 62.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -0.812 . . . . 0.0 110.065 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -89.05 -5.14 58.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.124 -0.985 . . . . 0.0 109.644 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 38' ' ' LYS . 9.1 t-20 -107.45 -4.36 18.57 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.496 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 66.7 t0 59.35 -68.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.357 0.599 . . . . 0.0 110.231 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 36' ' ' ASN . 33.5 pttt -88.12 87.15 7.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.382 -0.824 . . . . 0.0 108.924 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.509 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 24.5 p90 -113.83 143.59 44.41 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.403 0.621 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.509 ' CG ' ' O ' ' A' ' 39' ' ' TRP . 99.4 m-85 -156.68 120.85 4.39 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.491 ' C ' HD22 ' A' ' 42' ' ' LEU . . . -155.94 105.33 2.36 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.491 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.3 mm? -111.21 131.57 55.02 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.425 0.631 . . . . 0.0 109.694 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' CD1' ' CD2' ' A' ' 6' ' ' PHE . 7.8 tt -135.41 119.71 17.85 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.521 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.2 ptt? -162.5 163.29 27.56 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.082 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 33.0 p-10 -102.97 118.37 36.66 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.9 146.19 52.47 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.717 -0.614 . . . . 0.0 109.933 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -46.36 141.37 10.39 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.36 2.04 . . . . 0.0 112.765 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.45 -24.16 67.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.62 -0.675 . . . . 0.0 109.915 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.58 -29.29 69.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -0.863 . . . . 0.0 109.785 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -64.47 -35.63 81.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.244 -0.91 . . . . 0.0 110.379 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.436 HD11 HD12 ' A' ' 53' ' ' ILE . 14.2 pt -85.15 2.47 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.907 -1.12 . . . . 0.0 109.6 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.84 -7.43 62.94 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.436 HD12 HD11 ' A' ' 51' ' ' ILE . 66.1 mt -78.27 126.61 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.775 -1.426 . . . . 0.0 110.072 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -61.71 86.35 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.705 0.764 . . . . 0.0 109.539 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.52 137.29 3.38 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -95.17 5.71 51.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.408 -1.054 . . . . 0.0 108.204 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -71.71 143.25 49.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 110.477 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -78.76 140.55 38.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.563 -0.711 . . . . 0.0 110.117 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.7 159.98 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -88.19 134.06 33.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.463 -0.773 . . . . 0.0 109.929 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -137.49 153.44 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.496 -0.752 . . . . 0.0 109.714 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.7 pt -141.59 145.01 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.535 0.683 . . . . 0.0 110.151 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -79.82 142.23 35.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.543 -0.723 . . . . 0.0 109.84 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.695 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -127.31 127.81 44.93 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.695 ' N ' HD13 ' A' ' 64' ' ' LEU . 18.0 ttmm -82.11 130.39 35.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.639 -0.663 . . . . 0.0 109.937 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -139.13 163.59 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -0.785 . . . . 0.0 109.879 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -85.96 150.94 53.92 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.425 -0.797 . . . . 0.0 109.65 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.473 ' O ' HG12 ' A' ' 71' ' ' VAL . 53.8 Cg_exo -45.94 -26.7 3.6 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.271 1.981 . . . . 0.0 111.598 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 57.2 mp0 -94.31 -31.37 14.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.549 -0.719 . . . . 0.0 109.881 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.7 mt -87.12 -3.63 59.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 109.742 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 72' ' ' GLY . 9.0 p -67.51 -44.41 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.066 -1.021 . . . . 0.0 109.642 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.565 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.63 -41.32 99.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -62.79 -53.63 51.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -1.19 . . . . 0.0 110.233 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.454 HD12 HD22 ' A' ' 108' ' ' LEU . 2.0 tt -67.71 -44.5 77.51 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.813 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.51 -30.66 71.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.542 -0.724 . . . . 0.0 109.656 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -32.34 72.53 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -58.99 114.96 10.25 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.42 -0.8 . . . . 0.0 109.705 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.31 149.31 23.04 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.195 1.93 . . . . 0.0 113.186 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.92 -14.65 64.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.3 mt -106.57 120.09 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.599 -0.942 . . . . 0.0 109.345 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -105.15 150.36 38.72 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.593 -0.692 . . . . 0.0 109.668 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.6 149.32 79.4 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.436 2.091 . . . . 0.0 112.324 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.55 142.77 56.41 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.781 0.8 . . . . 0.0 110.502 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -86.52 -4.93 59.25 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.537 ' CG ' ' H ' ' A' ' 86' ' ' MET . 71.1 t60 -93.34 175.06 6.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.316 -0.865 . . . . 0.0 110.447 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 88' ' ' LYS . 79.1 mtm -52.11 -172.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.626 -0.671 . . . . 0.0 111.26 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 56.26 -78.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 86' ' ' MET . 31.5 ttmt 69.76 -46.13 0.59 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.387 0.613 . . . . 0.0 109.786 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -68.98 -44.39 72.98 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.39 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -69.62 -45.52 68.34 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.391 -0.818 . . . . 0.0 110.439 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -112.36 142.34 44.99 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.47 -0.769 . . . . 0.0 110.869 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 mm -132.09 139.88 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.6 m -83.76 129.53 34.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 109.594 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.1 t -115.01 132.01 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.7 tp -87.75 104.02 16.16 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.641 0.734 . . . . 0.0 110.019 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -66.36 -39.48 89.18 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.571 0.7 . . . . 0.0 109.123 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.28 8.08 4.49 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -85.76 -161.39 34.85 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.49 -3.77 12.66 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.958 2.439 . . . . 0.0 111.874 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 100' ' ' LEU . 4.4 mm? -59.6 132.31 53.58 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.926 0.87 . . . . 0.0 110.052 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.98 161.52 38.07 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.11 97.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.807 -0.819 . . . . 0.0 109.514 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -72.04 -35.4 69.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.436 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.23 -42.55 93.27 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.352 -0.843 . . . . 0.0 109.31 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 93.0 mt -64.74 -43.02 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -56.67 -45.16 81.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 109.943 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.3 m -61.43 -43.73 98.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 109.715 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.454 HD22 HD12 ' A' ' 74' ' ' LEU . 95.2 mt -63.97 -40.97 97.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 109.547 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.95 -42.43 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 108.78 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -52.09 -42.87 63.59 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.446 -0.784 . . . . 0.0 108.991 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -62.2 -40.98 97.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 108.969 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 t -64.31 -36.83 85.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 109.358 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' ARG . 80.4 t80 -58.18 -43.09 87.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.543 -0.723 . . . . 0.0 109.52 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -54.29 -45.13 72.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.234 -0.916 . . . . 0.0 109.924 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.7 mp -66.75 -39.28 87.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.18 -0.95 . . . . 0.0 109.782 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.504 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 32.1 p -92.99 7.22 44.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.25 -0.906 . . . . 0.0 109.19 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 113' ' ' PHE . 42.2 ttm180 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.479 -0.763 . . . . 0.0 109.591 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 tpp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.358 0.599 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -101.1 162.84 12.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.435 -0.791 . . . . 0.0 110.17 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -61.53 -43.62 98.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.501 -0.75 . . . . 0.0 109.573 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.8 tp60 -65.9 -42.83 89.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.41 -41.87 96.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 0.0 109.482 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.431 ' CE1' HD13 ' A' ' 62' ' ' ILE . 87.3 t80 -62.26 -46.26 89.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 109.908 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.94 -43.71 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.252 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.01 -41.41 99.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.563 -0.71 . . . . 0.0 109.617 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -68.25 -36.61 79.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.49 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.44 73.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.433 -0.792 . . . . 0.0 110.344 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ASP . 2.8 pt20 -64.49 -37.53 87.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.601 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -61.42 -41.48 97.23 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.893 -1.129 . . . . 0.0 109.948 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -87.4 -33.8 18.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 111.503 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 16' ' ' THR . 88.3 m-85 -105.95 6.98 31.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.129 -0.982 . . . . 0.0 110.732 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 11' ' ' GLN . 2.1 p-10 39.91 29.74 0.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.427 -0.795 . . . . 0.0 109.643 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 14' ' ' TYR . 58.3 m -120.67 131.25 54.48 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.51 0.671 . . . . 0.0 109.915 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -87.35 156.82 53.84 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.556 -0.715 . . . . 0.0 109.374 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.66 133.29 26.66 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.077 1.851 . . . . 0.0 112.392 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -118.36 143.43 46.64 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.454 0.645 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.482 ' CG ' ' O ' ' A' ' 20' ' ' HIS . 20.0 p-80 -146.29 85.8 7.24 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.405 -0.809 . . . . 0.0 109.137 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.74 -10.71 9.41 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.737 2.291 . . . . 0.0 110.346 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -85.96 104.72 15.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.801 0.81 . . . . 0.0 109.647 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -68.08 -34.24 76.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.734 -0.604 . . . . 0.0 109.746 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -75.22 -6.08 47.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.857 . . . . 0.0 109.501 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.76 71.1 30.31 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.425 -0.797 . . . . 0.0 109.002 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.0 -17.59 40.97 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.458 2.106 . . . . 0.0 111.735 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -85.07 -4.41 59.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.386 -0.821 . . . . 0.0 109.328 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.3 m-85 -85.41 148.04 26.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 109.911 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.17 134.32 46.4 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.554 ' CG1' ' HE ' ' A' ' 32' ' ' ARG . 2.9 t -118.21 129.65 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.92 113.33 22.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.797 -0.565 . . . . 0.0 109.523 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.554 ' HE ' ' CG1' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -135.58 159.55 41.27 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.42 -0.8 . . . . 0.0 109.407 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.742 ' N ' ' HE1' ' A' ' 39' ' ' TRP . 0.5 OUTLIER -77.51 153.94 32.95 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.929 0.871 . . . . 0.0 110.516 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.8 p -88.37 -50.53 6.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -96.41 -25.66 15.62 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.326 -0.859 . . . . 0.0 111.247 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -105.07 30.02 5.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.096 -1.002 . . . . 0.0 110.037 -178.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 33' ' ' HIS . 10.4 m-20 -42.48 86.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.572 -0.705 . . . . 0.0 110.522 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.7 tttt -144.58 -29.02 0.48 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.742 ' HE1' ' N ' ' A' ' 33' ' ' HIS . 1.5 p-90 -95.89 159.27 15.06 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.384 -0.823 . . . . 0.0 109.368 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -138.58 126.2 22.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.617 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.75 150.48 31.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.495 -0.753 . . . . 0.0 109.421 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.51 152.85 33.53 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.494 -0.754 . . . . 0.0 109.089 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.51 ' C ' HD23 ' A' ' 43' ' ' LEU . 9.1 tt -119.9 128.18 53.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.592 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 8.0 ptt? -148.21 156.32 42.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 109.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -95.89 114.54 26.27 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.18 147.27 41.2 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.589 . . . . 0.0 109.662 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.1 145.33 98.69 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.545 2.163 . . . . 0.0 112.453 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.17 63.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.602 -0.686 . . . . 0.0 109.904 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.419 ' OE2' ' OD1' ' A' ' 56' ' ' ASP . 96.0 mt-10 -71.23 -19.39 62.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 110.254 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -84.72 -12.24 54.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.015 -1.053 . . . . 0.0 110.271 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 53' ' ' ILE . 5.0 pt -106.79 -0.32 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.287 -0.883 . . . . 0.0 109.245 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.11 -1.16 82.59 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.254 -0.974 . . . . 0.0 110.685 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 51' ' ' ILE . 75.3 mt -81.9 132.17 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.823 -1.398 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -85.44 96.99 9.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.553 -0.717 . . . . 0.0 109.858 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.9 -21.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.419 ' OD1' ' OE2' ' A' ' 49' ' ' GLU . 90.0 m-20 54.36 20.02 2.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.683 -0.893 . . . . 0.0 109.466 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -109.5 159.28 17.18 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.557 0.694 . . . . 0.0 110.082 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -84.38 142.26 30.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.648 -0.658 . . . . 0.0 109.662 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.56 159.18 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.494 -0.754 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.23 136.88 40.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.485 -0.759 . . . . 0.0 109.183 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.23 157.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.538 -0.726 . . . . 0.0 110.162 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.431 HD13 ' CE1' ' A' ' 6' ' ' PHE . 31.8 pt -137.0 145.24 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.48 0.657 . . . . 0.0 109.853 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -81.32 142.9 32.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.387 -0.82 . . . . 0.0 109.985 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -132.85 125.22 29.51 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.624 ' N ' HD13 ' A' ' 64' ' ' LEU . 88.1 tttt -82.02 130.33 35.05 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.394 -0.816 . . . . 0.0 110.414 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.69 163.73 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.456 -0.777 . . . . 0.0 109.609 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HG3' HD22 ' A' ' 115' ' ' LEU . 77.0 mt-30 -85.97 154.77 58.23 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 109.824 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.529 ' O ' HG12 ' A' ' 71' ' ' VAL . 75.9 Cg_exo -46.43 -35.0 15.45 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.511 2.141 . . . . 0.0 112.307 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -89.65 -21.72 22.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.171 -0.955 . . . . 0.0 110.157 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.1 mt -94.74 -6.06 43.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.096 -1.002 . . . . 0.0 109.334 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 68' ' ' PRO . 8.6 p -67.5 -41.46 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.339 -0.851 . . . . 0.0 109.544 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.522 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.43 -39.54 97.84 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.7 t -61.2 -47.23 87.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -1.099 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.483 HD12 HD22 ' A' ' 108' ' ' LEU . 3.2 tt -75.02 -42.16 57.91 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.445 -0.784 . . . . 0.0 109.809 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -69.91 -37.64 76.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.67 -0.644 . . . . 0.0 111.217 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -73.63 -3.41 27.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.922 -1.111 . . . . 0.0 109.762 -178.524 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -83.92 150.75 59.43 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.102 -0.999 . . . . 0.0 109.526 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.58 150.92 75.35 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.65 2.234 . . . . 0.0 113.1 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.96 2.89 79.46 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.0 127.74 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -1.049 . . . . 0.0 109.667 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -121.09 152.56 56.96 Favored Pre-proline 0 N--CA 1.494 1.733 0 CA-C-O 121.239 0.542 . . . . 0.0 109.786 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.423 ' O ' ' OG1' ' A' ' 93' ' ' THR . 43.4 Cg_endo -65.5 154.74 72.34 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.758 2.306 . . . . 0.0 112.322 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' HA ' HG23 ' A' ' 93' ' ' THR . . . -53.2 147.14 10.45 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.379 -0.826 . . . . 0.0 110.464 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 54.9 t80 -85.64 12.86 7.92 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -154.43 -169.54 3.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 0.0 109.811 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.6 mmm -60.41 -176.6 0.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.432 -0.792 . . . . 0.0 110.893 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.444 ' ND2' ' CH2' ' A' ' 91' ' ' TRP . 97.5 m-20 57.46 35.11 25.52 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.781 0.8 . . . . 0.0 109.186 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -63.13 -42.68 99.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.568 -0.708 . . . . 0.0 109.824 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.89 -44.02 81.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.348 -0.845 . . . . 0.0 110.081 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -70.05 -46.68 64.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 110.425 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.444 ' CH2' ' ND2' ' A' ' 87' ' ' ASN . 7.0 m0 -116.67 146.03 43.03 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.547 -0.72 . . . . 0.0 110.246 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.442 HG21 ' CD2' ' A' ' 74' ' ' LEU . 9.4 mm -130.16 146.25 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.426 HG23 ' HA ' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -91.36 137.78 32.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.755 . . . . 0.0 109.249 -179.528 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.7 t -118.05 133.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 tp -84.25 103.74 13.7 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.517 0.675 . . . . 0.0 110.122 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.04 -39.92 87.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.525 -0.734 . . . . 0.0 109.172 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -68.82 -4.8 17.58 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -76.44 -166.34 22.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -79.48 -3.14 12.78 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 123.106 2.538 . . . . 0.0 111.399 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.4 mm? -55.2 125.78 22.06 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.908 0.861 . . . . 0.0 109.912 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.61 161.34 35.12 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.91 95.92 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.642 -0.916 . . . . 0.0 109.173 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mtmm -64.42 -41.96 96.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 109.201 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.56 -43.58 89.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.402 -0.811 . . . . 0.0 109.21 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.22 -43.29 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 109.198 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -58.77 -41.64 87.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.828 . . . . 0.0 109.38 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.6 m -61.19 -43.38 98.98 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 109.229 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.483 HD22 HD12 ' A' ' 74' ' ' LEU . 91.8 mt -64.47 -41.66 96.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 109.592 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.73 -42.97 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.121 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -59.47 -39.41 83.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.383 -0.823 . . . . 0.0 108.989 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -65.19 -37.83 88.56 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.3 t -61.51 -42.12 98.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.845 . . . . 0.0 109.179 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 117' ' ' ARG . 77.4 t80 -61.13 -44.24 97.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.07 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.62 -43.28 99.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 108.83 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.436 HD22 ' HG3' ' A' ' 67' ' ' GLN . 91.4 mt -64.78 -39.98 94.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.561 -0.712 . . . . 0.0 109.372 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.1 p -99.14 14.97 27.47 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 113' ' ' PHE . 9.1 ptm180 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 121.796 0.808 . . . . 0.0 111.414 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.492 ' O ' ' NH2' ' A' ' 3' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.92 163.94 12.15 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.822 0.82 . . . . 0.0 110.24 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 1' ' ' MET . 13.8 mmp_? -59.91 -47.91 83.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.574 -0.704 . . . . 0.0 109.522 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -43.42 -43.15 5.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.558 -0.714 . . . . 0.0 109.962 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.03 -44.91 83.31 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 109.217 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -62.89 -46.03 89.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.35 -0.843 . . . . 0.0 109.635 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.7 mm -64.34 -45.0 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.361 -0.837 . . . . 0.0 109.722 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.08 -41.71 99.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.322 -0.862 . . . . 0.0 110.075 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.458 ' CE1' HG21 ' A' ' 109' ' ' ILE . 33.9 t80 -60.81 -44.56 96.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.531 -0.731 . . . . 0.0 109.988 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.41 84.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.485 -0.759 . . . . 0.0 110.117 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 15' ' ' ASP . 94.9 mt-30 -67.51 -35.92 80.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.844 -1.16 . . . . 0.0 109.603 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -64.9 -43.36 93.12 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.689 -1.257 . . . . 0.0 109.657 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -88.25 -11.84 45.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.378 -0.826 . . . . 0.0 111.346 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.606 ' CE1' ' NE2' ' A' ' 33' ' ' HIS . 91.4 m-85 -139.98 -20.34 0.89 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.837 -1.164 . . . . 0.0 111.139 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 11' ' ' GLN . 72.1 m-20 53.64 30.16 10.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.049 -1.032 . . . . 0.0 109.475 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -103.2 156.21 17.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.353 -0.842 . . . . 0.0 109.33 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -97.37 139.76 21.63 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.342 -0.849 . . . . 0.0 109.615 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -50.34 142.28 29.86 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.825 1.684 . . . . 0.0 112.906 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -125.97 121.68 33.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -89.55 146.44 35.75 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.184 -0.947 . . . . 0.0 109.867 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.32 -81.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.161 1.908 . . . . 0.0 111.561 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -87.2 137.03 32.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.448 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -61.51 -20.1 62.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.392 -0.817 . . . . 0.0 109.733 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -76.7 -5.19 46.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.0 109.629 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -129.8 70.12 81.87 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.469 -0.77 . . . . 0.0 109.286 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.92 -18.14 46.64 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.368 2.045 . . . . 0.0 112.015 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -79.78 -5.05 54.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.62 140.87 29.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.362 -0.836 . . . . 0.0 109.527 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.05 130.78 43.7 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.659 -0.65 . . . . 0.0 109.309 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 78.5 t -128.09 131.44 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -103.17 147.88 26.47 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.539 -0.726 . . . . 0.0 109.574 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -134.24 139.88 46.07 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.48 -0.762 . . . . 0.0 109.749 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.606 ' NE2' ' CE1' ' A' ' 14' ' ' TYR . 30.5 m170 -100.21 131.49 46.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.626 -0.671 . . . . 0.0 109.337 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -87.18 -32.11 19.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 0.0 110.59 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 31.4 p-10 -92.02 -1.6 57.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.092 -1.005 . . . . 0.0 111.491 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' LYS . 44.7 t30 -118.66 29.1 7.92 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.027 -1.046 . . . . 0.0 110.16 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.412 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 98.7 m-20 37.23 -86.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.425 0.631 . . . . 0.0 111.215 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 17.9 ptpt -77.53 157.58 30.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.501 -0.749 . . . . 0.0 110.325 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.432 ' CE3' ' O ' ' A' ' 39' ' ' TRP . 12.0 p-90 -177.44 153.13 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.534 -0.729 . . . . 0.0 109.421 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -149.17 118.8 6.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.58 124.53 5.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -150.91 143.02 24.08 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.75 -1.219 . . . . 0.0 110.235 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.498 HD21 ' OD1' ' A' ' 60' ' ' ASP . 9.5 tt -121.03 125.45 47.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -156.99 162.11 39.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.04 114.89 26.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.582 -0.699 . . . . 0.0 109.157 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.7 pt -121.19 145.5 42.19 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.515 -0.741 . . . . 0.0 109.45 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -45.34 135.86 11.67 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.903 1.735 . . . . 0.0 112.787 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.25 -25.64 65.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.589 -0.695 . . . . 0.0 110.162 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -17.7 63.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.296 -0.877 . . . . 0.0 110.346 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -84.64 -12.84 53.15 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.971 -1.08 . . . . 0.0 110.991 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 pt -102.67 6.35 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.188 -0.945 . . . . 0.0 109.465 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.03 -4.61 67.98 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.682 HD11 ' CZ ' ' A' ' 81' ' ' TYR . 77.2 mt -79.7 135.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.886 -1.361 . . . . 0.0 109.882 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -74.42 92.36 2.32 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.568 -0.707 . . . . 0.0 110.083 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.2 139.63 3.23 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 37.5 p-10 -88.99 4.55 47.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 108.394 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -80.62 152.94 28.27 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.642 -0.661 . . . . 0.0 110.023 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -97.6 150.01 21.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.563 -0.711 . . . . 0.0 109.814 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.33 163.05 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.715 -0.616 . . . . 0.0 109.642 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.498 ' OD1' HD21 ' A' ' 43' ' ' LEU . 8.3 t70 -91.57 128.81 37.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.583 -0.698 . . . . 0.0 109.39 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.83 160.18 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.0 110.348 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.15 150.97 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -84.96 127.27 34.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.466 -0.771 . . . . 0.0 109.975 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.584 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -118.99 121.31 39.61 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.584 ' N ' HD13 ' A' ' 64' ' ' LEU . 37.4 ttmt -82.93 132.2 35.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.855 . . . . 0.0 110.159 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 m -142.5 165.08 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.347 -0.846 . . . . 0.0 108.879 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.476 ' HG3' HD21 ' A' ' 115' ' ' LEU . 33.4 mt-30 -84.71 156.9 61.4 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 108.725 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 71' ' ' VAL . 20.3 Cg_endo -60.66 -22.84 74.26 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.382 2.055 . . . . 0.0 111.405 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -90.48 -29.64 17.81 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.441 -0.787 . . . . 0.0 109.352 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.9 mt -95.2 1.93 54.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.326 -0.859 . . . . 0.0 109.763 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 68' ' ' PRO . 10.0 p -64.33 -34.47 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.0 109.52 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.56 -14.59 67.33 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.453 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 55.9 p -68.27 -60.56 2.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -1.163 . . . . 0.0 111.101 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.629 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.7 pt? -88.24 -23.9 23.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.796 -1.19 . . . . 0.0 110.934 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.445 HH21 ' NZ ' ' A' ' 88' ' ' LYS . 78.9 ttt-85 -65.76 -22.8 66.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 110.097 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.453 ' CD ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -94.28 -9.34 36.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.205 -0.934 . . . . 0.0 108.833 179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -73.81 151.28 88.81 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.097 -1.002 . . . . 0.0 109.357 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.09 143.34 71.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.612 2.208 . . . . 0.0 112.53 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.15 -5.26 63.54 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.9 mm -98.41 125.18 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -1.157 . . . . 0.0 109.174 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.682 ' CZ ' HD11 ' A' ' 53' ' ' ILE . 77.3 m-85 -119.87 147.91 45.29 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.733 -0.604 . . . . 0.0 109.598 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HB3' ' HZ1' ' A' ' 88' ' ' LYS . 52.0 Cg_endo -69.95 153.68 67.8 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.054 1.836 . . . . 0.0 111.837 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.68 50.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 109.834 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 85' ' ' HIS . 32.1 p90 -66.2 179.31 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.261 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.509 ' CG ' ' O ' ' A' ' 85' ' ' HIS . 54.5 p-80 -40.85 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.471 0.653 . . . . 0.0 110.545 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.1 ttm -167.67 -78.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.526 -0.734 . . . . 0.0 109.193 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.622 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 98.9 m-20 -139.92 -31.84 0.64 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.445 ' NZ ' HH21 ' A' ' 75' ' ' ARG . 49.9 tttp 58.77 -68.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.238 0.542 . . . . 0.0 111.417 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 87' ' ' ASN . 74.2 mt-10 -60.92 -52.21 66.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.868 . . . . 0.0 112.001 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -66.54 -46.77 75.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.935 -1.103 . . . . 0.0 111.251 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.622 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 8.9 m0 -115.51 140.99 48.66 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.439 -0.788 . . . . 0.0 110.317 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mm -128.87 138.41 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 p -86.84 133.35 33.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.876 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.9 t -112.91 132.58 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.3 tp -87.02 104.07 15.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.518 0.675 . . . . 0.0 110.488 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.64 -39.75 84.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.567 -0.708 . . . . 0.0 109.482 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.87 1.78 6.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.529 -0.732 . . . . 0.0 109.386 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.83 -162.47 30.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.44 -3.39 11.4 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.892 2.394 . . . . 0.0 111.242 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -49.6 126.63 13.99 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.618 0.723 . . . . 0.0 110.0 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.21 169.29 34.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.84 94.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -1.133 . . . . 0.0 109.232 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -64.85 -42.02 95.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.692 . . . . 0.0 109.612 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.74 -42.69 94.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.28 -43.3 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -56.94 -43.84 81.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.387 -0.82 . . . . 0.0 109.564 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.3 m -61.16 -43.99 98.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.897 . . . . 0.0 109.654 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.87 -42.46 97.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.201 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.458 HG21 ' CE1' ' A' ' 9' ' ' TYR . 97.0 mt -63.8 -42.78 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 108.652 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -53.07 -40.9 64.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.475 -0.766 . . . . 0.0 108.936 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.64 -39.61 94.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 108.702 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 t -65.02 -40.34 94.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.836 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -57.99 -48.97 78.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.417 -0.802 . . . . 0.0 110.076 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -67.75 -32.12 72.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.087 -1.008 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.476 HD21 ' HG3' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -61.88 -41.12 97.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.7 p -90.78 14.93 12.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.49 -0.756 . . . . 0.0 109.395 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.467 -0.771 . . . . 0.0 110.319 -179.533 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -104.56 156.23 18.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.458 -0.776 . . . . 0.0 110.001 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.493 ' NH1' ' OD2' ' A' ' 45' ' ' ASP . 61.6 ttp180 -61.29 -42.9 99.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.54 -0.725 . . . . 0.0 109.336 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.56 -39.77 95.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.368 -0.832 . . . . 0.0 109.773 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -62.75 -42.44 99.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.013 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.404 ' CD1' HD12 ' A' ' 43' ' ' LEU . 60.2 t80 -61.08 -45.55 94.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.526 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.35 -44.51 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.487 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.12 -45.79 90.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.185 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -62.61 -43.19 99.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.782 . . . . 0.0 109.258 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.94 97.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.414 -0.803 . . . . 0.0 110.002 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 81.0 mt-30 -65.65 -45.0 84.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 110.123 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.37 -35.8 80.27 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.09 -1.006 . . . . 0.0 109.514 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -85.07 -37.24 20.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.398 -0.814 . . . . 0.0 111.686 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.543 ' CZ ' ' CE2' ' A' ' 39' ' ' TRP . 93.2 m-85 -114.55 6.63 15.88 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.015 -1.053 . . . . 0.0 111.698 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 2.4 p-10 39.04 29.12 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.162 -0.961 . . . . 0.0 110.434 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 14' ' ' TYR . 33.0 m -109.94 126.17 53.61 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 109.147 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 157.68 63.21 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.0 109.221 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.59 135.74 33.79 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.842 1.695 . . . . 0.0 112.316 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.433 ' C ' ' CD2' ' A' ' 20' ' ' HIS . 97.1 m-20 -118.27 140.22 50.14 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 20' ' ' HIS . 2.1 m-70 -136.99 85.43 22.76 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.365 -0.834 . . . . 0.0 109.165 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -54.83 -40.31 85.75 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.241 1.961 . . . . 0.0 111.626 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -91.92 130.7 37.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.677 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -84.44 -17.13 40.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.468 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -81.78 -5.16 57.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 109.391 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -128.81 62.04 59.18 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.57 -0.706 . . . . 0.0 109.405 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.93 -19.38 52.29 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.348 2.032 . . . . 0.0 111.828 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.35 -5.11 57.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.116 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.475 ' O ' ' ND1' ' A' ' 20' ' ' HIS . 21.8 m-85 -99.27 134.01 42.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.472 -0.768 . . . . 0.0 109.602 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.72 132.94 54.9 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.61 127.46 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -112.77 122.78 48.67 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.367 0.603 . . . . 0.0 109.862 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -151.57 143.98 24.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 109.106 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.82 124.11 42.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.266 -0.896 . . . . 0.0 109.769 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -80.0 -12.08 59.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.516 -0.74 . . . . 0.0 109.811 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -62.88 -45.23 93.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.095 -1.003 . . . . 0.0 110.528 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 54.3 p30 -123.6 -13.15 7.58 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.29 -0.881 . . . . 0.0 109.919 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 36' ' ' ASN . 45.8 t0 59.24 5.05 0.53 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.446 -0.784 . . . . 0.0 109.799 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 36' ' ' ASN . 28.6 mmtp -94.21 -8.95 37.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.055 -1.028 . . . . 0.0 109.086 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.543 ' CE2' ' CZ ' ' A' ' 14' ' ' TYR . 63.0 t-105 -90.35 108.36 19.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.461 -0.775 . . . . 0.0 109.298 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -107.88 128.62 54.78 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.554 -0.716 . . . . 0.0 109.171 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.33 123.92 8.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.495 -0.753 . . . . 0.0 108.98 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.8 tp -124.34 130.36 52.35 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.64 -0.663 . . . . 0.0 109.274 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 43' ' ' LEU . 9.4 tt -126.82 128.38 46.47 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.412 ' N ' HD23 ' A' ' 43' ' ' LEU . 6.2 ptt? -160.39 162.78 33.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 110.025 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.493 ' OD2' ' NH1' ' A' ' 3' ' ' ARG . 99.3 m-20 -100.28 117.37 34.35 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.7 pt -134.44 145.57 55.75 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.85 151.32 85.7 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.538 2.158 . . . . 0.0 112.917 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.82 64.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.593 -0.692 . . . . 0.0 109.761 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -66.22 -17.94 65.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.121 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -84.28 -14.67 49.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.064 -1.023 . . . . 0.0 111.253 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.64 10.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.174 -0.954 . . . . 0.0 109.885 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.34 -9.26 72.08 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.105 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.5 mt -79.96 135.12 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.802 -1.41 . . . . 0.0 109.722 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -74.61 95.67 2.85 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.14 133.52 1.75 Allowed Glycine 0 N--CA 1.482 1.717 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -91.1 11.72 22.23 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -64.96 157.63 27.64 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.1 mtp85 -100.35 135.98 40.95 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.3 m -137.55 157.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.418 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 96.6 m-20 -99.07 140.3 33.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.95 151.01 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.399 -0.813 . . . . 0.0 110.109 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 pt -131.32 161.07 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 66.8 t0 -133.73 140.76 47.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.236 -0.915 . . . . 0.0 109.732 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.519 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -132.9 159.19 40.62 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.444 0.64 . . . . 0.0 109.336 -179.718 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -88.36 138.93 31.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.491 -0.755 . . . . 0.0 110.629 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.1 161.92 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.56 -0.712 . . . . 0.0 109.298 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HG3' HD22 ' A' ' 115' ' ' LEU . 29.4 mt-30 -80.72 157.96 71.38 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.411 -0.805 . . . . 0.0 109.344 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.492 ' O ' HG12 ' A' ' 71' ' ' VAL . 29.3 Cg_endo -61.92 -23.85 76.35 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.532 2.155 . . . . 0.0 111.592 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -88.88 -30.81 18.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.279 -0.888 . . . . 0.0 109.574 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.5 mt -93.13 -0.16 57.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -0.84 . . . . 0.0 109.415 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 68' ' ' PRO . 11.3 p -63.95 -31.54 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.464 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.51 -15.44 78.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 p -69.01 -54.32 15.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 110.527 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.701 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.2 pt? -85.38 -28.04 25.43 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.0 -1.062 . . . . 0.0 110.499 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.3 ttt-85 -69.51 -21.96 63.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.192 -0.942 . . . . 0.0 110.585 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.25 -7.94 52.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.939 -1.101 . . . . 0.0 109.502 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -82.22 150.26 63.96 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.894 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.05 144.32 63.29 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.549 2.166 . . . . 0.0 112.293 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.78 -16.36 54.81 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.72 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.0 mp -90.16 127.14 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.044 -1.268 . . . . 0.0 108.905 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -115.55 126.16 28.03 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.394 -0.816 . . . . 0.0 110.212 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -52.28 146.51 31.47 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.41 1.406 . . . . 0.0 111.79 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.24 140.26 57.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.375 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -98.03 1.45 47.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.384 -0.823 . . . . 0.0 108.933 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -65.77 -176.91 0.41 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.458 -0.776 . . . . 0.0 110.374 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 74.4 mtm -64.29 -41.17 97.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.531 -0.731 . . . . 0.0 109.938 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -97.62 138.02 35.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.263 -0.898 . . . . 0.0 109.784 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -141.32 70.27 1.34 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.409 -0.807 . . . . 0.0 109.342 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -143.83 -54.29 0.36 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.46 -0.775 . . . . 0.0 109.07 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -99.31 -15.68 18.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -108.26 122.41 46.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.368 -0.833 . . . . 0.0 110.011 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.7 mm -125.9 137.04 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.5 m -95.01 144.22 25.86 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -120.59 136.67 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.1 tp -87.22 113.63 23.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.975 . . . . 0.0 110.276 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 98' ' ' GLY . 12.8 mt -64.62 -40.72 95.97 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -70.78 4.29 2.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.416 -0.802 . . . . 0.0 109.063 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -68.06 171.99 34.44 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.96 -4.97 15.5 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 123.445 2.763 . . . . 0.0 112.327 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.487 ' H ' HD23 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -72.14 150.06 44.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.144 -179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.09 171.53 42.62 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 120.489 -0.863 . . . . 0.0 111.04 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.42 83.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.95 . . . . 0.0 109.715 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.9 pttm -61.11 -36.32 79.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.219 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -65.87 -38.84 89.86 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.415 -0.803 . . . . 0.0 109.126 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.92 -44.18 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -58.94 -42.54 90.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.388 -0.82 . . . . 0.0 109.786 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.7 m -60.71 -45.09 95.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 110.172 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.78 -44.1 94.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.752 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.03 -43.12 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.501 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -51.9 -42.06 62.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 108.875 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.37 -43.92 97.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.226 -0.921 . . . . 0.0 109.061 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 t -63.67 -41.76 98.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.0 110.69 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -58.96 -45.3 90.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.257 -0.902 . . . . 0.0 110.893 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -60.8 -38.83 86.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.028 -1.045 . . . . 0.0 110.418 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.433 HD22 ' HG3' ' A' ' 67' ' ' GLN . 96.7 mt -63.01 -40.71 98.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.695 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.4 p -93.78 14.32 19.67 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.437 -0.789 . . . . 0.0 109.693 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.7 ttm . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.509 0.671 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -93.48 166.05 12.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.361 -0.837 . . . . 0.0 110.727 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -63.22 -42.76 99.31 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.348 0.594 . . . . 0.0 109.76 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -65.48 -39.45 91.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.3 -0.875 . . . . 0.0 109.673 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.02 -38.75 92.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.327 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.75 -45.53 93.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -0.815 . . . . 0.0 109.439 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.59 -43.77 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.409 -0.807 . . . . 0.0 109.412 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.14 -41.61 97.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.446 -0.784 . . . . 0.0 109.794 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -62.2 -42.66 99.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.415 -0.803 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.38 82.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.432 -0.793 . . . . 0.0 109.719 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 15' ' ' ASP . 88.6 mt-30 -63.45 -48.42 77.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.062 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -64.48 -37.45 87.59 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.721 -1.237 . . . . 0.0 109.466 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -68.79 -46.3 69.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.522 -0.736 . . . . 0.0 111.942 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.17 -20.43 4.13 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.0 110.677 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 25.4 t0 65.31 42.1 4.07 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.266 -0.896 . . . . 0.0 108.855 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.7 m -104.19 133.35 49.27 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.609 0.718 . . . . 0.0 109.595 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -83.75 151.4 61.23 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.725 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.21 153.55 71.3 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.818 2.345 . . . . 0.0 112.533 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 61.6 t0 -140.76 138.92 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 108.96 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.467 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 9.8 p80 -132.64 86.94 42.99 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.505 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -54.54 -37.92 90.28 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.502 2.135 . . . . 0.0 110.653 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -87.51 82.06 7.59 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -55.2 -14.45 1.71 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -65.18 -2.33 2.84 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.503 -0.748 . . . . 0.0 109.073 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -147.95 76.15 10.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.394 -0.817 . . . . 0.0 109.325 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.08 -19.22 65.61 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.635 2.224 . . . . 0.0 110.764 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 12.5 p-10 -81.19 -2.48 48.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -100.38 139.48 36.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.435 -0.791 . . . . 0.0 109.255 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.0 128.17 45.94 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -113.66 124.51 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.657 -0.652 . . . . 0.0 109.561 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.88 136.5 51.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.688 -0.632 . . . . 0.0 109.295 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -157.18 139.37 14.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -101.0 126.65 47.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.528 -0.733 . . . . 0.0 109.635 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 m -80.79 -10.62 59.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.473 -0.767 . . . . 0.0 109.168 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -64.03 -40.84 97.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.396 -0.815 . . . . 0.0 109.95 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 38' ' ' LYS . 2.1 m120 -113.16 -24.6 9.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.324 -0.86 . . . . 0.0 109.252 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.8 t0 63.36 -8.88 0.13 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.589 -0.694 . . . . 0.0 109.855 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 36' ' ' ASN . 64.5 mttp -97.64 -6.29 33.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.205 -0.934 . . . . 0.0 108.863 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.501 ' CE3' HG21 ' A' ' 116' ' ' THR . 15.0 t-105 -84.82 109.88 18.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 109.683 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -109.3 125.92 52.82 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB2' ' HE1' ' A' ' 39' ' ' TRP . . . -138.82 136.72 35.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.5 tp -145.1 122.95 11.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.647 ' C ' HD23 ' A' ' 43' ' ' LEU . 7.4 tt -120.23 124.48 45.78 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.558 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.68 164.76 26.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 0.0 109.689 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 88.9 m-20 -96.42 114.05 25.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.565 -0.71 . . . . 0.0 109.721 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.469 HG23 ' SD ' ' A' ' 44' ' ' MET . 16.2 pt -116.83 144.99 34.48 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -48.78 141.38 21.19 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.985 1.79 . . . . 0.0 112.421 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -63.08 -21.09 65.94 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.382 0.61 . . . . 0.0 109.972 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.29 -13.99 59.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.123 -0.986 . . . . 0.0 109.608 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -84.32 -10.85 57.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.412 ' CD1' HD12 ' A' ' 53' ' ' ILE . 11.3 pt -103.19 1.73 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.301 -0.874 . . . . 0.0 109.345 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.43 -14.39 59.43 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.565 ' C ' ' H ' ' A' ' 55' ' ' GLY . 76.4 mt -78.55 130.55 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.956 -1.32 . . . . 0.0 109.498 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -63.28 14.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.585 -0.697 . . . . 0.0 110.539 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -86.11 140.78 17.96 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -101.27 5.77 42.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.503 -0.998 . . . . 0.0 109.628 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 88.4 tttt -88.44 144.81 26.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -71.73 145.8 48.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.63 -0.669 . . . . 0.0 110.359 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.46 157.46 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.528 -0.732 . . . . 0.0 109.633 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 12.9 m-20 -93.81 131.63 39.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.495 -0.753 . . . . 0.0 109.355 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.95 156.89 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.42 -0.8 . . . . 0.0 110.292 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 pt -134.96 149.88 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.474 0.654 . . . . 0.0 109.739 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -81.68 146.64 29.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.11 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.657 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -132.95 127.08 33.46 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.657 ' N ' HD13 ' A' ' 64' ' ' LEU . 63.1 tttp -82.21 131.69 35.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.556 -0.715 . . . . 0.0 110.147 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.37 161.32 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 109.677 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -85.62 158.71 56.64 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 71' ' ' VAL . 19.2 Cg_endo -59.87 -19.79 56.44 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.61 2.207 . . . . 0.0 111.544 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -95.88 -28.24 14.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.346 -0.846 . . . . 0.0 109.116 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.04 -2.56 56.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.415 -0.803 . . . . 0.0 109.493 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 72' ' ' GLY . 7.1 p -63.7 -41.08 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.946 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.475 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.12 -40.66 99.44 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.7 m -62.13 -36.03 80.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.208 -1.172 . . . . 0.0 110.419 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.526 ' CD2' HG21 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -77.98 -39.07 43.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.079 . . . . 0.0 111.011 -179.254 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.575 HH21 ' CD1' ' A' ' 92' ' ' ILE . 95.9 mtt180 -76.71 -6.54 52.57 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.069 -1.019 . . . . 0.0 110.125 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -11.41 58.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.084 -1.01 . . . . 0.0 109.171 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -90.83 148.07 37.46 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 109.266 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' HD21 ' A' ' 100' ' ' LEU . 56.2 Cg_endo -69.07 144.73 58.74 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.716 2.278 . . . . 0.0 113.09 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.15 -5.0 85.92 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.81 122.87 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -1.109 . . . . 0.0 109.782 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -124.6 145.52 49.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.26 150.08 81.45 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.454 2.103 . . . . 0.0 112.387 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.1 138.88 58.06 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.708 0.766 . . . . 0.0 110.257 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 13.0 p90 -95.32 1.02 54.27 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 86' ' ' MET . 8.9 m170 -148.47 159.36 44.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.112 -0.993 . . . . 0.0 110.793 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.443 ' O ' ' O ' ' A' ' 87' ' ' ASN . 79.5 mtp 48.61 105.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.892 0.853 . . . . 0.0 111.023 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 86' ' ' MET . 99.2 m-20 44.01 -171.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.642 0.734 . . . . 0.0 110.751 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -144.92 -57.78 0.35 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.49 -0.756 . . . . 0.0 109.308 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.0 -37.75 84.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.212 -0.93 . . . . 0.0 109.125 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -57.01 -67.13 0.34 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.44 -0.788 . . . . 0.0 109.801 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -105.04 144.53 31.71 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.525 0.679 . . . . 0.0 110.094 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.575 ' CD1' HH21 ' A' ' 75' ' ' ARG . 7.1 mm -130.54 144.07 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.8 m -87.48 131.18 34.43 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.394 -0.816 . . . . 0.0 109.82 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.1 t -118.52 132.39 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.5 tp -87.9 101.98 14.26 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.622 0.725 . . . . 0.0 110.24 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 98' ' ' GLY . 84.1 mt -66.04 -40.39 90.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -71.96 5.49 2.63 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -84.63 -166.33 41.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.8 7.86 4.34 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.023 2.482 . . . . 0.0 111.611 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.3 mm? -62.24 130.55 45.9 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.973 0.892 . . . . 0.0 110.578 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.5 158.43 31.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.463 ' O ' ' ND1' ' A' ' 106' ' ' HIS . . . -60.16 -47.02 87.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.695 -0.885 . . . . 0.0 109.552 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -65.18 -40.52 94.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.511 -0.743 . . . . 0.0 109.447 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.0 -44.89 96.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.509 -0.744 . . . . 0.0 109.522 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.43 -43.32 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.554 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 102' ' ' ALA . 31.8 m80 -58.74 -42.62 89.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.368 -0.833 . . . . 0.0 109.888 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.9 m -61.43 -43.6 98.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.54 -40.7 96.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.454 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.92 -43.2 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.215 -0.928 . . . . 0.0 109.337 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -60.48 -37.8 82.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.66 -42.04 99.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.493 -0.754 . . . . 0.0 108.987 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 116' ' ' THR . 96.6 p -62.61 -36.24 82.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.363 -0.836 . . . . 0.0 109.155 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.69 -45.21 95.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.385 -0.822 . . . . 0.0 109.594 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -65.65 -27.63 68.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.009 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.2 mt -82.37 -13.15 57.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.536 -0.727 . . . . 0.0 109.317 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 112' ' ' SER . 79.4 p -110.64 14.66 22.32 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.863 0.84 . . . . 0.0 110.308 -179.322 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.6 ttp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.155 0.503 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -94.96 155.64 16.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.176 -0.952 . . . . 0.0 110.373 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.512 ' NH2' ' OD1' ' A' ' 45' ' ' ASP . 40.8 ttm180 -62.09 -42.63 99.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.549 -0.719 . . . . 0.0 109.546 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -53.99 -42.32 68.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 109.817 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.65 -35.54 80.4 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.129 -0.982 . . . . 0.0 109.49 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -60.89 -44.65 96.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.123 -0.985 . . . . 0.0 109.161 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.9 mm -64.0 -44.66 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.288 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.15 -41.13 99.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.519 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -60.32 -49.86 75.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.3 -35.25 75.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 17.4 tt0 -59.34 -49.91 76.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.385 -0.822 . . . . 0.0 110.28 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -64.26 -40.21 95.51 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.637 -1.289 . . . . 0.0 109.465 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -68.34 -44.29 75.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 112.259 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 113' ' ' PHE . 97.0 m-85 -127.64 -18.49 4.34 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.993 -1.067 . . . . 0.0 110.902 -178.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 24.9 t0 63.68 45.81 4.39 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.0 . . . . 0.0 109.084 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.0 m -113.72 127.9 56.21 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -83.95 155.19 64.51 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.12 -0.987 . . . . 0.0 109.759 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.55 140.54 64.79 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.77 1.647 . . . . 0.0 112.607 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -116.28 121.31 41.63 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 20' ' ' HIS . 11.8 m-70 -114.87 85.32 11.61 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.499 -0.751 . . . . 0.0 109.19 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.43 -12.82 16.91 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.928 1.752 . . . . 0.0 110.878 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -100.7 93.97 5.85 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -63.34 -17.57 62.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 0.0 109.848 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -83.87 -3.07 57.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.681 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -143.43 69.35 17.5 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.128 -0.983 . . . . 0.0 109.792 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.98 -29.53 89.55 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.55 2.167 . . . . 0.0 111.191 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.91 -6.94 45.53 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.429 -0.795 . . . . 0.0 109.366 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -102.72 135.41 44.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.457 -0.777 . . . . 0.0 109.13 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -123.35 146.78 47.67 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.6 t -125.62 130.49 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.559 -0.713 . . . . 0.0 109.209 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.48 112.03 22.91 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.69 -0.631 . . . . 0.0 109.319 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -134.24 138.45 45.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.306 -0.871 . . . . 0.0 108.665 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.594 ' ND1' ' CD1' ' A' ' 39' ' ' TRP . 35.9 m170 -100.87 118.2 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -0.852 . . . . 0.0 109.765 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.1 m -63.28 -36.73 84.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.351 -0.843 . . . . 0.0 109.342 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.03 -43.42 98.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 110.134 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 38' ' ' LYS . 15.9 m120 -91.99 5.45 50.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.067 -1.021 . . . . 0.0 108.882 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' LYS . 66.9 t0 51.25 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.778 -0.576 . . . . 0.0 110.712 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' ASN . 60.3 mttp -55.88 -110.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 110.582 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.594 ' CD1' ' ND1' ' A' ' 33' ' ' HIS . 48.5 t-105 40.8 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.756 -0.59 . . . . 0.0 109.831 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -107.97 125.77 51.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.459 -0.776 . . . . 0.0 109.325 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.89 128.25 10.61 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.95 146.0 40.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 109.388 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 tt -116.84 128.26 55.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -152.08 163.17 39.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.994 . . . . 0.0 109.392 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.512 ' OD1' ' NH2' ' A' ' 3' ' ' ARG . 98.5 m-20 -98.89 136.56 38.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -0.795 . . . . 0.0 108.858 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -139.95 145.73 43.68 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.208 -0.932 . . . . 0.0 109.767 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.17 135.73 30.65 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.844 1.696 . . . . 0.0 113.089 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 57' ' ' LYS . . . -65.83 -29.52 70.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 109.902 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 55' ' ' GLY . 15.7 pt-20 -55.57 -29.89 59.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.076 -1.015 . . . . 0.0 110.22 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -63.79 -34.94 79.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.977 -1.077 . . . . 0.0 110.322 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 53' ' ' ILE . 4.6 pt -96.41 -1.55 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.16 -0.963 . . . . 0.0 109.708 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.96 34.75 32.92 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.874 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 51' ' ' ILE . 35.0 mt -110.16 136.51 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.349 -1.089 . . . . 0.0 110.059 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.401 ' C ' ' OD1' ' A' ' 54' ' ' ASN . 49.1 t-20 43.03 -89.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.396 0.617 . . . . 0.0 110.252 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . -158.73 -110.87 0.29 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -108.76 47.82 0.89 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.628 -0.925 . . . . 0.0 109.517 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 88.1 tttt -91.8 129.67 37.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.224 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -71.87 136.4 46.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.58 164.22 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.346 -0.846 . . . . 0.0 109.233 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.437 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 83.4 m-20 -92.01 134.34 34.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.189 -0.945 . . . . 0.0 110.04 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -137.02 158.93 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.234 -0.916 . . . . 0.0 109.69 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.3 pt -135.04 146.74 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -110.59 140.15 45.17 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.553 -0.717 . . . . 0.0 109.621 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.27 164.28 28.45 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 132.08 52.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.483 -0.761 . . . . 0.0 109.877 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.22 162.78 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.342 -0.848 . . . . 0.0 110.144 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -72.03 133.96 83.51 Favored Pre-proline 0 C--N 1.298 -1.643 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.46 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.607 ' O ' HG12 ' A' ' 71' ' ' VAL . 71.1 Cg_exo -44.69 -38.18 12.27 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.962 1.775 . . . . 0.0 112.302 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.43 -32.21 66.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.054 -1.029 . . . . 0.0 110.442 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.7 mt -92.1 5.02 51.86 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.085 -1.01 . . . . 0.0 110.111 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 68' ' ' PRO . 12.7 p -61.47 -28.21 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.047 -1.033 . . . . 0.0 109.015 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.461 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -58.46 -39.46 93.0 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -59.5 -41.11 89.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.15 -1.206 . . . . 0.0 109.668 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 2.5 mm? -68.99 -44.9 71.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 110.781 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -78.2 -36.92 46.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.0 111.299 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.461 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -72.98 -1.72 18.2 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.066 -1.053 . . . . 0.0 109.654 -178.791 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.403 ' CB ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -96.49 139.99 21.96 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 109.157 179.47 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.99 143.69 45.56 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.124 1.883 . . . . 0.0 112.969 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.09 -17.42 56.98 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 80' ' ' ILE . 3.7 mp -93.92 127.44 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -1.178 . . . . 0.0 109.401 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -114.35 133.55 22.43 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.699 -0.625 . . . . 0.0 110.133 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -54.32 149.26 38.11 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.278 1.319 . . . . 0.0 111.352 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.23 143.42 55.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.832 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -92.45 21.96 4.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 109.404 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' MET . 7.5 p80 -148.0 167.89 23.73 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.017 -1.052 . . . . 0.0 110.409 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' HIS . 65.5 mtt -43.68 173.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.539 0.685 . . . . 0.0 111.497 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 57.83 34.12 24.01 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.618 0.723 . . . . 0.0 109.459 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.7 -43.0 99.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.458 -0.776 . . . . 0.0 109.832 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.05 -44.52 84.34 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.102 -0.999 . . . . 0.0 109.858 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -68.78 -46.7 68.05 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.114 -0.991 . . . . 0.0 110.857 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -115.7 145.78 42.45 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.419 -0.801 . . . . 0.0 110.291 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.502 HD11 HG23 ' A' ' 71' ' ' VAL . 8.0 mm -130.61 152.32 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.9 m -101.92 135.49 43.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.406 -0.809 . . . . 0.0 109.508 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.37 136.41 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 63.2 tp -90.66 116.26 28.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 110.085 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 mt -65.96 -40.22 91.12 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -72.28 3.58 4.52 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -56.56 164.94 5.22 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.74 -8.5 18.07 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.109 2.539 . . . . 0.0 111.576 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -75.93 162.29 28.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.217 -0.927 . . . . 0.0 110.66 -178.472 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.58 163.59 50.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.47 80.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.509 -0.995 . . . . 0.0 109.089 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.11 -39.55 92.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -0.858 . . . . 0.0 109.419 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -62.48 -42.12 99.27 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.114 -0.991 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.58 -43.89 96.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.213 -0.93 . . . . 0.0 109.354 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -66.03 -38.51 88.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.297 -0.877 . . . . 0.0 109.577 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.7 m -59.48 -44.57 93.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.116 -0.99 . . . . 0.0 109.809 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.37 -42.13 96.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 109.261 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.61 -42.94 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.061 -1.024 . . . . 0.0 109.058 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -53.09 -40.63 64.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.225 -0.922 . . . . 0.0 108.637 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.75 -40.89 98.66 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.3 -0.875 . . . . 0.0 108.724 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -60.2 -38.91 84.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.454 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 14' ' ' TYR . 74.8 t80 -61.39 -43.52 98.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.68 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -47.81 -39.55 18.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.194 -0.941 . . . . 0.0 109.68 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.9 mp -65.01 -39.19 93.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 109.684 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.5 p -90.94 9.68 29.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.149 -0.969 . . . . 0.0 109.172 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.864 -179.541 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.41 ' H1 ' HD12 ' A' ' 105' ' ' ILE . 21.4 ptp . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.271 0.558 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -94.17 165.45 12.6 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.411 -0.806 . . . . 0.0 109.993 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 42.6 ttm180 -62.31 -44.72 95.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.506 -0.746 . . . . 0.0 109.433 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -63.68 -39.72 95.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.843 . . . . 0.0 109.095 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -63.63 -37.26 86.67 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.399 -0.813 . . . . 0.0 109.264 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.436 ' CD2' HD12 ' A' ' 43' ' ' LEU . 63.4 t80 -60.63 -46.94 88.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.488 -0.757 . . . . 0.0 109.74 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.59 -45.41 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.262 -0.899 . . . . 0.0 108.605 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -62.32 -41.8 98.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 0.0 109.558 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.72 -49.6 76.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.201 -0.937 . . . . 0.0 109.074 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.25 -36.1 78.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.729 . . . . 0.0 109.608 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -61.8 -42.6 99.21 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.501 -0.75 . . . . 0.0 110.006 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -83.98 -20.87 32.1 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.096 -1.003 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.4 tptt -87.2 -51.31 6.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.256 -0.902 . . . . 0.0 111.321 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -118.05 -15.05 9.94 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.204 -0.935 . . . . 0.0 110.312 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.0 t0 58.11 41.71 23.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.359 -0.838 . . . . 0.0 109.933 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.6 m -99.85 134.22 43.07 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.174 -0.954 . . . . 0.0 108.704 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -84.4 132.69 46.48 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.031 -1.043 . . . . 0.0 109.244 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.86 151.07 56.54 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.832 1.688 . . . . 0.0 112.295 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -132.94 149.26 52.26 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.542 -0.724 . . . . 0.0 109.352 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.49 ' CG ' ' O ' ' A' ' 20' ' ' HIS . 13.9 p-80 -132.6 85.38 47.89 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.39 -0.819 . . . . 0.0 109.222 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -55.7 -37.05 95.9 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.312 2.008 . . . . 0.0 111.233 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -79.76 98.67 7.11 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.651 0.739 . . . . 0.0 109.43 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.95 -23.32 65.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.438 -0.789 . . . . 0.0 109.744 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -74.49 -3.9 33.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.675 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -145.16 76.56 13.41 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.23 -0.918 . . . . 0.0 109.705 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.77 -20.0 63.94 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.617 2.211 . . . . 0.0 110.768 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 12.8 p-10 -76.5 -2.4 32.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.722 -0.611 . . . . 0.0 109.65 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 6.6 m-85 -99.54 134.87 41.78 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.45 129.86 29.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.288 -0.882 . . . . 0.0 109.405 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.78 128.37 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.682 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 73.5 m-85 -100.34 124.06 45.34 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.366 -0.834 . . . . 0.0 109.849 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.7 mtm-85 -137.02 135.68 37.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.297 -0.877 . . . . 0.0 109.284 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.98 112.77 25.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.458 -0.776 . . . . 0.0 109.725 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.2 t -69.72 -26.56 64.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.437 -0.79 . . . . 0.0 109.406 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -64.25 -39.34 93.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.51 -0.744 . . . . 0.0 109.559 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.71 -11.03 22.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.323 -0.86 . . . . 0.0 108.887 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 61.41 38.41 16.07 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.426 0.631 . . . . 0.0 109.626 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 39' ' ' TRP . 17.8 ptmt -167.65 -120.33 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.453 -0.779 . . . . 0.0 109.55 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.41 ' N ' ' HG3' ' A' ' 38' ' ' LYS . 62.6 t-105 56.16 91.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.489 -0.757 . . . . 0.0 109.318 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -105.21 126.64 52.31 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.945 0.879 . . . . 0.0 110.041 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . . . -149.5 146.71 27.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.4 tp -140.53 120.55 13.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.951 -1.093 . . . . 0.0 110.268 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.1 tt -113.08 126.43 55.47 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.51 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.3 ptt? -153.27 165.18 36.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.997 -1.064 . . . . 0.0 109.843 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 92.9 m-20 -97.03 116.17 28.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 pt -127.55 145.55 55.1 Favored Pre-proline 0 N--CA 1.504 2.257 0 O-C-N 121.385 -0.822 . . . . 0.0 109.368 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.31 145.53 88.59 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.095 1.864 . . . . 0.0 112.116 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.43 -21.78 66.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.613 -0.679 . . . . 0.0 109.998 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 56' ' ' ASP . 9.8 pt-20 -56.62 -20.42 21.11 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 110.232 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.81 -13.0 59.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.107 -0.995 . . . . 0.0 110.705 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 53' ' ' ILE . 7.7 pt -116.43 -5.7 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.302 -0.874 . . . . 0.0 109.79 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.22 -2.29 81.05 Favored Glycine 0 N--CA 1.499 2.874 0 O-C-N 121.184 -0.947 . . . . 0.0 111.12 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 51' ' ' ILE . 39.3 mt -79.36 146.51 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.902 -1.352 . . . . 0.0 110.066 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 53' ' ' ILE . 18.2 m120 37.16 -88.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.493 0.664 . . . . 0.0 110.603 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . 143.94 116.43 1.11 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' H ' ' HB3' ' A' ' 49' ' ' GLU . 47.3 t0 60.26 41.44 16.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.946 . . . . 0.0 110.569 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -112.42 124.76 53.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.41 -0.806 . . . . 0.0 108.988 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -71.27 127.84 33.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 109.953 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 m -137.97 161.06 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.338 -0.851 . . . . 0.0 109.017 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -98.86 130.95 45.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.404 -0.81 . . . . 0.0 109.226 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.25 158.28 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.481 -0.762 . . . . 0.0 109.531 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 96' ' ' LEU . 37.5 pt -131.66 146.83 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -110.83 136.62 49.61 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 pp -137.88 156.79 47.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.287 -0.883 . . . . 0.0 109.48 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -90.65 144.72 25.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.815 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.07 162.1 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 0.0 109.621 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -70.25 155.64 93.12 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 71' ' ' VAL . 28.8 Cg_endo -64.17 -18.28 62.84 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.075 1.85 . . . . 0.0 110.953 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -94.28 -28.76 15.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.544 -0.722 . . . . 0.0 109.226 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.1 mt -94.32 -3.03 51.2 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.177 -0.952 . . . . 0.0 110.039 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 68' ' ' PRO . 7.6 p -63.45 -31.72 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.137 -0.977 . . . . 0.0 109.919 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.53 -14.72 81.83 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.44 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 34.7 t -70.41 -55.44 9.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -1.099 . . . . 0.0 111.483 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.586 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.8 pt? -84.28 -23.09 30.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.119 -0.988 . . . . 0.0 111.106 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -66.38 -41.42 89.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.106 -0.997 . . . . 0.0 111.264 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CD ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -76.29 -7.57 55.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.869 -1.145 . . . . 0.0 110.108 -178.502 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -77.69 149.22 77.5 Favored Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.799 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 80' ' ' ILE . 40.2 Cg_endo -66.34 155.37 70.3 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.12 2.547 . . . . 0.0 112.462 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.47 -25.77 0.9 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 78' ' ' PRO . 78.9 mt -93.7 115.35 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -1.216 . . . . 0.0 108.951 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.8 150.34 42.63 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.619 -0.675 . . . . 0.0 110.036 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.04 150.94 85.01 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.156 1.904 . . . . 0.0 111.809 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.4 143.88 56.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.345 -0.847 . . . . 0.0 109.625 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 52.4 p90 -92.08 126.9 37.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.119 -0.988 . . . . 0.0 109.899 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 85' ' ' HIS . 85.5 t60 41.53 43.51 2.28 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.561 -0.712 . . . . 0.0 110.405 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.0 mmm -143.46 65.32 1.32 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.234 -0.916 . . . . 0.0 109.044 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.612 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 22.2 m-20 68.39 -50.14 0.56 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.166 -0.334 . . . . 0.0 110.42 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 63.91 -37.63 0.19 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 120.979 0.419 . . . . 0.0 110.24 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 87' ' ' ASN . 83.1 tt0 -88.66 -20.19 25.23 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.903 -1.123 . . . . 0.0 109.817 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -96.88 -59.84 1.72 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.266 -0.896 . . . . 0.0 110.336 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TRP . . . . . 0.612 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 5.4 m0 -105.96 140.96 38.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.494 -0.754 . . . . 0.0 109.912 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.0 mm -121.14 138.55 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.1 m -85.43 134.46 34.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.707 -0.62 . . . . 0.0 109.834 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.4 t -119.63 134.82 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.596 -0.69 . . . . 0.0 109.157 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.2 tp -89.55 107.2 18.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.199 -0.938 . . . . 0.0 110.058 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.431 HD11 HG23 ' A' ' 62' ' ' ILE . 81.2 mt -66.23 -39.33 89.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.497 -0.752 . . . . 0.0 109.71 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -74.28 2.88 8.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.477 -0.765 . . . . 0.0 109.61 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.93 -166.05 30.28 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 100' ' ' LEU . 83.8 Cg_endo -85.34 10.63 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.396 2.731 . . . . 0.0 111.54 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.8 mm? -52.55 -107.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.629 0.728 . . . . 0.0 109.63 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.11 154.38 6.15 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.48 -46.3 86.93 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.303 -1.116 . . . . 0.0 109.357 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.65 -42.67 98.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.501 -0.749 . . . . 0.0 109.84 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -66.06 -42.73 89.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.397 -0.814 . . . . 0.0 109.743 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.41 HD12 ' H1 ' ' A' ' 1' ' ' MET . 94.9 mt -64.15 -43.25 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -55.16 -43.98 74.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.318 -0.864 . . . . 0.0 109.263 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 56.0 m -60.83 -42.37 97.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.855 . . . . 0.0 109.46 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.07 -42.95 99.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.432 -0.793 . . . . 0.0 109.323 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.06 -43.08 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.369 -0.832 . . . . 0.0 109.097 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -58.52 -37.71 76.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 108.593 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -62.57 -35.77 80.56 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.8 p -81.51 -23.55 37.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 109.306 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -61.65 -44.43 96.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.427 -0.796 . . . . 0.0 109.885 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.462 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 13.8 pt20 -50.9 -41.25 58.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.337 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.462 ' N ' ' CG ' ' A' ' 114' ' ' GLN . 84.6 mt -64.77 -39.71 94.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.526 -0.733 . . . . 0.0 109.745 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.3 p -92.99 14.83 16.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.135 -0.978 . . . . 0.0 109.522 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.145 -0.972 . . . . 0.0 109.58 -179.569 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.468 ' SD ' HD12 ' A' ' 105' ' ' ILE . 6.3 ttt . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -146.73 -178.33 6.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.104 -0.998 . . . . 0.0 110.116 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.53 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 40.8 ttm180 -62.25 -44.61 96.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.593 -0.692 . . . . 0.0 109.81 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -61.83 -37.33 84.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.898 . . . . 0.0 109.521 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -59.98 -40.44 89.13 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.346 -0.846 . . . . 0.0 109.04 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -62.65 -41.63 99.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.696 -0.628 . . . . 0.0 110.363 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.5 mm -59.24 -47.7 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.059 -1.025 . . . . 0.0 110.018 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 9' ' ' TYR . 0.6 OUTLIER -63.8 -43.86 95.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.914 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.622 ' CE2' ' CD2' ' A' ' 106' ' ' HIS . 43.4 t80 -62.53 -48.29 80.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.562 -0.711 . . . . 0.0 109.872 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.01 86.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.4 -0.813 . . . . 0.0 110.102 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 15' ' ' ASP . 11.6 tp-100 -64.75 -48.95 72.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.384 -0.822 . . . . 0.0 109.896 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -66.71 -33.63 76.07 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.931 -1.106 . . . . 0.0 110.599 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -87.05 -12.09 48.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.118 -0.989 . . . . 0.0 111.83 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.609 ' CD1' ' NE2' ' A' ' 33' ' ' HIS . 95.8 m-85 -141.62 -0.22 1.39 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.653 -1.279 . . . . 0.0 110.446 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER 41.06 35.18 0.34 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -109.76 138.06 46.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.507 0.67 . . . . 0.0 109.653 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HA ' HE22 ' A' ' 11' ' ' GLN . 86.5 mttt -91.1 151.13 42.81 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.504 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.65 149.05 73.32 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.596 2.198 . . . . 0.0 112.186 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -123.83 134.36 53.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.623 -0.673 . . . . 0.0 109.343 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 20' ' ' HIS . 18.6 p80 -128.78 85.4 60.33 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.37 -12.76 11.36 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.452 2.101 . . . . 0.0 110.973 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -92.38 97.52 10.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -70.15 -18.59 63.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.507 -0.746 . . . . 0.0 109.934 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 10.0 mtpm? -76.56 -4.65 43.93 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.142 -0.974 . . . . 0.0 109.14 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 24' ' ' LYS . 53.3 m-85 -156.85 79.47 3.71 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.433 -0.792 . . . . 0.0 108.903 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.3 -19.48 50.71 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.723 2.282 . . . . 0.0 111.294 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -73.13 -5.96 42.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.521 -0.737 . . . . 0.0 109.183 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.586 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 4.9 m-85 -87.55 137.95 31.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.573 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.88 141.38 34.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 0.0 109.156 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.09 126.44 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -106.66 120.08 41.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.54 -0.725 . . . . 0.0 109.5 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.449 ' NH2' ' O ' ' A' ' 37' ' ' ASP . 17.5 ptm180 -150.61 158.3 43.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.135 -0.978 . . . . 0.0 109.61 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.609 ' NE2' ' CD1' ' A' ' 14' ' ' TYR . 4.4 m170 -97.94 126.52 43.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 109.713 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.4 p -66.45 -34.26 77.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.469 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.76 -39.54 94.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.36 -0.838 . . . . 0.0 109.86 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 38' ' ' LYS . 53.0 t-20 -93.23 -12.26 30.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.409 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.449 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 37.7 t70 57.93 -71.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.695 -0.628 . . . . 0.0 110.713 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.6 tttt -63.61 124.66 21.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 110.506 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.428 ' CZ2' HG21 ' A' ' 116' ' ' THR . 0.0 OUTLIER -178.86 126.46 0.1 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.345 -0.847 . . . . 0.0 108.975 179.075 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -115.09 123.29 48.61 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.553 0.692 . . . . 0.0 109.524 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.469 ' C ' HD22 ' A' ' 42' ' ' LEU . . . -153.8 106.23 2.85 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.469 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.2 mm? -107.59 128.25 54.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.524 -0.735 . . . . 0.0 109.788 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.572 ' C ' HD23 ' A' ' 43' ' ' LEU . 7.1 tt -122.61 118.19 27.59 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.586 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -162.82 166.67 23.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.968 . . . . 0.0 109.92 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.53 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 91.5 m-20 -93.6 143.5 26.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.56 -0.713 . . . . 0.0 109.33 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.9 pt -150.67 146.23 19.31 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.254 -0.904 . . . . 0.0 109.435 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.62 145.82 6.02 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.127 1.885 . . . . 0.0 112.697 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.6 -20.98 62.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.48 -0.763 . . . . 0.0 109.959 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.61 -17.59 63.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.887 . . . . 0.0 110.135 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.95 -10.45 57.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.05 -1.031 . . . . 0.0 111.042 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 51' ' ' ILE . 7.2 pt -105.82 7.12 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.142 -0.974 . . . . 0.0 109.428 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 -13.83 63.24 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.59 129.01 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.845 -1.386 . . . . 0.0 110.028 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -88.52 100.84 13.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.454 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.06 -22.48 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 56.76 31.53 19.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.795 -0.827 . . . . 0.0 109.708 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -102.8 144.98 30.44 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.323 -0.861 . . . . 0.0 109.775 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -74.15 128.19 34.88 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.326 -0.858 . . . . 0.0 109.278 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.25 161.19 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.482 -0.761 . . . . 0.0 109.769 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.418 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 28.3 m-20 -93.28 132.32 37.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.795 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.11 155.95 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.39 -0.818 . . . . 0.0 110.249 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 96' ' ' LEU . 44.0 pt -130.93 155.3 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 42' ' ' LEU . 53.0 t0 -92.86 119.74 32.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 110.2 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.583 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -115.7 119.81 37.31 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.279 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.583 ' N ' HD13 ' A' ' 64' ' ' LEU . 9.9 ptmm? -86.71 135.86 33.23 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.461 -0.774 . . . . 0.0 110.588 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.462 HG11 HD13 ' A' ' 74' ' ' LEU . 31.3 m -140.66 165.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.426 -0.796 . . . . 0.0 109.946 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -75.31 152.78 85.98 Favored Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 121.362 -0.836 . . . . 0.0 110.176 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.552 ' O ' HG12 ' A' ' 71' ' ' VAL . 61.7 Cg_exo -48.93 -34.01 27.54 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.13 1.887 . . . . 0.0 111.77 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -85.51 -29.21 24.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.393 -0.817 . . . . 0.0 110.087 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.0 mt -88.25 1.03 55.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.985 -1.072 . . . . 0.0 109.847 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 68' ' ' PRO . 14.8 p -66.13 -42.5 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.136 -0.977 . . . . 0.0 109.516 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.549 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -66.05 -40.61 95.23 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -60.75 -36.75 79.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -1.217 . . . . 0.0 109.524 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.543 ' CD2' HG21 ' A' ' 92' ' ' ILE . 1.6 tt -85.75 -37.39 19.37 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.553 -0.717 . . . . 0.0 109.825 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 ttp85 -73.92 -16.98 61.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.794 . . . . 0.0 110.644 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -7.65 58.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.95 -1.094 . . . . 0.0 109.081 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.75 ' NZ ' HD21 ' A' ' 108' ' ' LEU . 40.9 mtmt -85.32 122.83 73.68 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.181 -0.95 . . . . 0.0 109.397 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.24 146.28 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.216 1.944 . . . . 0.0 113.137 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.71 -21.29 39.76 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.4 mt -104.45 122.97 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.296 -1.12 . . . . 0.0 109.307 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -118.8 149.3 46.25 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.69 -0.631 . . . . 0.0 109.858 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -40.56 165.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.564 2.176 . . . . 0.0 112.619 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.07 147.08 50.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.353 -0.842 . . . . 0.0 110.603 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.453 ' OH ' ' CE ' ' A' ' 44' ' ' MET . 5.9 p90 -76.64 167.39 21.92 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.731 0.777 . . . . 0.0 110.759 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 73.8 m80 53.29 -94.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.622 -0.674 . . . . 0.0 110.147 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 93.7 mtp -138.48 -151.79 0.4 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.389 -0.819 . . . . 0.0 109.747 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 59.35 34.96 23.04 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -88.62 62.47 6.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.471 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -146.16 -67.01 0.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 108.889 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -96.36 -19.13 19.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.391 -0.818 . . . . 0.0 109.668 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 -110.51 138.15 47.27 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.461 -0.775 . . . . 0.0 110.085 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.543 HG21 ' CD2' ' A' ' 74' ' ' LEU . 19.8 mm -136.27 154.31 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.462 -0.774 . . . . 0.0 108.938 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.4 m -98.85 131.28 45.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.853 . . . . 0.0 110.814 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.5 t -113.16 133.84 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.6 tp -93.71 112.76 24.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.432 -0.793 . . . . 0.0 110.256 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.444 HD11 HG23 ' A' ' 62' ' ' ILE . 84.3 mt -66.03 -39.54 90.28 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.637 0.732 . . . . 0.0 109.432 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -71.89 -6.21 40.15 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.285 -0.884 . . . . 0.0 109.245 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.02 177.65 1.52 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.72 -12.73 24.46 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 123.038 2.492 . . . . 0.0 111.404 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.82 136.9 54.86 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.562 0.696 . . . . 0.0 110.684 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.96 -178.73 46.03 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.49 81.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.618 -0.931 . . . . 0.0 109.671 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 104' ' ' GLU . 25.1 pttm -56.55 -42.07 77.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.887 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 103' ' ' LYS . 46.0 tp10 -69.09 -40.05 78.66 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.013 -1.054 . . . . 0.0 109.443 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.468 HD12 ' SD ' ' A' ' 1' ' ' MET . 97.2 mt -64.77 -43.13 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.351 -0.843 . . . . 0.0 109.484 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.622 ' CD2' ' CE2' ' A' ' 9' ' ' TYR . 62.7 m170 -56.89 -44.33 82.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 109.487 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.5 t -62.72 -43.45 98.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.37 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.75 HD21 ' NZ ' ' A' ' 77' ' ' LYS . 88.9 mt -63.39 -41.02 98.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.362 -0.836 . . . . 0.0 109.209 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.0 -42.45 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -56.3 -42.26 77.28 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.256 -0.903 . . . . 0.0 108.781 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.23 -37.69 88.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' SER . . . . . 0.56 ' OG ' HD21 ' A' ' 64' ' ' LEU . 2.4 m -60.75 -39.66 89.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.46 -0.775 . . . . 0.0 109.29 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -59.89 -42.9 94.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.573 -0.704 . . . . 0.0 109.688 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -52.62 -46.36 67.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 110.091 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 115' ' ' LEU . 4.1 mm? -65.9 -40.11 91.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.413 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.428 HG21 ' CZ2' ' A' ' 39' ' ' TRP . 15.9 p -93.94 15.46 16.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.978 . . . . 0.0 109.147 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 121.687 0.756 . . . . 0.0 110.673 -179.724 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.9 ttp . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.711 0.767 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.8 p30 -92.17 170.32 9.91 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.997 0.903 . . . . 0.0 110.408 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -63.5 -42.07 98.51 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.567 0.699 . . . . 0.0 109.607 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -51.33 -43.02 61.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.759 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -66.83 -37.78 85.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 109.457 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -61.21 -44.22 97.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.337 -0.852 . . . . 0.0 109.889 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.44 -46.66 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.184 -0.947 . . . . 0.0 109.726 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -63.9 -45.62 88.52 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 110.001 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.448 ' CD2' ' NE2' ' A' ' 106' ' ' HIS . 56.0 t80 -66.25 -42.16 88.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 110.195 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.41 98.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.208 -0.932 . . . . 0.0 109.99 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ASP . 84.6 mt-30 -65.75 -41.72 91.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.287 -0.883 . . . . 0.0 110.031 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -62.76 -31.49 72.45 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.889 -1.132 . . . . 0.0 109.185 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -87.93 -45.29 10.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 111.69 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -107.4 -13.85 15.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.013 -1.054 . . . . 0.0 111.251 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 11' ' ' GLN . 99.3 m-20 54.52 34.16 20.52 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.08 -1.012 . . . . 0.0 108.776 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.9 m -121.64 132.09 54.47 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.857 0.836 . . . . 0.0 110.273 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -83.04 152.25 65.05 Favored Pre-proline 0 N--CA 1.486 1.367 0 O-C-N 121.595 -0.69 . . . . 0.0 109.166 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.61 134.58 27.15 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.172 1.915 . . . . 0.0 112.481 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -106.03 121.61 44.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.478 -0.763 . . . . 0.0 109.232 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -85.37 116.88 67.4 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.42 -0.8 . . . . 0.0 109.825 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 22' ' ' TRP . 72.4 Cg_endo -80.19 -90.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.52 2.147 . . . . 0.0 111.999 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.411 ' H ' ' HG2' ' A' ' 21' ' ' PRO . 5.5 m-90 -81.18 137.5 35.89 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.855 0.836 . . . . 0.0 110.055 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -65.77 -30.69 71.38 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.542 0.686 . . . . 0.0 110.066 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -67.84 -0.56 4.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.808 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -143.77 73.02 17.04 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.039 -1.038 . . . . 0.0 109.61 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.61 -19.0 25.01 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.363 2.042 . . . . 0.0 110.881 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -81.18 -4.23 54.77 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.631 0.729 . . . . 0.0 109.209 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -96.11 139.1 32.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.468 -0.77 . . . . 0.0 109.222 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.97 146.37 47.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.697 . . . . 0.0 109.398 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.4 t -127.87 129.58 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.396 0.617 . . . . 0.0 109.395 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -118.24 113.87 22.14 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -146.49 161.36 40.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.15 -0.969 . . . . 0.0 110.086 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 37' ' ' ASP . 53.1 m170 -96.68 129.34 44.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.527 -0.733 . . . . 0.0 109.784 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.6 m -69.6 -20.66 63.63 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.58 0.705 . . . . 0.0 109.673 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.39 -45.64 90.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.09 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 37' ' ' ASP . 93.8 m-20 -125.58 -30.73 3.05 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.403 -0.81 . . . . 0.0 109.838 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 33' ' ' HIS . 1.2 p30 50.68 25.19 1.96 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.564 0.697 . . . . 0.0 110.04 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.24 -8.53 45.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.138 -0.977 . . . . 0.0 108.777 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -91.19 146.52 23.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.378 -0.826 . . . . 0.0 110.02 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.8 124.35 43.1 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.698 0.761 . . . . 0.0 109.493 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.61 105.71 2.84 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -132.86 149.36 52.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.267 -0.895 . . . . 0.0 109.457 -179.417 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 43' ' ' LEU . 9.6 tt -118.91 128.04 54.05 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.413 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.98 163.97 39.55 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.875 0.845 . . . . 0.0 110.211 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 46' ' ' ILE . 51.9 p-10 -93.52 145.61 24.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.537 0.684 . . . . 0.0 110.016 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 45' ' ' ASP . 22.6 pt -155.75 146.96 16.63 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.606 -0.684 . . . . 0.0 109.467 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.44 141.67 97.83 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.099 1.866 . . . . 0.0 111.619 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' A' ' 53' ' ' ILE . . . -64.53 -20.26 66.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.484 -0.76 . . . . 0.0 109.902 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -54.76 -16.59 2.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.431 -0.793 . . . . 0.0 110.214 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -85.5 -23.72 27.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.253 -0.905 . . . . 0.0 111.171 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 pt -95.64 10.69 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.892 -1.13 . . . . 0.0 109.726 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.13 -8.27 75.82 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.532 ' HB ' ' HB1' ' A' ' 48' ' ' ALA . 81.3 mt -78.77 129.98 36.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.806 -1.408 . . . . 0.0 109.996 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -62.23 -39.9 94.34 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.591 0.71 . . . . 0.0 109.34 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -42.07 133.23 4.12 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.8 p30 -89.6 3.08 53.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.462 -1.022 . . . . 0.0 108.93 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.8 144.65 56.18 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.731 0.777 . . . . 0.0 110.485 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -87.11 145.57 26.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.52 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.51 160.42 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.658 0.742 . . . . 0.0 110.321 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.77 132.89 34.99 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.305 0.574 . . . . 0.0 110.019 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.41 156.16 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.659 0.743 . . . . 0.0 110.017 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.8 pt -136.09 146.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.596 0.713 . . . . 0.0 109.963 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -81.87 143.34 31.77 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.524 0.678 . . . . 0.0 110.308 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -133.26 125.97 30.48 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.624 ' N ' HD13 ' A' ' 64' ' ' LEU . 63.3 tttm -82.95 131.28 35.19 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.689 0.757 . . . . 0.0 110.67 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.83 161.8 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.739 0.78 . . . . 0.0 109.726 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.473 ' H ' ' HB2' ' A' ' 70' ' ' LEU . 52.0 mt-30 -87.11 153.14 54.03 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.529 -0.732 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.505 ' O ' HG12 ' A' ' 71' ' ' VAL . 51.6 Cg_exo -47.5 -26.18 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.159 1.906 . . . . 0.0 111.577 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -94.78 -29.17 14.89 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.708 0.766 . . . . 0.0 109.345 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.473 ' HB2' ' H ' ' A' ' 67' ' ' GLN . 93.5 mt -86.77 -6.51 58.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 0.0 109.644 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 68' ' ' PRO . 12.1 p -67.29 -39.58 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 109.553 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.482 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -61.32 -47.04 93.03 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.6 m -59.59 -42.49 92.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.295 -1.121 . . . . 0.0 110.532 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.2 tt -84.65 -24.37 29.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 110.576 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.605 ' NH1' ' NZ ' ' A' ' 88' ' ' LYS . 69.7 ttt180 -82.72 -40.56 20.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.868 -1.145 . . . . 0.0 109.173 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -69.02 1.22 3.66 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.784 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -88.01 116.03 64.94 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.473 -0.767 . . . . 0.0 109.459 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.26 144.92 37.3 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.331 2.02 . . . . 0.0 113.045 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.61 -20.76 46.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.01 125.67 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.477 -1.013 . . . . 0.0 109.396 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -106.0 151.65 40.11 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.593 -0.692 . . . . 0.0 109.996 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.22 146.62 81.87 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.5 2.133 . . . . 0.0 112.194 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.525 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -67.09 153.23 44.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.546 -0.721 . . . . 0.0 110.592 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.09 -143.02 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.916 0.865 . . . . 0.0 110.52 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 46.16 -113.54 0.44 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.443 0.639 . . . . 0.0 109.954 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 98.2 mmm -141.07 0.89 1.59 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 89' ' ' GLU . 81.8 m-20 -59.64 -85.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 109.691 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.605 ' NZ ' ' NH1' ' A' ' 75' ' ' ARG . 62.7 tttm 56.86 -76.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.648 -0.657 . . . . 0.0 110.222 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' ASN . 97.5 mt-10 -65.35 -38.7 90.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 0.0 109.673 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -68.51 -68.12 0.42 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.584 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -120.57 159.4 25.33 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.525 -0.734 . . . . 0.0 109.634 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 mm -129.6 147.69 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.919 0.866 . . . . 0.0 109.826 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 p -90.59 134.6 34.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.683 -0.636 . . . . 0.0 110.076 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -115.48 129.87 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 34.0 tp -86.77 104.84 16.53 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.669 0.747 . . . . 0.0 109.976 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.76 -38.4 88.96 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.788 0.804 . . . . 0.0 109.237 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.39 -5.88 44.97 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.897 0.856 . . . . 0.0 109.113 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.92 -175.41 8.96 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.514 ' O ' ' C ' ' A' ' 100' ' ' LEU . 44.5 Cg_endo -71.63 -81.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.633 2.222 . . . . 0.0 112.226 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.514 ' C ' ' O ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER 19.2 -120.7 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 121.158 0.504 . . . . 0.0 111.689 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.95 165.61 30.19 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.22 -39.07 86.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.528 -0.984 . . . . 0.0 109.461 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -64.91 -35.5 81.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.447 -0.783 . . . . 0.0 109.611 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -67.09 -40.7 87.01 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.201 -0.937 . . . . 0.0 109.411 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.71 -43.3 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 109.273 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' HIS . . . . . 0.448 ' NE2' ' CD2' ' A' ' 9' ' ' TYR . 52.1 m170 -56.65 -44.95 81.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 109.76 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.2 m -62.25 -42.44 99.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.744 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.52 -41.03 96.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 109.194 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.1 -42.7 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.339 -0.85 . . . . 0.0 108.988 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -53.77 -46.55 71.0 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.502 -0.749 . . . . 0.0 109.438 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -64.43 -38.53 91.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.075 -1.016 . . . . 0.0 108.851 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.6 p -62.18 -36.24 81.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 0.0 109.226 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -61.75 -44.6 96.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.413 -0.805 . . . . 0.0 109.664 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.16 -41.86 89.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.296 -0.877 . . . . 0.0 109.612 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.8 mt -66.53 -38.7 87.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.341 -0.849 . . . . 0.0 109.798 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.8 p -89.09 5.84 42.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.216 -0.927 . . . . 0.0 109.372 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 108.903 179.624 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -100.41 156.79 17.06 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.821 0.82 . . . . 0.0 110.367 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.0 mtp-105 -60.6 -46.58 89.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.64 -0.662 . . . . 0.0 110.171 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -47.73 -40.51 20.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.992 . . . . 0.0 109.677 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.77 -41.6 87.43 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.344 -0.848 . . . . 0.0 109.366 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -63.72 -45.43 89.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.458 -0.777 . . . . 0.0 110.095 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.2 mm -63.84 -46.02 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.79 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -67.38 -39.04 85.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 0.0 108.925 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -61.78 -46.14 90.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.456 -0.778 . . . . 0.0 109.936 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.28 86.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.477 -0.765 . . . . 0.0 109.914 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -65.95 -21.71 66.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -84.42 -53.22 5.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 109.914 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -88.87 -44.02 10.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.446 -0.784 . . . . 0.0 111.601 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 15' ' ' ASP . 45.6 m-85 -93.45 -6.16 47.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.785 -1.197 . . . . 0.0 110.071 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER 37.4 34.55 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.622 0.725 . . . . 0.0 109.796 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 14' ' ' TYR . 7.8 t -104.45 145.74 29.85 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.564 0.697 . . . . 0.0 110.085 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -98.47 151.28 37.4 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.66 149.35 73.51 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.712 2.275 . . . . 0.0 112.659 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -136.33 151.16 49.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.673 -0.642 . . . . 0.0 109.354 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -139.64 86.0 14.3 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -55.17 -38.1 93.8 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.566 2.178 . . . . 0.0 110.758 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -94.71 116.44 28.75 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.373 0.606 . . . . 0.0 109.509 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 25' ' ' PHE . 17.4 pt-20 -69.49 -31.31 69.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.493 -0.754 . . . . 0.0 109.405 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -64.78 -0.66 1.55 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.564 -0.71 . . . . 0.0 109.464 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 23' ' ' GLU . 73.2 m-85 -137.05 71.75 54.95 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 109.333 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.7 -20.58 30.26 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.471 2.114 . . . . 0.0 111.615 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.18 -6.0 58.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.477 -0.764 . . . . 0.0 109.306 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.76 140.19 29.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.65 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.11 133.15 50.44 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.73 129.97 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.682 -0.636 . . . . 0.0 109.348 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -113.62 134.15 54.88 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -158.41 149.48 20.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.533 ' O ' ' NE1' ' A' ' 39' ' ' TRP . 81.2 m-70 -99.57 118.04 35.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.538 -0.726 . . . . 0.0 109.604 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 m -76.52 -15.09 59.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.534 -0.728 . . . . 0.0 109.149 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.59 -5.34 51.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.899 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 116' ' ' THR . 45.8 t-20 -115.24 -30.9 6.16 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.541 -0.724 . . . . 0.0 109.469 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 38' ' ' LYS . 65.1 t0 57.73 134.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.851 0.834 . . . . 0.0 111.018 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 6.3 tmtt? 82.41 102.2 0.05 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.515 0.674 . . . . 0.0 109.739 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -171.01 175.19 4.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.45 -0.781 . . . . 0.0 109.618 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.511 ' CG ' ' O ' ' A' ' 39' ' ' TRP . 80.3 m-85 -158.44 119.14 3.34 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.45 105.39 2.07 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -133.93 138.64 45.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 0.0 109.091 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.629 HD21 ' OD1' ' A' ' 60' ' ' ASP . 9.1 tt -116.4 124.76 50.83 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.8 ptt? -152.39 156.01 38.71 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.815 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.413 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 98.3 m-20 -94.4 114.49 26.53 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.6 pt -118.03 145.29 36.51 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.766 -0.583 . . . . 0.0 109.998 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -46.81 143.26 9.46 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.144 1.896 . . . . 0.0 112.431 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 57' ' ' LYS . . . -64.09 -21.78 66.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -77.36 -14.23 59.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 109.783 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -84.57 -10.7 57.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 110.158 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 13.7 pt -105.08 1.45 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.2 -8.36 60.71 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 55' ' ' GLY . 77.0 mt -79.72 139.2 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.848 -1.383 . . . . 0.0 110.14 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.37 -38.22 88.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.742 -0.599 . . . . 0.0 110.746 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -49.66 145.36 8.32 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.862 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -101.8 9.19 41.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.596 -0.943 . . . . 0.0 108.929 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 62.5 pttt -76.5 146.28 38.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 110.305 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.6 144.0 37.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.563 -0.711 . . . . 0.0 109.77 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.93 161.89 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.417 -0.802 . . . . 0.0 110.407 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.629 ' OD1' HD21 ' A' ' 43' ' ' LEU . 24.1 t70 -100.73 128.17 46.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.845 -0.534 . . . . 0.0 109.934 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.07 157.69 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.604 -0.685 . . . . 0.0 109.771 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 pt -132.61 150.15 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.48 0.657 . . . . 0.0 109.706 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 64.5 t0 -80.13 134.65 36.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.67 -0.644 . . . . 0.0 109.864 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.654 HD12 HG13 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -125.82 124.0 39.98 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.643 ' N ' HD13 ' A' ' 64' ' ' LEU . 36.2 ttmt -89.91 129.47 36.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.943 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.654 HG13 HD12 ' A' ' 64' ' ' LEU . 15.0 m -138.64 164.68 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.895 0.855 . . . . 0.0 110.663 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.3 155.1 90.08 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.433 ' O ' HG12 ' A' ' 71' ' ' VAL . 31.3 Cg_endo -62.55 -24.62 75.3 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.752 2.302 . . . . 0.0 112.402 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -91.16 -23.59 20.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -0.968 . . . . 0.0 110.161 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.4 mt -92.68 1.18 57.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.03 -1.044 . . . . 0.0 109.469 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 72' ' ' GLY . 10.6 p -63.98 -41.56 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 108.831 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.511 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -61.94 -40.52 98.98 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.2 t -65.34 -54.79 23.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -1.133 . . . . 0.0 110.281 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.533 HD13 HG11 ' A' ' 66' ' ' VAL . 2.3 tt -68.25 -43.89 76.84 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 110.638 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -69.93 -18.29 63.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.457 -0.777 . . . . 0.0 110.214 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -71.66 -32.86 68.34 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.828 -1.17 . . . . 0.0 108.868 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -66.63 139.98 96.22 Favored Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.807 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.06 157.84 53.54 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.191 1.927 . . . . 0.0 112.562 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.44 -18.49 49.03 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.8 mt -103.23 117.11 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.971 . . . . 0.0 109.209 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 63.0 m-85 -105.82 151.2 39.89 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.694 -0.629 . . . . 0.0 109.445 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.583 ' CB ' ' HZ1' ' A' ' 88' ' ' LYS . 57.9 Cg_endo -68.75 153.17 73.61 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.608 2.205 . . . . 0.0 112.648 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.53 139.73 58.8 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.356 -0.84 . . . . 0.0 110.059 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -90.13 2.76 54.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.557 -0.714 . . . . 0.0 109.207 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -79.9 -168.34 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.393 -0.817 . . . . 0.0 110.65 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.0 mtt -63.38 -40.37 97.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.518 -0.739 . . . . 0.0 109.574 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.504 ' ND2' ' CH2' ' A' ' 91' ' ' TRP . 94.1 m-20 -81.31 -172.79 3.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.258 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.583 ' HZ1' ' CB ' ' A' ' 82' ' ' PRO . 48.8 tttp -165.31 -61.06 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -67.87 -38.7 83.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.567 -0.708 . . . . 0.0 109.455 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.86 -50.07 68.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.486 -0.759 . . . . 0.0 109.988 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.504 ' CH2' ' ND2' ' A' ' 87' ' ' ASN . 6.8 m0 -115.96 137.01 52.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.675 -0.64 . . . . 0.0 109.732 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.46 HG21 ' CD2' ' A' ' 74' ' ' LEU . 6.8 mm -129.16 133.39 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.569 0.699 . . . . 0.0 109.189 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.9 m -81.58 130.82 35.19 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.634 -0.666 . . . . 0.0 109.702 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.18 132.98 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.598 -0.689 . . . . 0.0 109.245 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.5 tp -87.54 103.84 15.93 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.509 0.671 . . . . 0.0 110.095 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 98' ' ' GLY . 72.2 mt -65.73 -40.08 91.82 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.607 0.717 . . . . 0.0 109.218 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -76.83 11.12 1.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -89.66 -164.5 40.13 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.89 0.41 10.02 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 123.226 2.617 . . . . 0.0 111.697 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.3 mm? -61.25 135.22 57.66 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.95 0.881 . . . . 0.0 110.985 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.68 157.43 28.7 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.08 97.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.561 -0.964 . . . . 0.0 109.538 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -70.26 -34.87 73.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.337 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.06 -43.25 92.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.457 -0.777 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.73 -42.91 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.511 -0.743 . . . . 0.0 109.37 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -56.49 -43.76 79.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 109.673 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.5 t -61.93 -44.82 95.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.395 -0.816 . . . . 0.0 109.963 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.65 -41.0 98.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.48 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.56 -42.64 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.018 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -51.7 -43.86 62.95 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -62.71 -43.23 99.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.618 -0.676 . . . . 0.0 109.324 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.2 p -70.02 -30.86 68.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 0.0 109.433 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.16 -43.91 87.63 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.441 -0.787 . . . . 0.0 109.179 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -49.84 -31.01 10.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.541 -0.724 . . . . 0.0 109.698 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.2 mp -84.25 -17.43 39.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -0.857 . . . . 0.0 109.617 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.534 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 32.3 p -102.92 15.23 29.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.453 -0.78 . . . . 0.0 109.211 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 18.2 mmm180 -63.77 141.51 58.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.973 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 118' ' ' LEU . 10.6 mp -77.31 152.1 34.7 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.564 0.697 . . . . 0.0 110.821 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 56.99 75.69 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.654 0.74 . . . . 0.0 110.118 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.642 ' N ' ' ND1' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -66.51 -39.69 88.8 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.629 -0.669 . . . . 0.0 109.404 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.416 ' N ' ' ND1' ' A' ' 120' ' ' HIS . 19.3 p80 -154.54 146.4 23.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 110.23 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -174.37 83.78 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -157.51 123.76 4.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.407 -0.808 . . . . 0.0 109.466 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -66.77 -39.98 88.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.49 -0.756 . . . . 0.0 109.617 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.191 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 tpp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -95.02 165.96 12.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.394 -0.817 . . . . 0.0 110.446 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -63.09 -42.52 99.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.75 -0.594 . . . . 0.0 109.731 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.549 HE22 ' CG ' ' A' ' 8' ' ' ASP . 2.2 tm0? -64.04 -38.59 91.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.146 -0.972 . . . . 0.0 109.471 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -63.57 -39.64 94.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.524 -0.735 . . . . 0.0 109.415 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -61.94 -46.86 87.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.438 -0.789 . . . . 0.0 109.83 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.66 -44.36 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.615 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.549 ' CG ' HE22 ' A' ' 4' ' ' GLN . 54.3 m-20 -65.87 -38.26 88.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.82 . . . . 0.0 109.023 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.462 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 91.6 t80 -61.58 -44.52 96.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.803 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' TYR . . . -64.13 -36.65 84.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 110.312 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.567 ' O ' ' N ' ' A' ' 15' ' ' ASP . 58.3 mm-40 -61.88 -44.27 97.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.147 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -66.78 -38.44 86.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.893 -1.129 . . . . 0.0 109.552 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 29.9 mmtp -88.19 -11.73 45.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.491 -0.756 . . . . 0.0 111.302 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' ALA . 80.7 m-85 -144.61 -21.68 0.52 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.821 -1.174 . . . . 0.0 110.818 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 11' ' ' GLN . 65.0 m-20 53.83 32.94 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 0.0 109.063 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.533 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 12.3 t -103.15 134.91 45.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.499 -0.75 . . . . 0.0 109.674 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -82.52 149.14 60.35 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.611 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.33 151.98 71.5 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.44 2.093 . . . . 0.0 112.346 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -132.77 130.21 39.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.646 -0.659 . . . . 0.0 109.288 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.424 ' O ' ' CD2' ' A' ' 20' ' ' HIS . 31.5 p-80 -132.4 86.33 45.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.72 -35.85 93.99 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.515 2.143 . . . . 0.0 111.381 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -81.35 104.06 11.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.588 -0.695 . . . . 0.0 109.977 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -68.07 -34.99 77.48 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.501 0.667 . . . . 0.0 109.359 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -67.24 -3.13 7.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.402 -0.811 . . . . 0.0 109.708 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -135.08 71.51 68.6 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.493 -0.754 . . . . 0.0 109.463 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.75 -17.54 42.25 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.323 2.015 . . . . 0.0 111.126 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -80.16 -5.92 56.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.495 -0.753 . . . . 0.0 109.221 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -104.68 135.91 45.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.505 -0.747 . . . . 0.0 109.471 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.67 147.87 47.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.583 -0.698 . . . . 0.0 109.318 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.86 126.4 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.759 -0.588 . . . . 0.0 109.682 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -108.92 117.75 35.0 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -149.45 153.17 36.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.066 -1.021 . . . . 0.0 109.792 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.689 ' N ' ' HE1' ' A' ' 39' ' ' TRP . 28.1 m80 -83.76 132.07 34.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 110.379 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -67.8 -40.19 83.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 109.828 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -92.68 -42.4 9.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.401 -0.812 . . . . 0.0 109.756 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' A' ' 38' ' ' LYS . 1.4 m-20 -95.01 31.76 1.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 37' ' ' ASP . 52.9 p-10 -48.38 83.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.541 0.686 . . . . 0.0 110.444 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 36' ' ' ASN . 6.1 tmtt? -147.32 -22.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.689 ' HE1' ' N ' ' A' ' 33' ' ' HIS . 4.4 p-90 -101.52 127.94 47.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.559 -0.713 . . . . 0.0 109.32 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -112.43 129.77 56.21 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.599 0.714 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.9 121.11 7.25 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.19 147.98 45.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.72 -0.612 . . . . 0.0 109.595 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.27 126.08 54.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.468 ' O ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -157.67 161.25 38.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.953 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' OD2' ' NH1' ' A' ' 58' ' ' ARG . 92.6 m-20 -99.67 142.57 30.98 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.9 pt -149.27 146.46 21.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.897 . . . . 0.0 109.306 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -49.74 144.02 21.27 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.869 1.713 . . . . 0.0 112.849 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -64.49 -21.81 66.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.594 -0.691 . . . . 0.0 109.802 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.18 -16.27 59.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.903 . . . . 0.0 110.103 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -84.87 -10.08 57.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.169 -0.957 . . . . 0.0 110.093 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 12.6 pt -103.57 3.32 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.285 -0.884 . . . . 0.0 109.206 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.15 -8.7 60.98 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.5 mt -83.93 129.98 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.81 -1.406 . . . . 0.0 110.334 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -65.77 87.0 0.09 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.622 -0.674 . . . . 0.0 109.335 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -176.29 136.32 3.21 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -95.81 11.94 31.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -1.078 . . . . 0.0 108.993 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -74.86 144.85 43.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 110.64 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.51 ' NH1' ' OD2' ' A' ' 45' ' ' ASP . 72.4 ttp85 -76.48 137.06 39.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.504 -0.747 . . . . 0.0 109.806 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.14 161.54 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -100.66 127.58 47.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.519 -0.738 . . . . 0.0 109.464 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -132.98 158.4 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.443 -0.785 . . . . 0.0 110.353 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 pt -135.02 152.8 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.546 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -116.14 145.27 43.2 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.437 0.637 . . . . 0.0 109.875 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.44 157.78 45.26 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -87.81 137.58 32.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.343 -0.848 . . . . 0.0 110.882 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.9 m -143.58 163.35 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.514 -0.741 . . . . 0.0 109.862 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.444 ' CD ' HD22 ' A' ' 115' ' ' LEU . 57.7 mt-30 -77.92 154.78 80.51 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.512 -0.743 . . . . 0.0 109.664 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.507 ' O ' HG12 ' A' ' 71' ' ' VAL . 27.9 Cg_endo -65.14 -21.5 62.57 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.411 2.074 . . . . 0.0 111.151 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -87.48 -26.92 22.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.131 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.3 mt -96.69 6.51 48.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.414 -0.803 . . . . 0.0 109.334 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 68' ' ' PRO . 7.5 p -63.09 -36.49 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.513 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.72 -21.45 79.33 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.0 m -62.27 -59.07 5.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.18 -1.188 . . . . 0.0 110.914 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.835 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -85.49 -29.25 24.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.057 -1.027 . . . . 0.0 110.698 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.405 ' HE ' ' HB3' ' A' ' 82' ' ' PRO . 78.1 ttt-85 -67.73 -21.53 65.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.987 -1.07 . . . . 0.0 110.231 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.74 -8.14 55.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.051 -1.031 . . . . 0.0 109.229 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -75.92 149.09 82.55 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 110.081 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.402 ' O ' HD12 ' A' ' 80' ' ' ILE . 47.7 Cg_endo -68.5 140.87 49.03 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.435 2.09 . . . . 0.0 112.533 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.32 -21.1 18.56 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.746 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.7 mp -89.06 124.39 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.388 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 55.5 m-85 -123.84 151.14 64.06 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.751 -0.593 . . . . 0.0 109.588 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 84' ' ' TYR . 41.2 Cg_endo -67.95 158.57 56.77 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.412 2.075 . . . . 0.0 112.16 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 85' ' ' HIS . . . -66.17 65.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.451 -0.78 . . . . 0.0 109.423 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER 50.84 -83.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.696 -0.627 . . . . 0.0 109.719 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.574 ' N ' ' O ' ' A' ' 83' ' ' ALA . 60.8 t-80 -174.97 -7.66 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.406 ' H ' ' H ' ' A' ' 85' ' ' HIS . 65.2 mtt -63.92 -41.27 97.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.702 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 88' ' ' LYS . 36.0 m120 -119.61 -74.65 0.6 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.509 -0.744 . . . . 0.0 109.492 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.509 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 84.9 tttt 57.9 150.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.611 0.72 . . . . 0.0 110.264 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 88' ' ' LYS . 31.7 tt0 75.51 -67.42 0.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -65.53 -52.61 51.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.468 -0.77 . . . . 0.0 109.825 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.401 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 7.3 m0 -119.0 132.94 56.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.698 -0.626 . . . . 0.0 109.858 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.19 133.95 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.8 p -87.42 143.14 27.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.773 -0.579 . . . . 0.0 110.152 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.4 t -122.29 134.91 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.6 tp -84.68 108.11 17.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.465 -0.772 . . . . 0.0 109.877 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.03 -39.58 93.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.656 -0.652 . . . . 0.0 109.353 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -75.25 1.18 14.21 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.092 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.0 177.14 20.26 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.71 -10.05 21.5 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.065 2.51 . . . . 0.0 111.844 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.61 143.32 57.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 110.403 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.78 170.52 48.04 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.153 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.67 78.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.727 -0.867 . . . . 0.0 109.13 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -62.21 -39.14 91.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -65.08 -37.61 88.07 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.336 -0.853 . . . . 0.0 108.904 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.42 -43.75 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 109.035 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -61.1 -45.46 94.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.426 -0.796 . . . . 0.0 109.762 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.9 m -61.39 -44.0 97.91 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.402 -0.811 . . . . 0.0 109.815 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.34 -44.52 91.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.58 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.16 -42.76 91.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.399 -0.813 . . . . 0.0 108.939 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -55.03 -40.63 70.44 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -63.64 -42.19 98.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.6 m -61.21 -41.94 97.73 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.11 -45.3 94.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.602 -0.686 . . . . 0.0 110.224 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -59.9 -29.03 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.493 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.444 HD22 ' CD ' ' A' ' 67' ' ' GLN . 88.1 mt -79.53 -15.7 57.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.723 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -120.43 14.45 11.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.492 -0.755 . . . . 0.0 109.081 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -56.78 138.85 52.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.878 . . . . 0.0 109.862 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HB2' ' ND2' ' A' ' 36' ' ' ASN . 6.1 tp -90.88 136.71 32.89 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.428 -0.795 . . . . 0.0 110.507 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -112.92 76.52 0.98 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.577 ' N ' ' ND1' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -67.67 -37.97 83.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.536 -0.727 . . . . 0.0 109.719 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -135.0 149.54 50.2 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.629 0.728 . . . . 0.0 110.221 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -67.01 -39.22 87.02 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.794 -0.566 . . . . 0.0 109.853 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -147.68 155.4 41.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.083 -1.011 . . . . 0.0 109.944 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.423 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 26.7 p-80 -152.27 165.7 34.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.423 ' CG ' ' O ' ' A' ' 124' ' ' HIS . 77.9 m80 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.858 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.297 0.57 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -93.78 168.13 11.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -0.794 . . . . 0.0 110.511 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -62.08 -43.38 98.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.692 -0.63 . . . . 0.0 109.8 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -65.72 -37.55 86.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 0.0 109.612 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.9 -42.38 97.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.543 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -61.93 -45.41 93.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.741 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.8 -43.78 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.391 -0.818 . . . . 0.0 109.448 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.495 ' OD2' ' NZ ' ' A' ' 12' ' ' LYS . 45.6 t0 -65.26 -37.64 87.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.381 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.472 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 83.4 t80 -59.97 -48.52 81.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.196 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.54 -30.69 71.06 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.478 -0.764 . . . . 0.0 109.115 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.56 ' O ' ' N ' ' A' ' 15' ' ' ASP . 36.0 tt0 -64.55 -42.26 95.8 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.46 -0.775 . . . . 0.0 109.404 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' NZ ' ' OD2' ' A' ' 8' ' ' ASP . 60.0 mttp -69.11 -36.8 77.93 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.882 -1.136 . . . . 0.0 109.814 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.472 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 30.3 mmtp -88.17 -12.37 44.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 111.292 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -145.24 -22.11 0.49 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.869 -1.144 . . . . 0.0 110.46 -179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 11' ' ' GLN . 43.0 t0 54.82 34.58 22.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 109.011 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.7 m -102.01 130.1 48.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.404 -0.81 . . . . 0.0 109.402 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -87.02 156.71 54.82 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.445 -0.785 . . . . 0.0 109.985 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.54 140.16 45.49 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.188 1.925 . . . . 0.0 112.85 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -120.86 139.71 52.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -122.89 85.96 50.34 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.528 -0.732 . . . . 0.0 109.931 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.14 -39.55 90.5 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.65 2.233 . . . . 0.0 110.804 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -96.34 131.78 42.51 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.709 0.766 . . . . 0.0 110.137 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.657 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 1.1 pm0 -73.53 -36.06 65.64 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.695 -0.628 . . . . 0.0 109.772 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' C ' ' CD1' ' A' ' 25' ' ' PHE . 18.8 mtpp -67.95 10.45 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.439 -0.788 . . . . 0.0 111.16 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 24' ' ' LYS . 81.2 m-85 -145.43 67.25 12.82 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.837 -1.164 . . . . 0.0 109.981 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.22 -20.37 32.74 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.571 2.18 . . . . 0.0 111.777 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -84.93 -4.11 58.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.068 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -88.42 150.8 22.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.788 . . . . 0.0 109.949 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.71 132.47 48.0 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.2 t -125.14 127.03 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.568 -0.707 . . . . 0.0 109.523 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.534 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 97.7 m-85 -111.11 119.52 39.26 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -142.12 135.09 28.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.224 -0.922 . . . . 0.0 109.572 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.419 ' ND1' ' NE1' ' A' ' 39' ' ' TRP . 15.1 m80 -100.1 127.52 46.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 109.818 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p -69.76 -25.06 63.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.49 -0.756 . . . . 0.0 109.506 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -78.15 -7.19 56.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 109.797 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 116' ' ' THR . 13.4 t-20 -117.43 30.19 7.44 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 38' ' ' LYS . 53.2 t0 60.97 29.19 18.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.34 0.59 . . . . 0.0 110.212 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 37' ' ' ASP . 57.4 mttp 53.17 106.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.357 -0.839 . . . . 0.0 110.053 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.668 ' CZ3' ' HB2' ' A' ' 41' ' ' ALA . 7.9 p-90 -101.53 -177.47 3.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.523 -0.736 . . . . 0.0 110.202 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.31 129.21 46.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.572 -0.705 . . . . 0.0 110.252 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.668 ' HB2' ' CZ3' ' A' ' 39' ' ' TRP . . . -151.03 105.75 3.28 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 63' ' ' ASP . 1.3 mm? -111.43 125.72 54.18 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.577 0.703 . . . . 0.0 109.57 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.642 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.6 tt -129.66 112.91 14.15 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -162.88 174.13 12.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.41 -0.806 . . . . 0.0 109.568 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 87.7 m-20 -101.57 141.43 34.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.684 -0.635 . . . . 0.0 109.716 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.3 pt -143.34 145.54 32.56 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.565 -0.709 . . . . 0.0 109.464 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -48.5 144.28 14.18 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.989 1.792 . . . . 0.0 112.63 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.05 -24.06 67.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.6 -0.688 . . . . 0.0 110.191 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.86 -14.71 62.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 109.605 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -82.98 -12.58 57.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.399 -0.813 . . . . 0.0 110.501 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.471 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 11.2 pt -109.59 4.56 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.408 -0.808 . . . . 0.0 109.244 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.08 -17.19 59.06 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.75 130.82 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.864 -1.374 . . . . 0.0 110.39 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -86.05 99.18 11.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.534 -0.729 . . . . 0.0 109.362 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' LYS . . . -156.27 -8.17 0.07 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 55' ' ' GLY . 7.5 p-10 41.79 20.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.995 -0.709 . . . . 0.0 109.647 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 55' ' ' GLY . 26.2 pttm -101.51 145.33 29.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.521 -0.737 . . . . 0.0 109.671 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -75.83 138.39 41.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.517 -0.739 . . . . 0.0 109.81 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.52 161.11 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.69 -0.631 . . . . 0.0 109.699 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 96.3 m-20 -88.79 132.42 34.64 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.559 -0.713 . . . . 0.0 109.433 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.01 149.23 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 109.836 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 pt -131.55 151.98 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.414 0.626 . . . . 0.0 109.823 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 67.9 t0 -86.05 142.54 28.66 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.456 -0.778 . . . . 0.0 109.457 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.63 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -133.01 126.71 32.51 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.63 ' N ' HD13 ' A' ' 64' ' ' LEU . 65.6 tttm -88.96 126.72 35.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.642 -0.661 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 m -137.91 163.88 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.541 -0.724 . . . . 0.0 109.588 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -80.74 157.31 72.11 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.083 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' O ' HG12 ' A' ' 71' ' ' VAL . 17.7 Cg_endo -60.88 -18.02 54.37 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.6 2.2 . . . . 0.0 110.987 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -95.44 -27.83 15.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.534 -0.729 . . . . 0.0 109.597 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.7 mt -89.89 -2.96 58.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.262 -0.898 . . . . 0.0 109.852 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.559 HG23 HD11 ' A' ' 92' ' ' ILE . 7.5 p -64.87 -38.87 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.867 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.45 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -59.32 -42.79 97.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.0 m -68.58 -56.26 8.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.329 . . . . 0.0 110.639 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.56 HD12 HD22 ' A' ' 108' ' ' LEU . 2.9 tt -65.56 -43.5 89.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 0.0 110.811 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 82' ' ' PRO . 69.0 ttt-85 -67.81 -17.15 64.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.022 -1.049 . . . . 0.0 110.033 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -78.59 -31.52 47.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.032 -1.043 . . . . 0.0 108.94 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -58.24 146.11 71.81 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.241 -0.912 . . . . 0.0 110.264 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.71 148.31 58.63 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.332 2.021 . . . . 0.0 112.612 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.53 -17.89 46.01 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.726 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.0 mp -87.72 123.15 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.353 -1.087 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 65.7 m-85 -116.79 149.38 43.9 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.82 -0.55 . . . . 0.0 109.696 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HB3' ' HE ' ' A' ' 75' ' ' ARG . 51.7 Cg_endo -67.8 144.52 65.58 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.575 2.183 . . . . 0.0 112.15 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.83 144.9 55.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 109.989 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.485 ' CE1' ' CE1' ' A' ' 85' ' ' HIS . 43.9 p90 -78.1 9.0 4.05 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.438 -0.789 . . . . 0.0 109.334 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.485 ' CE1' ' CE1' ' A' ' 84' ' ' TYR . 96.3 m-70 -88.03 165.64 15.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 110.043 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.8 mtp -68.55 -8.39 41.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.621 ' C ' ' H ' ' A' ' 89' ' ' GLU . 32.7 m120 -77.73 -67.47 0.72 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.32 -0.862 . . . . 0.0 109.549 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 63.3 -26.76 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.95 -0.468 . . . . 0.0 109.77 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 87' ' ' ASN . 97.6 mt-10 -98.67 -63.86 1.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -59.35 -46.52 88.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.318 -0.863 . . . . 0.0 110.338 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.453 ' CE3' ' OD1' ' A' ' 87' ' ' ASN . 9.3 m0 -116.41 138.55 51.27 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.618 0.723 . . . . 0.0 110.006 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.559 HD11 HG23 ' A' ' 71' ' ' VAL . 88.8 mt -138.56 153.51 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.6 m -97.56 138.4 35.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 110.036 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.6 t -120.34 133.44 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.4 tp -88.63 109.43 20.1 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.594 0.712 . . . . 0.0 110.408 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.63 -39.32 88.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -69.17 -8.65 47.55 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -57.25 178.26 0.96 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.29 -12.75 25.44 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.976 2.451 . . . . 0.0 111.686 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 pp -68.28 137.18 54.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.347 -0.846 . . . . 0.0 110.266 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.7 176.02 47.53 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.158 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.0 77.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.789 -0.83 . . . . 0.0 109.459 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 103' ' ' LYS . 13.5 mptt -62.0 -40.49 95.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.406 -0.808 . . . . 0.0 108.82 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.9 -41.99 95.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.34 -0.85 . . . . 0.0 108.869 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.4 -43.06 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.441 -0.787 . . . . 0.0 109.482 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -56.15 -43.57 78.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.703 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.2 p -64.22 -41.92 96.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 109.719 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.56 HD22 HD12 ' A' ' 74' ' ' LEU . 94.7 mt -64.81 -39.75 94.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.602 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.73 -42.6 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.385 -0.822 . . . . 0.0 109.182 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -57.95 -39.26 77.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 109.083 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.45 -42.91 98.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.303 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 99.6 p -63.94 -34.74 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 109.36 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 117' ' ' ARG . 88.9 t80 -60.14 -44.78 94.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.404 -0.81 . . . . 0.0 109.306 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.37 -43.54 96.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.5 -41.26 96.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.445 -0.784 . . . . 0.0 110.14 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.442 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 67.2 p -99.41 14.71 28.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.366 -0.834 . . . . 0.0 109.275 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.5 ' HG2' ' H ' ' A' ' 119' ' ' GLU . 38.6 ttp-105 -43.06 122.8 2.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.166 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.1 11.42 39.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.521 -0.737 . . . . 0.0 109.088 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 117' ' ' ARG . 72.6 mm-40 -63.65 140.6 58.89 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.466 -0.771 . . . . 0.0 109.755 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.562 ' ND1' ' N ' ' A' ' 121' ' ' HIS . 60.4 t-80 -153.85 173.53 15.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.922 . . . . 0.0 109.981 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.562 ' N ' ' ND1' ' A' ' 120' ' ' HIS . 58.5 m170 -67.77 8.1 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.508 -0.745 . . . . 0.0 109.621 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' A' ' 120' ' ' HIS . 99.5 m-70 56.26 109.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.64 0.733 . . . . 0.0 110.382 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -66.95 -38.66 86.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.489 -0.757 . . . . 0.0 109.443 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -148.79 159.44 44.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.023 -179.509 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -93.57 -177.98 4.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 0.0 110.08 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.458 ' NH2' ' OD1' ' A' ' 60' ' ' ASP . 12.0 ptp85 -63.2 -32.9 74.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 109.541 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -56.44 -43.39 79.41 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.329 -0.857 . . . . 0.0 109.127 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.03 -42.44 84.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.067 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -62.05 -45.37 93.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.52 -0.737 . . . . 0.0 109.752 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.36 -43.09 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.408 -0.808 . . . . 0.0 109.36 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.72 -39.32 91.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.372 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -60.58 -44.46 96.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.818 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.06 86.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.521 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -65.19 -45.89 82.98 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 110.021 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.99 -37.27 83.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -63.71 -50.51 68.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.105 -0.997 . . . . 0.0 111.94 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -147.02 17.53 1.23 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.53 -1.357 . . . . 0.0 110.225 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 55.05 47.53 21.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.149 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.3 m -101.07 123.74 45.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.294 -0.879 . . . . 0.0 109.7 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' HB3' ' HZ3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -93.67 148.83 36.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 157.36 60.77 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.206 1.937 . . . . 0.0 112.672 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -108.71 155.15 21.06 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -136.85 86.56 21.15 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.478 -0.764 . . . . 0.0 110.047 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.78 -10.99 5.87 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.782 2.322 . . . . 0.0 110.393 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -102.04 98.66 8.83 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.5 0.667 . . . . 0.0 109.816 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 24' ' ' LYS . 14.9 pt-20 -68.55 -37.35 79.86 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.545 0.688 . . . . 0.0 109.658 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 23' ' ' GLU . 9.8 mtpm? -70.79 -3.54 19.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.479 -0.763 . . . . 0.0 110.788 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -142.95 77.38 16.25 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.078 -1.014 . . . . 0.0 110.018 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.66 -14.84 33.56 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.562 2.175 . . . . 0.0 112.099 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -78.72 -4.94 51.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.252 -0.905 . . . . 0.0 109.521 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -94.72 142.73 27.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.255 -0.903 . . . . 0.0 110.102 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.93 139.57 52.06 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -124.48 128.32 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.516 -0.74 . . . . 0.0 110.245 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.37 114.44 27.88 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 37' ' ' ASP . 77.8 ttt-85 -145.35 138.64 26.45 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.196 -0.94 . . . . 0.0 109.459 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.458 ' ND1' ' CD1' ' A' ' 39' ' ' TRP . 32.5 m170 -100.58 124.63 46.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.472 -0.767 . . . . 0.0 109.951 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.2 m -75.79 -22.71 56.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.428 -0.795 . . . . 0.0 109.983 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.64 -41.86 99.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.124 -0.985 . . . . 0.0 110.208 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 38' ' ' LYS . 12.3 m120 -93.49 4.07 54.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 0.0 108.531 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 98.8 m-20 47.56 11.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.77 . . . . 0.0 110.182 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 36' ' ' ASN . 8.4 mtmp? -139.99 -121.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.258 -0.901 . . . . 0.0 109.532 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.458 ' CD1' ' ND1' ' A' ' 33' ' ' HIS . 56.7 t-105 46.53 96.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.659 -0.651 . . . . 0.0 109.321 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -106.63 126.28 52.07 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.707 0.765 . . . . 0.0 109.981 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.06 128.53 10.68 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 140.55 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.943 -1.098 . . . . 0.0 109.812 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.6 130.74 55.49 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -157.19 157.88 35.2 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.943 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 33.6 p-10 -98.98 116.6 31.58 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 pt -125.74 145.8 52.85 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.688 -0.633 . . . . 0.0 109.722 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.2 139.05 22.02 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.811 1.674 . . . . 0.0 112.304 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.5 -22.03 65.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.191 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -62.67 -29.76 70.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.142 -0.974 . . . . 0.0 109.641 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.71 -40.55 95.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.802 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.472 HD12 HD12 ' A' ' 53' ' ' ILE . 12.2 pt -79.08 16.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.758 -1.214 . . . . 0.0 109.739 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.19 -8.24 58.36 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.443 -0.884 . . . . 0.0 110.927 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.472 HD12 HD12 ' A' ' 51' ' ' ILE . 80.9 mt -82.7 129.01 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.638 -1.507 . . . . 0.0 109.81 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -85.39 97.12 9.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.494 -0.754 . . . . 0.0 110.276 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.59 -16.96 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.516 -1.833 . . . . 0.0 108.516 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.424 ' OD1' ' O ' ' A' ' 56' ' ' ASP . 57.6 t0 51.19 19.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -1.032 . . . . 0.0 109.069 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -107.9 146.3 32.55 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.583 -0.698 . . . . 0.0 110.138 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -73.91 139.3 44.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.493 -0.754 . . . . 0.0 109.7 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.44 157.88 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.424 -0.797 . . . . 0.0 109.464 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.458 ' OD1' ' NH2' ' A' ' 3' ' ' ARG . 90.2 m-20 -91.21 131.32 36.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.466 -0.771 . . . . 0.0 109.755 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.26 158.6 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.535 -0.728 . . . . 0.0 109.446 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.5 pt -134.53 146.49 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.421 0.629 . . . . 0.0 109.614 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 64.4 t0 -79.29 134.78 36.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.407 -0.808 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -127.14 121.82 32.45 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.589 ' N ' HD13 ' A' ' 64' ' ' LEU . 7.3 tmtm? -83.89 134.83 34.67 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.418 -0.801 . . . . 0.0 110.114 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.0 m -143.84 164.28 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -93.32 155.34 41.04 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.521 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.507 ' O ' HG12 ' A' ' 71' ' ' VAL . 47.6 Cg_exo -48.75 -28.9 13.55 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.167 1.911 . . . . 0.0 111.26 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.02 -32.11 16.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.459 -0.776 . . . . 0.0 109.376 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.59 -5.25 58.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 109.466 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 68' ' ' PRO . 9.2 p -68.53 -40.44 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -0.909 . . . . 0.0 109.863 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.482 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.87 -44.0 96.75 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.5 t -64.73 -26.32 68.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.938 -1.331 . . . . 0.0 110.21 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.537 HD12 HD22 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -86.98 -33.89 19.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.866 -1.146 . . . . 0.0 109.829 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -76.21 -7.49 54.97 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.375 -0.828 . . . . 0.0 109.105 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -7.33 59.68 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.476 ' HB2' HD12 ' A' ' 80' ' ' ILE . 61.2 mttm -94.14 113.76 61.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.634 -0.667 . . . . 0.0 109.474 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.94 147.05 19.95 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.303 2.002 . . . . 0.0 113.282 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.07 -13.28 67.31 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 77' ' ' LYS . 15.4 mt -107.28 124.43 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.529 -0.983 . . . . 0.0 109.085 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.404 ' O ' ' OG1' ' A' ' 93' ' ' THR . 56.1 m-85 -119.47 150.07 49.04 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.76 -0.588 . . . . 0.0 110.01 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 83' ' ' ALA . 37.1 Cg_exo -56.13 149.45 53.66 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.124 1.882 . . . . 0.0 112.576 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . . . -45.99 174.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.825 0.822 . . . . 0.0 111.129 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.62 -71.73 0.28 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -137.97 140.95 40.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.551 -0.718 . . . . 0.0 109.934 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.0 mmm 57.59 154.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.738 0.78 . . . . 0.0 111.231 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.546 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 85.1 m-20 56.56 33.21 22.27 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.51 0.672 . . . . 0.0 109.388 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.463 ' O ' HD13 ' A' ' 92' ' ' ILE . 37.8 ttpt -63.27 -46.96 84.38 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.454 -0.779 . . . . 0.0 109.262 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -79.37 -35.87 40.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.122 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -66.35 -50.71 62.65 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.339 -0.851 . . . . 0.0 110.243 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.546 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 11.1 m0 -117.5 152.08 35.8 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.587 -0.696 . . . . 0.0 109.753 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 88' ' ' LYS . 6.4 mm -136.22 157.68 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.567 -0.708 . . . . 0.0 109.451 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 7.6 p -105.85 123.68 48.35 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.8 t -108.46 131.06 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.5 tp -89.91 104.18 16.77 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.206 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.06 -39.49 86.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.539 -0.725 . . . . 0.0 109.264 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -69.28 -6.1 27.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.41 -0.806 . . . . 0.0 109.047 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -77.83 -162.26 18.12 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.72 6.26 5.89 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.348 2.699 . . . . 0.0 111.564 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.71 130.94 48.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 110.254 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.91 154.79 24.91 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.38 95.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.543 -0.975 . . . . 0.0 109.297 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.71 -42.08 95.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.943 . . . . 0.0 109.074 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -66.03 -43.95 86.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.446 -0.784 . . . . 0.0 109.198 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.58 -43.48 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.069 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -60.43 -43.57 96.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.462 -0.774 . . . . 0.0 109.654 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -62.77 -42.72 99.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.819 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.537 HD22 HD12 ' A' ' 74' ' ' LEU . 95.1 mt -64.79 -41.92 95.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.931 . . . . 0.0 109.584 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.79 -43.17 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.872 . . . . 0.0 108.919 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -61.19 -41.99 97.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -64.04 -41.58 97.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.7 p -66.07 -33.91 76.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.79 . . . . 0.0 109.304 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.25 -47.93 83.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.633 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.49 -29.03 63.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.94 -42.23 97.39 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.185 -0.947 . . . . 0.0 109.511 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 117' ' ' ARG . 62.2 p -97.11 14.73 24.75 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.569 -0.707 . . . . 0.0 109.1 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.475 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 77.7 ttt-85 -40.78 -95.57 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.881 -0.512 . . . . 0.0 110.167 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.51 93.04 1.17 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.86 82.86 1.94 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -152.59 -59.99 0.15 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -84.08 138.69 32.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.649 -0.657 . . . . 0.0 110.22 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -148.55 -25.81 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -67.37 -39.35 85.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.476 -0.765 . . . . 0.0 109.664 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -65.79 -41.7 91.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.838 . . . . 0.0 109.705 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.527 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.326 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpp . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -105.77 163.85 12.39 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.553 -0.717 . . . . 0.0 110.019 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -61.48 -43.25 99.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.585 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -64.26 -40.91 96.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.452 -0.78 . . . . 0.0 109.754 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.89 -42.27 94.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 109.572 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.42 -45.03 96.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.767 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.29 -44.67 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.26 -0.9 . . . . 0.0 109.153 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.63 -44.13 94.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.816 . . . . 0.0 109.487 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -64.15 -42.1 96.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.483 -0.76 . . . . 0.0 109.872 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.5 -54.31 48.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.379 -0.826 . . . . 0.0 110.698 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -64.9 -33.1 75.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.244 -0.91 . . . . 0.0 109.756 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -60.57 -46.59 89.65 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 109.791 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -87.2 -37.61 17.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.348 -0.845 . . . . 0.0 111.416 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 77.2 m-85 -94.57 -0.73 54.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.924 -1.11 . . . . 0.0 111.115 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 14' ' ' TYR . 3.4 p30 40.97 35.61 0.36 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.379 -0.825 . . . . 0.0 109.907 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.6 t -118.64 143.88 46.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.566 -0.709 . . . . 0.0 109.359 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -96.23 151.81 38.4 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.308 -0.87 . . . . 0.0 109.564 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.22 149.55 85.32 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.469 2.112 . . . . 0.0 112.162 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 66.1 t0 -132.8 138.51 47.14 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.517 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 14.8 p-80 -131.24 85.58 53.43 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -79.29 -10.52 14.87 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.943 1.762 . . . . 0.0 111.14 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -89.15 102.87 15.52 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.456 0.646 . . . . 0.0 109.555 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.86 -33.84 74.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -0.766 . . . . 0.0 109.592 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 25' ' ' PHE . 60.1 mttp -68.06 -5.75 19.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.348 -0.845 . . . . 0.0 109.849 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 24' ' ' LYS . 64.1 m-85 -153.29 83.84 4.49 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.202 -0.936 . . . . 0.0 109.463 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.4 -15.61 31.15 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.565 1.51 . . . . 0.0 111.209 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.63 -5.92 47.84 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.4 m-85 -86.08 141.68 29.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 109.106 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.98 135.93 38.08 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.4 HG11 ' NH1' ' A' ' 32' ' ' ARG . 3.1 t -117.44 126.01 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 93.9 m-85 -110.26 122.66 48.2 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.4 ' NH1' HG11 ' A' ' 30' ' ' VAL . 95.6 mtm-85 -134.3 155.22 50.6 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.051 -1.031 . . . . 0.0 109.267 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 37' ' ' ASP . 1.4 t-160 -85.42 113.84 22.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.317 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 t -65.35 -23.43 66.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.525 -0.735 . . . . 0.0 109.799 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.8 -44.57 92.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.377 -0.827 . . . . 0.0 110.639 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.541 ' OD1' ' N ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -122.48 -26.73 4.53 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.377 -0.827 . . . . 0.0 109.63 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 33' ' ' HIS . 54.4 m-20 58.49 -159.12 0.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.438 0.637 . . . . 0.0 109.938 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 59.9 24.51 13.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.934 -0.479 . . . . 0.0 110.274 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.405 ' HE1' ' HB2' ' A' ' 36' ' ' ASN . 44.0 m95 -112.25 149.02 32.91 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.396 -0.815 . . . . 0.0 109.553 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -113.71 131.53 56.14 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.676 0.75 . . . . 0.0 110.239 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 31' ' ' PHE . . . -151.15 105.62 3.24 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.2 mm? -107.58 131.89 53.87 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.724 0.773 . . . . 0.0 110.417 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 tt -126.76 120.29 28.99 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.592 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 3.7 ptt? -160.41 164.19 32.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.01 . . . . 0.0 109.507 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 96.9 m-20 -98.38 118.78 35.81 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.2 pt -120.73 145.95 42.36 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.44 -0.788 . . . . 0.0 109.45 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.21 141.74 96.67 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.902 1.735 . . . . 0.0 112.719 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.19 -20.74 65.69 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.493 0.663 . . . . 0.0 109.263 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 56' ' ' ASP . 95.6 mt-10 -53.69 -36.0 61.72 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.625 -0.672 . . . . 0.0 109.899 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.05 -39.01 93.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 110.317 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.9 HD12 HD12 ' A' ' 53' ' ' ILE . 5.2 pt -92.94 -0.94 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.08 36.44 85.73 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.153 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.9 HD12 HD12 ' A' ' 51' ' ' ILE . 6.0 mt -104.46 133.63 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.182 -1.187 . . . . 0.0 109.713 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 52.77 -83.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.707 -0.621 . . . . 0.0 109.806 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . 143.46 114.65 1.0 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.6 OUTLIER 61.47 39.35 15.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.623 -0.928 . . . . 0.0 110.67 178.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -113.46 118.63 35.04 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -72.39 133.35 44.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.181 -0.949 . . . . 0.0 109.516 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.11 161.66 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 20.3 m-20 -99.43 138.07 37.03 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.29 -0.881 . . . . 0.0 109.444 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.75 156.59 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.304 -0.872 . . . . 0.0 109.344 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.8 pt -133.74 157.98 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.549 0.69 . . . . 0.0 109.702 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 42' ' ' LEU . 44.5 t0 -90.48 122.07 32.99 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.539 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -115.85 120.47 39.36 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.539 ' N ' HD13 ' A' ' 64' ' ' LEU . 37.9 ttmt -84.23 135.55 34.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.321 -0.862 . . . . 0.0 109.849 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.604 HG11 HD13 ' A' ' 74' ' ' LEU . 30.0 m -143.29 169.65 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.287 -0.883 . . . . 0.0 109.63 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -78.11 153.59 79.86 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.583 -0.698 . . . . 0.0 109.489 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' O ' HG12 ' A' ' 71' ' ' VAL . 28.8 Cg_endo -63.77 -19.26 66.81 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.256 1.97 . . . . 0.0 111.313 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -91.42 -27.56 18.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.763 . . . . 0.0 109.395 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.21 7.62 44.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.322 -0.861 . . . . 0.0 109.221 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 72' ' ' GLY . 7.1 p -63.26 -37.53 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.465 -0.772 . . . . 0.0 109.981 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -78.3 -15.1 81.47 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.522 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -71.25 -60.6 2.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.014 -1.286 . . . . 0.0 110.737 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.737 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -75.49 -37.23 60.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.184 -0.947 . . . . 0.0 110.537 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.432 ' HE ' ' HB3' ' A' ' 82' ' ' PRO . 79.0 ttt-85 -60.61 -33.07 72.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.389 -0.819 . . . . 0.0 109.475 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -32.84 73.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.315 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -68.09 120.36 73.78 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.176 -0.952 . . . . 0.0 110.059 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.05 147.28 20.06 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.938 1.759 . . . . 0.0 112.61 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.88 -22.56 34.97 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.8 mt -105.85 120.89 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.535 -0.98 . . . . 0.0 109.279 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -107.08 150.76 40.27 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.497 -0.752 . . . . 0.0 109.923 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.502 ' CB ' ' HZ2' ' A' ' 88' ' ' LYS . 53.6 Cg_endo -69.41 159.15 54.8 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.223 1.949 . . . . 0.0 111.92 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.03 142.37 58.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 109.984 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -79.29 12.9 2.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 109.843 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -156.63 -161.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -0.919 . . . . 0.0 110.176 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 78.9 mtm -52.77 -175.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.571 0.701 . . . . 0.0 111.078 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.9 m120 59.1 33.19 22.74 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.514 0.673 . . . . 0.0 109.687 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.502 ' HZ2' ' CB ' ' A' ' 82' ' ' PRO . 64.4 tttp -64.65 -39.22 93.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.556 -0.715 . . . . 0.0 109.605 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.28 -16.99 29.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.116 -0.99 . . . . 0.0 109.934 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -94.48 -53.33 3.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.24 -0.913 . . . . 0.0 110.358 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -111.19 131.32 55.21 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.389 -0.819 . . . . 0.0 109.781 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.98 141.12 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.4 m -86.77 129.46 34.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.218 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.1 t -114.16 133.17 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.1 tp -91.05 108.51 19.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.648 -0.657 . . . . 0.0 109.923 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.34 -39.46 92.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.53 -0.731 . . . . 0.0 109.086 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -76.03 5.56 6.48 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.5 -0.75 . . . . 0.0 109.034 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.51 -176.44 20.43 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.42 -6.59 14.7 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.113 2.542 . . . . 0.0 111.701 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.83 145.84 48.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.646 -0.659 . . . . 0.0 109.794 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.08 173.01 31.28 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.55 -29.1 70.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.653 -0.91 . . . . 0.0 109.332 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.18 -41.31 98.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.456 -0.778 . . . . 0.0 109.234 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 104' ' ' GLU . 58.2 mp0 -65.69 -41.61 92.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.19 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.38 -43.42 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.418 -0.801 . . . . 0.0 109.931 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -56.03 -45.75 79.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.83 . . . . 0.0 109.589 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.6 t -61.94 -44.27 97.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.4 -0.812 . . . . 0.0 109.935 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.9 -41.32 99.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.427 -0.796 . . . . 0.0 109.658 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.77 -43.18 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -56.29 -43.69 79.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 0.0 109.089 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -60.06 -44.75 94.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.365 -0.835 . . . . 0.0 109.09 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.7 p -70.38 -27.18 64.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.258 -0.902 . . . . 0.0 109.983 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.07 -44.85 91.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.331 -0.856 . . . . 0.0 109.382 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -58.46 -43.31 88.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.893 . . . . 0.0 109.653 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.9 mp -63.33 -39.59 94.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.262 -0.899 . . . . 0.0 109.512 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.0 p -88.98 4.94 46.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.461 -0.774 . . . . 0.0 109.62 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -74.06 145.77 44.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.404 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.2 tp -67.11 136.07 54.57 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -77.75 110.37 12.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 109.709 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.429 ' CG ' ' O ' ' A' ' 120' ' ' HIS . 85.8 t60 -96.52 10.33 38.7 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.427 -0.796 . . . . 0.0 108.898 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 50.3 m80 54.5 175.44 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.367 0.603 . . . . 0.0 110.524 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -144.49 141.11 29.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.388 -0.82 . . . . 0.0 109.783 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -79.01 144.52 34.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.394 -0.816 . . . . 0.0 110.192 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -65.05 145.77 55.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.494 -0.754 . . . . 0.0 110.024 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.526 ' OXT' ' CG ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.413 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.438 ' OD1' ' OE1' ' A' ' 5' ' ' GLN . 28.7 p30 -152.77 -179.03 7.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.22 -0.925 . . . . 0.0 109.536 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.615 ' HE ' HD21 ' A' ' 43' ' ' LEU . 12.6 ptm180 -61.53 -33.0 73.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.456 -0.778 . . . . 0.0 109.369 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.587 HE22 ' CG ' ' A' ' 8' ' ' ASP . 4.5 tm0? -61.36 -44.12 97.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 110.001 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.438 ' OE1' ' OD1' ' A' ' 2' ' ' ASN . 4.3 mp0 -64.44 -38.42 90.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 108.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -60.2 -45.12 94.25 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.309 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.74 -44.83 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.3 -0.875 . . . . 0.0 109.547 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.587 ' CG ' HE22 ' A' ' 4' ' ' GLN . 54.4 m-20 -64.73 -46.11 83.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 108.727 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -63.48 -39.91 95.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.383 -0.823 . . . . 0.0 109.093 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.09 -43.56 70.47 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.461 -0.774 . . . . 0.0 109.679 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 86.0 mt-30 -67.21 -40.63 86.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.156 -0.965 . . . . 0.0 109.651 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -63.4 -38.17 90.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.852 -1.155 . . . . 0.0 109.265 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -86.76 -35.84 18.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 111.691 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -118.74 -20.8 8.12 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.134 -0.978 . . . . 0.0 111.032 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 44.2 t0 59.0 38.66 24.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.949 -1.094 . . . . 0.0 109.118 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -107.07 135.79 48.03 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.558 -0.714 . . . . 0.0 109.334 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -82.15 131.21 57.06 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.837 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.52 143.11 22.04 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.17 1.914 . . . . 0.0 112.982 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -127.72 121.89 31.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.634 -0.666 . . . . 0.0 109.276 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.48 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -119.62 86.83 35.64 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.2 -37.13 87.66 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.462 2.108 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.476 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -87.81 83.87 7.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 0.0 109.064 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -54.59 -14.43 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.458 -0.776 . . . . 0.0 109.564 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -76.18 -2.62 32.06 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -141.25 75.63 22.92 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.287 -0.883 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.65 -31.42 91.86 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.723 2.282 . . . . 0.0 111.327 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.472 ' O ' ' NH2' ' A' ' 3' ' ' ARG . 98.9 m-20 -68.22 -16.04 63.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.401 -0.812 . . . . 0.0 109.347 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -92.56 132.16 37.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 0.0 109.213 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.09 141.07 50.12 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.15 133.55 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 109.043 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -107.95 143.81 36.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.56 -0.712 . . . . 0.0 109.217 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -132.85 129.68 38.77 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.34 -0.85 . . . . 0.0 110.051 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.467 ' H ' ' HB2' ' A' ' 39' ' ' TRP . 80.2 m80 -103.28 111.99 24.65 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.0 p -88.21 -16.66 32.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -94.39 -0.73 54.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.183 -0.948 . . . . 0.0 110.337 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 38' ' ' LYS . 20.3 t-20 -115.99 29.8 7.75 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.382 -0.823 . . . . 0.0 109.854 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 67.9 t0 46.68 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.575 -0.703 . . . . 0.0 110.511 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.1 tttt -79.98 136.15 36.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' A' ' 39' ' ' TRP . 7.8 p90 -141.96 141.38 32.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.281 -0.887 . . . . 0.0 110.607 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 39' ' ' TRP . 29.0 m-85 -159.51 119.96 3.1 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.517 ' C ' HD22 ' A' ' 42' ' ' LEU . . . -156.83 105.4 2.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 108.769 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.2 mm? -113.09 125.01 53.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.537 -0.727 . . . . 0.0 109.286 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.634 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.8 tt -123.59 116.71 23.58 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -162.74 167.46 22.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.026 -1.046 . . . . 0.0 109.499 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.523 ' OD2' ' NH2' ' A' ' 58' ' ' ARG . 34.7 p-10 -106.95 116.75 32.47 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.6 pt -118.71 146.65 40.44 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.837 -0.539 . . . . 0.0 110.248 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.27 145.33 11.5 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.104 1.869 . . . . 0.0 112.846 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -61.44 -21.48 64.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.948 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 54' ' ' ASN . 61.9 mm-40 -70.31 -15.41 62.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.917 -1.114 . . . . 0.0 110.28 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -84.67 -10.99 56.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.982 -1.074 . . . . 0.0 110.605 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.445 ' CD1' HD12 ' A' ' 53' ' ' ILE . 4.7 pt -104.53 2.82 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.216 -0.927 . . . . 0.0 109.027 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.69 -5.0 69.53 Favored Glycine 0 N--CA 1.496 2.662 0 O-C-N 121.245 -0.91 . . . . 0.0 110.854 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 55' ' ' GLY . 86.6 mt -81.47 138.09 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.912 -1.346 . . . . 0.0 110.235 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.425 ' O ' ' OE2' ' A' ' 49' ' ' GLU . 56.4 m-80 -61.58 -39.34 90.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.603 -0.686 . . . . 0.0 109.397 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 53' ' ' ILE . . . -42.59 139.8 2.4 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 36.9 p-10 -103.33 14.0 32.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.973 . . . . 0.0 109.065 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 78.5 tttt -82.15 143.06 31.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.366 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 84.9 mtp180 -72.48 144.28 48.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.51 -0.744 . . . . 0.0 109.99 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HB ' HD11 ' A' ' 95' ' ' LEU . 27.3 m -136.36 162.89 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.495 -0.753 . . . . 0.0 110.003 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -97.37 136.93 37.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.474 -0.766 . . . . 0.0 109.789 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.37 155.59 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.39 -0.819 . . . . 0.0 110.374 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.2 pt -138.32 150.51 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.98 152.38 26.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 110.065 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.622 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -141.1 125.06 17.13 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.35 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.622 ' N ' HD13 ' A' ' 64' ' ' LEU . 3.5 pttm -84.84 131.06 34.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.94 . . . . 0.0 109.359 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.97 165.31 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.269 -0.894 . . . . 0.0 109.445 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -87.41 157.99 52.36 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 109.086 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.71 -21.03 68.19 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.577 2.185 . . . . 0.0 111.352 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -95.01 -29.39 14.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.063 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.47 -3.47 49.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 109.81 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.1 p -65.08 -36.14 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.058 -1.027 . . . . 0.0 109.591 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.45 99.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.5 m -61.7 -42.7 99.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.27 . . . . 0.0 110.47 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.484 HD12 HD22 ' A' ' 108' ' ' LEU . 3.5 tt -85.0 -31.82 23.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.059 -1.026 . . . . 0.0 110.376 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -77.02 -21.87 53.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.114 -0.991 . . . . 0.0 110.401 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -85.61 -2.86 58.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 109.21 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HB2' HD12 ' A' ' 80' ' ' ILE . 50.3 mttm -77.41 151.56 80.78 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 80' ' ' ILE . 73.7 Cg_endo -72.28 151.64 54.67 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.864 2.376 . . . . 0.0 112.565 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.04 -20.12 2.59 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 77' ' ' LYS . 72.2 mt -97.43 116.12 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -1.117 . . . . 0.0 108.363 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.408 ' O ' ' OG1' ' A' ' 93' ' ' THR . 18.1 m-85 -123.08 161.22 46.0 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.887 -0.508 . . . . 0.0 110.087 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.61 153.07 69.51 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.006 1.804 . . . . 0.0 111.961 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.33 140.37 33.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 110.585 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -74.77 7.62 2.97 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.473 -0.767 . . . . 0.0 109.125 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.406 ' O ' ' C ' ' A' ' 86' ' ' MET . 51.6 p-80 -157.7 -172.73 4.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 85' ' ' HIS . 79.0 mtm -38.06 158.92 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.457 0.646 . . . . 0.0 111.623 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 m120 72.96 79.96 0.14 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.426 0.631 . . . . 0.0 110.339 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -114.16 -36.3 4.76 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 109.547 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.81 -85.13 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.946 -1.096 . . . . 0.0 111.087 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 81.0 m80 -67.92 -33.38 74.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 110.677 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.439 ' HE1' ' CB ' ' A' ' 40' ' ' TYR . 24.8 m-90 -93.93 130.62 39.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.014 . . . . 0.0 110.542 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.0 mm -134.89 143.8 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.437 -0.79 . . . . 0.0 109.021 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 1.1 p -91.51 134.57 34.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.485 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.82 133.82 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.411 HD11 ' HB ' ' A' ' 59' ' ' VAL . 46.6 tp -91.47 123.74 35.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.688 -0.633 . . . . 0.0 109.897 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.6 mt -87.64 -13.93 41.36 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -94.39 0.21 55.3 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 100' ' ' LEU . . . -89.14 -165.45 41.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.62 9.01 0.36 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 123.225 2.617 . . . . 0.0 111.259 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.7 mm? -70.35 124.86 25.2 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.16 161.47 20.8 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.28 89.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.567 -0.961 . . . . 0.0 109.364 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -64.72 -41.7 95.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -65.07 -44.93 87.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -0.806 . . . . 0.0 109.595 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.21 -43.4 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.276 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -58.98 -42.68 90.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -61.34 -44.02 97.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 109.95 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.484 HD22 HD12 ' A' ' 74' ' ' LEU . 96.2 mt -63.99 -41.81 97.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.348 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.66 -42.77 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.388 -0.82 . . . . 0.0 109.187 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -55.54 -42.42 74.58 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.203 -0.935 . . . . 0.0 109.09 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -63.36 -40.65 97.85 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.343 -0.848 . . . . 0.0 109.19 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.454 ' OG ' HD11 ' A' ' 64' ' ' LEU . 1.4 m -63.24 -36.86 85.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.434 -0.791 . . . . 0.0 109.325 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -60.54 -47.27 86.92 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.426 -0.796 . . . . 0.0 110.409 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.415 ' HG2' ' H ' ' A' ' 114' ' ' GLN . 4.6 pt20 -77.0 -20.59 55.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 0.0 109.856 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.68 -42.01 98.35 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.16 -0.962 . . . . 0.0 109.951 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.487 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 6.2 p -101.21 16.77 24.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.453 -0.779 . . . . 0.0 109.364 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -37.84 138.94 0.35 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.726 0.774 . . . . 0.0 110.844 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 67.7 mt -73.98 150.49 40.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.631 -0.668 . . . . 0.0 110.569 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 56.15 27.95 12.32 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.579 0.704 . . . . 0.0 109.769 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -67.18 -40.14 86.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.403 -0.811 . . . . 0.0 109.68 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -68.44 119.4 12.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -84.77 136.12 33.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 109.945 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -144.95 143.37 30.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.168 -0.957 . . . . 0.0 109.424 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -60.14 -40.96 91.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.38 -0.825 . . . . 0.0 109.823 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.519 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 85.7 t60 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.196 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.317 0.579 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.72 165.34 12.35 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.301 -0.874 . . . . 0.0 110.189 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.63 -43.83 97.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.464 -0.773 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -62.65 -39.47 93.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 109.909 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -63.34 -37.5 87.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.94 . . . . 0.0 109.545 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.52 -44.31 96.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.441 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.46 -45.06 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.158 -0.963 . . . . 0.0 109.43 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -61.82 -44.29 97.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.968 . . . . 0.0 109.64 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.518 ' CD1' ' NE2' ' A' ' 106' ' ' HIS . 80.3 t80 -61.66 -47.18 86.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.837 . . . . 0.0 109.668 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.62 87.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 109.868 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.543 ' O ' ' N ' ' A' ' 15' ' ' ASP . 7.2 tp-100 -64.34 -48.59 74.97 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.453 -0.78 . . . . 0.0 109.932 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -65.44 -35.18 80.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.997 -1.064 . . . . 0.0 109.674 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -82.08 -35.8 28.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.349 -0.844 . . . . 0.0 111.737 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CG ' ' NE2' ' A' ' 33' ' ' HIS . 78.1 m-85 -124.2 -20.71 5.19 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.033 -1.042 . . . . 0.0 110.998 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 11' ' ' GLN . 56.2 t0 56.92 36.31 27.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 109.026 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -108.4 148.64 29.84 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.54 -0.725 . . . . 0.0 109.371 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.435 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 13.0 mptt -91.84 153.15 43.61 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.201 -0.937 . . . . 0.0 109.298 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.0 154.78 73.52 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.474 2.116 . . . . 0.0 111.66 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -139.72 142.05 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 109.118 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -127.54 86.14 59.2 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -55.56 -36.75 95.08 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.273 1.982 . . . . 0.0 110.708 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -81.24 106.31 13.12 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.466 0.65 . . . . 0.0 109.53 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -66.42 -21.26 66.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.417 -0.802 . . . . 0.0 109.613 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -78.6 -3.88 46.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.316 -0.865 . . . . 0.0 109.49 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -137.74 66.46 48.95 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.35 -19.25 49.92 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.301 2.001 . . . . 0.0 111.616 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -81.19 -5.79 58.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -90.18 147.58 23.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.24 -0.912 . . . . 0.0 109.215 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.03 131.65 53.58 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.53 -0.731 . . . . 0.0 109.363 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.78 132.04 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -111.97 137.53 49.85 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.356 -0.84 . . . . 0.0 109.488 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.456 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . 13.3 ptp180 -139.44 132.23 29.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.203 -0.936 . . . . 0.0 109.33 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.592 ' NE2' ' CG ' ' A' ' 14' ' ' TYR . 70.2 m80 -100.76 110.16 22.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.294 -0.879 . . . . 0.0 109.363 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -78.4 -12.29 60.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.83 -1.66 58.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 110.02 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' LYS . 74.4 m-80 -119.79 19.57 12.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.506 -0.747 . . . . 0.0 109.217 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.403 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 67.0 t0 56.82 -76.84 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.814 -0.554 . . . . 0.0 109.879 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 54.0 mtmt -83.81 152.71 24.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.88 . . . . 0.0 109.958 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.561 ' CD1' ' O ' ' A' ' 39' ' ' TRP . 8.1 p90 -168.19 140.23 2.92 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.264 -0.897 . . . . 0.0 109.587 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -150.86 121.46 7.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.996 -1.065 . . . . 0.0 108.582 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.54 104.86 2.59 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -114.47 116.19 28.46 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.546 ' N ' HD13 ' A' ' 42' ' ' LEU . 7.4 tt -120.15 126.45 50.72 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -157.9 150.96 23.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.143 -0.973 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -97.75 117.21 31.55 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 23.3 pt -125.01 147.01 55.45 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.388 -0.82 . . . . 0.0 110.295 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -48.37 144.12 13.99 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.873 1.715 . . . . 0.0 112.262 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -63.84 -22.73 67.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -0.837 . . . . 0.0 110.258 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 10.7 pt-20 -71.99 -13.5 61.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.022 . . . . 0.0 109.94 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -84.61 -10.66 57.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.148 -0.97 . . . . 0.0 110.677 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.456 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 8.5 pt -104.89 5.17 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.101 -0.999 . . . . 0.0 109.56 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 -7.42 60.64 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 121.186 -0.946 . . . . 0.0 111.018 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 55' ' ' GLY . 88.2 mt -79.04 142.05 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.874 -1.369 . . . . 0.0 110.448 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.88 -39.95 93.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 110.048 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.564 ' H ' HG22 ' A' ' 53' ' ' ILE . . . -58.75 142.82 45.58 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.039 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -101.94 7.49 41.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.557 -0.966 . . . . 0.0 108.709 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -63.52 139.75 58.8 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 110.303 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -69.53 136.34 51.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.585 -0.697 . . . . 0.0 110.274 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.07 161.27 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.522 -0.736 . . . . 0.0 109.313 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -101.55 133.23 46.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 0.0 109.806 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 m -132.59 157.91 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.446 -0.783 . . . . 0.0 110.111 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 pt -136.66 153.4 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -118.45 126.98 53.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.451 -0.781 . . . . 0.0 109.656 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.4 160.31 30.83 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.851 0.834 . . . . 0.0 109.259 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -84.09 136.51 33.98 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.844 -0.535 . . . . 0.0 109.803 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.654 HG11 HD13 ' A' ' 74' ' ' LEU . 4.2 m -133.23 163.72 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -73.78 145.49 84.31 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.044 -1.035 . . . . 0.0 109.814 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.61 ' O ' HG12 ' A' ' 71' ' ' VAL . 49.7 Cg_exo -49.24 -30.23 18.95 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.268 1.979 . . . . 0.0 111.966 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -85.32 -28.0 25.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.416 -0.802 . . . . 0.0 110.238 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.58 0.94 55.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.108 -0.995 . . . . 0.0 109.968 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 68' ' ' PRO . 7.4 p -63.45 -43.7 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.919 -1.113 . . . . 0.0 109.281 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.548 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -66.18 -48.46 64.55 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 t -61.33 -49.55 76.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.167 -1.196 . . . . 0.0 110.693 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.654 HD13 HG11 ' A' ' 66' ' ' VAL . 2.0 tt -67.24 -42.7 83.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.813 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -75.29 -7.38 53.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.391 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -28.61 16.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -61.79 149.72 84.33 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.402 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' O ' HD12 ' A' ' 80' ' ' ILE . 24.7 Cg_exo -62.77 146.02 95.01 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 122.215 1.943 . . . . 0.0 113.058 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.06 -28.92 5.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.774 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.7 mp -83.65 128.41 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -1.215 . . . . 0.0 109.402 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 49.3 m-85 -124.07 153.03 67.86 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.801 -0.562 . . . . 0.0 109.773 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' O ' ' OG1' ' A' ' 93' ' ' THR . 53.9 Cg_exo -45.15 159.52 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.115 1.876 . . . . 0.0 112.089 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.72 144.05 56.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.144 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 88.0 t80 -89.28 4.27 49.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.805 . . . . 0.0 109.246 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 86' ' ' MET . 33.0 t-80 -105.7 177.91 4.71 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.45 -0.781 . . . . 0.0 110.265 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.613 ' H ' ' CG ' ' A' ' 85' ' ' HIS . 91.7 mtp -64.69 -39.71 94.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.55 -0.719 . . . . 0.0 110.143 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -74.99 130.65 39.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.202 -0.936 . . . . 0.0 110.519 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -146.55 96.23 2.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -178.77 -43.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -111.9 -23.9 10.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 109.378 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.85 ' C ' HD12 ' A' ' 92' ' ' ILE . 2.0 m-90 -111.76 132.91 54.33 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.43 -0.794 . . . . 0.0 109.495 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.85 HD12 ' C ' ' A' ' 91' ' ' TRP . 3.0 mp -137.06 147.56 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.218 -0.926 . . . . 0.0 109.006 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 82' ' ' PRO . 3.2 p -87.49 147.6 25.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.602 -0.686 . . . . 0.0 110.051 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.43 134.72 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.4 tp -87.04 112.44 21.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 0.0 110.104 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.93 -38.68 83.19 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.44 -0.788 . . . . 0.0 108.996 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -73.81 -0.1 14.81 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.35 171.56 19.24 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.79 -16.03 33.23 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 123.365 2.71 . . . . 0.0 111.972 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.22 138.7 58.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.95 169.29 54.98 Favored Glycine 0 N--CA 1.493 2.439 0 CA-C-O 122.079 0.822 . . . . 0.0 111.222 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.63 -36.11 83.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.691 -0.887 . . . . 0.0 109.716 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -61.44 -38.75 88.29 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.356 -0.84 . . . . 0.0 108.986 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.09 -37.66 88.22 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.432 -0.792 . . . . 0.0 109.431 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.94 -43.87 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.968 . . . . 0.0 109.527 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.518 ' NE2' ' CD1' ' A' ' 9' ' ' TYR . 48.4 m170 -61.47 -42.76 99.27 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.153 -0.967 . . . . 0.0 109.659 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -62.21 -44.66 96.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.7 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.66 -44.05 91.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.706 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.39 -42.83 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.309 -0.869 . . . . 0.0 109.476 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -53.9 -41.33 67.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.273 -0.892 . . . . 0.0 109.137 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.97 -44.74 96.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.5 m -60.64 -37.54 81.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.57 -43.4 97.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.221 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -51.45 -40.05 58.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 110.049 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 115' ' ' LEU . 9.0 mp -63.49 -40.06 96.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.878 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 117' ' ' ARG . 5.6 p -92.19 6.53 46.3 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -0.964 . . . . 0.0 109.538 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 116' ' ' THR . 53.3 ptt85 -40.16 162.14 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.566 0.698 . . . . 0.0 110.922 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.0 mt -83.75 136.14 34.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.467 -0.771 . . . . 0.0 110.327 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -78.44 163.61 25.48 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.613 0.721 . . . . 0.0 110.283 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 54.25 -92.74 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.546 -0.721 . . . . 0.0 110.632 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -75.32 119.13 19.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.389 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -96.5 -7.28 35.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.5 m170 53.18 84.82 0.05 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.596 -0.69 . . . . 0.0 109.92 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -75.28 141.54 43.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.53 -0.731 . . . . 0.0 109.993 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.841 179.833 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 ttm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -100.23 161.66 13.46 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.26 -0.9 . . . . 0.0 110.221 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -61.54 -42.99 99.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.771 . . . . 0.0 109.689 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -61.38 -39.22 89.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.791 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.46 -37.08 85.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.456 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -60.7 -44.23 96.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.72 -46.45 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.261 -0.899 . . . . 0.0 109.653 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.41 -41.34 98.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -60.64 -49.9 75.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 109.446 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.38 80.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 15' ' ' ASP . 35.3 tt0 -62.83 -50.39 71.15 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.271 -0.893 . . . . 0.0 109.979 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.48 -40.49 97.25 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.628 -1.295 . . . . 0.0 109.132 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -70.33 -46.42 64.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.864 . . . . 0.0 112.129 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CE1' ' CE1' ' A' ' 33' ' ' HIS . 86.4 m-85 -120.43 -17.97 8.02 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.026 -1.046 . . . . 0.0 111.547 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 11' ' ' GLN . 30.1 t0 60.94 42.38 12.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.927 -1.108 . . . . 0.0 109.457 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.4 t -108.41 136.4 48.11 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -92.9 157.34 39.53 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.094 -1.004 . . . . 0.0 109.779 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.88 143.7 90.64 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.761 1.641 . . . . 0.0 112.775 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -132.28 135.67 46.4 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -133.72 85.1 42.81 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.184 -0.948 . . . . 0.0 109.376 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.77 -34.94 97.51 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.499 2.133 . . . . 0.0 111.394 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -85.87 110.88 19.71 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.572 -0.705 . . . . 0.0 109.625 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -68.56 -31.09 70.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.838 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -67.2 -4.35 10.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.923 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -133.33 70.49 77.16 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.433 -0.792 . . . . 0.0 108.939 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.68 -16.34 33.68 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.229 1.952 . . . . 0.0 111.883 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 22.7 p-10 -88.68 0.27 56.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.336 -0.853 . . . . 0.0 109.258 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.0 m-85 -92.71 139.19 30.81 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.197 -0.939 . . . . 0.0 109.186 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.46 114.92 21.36 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.75 128.28 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.419 -0.801 . . . . 0.0 109.012 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -111.47 134.19 53.22 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.66 -0.65 . . . . 0.0 109.262 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -145.19 150.67 37.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.235 -0.916 . . . . 0.0 109.291 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 14' ' ' TYR . 64.1 m170 -100.08 160.99 13.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.339 -0.851 . . . . 0.0 109.926 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.3 t -102.91 -50.91 3.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.226 -0.921 . . . . 0.0 110.132 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -96.86 -0.82 47.2 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.097 -1.002 . . . . 0.0 110.83 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 116' ' ' THR . 14.2 t-20 -104.99 31.82 4.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.162 -0.961 . . . . 0.0 109.129 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 38' ' ' LYS . 98.9 m-20 59.38 40.05 21.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.972 -0.455 . . . . 0.0 110.066 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.471 ' HA ' ' H ' ' A' ' 33' ' ' HIS . 6.3 ptpp? 31.23 76.22 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.676 0.75 . . . . 0.0 110.958 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -55.59 -170.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.635 -0.666 . . . . 0.0 109.909 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CE2' ' OD2' ' A' ' 63' ' ' ASP . 63.0 t80 -115.04 122.69 46.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.611 -0.681 . . . . 0.0 109.167 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . . . -154.79 129.99 9.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.503 -0.748 . . . . 0.0 109.209 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.2 tp -140.86 129.05 22.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 109.349 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.576 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.7 tt -122.09 125.97 47.38 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.573 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.9 ptt? -159.05 157.35 30.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 59' ' ' VAL . 46.6 t0 -96.19 114.03 25.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.143 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 pt -116.67 144.79 33.97 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.616 -0.678 . . . . 0.0 109.206 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -48.3 143.77 14.37 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.58 1.52 . . . . 0.0 112.412 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -61.39 -22.08 64.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.394 -0.816 . . . . 0.0 109.458 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.62 -16.83 62.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.132 . . . . 0.0 110.278 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -84.72 -11.67 55.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.003 -1.061 . . . . 0.0 111.092 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.477 ' O ' ' CD2' ' A' ' 81' ' ' TYR . 11.4 pt -100.97 4.96 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 120.953 -1.092 . . . . 0.0 109.398 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.06 -11.07 65.91 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.515 ' C ' ' H ' ' A' ' 55' ' ' GLY . 61.6 mt -81.64 132.56 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.848 -1.383 . . . . 0.0 109.414 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -67.02 13.51 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.571 -0.706 . . . . 0.0 109.944 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -83.97 141.44 20.08 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 32.0 p-10 -101.04 8.9 42.71 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.452 -1.028 . . . . 0.0 109.019 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 64.1 tttp -84.03 141.39 31.21 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.494 -0.754 . . . . 0.0 109.556 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -72.52 145.44 47.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.867 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.435 ' HB ' HD11 ' A' ' 95' ' ' LEU . 31.6 m -136.13 161.3 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.486 -0.758 . . . . 0.0 109.721 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -102.3 139.0 38.5 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.1 153.53 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.397 -0.815 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 pt -137.01 148.31 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.694 -0.629 . . . . 0.0 109.446 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.538 ' OD2' ' CE2' ' A' ' 40' ' ' TYR . 86.5 m-20 -74.61 144.63 43.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.305 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.666 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -133.11 131.92 41.08 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.666 ' N ' HD13 ' A' ' 64' ' ' LEU . 10.0 mtpm? -97.73 130.3 44.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.223 -0.923 . . . . 0.0 109.912 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.11 165.6 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.369 -0.832 . . . . 0.0 110.316 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -70.61 152.9 95.23 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.512 -0.742 . . . . 0.0 109.129 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.461 ' O ' HG12 ' A' ' 71' ' ' VAL . 37.3 Cg_endo -65.57 -22.2 58.69 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.23 1.953 . . . . 0.0 111.353 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -86.47 -30.64 21.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.2 mt -97.38 10.62 39.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.244 -0.91 . . . . 0.0 109.291 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.532 HG13 ' N ' ' A' ' 72' ' ' GLY . 5.4 p -60.38 -46.74 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 110.1 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.532 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -75.92 -14.74 81.9 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.907 -1.139 . . . . 0.0 110.416 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 5.0 t -59.34 -55.46 34.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.015 -1.285 . . . . 0.0 110.898 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.004 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.9 pt? -86.3 -21.57 27.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.874 . . . . 0.0 110.864 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.847 ' CZ ' HG21 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -57.77 -42.27 83.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.772 -1.205 . . . . 0.0 111.275 -177.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -79.91 0.43 31.35 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.465 -1.397 . . . . 0.0 110.594 -178.525 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -83.82 125.34 73.41 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.693 -1.254 . . . . 0.0 109.256 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.42 144.34 18.49 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 121.942 1.761 . . . . 0.0 113.141 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.57 -6.08 67.62 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.62 ' CG2' HH21 ' A' ' 75' ' ' ARG . 96.4 mt -122.47 128.77 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.208 -1.172 . . . . 0.0 109.805 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 31.7 m-85 -120.46 152.6 55.45 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.498 -0.751 . . . . 0.0 109.934 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.83 154.77 67.09 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.471 2.114 . . . . 0.0 111.895 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.81 147.22 53.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.204 -0.935 . . . . 0.0 110.127 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.511 ' C ' ' H ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -98.6 119.47 37.37 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 25.5 t60 66.74 -33.42 0.2 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.628 -0.67 . . . . 0.0 110.736 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.511 ' H ' ' C ' ' A' ' 84' ' ' TYR . 90.4 mmm -84.32 159.55 20.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.076 -1.015 . . . . 0.0 110.598 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 91' ' ' TRP . 57.9 t-20 -40.52 122.05 1.55 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.666 0.746 . . . . 0.0 110.939 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -94.41 -15.05 24.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.644 -0.66 . . . . 0.0 109.734 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' N ' ' OD1' ' A' ' 87' ' ' ASN . 98.1 mt-10 -80.87 -85.2 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.946 . . . . 0.0 110.66 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -60.6 -44.18 96.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -0.884 . . . . 0.0 110.739 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.439 ' CD1' ' N ' ' A' ' 91' ' ' TRP . 16.5 m0 -101.56 138.15 38.94 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.49 -0.756 . . . . 0.0 109.684 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.847 HG21 ' CZ ' ' A' ' 75' ' ' ARG . 9.3 mt -143.51 165.84 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.322 -0.861 . . . . 0.0 109.519 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 81' ' ' TYR . 6.3 p -107.77 138.58 43.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.9 t -121.1 133.97 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.435 HD11 ' HB ' ' A' ' 59' ' ' VAL . 31.0 tp -90.82 109.64 20.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 109.817 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.8 mt -64.95 -39.21 93.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -74.41 5.76 4.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 109.66 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.85 165.18 15.33 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.52 -16.88 30.51 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.937 2.425 . . . . 0.0 111.293 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 100' ' ' LEU . 1.9 pp -60.22 169.3 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.648 -0.658 . . . . 0.0 110.46 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -99.99 169.13 21.71 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 121.231 -0.918 . . . . 0.0 110.913 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.88 82.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.629 -0.924 . . . . 0.0 109.365 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.497 ' NZ ' ' OE2' ' A' ' 104' ' ' GLU . 22.7 pttp -60.29 -37.05 79.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.329 -0.857 . . . . 0.0 108.973 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' A' ' 103' ' ' LYS . 72.9 mm-40 -65.33 -44.62 87.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.311 -0.868 . . . . 0.0 109.12 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.05 -43.83 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.0 109.548 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -58.0 -44.29 87.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.273 -0.892 . . . . 0.0 109.911 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.0 p -61.15 -43.39 98.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 0.0 109.689 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.61 -42.05 98.24 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 109.034 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.68 -43.0 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.177 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -51.64 -44.83 63.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.109 -0.994 . . . . 0.0 108.879 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.21 -42.28 98.32 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.158 -0.964 . . . . 0.0 108.573 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 t -62.72 -38.75 91.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.2 -43.33 74.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.259 -0.901 . . . . 0.0 108.973 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -54.5 -31.81 56.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.773 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 115' ' ' LEU . 9.0 mp -83.55 -13.48 54.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.084 -1.01 . . . . 0.0 109.974 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.513 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 45.0 p -102.04 13.87 33.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.297 -0.877 . . . . 0.0 109.306 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.34 148.51 51.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 110.168 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 68.8 mt -71.42 145.82 49.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.535 -0.728 . . . . 0.0 110.109 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -71.56 146.24 48.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.53 -0.731 . . . . 0.0 110.293 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -154.1 150.62 28.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.433 -0.792 . . . . 0.0 109.264 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -100.72 3.14 42.05 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -99.36 120.5 39.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.547 -0.72 . . . . 0.0 109.393 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -80.36 128.74 33.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.32 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -74.65 146.47 42.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.545 ' OXT' ' CG ' ' A' ' 125' ' ' HIS . 51.5 p-80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.79 -1.1 . . . . 0.0 109.845 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 ttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.284 0.564 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -87.2 159.29 18.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.313 -0.867 . . . . 0.0 110.495 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.27 -42.89 96.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.646 -0.659 . . . . 0.0 109.588 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -59.24 -43.22 92.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.845 . . . . 0.0 109.497 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.86 -32.36 73.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.222 -0.923 . . . . 0.0 109.468 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -60.9 -47.66 85.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.664 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.0 mp -64.98 -46.77 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.207 -0.933 . . . . 0.0 109.184 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.75 -43.22 99.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 109.819 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.417 ' CE1' ' CE1' ' A' ' 106' ' ' HIS . 89.8 t80 -64.12 -44.15 93.09 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.868 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.86 -51.49 69.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.625 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 15' ' ' ASP . 3.5 pt20 -70.11 -38.17 75.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.033 -1.042 . . . . 0.0 110.255 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -60.01 -43.45 95.22 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.626 -1.296 . . . . 0.0 109.35 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -88.2 -32.06 18.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.145 -0.972 . . . . 0.0 111.698 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.525 ' CE1' ' CD1' ' A' ' 113' ' ' PHE . 73.5 m-85 -121.25 -8.56 9.21 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.065 -1.022 . . . . 0.0 111.654 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 11' ' ' GLN . 91.4 m-20 54.97 37.48 28.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 109.54 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 17' ' ' LYS . 96.7 m -79.69 162.2 25.36 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.512 -0.742 . . . . 0.0 109.152 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' N ' HG22 ' A' ' 16' ' ' THR . 37.1 tptt -123.01 93.12 48.66 Favored Pre-proline 0 N--CA 1.497 1.895 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -56.49 146.5 74.24 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.405 2.07 . . . . 0.0 112.365 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 60.4 t0 -132.15 152.25 51.36 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.8 OUTLIER -118.93 86.26 30.73 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 0.0 109.497 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.78 -36.84 83.73 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.235 1.956 . . . . 0.0 111.469 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -87.4 126.99 35.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.575 -0.703 . . . . 0.0 109.357 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -87.51 -28.84 21.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.371 -0.83 . . . . 0.0 109.715 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -81.84 -7.56 59.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.326 -0.859 . . . . 0.0 110.0 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -123.57 75.35 54.38 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.449 -0.782 . . . . 0.0 109.518 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.86 -17.66 41.63 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.985 1.79 . . . . 0.0 111.634 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -80.64 -5.04 56.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.472 -0.768 . . . . 0.0 109.573 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -100.39 135.09 42.36 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.414 -0.804 . . . . 0.0 109.333 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.91 147.54 44.47 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.16 129.47 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.47 -0.769 . . . . 0.0 109.394 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 43.6 m-85 -108.45 109.92 21.31 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -142.21 146.15 34.89 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.145 -0.972 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.505 ' NE2' ' OG1' ' A' ' 16' ' ' THR . 63.8 m170 -99.86 113.56 26.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.521 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.3 p -69.79 -17.89 63.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.307 -0.87 . . . . 0.0 109.585 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -62.74 -44.12 97.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.826 . . . . 0.0 109.808 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 38' ' ' LYS . 56.7 p30 -112.4 -1.49 15.02 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.425 -0.797 . . . . 0.0 109.133 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.4 t0 58.4 0.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.731 . . . . 0.0 109.925 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 36' ' ' ASN . 53.6 mtmt -101.3 -156.91 0.58 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 109.69 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 46.9 t-105 57.15 94.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.644 -0.66 . . . . 0.0 109.491 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.59 125.2 54.02 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.54 143.93 24.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.42 144.01 32.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.193 -0.942 . . . . 0.0 109.014 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.615 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.1 tt -117.61 127.11 53.63 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.528 ' N ' HD23 ' A' ' 43' ' ' LEU . 6.6 ptt? -146.63 158.09 43.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.097 -1.002 . . . . 0.0 109.485 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' OD1' ' N ' ' A' ' 45' ' ' ASP . 34.6 p-10 -95.59 115.6 27.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.366 -0.834 . . . . 0.0 109.265 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.2 pt -126.31 145.73 53.71 Favored Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.478 -0.764 . . . . 0.0 109.231 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.67 144.03 99.49 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.075 1.85 . . . . 0.0 112.78 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -62.82 -20.99 65.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.692 -0.63 . . . . 0.0 109.64 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.76 -36.54 76.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.051 -1.03 . . . . 0.0 110.465 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 52' ' ' GLY . 97.2 mttt -63.74 -43.49 96.33 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.97 -1.081 . . . . 0.0 111.239 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.456 ' CD1' HD12 ' A' ' 53' ' ' ILE . 9.4 pt -71.57 15.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.958 -1.089 . . . . 0.0 110.145 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . 80.75 -7.49 58.57 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.088 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 55' ' ' GLY . 71.0 mt -79.4 133.06 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.775 -1.427 . . . . 0.0 109.335 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -68.91 26.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.374 -0.829 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -91.97 132.8 11.44 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 32.2 p-10 -101.79 8.86 41.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.333 -1.098 . . . . 0.0 108.962 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -83.89 154.92 23.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.388 -0.82 . . . . 0.0 109.767 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -82.28 130.38 35.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 108.667 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.446 ' HA ' HD22 ' A' ' 97' ' ' ASN . 16.3 m -125.79 143.61 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.535 -0.728 . . . . 0.0 109.615 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -89.57 141.62 28.42 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.265 -0.897 . . . . 0.0 109.927 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.401 HG12 HD12 ' A' ' 95' ' ' LEU . 3.8 m -135.8 158.96 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.416 -0.802 . . . . 0.0 109.468 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 pt -134.24 151.38 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -112.16 140.35 46.93 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.471 -0.768 . . . . 0.0 110.126 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -138.33 157.22 46.68 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.656 -0.653 . . . . 0.0 109.362 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -92.73 139.92 30.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 0.0 110.867 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 m -141.39 164.68 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.41 -0.806 . . . . 0.0 109.547 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -74.78 156.74 86.39 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.527 -0.733 . . . . 0.0 109.628 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 71' ' ' VAL . 31.2 Cg_endo -64.47 -23.39 64.77 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.327 2.018 . . . . 0.0 111.207 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -86.57 -25.8 24.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.38 -0.825 . . . . 0.0 109.429 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.22 5.67 49.69 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.21 -0.931 . . . . 0.0 109.38 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 72' ' ' GLY . 11.6 p -63.28 -39.93 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.499 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -77.47 -15.42 81.44 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -68.17 -55.96 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.123 -1.222 . . . . 0.0 110.753 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.0 pt? -86.48 -25.26 25.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.962 -1.086 . . . . 0.0 110.614 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -71.08 -21.63 62.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.947 -1.096 . . . . 0.0 109.627 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.22 -6.68 57.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 108.727 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.42 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 9.0 mtpm? -84.54 152.65 60.78 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.1 148.45 69.34 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.957 2.438 . . . . 0.0 113.19 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.47 -23.69 11.81 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.2 mt -96.02 121.14 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -1.189 . . . . 0.0 110.066 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -117.56 157.28 48.05 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.793 -0.567 . . . . 0.0 109.979 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.34 152.55 66.18 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.848 1.698 . . . . 0.0 112.36 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.87 151.37 39.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.399 -0.813 . . . . 0.0 109.962 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -90.48 1.24 56.86 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.344 -0.847 . . . . 0.0 109.259 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.17 -174.02 2.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.405 -0.809 . . . . 0.0 110.047 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.4 ttm -63.82 -39.39 94.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.714 . . . . 0.0 110.148 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -67.9 153.55 43.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.532 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -148.59 -54.97 0.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.75 -17.6 59.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.364 -0.835 . . . . 0.0 109.257 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.41 ' CD2' ' N ' ' A' ' 90' ' ' HIS . 4.0 m170 -82.13 -62.84 1.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.949 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -109.79 148.08 32.1 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.658 -0.651 . . . . 0.0 109.903 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 mm -130.9 137.25 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.1 m -87.19 131.03 34.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.671 -0.643 . . . . 0.0 110.147 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 64' ' ' LEU . 72.6 t -113.22 134.81 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.435 HD11 ' HB ' ' A' ' 59' ' ' VAL . 46.1 tp -89.22 108.73 19.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.941 . . . . 0.0 110.273 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.64 -41.06 96.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 59' ' ' VAL . 97.0 m-20 -84.51 20.22 1.76 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 109.009 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.78 -176.43 39.76 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.26 -37.24 94.55 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.047 2.498 . . . . 0.0 112.774 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -57.97 138.22 56.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 0.0 110.418 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.92 -174.15 39.45 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.94 92.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.683 -0.892 . . . . 0.0 109.882 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -62.79 -40.93 98.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.27 -40.21 96.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.507 -0.746 . . . . 0.0 109.775 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.41 -43.61 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.771 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.417 ' CE1' ' CE1' ' A' ' 9' ' ' TYR . 55.9 m170 -59.59 -47.3 86.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.756 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.3 m -62.35 -43.93 97.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.957 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.31 -44.96 93.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.39 -0.819 . . . . 0.0 109.732 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.5 mt -65.32 -43.02 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -0.842 . . . . 0.0 109.337 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -52.2 -43.68 64.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.025 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -61.95 -44.18 97.3 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 109.273 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.0 p -67.34 -39.24 85.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.79 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 87.6 t80 -61.62 -45.52 93.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.911 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.24 -42.07 69.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.371 -0.83 . . . . 0.0 109.578 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.56 -39.83 92.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.378 -0.826 . . . . 0.0 110.113 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 p -99.99 14.54 30.2 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.157 -0.964 . . . . 0.0 109.835 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 113' ' ' PHE . 35.7 ptt180 -50.58 156.86 0.83 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 110.092 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.7 mp -92.26 -145.88 0.21 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.595 -0.691 . . . . 0.0 109.728 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 58.15 -148.81 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.73 -0.606 . . . . 0.0 110.215 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.0 t60 54.75 78.17 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.609 -0.682 . . . . 0.0 109.384 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -79.74 155.15 28.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.599 -0.688 . . . . 0.0 109.628 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -61.85 -40.58 95.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.547 -0.72 . . . . 0.0 110.152 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.5 130.78 42.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.266 -0.896 . . . . 0.0 110.159 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -83.81 144.87 29.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.388 -0.82 . . . . 0.0 110.138 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.641 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.7 ttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.603 0.716 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -102.14 163.22 12.36 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.733 0.777 . . . . 0.0 110.183 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.408 HH21 ' CG ' ' A' ' 60' ' ' ASP . 41.3 ttm180 -61.29 -43.82 98.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.586 0.708 . . . . 0.0 109.6 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -58.89 -40.06 83.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.779 . . . . 0.0 109.842 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.14 -37.6 88.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.441 -0.787 . . . . 0.0 109.817 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -60.94 -43.8 98.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.317 -0.864 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.42 -44.26 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -0.783 . . . . 0.0 109.474 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.76 -44.32 96.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.634 ' CE1' ' CD2' ' A' ' 106' ' ' HIS . 63.9 t80 -63.46 -48.58 77.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.443 -0.786 . . . . 0.0 109.696 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.2 85.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.492 -0.755 . . . . 0.0 109.811 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 15' ' ' ASP . 5.5 tp-100 -68.53 -49.91 56.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.824 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.84 -31.67 73.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.957 -1.089 . . . . 0.0 109.087 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' NZ ' ' CZ ' ' A' ' 14' ' ' TYR . 65.8 tttm -83.44 -38.36 21.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 111.74 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.484 ' CZ ' ' NZ ' ' A' ' 13' ' ' LYS . 74.9 m-85 -116.63 -21.41 9.14 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.824 -1.173 . . . . 0.0 111.148 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 49.7 t0 62.8 36.79 12.83 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.27 -0.894 . . . . 0.0 109.466 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 14.5 t -114.88 134.75 54.89 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.593 0.711 . . . . 0.0 109.707 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -84.69 151.66 58.7 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.613 -0.679 . . . . 0.0 109.332 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.54 146.44 79.69 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.786 2.324 . . . . 0.0 112.477 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -115.38 155.17 27.87 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.693 0.759 . . . . 0.0 109.3 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -143.41 88.2 8.1 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 -15.28 21.12 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.339 2.026 . . . . 0.0 110.617 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -100.72 110.5 22.61 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.498 0.666 . . . . 0.0 109.335 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -68.32 -33.61 74.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.797 0.808 . . . . 0.0 109.186 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -67.76 -2.41 7.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.404 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -143.68 74.72 16.63 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.296 -0.878 . . . . 0.0 109.372 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.86 -15.8 29.63 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.605 2.203 . . . . 0.0 111.301 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -86.46 -4.96 59.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.494 -0.754 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -84.57 142.38 30.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.373 -0.829 . . . . 0.0 109.611 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.07 140.77 50.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.589 -0.694 . . . . 0.0 109.69 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.78 132.66 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -109.07 136.47 48.52 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.394 0.616 . . . . 0.0 109.699 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -156.12 149.23 24.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.342 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.5 ' O ' ' NE1' ' A' ' 39' ' ' TRP . 80.3 m80 -100.75 128.95 46.6 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.611 0.719 . . . . 0.0 109.443 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.4 p -75.92 -6.89 53.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.471 -0.768 . . . . 0.0 109.518 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -94.33 -9.84 34.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.262 -0.899 . . . . 0.0 109.815 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -109.78 -30.23 7.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.147 -0.971 . . . . 0.0 108.783 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.8 t0 54.18 28.04 8.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.468 -0.77 . . . . 0.0 109.699 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 50.8 tptt -170.11 112.03 0.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.143 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.614 ' CD2' ' N ' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -173.22 -174.48 1.05 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.207 1.003 . . . . 0.0 109.75 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.432 ' CE2' ' CD2' ' A' ' 42' ' ' LEU . 9.7 t80 -160.18 118.93 2.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.199 -0.938 . . . . 0.0 109.137 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.12 121.72 4.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.432 ' CD2' ' CE2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -138.34 149.28 45.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.462 -0.774 . . . . 0.0 109.163 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.663 ' C ' HD23 ' A' ' 43' ' ' LEU . 7.4 tt -129.31 122.56 29.81 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.547 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.43 162.23 41.48 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.688 0.756 . . . . 0.0 109.928 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 42.5 p-10 -97.25 114.82 26.61 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.289 0.566 . . . . 0.0 109.518 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.7 pt -117.56 146.19 38.01 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.38 143.6 99.66 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.692 2.262 . . . . 0.0 112.495 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.77 -19.89 64.45 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.578 0.704 . . . . 0.0 109.794 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.91 -38.85 87.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.235 -0.915 . . . . 0.0 110.238 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.87 -43.76 95.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.23 -0.918 . . . . 0.0 111.174 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.669 HD12 HD12 ' A' ' 53' ' ' ILE . 2.8 pt -76.95 12.17 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.036 -1.04 . . . . 0.0 109.834 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.1 31.16 77.83 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.365 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.669 HD12 HD12 ' A' ' 51' ' ' ILE . 47.9 mt -101.23 128.57 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.111 -1.229 . . . . 0.0 109.737 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -55.93 81.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.644 0.735 . . . . 0.0 110.458 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . -176.98 151.48 11.19 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.71 15.35 18.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.513 -0.992 . . . . 0.0 108.446 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -88.45 155.04 19.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.36 -0.838 . . . . 0.0 110.256 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -86.36 141.83 28.91 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.526 0.679 . . . . 0.0 110.095 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 95' ' ' LEU . 29.6 m -134.04 153.32 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.548 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.408 ' CG ' HH21 ' A' ' 3' ' ' ARG . 96.4 m-20 -90.47 139.4 30.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.696 -0.628 . . . . 0.0 110.167 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.465 ' CG2' ' SD ' ' A' ' 44' ' ' MET . 33.4 m -137.87 154.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.707 0.765 . . . . 0.0 109.987 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.6 pt -135.2 147.92 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.493 0.663 . . . . 0.0 109.871 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.76 143.37 34.54 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.419 0.628 . . . . 0.0 110.389 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.667 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -133.33 126.91 32.42 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.667 ' N ' HD13 ' A' ' 64' ' ' LEU . 64.8 tttm -82.81 135.88 34.83 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.671 0.748 . . . . 0.0 110.569 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.76 158.35 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.597 0.713 . . . . 0.0 109.782 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' H ' ' HB2' ' A' ' 70' ' ' LEU . 61.7 mt-30 -89.83 154.45 47.82 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.529 -0.732 . . . . 0.0 109.319 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.485 ' O ' HG12 ' A' ' 71' ' ' VAL . 52.6 Cg_exo -45.67 -28.86 4.84 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.252 1.968 . . . . 0.0 111.563 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -91.48 -29.11 17.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 0.0 109.54 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.433 ' HB2' ' H ' ' A' ' 67' ' ' GLN . 89.2 mt -91.53 -8.33 47.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.269 -0.894 . . . . 0.0 109.668 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 68' ' ' PRO . 10.5 p -66.68 -40.01 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.652 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -62.88 -42.37 99.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.3 t -61.1 -48.76 80.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.353 -1.087 . . . . 0.0 110.073 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.07 -39.1 63.7 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.419 -0.8 . . . . 0.0 110.189 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.426 ' HE ' ' HG3' ' A' ' 82' ' ' PRO . 72.9 ttt180 -72.17 -38.99 69.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.554 -0.716 . . . . 0.0 111.308 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -73.73 -5.06 38.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.909 -1.12 . . . . 0.0 110.051 -178.565 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -78.95 147.67 70.61 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.126 -0.984 . . . . 0.0 109.714 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.416 ' O ' HD12 ' A' ' 80' ' ' ILE . 55.2 Cg_endo -69.95 145.66 56.71 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.473 2.116 . . . . 0.0 112.542 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.31 -20.9 19.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.701 HD12 ' N ' ' A' ' 80' ' ' ILE . 3.0 mp -91.83 122.59 43.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.323 -1.104 . . . . 0.0 109.449 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.533 ' CZ ' HD11 ' A' ' 53' ' ' ILE . 82.8 m-85 -115.06 154.94 47.17 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.23 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HG3' ' HE ' ' A' ' 75' ' ' ARG . 31.4 Cg_exo -60.44 146.81 96.04 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.841 2.361 . . . . 0.0 112.869 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.47 43.83 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.389 -0.819 . . . . 0.0 110.515 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 85' ' ' HIS . 45.7 p90 -96.13 3.86 52.93 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.63 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 71.9 m80 -87.93 -162.83 0.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.461 -0.774 . . . . 0.0 110.294 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' ASN . 42.0 ttp -55.32 160.86 2.08 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.56 0.695 . . . . 0.0 110.71 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 86' ' ' MET . 13.2 p30 42.32 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.864 0.84 . . . . 0.0 110.735 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.454 ' O ' HD11 ' A' ' 92' ' ' ILE . 81.9 tttt -151.83 -22.94 0.19 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 109.108 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 57.3 mp0 -96.02 -19.69 19.27 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.162 -0.962 . . . . 0.0 110.027 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -75.0 -69.82 0.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.633 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -110.39 138.81 46.29 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.392 -0.818 . . . . 0.0 110.026 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.454 HD11 ' O ' ' A' ' 88' ' ' LYS . 49.5 mm -120.13 157.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.429 ' N ' HG22 ' A' ' 92' ' ' ILE . 2.0 p -98.92 138.44 36.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.504 -0.747 . . . . 0.0 110.006 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.55 134.52 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.415 HD11 ' HB ' ' A' ' 59' ' ' VAL . 38.4 tp -86.3 105.89 16.98 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.585 0.707 . . . . 0.0 110.097 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.51 -39.67 88.79 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.805 0.812 . . . . 0.0 109.012 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -68.57 -7.55 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.77 -169.04 13.18 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.78 18.83 1.21 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.239 2.626 . . . . 0.0 111.425 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 80' ' ' ILE . 3.9 mm? -66.06 132.9 49.62 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.95 0.881 . . . . 0.0 110.38 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.74 155.79 22.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.67 79.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.804 -0.821 . . . . 0.0 109.898 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.55 -40.06 92.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.386 -0.821 . . . . 0.0 109.207 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.99 -44.78 96.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.81 -43.4 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.243 -0.91 . . . . 0.0 109.583 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.634 ' CD2' ' CE1' ' A' ' 9' ' ' TYR . 54.2 m170 -58.94 -42.34 89.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 109.849 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -63.99 -42.14 97.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 109.853 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.8 -41.22 95.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.361 -0.837 . . . . 0.0 109.515 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.76 -42.88 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.75 -42.34 75.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.202 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.26 -41.03 98.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.23 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.4 t -60.19 -40.08 88.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.827 . . . . 0.0 109.649 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -58.36 -44.18 88.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 109.227 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -57.91 -46.1 85.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.359 -0.838 . . . . 0.0 109.844 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.29 -37.77 88.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 0.0 109.623 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.3 p -88.08 13.19 11.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.157 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -72.37 48.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.8 0.809 . . . . 0.0 109.022 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 118' ' ' LEU . 10.3 mp 52.67 173.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.868 0.842 . . . . 0.0 110.543 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -96.75 -151.6 0.36 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.748 0.785 . . . . 0.0 109.924 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.3 t60 53.3 92.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.89 0.852 . . . . 0.0 109.618 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -79.83 138.85 37.32 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.591 0.71 . . . . 0.0 109.965 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -51.45 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.61 0.719 . . . . 0.0 110.287 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -152.56 142.79 22.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.379 -0.825 . . . . 0.0 109.751 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.445 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 50.3 t-80 42.89 -101.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.411 0.624 . . . . 0.0 110.361 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 124' ' ' HIS . 80.3 m80 . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.277 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.6 ttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -104.62 155.08 19.16 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.67 -0.643 . . . . 0.0 109.884 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -61.6 -43.54 98.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.571 -0.706 . . . . 0.0 109.73 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -58.09 -41.79 84.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.596 -0.69 . . . . 0.0 110.019 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.36 -35.71 81.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.783 . . . . 0.0 110.122 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -60.16 -45.57 92.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.749 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.65 -45.46 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -62.82 -38.27 90.04 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.593 0.711 . . . . 0.0 109.506 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.516 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 59.9 t80 -69.5 -43.89 72.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 110.141 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.78 75.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.434 -0.791 . . . . 0.0 110.5 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 15' ' ' ASP . 4.8 pt20 -66.53 -30.41 70.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 109.984 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.4 -48.54 80.75 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 0.0 110.225 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.516 ' NZ ' ' CE2' ' A' ' 9' ' ' TYR . 63.3 mttp -90.34 -12.4 37.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.217 -0.927 . . . . 0.0 111.875 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -134.65 -20.38 1.79 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.981 -1.075 . . . . 0.0 111.012 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 11' ' ' GLN . 43.0 t0 58.42 39.45 25.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.119 -0.988 . . . . 0.0 109.263 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.5 m -106.93 127.1 53.14 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -89.34 156.04 48.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.715 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.66 141.3 43.98 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.981 1.787 . . . . 0.0 112.359 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -125.88 121.73 34.04 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.508 ' CG ' ' O ' ' A' ' 20' ' ' HIS . 25.2 p-80 -125.39 86.17 57.47 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.562 -0.711 . . . . 0.0 109.425 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.86 -32.3 91.62 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.537 2.158 . . . . 0.0 111.201 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -83.45 135.59 34.62 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.589 0.709 . . . . 0.0 110.161 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.661 ' CD ' ' H ' ' A' ' 23' ' ' GLU . 1.4 pm0 -89.41 -24.26 21.95 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -78.11 -3.1 40.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.488 -0.757 . . . . 0.0 109.825 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -137.18 66.04 52.1 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.4 -0.812 . . . . 0.0 109.458 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.47 -20.2 36.51 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.433 2.088 . . . . 0.0 111.425 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -81.94 -5.61 58.44 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.53 -0.731 . . . . 0.0 109.063 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -90.96 140.35 29.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.497 -0.752 . . . . 0.0 109.117 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.72 121.52 34.87 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -109.44 125.49 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -108.76 116.55 32.19 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -145.07 135.31 24.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.092 -1.005 . . . . 0.0 109.285 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -99.95 115.0 28.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.486 -0.759 . . . . 0.0 109.716 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 m -63.69 -35.78 81.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.605 -0.684 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -71.68 -5.37 33.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.961 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 38' ' ' LYS . 10.7 t-20 -113.74 -30.8 6.66 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 42.66 18.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.766 -0.584 . . . . 0.0 109.96 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 36' ' ' ASN . 63.6 tttp -136.53 -19.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 39' ' ' TRP . 18.1 t-105 -78.01 117.99 19.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.491 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -115.26 125.72 53.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.614 -0.679 . . . . 0.0 109.274 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.42 129.01 11.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 108.739 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.3 tp -132.29 123.68 27.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.511 -0.743 . . . . 0.0 109.112 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.588 ' C ' HD23 ' A' ' 43' ' ' LEU . 7.4 tt -117.58 124.66 49.2 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.52 ' N ' HD23 ' A' ' 43' ' ' LEU . 7.5 ptt? -153.95 161.38 42.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 109.212 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 38.1 p-10 -98.05 114.53 26.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.267 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.9 pt -124.54 145.97 50.93 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.548 -0.72 . . . . 0.0 109.193 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.1 143.87 99.05 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.026 1.817 . . . . 0.0 112.573 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -63.81 -20.98 66.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.754 -0.591 . . . . 0.0 109.909 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.5 -35.51 74.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.993 . . . . 0.0 110.165 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -64.69 -41.85 95.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 0.0 110.94 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.463 ' CD1' HD12 ' A' ' 53' ' ' ILE . 5.0 pt -81.82 20.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 109.893 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.22 -4.89 53.29 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.282 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.617 ' HB ' ' HB1' ' A' ' 48' ' ' ALA . 79.4 mt -78.92 134.03 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.939 -1.33 . . . . 0.0 110.075 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 55' ' ' GLY . 92.6 m-20 -61.38 -39.35 90.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.74 -0.6 . . . . 0.0 110.101 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.828 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -37.06 109.48 0.08 OUTLIER Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -80.81 4.35 19.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.517 -0.99 . . . . 0.0 109.007 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -84.12 161.55 20.59 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.654 0.74 . . . . 0.0 110.148 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.01 146.91 33.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.65 -0.656 . . . . 0.0 110.186 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 m -135.26 159.6 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.493 -0.754 . . . . 0.0 109.543 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -102.05 135.77 43.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.362 -0.836 . . . . 0.0 109.681 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.45 155.94 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.395 -0.816 . . . . 0.0 110.057 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.498 HG23 HD11 ' A' ' 96' ' ' LEU . 25.2 pt -133.83 146.71 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -84.39 142.56 30.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.842 . . . . 0.0 109.825 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -136.71 121.67 18.85 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.592 ' N ' HD13 ' A' ' 64' ' ' LEU . 21.5 ptmt -84.98 136.71 33.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 110.115 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.442 HG11 HD13 ' A' ' 74' ' ' LEU . 28.6 m -142.52 165.93 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.253 -0.904 . . . . 0.0 109.88 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -78.01 149.25 76.48 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 0.0 109.669 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.639 ' O ' HG12 ' A' ' 71' ' ' VAL . 51.3 Cg_exo -50.2 -39.31 52.14 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.963 1.776 . . . . 0.0 111.639 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 69' ' ' GLU . 2.4 pt-20 -70.7 -33.79 71.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.726 -0.609 . . . . 0.0 110.037 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -84.67 2.66 40.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 0.0 109.837 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 68' ' ' PRO . 8.0 p -64.34 -42.56 95.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.506 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -69.92 -40.22 74.28 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -62.36 -32.31 73.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.471 -1.017 . . . . 0.0 109.348 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.478 HD12 HD22 ' A' ' 108' ' ' LEU . 2.2 tt -84.85 -35.86 21.96 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.48 -0.762 . . . . 0.0 109.871 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -73.49 -8.16 54.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 110.003 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -2.96 58.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.193 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.573 ' HB2' HD12 ' A' ' 80' ' ' ILE . 31.0 mtpt -96.21 111.43 56.49 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.602 -0.686 . . . . 0.0 109.337 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.15 143.14 42.98 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.061 1.841 . . . . 0.0 113.551 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -19.97 52.02 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.573 HD12 ' HB2' ' A' ' 77' ' ' LYS . 69.2 mt -100.76 121.24 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.321 -1.105 . . . . 0.0 109.299 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -108.78 151.07 41.58 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.468 -0.77 . . . . 0.0 109.765 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.56 163.66 37.29 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.466 2.11 . . . . 0.0 112.512 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -47.5 148.81 1.29 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.565 -0.71 . . . . 0.0 110.302 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.575 ' CZ ' HG21 ' A' ' 93' ' ' THR . 12.1 m-85 -63.07 -43.86 97.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.613 -0.679 . . . . 0.0 109.882 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -160.13 -26.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 109.223 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.407 ' CG ' ' H ' ' A' ' 87' ' ' ASN . 5.8 tpt -61.61 -140.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.51 -0.744 . . . . 0.0 110.42 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.464 ' CG ' ' ND1' ' A' ' 90' ' ' HIS . 82.7 m-20 -72.75 131.3 42.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.631 -0.668 . . . . 0.0 110.009 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -94.53 -21.93 18.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.502 -0.749 . . . . 0.0 109.788 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -100.98 -43.49 6.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.477 -0.764 . . . . 0.0 109.678 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.491 ' CD2' ' N ' ' A' ' 90' ' ' HIS . 3.4 m170 -63.21 -67.18 0.45 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 110.421 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.823 ' O ' HD13 ' A' ' 92' ' ' ILE . 8.3 m0 -111.39 148.48 32.95 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.628 -0.67 . . . . 0.0 109.713 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.823 HD13 ' O ' ' A' ' 91' ' ' TRP . 3.0 mm -132.75 161.77 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.575 HG21 ' CZ ' ' A' ' 84' ' ' TYR . 38.3 p -107.07 133.02 52.32 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.533 HG22 HG23 ' A' ' 80' ' ' ILE . 48.8 t -118.11 133.77 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.5 tp -90.75 108.45 19.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.508 -0.745 . . . . 0.0 109.957 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 62' ' ' ILE . 88.6 mt -65.58 -40.22 92.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.589 -0.694 . . . . 0.0 109.542 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 23.9 m120 -78.32 6.2 8.82 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.475 -0.766 . . . . 0.0 109.164 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.83 178.84 53.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 100' ' ' LEU . 47.2 Cg_endo -68.02 -79.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.85 2.367 . . . . 0.0 112.079 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.495 ' C ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 22.92 -122.03 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.221 0.534 . . . . 0.0 111.085 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.9 159.63 21.48 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.202 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.56 -37.23 86.84 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.64 -0.918 . . . . 0.0 109.489 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.68 -40.06 95.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.581 -0.699 . . . . 0.0 109.401 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.17 -42.72 99.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.537 -0.727 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.23 -43.24 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 109.638 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -56.33 -44.13 79.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.47 -0.769 . . . . 0.0 109.494 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 t -61.9 -43.96 97.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.577 -0.702 . . . . 0.0 109.621 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.478 HD22 HD12 ' A' ' 74' ' ' LEU . 95.7 mt -63.3 -40.95 98.78 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.482 -0.761 . . . . 0.0 109.363 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.37 -43.18 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.49 -0.756 . . . . 0.0 109.24 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -60.42 -39.3 86.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.258 -0.902 . . . . 0.0 108.855 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.44 -41.14 98.52 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 116' ' ' THR . 38.8 t -62.73 -40.43 97.2 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.21 -44.5 83.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.545 -0.722 . . . . 0.0 109.209 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.83 -29.15 70.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.418 -0.801 . . . . 0.0 109.537 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.9 mt -86.1 -18.14 33.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.263 -0.898 . . . . 0.0 110.025 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 112' ' ' SER . 68.0 p -102.88 15.02 30.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.385 -0.822 . . . . 0.0 109.224 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -48.67 143.87 4.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 110.209 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.0 mt -78.06 142.96 37.82 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.53 0.681 . . . . 0.0 110.668 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 57.58 68.12 0.88 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.393 0.616 . . . . 0.0 109.632 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -82.63 -72.26 0.45 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.453 -0.78 . . . . 0.0 110.027 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -87.58 5.12 40.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -0.751 . . . . 0.0 109.226 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -80.57 142.27 34.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.654 -0.654 . . . . 0.0 110.054 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -82.83 136.7 34.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -0.771 . . . . 0.0 110.37 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 125' ' ' HIS . 0.1 OUTLIER -67.75 -40.98 84.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.683 . . . . 0.0 109.73 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 124' ' ' HIS . 3.1 p80 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpp . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.474 0.654 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -95.23 162.33 13.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.356 -0.84 . . . . 0.0 110.489 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -61.52 -42.72 99.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 109.847 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -60.88 -39.04 87.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 109.756 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -63.59 -36.63 84.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.814 . . . . 0.0 109.059 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 56.5 t80 -60.98 -43.76 98.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 108.919 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.1 mm -61.1 -48.48 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.485 -0.76 . . . . 0.0 109.822 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -65.52 -41.47 93.1 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 109.452 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -61.54 -47.61 84.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -0.775 . . . . 0.0 109.849 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.66 -46.18 90.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.157 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ASP . 86.2 mt-30 -63.64 -32.28 73.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 110.465 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.39 -47.91 77.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.99 -1.069 . . . . 0.0 109.729 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -90.03 -12.21 39.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.302 -0.873 . . . . 0.0 111.844 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 15' ' ' ASP . 97.7 m-85 -132.93 -18.04 2.39 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.839 -1.163 . . . . 0.0 110.915 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' GLN . 4.4 p-10 43.85 31.92 0.54 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.365 -0.834 . . . . 0.0 109.418 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.0 m -102.37 136.96 41.27 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.657 0.741 . . . . 0.0 110.069 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -83.04 148.79 57.57 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.58 -0.7 . . . . 0.0 109.275 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.2 145.39 72.45 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.403 2.069 . . . . 0.0 112.129 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -121.91 143.44 49.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.617 -0.677 . . . . 0.0 109.485 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 86.44 47.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.62 -40.68 82.97 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.269 1.979 . . . . 0.0 111.068 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -90.3 136.54 32.99 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.61 0.719 . . . . 0.0 109.811 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 16.4 pt-20 -86.98 -22.02 25.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.62 -0.675 . . . . 0.0 109.516 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -75.85 -5.13 44.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.411 -0.806 . . . . 0.0 109.03 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -136.33 72.82 58.16 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.536 -0.728 . . . . 0.0 109.114 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.37 -12.08 24.99 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.499 2.133 . . . . 0.0 111.055 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 17.7 p-10 -87.53 -1.9 58.25 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.521 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.2 m-85 -87.15 142.09 28.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.511 -0.743 . . . . 0.0 109.892 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.93 129.18 47.66 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.411 HG22 HD13 ' A' ' 42' ' ' LEU . 48.2 t -132.03 131.14 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.532 -0.73 . . . . 0.0 109.888 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -109.4 139.08 44.81 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.496 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . 11.9 ptp180 -142.93 130.51 21.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.141 -0.974 . . . . 0.0 109.853 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.405 ' H ' ' CB ' ' A' ' 39' ' ' TRP . 1.0 OUTLIER -102.87 110.21 22.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.552 -0.718 . . . . 0.0 109.129 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.6 p -70.94 -16.31 62.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -0.812 . . . . 0.0 110.065 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -89.05 -5.14 58.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.124 -0.985 . . . . 0.0 109.644 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 38' ' ' LYS . 9.1 t-20 -107.45 -4.36 18.57 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.496 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 66.7 t0 59.35 -68.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.357 0.599 . . . . 0.0 110.231 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 36' ' ' ASN . 33.5 pttt -88.12 87.15 7.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.382 -0.824 . . . . 0.0 108.924 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.509 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 24.5 p90 -113.83 143.59 44.41 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.403 0.621 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.509 ' CG ' ' O ' ' A' ' 39' ' ' TRP . 99.4 m-85 -156.68 120.85 4.39 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.491 ' C ' HD22 ' A' ' 42' ' ' LEU . . . -155.94 105.33 2.36 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.3 mm? -111.21 131.57 55.02 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.425 0.631 . . . . 0.0 109.694 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' CD1' ' CD2' ' A' ' 6' ' ' PHE . 7.8 tt -135.41 119.71 17.85 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.521 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.2 ptt? -162.5 163.29 27.56 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.082 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 33.0 p-10 -102.97 118.37 36.66 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.9 146.19 52.47 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.717 -0.614 . . . . 0.0 109.933 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -46.36 141.37 10.39 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.36 2.04 . . . . 0.0 112.765 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.45 -24.16 67.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.62 -0.675 . . . . 0.0 109.915 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.58 -29.29 69.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -0.863 . . . . 0.0 109.785 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -64.47 -35.63 81.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.244 -0.91 . . . . 0.0 110.379 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.436 HD11 HD12 ' A' ' 53' ' ' ILE . 14.2 pt -85.15 2.47 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.907 -1.12 . . . . 0.0 109.6 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.84 -7.43 62.94 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.436 HD12 HD11 ' A' ' 51' ' ' ILE . 66.1 mt -78.27 126.61 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.775 -1.426 . . . . 0.0 110.072 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -61.71 86.35 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.705 0.764 . . . . 0.0 109.539 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.52 137.29 3.38 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -95.17 5.71 51.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.408 -1.054 . . . . 0.0 108.204 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -71.71 143.25 49.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 110.477 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -78.76 140.55 38.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.563 -0.711 . . . . 0.0 110.117 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.7 159.98 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -88.19 134.06 33.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.463 -0.773 . . . . 0.0 109.929 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -137.49 153.44 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.496 -0.752 . . . . 0.0 109.714 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.7 pt -141.59 145.01 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.535 0.683 . . . . 0.0 110.151 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -79.82 142.23 35.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.543 -0.723 . . . . 0.0 109.84 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.695 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -127.31 127.81 44.93 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.695 ' N ' HD13 ' A' ' 64' ' ' LEU . 18.0 ttmm -82.11 130.39 35.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.639 -0.663 . . . . 0.0 109.937 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -139.13 163.59 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -0.785 . . . . 0.0 109.879 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -85.96 150.94 53.92 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.425 -0.797 . . . . 0.0 109.65 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.473 ' O ' HG12 ' A' ' 71' ' ' VAL . 53.8 Cg_exo -45.94 -26.7 3.6 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.271 1.981 . . . . 0.0 111.598 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.541 ' OE1' ' N ' ' A' ' 69' ' ' GLU . 57.2 mp0 -94.31 -31.37 14.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.549 -0.719 . . . . 0.0 109.881 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.7 mt -87.12 -3.63 59.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 109.742 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 72' ' ' GLY . 9.0 p -67.51 -44.41 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.066 -1.021 . . . . 0.0 109.642 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.565 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.63 -41.32 99.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -62.79 -53.63 51.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -1.19 . . . . 0.0 110.233 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.454 HD12 HD22 ' A' ' 108' ' ' LEU . 2.0 tt -67.71 -44.5 77.51 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.813 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.51 -30.66 71.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.542 -0.724 . . . . 0.0 109.656 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -32.34 72.53 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -58.99 114.96 10.25 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.42 -0.8 . . . . 0.0 109.705 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.31 149.31 23.04 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.195 1.93 . . . . 0.0 113.186 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.92 -14.65 64.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.3 mt -106.57 120.09 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.599 -0.942 . . . . 0.0 109.345 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -105.15 150.36 38.72 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.593 -0.692 . . . . 0.0 109.668 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.6 149.32 79.4 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.436 2.091 . . . . 0.0 112.324 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.55 142.77 56.41 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.781 0.8 . . . . 0.0 110.502 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -86.52 -4.93 59.25 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.537 ' CG ' ' H ' ' A' ' 86' ' ' MET . 71.1 t60 -93.34 175.06 6.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.316 -0.865 . . . . 0.0 110.447 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 88' ' ' LYS . 79.1 mtm -52.11 -172.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.626 -0.671 . . . . 0.0 111.26 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 56.26 -78.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 86' ' ' MET . 31.5 ttmt 69.76 -46.13 0.59 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.387 0.613 . . . . 0.0 109.786 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -68.98 -44.39 72.98 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.39 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -69.62 -45.52 68.34 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.391 -0.818 . . . . 0.0 110.439 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -112.36 142.34 44.99 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.47 -0.769 . . . . 0.0 110.869 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 mm -132.09 139.88 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.6 m -83.76 129.53 34.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 109.594 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.1 t -115.01 132.01 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.7 tp -87.75 104.02 16.16 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.641 0.734 . . . . 0.0 110.019 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -66.36 -39.48 89.18 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.571 0.7 . . . . 0.0 109.123 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.28 8.08 4.49 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -85.76 -161.39 34.85 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.49 -3.77 12.66 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.958 2.439 . . . . 0.0 111.874 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 100' ' ' LEU . 4.4 mm? -59.6 132.31 53.58 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.926 0.87 . . . . 0.0 110.052 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.98 161.52 38.07 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.11 97.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.807 -0.819 . . . . 0.0 109.514 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -72.04 -35.4 69.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.436 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.23 -42.55 93.27 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.352 -0.843 . . . . 0.0 109.31 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 93.0 mt -64.74 -43.02 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -56.67 -45.16 81.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 109.943 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.3 m -61.43 -43.73 98.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 109.715 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.454 HD22 HD12 ' A' ' 74' ' ' LEU . 95.2 mt -63.97 -40.97 97.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 109.547 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.95 -42.43 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 108.78 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -52.09 -42.87 63.59 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.446 -0.784 . . . . 0.0 108.991 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -62.2 -40.98 97.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 108.969 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 t -64.31 -36.83 85.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 109.358 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' ARG . 80.4 t80 -58.18 -43.09 87.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.543 -0.723 . . . . 0.0 109.52 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -54.29 -45.13 72.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.234 -0.916 . . . . 0.0 109.924 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.7 mp -66.75 -39.28 87.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.18 -0.95 . . . . 0.0 109.782 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.504 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 32.1 p -92.99 7.22 44.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.25 -0.906 . . . . 0.0 109.19 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 113' ' ' PHE . 42.2 ttm180 -59.85 144.53 48.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.479 -0.763 . . . . 0.0 109.591 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mt -73.26 144.48 46.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.363 -0.836 . . . . 0.0 110.736 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -171.77 96.76 0.17 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -137.87 145.08 41.75 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.308 -0.87 . . . . 0.0 109.514 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -121.79 156.64 32.75 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.603 0.716 . . . . 0.0 110.084 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -61.61 -45.16 95.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.553 -0.717 . . . . 0.0 109.787 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.49 ' ND1' ' NE2' ' A' ' 124' ' ' HIS . 56.1 t-80 -67.22 -44.55 79.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.278 -0.888 . . . . 0.0 109.711 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.49 ' NE2' ' ND1' ' A' ' 123' ' ' HIS . 32.6 m170 -109.35 117.57 34.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.536 -0.728 . . . . 0.0 109.885 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.542 ' OXT' ' CG ' ' A' ' 125' ' ' HIS . 49.3 p-80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.894 -1.05 . . . . 0.0 108.95 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 tpp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.358 0.599 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -101.1 162.84 12.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.435 -0.791 . . . . 0.0 110.17 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -61.53 -43.62 98.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.501 -0.75 . . . . 0.0 109.573 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.8 tp60 -65.9 -42.83 89.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.41 -41.87 96.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 0.0 109.482 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.431 ' CE1' HD13 ' A' ' 62' ' ' ILE . 87.3 t80 -62.26 -46.26 89.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 109.908 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.94 -43.71 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.252 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.01 -41.41 99.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.563 -0.71 . . . . 0.0 109.617 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -68.25 -36.61 79.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.49 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.44 73.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.433 -0.792 . . . . 0.0 110.344 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ASP . 2.8 pt20 -64.49 -37.53 87.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.601 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -61.42 -41.48 97.23 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.893 -1.129 . . . . 0.0 109.948 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -87.4 -33.8 18.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 111.503 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 16' ' ' THR . 88.3 m-85 -105.95 6.98 31.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.129 -0.982 . . . . 0.0 110.732 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 11' ' ' GLN . 2.1 p-10 39.91 29.74 0.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.427 -0.795 . . . . 0.0 109.643 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 14' ' ' TYR . 58.3 m -120.67 131.25 54.48 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.51 0.671 . . . . 0.0 109.915 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -87.35 156.82 53.84 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.556 -0.715 . . . . 0.0 109.374 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.66 133.29 26.66 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.077 1.851 . . . . 0.0 112.392 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -118.36 143.43 46.64 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.454 0.645 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.482 ' CG ' ' O ' ' A' ' 20' ' ' HIS . 20.0 p-80 -146.29 85.8 7.24 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.405 -0.809 . . . . 0.0 109.137 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.74 -10.71 9.41 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.737 2.291 . . . . 0.0 110.346 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -85.96 104.72 15.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.801 0.81 . . . . 0.0 109.647 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -68.08 -34.24 76.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.734 -0.604 . . . . 0.0 109.746 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -75.22 -6.08 47.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.857 . . . . 0.0 109.501 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.76 71.1 30.31 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.425 -0.797 . . . . 0.0 109.002 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.0 -17.59 40.97 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.458 2.106 . . . . 0.0 111.735 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -85.07 -4.41 59.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.386 -0.821 . . . . 0.0 109.328 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.3 m-85 -85.41 148.04 26.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 109.911 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.17 134.32 46.4 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.554 ' CG1' ' HE ' ' A' ' 32' ' ' ARG . 2.9 t -118.21 129.65 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.92 113.33 22.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.797 -0.565 . . . . 0.0 109.523 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.554 ' HE ' ' CG1' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -135.58 159.55 41.27 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.42 -0.8 . . . . 0.0 109.407 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.742 ' N ' ' HE1' ' A' ' 39' ' ' TRP . 0.5 OUTLIER -77.51 153.94 32.95 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.929 0.871 . . . . 0.0 110.516 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.8 p -88.37 -50.53 6.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -96.41 -25.66 15.62 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.326 -0.859 . . . . 0.0 111.247 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -105.07 30.02 5.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.096 -1.002 . . . . 0.0 110.037 -178.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 33' ' ' HIS . 10.4 m-20 -42.48 86.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.572 -0.705 . . . . 0.0 110.522 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.7 tttt -144.58 -29.02 0.48 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.742 ' HE1' ' N ' ' A' ' 33' ' ' HIS . 1.5 p-90 -95.89 159.27 15.06 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.384 -0.823 . . . . 0.0 109.368 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -138.58 126.2 22.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.617 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.75 150.48 31.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.495 -0.753 . . . . 0.0 109.421 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.51 152.85 33.53 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.494 -0.754 . . . . 0.0 109.089 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.51 ' C ' HD23 ' A' ' 43' ' ' LEU . 9.1 tt -119.9 128.18 53.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.592 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 8.0 ptt? -148.21 156.32 42.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 109.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -95.89 114.54 26.27 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.18 147.27 41.2 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.589 . . . . 0.0 109.662 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.1 145.33 98.69 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.545 2.163 . . . . 0.0 112.453 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.17 63.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.602 -0.686 . . . . 0.0 109.904 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' OE2' ' OD1' ' A' ' 56' ' ' ASP . 96.0 mt-10 -71.23 -19.39 62.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 110.254 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -84.72 -12.24 54.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.015 -1.053 . . . . 0.0 110.271 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 53' ' ' ILE . 5.0 pt -106.79 -0.32 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.287 -0.883 . . . . 0.0 109.245 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.11 -1.16 82.59 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.254 -0.974 . . . . 0.0 110.685 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 51' ' ' ILE . 75.3 mt -81.9 132.17 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.823 -1.398 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -85.44 96.99 9.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.553 -0.717 . . . . 0.0 109.858 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.9 -21.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.419 ' OD1' ' OE2' ' A' ' 49' ' ' GLU . 90.0 m-20 54.36 20.02 2.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.683 -0.893 . . . . 0.0 109.466 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -109.5 159.28 17.18 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.557 0.694 . . . . 0.0 110.082 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -84.38 142.26 30.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.648 -0.658 . . . . 0.0 109.662 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.56 159.18 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.494 -0.754 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.23 136.88 40.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.485 -0.759 . . . . 0.0 109.183 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.23 157.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.538 -0.726 . . . . 0.0 110.162 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.431 HD13 ' CE1' ' A' ' 6' ' ' PHE . 31.8 pt -137.0 145.24 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.48 0.657 . . . . 0.0 109.853 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -81.32 142.9 32.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.387 -0.82 . . . . 0.0 109.985 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -132.85 125.22 29.51 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.624 ' N ' HD13 ' A' ' 64' ' ' LEU . 88.1 tttt -82.02 130.33 35.05 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.394 -0.816 . . . . 0.0 110.414 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.69 163.73 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.456 -0.777 . . . . 0.0 109.609 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HG3' HD22 ' A' ' 115' ' ' LEU . 77.0 mt-30 -85.97 154.77 58.23 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 109.824 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.529 ' O ' HG12 ' A' ' 71' ' ' VAL . 75.9 Cg_exo -46.43 -35.0 15.45 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.511 2.141 . . . . 0.0 112.307 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -89.65 -21.72 22.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.171 -0.955 . . . . 0.0 110.157 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.1 mt -94.74 -6.06 43.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.096 -1.002 . . . . 0.0 109.334 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 68' ' ' PRO . 8.6 p -67.5 -41.46 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.339 -0.851 . . . . 0.0 109.544 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.522 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.43 -39.54 97.84 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.7 t -61.2 -47.23 87.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -1.099 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.483 HD12 HD22 ' A' ' 108' ' ' LEU . 3.2 tt -75.02 -42.16 57.91 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.445 -0.784 . . . . 0.0 109.809 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -69.91 -37.64 76.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.67 -0.644 . . . . 0.0 111.217 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -73.63 -3.41 27.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.922 -1.111 . . . . 0.0 109.762 -178.524 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -83.92 150.75 59.43 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.102 -0.999 . . . . 0.0 109.526 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.58 150.92 75.35 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.65 2.234 . . . . 0.0 113.1 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.96 2.89 79.46 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.0 127.74 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -1.049 . . . . 0.0 109.667 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -121.09 152.56 56.96 Favored Pre-proline 0 N--CA 1.494 1.733 0 CA-C-O 121.239 0.542 . . . . 0.0 109.786 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.423 ' O ' ' OG1' ' A' ' 93' ' ' THR . 43.4 Cg_endo -65.5 154.74 72.34 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.758 2.306 . . . . 0.0 112.322 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' HA ' HG23 ' A' ' 93' ' ' THR . . . -53.2 147.14 10.45 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.379 -0.826 . . . . 0.0 110.464 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 54.9 t80 -85.64 12.86 7.92 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -154.43 -169.54 3.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 0.0 109.811 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.6 mmm -60.41 -176.6 0.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.432 -0.792 . . . . 0.0 110.893 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.444 ' ND2' ' CH2' ' A' ' 91' ' ' TRP . 97.5 m-20 57.46 35.11 25.52 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.781 0.8 . . . . 0.0 109.186 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -63.13 -42.68 99.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.568 -0.708 . . . . 0.0 109.824 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.89 -44.02 81.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.348 -0.845 . . . . 0.0 110.081 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -70.05 -46.68 64.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 110.425 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.444 ' CH2' ' ND2' ' A' ' 87' ' ' ASN . 7.0 m0 -116.67 146.03 43.03 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.547 -0.72 . . . . 0.0 110.246 -178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.442 HG21 ' CD2' ' A' ' 74' ' ' LEU . 9.4 mm -130.16 146.25 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.426 HG23 ' HA ' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -91.36 137.78 32.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.755 . . . . 0.0 109.249 -179.528 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.7 t -118.05 133.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 tp -84.25 103.74 13.7 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.517 0.675 . . . . 0.0 110.122 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.04 -39.92 87.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.525 -0.734 . . . . 0.0 109.172 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -68.82 -4.8 17.58 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -76.44 -166.34 22.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -79.48 -3.14 12.78 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 123.106 2.538 . . . . 0.0 111.399 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.4 mm? -55.2 125.78 22.06 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.908 0.861 . . . . 0.0 109.912 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.61 161.34 35.12 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.91 95.92 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.642 -0.916 . . . . 0.0 109.173 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mtmm -64.42 -41.96 96.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 109.201 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.56 -43.58 89.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.402 -0.811 . . . . 0.0 109.21 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.22 -43.29 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 109.198 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -58.77 -41.64 87.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.828 . . . . 0.0 109.38 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.6 m -61.19 -43.38 98.98 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 109.229 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.483 HD22 HD12 ' A' ' 74' ' ' LEU . 91.8 mt -64.47 -41.66 96.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 109.592 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.73 -42.97 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.121 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -59.47 -39.41 83.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.383 -0.823 . . . . 0.0 108.989 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -65.19 -37.83 88.56 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.3 t -61.51 -42.12 98.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.845 . . . . 0.0 109.179 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 117' ' ' ARG . 77.4 t80 -61.13 -44.24 97.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.07 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.62 -43.28 99.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 108.83 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.436 HD22 ' HG3' ' A' ' 67' ' ' GLN . 91.4 mt -64.78 -39.98 94.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.561 -0.712 . . . . 0.0 109.372 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.1 p -99.14 14.97 27.47 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 113' ' ' PHE . 9.1 ptm180 -38.57 144.27 0.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.796 0.808 . . . . 0.0 111.414 -178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 63.3 tp -74.72 142.86 44.35 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 121.567 -0.708 . . . . 0.0 109.813 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.78 22.52 2.88 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -150.35 97.25 2.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.433 -0.792 . . . . 0.0 109.257 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -86.57 112.93 22.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.412 -0.805 . . . . 0.0 109.846 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -69.93 -35.95 74.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.533 -0.729 . . . . 0.0 109.583 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 57.59 68.19 0.88 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.608 0.718 . . . . 0.0 109.845 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.96 -42.89 84.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.595 -0.691 . . . . 0.0 109.589 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 56.5 p-80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.298 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.492 ' O ' ' NH2' ' A' ' 3' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.92 163.94 12.15 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.822 0.82 . . . . 0.0 110.24 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 1' ' ' MET . 13.8 mmp_? -59.91 -47.91 83.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.574 -0.704 . . . . 0.0 109.522 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -43.42 -43.15 5.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.558 -0.714 . . . . 0.0 109.962 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.03 -44.91 83.31 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 109.217 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -62.89 -46.03 89.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.35 -0.843 . . . . 0.0 109.635 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.7 mm -64.34 -45.0 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.361 -0.837 . . . . 0.0 109.722 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.08 -41.71 99.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.322 -0.862 . . . . 0.0 110.075 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.458 ' CE1' HG21 ' A' ' 109' ' ' ILE . 33.9 t80 -60.81 -44.56 96.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.531 -0.731 . . . . 0.0 109.988 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.41 84.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.485 -0.759 . . . . 0.0 110.117 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 15' ' ' ASP . 94.9 mt-30 -67.51 -35.92 80.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.844 -1.16 . . . . 0.0 109.603 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -64.9 -43.36 93.12 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.689 -1.257 . . . . 0.0 109.657 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -88.25 -11.84 45.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.378 -0.826 . . . . 0.0 111.346 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.606 ' CE1' ' NE2' ' A' ' 33' ' ' HIS . 91.4 m-85 -139.98 -20.34 0.89 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.837 -1.164 . . . . 0.0 111.139 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 11' ' ' GLN . 72.1 m-20 53.64 30.16 10.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.049 -1.032 . . . . 0.0 109.475 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -103.2 156.21 17.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.353 -0.842 . . . . 0.0 109.33 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -97.37 139.76 21.63 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.342 -0.849 . . . . 0.0 109.615 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -50.34 142.28 29.86 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.825 1.684 . . . . 0.0 112.906 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -125.97 121.68 33.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -89.55 146.44 35.75 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.184 -0.947 . . . . 0.0 109.867 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.32 -81.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.161 1.908 . . . . 0.0 111.561 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -87.2 137.03 32.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.448 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -61.51 -20.1 62.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.392 -0.817 . . . . 0.0 109.733 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -76.7 -5.19 46.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.0 109.629 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -129.8 70.12 81.87 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.469 -0.77 . . . . 0.0 109.286 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.92 -18.14 46.64 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.368 2.045 . . . . 0.0 112.015 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -79.78 -5.05 54.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.62 140.87 29.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.362 -0.836 . . . . 0.0 109.527 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.05 130.78 43.7 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.659 -0.65 . . . . 0.0 109.309 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 78.5 t -128.09 131.44 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -103.17 147.88 26.47 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.539 -0.726 . . . . 0.0 109.574 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -134.24 139.88 46.07 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.48 -0.762 . . . . 0.0 109.749 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.606 ' NE2' ' CE1' ' A' ' 14' ' ' TYR . 30.5 m170 -100.21 131.49 46.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.626 -0.671 . . . . 0.0 109.337 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -87.18 -32.11 19.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 0.0 110.59 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 31.4 p-10 -92.02 -1.6 57.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.092 -1.005 . . . . 0.0 111.491 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' LYS . 44.7 t30 -118.66 29.1 7.92 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.027 -1.046 . . . . 0.0 110.16 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.412 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 98.7 m-20 37.23 -86.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.425 0.631 . . . . 0.0 111.215 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 17.9 ptpt -77.53 157.58 30.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.501 -0.749 . . . . 0.0 110.325 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.432 ' CE3' ' O ' ' A' ' 39' ' ' TRP . 12.0 p-90 -177.44 153.13 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.534 -0.729 . . . . 0.0 109.421 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -149.17 118.8 6.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.58 124.53 5.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -150.91 143.02 24.08 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.75 -1.219 . . . . 0.0 110.235 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.498 HD21 ' OD1' ' A' ' 60' ' ' ASP . 9.5 tt -121.03 125.45 47.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -156.99 162.11 39.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.04 114.89 26.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.582 -0.699 . . . . 0.0 109.157 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.7 pt -121.19 145.5 42.19 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.515 -0.741 . . . . 0.0 109.45 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -45.34 135.86 11.67 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.903 1.735 . . . . 0.0 112.787 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.25 -25.64 65.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.589 -0.695 . . . . 0.0 110.162 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -17.7 63.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.296 -0.877 . . . . 0.0 110.346 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -84.64 -12.84 53.15 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.971 -1.08 . . . . 0.0 110.991 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 pt -102.67 6.35 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.188 -0.945 . . . . 0.0 109.465 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.03 -4.61 67.98 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.682 HD11 ' CZ ' ' A' ' 81' ' ' TYR . 77.2 mt -79.7 135.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.886 -1.361 . . . . 0.0 109.882 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -74.42 92.36 2.32 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.568 -0.707 . . . . 0.0 110.083 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.2 139.63 3.23 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 37.5 p-10 -88.99 4.55 47.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 108.394 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -80.62 152.94 28.27 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.642 -0.661 . . . . 0.0 110.023 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -97.6 150.01 21.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.563 -0.711 . . . . 0.0 109.814 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.33 163.05 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.715 -0.616 . . . . 0.0 109.642 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.498 ' OD1' HD21 ' A' ' 43' ' ' LEU . 8.3 t70 -91.57 128.81 37.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.583 -0.698 . . . . 0.0 109.39 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.83 160.18 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.0 110.348 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.15 150.97 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -84.96 127.27 34.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.466 -0.771 . . . . 0.0 109.975 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.584 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -118.99 121.31 39.61 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.584 ' N ' HD13 ' A' ' 64' ' ' LEU . 37.4 ttmt -82.93 132.2 35.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.855 . . . . 0.0 110.159 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 m -142.5 165.08 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.347 -0.846 . . . . 0.0 108.879 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.476 ' HG3' HD21 ' A' ' 115' ' ' LEU . 33.4 mt-30 -84.71 156.9 61.4 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 108.725 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 71' ' ' VAL . 20.3 Cg_endo -60.66 -22.84 74.26 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.382 2.055 . . . . 0.0 111.405 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -90.48 -29.64 17.81 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.441 -0.787 . . . . 0.0 109.352 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 80.9 mt -95.2 1.93 54.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.326 -0.859 . . . . 0.0 109.763 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 68' ' ' PRO . 10.0 p -64.33 -34.47 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.0 109.52 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.56 -14.59 67.33 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.453 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 55.9 p -68.27 -60.56 2.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -1.163 . . . . 0.0 111.101 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.629 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.7 pt? -88.24 -23.9 23.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.796 -1.19 . . . . 0.0 110.934 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.445 HH21 ' NZ ' ' A' ' 88' ' ' LYS . 78.9 ttt-85 -65.76 -22.8 66.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 110.097 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.453 ' CD ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -94.28 -9.34 36.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.205 -0.934 . . . . 0.0 108.833 179.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -73.81 151.28 88.81 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.097 -1.002 . . . . 0.0 109.357 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.09 143.34 71.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.612 2.208 . . . . 0.0 112.53 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.15 -5.26 63.54 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.9 mm -98.41 125.18 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -1.157 . . . . 0.0 109.174 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.682 ' CZ ' HD11 ' A' ' 53' ' ' ILE . 77.3 m-85 -119.87 147.91 45.29 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.733 -0.604 . . . . 0.0 109.598 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HB3' ' HZ1' ' A' ' 88' ' ' LYS . 52.0 Cg_endo -69.95 153.68 67.8 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.054 1.836 . . . . 0.0 111.837 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.68 50.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 109.834 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 85' ' ' HIS . 32.1 p90 -66.2 179.31 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.261 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.509 ' CG ' ' O ' ' A' ' 85' ' ' HIS . 54.5 p-80 -40.85 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.471 0.653 . . . . 0.0 110.545 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.1 ttm -167.67 -78.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.526 -0.734 . . . . 0.0 109.193 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.622 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 98.9 m-20 -139.92 -31.84 0.64 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.445 ' NZ ' HH21 ' A' ' 75' ' ' ARG . 49.9 tttp 58.77 -68.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.238 0.542 . . . . 0.0 111.417 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 87' ' ' ASN . 74.2 mt-10 -60.92 -52.21 66.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.868 . . . . 0.0 112.001 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -66.54 -46.77 75.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.935 -1.103 . . . . 0.0 111.251 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.622 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 8.9 m0 -115.51 140.99 48.66 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.439 -0.788 . . . . 0.0 110.317 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mm -128.87 138.41 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 p -86.84 133.35 33.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.876 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.9 t -112.91 132.58 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.3 tp -87.02 104.07 15.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.518 0.675 . . . . 0.0 110.488 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.64 -39.75 84.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.567 -0.708 . . . . 0.0 109.482 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.87 1.78 6.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.529 -0.732 . . . . 0.0 109.386 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.83 -162.47 30.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.44 -3.39 11.4 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.892 2.394 . . . . 0.0 111.242 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -49.6 126.63 13.99 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.618 0.723 . . . . 0.0 110.0 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.21 169.29 34.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.84 94.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -1.133 . . . . 0.0 109.232 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -64.85 -42.02 95.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.692 . . . . 0.0 109.612 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.74 -42.69 94.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.28 -43.3 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -56.94 -43.84 81.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.387 -0.82 . . . . 0.0 109.564 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.3 m -61.16 -43.99 98.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.897 . . . . 0.0 109.654 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.87 -42.46 97.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.201 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.458 HG21 ' CE1' ' A' ' 9' ' ' TYR . 97.0 mt -63.8 -42.78 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 108.652 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -53.07 -40.9 64.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.475 -0.766 . . . . 0.0 108.936 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.64 -39.61 94.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 108.702 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 t -65.02 -40.34 94.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.836 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -57.99 -48.97 78.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.417 -0.802 . . . . 0.0 110.076 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -67.75 -32.12 72.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.087 -1.008 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.476 HD21 ' HG3' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -61.88 -41.12 97.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.7 p -90.78 14.93 12.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.49 -0.756 . . . . 0.0 109.395 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -53.93 145.69 15.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.467 -0.771 . . . . 0.0 110.319 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.429 HD22 ' O ' ' A' ' 35' ' ' ASP . 57.2 mt -71.51 141.19 50.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.642 0.734 . . . . 0.0 110.547 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -97.09 21.95 9.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.649 . . . . 0.0 109.551 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -150.04 162.93 39.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.937 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -80.5 155.63 26.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.545 -0.722 . . . . 0.0 110.175 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -60.44 -41.28 93.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.553 -0.717 . . . . 0.0 109.678 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -73.92 129.12 37.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.582 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -76.32 135.12 39.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.469 -0.769 . . . . 0.0 110.261 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.501 ' CG ' ' O ' ' A' ' 125' ' ' HIS . 86.8 t60 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.346 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -104.56 156.23 18.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.458 -0.776 . . . . 0.0 110.001 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.493 ' NH1' ' OD2' ' A' ' 45' ' ' ASP . 61.6 ttp180 -61.29 -42.9 99.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.54 -0.725 . . . . 0.0 109.336 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.56 -39.77 95.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.368 -0.832 . . . . 0.0 109.773 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' OE1' ' N ' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -62.75 -42.44 99.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.013 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.404 ' CD1' HD12 ' A' ' 43' ' ' LEU . 60.2 t80 -61.08 -45.55 94.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.526 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.35 -44.51 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.487 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.12 -45.79 90.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.185 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -62.61 -43.19 99.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.782 . . . . 0.0 109.258 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.94 97.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.414 -0.803 . . . . 0.0 110.002 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 81.0 mt-30 -65.65 -45.0 84.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 110.123 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.37 -35.8 80.27 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.09 -1.006 . . . . 0.0 109.514 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -85.07 -37.24 20.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.398 -0.814 . . . . 0.0 111.686 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.543 ' CZ ' ' CE2' ' A' ' 39' ' ' TRP . 93.2 m-85 -114.55 6.63 15.88 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.015 -1.053 . . . . 0.0 111.698 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 2.4 p-10 39.04 29.12 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.162 -0.961 . . . . 0.0 110.434 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 14' ' ' TYR . 33.0 m -109.94 126.17 53.61 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 109.147 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 157.68 63.21 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.0 109.221 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.59 135.74 33.79 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.842 1.695 . . . . 0.0 112.316 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.433 ' C ' ' CD2' ' A' ' 20' ' ' HIS . 97.1 m-20 -118.27 140.22 50.14 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 20' ' ' HIS . 2.1 m-70 -136.99 85.43 22.76 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.365 -0.834 . . . . 0.0 109.165 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -54.83 -40.31 85.75 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.241 1.961 . . . . 0.0 111.626 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -91.92 130.7 37.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.677 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -84.44 -17.13 40.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.468 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -81.78 -5.16 57.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 109.391 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -128.81 62.04 59.18 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.57 -0.706 . . . . 0.0 109.405 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.93 -19.38 52.29 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.348 2.032 . . . . 0.0 111.828 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.35 -5.11 57.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.116 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.475 ' O ' ' ND1' ' A' ' 20' ' ' HIS . 21.8 m-85 -99.27 134.01 42.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.472 -0.768 . . . . 0.0 109.602 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.72 132.94 54.9 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.61 127.46 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -112.77 122.78 48.67 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.367 0.603 . . . . 0.0 109.862 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -151.57 143.98 24.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 109.106 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.82 124.11 42.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.266 -0.896 . . . . 0.0 109.769 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -80.0 -12.08 59.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.516 -0.74 . . . . 0.0 109.811 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -62.88 -45.23 93.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.095 -1.003 . . . . 0.0 110.528 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 54.3 p30 -123.6 -13.15 7.58 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.29 -0.881 . . . . 0.0 109.919 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 36' ' ' ASN . 45.8 t0 59.24 5.05 0.53 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.446 -0.784 . . . . 0.0 109.799 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 36' ' ' ASN . 28.6 mmtp -94.21 -8.95 37.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.055 -1.028 . . . . 0.0 109.086 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.543 ' CE2' ' CZ ' ' A' ' 14' ' ' TYR . 63.0 t-105 -90.35 108.36 19.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.461 -0.775 . . . . 0.0 109.298 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -107.88 128.62 54.78 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.554 -0.716 . . . . 0.0 109.171 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.33 123.92 8.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.495 -0.753 . . . . 0.0 108.98 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.8 tp -124.34 130.36 52.35 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.64 -0.663 . . . . 0.0 109.274 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.502 ' C ' HD23 ' A' ' 43' ' ' LEU . 9.4 tt -126.82 128.38 46.47 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.412 ' N ' HD23 ' A' ' 43' ' ' LEU . 6.2 ptt? -160.39 162.78 33.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 110.025 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.493 ' OD2' ' NH1' ' A' ' 3' ' ' ARG . 99.3 m-20 -100.28 117.37 34.35 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.7 pt -134.44 145.57 55.75 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.85 151.32 85.7 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.538 2.158 . . . . 0.0 112.917 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.82 64.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.593 -0.692 . . . . 0.0 109.761 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -66.22 -17.94 65.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.121 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -84.28 -14.67 49.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.064 -1.023 . . . . 0.0 111.253 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.64 10.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.174 -0.954 . . . . 0.0 109.885 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.34 -9.26 72.08 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.105 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.5 mt -79.96 135.12 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.802 -1.41 . . . . 0.0 109.722 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -74.61 95.67 2.85 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.14 133.52 1.75 Allowed Glycine 0 N--CA 1.482 1.717 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -91.1 11.72 22.23 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -64.96 157.63 27.64 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.1 mtp85 -100.35 135.98 40.95 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.3 m -137.55 157.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.418 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 96.6 m-20 -99.07 140.3 33.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.95 151.01 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.399 -0.813 . . . . 0.0 110.109 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 pt -131.32 161.07 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 66.8 t0 -133.73 140.76 47.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.236 -0.915 . . . . 0.0 109.732 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.519 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -132.9 159.19 40.62 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.444 0.64 . . . . 0.0 109.336 -179.718 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -88.36 138.93 31.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.491 -0.755 . . . . 0.0 110.629 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.1 161.92 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.56 -0.712 . . . . 0.0 109.298 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HG3' HD22 ' A' ' 115' ' ' LEU . 29.4 mt-30 -80.72 157.96 71.38 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.411 -0.805 . . . . 0.0 109.344 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.492 ' O ' HG12 ' A' ' 71' ' ' VAL . 29.3 Cg_endo -61.92 -23.85 76.35 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.532 2.155 . . . . 0.0 111.592 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -88.88 -30.81 18.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.279 -0.888 . . . . 0.0 109.574 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.5 mt -93.13 -0.16 57.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -0.84 . . . . 0.0 109.415 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 68' ' ' PRO . 11.3 p -63.95 -31.54 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.464 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.51 -15.44 78.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 p -69.01 -54.32 15.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 110.527 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.701 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.2 pt? -85.38 -28.04 25.43 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.0 -1.062 . . . . 0.0 110.499 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.3 ttt-85 -69.51 -21.96 63.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.192 -0.942 . . . . 0.0 110.585 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.25 -7.94 52.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.939 -1.101 . . . . 0.0 109.502 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -82.22 150.26 63.96 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.894 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.05 144.32 63.29 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.549 2.166 . . . . 0.0 112.293 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.78 -16.36 54.81 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.72 HD12 ' N ' ' A' ' 80' ' ' ILE . 2.0 mp -90.16 127.14 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.044 -1.268 . . . . 0.0 108.905 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -115.55 126.16 28.03 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.394 -0.816 . . . . 0.0 110.212 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -52.28 146.51 31.47 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.41 1.406 . . . . 0.0 111.79 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.24 140.26 57.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.375 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -98.03 1.45 47.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.384 -0.823 . . . . 0.0 108.933 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -65.77 -176.91 0.41 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.458 -0.776 . . . . 0.0 110.374 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 74.4 mtm -64.29 -41.17 97.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.531 -0.731 . . . . 0.0 109.938 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -97.62 138.02 35.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.263 -0.898 . . . . 0.0 109.784 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -141.32 70.27 1.34 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.409 -0.807 . . . . 0.0 109.342 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -143.83 -54.29 0.36 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.46 -0.775 . . . . 0.0 109.07 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -99.31 -15.68 18.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -108.26 122.41 46.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.368 -0.833 . . . . 0.0 110.011 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.7 mm -125.9 137.04 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.5 m -95.01 144.22 25.86 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -120.59 136.67 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.1 tp -87.22 113.63 23.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.975 . . . . 0.0 110.276 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 98' ' ' GLY . 12.8 mt -64.62 -40.72 95.97 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -70.78 4.29 2.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.416 -0.802 . . . . 0.0 109.063 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -68.06 171.99 34.44 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.96 -4.97 15.5 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 123.445 2.763 . . . . 0.0 112.327 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.487 ' H ' HD23 ' A' ' 100' ' ' LEU . 0.4 OUTLIER -72.14 150.06 44.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.144 -179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.09 171.53 42.62 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 120.489 -0.863 . . . . 0.0 111.04 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.42 83.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.95 . . . . 0.0 109.715 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.9 pttm -61.11 -36.32 79.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.219 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -65.87 -38.84 89.86 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.415 -0.803 . . . . 0.0 109.126 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.92 -44.18 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -58.94 -42.54 90.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.388 -0.82 . . . . 0.0 109.786 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.7 m -60.71 -45.09 95.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 110.172 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.78 -44.1 94.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.752 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.03 -43.12 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.501 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -51.9 -42.06 62.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 108.875 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.37 -43.92 97.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.226 -0.921 . . . . 0.0 109.061 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 t -63.67 -41.76 98.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.0 110.69 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -58.96 -45.3 90.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.257 -0.902 . . . . 0.0 110.893 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -60.8 -38.83 86.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.028 -1.045 . . . . 0.0 110.418 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.433 HD22 ' HG3' ' A' ' 67' ' ' GLN . 96.7 mt -63.01 -40.71 98.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.695 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.4 p -93.78 14.32 19.67 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -45.71 142.48 2.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.437 -0.789 . . . . 0.0 109.693 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 76.1 mt -68.69 147.57 51.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.33 -0.857 . . . . 0.0 109.941 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.67 ' CD ' ' H ' ' A' ' 119' ' ' GLU . 1.3 pm0 -74.66 43.98 0.2 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.537 -0.727 . . . . 0.0 109.756 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.539 ' ND1' ' N ' ' A' ' 121' ' ' HIS . 63.3 t-80 60.35 167.14 0.08 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.536 0.684 . . . . 0.0 110.636 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.539 ' N ' ' ND1' ' A' ' 120' ' ' HIS . 75.7 m80 -82.31 150.59 27.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.555 -0.716 . . . . 0.0 110.058 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -84.44 167.56 16.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 109.965 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -76.34 123.41 25.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 110.425 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -68.29 -37.99 81.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.572 -0.705 . . . . 0.0 109.946 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.564 -179.421 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.7 ttm . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.509 0.671 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -93.48 166.05 12.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.361 -0.837 . . . . 0.0 110.727 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -63.22 -42.76 99.31 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.348 0.594 . . . . 0.0 109.76 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -65.48 -39.45 91.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.3 -0.875 . . . . 0.0 109.673 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.02 -38.75 92.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.327 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.75 -45.53 93.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -0.815 . . . . 0.0 109.439 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.59 -43.77 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.409 -0.807 . . . . 0.0 109.412 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.14 -41.61 97.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.446 -0.784 . . . . 0.0 109.794 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -62.2 -42.66 99.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.415 -0.803 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.38 82.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.432 -0.793 . . . . 0.0 109.719 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 15' ' ' ASP . 88.6 mt-30 -63.45 -48.42 77.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.062 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -64.48 -37.45 87.59 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.721 -1.237 . . . . 0.0 109.466 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -68.79 -46.3 69.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.522 -0.736 . . . . 0.0 111.942 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.17 -20.43 4.13 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.0 110.677 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 25.4 t0 65.31 42.1 4.07 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.266 -0.896 . . . . 0.0 108.855 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.7 m -104.19 133.35 49.27 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.609 0.718 . . . . 0.0 109.595 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -83.75 151.4 61.23 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.725 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.21 153.55 71.3 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.818 2.345 . . . . 0.0 112.533 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 61.6 t0 -140.76 138.92 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 108.96 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.467 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 9.8 p80 -132.64 86.94 42.99 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.505 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -54.54 -37.92 90.28 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.502 2.135 . . . . 0.0 110.653 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -87.51 82.06 7.59 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -55.2 -14.45 1.71 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -65.18 -2.33 2.84 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.503 -0.748 . . . . 0.0 109.073 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -147.95 76.15 10.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.394 -0.817 . . . . 0.0 109.325 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.08 -19.22 65.61 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.635 2.224 . . . . 0.0 110.764 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 12.5 p-10 -81.19 -2.48 48.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -100.38 139.48 36.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.435 -0.791 . . . . 0.0 109.255 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.0 128.17 45.94 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -113.66 124.51 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.657 -0.652 . . . . 0.0 109.561 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.88 136.5 51.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.688 -0.632 . . . . 0.0 109.295 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -157.18 139.37 14.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -101.0 126.65 47.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.528 -0.733 . . . . 0.0 109.635 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 m -80.79 -10.62 59.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.473 -0.767 . . . . 0.0 109.168 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -64.03 -40.84 97.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.396 -0.815 . . . . 0.0 109.95 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.705 ' ND2' HD21 ' A' ' 118' ' ' LEU . 2.1 m120 -113.16 -24.6 9.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.324 -0.86 . . . . 0.0 109.252 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.8 t0 63.36 -8.88 0.13 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.589 -0.694 . . . . 0.0 109.855 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 36' ' ' ASN . 64.5 mttp -97.64 -6.29 33.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.205 -0.934 . . . . 0.0 108.863 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.501 ' CE3' HG21 ' A' ' 116' ' ' THR . 15.0 t-105 -84.82 109.88 18.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 109.683 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -109.3 125.92 52.82 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB2' ' HE1' ' A' ' 39' ' ' TRP . . . -138.82 136.72 35.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.5 tp -145.1 122.95 11.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.647 ' C ' HD23 ' A' ' 43' ' ' LEU . 7.4 tt -120.23 124.48 45.78 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.558 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.68 164.76 26.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 0.0 109.689 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 88.9 m-20 -96.42 114.05 25.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.565 -0.71 . . . . 0.0 109.721 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.469 HG23 ' SD ' ' A' ' 44' ' ' MET . 16.2 pt -116.83 144.99 34.48 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -48.78 141.38 21.19 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.985 1.79 . . . . 0.0 112.421 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -63.08 -21.09 65.94 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.382 0.61 . . . . 0.0 109.972 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.29 -13.99 59.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.123 -0.986 . . . . 0.0 109.608 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -84.32 -10.85 57.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.412 ' CD1' HD12 ' A' ' 53' ' ' ILE . 11.3 pt -103.19 1.73 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.301 -0.874 . . . . 0.0 109.345 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.43 -14.39 59.43 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.565 ' C ' ' H ' ' A' ' 55' ' ' GLY . 76.4 mt -78.55 130.55 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.956 -1.32 . . . . 0.0 109.498 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -63.28 14.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.585 -0.697 . . . . 0.0 110.539 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -86.11 140.78 17.96 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -101.27 5.77 42.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.503 -0.998 . . . . 0.0 109.628 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 88.4 tttt -88.44 144.81 26.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -71.73 145.8 48.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.63 -0.669 . . . . 0.0 110.359 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.46 157.46 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.528 -0.732 . . . . 0.0 109.633 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 12.9 m-20 -93.81 131.63 39.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.495 -0.753 . . . . 0.0 109.355 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.95 156.89 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.42 -0.8 . . . . 0.0 110.292 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 pt -134.96 149.88 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.474 0.654 . . . . 0.0 109.739 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -81.68 146.64 29.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.11 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.657 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -132.95 127.08 33.46 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.657 ' N ' HD13 ' A' ' 64' ' ' LEU . 63.1 tttp -82.21 131.69 35.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.556 -0.715 . . . . 0.0 110.147 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.37 161.32 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 109.677 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -85.62 158.71 56.64 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 71' ' ' VAL . 19.2 Cg_endo -59.87 -19.79 56.44 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.61 2.207 . . . . 0.0 111.544 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -95.88 -28.24 14.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.346 -0.846 . . . . 0.0 109.116 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.04 -2.56 56.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.415 -0.803 . . . . 0.0 109.493 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 72' ' ' GLY . 7.1 p -63.7 -41.08 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.946 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.475 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.12 -40.66 99.44 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.7 m -62.13 -36.03 80.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.208 -1.172 . . . . 0.0 110.419 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' CD2' HG21 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -77.98 -39.07 43.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.079 . . . . 0.0 111.011 -179.254 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.575 HH21 ' CD1' ' A' ' 92' ' ' ILE . 95.9 mtt180 -76.71 -6.54 52.57 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.069 -1.019 . . . . 0.0 110.125 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -11.41 58.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.084 -1.01 . . . . 0.0 109.171 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -90.83 148.07 37.46 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 109.266 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' HD21 ' A' ' 100' ' ' LEU . 56.2 Cg_endo -69.07 144.73 58.74 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.716 2.278 . . . . 0.0 113.09 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.15 -5.0 85.92 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.81 122.87 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -1.109 . . . . 0.0 109.782 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -124.6 145.52 49.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.26 150.08 81.45 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.454 2.103 . . . . 0.0 112.387 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.1 138.88 58.06 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.708 0.766 . . . . 0.0 110.257 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 13.0 p90 -95.32 1.02 54.27 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 86' ' ' MET . 8.9 m170 -148.47 159.36 44.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.112 -0.993 . . . . 0.0 110.793 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.443 ' O ' ' O ' ' A' ' 87' ' ' ASN . 79.5 mtp 48.61 105.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.892 0.853 . . . . 0.0 111.023 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 86' ' ' MET . 99.2 m-20 44.01 -171.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.642 0.734 . . . . 0.0 110.751 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -144.92 -57.78 0.35 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.49 -0.756 . . . . 0.0 109.308 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.0 -37.75 84.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.212 -0.93 . . . . 0.0 109.125 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -57.01 -67.13 0.34 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.44 -0.788 . . . . 0.0 109.801 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -105.04 144.53 31.71 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.525 0.679 . . . . 0.0 110.094 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.575 ' CD1' HH21 ' A' ' 75' ' ' ARG . 7.1 mm -130.54 144.07 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.8 m -87.48 131.18 34.43 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.394 -0.816 . . . . 0.0 109.82 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.1 t -118.52 132.39 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.5 tp -87.9 101.98 14.26 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.622 0.725 . . . . 0.0 110.24 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 98' ' ' GLY . 84.1 mt -66.04 -40.39 90.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -71.96 5.49 2.63 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -84.63 -166.33 41.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.8 7.86 4.34 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.023 2.482 . . . . 0.0 111.611 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.3 mm? -62.24 130.55 45.9 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.973 0.892 . . . . 0.0 110.578 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.5 158.43 31.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.463 ' O ' ' ND1' ' A' ' 106' ' ' HIS . . . -60.16 -47.02 87.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.695 -0.885 . . . . 0.0 109.552 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -65.18 -40.52 94.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.511 -0.743 . . . . 0.0 109.447 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.0 -44.89 96.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.509 -0.744 . . . . 0.0 109.522 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.43 -43.32 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.554 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 102' ' ' ALA . 31.8 m80 -58.74 -42.62 89.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.368 -0.833 . . . . 0.0 109.888 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.9 m -61.43 -43.6 98.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.54 -40.7 96.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.454 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.92 -43.2 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.215 -0.928 . . . . 0.0 109.337 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -60.48 -37.8 82.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.66 -42.04 99.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.493 -0.754 . . . . 0.0 108.987 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 116' ' ' THR . 96.6 p -62.61 -36.24 82.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.363 -0.836 . . . . 0.0 109.155 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.69 -45.21 95.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.385 -0.822 . . . . 0.0 109.594 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -65.65 -27.63 68.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.009 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.2 mt -82.37 -13.15 57.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.536 -0.727 . . . . 0.0 109.317 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 112' ' ' SER . 79.4 p -110.64 14.66 22.32 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -68.15 140.06 56.14 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.863 0.84 . . . . 0.0 110.308 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.705 HD21 ' ND2' ' A' ' 36' ' ' ASN . 88.3 mt -81.9 177.02 9.09 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.668 0.747 . . . . 0.0 110.912 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 56.94 108.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.64 0.734 . . . . 0.0 109.984 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 122' ' ' HIS . 54.7 t-80 -84.47 90.37 7.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.436 -0.79 . . . . 0.0 109.681 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 74.6 m80 46.61 13.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 120' ' ' HIS . 3.3 m-70 -110.98 149.93 29.98 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.906 0.86 . . . . 0.0 109.988 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 53.18 90.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.74 0.781 . . . . 0.0 110.187 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.9 m80 46.87 83.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.717 0.77 . . . . 0.0 110.021 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.937 179.638 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.6 ttp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.155 0.503 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -94.96 155.64 16.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.176 -0.952 . . . . 0.0 110.373 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.512 ' NH2' ' OD1' ' A' ' 45' ' ' ASP . 40.8 ttm180 -62.09 -42.63 99.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.549 -0.719 . . . . 0.0 109.546 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -53.99 -42.32 68.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 109.817 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.65 -35.54 80.4 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.129 -0.982 . . . . 0.0 109.49 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -60.89 -44.65 96.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.123 -0.985 . . . . 0.0 109.161 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.9 mm -64.0 -44.66 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.288 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.15 -41.13 99.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.519 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -60.32 -49.86 75.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.3 -35.25 75.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 17.4 tt0 -59.34 -49.91 76.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.385 -0.822 . . . . 0.0 110.28 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -64.26 -40.21 95.51 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.637 -1.289 . . . . 0.0 109.465 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -68.34 -44.29 75.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 112.259 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 113' ' ' PHE . 97.0 m-85 -127.64 -18.49 4.34 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.993 -1.067 . . . . 0.0 110.902 -178.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 24.9 t0 63.68 45.81 4.39 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.0 . . . . 0.0 109.084 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.0 m -113.72 127.9 56.21 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -83.95 155.19 64.51 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.12 -0.987 . . . . 0.0 109.759 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.55 140.54 64.79 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.77 1.647 . . . . 0.0 112.607 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -116.28 121.31 41.63 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 20' ' ' HIS . 11.8 m-70 -114.87 85.32 11.61 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.499 -0.751 . . . . 0.0 109.19 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.43 -12.82 16.91 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.928 1.752 . . . . 0.0 110.878 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -100.7 93.97 5.85 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -63.34 -17.57 62.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 0.0 109.848 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -83.87 -3.07 57.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.681 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -143.43 69.35 17.5 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.128 -0.983 . . . . 0.0 109.792 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.98 -29.53 89.55 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.55 2.167 . . . . 0.0 111.191 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.91 -6.94 45.53 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.429 -0.795 . . . . 0.0 109.366 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -102.72 135.41 44.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.457 -0.777 . . . . 0.0 109.13 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -123.35 146.78 47.67 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.6 t -125.62 130.49 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.559 -0.713 . . . . 0.0 109.209 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.48 112.03 22.91 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.69 -0.631 . . . . 0.0 109.319 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -134.24 138.45 45.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.306 -0.871 . . . . 0.0 108.665 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.594 ' ND1' ' CD1' ' A' ' 39' ' ' TRP . 35.9 m170 -100.87 118.2 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -0.852 . . . . 0.0 109.765 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.1 m -63.28 -36.73 84.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.351 -0.843 . . . . 0.0 109.342 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.03 -43.42 98.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 110.134 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 38' ' ' LYS . 30.0 m-80 -91.99 5.45 50.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.067 -1.021 . . . . 0.0 108.882 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' LYS . 66.9 t0 51.25 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.778 -0.576 . . . . 0.0 110.712 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' ASN . 60.3 mttp -55.88 -110.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 110.582 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.594 ' CD1' ' ND1' ' A' ' 33' ' ' HIS . 48.5 t-105 40.8 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.756 -0.59 . . . . 0.0 109.831 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -107.97 125.77 51.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.459 -0.776 . . . . 0.0 109.325 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.89 128.25 10.61 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.95 146.0 40.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 109.388 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 tt -116.84 128.26 55.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -152.08 163.17 39.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.994 . . . . 0.0 109.392 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.512 ' OD1' ' NH2' ' A' ' 3' ' ' ARG . 98.5 m-20 -98.89 136.56 38.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -0.795 . . . . 0.0 108.858 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -139.95 145.73 43.68 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.208 -0.932 . . . . 0.0 109.767 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.17 135.73 30.65 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.844 1.696 . . . . 0.0 113.089 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 57' ' ' LYS . . . -65.83 -29.52 70.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 109.902 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 55' ' ' GLY . 15.7 pt-20 -55.57 -29.89 59.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.076 -1.015 . . . . 0.0 110.22 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -63.79 -34.94 79.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.977 -1.077 . . . . 0.0 110.322 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 53' ' ' ILE . 4.6 pt -96.41 -1.55 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.16 -0.963 . . . . 0.0 109.708 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.96 34.75 32.92 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.874 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 51' ' ' ILE . 35.0 mt -110.16 136.51 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.349 -1.089 . . . . 0.0 110.059 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.401 ' C ' ' OD1' ' A' ' 54' ' ' ASN . 49.1 t-20 43.03 -89.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.396 0.617 . . . . 0.0 110.252 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . -158.73 -110.87 0.29 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -108.76 47.82 0.89 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.628 -0.925 . . . . 0.0 109.517 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 88.1 tttt -91.8 129.67 37.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.224 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -71.87 136.4 46.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.58 164.22 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.346 -0.846 . . . . 0.0 109.233 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.437 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 83.4 m-20 -92.01 134.34 34.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.189 -0.945 . . . . 0.0 110.04 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -137.02 158.93 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.234 -0.916 . . . . 0.0 109.69 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.3 pt -135.04 146.74 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -110.59 140.15 45.17 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.553 -0.717 . . . . 0.0 109.621 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.27 164.28 28.45 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 132.08 52.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.483 -0.761 . . . . 0.0 109.877 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.22 162.78 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.342 -0.848 . . . . 0.0 110.144 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -72.03 133.96 83.51 Favored Pre-proline 0 C--N 1.298 -1.643 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.46 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.607 ' O ' HG12 ' A' ' 71' ' ' VAL . 71.1 Cg_exo -44.69 -38.18 12.27 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.962 1.775 . . . . 0.0 112.302 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.43 -32.21 66.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.054 -1.029 . . . . 0.0 110.442 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.7 mt -92.1 5.02 51.86 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.085 -1.01 . . . . 0.0 110.111 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 68' ' ' PRO . 12.7 p -61.47 -28.21 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.047 -1.033 . . . . 0.0 109.015 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.461 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -58.46 -39.46 93.0 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -59.5 -41.11 89.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.15 -1.206 . . . . 0.0 109.668 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 74' ' ' LEU . 2.5 mm? -68.99 -44.9 71.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 110.781 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -78.2 -36.92 46.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.0 111.299 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.461 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -72.98 -1.72 18.2 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.066 -1.053 . . . . 0.0 109.654 -178.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.403 ' CB ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -96.49 139.99 21.96 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 109.157 179.47 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.99 143.69 45.56 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.124 1.883 . . . . 0.0 112.969 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.09 -17.42 56.98 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.619 HD12 ' N ' ' A' ' 80' ' ' ILE . 3.7 mp -93.92 127.44 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -1.178 . . . . 0.0 109.401 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -114.35 133.55 22.43 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.699 -0.625 . . . . 0.0 110.133 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -54.32 149.26 38.11 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.278 1.319 . . . . 0.0 111.352 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.23 143.42 55.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.832 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -92.45 21.96 4.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 109.404 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' MET . 7.5 p80 -148.0 167.89 23.73 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.017 -1.052 . . . . 0.0 110.409 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' HIS . 65.5 mtt -43.68 173.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.539 0.685 . . . . 0.0 111.497 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 57.83 34.12 24.01 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.618 0.723 . . . . 0.0 109.459 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.7 -43.0 99.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.458 -0.776 . . . . 0.0 109.832 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.05 -44.52 84.34 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.102 -0.999 . . . . 0.0 109.858 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -68.78 -46.7 68.05 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.114 -0.991 . . . . 0.0 110.857 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -115.7 145.78 42.45 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.419 -0.801 . . . . 0.0 110.291 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.502 HD11 HG23 ' A' ' 71' ' ' VAL . 8.0 mm -130.61 152.32 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.9 m -101.92 135.49 43.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.406 -0.809 . . . . 0.0 109.508 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.37 136.41 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 63.2 tp -90.66 116.26 28.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 110.085 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 mt -65.96 -40.22 91.12 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -72.28 3.58 4.52 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -56.56 164.94 5.22 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.74 -8.5 18.07 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.109 2.539 . . . . 0.0 111.576 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -75.93 162.29 28.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.217 -0.927 . . . . 0.0 110.66 -178.472 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.58 163.59 50.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.47 80.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.509 -0.995 . . . . 0.0 109.089 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.11 -39.55 92.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -0.858 . . . . 0.0 109.419 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -62.48 -42.12 99.27 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.114 -0.991 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.58 -43.89 96.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.213 -0.93 . . . . 0.0 109.354 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -66.03 -38.51 88.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.297 -0.877 . . . . 0.0 109.577 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.7 m -59.48 -44.57 93.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.116 -0.99 . . . . 0.0 109.809 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.37 -42.13 96.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 109.261 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.61 -42.94 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.061 -1.024 . . . . 0.0 109.058 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -53.09 -40.63 64.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.225 -0.922 . . . . 0.0 108.637 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.75 -40.89 98.66 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.3 -0.875 . . . . 0.0 108.724 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -60.2 -38.91 84.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.454 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 14' ' ' TYR . 74.8 t80 -61.39 -43.52 98.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.68 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -47.81 -39.55 18.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.194 -0.941 . . . . 0.0 109.68 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.9 mp -65.01 -39.19 93.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 109.684 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.5 p -90.94 9.68 29.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.149 -0.969 . . . . 0.0 109.172 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -49.57 136.68 16.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.864 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.492 HD21 ' OD1' ' A' ' 36' ' ' ASN . 92.9 mt -80.81 -133.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.0 109.881 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 118' ' ' LEU . 16.1 pt-20 38.84 -160.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.376 0.608 . . . . 0.0 110.942 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.504 ' CG ' ' N ' ' A' ' 121' ' ' HIS . 47.2 t60 -156.81 170.57 22.16 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.265 -0.897 . . . . 0.0 109.541 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' HIS . . . . . 0.504 ' N ' ' CG ' ' A' ' 120' ' ' HIS . 45.9 p-80 -148.54 167.18 26.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 0.0 109.462 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -69.83 142.08 53.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.282 -0.887 . . . . 0.0 110.448 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.86 164.19 14.14 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.284 -0.885 . . . . 0.0 110.302 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -113.31 145.54 40.9 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.0 110.124 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 117.716 -1.135 . . . . 0.0 108.704 179.539 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' H1 ' HD12 ' A' ' 105' ' ' ILE . 21.4 ptp . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.271 0.558 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -94.17 165.45 12.6 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.411 -0.806 . . . . 0.0 109.993 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 42.6 ttm180 -62.31 -44.72 95.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.506 -0.746 . . . . 0.0 109.433 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -63.68 -39.72 95.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.843 . . . . 0.0 109.095 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -63.63 -37.26 86.67 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.399 -0.813 . . . . 0.0 109.264 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.436 ' CD2' HD12 ' A' ' 43' ' ' LEU . 63.4 t80 -60.63 -46.94 88.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.488 -0.757 . . . . 0.0 109.74 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.59 -45.41 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.262 -0.899 . . . . 0.0 108.605 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -62.32 -41.8 98.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 0.0 109.558 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.72 -49.6 76.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.201 -0.937 . . . . 0.0 109.074 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.25 -36.1 78.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.729 . . . . 0.0 109.608 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -61.8 -42.6 99.21 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.501 -0.75 . . . . 0.0 110.006 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -83.98 -20.87 32.1 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.096 -1.003 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.4 tptt -87.2 -51.31 6.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.256 -0.902 . . . . 0.0 111.321 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -118.05 -15.05 9.94 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.204 -0.935 . . . . 0.0 110.312 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.0 t0 58.11 41.71 23.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.359 -0.838 . . . . 0.0 109.933 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.6 m -99.85 134.22 43.07 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.174 -0.954 . . . . 0.0 108.704 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -84.4 132.69 46.48 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.031 -1.043 . . . . 0.0 109.244 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.86 151.07 56.54 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.832 1.688 . . . . 0.0 112.295 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -132.94 149.26 52.26 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.542 -0.724 . . . . 0.0 109.352 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.49 ' CG ' ' O ' ' A' ' 20' ' ' HIS . 13.9 p-80 -132.6 85.38 47.89 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.39 -0.819 . . . . 0.0 109.222 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -55.7 -37.05 95.9 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.312 2.008 . . . . 0.0 111.233 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -79.76 98.67 7.11 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.651 0.739 . . . . 0.0 109.43 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.95 -23.32 65.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.438 -0.789 . . . . 0.0 109.744 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -74.49 -3.9 33.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.675 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -145.16 76.56 13.41 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.23 -0.918 . . . . 0.0 109.705 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.77 -20.0 63.94 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.617 2.211 . . . . 0.0 110.768 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 12.8 p-10 -76.5 -2.4 32.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.722 -0.611 . . . . 0.0 109.65 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 6.6 m-85 -99.54 134.87 41.78 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.45 129.86 29.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.288 -0.882 . . . . 0.0 109.405 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.78 128.37 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.682 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 73.5 m-85 -100.34 124.06 45.34 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.366 -0.834 . . . . 0.0 109.849 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.7 mtm-85 -137.02 135.68 37.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.297 -0.877 . . . . 0.0 109.284 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.98 112.77 25.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.458 -0.776 . . . . 0.0 109.725 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.2 t -69.72 -26.56 64.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.437 -0.79 . . . . 0.0 109.406 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -64.25 -39.34 93.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.51 -0.744 . . . . 0.0 109.559 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.71 -11.03 22.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.323 -0.86 . . . . 0.0 108.887 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 61.41 38.41 16.07 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.426 0.631 . . . . 0.0 109.626 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 39' ' ' TRP . 17.8 ptmt -167.65 -120.33 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.453 -0.779 . . . . 0.0 109.55 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.41 ' N ' ' HG3' ' A' ' 38' ' ' LYS . 62.6 t-105 56.16 91.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.489 -0.757 . . . . 0.0 109.318 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -105.21 126.64 52.31 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.945 0.879 . . . . 0.0 110.041 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . . . -149.5 146.71 27.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.4 tp -140.53 120.55 13.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.951 -1.093 . . . . 0.0 110.268 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.539 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.1 tt -113.08 126.43 55.47 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.51 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.3 ptt? -153.27 165.18 36.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.997 -1.064 . . . . 0.0 109.843 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 92.9 m-20 -97.03 116.17 28.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 pt -127.55 145.55 55.1 Favored Pre-proline 0 N--CA 1.504 2.257 0 O-C-N 121.385 -0.822 . . . . 0.0 109.368 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.31 145.53 88.59 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.095 1.864 . . . . 0.0 112.116 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.43 -21.78 66.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.613 -0.679 . . . . 0.0 109.998 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 56' ' ' ASP . 9.8 pt-20 -56.62 -20.42 21.11 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 110.232 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.81 -13.0 59.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.107 -0.995 . . . . 0.0 110.705 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 53' ' ' ILE . 7.7 pt -116.43 -5.7 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.302 -0.874 . . . . 0.0 109.79 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.22 -2.29 81.05 Favored Glycine 0 N--CA 1.499 2.874 0 O-C-N 121.184 -0.947 . . . . 0.0 111.12 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 51' ' ' ILE . 39.3 mt -79.36 146.51 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.902 -1.352 . . . . 0.0 110.066 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 53' ' ' ILE . 18.2 m120 37.16 -88.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.493 0.664 . . . . 0.0 110.603 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . 143.94 116.43 1.11 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' H ' ' HB3' ' A' ' 49' ' ' GLU . 47.3 t0 60.26 41.44 16.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.946 . . . . 0.0 110.569 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -112.42 124.76 53.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.41 -0.806 . . . . 0.0 108.988 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -71.27 127.84 33.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 109.953 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 m -137.97 161.06 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.338 -0.851 . . . . 0.0 109.017 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -98.86 130.95 45.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.404 -0.81 . . . . 0.0 109.226 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.25 158.28 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.481 -0.762 . . . . 0.0 109.531 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 96' ' ' LEU . 37.5 pt -131.66 146.83 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -110.83 136.62 49.61 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 pp -137.88 156.79 47.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.287 -0.883 . . . . 0.0 109.48 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -90.65 144.72 25.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.815 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.07 162.1 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 0.0 109.621 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -70.25 155.64 93.12 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 71' ' ' VAL . 28.8 Cg_endo -64.17 -18.28 62.84 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.075 1.85 . . . . 0.0 110.953 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -94.28 -28.76 15.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.544 -0.722 . . . . 0.0 109.226 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 89.1 mt -94.32 -3.03 51.2 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.177 -0.952 . . . . 0.0 110.039 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 68' ' ' PRO . 7.6 p -63.45 -31.72 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.137 -0.977 . . . . 0.0 109.919 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.53 -14.72 81.83 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.44 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 34.7 t -70.41 -55.44 9.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -1.099 . . . . 0.0 111.483 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.586 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.8 pt? -84.28 -23.09 30.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.119 -0.988 . . . . 0.0 111.106 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -66.38 -41.42 89.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.106 -0.997 . . . . 0.0 111.264 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CD ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -76.29 -7.57 55.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.869 -1.145 . . . . 0.0 110.108 -178.502 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -77.69 149.22 77.5 Favored Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.799 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 80' ' ' ILE . 40.2 Cg_endo -66.34 155.37 70.3 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.12 2.547 . . . . 0.0 112.462 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.47 -25.77 0.9 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 78' ' ' PRO . 78.9 mt -93.7 115.35 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -1.216 . . . . 0.0 108.951 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.8 150.34 42.63 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.619 -0.675 . . . . 0.0 110.036 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.04 150.94 85.01 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.156 1.904 . . . . 0.0 111.809 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.4 143.88 56.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.345 -0.847 . . . . 0.0 109.625 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 52.4 p90 -92.08 126.9 37.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.119 -0.988 . . . . 0.0 109.899 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.485 ' CG ' ' O ' ' A' ' 85' ' ' HIS . 85.5 t60 41.53 43.51 2.28 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.561 -0.712 . . . . 0.0 110.405 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.0 mmm -143.46 65.32 1.32 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.234 -0.916 . . . . 0.0 109.044 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.612 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 22.2 m-20 68.39 -50.14 0.56 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.166 -0.334 . . . . 0.0 110.42 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 63.91 -37.63 0.19 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 120.979 0.419 . . . . 0.0 110.24 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 87' ' ' ASN . 83.1 tt0 -88.66 -20.19 25.23 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.903 -1.123 . . . . 0.0 109.817 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -96.88 -59.84 1.72 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.266 -0.896 . . . . 0.0 110.336 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.612 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 5.4 m0 -105.96 140.96 38.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.494 -0.754 . . . . 0.0 109.912 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.0 mm -121.14 138.55 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.1 m -85.43 134.46 34.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.707 -0.62 . . . . 0.0 109.834 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.4 t -119.63 134.82 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.596 -0.69 . . . . 0.0 109.157 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.2 tp -89.55 107.2 18.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.199 -0.938 . . . . 0.0 110.058 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.431 HD11 HG23 ' A' ' 62' ' ' ILE . 81.2 mt -66.23 -39.33 89.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.497 -0.752 . . . . 0.0 109.71 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -74.28 2.88 8.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.477 -0.765 . . . . 0.0 109.61 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.93 -166.05 30.28 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 100' ' ' LEU . 83.8 Cg_endo -85.34 10.63 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.396 2.731 . . . . 0.0 111.54 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.8 mm? -52.55 -107.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.629 0.728 . . . . 0.0 109.63 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.11 154.38 6.15 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.48 -46.3 86.93 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.303 -1.116 . . . . 0.0 109.357 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.65 -42.67 98.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.501 -0.749 . . . . 0.0 109.84 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -66.06 -42.73 89.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.397 -0.814 . . . . 0.0 109.743 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.41 HD12 ' H1 ' ' A' ' 1' ' ' MET . 94.9 mt -64.15 -43.25 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -55.16 -43.98 74.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.318 -0.864 . . . . 0.0 109.263 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 56.0 m -60.83 -42.37 97.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.855 . . . . 0.0 109.46 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.07 -42.95 99.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.432 -0.793 . . . . 0.0 109.323 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.06 -43.08 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.369 -0.832 . . . . 0.0 109.097 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -58.52 -37.71 76.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 108.593 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -62.57 -35.77 80.56 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.8 p -81.51 -23.55 37.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 109.306 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -61.65 -44.43 96.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.427 -0.796 . . . . 0.0 109.885 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.462 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 13.8 pt20 -50.9 -41.25 58.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.337 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.462 ' N ' ' CG ' ' A' ' 114' ' ' GLN . 84.6 mt -64.77 -39.71 94.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.526 -0.733 . . . . 0.0 109.745 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.3 p -92.99 14.83 16.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.135 -0.978 . . . . 0.0 109.522 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -58.09 141.22 50.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.145 -0.972 . . . . 0.0 109.58 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mt -75.83 147.92 38.77 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.739 0.781 . . . . 0.0 110.409 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.09 136.47 56.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.619 -0.676 . . . . 0.0 109.816 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -154.01 137.95 16.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.395 -0.816 . . . . 0.0 108.966 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -82.38 146.02 29.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.0 110.639 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -61.36 -42.89 99.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.699 -0.626 . . . . 0.0 110.025 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' A' ' 123' ' ' HIS . 56.8 p-80 -98.28 108.04 20.65 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.364 -0.835 . . . . 0.0 109.874 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -133.0 124.01 26.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.485 -0.759 . . . . 0.0 108.998 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.436 -179.963 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.468 ' SD ' HD12 ' A' ' 105' ' ' ILE . 6.3 ttt . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -146.73 -178.33 6.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.104 -0.998 . . . . 0.0 110.116 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.53 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 40.8 ttm180 -62.25 -44.61 96.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.593 -0.692 . . . . 0.0 109.81 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -61.83 -37.33 84.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.898 . . . . 0.0 109.521 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -59.98 -40.44 89.13 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.346 -0.846 . . . . 0.0 109.04 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -62.65 -41.63 99.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.696 -0.628 . . . . 0.0 110.363 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.5 mm -59.24 -47.7 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.059 -1.025 . . . . 0.0 110.018 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 9' ' ' TYR . 0.6 OUTLIER -63.8 -43.86 95.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.914 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.622 ' CE2' ' CD2' ' A' ' 106' ' ' HIS . 43.4 t80 -62.53 -48.29 80.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.562 -0.711 . . . . 0.0 109.872 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.01 86.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.4 -0.813 . . . . 0.0 110.102 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 15' ' ' ASP . 11.6 tp-100 -64.75 -48.95 72.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.384 -0.822 . . . . 0.0 109.896 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -66.71 -33.63 76.07 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.931 -1.106 . . . . 0.0 110.599 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -87.05 -12.09 48.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.118 -0.989 . . . . 0.0 111.83 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.609 ' CD1' ' NE2' ' A' ' 33' ' ' HIS . 95.8 m-85 -141.62 -0.22 1.39 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.653 -1.279 . . . . 0.0 110.446 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER 41.06 35.18 0.34 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -109.76 138.06 46.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.507 0.67 . . . . 0.0 109.653 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HA ' HE22 ' A' ' 11' ' ' GLN . 86.5 mttt -91.1 151.13 42.81 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.504 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.65 149.05 73.32 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.596 2.198 . . . . 0.0 112.186 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -123.83 134.36 53.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.623 -0.673 . . . . 0.0 109.343 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 20' ' ' HIS . 18.6 p80 -128.78 85.4 60.33 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.37 -12.76 11.36 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.452 2.101 . . . . 0.0 110.973 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -92.38 97.52 10.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -70.15 -18.59 63.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.507 -0.746 . . . . 0.0 109.934 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 10.0 mtpm? -76.56 -4.65 43.93 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.142 -0.974 . . . . 0.0 109.14 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 24' ' ' LYS . 53.3 m-85 -156.85 79.47 3.71 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.433 -0.792 . . . . 0.0 108.903 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.3 -19.48 50.71 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.723 2.282 . . . . 0.0 111.294 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -73.13 -5.96 42.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.521 -0.737 . . . . 0.0 109.183 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.586 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 4.9 m-85 -87.55 137.95 31.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.573 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.88 141.38 34.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 0.0 109.156 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.09 126.44 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -106.66 120.08 41.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.54 -0.725 . . . . 0.0 109.5 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.449 ' NH2' ' O ' ' A' ' 37' ' ' ASP . 17.5 ptm180 -150.61 158.3 43.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.135 -0.978 . . . . 0.0 109.61 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.609 ' NE2' ' CD1' ' A' ' 14' ' ' TYR . 4.4 m170 -97.94 126.52 43.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 109.713 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.4 p -66.45 -34.26 77.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.469 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.76 -39.54 94.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.36 -0.838 . . . . 0.0 109.86 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 38' ' ' LYS . 53.0 t-20 -93.23 -12.26 30.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.409 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.449 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 37.7 t70 57.93 -71.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.695 -0.628 . . . . 0.0 110.713 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.6 tttt -63.61 124.66 21.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 110.506 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.428 ' CZ2' HG21 ' A' ' 116' ' ' THR . 0.0 OUTLIER -178.86 126.46 0.1 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.345 -0.847 . . . . 0.0 108.975 179.075 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -115.09 123.29 48.61 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.553 0.692 . . . . 0.0 109.524 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.469 ' C ' HD22 ' A' ' 42' ' ' LEU . . . -153.8 106.23 2.85 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.469 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.2 mm? -107.59 128.25 54.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.524 -0.735 . . . . 0.0 109.788 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.572 ' C ' HD23 ' A' ' 43' ' ' LEU . 7.1 tt -122.61 118.19 27.59 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.586 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -162.82 166.67 23.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.968 . . . . 0.0 109.92 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.53 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 91.5 m-20 -93.6 143.5 26.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.56 -0.713 . . . . 0.0 109.33 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.9 pt -150.67 146.23 19.31 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.254 -0.904 . . . . 0.0 109.435 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.62 145.82 6.02 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.127 1.885 . . . . 0.0 112.697 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.6 -20.98 62.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.48 -0.763 . . . . 0.0 109.959 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.61 -17.59 63.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.887 . . . . 0.0 110.135 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.95 -10.45 57.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.05 -1.031 . . . . 0.0 111.042 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 51' ' ' ILE . 7.2 pt -105.82 7.12 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.142 -0.974 . . . . 0.0 109.428 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 -13.83 63.24 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.59 129.01 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.845 -1.386 . . . . 0.0 110.028 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -88.52 100.84 13.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.454 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.06 -22.48 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 56.76 31.53 19.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.795 -0.827 . . . . 0.0 109.708 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -102.8 144.98 30.44 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.323 -0.861 . . . . 0.0 109.775 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -74.15 128.19 34.88 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.326 -0.858 . . . . 0.0 109.278 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.25 161.19 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.482 -0.761 . . . . 0.0 109.769 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.418 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 28.3 m-20 -93.28 132.32 37.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.795 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.11 155.95 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.39 -0.818 . . . . 0.0 110.249 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 96' ' ' LEU . 44.0 pt -130.93 155.3 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 42' ' ' LEU . 53.0 t0 -92.86 119.74 32.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 110.2 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.583 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -115.7 119.81 37.31 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.279 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.583 ' N ' HD13 ' A' ' 64' ' ' LEU . 9.9 ptmm? -86.71 135.86 33.23 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.461 -0.774 . . . . 0.0 110.588 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.462 HG11 HD13 ' A' ' 74' ' ' LEU . 31.3 m -140.66 165.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.426 -0.796 . . . . 0.0 109.946 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -75.31 152.78 85.98 Favored Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 121.362 -0.836 . . . . 0.0 110.176 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.552 ' O ' HG12 ' A' ' 71' ' ' VAL . 61.7 Cg_exo -48.93 -34.01 27.54 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.13 1.887 . . . . 0.0 111.77 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -85.51 -29.21 24.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.393 -0.817 . . . . 0.0 110.087 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.0 mt -88.25 1.03 55.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.985 -1.072 . . . . 0.0 109.847 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 68' ' ' PRO . 14.8 p -66.13 -42.5 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.136 -0.977 . . . . 0.0 109.516 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.549 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -66.05 -40.61 95.23 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -60.75 -36.75 79.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -1.217 . . . . 0.0 109.524 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.543 ' CD2' HG21 ' A' ' 92' ' ' ILE . 1.6 tt -85.75 -37.39 19.37 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.553 -0.717 . . . . 0.0 109.825 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 ttp85 -73.92 -16.98 61.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.794 . . . . 0.0 110.644 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -7.65 58.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.95 -1.094 . . . . 0.0 109.081 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.75 ' NZ ' HD21 ' A' ' 108' ' ' LEU . 40.9 mtmt -85.32 122.83 73.68 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.181 -0.95 . . . . 0.0 109.397 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.24 146.28 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.216 1.944 . . . . 0.0 113.137 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.71 -21.29 39.76 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.4 mt -104.45 122.97 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.296 -1.12 . . . . 0.0 109.307 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -118.8 149.3 46.25 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.69 -0.631 . . . . 0.0 109.858 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -40.56 165.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.564 2.176 . . . . 0.0 112.619 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.07 147.08 50.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.353 -0.842 . . . . 0.0 110.603 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.453 ' OH ' ' CE ' ' A' ' 44' ' ' MET . 5.9 p90 -76.64 167.39 21.92 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.731 0.777 . . . . 0.0 110.759 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 73.8 m80 53.29 -94.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.622 -0.674 . . . . 0.0 110.147 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 93.7 mtp -138.48 -151.79 0.4 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.389 -0.819 . . . . 0.0 109.747 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 59.35 34.96 23.04 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -88.62 62.47 6.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.471 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -146.16 -67.01 0.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 108.889 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -96.36 -19.13 19.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.391 -0.818 . . . . 0.0 109.668 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 -110.51 138.15 47.27 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.461 -0.775 . . . . 0.0 110.085 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.543 HG21 ' CD2' ' A' ' 74' ' ' LEU . 19.8 mm -136.27 154.31 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.462 -0.774 . . . . 0.0 108.938 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.4 m -98.85 131.28 45.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.853 . . . . 0.0 110.814 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.5 t -113.16 133.84 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.6 tp -93.71 112.76 24.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.432 -0.793 . . . . 0.0 110.256 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD11 HG23 ' A' ' 62' ' ' ILE . 84.3 mt -66.03 -39.54 90.28 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.637 0.732 . . . . 0.0 109.432 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -71.89 -6.21 40.15 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.285 -0.884 . . . . 0.0 109.245 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.02 177.65 1.52 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.72 -12.73 24.46 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 123.038 2.492 . . . . 0.0 111.404 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.82 136.9 54.86 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.562 0.696 . . . . 0.0 110.684 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.96 -178.73 46.03 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.49 81.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.618 -0.931 . . . . 0.0 109.671 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 104' ' ' GLU . 25.1 pttm -56.55 -42.07 77.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.887 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 103' ' ' LYS . 46.0 tp10 -69.09 -40.05 78.66 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.013 -1.054 . . . . 0.0 109.443 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.468 HD12 ' SD ' ' A' ' 1' ' ' MET . 97.2 mt -64.77 -43.13 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.351 -0.843 . . . . 0.0 109.484 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.622 ' CD2' ' CE2' ' A' ' 9' ' ' TYR . 62.7 m170 -56.89 -44.33 82.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 109.487 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.5 t -62.72 -43.45 98.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.37 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.75 HD21 ' NZ ' ' A' ' 77' ' ' LYS . 88.9 mt -63.39 -41.02 98.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.362 -0.836 . . . . 0.0 109.209 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.0 -42.45 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -56.3 -42.26 77.28 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.256 -0.903 . . . . 0.0 108.781 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.23 -37.69 88.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.56 ' OG ' HD21 ' A' ' 64' ' ' LEU . 2.4 m -60.75 -39.66 89.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.46 -0.775 . . . . 0.0 109.29 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -59.89 -42.9 94.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.573 -0.704 . . . . 0.0 109.688 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -52.62 -46.36 67.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 110.091 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.521 HD22 ' N ' ' A' ' 115' ' ' LEU . 4.1 mm? -65.9 -40.11 91.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.413 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.428 HG21 ' CZ2' ' A' ' 39' ' ' TRP . 15.9 p -93.94 15.46 16.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.978 . . . . 0.0 109.147 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.96 143.0 56.02 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.687 0.756 . . . . 0.0 110.673 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.07 157.98 32.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.54 -0.725 . . . . 0.0 110.702 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 57.23 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.55 0.691 . . . . 0.0 110.031 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -87.22 138.1 31.78 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.559 0.695 . . . . 0.0 109.937 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -70.3 149.72 47.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 124' ' ' HIS . 23.9 p80 -144.48 161.83 38.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.247 -0.908 . . . . 0.0 109.922 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -88.64 -13.24 40.32 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.529 ' HD1' ' C ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -151.81 164.52 36.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 0.0 109.868 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 76.0 m80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.859 -1.067 . . . . 0.0 109.996 -179.682 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.9 ttp . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.711 0.767 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.8 p30 -92.17 170.32 9.91 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.997 0.903 . . . . 0.0 110.408 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -63.5 -42.07 98.51 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.567 0.699 . . . . 0.0 109.607 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -51.33 -43.02 61.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.759 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -66.83 -37.78 85.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 109.457 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -61.21 -44.22 97.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.337 -0.852 . . . . 0.0 109.889 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.44 -46.66 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.184 -0.947 . . . . 0.0 109.726 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -63.9 -45.62 88.52 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 110.001 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.448 ' CD2' ' NE2' ' A' ' 106' ' ' HIS . 56.0 t80 -66.25 -42.16 88.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 110.195 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.41 98.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.208 -0.932 . . . . 0.0 109.99 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ASP . 84.6 mt-30 -65.75 -41.72 91.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.287 -0.883 . . . . 0.0 110.031 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -62.76 -31.49 72.45 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.889 -1.132 . . . . 0.0 109.185 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -87.93 -45.29 10.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 111.69 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -107.4 -13.85 15.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.013 -1.054 . . . . 0.0 111.251 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 11' ' ' GLN . 99.3 m-20 54.52 34.16 20.52 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.08 -1.012 . . . . 0.0 108.776 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.9 m -121.64 132.09 54.47 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.857 0.836 . . . . 0.0 110.273 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -83.04 152.25 65.05 Favored Pre-proline 0 N--CA 1.486 1.367 0 O-C-N 121.595 -0.69 . . . . 0.0 109.166 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.61 134.58 27.15 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.172 1.915 . . . . 0.0 112.481 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -106.03 121.61 44.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.478 -0.763 . . . . 0.0 109.232 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -85.37 116.88 67.4 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.42 -0.8 . . . . 0.0 109.825 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 22' ' ' TRP . 72.4 Cg_endo -80.19 -90.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.52 2.147 . . . . 0.0 111.999 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.411 ' H ' ' HG2' ' A' ' 21' ' ' PRO . 5.5 m-90 -81.18 137.5 35.89 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.855 0.836 . . . . 0.0 110.055 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -65.77 -30.69 71.38 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.542 0.686 . . . . 0.0 110.066 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -67.84 -0.56 4.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.808 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -143.77 73.02 17.04 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.039 -1.038 . . . . 0.0 109.61 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.61 -19.0 25.01 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.363 2.042 . . . . 0.0 110.881 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -81.18 -4.23 54.77 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.631 0.729 . . . . 0.0 109.209 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -96.11 139.1 32.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.468 -0.77 . . . . 0.0 109.222 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.97 146.37 47.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.697 . . . . 0.0 109.398 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.4 t -127.87 129.58 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.396 0.617 . . . . 0.0 109.395 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -118.24 113.87 22.14 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -146.49 161.36 40.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.15 -0.969 . . . . 0.0 110.086 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 37' ' ' ASP . 53.1 m170 -96.68 129.34 44.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.527 -0.733 . . . . 0.0 109.784 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.6 m -69.6 -20.66 63.63 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.58 0.705 . . . . 0.0 109.673 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.39 -45.64 90.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.09 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 37' ' ' ASP . 93.8 m-20 -125.58 -30.73 3.05 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.403 -0.81 . . . . 0.0 109.838 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 33' ' ' HIS . 1.2 p30 50.68 25.19 1.96 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.564 0.697 . . . . 0.0 110.04 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.24 -8.53 45.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.138 -0.977 . . . . 0.0 108.777 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -91.19 146.52 23.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.378 -0.826 . . . . 0.0 110.02 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.8 124.35 43.1 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.698 0.761 . . . . 0.0 109.493 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.61 105.71 2.84 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -132.86 149.36 52.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.267 -0.895 . . . . 0.0 109.457 -179.417 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 43' ' ' LEU . 9.6 tt -118.91 128.04 54.05 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.413 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.98 163.97 39.55 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.875 0.845 . . . . 0.0 110.211 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 46' ' ' ILE . 51.9 p-10 -93.52 145.61 24.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.537 0.684 . . . . 0.0 110.016 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 45' ' ' ASP . 22.6 pt -155.75 146.96 16.63 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.606 -0.684 . . . . 0.0 109.467 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.44 141.67 97.83 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.099 1.866 . . . . 0.0 111.619 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' A' ' 53' ' ' ILE . . . -64.53 -20.26 66.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.484 -0.76 . . . . 0.0 109.902 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -54.76 -16.59 2.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.431 -0.793 . . . . 0.0 110.214 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -85.5 -23.72 27.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.253 -0.905 . . . . 0.0 111.171 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 pt -95.64 10.69 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.892 -1.13 . . . . 0.0 109.726 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.13 -8.27 75.82 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.532 ' HB ' ' HB1' ' A' ' 48' ' ' ALA . 81.3 mt -78.77 129.98 36.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.806 -1.408 . . . . 0.0 109.996 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -62.23 -39.9 94.34 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.591 0.71 . . . . 0.0 109.34 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -42.07 133.23 4.12 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.8 p30 -89.6 3.08 53.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.462 -1.022 . . . . 0.0 108.93 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.8 144.65 56.18 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.731 0.777 . . . . 0.0 110.485 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -87.11 145.57 26.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.52 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.51 160.42 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.658 0.742 . . . . 0.0 110.321 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.77 132.89 34.99 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.305 0.574 . . . . 0.0 110.019 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.41 156.16 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.659 0.743 . . . . 0.0 110.017 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.8 pt -136.09 146.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.596 0.713 . . . . 0.0 109.963 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -81.87 143.34 31.77 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.524 0.678 . . . . 0.0 110.308 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -133.26 125.97 30.48 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.624 ' N ' HD13 ' A' ' 64' ' ' LEU . 63.3 tttm -82.95 131.28 35.19 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.689 0.757 . . . . 0.0 110.67 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.83 161.8 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.739 0.78 . . . . 0.0 109.726 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.473 ' H ' ' HB2' ' A' ' 70' ' ' LEU . 52.0 mt-30 -87.11 153.14 54.03 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.529 -0.732 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.505 ' O ' HG12 ' A' ' 71' ' ' VAL . 51.6 Cg_exo -47.5 -26.18 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.159 1.906 . . . . 0.0 111.577 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -94.78 -29.17 14.89 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.708 0.766 . . . . 0.0 109.345 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.473 ' HB2' ' H ' ' A' ' 67' ' ' GLN . 93.5 mt -86.77 -6.51 58.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 0.0 109.644 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 68' ' ' PRO . 12.1 p -67.29 -39.58 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 109.553 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.482 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -61.32 -47.04 93.03 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.6 m -59.59 -42.49 92.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.295 -1.121 . . . . 0.0 110.532 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.2 tt -84.65 -24.37 29.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 110.576 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.605 ' NH1' ' NZ ' ' A' ' 88' ' ' LYS . 69.7 ttt180 -82.72 -40.56 20.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.868 -1.145 . . . . 0.0 109.173 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -69.02 1.22 3.66 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.784 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -88.01 116.03 64.94 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.473 -0.767 . . . . 0.0 109.459 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.26 144.92 37.3 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.331 2.02 . . . . 0.0 113.045 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.61 -20.76 46.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.01 125.67 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.477 -1.013 . . . . 0.0 109.396 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -106.0 151.65 40.11 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.593 -0.692 . . . . 0.0 109.996 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.22 146.62 81.87 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.5 2.133 . . . . 0.0 112.194 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.525 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -67.09 153.23 44.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.546 -0.721 . . . . 0.0 110.592 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.09 -143.02 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.916 0.865 . . . . 0.0 110.52 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 46.16 -113.54 0.44 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.443 0.639 . . . . 0.0 109.954 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 98.2 mmm -141.07 0.89 1.59 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 89' ' ' GLU . 81.8 m-20 -59.64 -85.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 109.691 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.605 ' NZ ' ' NH1' ' A' ' 75' ' ' ARG . 62.7 tttm 56.86 -76.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.648 -0.657 . . . . 0.0 110.222 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' ASN . 97.5 mt-10 -65.35 -38.7 90.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 0.0 109.673 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -68.51 -68.12 0.42 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.584 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -120.57 159.4 25.33 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.525 -0.734 . . . . 0.0 109.634 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 mm -129.6 147.69 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.919 0.866 . . . . 0.0 109.826 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 p -90.59 134.6 34.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.683 -0.636 . . . . 0.0 110.076 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -115.48 129.87 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 34.0 tp -86.77 104.84 16.53 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.669 0.747 . . . . 0.0 109.976 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.76 -38.4 88.96 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.788 0.804 . . . . 0.0 109.237 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.39 -5.88 44.97 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.897 0.856 . . . . 0.0 109.113 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.92 -175.41 8.96 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.514 ' O ' ' C ' ' A' ' 100' ' ' LEU . 44.5 Cg_endo -71.63 -81.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.633 2.222 . . . . 0.0 112.226 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.514 ' C ' ' O ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER 19.2 -120.7 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 121.158 0.504 . . . . 0.0 111.689 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.95 165.61 30.19 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.22 -39.07 86.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.528 -0.984 . . . . 0.0 109.461 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -64.91 -35.5 81.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.447 -0.783 . . . . 0.0 109.611 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -67.09 -40.7 87.01 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.201 -0.937 . . . . 0.0 109.411 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.71 -43.3 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 109.273 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.448 ' NE2' ' CD2' ' A' ' 9' ' ' TYR . 52.1 m170 -56.65 -44.95 81.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 109.76 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.2 m -62.25 -42.44 99.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.744 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.52 -41.03 96.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 109.194 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.1 -42.7 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.339 -0.85 . . . . 0.0 108.988 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -53.77 -46.55 71.0 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.502 -0.749 . . . . 0.0 109.438 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -64.43 -38.53 91.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.075 -1.016 . . . . 0.0 108.851 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.6 p -62.18 -36.24 81.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 0.0 109.226 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -61.75 -44.6 96.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.413 -0.805 . . . . 0.0 109.664 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.16 -41.86 89.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.296 -0.877 . . . . 0.0 109.612 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.8 mt -66.53 -38.7 87.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.341 -0.849 . . . . 0.0 109.798 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.8 p -89.09 5.84 42.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.216 -0.927 . . . . 0.0 109.372 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 118' ' ' LEU . 34.4 ttm180 -73.86 51.47 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 108.903 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 117' ' ' ARG . 5.3 mp 40.03 -161.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.532 0.682 . . . . 0.0 110.833 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -94.14 -122.25 0.1 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.247 -0.908 . . . . 0.0 109.813 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 120' ' ' HIS . 52.5 p-80 -146.55 59.9 1.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.579 -0.701 . . . . 0.0 109.537 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -84.76 156.98 21.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.451 -0.781 . . . . 0.0 110.633 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 86.3 t60 56.03 10.76 0.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.556 0.693 . . . . 0.0 109.439 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -81.48 62.24 5.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.799 . . . . 0.0 109.209 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -67.33 -39.87 85.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 0.0 109.425 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 80.7 m80 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.935 -179.425 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -100.41 156.79 17.06 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.821 0.82 . . . . 0.0 110.367 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.0 mtp-105 -60.6 -46.58 89.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.64 -0.662 . . . . 0.0 110.171 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -47.73 -40.51 20.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.992 . . . . 0.0 109.677 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.77 -41.6 87.43 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.344 -0.848 . . . . 0.0 109.366 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -63.72 -45.43 89.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.458 -0.777 . . . . 0.0 110.095 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.2 mm -63.84 -46.02 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.79 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -67.38 -39.04 85.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 0.0 108.925 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -61.78 -46.14 90.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.456 -0.778 . . . . 0.0 109.936 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.28 86.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.477 -0.765 . . . . 0.0 109.914 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -65.95 -21.71 66.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -84.42 -53.22 5.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 109.914 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -88.87 -44.02 10.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.446 -0.784 . . . . 0.0 111.601 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 15' ' ' ASP . 45.6 m-85 -93.45 -6.16 47.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.785 -1.197 . . . . 0.0 110.071 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER 37.4 34.55 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.622 0.725 . . . . 0.0 109.796 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 14' ' ' TYR . 7.8 t -104.45 145.74 29.85 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.564 0.697 . . . . 0.0 110.085 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -98.47 151.28 37.4 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.66 149.35 73.51 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.712 2.275 . . . . 0.0 112.659 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -136.33 151.16 49.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.673 -0.642 . . . . 0.0 109.354 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -139.64 86.0 14.3 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -55.17 -38.1 93.8 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.566 2.178 . . . . 0.0 110.758 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -94.71 116.44 28.75 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.373 0.606 . . . . 0.0 109.509 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 25' ' ' PHE . 17.4 pt-20 -69.49 -31.31 69.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.493 -0.754 . . . . 0.0 109.405 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -64.78 -0.66 1.55 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.564 -0.71 . . . . 0.0 109.464 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 23' ' ' GLU . 73.2 m-85 -137.05 71.75 54.95 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 109.333 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.7 -20.58 30.26 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.471 2.114 . . . . 0.0 111.615 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.18 -6.0 58.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.477 -0.764 . . . . 0.0 109.306 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.76 140.19 29.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.65 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.11 133.15 50.44 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.73 129.97 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.682 -0.636 . . . . 0.0 109.348 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -113.62 134.15 54.88 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -158.41 149.48 20.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.533 ' O ' ' NE1' ' A' ' 39' ' ' TRP . 81.2 m-70 -99.57 118.04 35.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.538 -0.726 . . . . 0.0 109.604 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 m -76.52 -15.09 59.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.534 -0.728 . . . . 0.0 109.149 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.59 -5.34 51.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.899 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 116' ' ' THR . 45.8 t-20 -115.24 -30.9 6.16 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.541 -0.724 . . . . 0.0 109.469 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 38' ' ' LYS . 65.1 t0 57.73 134.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.851 0.834 . . . . 0.0 111.018 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 6.3 tmtt? 82.41 102.2 0.05 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.515 0.674 . . . . 0.0 109.739 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -171.01 175.19 4.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.45 -0.781 . . . . 0.0 109.618 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.511 ' CG ' ' O ' ' A' ' 39' ' ' TRP . 80.3 m-85 -158.44 119.14 3.34 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.45 105.39 2.07 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -133.93 138.64 45.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 0.0 109.091 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.629 HD21 ' OD1' ' A' ' 60' ' ' ASP . 9.1 tt -116.4 124.76 50.83 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.8 ptt? -152.39 156.01 38.71 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.815 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.413 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 98.3 m-20 -94.4 114.49 26.53 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.6 pt -118.03 145.29 36.51 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.766 -0.583 . . . . 0.0 109.998 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -46.81 143.26 9.46 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.144 1.896 . . . . 0.0 112.431 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 57' ' ' LYS . . . -64.09 -21.78 66.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -77.36 -14.23 59.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 109.783 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -84.57 -10.7 57.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 110.158 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 13.7 pt -105.08 1.45 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.2 -8.36 60.71 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 55' ' ' GLY . 77.0 mt -79.72 139.2 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.848 -1.383 . . . . 0.0 110.14 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.37 -38.22 88.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.742 -0.599 . . . . 0.0 110.746 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -49.66 145.36 8.32 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.862 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -101.8 9.19 41.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.596 -0.943 . . . . 0.0 108.929 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 62.5 pttt -76.5 146.28 38.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 110.305 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.6 144.0 37.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.563 -0.711 . . . . 0.0 109.77 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.93 161.89 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.417 -0.802 . . . . 0.0 110.407 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.629 ' OD1' HD21 ' A' ' 43' ' ' LEU . 24.1 t70 -100.73 128.17 46.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.845 -0.534 . . . . 0.0 109.934 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.07 157.69 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.604 -0.685 . . . . 0.0 109.771 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 pt -132.61 150.15 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.48 0.657 . . . . 0.0 109.706 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 64.5 t0 -80.13 134.65 36.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.67 -0.644 . . . . 0.0 109.864 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.654 HD12 HG13 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -125.82 124.0 39.98 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.643 ' N ' HD13 ' A' ' 64' ' ' LEU . 36.2 ttmt -89.91 129.47 36.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.943 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.654 HG13 HD12 ' A' ' 64' ' ' LEU . 15.0 m -138.64 164.68 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.895 0.855 . . . . 0.0 110.663 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.3 155.1 90.08 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.433 ' O ' HG12 ' A' ' 71' ' ' VAL . 31.3 Cg_endo -62.55 -24.62 75.3 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.752 2.302 . . . . 0.0 112.402 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -91.16 -23.59 20.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -0.968 . . . . 0.0 110.161 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.4 mt -92.68 1.18 57.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.03 -1.044 . . . . 0.0 109.469 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 72' ' ' GLY . 10.6 p -63.98 -41.56 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 108.831 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.511 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -61.94 -40.52 98.98 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.2 t -65.34 -54.79 23.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -1.133 . . . . 0.0 110.281 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.533 HD13 HG11 ' A' ' 66' ' ' VAL . 2.3 tt -68.25 -43.89 76.84 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 110.638 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -69.93 -18.29 63.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.457 -0.777 . . . . 0.0 110.214 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -71.66 -32.86 68.34 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.828 -1.17 . . . . 0.0 108.868 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -66.63 139.98 96.22 Favored Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.807 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.06 157.84 53.54 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.191 1.927 . . . . 0.0 112.562 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.44 -18.49 49.03 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.8 mt -103.23 117.11 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.971 . . . . 0.0 109.209 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 63.0 m-85 -105.82 151.2 39.89 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.694 -0.629 . . . . 0.0 109.445 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.583 ' CB ' ' HZ1' ' A' ' 88' ' ' LYS . 57.9 Cg_endo -68.75 153.17 73.61 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.608 2.205 . . . . 0.0 112.648 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.53 139.73 58.8 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.356 -0.84 . . . . 0.0 110.059 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.52 ' CZ ' ' CE1' ' A' ' 85' ' ' HIS . 54.2 p90 -90.13 2.76 54.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.557 -0.714 . . . . 0.0 109.207 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.52 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 78.5 m80 -79.9 -168.34 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.393 -0.817 . . . . 0.0 110.65 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.0 mtt -63.38 -40.37 97.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.518 -0.739 . . . . 0.0 109.574 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -81.31 -172.79 3.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.258 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.583 ' HZ1' ' CB ' ' A' ' 82' ' ' PRO . 48.8 tttp -165.31 -61.06 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -67.87 -38.7 83.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.567 -0.708 . . . . 0.0 109.455 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.86 -50.07 68.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.486 -0.759 . . . . 0.0 109.988 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -115.96 137.01 52.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.675 -0.64 . . . . 0.0 109.732 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.46 HG21 ' CD2' ' A' ' 74' ' ' LEU . 6.8 mm -129.16 133.39 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.569 0.699 . . . . 0.0 109.189 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.9 m -81.58 130.82 35.19 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.634 -0.666 . . . . 0.0 109.702 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.18 132.98 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.598 -0.689 . . . . 0.0 109.245 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.5 tp -87.54 103.84 15.93 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.509 0.671 . . . . 0.0 110.095 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 98' ' ' GLY . 72.2 mt -65.73 -40.08 91.82 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.607 0.717 . . . . 0.0 109.218 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -76.83 11.12 1.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -89.66 -164.5 40.13 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.89 0.41 10.02 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 123.226 2.617 . . . . 0.0 111.697 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.3 mm? -61.25 135.22 57.66 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.95 0.881 . . . . 0.0 110.985 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.68 157.43 28.7 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.08 97.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.561 -0.964 . . . . 0.0 109.538 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -70.26 -34.87 73.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.337 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.06 -43.25 92.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.457 -0.777 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.73 -42.91 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.511 -0.743 . . . . 0.0 109.37 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -56.49 -43.76 79.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 109.673 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.5 t -61.93 -44.82 95.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.395 -0.816 . . . . 0.0 109.963 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.65 -41.0 98.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.48 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.56 -42.64 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.018 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -51.7 -43.86 62.95 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -62.71 -43.23 99.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.618 -0.676 . . . . 0.0 109.324 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.2 p -70.02 -30.86 68.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 0.0 109.433 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.16 -43.91 87.63 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.441 -0.787 . . . . 0.0 109.179 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -49.84 -31.01 10.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.541 -0.724 . . . . 0.0 109.698 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.2 mp -84.25 -17.43 39.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -0.857 . . . . 0.0 109.617 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.534 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 32.3 p -102.92 15.23 29.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.453 -0.78 . . . . 0.0 109.211 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 18.2 mmm180 . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.973 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 tpp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.02 165.96 12.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.394 -0.817 . . . . 0.0 110.446 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -63.09 -42.52 99.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.75 -0.594 . . . . 0.0 109.731 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.549 HE22 ' CG ' ' A' ' 8' ' ' ASP . 2.2 tm0? -64.04 -38.59 91.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.146 -0.972 . . . . 0.0 109.471 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -63.57 -39.64 94.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.524 -0.735 . . . . 0.0 109.415 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -61.94 -46.86 87.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.438 -0.789 . . . . 0.0 109.83 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.66 -44.36 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.615 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.549 ' CG ' HE22 ' A' ' 4' ' ' GLN . 54.3 m-20 -65.87 -38.26 88.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.82 . . . . 0.0 109.023 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.462 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 91.6 t80 -61.58 -44.52 96.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.803 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' TYR . . . -64.13 -36.65 84.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 110.312 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.567 ' O ' ' N ' ' A' ' 15' ' ' ASP . 58.3 mm-40 -61.88 -44.27 97.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.147 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -66.78 -38.44 86.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.893 -1.129 . . . . 0.0 109.552 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 29.9 mmtp -88.19 -11.73 45.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.491 -0.756 . . . . 0.0 111.302 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' ALA . 80.7 m-85 -144.61 -21.68 0.52 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.821 -1.174 . . . . 0.0 110.818 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 11' ' ' GLN . 65.0 m-20 53.83 32.94 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 0.0 109.063 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.533 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 12.3 t -103.15 134.91 45.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.499 -0.75 . . . . 0.0 109.674 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -82.52 149.14 60.35 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.611 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.33 151.98 71.5 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.44 2.093 . . . . 0.0 112.346 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -132.77 130.21 39.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.646 -0.659 . . . . 0.0 109.288 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.424 ' CD2' ' O ' ' A' ' 20' ' ' HIS . 31.5 p-80 -132.4 86.33 45.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.72 -35.85 93.99 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.515 2.143 . . . . 0.0 111.381 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -81.35 104.06 11.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.588 -0.695 . . . . 0.0 109.977 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -68.07 -34.99 77.48 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.501 0.667 . . . . 0.0 109.359 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -67.24 -3.13 7.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.402 -0.811 . . . . 0.0 109.708 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -135.08 71.51 68.6 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.493 -0.754 . . . . 0.0 109.463 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.75 -17.54 42.25 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.323 2.015 . . . . 0.0 111.126 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -80.16 -5.92 56.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.495 -0.753 . . . . 0.0 109.221 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -104.68 135.91 45.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.505 -0.747 . . . . 0.0 109.471 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.67 147.87 47.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.583 -0.698 . . . . 0.0 109.318 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.86 126.4 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.759 -0.588 . . . . 0.0 109.682 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -108.92 117.75 35.0 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -149.45 153.17 36.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.066 -1.021 . . . . 0.0 109.792 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.689 ' N ' ' HE1' ' A' ' 39' ' ' TRP . 28.1 m80 -83.76 132.07 34.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 110.379 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -67.8 -40.19 83.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 109.828 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -92.68 -42.4 9.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.401 -0.812 . . . . 0.0 109.756 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' A' ' 38' ' ' LYS . 1.4 m-20 -95.01 31.76 1.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 52.9 p-10 -48.38 83.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.541 0.686 . . . . 0.0 110.444 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 36' ' ' ASN . 6.1 tmtt? -147.32 -22.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.689 ' HE1' ' N ' ' A' ' 33' ' ' HIS . 4.4 p-90 -101.52 127.94 47.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.559 -0.713 . . . . 0.0 109.32 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -112.43 129.77 56.21 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.599 0.714 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.9 121.11 7.25 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.19 147.98 45.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.72 -0.612 . . . . 0.0 109.595 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.27 126.08 54.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.468 ' O ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -157.67 161.25 38.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.953 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.51 ' OD2' ' NH1' ' A' ' 58' ' ' ARG . 92.6 m-20 -99.67 142.57 30.98 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.9 pt -149.27 146.46 21.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.897 . . . . 0.0 109.306 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -49.74 144.02 21.27 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.869 1.713 . . . . 0.0 112.849 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -64.49 -21.81 66.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.594 -0.691 . . . . 0.0 109.802 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.18 -16.27 59.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.903 . . . . 0.0 110.103 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -84.87 -10.08 57.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.169 -0.957 . . . . 0.0 110.093 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 12.6 pt -103.57 3.32 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.285 -0.884 . . . . 0.0 109.206 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.15 -8.7 60.98 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.5 mt -83.93 129.98 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.81 -1.406 . . . . 0.0 110.334 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -65.77 87.0 0.09 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.622 -0.674 . . . . 0.0 109.335 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -176.29 136.32 3.21 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -95.81 11.94 31.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -1.078 . . . . 0.0 108.993 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -74.86 144.85 43.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 110.64 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.51 ' NH1' ' OD2' ' A' ' 45' ' ' ASP . 72.4 ttp85 -76.48 137.06 39.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.504 -0.747 . . . . 0.0 109.806 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.14 161.54 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -100.66 127.58 47.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.519 -0.738 . . . . 0.0 109.464 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -132.98 158.4 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.443 -0.785 . . . . 0.0 110.353 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 pt -135.02 152.8 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -116.14 145.27 43.2 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.437 0.637 . . . . 0.0 109.875 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.44 157.78 45.26 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -87.81 137.58 32.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.343 -0.848 . . . . 0.0 110.882 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.9 m -143.58 163.35 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.514 -0.741 . . . . 0.0 109.862 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.444 ' CD ' HD22 ' A' ' 115' ' ' LEU . 57.7 mt-30 -77.92 154.78 80.51 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.512 -0.743 . . . . 0.0 109.664 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.507 ' O ' HG12 ' A' ' 71' ' ' VAL . 27.9 Cg_endo -65.14 -21.5 62.57 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.411 2.074 . . . . 0.0 111.151 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -87.48 -26.92 22.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.131 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.3 mt -96.69 6.51 48.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.414 -0.803 . . . . 0.0 109.334 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 68' ' ' PRO . 7.5 p -63.09 -36.49 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.513 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.72 -21.45 79.33 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.0 m -62.27 -59.07 5.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.18 -1.188 . . . . 0.0 110.914 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.835 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -85.49 -29.25 24.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.057 -1.027 . . . . 0.0 110.698 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.405 ' HE ' ' HB3' ' A' ' 82' ' ' PRO . 78.1 ttt-85 -67.73 -21.53 65.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.987 -1.07 . . . . 0.0 110.231 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.74 -8.14 55.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.051 -1.031 . . . . 0.0 109.229 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -75.92 149.09 82.55 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 110.081 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.402 ' O ' HD12 ' A' ' 80' ' ' ILE . 47.7 Cg_endo -68.5 140.87 49.03 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.435 2.09 . . . . 0.0 112.533 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.32 -21.1 18.56 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.746 ' N ' HD12 ' A' ' 80' ' ' ILE . 2.7 mp -89.06 124.39 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.388 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 55.5 m-85 -123.84 151.14 64.06 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.751 -0.593 . . . . 0.0 109.588 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 84' ' ' TYR . 41.2 Cg_endo -67.95 158.57 56.77 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.412 2.075 . . . . 0.0 112.16 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 85' ' ' HIS . . . -66.17 65.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.451 -0.78 . . . . 0.0 109.423 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER 50.84 -83.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.696 -0.627 . . . . 0.0 109.719 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.574 ' N ' ' O ' ' A' ' 83' ' ' ALA . 60.8 t-80 -174.97 -7.66 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.406 ' H ' ' H ' ' A' ' 85' ' ' HIS . 65.2 mtt -63.92 -41.27 97.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.702 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 88' ' ' LYS . 36.0 m120 -119.61 -74.65 0.6 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.509 -0.744 . . . . 0.0 109.492 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.509 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 84.9 tttt 57.9 150.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.611 0.72 . . . . 0.0 110.264 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 88' ' ' LYS . 31.7 tt0 75.51 -67.42 0.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -65.53 -52.61 51.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.468 -0.77 . . . . 0.0 109.825 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.401 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 7.3 m0 -119.0 132.94 56.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.698 -0.626 . . . . 0.0 109.858 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.19 133.95 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.8 p -87.42 143.14 27.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.773 -0.579 . . . . 0.0 110.152 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.4 t -122.29 134.91 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.6 tp -84.68 108.11 17.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.465 -0.772 . . . . 0.0 109.877 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.03 -39.58 93.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.656 -0.652 . . . . 0.0 109.353 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -75.25 1.18 14.21 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.092 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.0 177.14 20.26 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.71 -10.05 21.5 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.065 2.51 . . . . 0.0 111.844 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.61 143.32 57.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 110.403 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.78 170.52 48.04 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.153 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.67 78.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.727 -0.867 . . . . 0.0 109.13 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -62.21 -39.14 91.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -65.08 -37.61 88.07 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.336 -0.853 . . . . 0.0 108.904 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.42 -43.75 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 109.035 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -61.1 -45.46 94.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.426 -0.796 . . . . 0.0 109.762 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.9 m -61.39 -44.0 97.91 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.402 -0.811 . . . . 0.0 109.815 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.34 -44.52 91.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.58 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.16 -42.76 91.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.399 -0.813 . . . . 0.0 108.939 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -55.03 -40.63 70.44 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -63.64 -42.19 98.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.6 m -61.21 -41.94 97.73 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.11 -45.3 94.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.602 -0.686 . . . . 0.0 110.224 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -59.9 -29.03 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.493 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.444 HD22 ' CD ' ' A' ' 67' ' ' GLN . 88.1 mt -79.53 -15.7 57.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.723 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -120.43 14.45 11.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.492 -0.755 . . . . 0.0 109.081 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.878 . . . . 0.0 109.862 -179.362 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.297 0.57 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -93.78 168.13 11.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -0.794 . . . . 0.0 110.511 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -62.08 -43.38 98.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.692 -0.63 . . . . 0.0 109.8 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -65.72 -37.55 86.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 0.0 109.612 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.9 -42.38 97.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.543 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -61.93 -45.41 93.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.741 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.8 -43.78 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.391 -0.818 . . . . 0.0 109.448 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.495 ' OD2' ' NZ ' ' A' ' 12' ' ' LYS . 45.6 t0 -65.26 -37.64 87.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.381 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.472 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 83.4 t80 -59.97 -48.52 81.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.196 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.54 -30.69 71.06 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.478 -0.764 . . . . 0.0 109.115 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.56 ' O ' ' N ' ' A' ' 15' ' ' ASP . 36.0 tt0 -64.55 -42.26 95.8 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.46 -0.775 . . . . 0.0 109.404 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.495 ' NZ ' ' OD2' ' A' ' 8' ' ' ASP . 60.0 mttp -69.11 -36.8 77.93 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.882 -1.136 . . . . 0.0 109.814 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 30.3 mmtp -88.17 -12.37 44.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 111.292 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.496 ' CG ' ' CE1' ' A' ' 33' ' ' HIS . 94.2 m-85 -145.24 -22.11 0.49 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.869 -1.144 . . . . 0.0 110.46 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 11' ' ' GLN . 43.0 t0 54.82 34.58 22.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 109.011 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.7 m -102.01 130.1 48.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.404 -0.81 . . . . 0.0 109.402 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -87.02 156.71 54.82 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.445 -0.785 . . . . 0.0 109.985 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.54 140.16 45.49 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.188 1.925 . . . . 0.0 112.85 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -120.86 139.71 52.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -122.89 85.96 50.34 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.528 -0.732 . . . . 0.0 109.931 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.14 -39.55 90.5 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.65 2.233 . . . . 0.0 110.804 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -96.34 131.78 42.51 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.709 0.766 . . . . 0.0 110.137 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.657 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 1.1 pm0 -73.53 -36.06 65.64 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.695 -0.628 . . . . 0.0 109.772 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.418 ' C ' ' CD1' ' A' ' 25' ' ' PHE . 18.8 mtpp -67.95 10.45 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.439 -0.788 . . . . 0.0 111.16 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 24' ' ' LYS . 81.2 m-85 -145.43 67.25 12.82 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.837 -1.164 . . . . 0.0 109.981 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.22 -20.37 32.74 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.571 2.18 . . . . 0.0 111.777 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -84.93 -4.11 58.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.068 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -88.42 150.8 22.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.788 . . . . 0.0 109.949 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.71 132.47 48.0 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.2 t -125.14 127.03 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.568 -0.707 . . . . 0.0 109.523 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.534 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 97.7 m-85 -111.11 119.52 39.26 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -142.12 135.09 28.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.224 -0.922 . . . . 0.0 109.572 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.685 ' CD2' ' HE1' ' A' ' 39' ' ' TRP . 32.0 m-70 -100.1 127.52 46.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 109.818 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p -69.76 -25.06 63.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.49 -0.756 . . . . 0.0 109.506 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -78.15 -7.19 56.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 109.797 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 116' ' ' THR . 13.4 t-20 -117.43 30.19 7.44 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 38' ' ' LYS . 53.2 t0 60.97 29.19 18.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.34 0.59 . . . . 0.0 110.212 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 37' ' ' ASP . 57.4 mttp 53.17 106.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.357 -0.839 . . . . 0.0 110.053 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.685 ' HE1' ' CD2' ' A' ' 33' ' ' HIS . 7.9 p-90 -101.53 -177.47 3.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.523 -0.736 . . . . 0.0 110.202 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.31 129.21 46.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.572 -0.705 . . . . 0.0 110.252 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.668 ' HB2' ' CZ3' ' A' ' 39' ' ' TRP . . . -151.03 105.75 3.28 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 63' ' ' ASP . 1.3 mm? -111.43 125.72 54.18 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.577 0.703 . . . . 0.0 109.57 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.642 HD23 ' C ' ' A' ' 43' ' ' LEU . 8.6 tt -129.66 112.91 14.15 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -162.88 174.13 12.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.41 -0.806 . . . . 0.0 109.568 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 87.7 m-20 -101.57 141.43 34.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.684 -0.635 . . . . 0.0 109.716 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.3 pt -143.34 145.54 32.56 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.565 -0.709 . . . . 0.0 109.464 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -48.5 144.28 14.18 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.989 1.792 . . . . 0.0 112.63 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.05 -24.06 67.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.6 -0.688 . . . . 0.0 110.191 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.86 -14.71 62.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 109.605 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -82.98 -12.58 57.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.399 -0.813 . . . . 0.0 110.501 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.471 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 11.2 pt -109.59 4.56 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.408 -0.808 . . . . 0.0 109.244 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.08 -17.19 59.06 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.75 130.82 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.864 -1.374 . . . . 0.0 110.39 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -86.05 99.18 11.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.534 -0.729 . . . . 0.0 109.362 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' LYS . . . -156.27 -8.17 0.07 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 55' ' ' GLY . 7.5 p-10 41.79 20.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.995 -0.709 . . . . 0.0 109.647 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 55' ' ' GLY . 26.2 pttm -101.51 145.33 29.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.521 -0.737 . . . . 0.0 109.671 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -75.83 138.39 41.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.517 -0.739 . . . . 0.0 109.81 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.52 161.11 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.69 -0.631 . . . . 0.0 109.699 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 96.3 m-20 -88.79 132.42 34.64 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.559 -0.713 . . . . 0.0 109.433 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.01 149.23 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 109.836 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 pt -131.55 151.98 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.414 0.626 . . . . 0.0 109.823 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 67.9 t0 -86.05 142.54 28.66 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.456 -0.778 . . . . 0.0 109.457 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.63 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -133.01 126.71 32.51 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.63 ' N ' HD13 ' A' ' 64' ' ' LEU . 65.6 tttm -88.96 126.72 35.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.642 -0.661 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 m -137.91 163.88 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.541 -0.724 . . . . 0.0 109.588 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -80.74 157.31 72.11 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.083 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' O ' HG12 ' A' ' 71' ' ' VAL . 17.7 Cg_endo -60.88 -18.02 54.37 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.6 2.2 . . . . 0.0 110.987 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -95.44 -27.83 15.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.534 -0.729 . . . . 0.0 109.597 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.7 mt -89.89 -2.96 58.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.262 -0.898 . . . . 0.0 109.852 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.559 HG23 HD11 ' A' ' 92' ' ' ILE . 7.5 p -64.87 -38.87 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.867 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.45 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -59.32 -42.79 97.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.0 m -68.58 -56.26 8.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.329 . . . . 0.0 110.639 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.56 HD12 HD22 ' A' ' 108' ' ' LEU . 2.9 tt -65.56 -43.5 89.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 0.0 110.811 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 82' ' ' PRO . 69.0 ttt-85 -67.81 -17.15 64.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.022 -1.049 . . . . 0.0 110.033 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -78.59 -31.52 47.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.032 -1.043 . . . . 0.0 108.94 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -58.24 146.11 71.81 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.241 -0.912 . . . . 0.0 110.264 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.71 148.31 58.63 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.332 2.021 . . . . 0.0 112.612 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.53 -17.89 46.01 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.726 ' N ' HD12 ' A' ' 80' ' ' ILE . 2.0 mp -87.72 123.15 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.353 -1.087 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 65.7 m-85 -116.79 149.38 43.9 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.82 -0.55 . . . . 0.0 109.696 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HB3' ' HE ' ' A' ' 75' ' ' ARG . 51.7 Cg_endo -67.8 144.52 65.58 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.575 2.183 . . . . 0.0 112.15 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.83 144.9 55.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 109.989 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.485 ' CE1' ' CE1' ' A' ' 85' ' ' HIS . 43.9 p90 -78.1 9.0 4.05 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.438 -0.789 . . . . 0.0 109.334 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.485 ' CE1' ' CE1' ' A' ' 84' ' ' TYR . 96.3 m-70 -88.03 165.64 15.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 110.043 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.8 mtp -68.55 -8.39 41.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.621 ' C ' ' H ' ' A' ' 89' ' ' GLU . 60.6 m-80 -77.73 -67.47 0.72 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.32 -0.862 . . . . 0.0 109.549 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 63.3 -26.76 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.95 -0.468 . . . . 0.0 109.77 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 87' ' ' ASN . 97.6 mt-10 -98.67 -63.86 1.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -59.35 -46.52 88.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.318 -0.863 . . . . 0.0 110.338 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.609 ' CE3' ' ND2' ' A' ' 87' ' ' ASN . 9.3 m0 -116.41 138.55 51.27 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.618 0.723 . . . . 0.0 110.006 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.559 HD11 HG23 ' A' ' 71' ' ' VAL . 88.8 mt -138.56 153.51 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.6 m -97.56 138.4 35.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 110.036 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.6 t -120.34 133.44 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.4 tp -88.63 109.43 20.1 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.594 0.712 . . . . 0.0 110.408 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.63 -39.32 88.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -69.17 -8.65 47.55 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -57.25 178.26 0.96 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.29 -12.75 25.44 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.976 2.451 . . . . 0.0 111.686 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 pp -68.28 137.18 54.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.347 -0.846 . . . . 0.0 110.266 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.7 176.02 47.53 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.158 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.0 77.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.789 -0.83 . . . . 0.0 109.459 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 103' ' ' LYS . 13.5 mptt -62.0 -40.49 95.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.406 -0.808 . . . . 0.0 108.82 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.9 -41.99 95.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.34 -0.85 . . . . 0.0 108.869 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.4 -43.06 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.441 -0.787 . . . . 0.0 109.482 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -56.15 -43.57 78.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.703 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.2 p -64.22 -41.92 96.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 109.719 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.56 HD22 HD12 ' A' ' 74' ' ' LEU . 94.7 mt -64.81 -39.75 94.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.602 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.73 -42.6 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.385 -0.822 . . . . 0.0 109.182 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -57.95 -39.26 77.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 109.083 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.45 -42.91 98.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.303 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 99.6 p -63.94 -34.74 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 109.36 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 117' ' ' ARG . 88.9 t80 -60.14 -44.78 94.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.404 -0.81 . . . . 0.0 109.306 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.37 -43.54 96.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.5 -41.26 96.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.445 -0.784 . . . . 0.0 110.14 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.442 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 67.2 p -99.41 14.71 28.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.366 -0.834 . . . . 0.0 109.275 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.456 ' N ' ' O ' ' A' ' 113' ' ' PHE . 38.6 ttp-105 . . . . . 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.166 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -93.57 -177.98 4.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 0.0 110.08 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.458 ' NH2' ' OD1' ' A' ' 60' ' ' ASP . 12.0 ptp85 -63.2 -32.9 74.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 109.541 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -56.44 -43.39 79.41 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.329 -0.857 . . . . 0.0 109.127 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.03 -42.44 84.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.067 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -62.05 -45.37 93.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.52 -0.737 . . . . 0.0 109.752 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.36 -43.09 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.408 -0.808 . . . . 0.0 109.36 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.72 -39.32 91.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.372 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -60.58 -44.46 96.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.818 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.06 86.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.521 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 16' ' ' THR . 98.9 mm-40 -65.19 -45.89 82.98 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 110.021 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.99 -37.27 83.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -63.71 -50.51 68.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.105 -0.997 . . . . 0.0 111.94 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -147.02 17.53 1.23 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.53 -1.357 . . . . 0.0 110.225 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 55.05 47.53 21.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.149 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.537 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 88.3 m -101.07 123.74 45.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.294 -0.879 . . . . 0.0 109.7 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.447 ' HB3' ' HZ3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -93.67 148.83 36.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 157.36 60.77 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.206 1.937 . . . . 0.0 112.672 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -108.71 155.15 21.06 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -136.85 86.56 21.15 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.478 -0.764 . . . . 0.0 110.047 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.78 -10.99 5.87 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.782 2.322 . . . . 0.0 110.393 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -102.04 98.66 8.83 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.5 0.667 . . . . 0.0 109.816 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 24' ' ' LYS . 14.9 pt-20 -68.55 -37.35 79.86 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.545 0.688 . . . . 0.0 109.658 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 23' ' ' GLU . 9.8 mtpm? -70.79 -3.54 19.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.479 -0.763 . . . . 0.0 110.788 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -142.95 77.38 16.25 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.078 -1.014 . . . . 0.0 110.018 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.66 -14.84 33.56 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.562 2.175 . . . . 0.0 112.099 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -78.72 -4.94 51.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.252 -0.905 . . . . 0.0 109.521 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -94.72 142.73 27.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.255 -0.903 . . . . 0.0 110.102 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.93 139.57 52.06 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -124.48 128.32 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.516 -0.74 . . . . 0.0 110.245 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.37 114.44 27.88 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 37' ' ' ASP . 77.8 ttt-85 -145.35 138.64 26.45 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.196 -0.94 . . . . 0.0 109.459 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.458 ' ND1' ' CD1' ' A' ' 39' ' ' TRP . 32.5 m170 -100.58 124.63 46.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.472 -0.767 . . . . 0.0 109.951 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.2 m -75.79 -22.71 56.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.428 -0.795 . . . . 0.0 109.983 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.64 -41.86 99.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.124 -0.985 . . . . 0.0 110.208 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 38' ' ' LYS . 12.3 m120 -93.49 4.07 54.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 0.0 108.531 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.439 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 98.8 m-20 47.56 11.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.77 . . . . 0.0 110.182 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 36' ' ' ASN . 8.4 mtmp? -139.99 -121.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.258 -0.901 . . . . 0.0 109.532 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.458 ' CD1' ' ND1' ' A' ' 33' ' ' HIS . 56.7 t-105 46.53 96.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.659 -0.651 . . . . 0.0 109.321 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -106.63 126.28 52.07 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.707 0.765 . . . . 0.0 109.981 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.06 128.53 10.68 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 140.55 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.943 -1.098 . . . . 0.0 109.812 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.6 130.74 55.49 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -157.19 157.88 35.2 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.943 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 33.6 p-10 -98.98 116.6 31.58 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 pt -125.74 145.8 52.85 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.688 -0.633 . . . . 0.0 109.722 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.2 139.05 22.02 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.811 1.674 . . . . 0.0 112.304 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.5 -22.03 65.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.191 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -62.67 -29.76 70.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.142 -0.974 . . . . 0.0 109.641 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.71 -40.55 95.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.802 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.472 HD12 HD12 ' A' ' 53' ' ' ILE . 12.2 pt -79.08 16.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.758 -1.214 . . . . 0.0 109.739 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.19 -8.24 58.36 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.443 -0.884 . . . . 0.0 110.927 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.472 HD12 HD12 ' A' ' 51' ' ' ILE . 80.9 mt -82.7 129.01 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.638 -1.507 . . . . 0.0 109.81 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -85.39 97.12 9.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.494 -0.754 . . . . 0.0 110.276 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.59 -16.96 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.516 -1.833 . . . . 0.0 108.516 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 57.6 t0 51.19 19.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -1.032 . . . . 0.0 109.069 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -107.9 146.3 32.55 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.583 -0.698 . . . . 0.0 110.138 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -73.91 139.3 44.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.493 -0.754 . . . . 0.0 109.7 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.44 157.88 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.424 -0.797 . . . . 0.0 109.464 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.458 ' OD1' ' NH2' ' A' ' 3' ' ' ARG . 90.2 m-20 -91.21 131.32 36.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.466 -0.771 . . . . 0.0 109.755 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.26 158.6 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.535 -0.728 . . . . 0.0 109.446 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.5 pt -134.53 146.49 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.421 0.629 . . . . 0.0 109.614 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 64.4 t0 -79.29 134.78 36.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.407 -0.808 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -127.14 121.82 32.45 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.589 ' N ' HD13 ' A' ' 64' ' ' LEU . 7.3 tmtm? -83.89 134.83 34.67 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.418 -0.801 . . . . 0.0 110.114 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.0 m -143.84 164.28 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -93.32 155.34 41.04 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.521 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.507 ' O ' HG12 ' A' ' 71' ' ' VAL . 47.6 Cg_exo -48.75 -28.9 13.55 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.167 1.911 . . . . 0.0 111.26 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.02 -32.11 16.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.459 -0.776 . . . . 0.0 109.376 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.59 -5.25 58.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 109.466 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 68' ' ' PRO . 9.2 p -68.53 -40.44 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -0.909 . . . . 0.0 109.863 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.482 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.87 -44.0 96.75 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.5 t -64.73 -26.32 68.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.938 -1.331 . . . . 0.0 110.21 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.537 HD12 HD22 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -86.98 -33.89 19.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.866 -1.146 . . . . 0.0 109.829 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -76.21 -7.49 54.97 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.375 -0.828 . . . . 0.0 109.105 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -7.33 59.68 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.476 ' HB2' HD12 ' A' ' 80' ' ' ILE . 61.2 mttm -94.14 113.76 61.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.634 -0.667 . . . . 0.0 109.474 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.94 147.05 19.95 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.303 2.002 . . . . 0.0 113.282 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.07 -13.28 67.31 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 77' ' ' LYS . 15.4 mt -107.28 124.43 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.529 -0.983 . . . . 0.0 109.085 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.404 ' O ' ' OG1' ' A' ' 93' ' ' THR . 56.1 m-85 -119.47 150.07 49.04 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.76 -0.588 . . . . 0.0 110.01 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 83' ' ' ALA . 37.1 Cg_exo -56.13 149.45 53.66 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.124 1.882 . . . . 0.0 112.576 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . . . -45.99 174.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.825 0.822 . . . . 0.0 111.129 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.62 -71.73 0.28 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -137.97 140.95 40.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.551 -0.718 . . . . 0.0 109.934 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.0 mmm 57.59 154.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.738 0.78 . . . . 0.0 111.231 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.546 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 85.1 m-20 56.56 33.21 22.27 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.51 0.672 . . . . 0.0 109.388 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.463 ' O ' HD13 ' A' ' 92' ' ' ILE . 37.8 ttpt -63.27 -46.96 84.38 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.454 -0.779 . . . . 0.0 109.262 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -79.37 -35.87 40.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.122 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -66.35 -50.71 62.65 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.339 -0.851 . . . . 0.0 110.243 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.546 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 11.1 m0 -117.5 152.08 35.8 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.587 -0.696 . . . . 0.0 109.753 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 88' ' ' LYS . 6.4 mm -136.22 157.68 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.567 -0.708 . . . . 0.0 109.451 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 7.6 p -105.85 123.68 48.35 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.8 t -108.46 131.06 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.5 tp -89.91 104.18 16.77 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.206 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.06 -39.49 86.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.539 -0.725 . . . . 0.0 109.264 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -69.28 -6.1 27.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.41 -0.806 . . . . 0.0 109.047 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -77.83 -162.26 18.12 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.72 6.26 5.89 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.348 2.699 . . . . 0.0 111.564 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.71 130.94 48.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 110.254 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.91 154.79 24.91 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.38 95.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.543 -0.975 . . . . 0.0 109.297 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.71 -42.08 95.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.943 . . . . 0.0 109.074 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -66.03 -43.95 86.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.446 -0.784 . . . . 0.0 109.198 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.58 -43.48 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.069 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -60.43 -43.57 96.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.462 -0.774 . . . . 0.0 109.654 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -62.77 -42.72 99.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.819 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.537 HD22 HD12 ' A' ' 74' ' ' LEU . 95.1 mt -64.79 -41.92 95.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.931 . . . . 0.0 109.584 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.79 -43.17 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.872 . . . . 0.0 108.919 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -61.19 -41.99 97.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -64.04 -41.58 97.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.7 p -66.07 -33.91 76.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.79 . . . . 0.0 109.304 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.25 -47.93 83.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.633 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.49 -29.03 63.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.94 -42.23 97.39 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.185 -0.947 . . . . 0.0 109.511 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 117' ' ' ARG . 62.2 p -97.11 14.73 24.75 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.569 -0.707 . . . . 0.0 109.1 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.475 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 77.7 ttt-85 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.881 -0.512 . . . . 0.0 110.167 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpp . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -105.77 163.85 12.39 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.553 -0.717 . . . . 0.0 110.019 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -61.48 -43.25 99.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.585 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -64.26 -40.91 96.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.452 -0.78 . . . . 0.0 109.754 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.89 -42.27 94.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 109.572 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.42 -45.03 96.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.767 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.29 -44.67 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.26 -0.9 . . . . 0.0 109.153 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.63 -44.13 94.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.816 . . . . 0.0 109.487 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -64.15 -42.1 96.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.483 -0.76 . . . . 0.0 109.872 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.5 -54.31 48.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.379 -0.826 . . . . 0.0 110.698 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -64.9 -33.1 75.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.244 -0.91 . . . . 0.0 109.756 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -60.57 -46.59 89.65 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 109.791 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -87.2 -37.61 17.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.348 -0.845 . . . . 0.0 111.416 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 77.2 m-85 -94.57 -0.73 54.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.924 -1.11 . . . . 0.0 111.115 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 14' ' ' TYR . 3.4 p30 40.97 35.61 0.36 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.379 -0.825 . . . . 0.0 109.907 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.6 t -118.64 143.88 46.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.566 -0.709 . . . . 0.0 109.359 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -96.23 151.81 38.4 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.308 -0.87 . . . . 0.0 109.564 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.22 149.55 85.32 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.469 2.112 . . . . 0.0 112.162 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 66.1 t0 -132.8 138.51 47.14 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.517 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 5.5 p80 -131.24 85.58 53.43 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -79.29 -10.52 14.87 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.943 1.762 . . . . 0.0 111.14 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -89.15 102.87 15.52 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.456 0.646 . . . . 0.0 109.555 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.86 -33.84 74.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -0.766 . . . . 0.0 109.592 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 25' ' ' PHE . 60.1 mttp -68.06 -5.75 19.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.348 -0.845 . . . . 0.0 109.849 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 24' ' ' LYS . 64.1 m-85 -153.29 83.84 4.49 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.202 -0.936 . . . . 0.0 109.463 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.4 -15.61 31.15 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.565 1.51 . . . . 0.0 111.209 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.63 -5.92 47.84 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.4 m-85 -86.08 141.68 29.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 109.106 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.98 135.93 38.08 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.4 HG11 ' NH1' ' A' ' 32' ' ' ARG . 3.1 t -117.44 126.01 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 93.9 m-85 -110.26 122.66 48.2 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.4 ' NH1' HG11 ' A' ' 30' ' ' VAL . 95.6 mtm-85 -134.3 155.22 50.6 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.051 -1.031 . . . . 0.0 109.267 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 37' ' ' ASP . 1.4 t-160 -85.42 113.84 22.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.317 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 t -65.35 -23.43 66.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.525 -0.735 . . . . 0.0 109.799 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.8 -44.57 92.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.377 -0.827 . . . . 0.0 110.639 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -122.48 -26.73 4.53 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.377 -0.827 . . . . 0.0 109.63 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 33' ' ' HIS . 54.4 m-20 58.49 -159.12 0.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.438 0.637 . . . . 0.0 109.938 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 59.9 24.51 13.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.934 -0.479 . . . . 0.0 110.274 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.405 ' HE1' ' HB2' ' A' ' 36' ' ' ASN . 44.0 m95 -112.25 149.02 32.91 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.396 -0.815 . . . . 0.0 109.553 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -113.71 131.53 56.14 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.676 0.75 . . . . 0.0 110.239 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 31' ' ' PHE . . . -151.15 105.62 3.24 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.2 mm? -107.58 131.89 53.87 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.724 0.773 . . . . 0.0 110.417 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 tt -126.76 120.29 28.99 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.592 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 3.7 ptt? -160.41 164.19 32.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.01 . . . . 0.0 109.507 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 96.9 m-20 -98.38 118.78 35.81 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.2 pt -120.73 145.95 42.36 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.44 -0.788 . . . . 0.0 109.45 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.21 141.74 96.67 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.902 1.735 . . . . 0.0 112.719 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.19 -20.74 65.69 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.493 0.663 . . . . 0.0 109.263 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 56' ' ' ASP . 95.6 mt-10 -53.69 -36.0 61.72 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.625 -0.672 . . . . 0.0 109.899 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.05 -39.01 93.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 110.317 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.9 HD12 HD12 ' A' ' 53' ' ' ILE . 5.2 pt -92.94 -0.94 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.08 36.44 85.73 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.153 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.9 HD12 HD12 ' A' ' 51' ' ' ILE . 6.0 mt -104.46 133.63 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.182 -1.187 . . . . 0.0 109.713 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 52.77 -83.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.707 -0.621 . . . . 0.0 109.806 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . 143.46 114.65 1.0 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.6 OUTLIER 61.47 39.35 15.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.623 -0.928 . . . . 0.0 110.67 178.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -113.46 118.63 35.04 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -72.39 133.35 44.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.181 -0.949 . . . . 0.0 109.516 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.11 161.66 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 20.3 m-20 -99.43 138.07 37.03 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.29 -0.881 . . . . 0.0 109.444 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.75 156.59 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.304 -0.872 . . . . 0.0 109.344 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.8 pt -133.74 157.98 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.549 0.69 . . . . 0.0 109.702 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 42' ' ' LEU . 44.5 t0 -90.48 122.07 32.99 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.539 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -115.85 120.47 39.36 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.539 ' N ' HD13 ' A' ' 64' ' ' LEU . 37.9 ttmt -84.23 135.55 34.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.321 -0.862 . . . . 0.0 109.849 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.604 HG11 HD13 ' A' ' 74' ' ' LEU . 30.0 m -143.29 169.65 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.287 -0.883 . . . . 0.0 109.63 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -78.11 153.59 79.86 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.583 -0.698 . . . . 0.0 109.489 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' O ' HG12 ' A' ' 71' ' ' VAL . 28.8 Cg_endo -63.77 -19.26 66.81 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.256 1.97 . . . . 0.0 111.313 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -91.42 -27.56 18.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.763 . . . . 0.0 109.395 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.21 7.62 44.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.322 -0.861 . . . . 0.0 109.221 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 72' ' ' GLY . 7.1 p -63.26 -37.53 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.465 -0.772 . . . . 0.0 109.981 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -78.3 -15.1 81.47 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.522 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -71.25 -60.6 2.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.014 -1.286 . . . . 0.0 110.737 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.737 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -75.49 -37.23 60.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.184 -0.947 . . . . 0.0 110.537 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.432 ' HE ' ' HB3' ' A' ' 82' ' ' PRO . 79.0 ttt-85 -60.61 -33.07 72.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.389 -0.819 . . . . 0.0 109.475 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -32.84 73.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.315 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -68.09 120.36 73.78 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.176 -0.952 . . . . 0.0 110.059 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.05 147.28 20.06 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.938 1.759 . . . . 0.0 112.61 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.88 -22.56 34.97 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.8 mt -105.85 120.89 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.535 -0.98 . . . . 0.0 109.279 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -107.08 150.76 40.27 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.497 -0.752 . . . . 0.0 109.923 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.502 ' CB ' ' HZ2' ' A' ' 88' ' ' LYS . 53.6 Cg_endo -69.41 159.15 54.8 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.223 1.949 . . . . 0.0 111.92 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.03 142.37 58.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 109.984 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -79.29 12.9 2.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 109.843 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -156.63 -161.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -0.919 . . . . 0.0 110.176 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 78.9 mtm -52.77 -175.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.571 0.701 . . . . 0.0 111.078 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.9 m120 59.1 33.19 22.74 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.514 0.673 . . . . 0.0 109.687 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.502 ' HZ2' ' CB ' ' A' ' 82' ' ' PRO . 64.4 tttp -64.65 -39.22 93.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.556 -0.715 . . . . 0.0 109.605 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.28 -16.99 29.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.116 -0.99 . . . . 0.0 109.934 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -94.48 -53.33 3.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.24 -0.913 . . . . 0.0 110.358 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -111.19 131.32 55.21 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.389 -0.819 . . . . 0.0 109.781 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.98 141.12 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.4 m -86.77 129.46 34.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.218 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.1 t -114.16 133.17 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.1 tp -91.05 108.51 19.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.648 -0.657 . . . . 0.0 109.923 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.34 -39.46 92.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.53 -0.731 . . . . 0.0 109.086 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -76.03 5.56 6.48 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.5 -0.75 . . . . 0.0 109.034 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.51 -176.44 20.43 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.42 -6.59 14.7 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.113 2.542 . . . . 0.0 111.701 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.83 145.84 48.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.646 -0.659 . . . . 0.0 109.794 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.08 173.01 31.28 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.55 -29.1 70.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.653 -0.91 . . . . 0.0 109.332 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.18 -41.31 98.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.456 -0.778 . . . . 0.0 109.234 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 104' ' ' GLU . 58.2 mp0 -65.69 -41.61 92.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.19 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.38 -43.42 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.418 -0.801 . . . . 0.0 109.931 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -56.03 -45.75 79.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.83 . . . . 0.0 109.589 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.6 t -61.94 -44.27 97.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.4 -0.812 . . . . 0.0 109.935 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.9 -41.32 99.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.427 -0.796 . . . . 0.0 109.658 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.77 -43.18 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -56.29 -43.69 79.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 0.0 109.089 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -60.06 -44.75 94.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.365 -0.835 . . . . 0.0 109.09 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.7 p -70.38 -27.18 64.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.258 -0.902 . . . . 0.0 109.983 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.07 -44.85 91.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.331 -0.856 . . . . 0.0 109.382 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -58.46 -43.31 88.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.893 . . . . 0.0 109.653 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.9 mp -63.33 -39.59 94.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.262 -0.899 . . . . 0.0 109.512 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.0 p -88.98 4.94 46.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.461 -0.774 . . . . 0.0 109.62 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.404 179.548 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.438 ' OD1' ' OE1' ' A' ' 5' ' ' GLN . 28.7 p30 -152.77 -179.03 7.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.22 -0.925 . . . . 0.0 109.536 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.615 ' HE ' HD21 ' A' ' 43' ' ' LEU . 12.6 ptm180 -61.53 -33.0 73.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.456 -0.778 . . . . 0.0 109.369 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.587 HE22 ' CG ' ' A' ' 8' ' ' ASP . 4.5 tm0? -61.36 -44.12 97.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 110.001 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.438 ' OE1' ' OD1' ' A' ' 2' ' ' ASN . 4.3 mp0 -64.44 -38.42 90.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 108.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -60.2 -45.12 94.25 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.309 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.74 -44.83 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.3 -0.875 . . . . 0.0 109.547 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.587 ' CG ' HE22 ' A' ' 4' ' ' GLN . 54.4 m-20 -64.73 -46.11 83.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 108.727 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -63.48 -39.91 95.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.383 -0.823 . . . . 0.0 109.093 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.09 -43.56 70.47 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.461 -0.774 . . . . 0.0 109.679 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 86.0 mt-30 -67.21 -40.63 86.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.156 -0.965 . . . . 0.0 109.651 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -63.4 -38.17 90.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.852 -1.155 . . . . 0.0 109.265 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -86.76 -35.84 18.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 111.691 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -118.74 -20.8 8.12 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.134 -0.978 . . . . 0.0 111.032 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 44.2 t0 59.0 38.66 24.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.949 -1.094 . . . . 0.0 109.118 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -107.07 135.79 48.03 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.558 -0.714 . . . . 0.0 109.334 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -82.15 131.21 57.06 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.837 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.52 143.11 22.04 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.17 1.914 . . . . 0.0 112.982 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -127.72 121.89 31.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.634 -0.666 . . . . 0.0 109.276 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.48 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -119.62 86.83 35.64 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.2 -37.13 87.66 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.462 2.108 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.476 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -87.81 83.87 7.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 0.0 109.064 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -54.59 -14.43 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.458 -0.776 . . . . 0.0 109.564 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -76.18 -2.62 32.06 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -141.25 75.63 22.92 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.287 -0.883 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.65 -31.42 91.86 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.723 2.282 . . . . 0.0 111.327 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.472 ' O ' ' NH2' ' A' ' 3' ' ' ARG . 98.9 m-20 -68.22 -16.04 63.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.401 -0.812 . . . . 0.0 109.347 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -92.56 132.16 37.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 0.0 109.213 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.09 141.07 50.12 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.15 133.55 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 109.043 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -107.95 143.81 36.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.56 -0.712 . . . . 0.0 109.217 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -132.85 129.68 38.77 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.34 -0.85 . . . . 0.0 110.051 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.467 ' H ' ' HB2' ' A' ' 39' ' ' TRP . 80.2 m80 -103.28 111.99 24.65 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.0 p -88.21 -16.66 32.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -94.39 -0.73 54.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.183 -0.948 . . . . 0.0 110.337 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 38' ' ' LYS . 20.3 t-20 -115.99 29.8 7.75 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.382 -0.823 . . . . 0.0 109.854 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 67.9 t0 46.68 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.575 -0.703 . . . . 0.0 110.511 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.1 tttt -79.98 136.15 36.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.54 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 7.8 p90 -141.96 141.38 32.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.281 -0.887 . . . . 0.0 110.607 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 39' ' ' TRP . 29.0 m-85 -159.51 119.96 3.1 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.517 ' C ' HD22 ' A' ' 42' ' ' LEU . . . -156.83 105.4 2.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 108.769 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.2 mm? -113.09 125.01 53.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.537 -0.727 . . . . 0.0 109.286 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.634 HD23 ' C ' ' A' ' 43' ' ' LEU . 8.8 tt -123.59 116.71 23.58 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -162.74 167.46 22.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.026 -1.046 . . . . 0.0 109.499 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.523 ' OD2' ' NH2' ' A' ' 58' ' ' ARG . 34.7 p-10 -106.95 116.75 32.47 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.6 pt -118.71 146.65 40.44 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.837 -0.539 . . . . 0.0 110.248 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.27 145.33 11.5 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.104 1.869 . . . . 0.0 112.846 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -61.44 -21.48 64.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.948 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 54' ' ' ASN . 61.9 mm-40 -70.31 -15.41 62.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.917 -1.114 . . . . 0.0 110.28 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -84.67 -10.99 56.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.982 -1.074 . . . . 0.0 110.605 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.445 ' CD1' HD12 ' A' ' 53' ' ' ILE . 4.7 pt -104.53 2.82 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.216 -0.927 . . . . 0.0 109.027 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.69 -5.0 69.53 Favored Glycine 0 N--CA 1.496 2.662 0 O-C-N 121.245 -0.91 . . . . 0.0 110.854 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 55' ' ' GLY . 86.6 mt -81.47 138.09 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.912 -1.346 . . . . 0.0 110.235 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.425 ' O ' ' OE2' ' A' ' 49' ' ' GLU . 56.4 m-80 -61.58 -39.34 90.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.603 -0.686 . . . . 0.0 109.397 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 53' ' ' ILE . . . -42.59 139.8 2.4 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 36.9 p-10 -103.33 14.0 32.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.973 . . . . 0.0 109.065 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 78.5 tttt -82.15 143.06 31.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.366 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 84.9 mtp180 -72.48 144.28 48.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.51 -0.744 . . . . 0.0 109.99 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HB ' HD11 ' A' ' 95' ' ' LEU . 27.3 m -136.36 162.89 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.495 -0.753 . . . . 0.0 110.003 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -97.37 136.93 37.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.474 -0.766 . . . . 0.0 109.789 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.37 155.59 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.39 -0.819 . . . . 0.0 110.374 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.2 pt -138.32 150.51 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.98 152.38 26.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 110.065 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.622 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -141.1 125.06 17.13 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.622 ' N ' HD13 ' A' ' 64' ' ' LEU . 3.5 pttm -84.84 131.06 34.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.94 . . . . 0.0 109.359 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.97 165.31 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.269 -0.894 . . . . 0.0 109.445 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -87.41 157.99 52.36 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 109.086 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.71 -21.03 68.19 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.577 2.185 . . . . 0.0 111.352 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -95.01 -29.39 14.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.063 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.47 -3.47 49.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 109.81 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.1 p -65.08 -36.14 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.058 -1.027 . . . . 0.0 109.591 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.45 99.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.5 m -61.7 -42.7 99.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.27 . . . . 0.0 110.47 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.484 HD12 HD22 ' A' ' 108' ' ' LEU . 3.5 tt -85.0 -31.82 23.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.059 -1.026 . . . . 0.0 110.376 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -77.02 -21.87 53.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.114 -0.991 . . . . 0.0 110.401 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -85.61 -2.86 58.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 109.21 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HB2' HD12 ' A' ' 80' ' ' ILE . 50.3 mttm -77.41 151.56 80.78 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 80' ' ' ILE . 73.7 Cg_endo -72.28 151.64 54.67 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.864 2.376 . . . . 0.0 112.565 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.04 -20.12 2.59 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 77' ' ' LYS . 72.2 mt -97.43 116.12 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -1.117 . . . . 0.0 108.363 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.408 ' O ' ' OG1' ' A' ' 93' ' ' THR . 18.1 m-85 -123.08 161.22 46.0 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.887 -0.508 . . . . 0.0 110.087 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.61 153.07 69.51 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.006 1.804 . . . . 0.0 111.961 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.33 140.37 33.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 110.585 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -74.77 7.62 2.97 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.473 -0.767 . . . . 0.0 109.125 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.406 ' O ' ' C ' ' A' ' 86' ' ' MET . 51.6 p-80 -157.7 -172.73 4.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 85' ' ' HIS . 79.0 mtm -38.06 158.92 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.457 0.646 . . . . 0.0 111.623 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 m120 72.96 79.96 0.14 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.426 0.631 . . . . 0.0 110.339 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -114.16 -36.3 4.76 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 109.547 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.81 -85.13 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.946 -1.096 . . . . 0.0 111.087 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -67.92 -33.38 74.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 110.677 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.439 ' HE1' ' CB ' ' A' ' 40' ' ' TYR . 24.8 m-90 -93.93 130.62 39.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.014 . . . . 0.0 110.542 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.0 mm -134.89 143.8 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.437 -0.79 . . . . 0.0 109.021 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 1.1 p -91.51 134.57 34.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.485 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.82 133.82 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.411 HD11 ' HB ' ' A' ' 59' ' ' VAL . 46.6 tp -91.47 123.74 35.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.688 -0.633 . . . . 0.0 109.897 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.6 mt -87.64 -13.93 41.36 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -94.39 0.21 55.3 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 100' ' ' LEU . . . -89.14 -165.45 41.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.62 9.01 0.36 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 123.225 2.617 . . . . 0.0 111.259 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.7 mm? -70.35 124.86 25.2 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.16 161.47 20.8 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.28 89.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.567 -0.961 . . . . 0.0 109.364 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -64.72 -41.7 95.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -65.07 -44.93 87.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -0.806 . . . . 0.0 109.595 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.21 -43.4 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.276 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -58.98 -42.68 90.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -61.34 -44.02 97.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 109.95 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.484 HD22 HD12 ' A' ' 74' ' ' LEU . 96.2 mt -63.99 -41.81 97.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.348 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.66 -42.77 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.388 -0.82 . . . . 0.0 109.187 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -55.54 -42.42 74.58 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.203 -0.935 . . . . 0.0 109.09 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.423 ' HA ' HE21 ' A' ' 114' ' ' GLN . 64.8 t0 -63.36 -40.65 97.85 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.343 -0.848 . . . . 0.0 109.19 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.454 ' OG ' HD11 ' A' ' 64' ' ' LEU . 1.4 m -63.24 -36.86 85.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.434 -0.791 . . . . 0.0 109.325 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -60.54 -47.27 86.92 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.426 -0.796 . . . . 0.0 110.409 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 111' ' ' ASP . 17.4 pt20 -77.0 -20.59 55.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 0.0 109.856 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.68 -42.01 98.35 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.16 -0.962 . . . . 0.0 109.951 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.487 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 6.2 p -101.21 16.77 24.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.453 -0.779 . . . . 0.0 109.364 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 . . . . . 0 N--CA 1.502 2.154 0 CA-C-O 121.726 0.774 . . . . 0.0 110.844 -179.222 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.317 0.579 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.72 165.34 12.35 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.301 -0.874 . . . . 0.0 110.189 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.63 -43.83 97.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.464 -0.773 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.563 HE22 ' CG ' ' A' ' 8' ' ' ASP . 9.6 tm0? -62.65 -39.47 93.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 109.909 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -63.34 -37.5 87.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.94 . . . . 0.0 109.545 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.52 -44.31 96.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.441 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.46 -45.06 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.158 -0.963 . . . . 0.0 109.43 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.563 ' CG ' HE22 ' A' ' 4' ' ' GLN . 95.8 m-20 -61.82 -44.29 97.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.968 . . . . 0.0 109.64 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.518 ' CD1' ' NE2' ' A' ' 106' ' ' HIS . 80.3 t80 -61.66 -47.18 86.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.837 . . . . 0.0 109.668 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.62 87.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 109.868 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.543 ' O ' ' N ' ' A' ' 15' ' ' ASP . 7.2 tp-100 -64.34 -48.59 74.97 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.453 -0.78 . . . . 0.0 109.932 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -65.44 -35.18 80.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.997 -1.064 . . . . 0.0 109.674 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -82.08 -35.8 28.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.349 -0.844 . . . . 0.0 111.737 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CG ' ' NE2' ' A' ' 33' ' ' HIS . 78.1 m-85 -124.2 -20.71 5.19 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.033 -1.042 . . . . 0.0 110.998 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 11' ' ' GLN . 56.2 t0 56.92 36.31 27.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 109.026 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -108.4 148.64 29.84 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.54 -0.725 . . . . 0.0 109.371 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.435 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 13.0 mptt -91.84 153.15 43.61 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.201 -0.937 . . . . 0.0 109.298 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.0 154.78 73.52 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.474 2.116 . . . . 0.0 111.66 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -139.72 142.05 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 109.118 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -127.54 86.14 59.2 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -55.56 -36.75 95.08 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.273 1.982 . . . . 0.0 110.708 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -81.24 106.31 13.12 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.466 0.65 . . . . 0.0 109.53 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -66.42 -21.26 66.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.417 -0.802 . . . . 0.0 109.613 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -78.6 -3.88 46.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.316 -0.865 . . . . 0.0 109.49 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -137.74 66.46 48.95 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.35 -19.25 49.92 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.301 2.001 . . . . 0.0 111.616 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -81.19 -5.79 58.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -90.18 147.58 23.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.24 -0.912 . . . . 0.0 109.215 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.03 131.65 53.58 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.53 -0.731 . . . . 0.0 109.363 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.78 132.04 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -111.97 137.53 49.85 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.356 -0.84 . . . . 0.0 109.488 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.456 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . 13.3 ptp180 -139.44 132.23 29.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.203 -0.936 . . . . 0.0 109.33 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.592 ' NE2' ' CG ' ' A' ' 14' ' ' TYR . 70.2 m80 -100.76 110.16 22.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.294 -0.879 . . . . 0.0 109.363 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -78.4 -12.29 60.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.83 -1.66 58.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 110.02 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' LYS . 33.8 m120 -119.79 19.57 12.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.506 -0.747 . . . . 0.0 109.217 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.403 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 67.0 t0 56.82 -76.84 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.814 -0.554 . . . . 0.0 109.879 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 54.0 mtmt -83.81 152.71 24.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.88 . . . . 0.0 109.958 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.561 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 8.1 p90 -168.19 140.23 2.92 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.264 -0.897 . . . . 0.0 109.587 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -150.86 121.46 7.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.996 -1.065 . . . . 0.0 108.582 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.54 104.86 2.59 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -114.47 116.19 28.46 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.546 ' N ' HD13 ' A' ' 42' ' ' LEU . 7.4 tt -120.15 126.45 50.72 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -157.9 150.96 23.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.143 -0.973 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -97.75 117.21 31.55 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 23.3 pt -125.01 147.01 55.45 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.388 -0.82 . . . . 0.0 110.295 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -48.37 144.12 13.99 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.873 1.715 . . . . 0.0 112.262 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -63.84 -22.73 67.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -0.837 . . . . 0.0 110.258 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 10.7 pt-20 -71.99 -13.5 61.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.022 . . . . 0.0 109.94 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -84.61 -10.66 57.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.148 -0.97 . . . . 0.0 110.677 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.456 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 8.5 pt -104.89 5.17 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.101 -0.999 . . . . 0.0 109.56 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 -7.42 60.64 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 121.186 -0.946 . . . . 0.0 111.018 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 55' ' ' GLY . 88.2 mt -79.04 142.05 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.874 -1.369 . . . . 0.0 110.448 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.88 -39.95 93.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 110.048 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.564 ' H ' HG22 ' A' ' 53' ' ' ILE . . . -58.75 142.82 45.58 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.039 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -101.94 7.49 41.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.557 -0.966 . . . . 0.0 108.709 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -63.52 139.75 58.8 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 110.303 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -69.53 136.34 51.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.585 -0.697 . . . . 0.0 110.274 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.07 161.27 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.522 -0.736 . . . . 0.0 109.313 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -101.55 133.23 46.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 0.0 109.806 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 m -132.59 157.91 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.446 -0.783 . . . . 0.0 110.111 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 pt -136.66 153.4 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -118.45 126.98 53.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.451 -0.781 . . . . 0.0 109.656 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.4 160.31 30.83 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.851 0.834 . . . . 0.0 109.259 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -84.09 136.51 33.98 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.844 -0.535 . . . . 0.0 109.803 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.654 HG11 HD13 ' A' ' 74' ' ' LEU . 4.2 m -133.23 163.72 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -73.78 145.49 84.31 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.044 -1.035 . . . . 0.0 109.814 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.61 ' O ' HG12 ' A' ' 71' ' ' VAL . 49.7 Cg_exo -49.24 -30.23 18.95 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.268 1.979 . . . . 0.0 111.966 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -85.32 -28.0 25.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.416 -0.802 . . . . 0.0 110.238 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.58 0.94 55.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.108 -0.995 . . . . 0.0 109.968 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 68' ' ' PRO . 7.4 p -63.45 -43.7 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.919 -1.113 . . . . 0.0 109.281 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.548 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -66.18 -48.46 64.55 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 t -61.33 -49.55 76.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.167 -1.196 . . . . 0.0 110.693 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.654 HD13 HG11 ' A' ' 66' ' ' VAL . 2.0 tt -67.24 -42.7 83.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.813 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -75.29 -7.38 53.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.391 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -28.61 16.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -61.79 149.72 84.33 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.402 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' O ' HD12 ' A' ' 80' ' ' ILE . 24.7 Cg_exo -62.77 146.02 95.01 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 122.215 1.943 . . . . 0.0 113.058 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.06 -28.92 5.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.774 ' N ' HD12 ' A' ' 80' ' ' ILE . 2.7 mp -83.65 128.41 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -1.215 . . . . 0.0 109.402 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 49.3 m-85 -124.07 153.03 67.86 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.801 -0.562 . . . . 0.0 109.773 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.406 ' O ' ' OG1' ' A' ' 93' ' ' THR . 53.9 Cg_exo -45.15 159.52 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.115 1.876 . . . . 0.0 112.089 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.72 144.05 56.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.144 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 88.0 t80 -89.28 4.27 49.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.805 . . . . 0.0 109.246 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 86' ' ' MET . 81.8 t60 -105.7 177.91 4.71 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.45 -0.781 . . . . 0.0 110.265 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.613 ' H ' ' CG ' ' A' ' 85' ' ' HIS . 91.7 mtp -64.69 -39.71 94.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.55 -0.719 . . . . 0.0 110.143 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -74.99 130.65 39.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.202 -0.936 . . . . 0.0 110.519 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -146.55 96.23 2.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -178.77 -43.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -111.9 -23.9 10.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 109.378 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.85 ' C ' HD12 ' A' ' 92' ' ' ILE . 2.0 m-90 -111.76 132.91 54.33 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.43 -0.794 . . . . 0.0 109.495 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.85 HD12 ' C ' ' A' ' 91' ' ' TRP . 3.0 mp -137.06 147.56 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.218 -0.926 . . . . 0.0 109.006 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 82' ' ' PRO . 3.2 p -87.49 147.6 25.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.602 -0.686 . . . . 0.0 110.051 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.43 134.72 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.4 tp -87.04 112.44 21.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 0.0 110.104 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.93 -38.68 83.19 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.44 -0.788 . . . . 0.0 108.996 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -73.81 -0.1 14.81 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.35 171.56 19.24 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.79 -16.03 33.23 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 123.365 2.71 . . . . 0.0 111.972 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.22 138.7 58.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.95 169.29 54.98 Favored Glycine 0 N--CA 1.493 2.439 0 CA-C-O 122.079 0.822 . . . . 0.0 111.222 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.63 -36.11 83.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.691 -0.887 . . . . 0.0 109.716 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -61.44 -38.75 88.29 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.356 -0.84 . . . . 0.0 108.986 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.09 -37.66 88.22 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.432 -0.792 . . . . 0.0 109.431 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.94 -43.87 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.968 . . . . 0.0 109.527 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.518 ' NE2' ' CD1' ' A' ' 9' ' ' TYR . 48.4 m170 -61.47 -42.76 99.27 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.153 -0.967 . . . . 0.0 109.659 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -62.21 -44.66 96.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.7 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.66 -44.05 91.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.706 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.39 -42.83 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.309 -0.869 . . . . 0.0 109.476 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -53.9 -41.33 67.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.273 -0.892 . . . . 0.0 109.137 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.97 -44.74 96.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.5 m -60.64 -37.54 81.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.57 -43.4 97.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.221 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -51.45 -40.05 58.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 110.049 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 115' ' ' LEU . 9.0 mp -63.49 -40.06 96.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.878 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 117' ' ' ARG . 5.6 p -92.19 6.53 46.3 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -0.964 . . . . 0.0 109.538 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 116' ' ' THR . 53.3 ptt85 . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.566 0.698 . . . . 0.0 110.922 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 ttm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -100.23 161.66 13.46 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.26 -0.9 . . . . 0.0 110.221 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -61.54 -42.99 99.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.771 . . . . 0.0 109.689 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -61.38 -39.22 89.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.791 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.46 -37.08 85.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.456 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -60.7 -44.23 96.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.72 -46.45 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.261 -0.899 . . . . 0.0 109.653 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.41 -41.34 98.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -60.64 -49.9 75.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 109.446 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.38 80.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 15' ' ' ASP . 35.3 tt0 -62.83 -50.39 71.15 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.271 -0.893 . . . . 0.0 109.979 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.48 -40.49 97.25 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.628 -1.295 . . . . 0.0 109.132 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -70.33 -46.42 64.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.864 . . . . 0.0 112.129 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CE1' ' CE1' ' A' ' 33' ' ' HIS . 86.4 m-85 -120.43 -17.97 8.02 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.026 -1.046 . . . . 0.0 111.547 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 11' ' ' GLN . 30.1 t0 60.94 42.38 12.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.927 -1.108 . . . . 0.0 109.457 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.4 t -108.41 136.4 48.11 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -92.9 157.34 39.53 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.094 -1.004 . . . . 0.0 109.779 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.88 143.7 90.64 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.761 1.641 . . . . 0.0 112.775 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -132.28 135.67 46.4 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -133.72 85.1 42.81 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.184 -0.948 . . . . 0.0 109.376 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.77 -34.94 97.51 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.499 2.133 . . . . 0.0 111.394 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -85.87 110.88 19.71 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.572 -0.705 . . . . 0.0 109.625 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -68.56 -31.09 70.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.838 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -67.2 -4.35 10.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.923 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -133.33 70.49 77.16 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.433 -0.792 . . . . 0.0 108.939 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.68 -16.34 33.68 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.229 1.952 . . . . 0.0 111.883 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 22.7 p-10 -88.68 0.27 56.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.336 -0.853 . . . . 0.0 109.258 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.0 m-85 -92.71 139.19 30.81 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.197 -0.939 . . . . 0.0 109.186 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.46 114.92 21.36 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.75 128.28 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.419 -0.801 . . . . 0.0 109.012 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -111.47 134.19 53.22 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.66 -0.65 . . . . 0.0 109.262 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -145.19 150.67 37.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.235 -0.916 . . . . 0.0 109.291 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 14' ' ' TYR . 64.1 m170 -100.08 160.99 13.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.339 -0.851 . . . . 0.0 109.926 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.3 t -102.91 -50.91 3.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.226 -0.921 . . . . 0.0 110.132 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -96.86 -0.82 47.2 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.097 -1.002 . . . . 0.0 110.83 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -104.99 31.82 4.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.162 -0.961 . . . . 0.0 109.129 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 38' ' ' LYS . 98.9 m-20 59.38 40.05 21.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.972 -0.455 . . . . 0.0 110.066 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.471 ' HA ' ' H ' ' A' ' 33' ' ' HIS . 6.3 ptpp? 31.23 76.22 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.676 0.75 . . . . 0.0 110.958 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -55.59 -170.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.635 -0.666 . . . . 0.0 109.909 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CE2' ' OD2' ' A' ' 63' ' ' ASP . 63.0 t80 -115.04 122.69 46.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.611 -0.681 . . . . 0.0 109.167 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . . . -154.79 129.99 9.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.503 -0.748 . . . . 0.0 109.209 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.2 tp -140.86 129.05 22.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 109.349 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 43' ' ' LEU . 8.7 tt -122.09 125.97 47.38 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.573 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.9 ptt? -159.05 157.35 30.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 59' ' ' VAL . 46.6 t0 -96.19 114.03 25.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.143 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 pt -116.67 144.79 33.97 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.616 -0.678 . . . . 0.0 109.206 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -48.3 143.77 14.37 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.58 1.52 . . . . 0.0 112.412 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -61.39 -22.08 64.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.394 -0.816 . . . . 0.0 109.458 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.62 -16.83 62.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.132 . . . . 0.0 110.278 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -84.72 -11.67 55.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.003 -1.061 . . . . 0.0 111.092 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.477 ' O ' ' CD2' ' A' ' 81' ' ' TYR . 11.4 pt -100.97 4.96 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 120.953 -1.092 . . . . 0.0 109.398 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.06 -11.07 65.91 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.515 ' C ' ' H ' ' A' ' 55' ' ' GLY . 61.6 mt -81.64 132.56 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.848 -1.383 . . . . 0.0 109.414 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -67.02 13.51 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.571 -0.706 . . . . 0.0 109.944 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -83.97 141.44 20.08 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 32.0 p-10 -101.04 8.9 42.71 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.452 -1.028 . . . . 0.0 109.019 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 64.1 tttp -84.03 141.39 31.21 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.494 -0.754 . . . . 0.0 109.556 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -72.52 145.44 47.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.867 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.435 ' HB ' HD11 ' A' ' 95' ' ' LEU . 31.6 m -136.13 161.3 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.486 -0.758 . . . . 0.0 109.721 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.684 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 95.7 m-20 -102.3 139.0 38.5 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.1 153.53 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.397 -0.815 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 pt -137.01 148.31 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.694 -0.629 . . . . 0.0 109.446 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.538 ' OD2' ' CE2' ' A' ' 40' ' ' TYR . 86.5 m-20 -74.61 144.63 43.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.305 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.666 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -133.11 131.92 41.08 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.666 ' N ' HD13 ' A' ' 64' ' ' LEU . 10.0 mtpm? -97.73 130.3 44.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.223 -0.923 . . . . 0.0 109.912 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.11 165.6 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.369 -0.832 . . . . 0.0 110.316 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -70.61 152.9 95.23 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.512 -0.742 . . . . 0.0 109.129 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.461 ' O ' HG12 ' A' ' 71' ' ' VAL . 37.3 Cg_endo -65.57 -22.2 58.69 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.23 1.953 . . . . 0.0 111.353 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -86.47 -30.64 21.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.2 mt -97.38 10.62 39.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.244 -0.91 . . . . 0.0 109.291 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.532 HG13 ' N ' ' A' ' 72' ' ' GLY . 5.4 p -60.38 -46.74 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 110.1 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.532 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -75.92 -14.74 81.9 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.907 -1.139 . . . . 0.0 110.416 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 5.0 t -59.34 -55.46 34.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.015 -1.285 . . . . 0.0 110.898 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.004 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.9 pt? -86.3 -21.57 27.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.874 . . . . 0.0 110.864 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.847 ' CZ ' HG21 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -57.77 -42.27 83.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.772 -1.205 . . . . 0.0 111.275 -177.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -79.91 0.43 31.35 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.465 -1.397 . . . . 0.0 110.594 -178.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -83.82 125.34 73.41 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.693 -1.254 . . . . 0.0 109.256 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.42 144.34 18.49 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 121.942 1.761 . . . . 0.0 113.141 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.57 -6.08 67.62 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.62 ' CG2' HH21 ' A' ' 75' ' ' ARG . 96.4 mt -122.47 128.77 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.208 -1.172 . . . . 0.0 109.805 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 31.7 m-85 -120.46 152.6 55.45 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.498 -0.751 . . . . 0.0 109.934 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.83 154.77 67.09 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.471 2.114 . . . . 0.0 111.895 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.81 147.22 53.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.204 -0.935 . . . . 0.0 110.127 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.511 ' C ' ' H ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -98.6 119.47 37.37 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 25.5 t60 66.74 -33.42 0.2 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.628 -0.67 . . . . 0.0 110.736 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.511 ' H ' ' C ' ' A' ' 84' ' ' TYR . 90.4 mmm -84.32 159.55 20.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.076 -1.015 . . . . 0.0 110.598 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 91' ' ' TRP . 57.9 t-20 -40.52 122.05 1.55 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.666 0.746 . . . . 0.0 110.939 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -94.41 -15.05 24.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.644 -0.66 . . . . 0.0 109.734 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.426 ' N ' ' OD1' ' A' ' 87' ' ' ASN . 98.1 mt-10 -80.87 -85.2 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.946 . . . . 0.0 110.66 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -60.6 -44.18 96.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -0.884 . . . . 0.0 110.739 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.439 ' N ' ' CD1' ' A' ' 91' ' ' TRP . 16.5 m0 -101.56 138.15 38.94 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.49 -0.756 . . . . 0.0 109.684 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.847 HG21 ' CZ ' ' A' ' 75' ' ' ARG . 9.3 mt -143.51 165.84 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.322 -0.861 . . . . 0.0 109.519 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 81' ' ' TYR . 6.3 p -107.77 138.58 43.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.9 t -121.1 133.97 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.435 HD11 ' HB ' ' A' ' 59' ' ' VAL . 31.0 tp -90.82 109.64 20.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 109.817 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.8 mt -64.95 -39.21 93.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.684 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 66.1 m-80 -74.41 5.76 4.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 109.66 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.85 165.18 15.33 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.52 -16.88 30.51 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.937 2.425 . . . . 0.0 111.293 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 100' ' ' LEU . 1.9 pp -60.22 169.3 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.648 -0.658 . . . . 0.0 110.46 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -99.99 169.13 21.71 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 121.231 -0.918 . . . . 0.0 110.913 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.88 82.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.629 -0.924 . . . . 0.0 109.365 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.497 ' NZ ' ' OE2' ' A' ' 104' ' ' GLU . 22.7 pttp -60.29 -37.05 79.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.329 -0.857 . . . . 0.0 108.973 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' A' ' 103' ' ' LYS . 72.9 mm-40 -65.33 -44.62 87.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.311 -0.868 . . . . 0.0 109.12 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.05 -43.83 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.0 109.548 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -58.0 -44.29 87.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.273 -0.892 . . . . 0.0 109.911 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.0 p -61.15 -43.39 98.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 0.0 109.689 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.61 -42.05 98.24 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 109.034 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.68 -43.0 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.177 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -51.64 -44.83 63.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.109 -0.994 . . . . 0.0 108.879 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.21 -42.28 98.32 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.158 -0.964 . . . . 0.0 108.573 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 t -62.72 -38.75 91.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.2 -43.33 74.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.259 -0.901 . . . . 0.0 108.973 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -54.5 -31.81 56.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.773 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 115' ' ' LEU . 9.0 mp -83.55 -13.48 54.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.084 -1.01 . . . . 0.0 109.974 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.472 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 45.0 p -102.04 13.87 33.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.297 -0.877 . . . . 0.0 109.306 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 110.168 -179.87 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 ttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.284 0.564 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -87.2 159.29 18.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.313 -0.867 . . . . 0.0 110.495 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.27 -42.89 96.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.646 -0.659 . . . . 0.0 109.588 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -59.24 -43.22 92.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.845 . . . . 0.0 109.497 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.86 -32.36 73.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.222 -0.923 . . . . 0.0 109.468 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -60.9 -47.66 85.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.664 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.0 mp -64.98 -46.77 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.207 -0.933 . . . . 0.0 109.184 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.75 -43.22 99.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 109.819 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.417 ' CE1' ' CE1' ' A' ' 106' ' ' HIS . 89.8 t80 -64.12 -44.15 93.09 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.868 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.86 -51.49 69.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.625 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 15' ' ' ASP . 3.5 pt20 -70.11 -38.17 75.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.033 -1.042 . . . . 0.0 110.255 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -60.01 -43.45 95.22 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.626 -1.296 . . . . 0.0 109.35 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -88.2 -32.06 18.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.145 -0.972 . . . . 0.0 111.698 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.525 ' CE1' ' CD1' ' A' ' 113' ' ' PHE . 73.5 m-85 -121.25 -8.56 9.21 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.065 -1.022 . . . . 0.0 111.654 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 11' ' ' GLN . 91.4 m-20 54.97 37.48 28.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 109.54 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 17' ' ' LYS . 96.7 m -79.69 162.2 25.36 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.512 -0.742 . . . . 0.0 109.152 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.516 ' N ' HG22 ' A' ' 16' ' ' THR . 37.1 tptt -123.01 93.12 48.66 Favored Pre-proline 0 N--CA 1.497 1.895 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -56.49 146.5 74.24 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.405 2.07 . . . . 0.0 112.365 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 60.4 t0 -132.15 152.25 51.36 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.605 ' N ' ' ND1' ' A' ' 20' ' ' HIS . 0.8 OUTLIER -118.93 86.26 30.73 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 0.0 109.497 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.78 -36.84 83.73 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.235 1.956 . . . . 0.0 111.469 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -87.4 126.99 35.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.575 -0.703 . . . . 0.0 109.357 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -87.51 -28.84 21.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.371 -0.83 . . . . 0.0 109.715 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -81.84 -7.56 59.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.326 -0.859 . . . . 0.0 110.0 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -123.57 75.35 54.38 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.449 -0.782 . . . . 0.0 109.518 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.86 -17.66 41.63 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.985 1.79 . . . . 0.0 111.634 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -80.64 -5.04 56.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.472 -0.768 . . . . 0.0 109.573 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -100.39 135.09 42.36 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.414 -0.804 . . . . 0.0 109.333 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.91 147.54 44.47 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.16 129.47 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.47 -0.769 . . . . 0.0 109.394 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 43.6 m-85 -108.45 109.92 21.31 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -142.21 146.15 34.89 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.145 -0.972 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.505 ' NE2' ' OG1' ' A' ' 16' ' ' THR . 63.8 m170 -99.86 113.56 26.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.521 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.3 p -69.79 -17.89 63.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.307 -0.87 . . . . 0.0 109.585 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -62.74 -44.12 97.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.826 . . . . 0.0 109.808 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 38' ' ' LYS . 56.7 p30 -112.4 -1.49 15.02 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.425 -0.797 . . . . 0.0 109.133 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.4 t0 58.4 0.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.731 . . . . 0.0 109.925 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 36' ' ' ASN . 53.6 mtmt -101.3 -156.91 0.58 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 109.69 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 46.9 t-105 57.15 94.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.644 -0.66 . . . . 0.0 109.491 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.59 125.2 54.02 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.54 143.93 24.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.42 144.01 32.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.193 -0.942 . . . . 0.0 109.014 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 43' ' ' LEU . 8.1 tt -117.61 127.11 53.63 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.528 ' N ' HD23 ' A' ' 43' ' ' LEU . 6.6 ptt? -146.63 158.09 43.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.097 -1.002 . . . . 0.0 109.485 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 34.6 p-10 -95.59 115.6 27.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.366 -0.834 . . . . 0.0 109.265 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.2 pt -126.31 145.73 53.71 Favored Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.478 -0.764 . . . . 0.0 109.231 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.67 144.03 99.49 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.075 1.85 . . . . 0.0 112.78 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -62.82 -20.99 65.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.692 -0.63 . . . . 0.0 109.64 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.76 -36.54 76.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.051 -1.03 . . . . 0.0 110.465 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 52' ' ' GLY . 97.2 mttt -63.74 -43.49 96.33 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.97 -1.081 . . . . 0.0 111.239 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.456 ' CD1' HD12 ' A' ' 53' ' ' ILE . 9.4 pt -71.57 15.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.958 -1.089 . . . . 0.0 110.145 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . 80.75 -7.49 58.57 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.088 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 55' ' ' GLY . 71.0 mt -79.4 133.06 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.775 -1.427 . . . . 0.0 109.335 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -68.91 26.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.374 -0.829 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -91.97 132.8 11.44 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 32.2 p-10 -101.79 8.86 41.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.333 -1.098 . . . . 0.0 108.962 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -83.89 154.92 23.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.388 -0.82 . . . . 0.0 109.767 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -82.28 130.38 35.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 108.667 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.446 ' HA ' HD22 ' A' ' 97' ' ' ASN . 16.3 m -125.79 143.61 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.535 -0.728 . . . . 0.0 109.615 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -89.57 141.62 28.42 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.265 -0.897 . . . . 0.0 109.927 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.401 HG12 HD12 ' A' ' 95' ' ' LEU . 3.8 m -135.8 158.96 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.416 -0.802 . . . . 0.0 109.468 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 pt -134.24 151.38 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -112.16 140.35 46.93 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.471 -0.768 . . . . 0.0 110.126 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -138.33 157.22 46.68 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.656 -0.653 . . . . 0.0 109.362 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -92.73 139.92 30.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 0.0 110.867 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 m -141.39 164.68 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.41 -0.806 . . . . 0.0 109.547 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -74.78 156.74 86.39 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.527 -0.733 . . . . 0.0 109.628 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 71' ' ' VAL . 31.2 Cg_endo -64.47 -23.39 64.77 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.327 2.018 . . . . 0.0 111.207 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -86.57 -25.8 24.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.38 -0.825 . . . . 0.0 109.429 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.22 5.67 49.69 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.21 -0.931 . . . . 0.0 109.38 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 72' ' ' GLY . 11.6 p -63.28 -39.93 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.499 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -77.47 -15.42 81.44 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -68.17 -55.96 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.123 -1.222 . . . . 0.0 110.753 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.0 pt? -86.48 -25.26 25.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.962 -1.086 . . . . 0.0 110.614 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -71.08 -21.63 62.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.947 -1.096 . . . . 0.0 109.627 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.22 -6.68 57.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 108.727 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.42 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 9.0 mtpm? -84.54 152.65 60.78 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.1 148.45 69.34 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.957 2.438 . . . . 0.0 113.19 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.47 -23.69 11.81 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.2 mt -96.02 121.14 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -1.189 . . . . 0.0 110.066 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -117.56 157.28 48.05 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.793 -0.567 . . . . 0.0 109.979 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.34 152.55 66.18 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.848 1.698 . . . . 0.0 112.36 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.87 151.37 39.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.399 -0.813 . . . . 0.0 109.962 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -90.48 1.24 56.86 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.344 -0.847 . . . . 0.0 109.259 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.17 -174.02 2.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.405 -0.809 . . . . 0.0 110.047 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.4 ttm -63.82 -39.39 94.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.714 . . . . 0.0 110.148 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -67.9 153.55 43.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.532 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -148.59 -54.97 0.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.75 -17.6 59.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.364 -0.835 . . . . 0.0 109.257 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.41 ' CD2' ' N ' ' A' ' 90' ' ' HIS . 4.0 m170 -82.13 -62.84 1.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.949 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -109.79 148.08 32.1 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.658 -0.651 . . . . 0.0 109.903 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 mm -130.9 137.25 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.1 m -87.19 131.03 34.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.671 -0.643 . . . . 0.0 110.147 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 64' ' ' LEU . 72.6 t -113.22 134.81 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.435 HD11 ' HB ' ' A' ' 59' ' ' VAL . 46.1 tp -89.22 108.73 19.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.941 . . . . 0.0 110.273 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.64 -41.06 96.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 59' ' ' VAL . 97.0 m-20 -84.51 20.22 1.76 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 109.009 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.78 -176.43 39.76 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.26 -37.24 94.55 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.047 2.498 . . . . 0.0 112.774 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -57.97 138.22 56.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 0.0 110.418 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.92 -174.15 39.45 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.94 92.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.683 -0.892 . . . . 0.0 109.882 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -62.79 -40.93 98.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.27 -40.21 96.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.507 -0.746 . . . . 0.0 109.775 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.41 -43.61 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.771 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.417 ' CE1' ' CE1' ' A' ' 9' ' ' TYR . 55.9 m170 -59.59 -47.3 86.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.756 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.3 m -62.35 -43.93 97.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.957 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.31 -44.96 93.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.39 -0.819 . . . . 0.0 109.732 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.5 mt -65.32 -43.02 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -0.842 . . . . 0.0 109.337 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -52.2 -43.68 64.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.025 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -61.95 -44.18 97.3 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 109.273 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.0 p -67.34 -39.24 85.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.79 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 87.6 t80 -61.62 -45.52 93.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.911 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.24 -42.07 69.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.371 -0.83 . . . . 0.0 109.578 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.56 -39.83 92.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.378 -0.826 . . . . 0.0 110.113 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 p -99.99 14.54 30.2 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.157 -0.964 . . . . 0.0 109.835 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 113' ' ' PHE . 35.7 ptt180 . . . . . 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 110.092 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.7 ttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.603 0.716 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -102.14 163.22 12.36 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.733 0.777 . . . . 0.0 110.183 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.408 HH21 ' CG ' ' A' ' 60' ' ' ASP . 41.3 ttm180 -61.29 -43.82 98.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.586 0.708 . . . . 0.0 109.6 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -58.89 -40.06 83.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.779 . . . . 0.0 109.842 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.14 -37.6 88.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.441 -0.787 . . . . 0.0 109.817 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -60.94 -43.8 98.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.317 -0.864 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.42 -44.26 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -0.783 . . . . 0.0 109.474 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.76 -44.32 96.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.634 ' CE1' ' CD2' ' A' ' 106' ' ' HIS . 63.9 t80 -63.46 -48.58 77.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.443 -0.786 . . . . 0.0 109.696 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.2 85.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.492 -0.755 . . . . 0.0 109.811 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.553 HE22 ' C ' ' A' ' 16' ' ' THR . 40.6 tp60 -68.53 -49.91 56.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.824 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.84 -31.67 73.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.957 -1.089 . . . . 0.0 109.087 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.484 ' NZ ' ' CZ ' ' A' ' 14' ' ' TYR . 65.8 tttm -83.44 -38.36 21.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 111.74 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.484 ' CZ ' ' NZ ' ' A' ' 13' ' ' LYS . 74.9 m-85 -116.63 -21.41 9.14 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.824 -1.173 . . . . 0.0 111.148 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 49.7 t0 62.8 36.79 12.83 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.27 -0.894 . . . . 0.0 109.466 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.553 ' C ' HE22 ' A' ' 11' ' ' GLN . 14.5 t -114.88 134.75 54.89 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.593 0.711 . . . . 0.0 109.707 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -84.69 151.66 58.7 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.613 -0.679 . . . . 0.0 109.332 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.54 146.44 79.69 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.786 2.324 . . . . 0.0 112.477 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -115.38 155.17 27.87 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.693 0.759 . . . . 0.0 109.3 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -143.41 88.2 8.1 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 -15.28 21.12 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.339 2.026 . . . . 0.0 110.617 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -100.72 110.5 22.61 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.498 0.666 . . . . 0.0 109.335 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -68.32 -33.61 74.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.797 0.808 . . . . 0.0 109.186 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -67.76 -2.41 7.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.404 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -143.68 74.72 16.63 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.296 -0.878 . . . . 0.0 109.372 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.86 -15.8 29.63 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.605 2.203 . . . . 0.0 111.301 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -86.46 -4.96 59.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.494 -0.754 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -84.57 142.38 30.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.373 -0.829 . . . . 0.0 109.611 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.07 140.77 50.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.589 -0.694 . . . . 0.0 109.69 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.78 132.66 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -109.07 136.47 48.52 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.394 0.616 . . . . 0.0 109.699 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -156.12 149.23 24.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.342 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.5 ' O ' ' NE1' ' A' ' 39' ' ' TRP . 80.3 m80 -100.75 128.95 46.6 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.611 0.719 . . . . 0.0 109.443 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.4 p -75.92 -6.89 53.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.471 -0.768 . . . . 0.0 109.518 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -94.33 -9.84 34.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.262 -0.899 . . . . 0.0 109.815 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -109.78 -30.23 7.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.147 -0.971 . . . . 0.0 108.783 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.8 t0 54.18 28.04 8.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.468 -0.77 . . . . 0.0 109.699 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 50.8 tptt -170.11 112.03 0.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.143 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.614 ' CD2' ' N ' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -173.22 -174.48 1.05 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.207 1.003 . . . . 0.0 109.75 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.432 ' CE2' ' CD2' ' A' ' 42' ' ' LEU . 9.7 t80 -160.18 118.93 2.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.199 -0.938 . . . . 0.0 109.137 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.12 121.72 4.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.432 ' CD2' ' CE2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -138.34 149.28 45.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.462 -0.774 . . . . 0.0 109.163 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.663 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.4 tt -129.31 122.56 29.81 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.547 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.43 162.23 41.48 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.688 0.756 . . . . 0.0 109.928 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 42.5 p-10 -97.25 114.82 26.61 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.289 0.566 . . . . 0.0 109.518 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.7 pt -117.56 146.19 38.01 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.38 143.6 99.66 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.692 2.262 . . . . 0.0 112.495 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.77 -19.89 64.45 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.578 0.704 . . . . 0.0 109.794 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.91 -38.85 87.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.235 -0.915 . . . . 0.0 110.238 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.87 -43.76 95.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.23 -0.918 . . . . 0.0 111.174 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.669 HD12 HD12 ' A' ' 53' ' ' ILE . 2.8 pt -76.95 12.17 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.036 -1.04 . . . . 0.0 109.834 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.1 31.16 77.83 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.365 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.669 HD12 HD12 ' A' ' 51' ' ' ILE . 47.9 mt -101.23 128.57 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.111 -1.229 . . . . 0.0 109.737 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -55.93 81.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.644 0.735 . . . . 0.0 110.458 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . -176.98 151.48 11.19 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.71 15.35 18.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.513 -0.992 . . . . 0.0 108.446 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -88.45 155.04 19.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.36 -0.838 . . . . 0.0 110.256 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -86.36 141.83 28.91 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.526 0.679 . . . . 0.0 110.095 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 95' ' ' LEU . 29.6 m -134.04 153.32 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.548 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.408 ' CG ' HH21 ' A' ' 3' ' ' ARG . 96.4 m-20 -90.47 139.4 30.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.696 -0.628 . . . . 0.0 110.167 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.465 ' CG2' ' SD ' ' A' ' 44' ' ' MET . 33.4 m -137.87 154.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.707 0.765 . . . . 0.0 109.987 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.6 pt -135.2 147.92 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.493 0.663 . . . . 0.0 109.871 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.76 143.37 34.54 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.419 0.628 . . . . 0.0 110.389 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.667 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -133.33 126.91 32.42 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.667 ' N ' HD13 ' A' ' 64' ' ' LEU . 64.8 tttm -82.81 135.88 34.83 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.671 0.748 . . . . 0.0 110.569 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.76 158.35 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.597 0.713 . . . . 0.0 109.782 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' H ' ' HB2' ' A' ' 70' ' ' LEU . 15.8 mt-30 -89.83 154.45 47.82 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.529 -0.732 . . . . 0.0 109.319 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.485 ' O ' HG12 ' A' ' 71' ' ' VAL . 52.6 Cg_exo -45.67 -28.86 4.84 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.252 1.968 . . . . 0.0 111.563 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -91.48 -29.11 17.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 0.0 109.54 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.433 ' HB2' ' H ' ' A' ' 67' ' ' GLN . 89.2 mt -91.53 -8.33 47.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.269 -0.894 . . . . 0.0 109.668 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 68' ' ' PRO . 10.5 p -66.68 -40.01 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.652 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -62.88 -42.37 99.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.3 t -61.1 -48.76 80.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.353 -1.087 . . . . 0.0 110.073 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.07 -39.1 63.7 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.419 -0.8 . . . . 0.0 110.189 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.426 ' HE ' ' HG3' ' A' ' 82' ' ' PRO . 72.9 ttt180 -72.17 -38.99 69.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.554 -0.716 . . . . 0.0 111.308 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -73.73 -5.06 38.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.909 -1.12 . . . . 0.0 110.051 -178.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -78.95 147.67 70.61 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.126 -0.984 . . . . 0.0 109.714 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.416 ' O ' HD12 ' A' ' 80' ' ' ILE . 55.2 Cg_endo -69.95 145.66 56.71 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.473 2.116 . . . . 0.0 112.542 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.31 -20.9 19.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.701 ' N ' HD12 ' A' ' 80' ' ' ILE . 3.0 mp -91.83 122.59 43.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.323 -1.104 . . . . 0.0 109.449 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.533 ' CZ ' HD11 ' A' ' 53' ' ' ILE . 82.8 m-85 -115.06 154.94 47.17 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.23 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HG3' ' HE ' ' A' ' 75' ' ' ARG . 31.4 Cg_exo -60.44 146.81 96.04 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.841 2.361 . . . . 0.0 112.869 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.47 43.83 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.389 -0.819 . . . . 0.0 110.515 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 85' ' ' HIS . 45.7 p90 -96.13 3.86 52.93 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.63 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 71.9 m80 -87.93 -162.83 0.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.461 -0.774 . . . . 0.0 110.294 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' ASN . 42.0 ttp -55.32 160.86 2.08 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.56 0.695 . . . . 0.0 110.71 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 86' ' ' MET . 13.2 p30 42.32 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.864 0.84 . . . . 0.0 110.735 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.454 ' O ' HD11 ' A' ' 92' ' ' ILE . 81.9 tttt -151.83 -22.94 0.19 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 109.108 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 57.3 mp0 -96.02 -19.69 19.27 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.162 -0.962 . . . . 0.0 110.027 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -75.0 -69.82 0.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.633 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -110.39 138.81 46.29 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.392 -0.818 . . . . 0.0 110.026 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.454 HD11 ' O ' ' A' ' 88' ' ' LYS . 49.5 mm -120.13 157.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.429 ' N ' HG22 ' A' ' 92' ' ' ILE . 2.0 p -98.92 138.44 36.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.504 -0.747 . . . . 0.0 110.006 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.55 134.52 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.415 HD11 ' HB ' ' A' ' 59' ' ' VAL . 38.4 tp -86.3 105.89 16.98 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.585 0.707 . . . . 0.0 110.097 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.51 -39.67 88.79 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.805 0.812 . . . . 0.0 109.012 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -68.57 -7.55 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.77 -169.04 13.18 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.78 18.83 1.21 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.239 2.626 . . . . 0.0 111.425 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 80' ' ' ILE . 3.9 mm? -66.06 132.9 49.62 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.95 0.881 . . . . 0.0 110.38 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.74 155.79 22.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.67 79.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.804 -0.821 . . . . 0.0 109.898 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.55 -40.06 92.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.386 -0.821 . . . . 0.0 109.207 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.99 -44.78 96.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.81 -43.4 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.243 -0.91 . . . . 0.0 109.583 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.634 ' CD2' ' CE1' ' A' ' 9' ' ' TYR . 54.2 m170 -58.94 -42.34 89.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 109.849 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -63.99 -42.14 97.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 109.853 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.8 -41.22 95.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.361 -0.837 . . . . 0.0 109.515 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.76 -42.88 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.75 -42.34 75.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.202 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.26 -41.03 98.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.23 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.4 t -60.19 -40.08 88.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.827 . . . . 0.0 109.649 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -58.36 -44.18 88.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 109.227 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -57.91 -46.1 85.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.359 -0.838 . . . . 0.0 109.844 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.29 -37.77 88.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 0.0 109.623 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.3 p -88.08 13.19 11.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.157 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.8 0.809 . . . . 0.0 109.022 179.703 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.6 ttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -104.62 155.08 19.16 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.67 -0.643 . . . . 0.0 109.884 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -61.6 -43.54 98.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.571 -0.706 . . . . 0.0 109.73 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -58.09 -41.79 84.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.596 -0.69 . . . . 0.0 110.019 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.36 -35.71 81.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.783 . . . . 0.0 110.122 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -60.16 -45.57 92.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.749 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.65 -45.46 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -62.82 -38.27 90.04 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.593 0.711 . . . . 0.0 109.506 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.516 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 59.9 t80 -69.5 -43.89 72.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 110.141 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.78 75.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.434 -0.791 . . . . 0.0 110.5 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 15' ' ' ASP . 4.8 pt20 -66.53 -30.41 70.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 109.984 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.4 -48.54 80.75 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 0.0 110.225 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.516 ' NZ ' ' CE2' ' A' ' 9' ' ' TYR . 63.3 mttp -90.34 -12.4 37.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.217 -0.927 . . . . 0.0 111.875 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -134.65 -20.38 1.79 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.981 -1.075 . . . . 0.0 111.012 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 11' ' ' GLN . 43.0 t0 58.42 39.45 25.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.119 -0.988 . . . . 0.0 109.263 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.5 m -106.93 127.1 53.14 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -89.34 156.04 48.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.715 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.66 141.3 43.98 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.981 1.787 . . . . 0.0 112.359 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -125.88 121.73 34.04 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.508 ' O ' ' CG ' ' A' ' 20' ' ' HIS . 25.2 p-80 -125.39 86.17 57.47 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.562 -0.711 . . . . 0.0 109.425 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.86 -32.3 91.62 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.537 2.158 . . . . 0.0 111.201 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -83.45 135.59 34.62 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.589 0.709 . . . . 0.0 110.161 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.661 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 1.4 pm0 -89.41 -24.26 21.95 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -78.11 -3.1 40.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.488 -0.757 . . . . 0.0 109.825 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -137.18 66.04 52.1 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.4 -0.812 . . . . 0.0 109.458 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.47 -20.2 36.51 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.433 2.088 . . . . 0.0 111.425 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -81.94 -5.61 58.44 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.53 -0.731 . . . . 0.0 109.063 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -90.96 140.35 29.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.497 -0.752 . . . . 0.0 109.117 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.72 121.52 34.87 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -109.44 125.49 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -108.76 116.55 32.19 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -145.07 135.31 24.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.092 -1.005 . . . . 0.0 109.285 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -99.95 115.0 28.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.486 -0.759 . . . . 0.0 109.716 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 m -63.69 -35.78 81.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.605 -0.684 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -71.68 -5.37 33.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.961 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 38' ' ' LYS . 10.7 t-20 -113.74 -30.8 6.66 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 42.66 18.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.766 -0.584 . . . . 0.0 109.96 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 36' ' ' ASN . 63.6 tttp -136.53 -19.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 39' ' ' TRP . 18.1 t-105 -78.01 117.99 19.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.491 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -115.26 125.72 53.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.614 -0.679 . . . . 0.0 109.274 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.42 129.01 11.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 108.739 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.3 tp -132.29 123.68 27.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.511 -0.743 . . . . 0.0 109.112 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.4 tt -117.58 124.66 49.2 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.52 ' N ' HD23 ' A' ' 43' ' ' LEU . 7.5 ptt? -153.95 161.38 42.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 109.212 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 38.1 p-10 -98.05 114.53 26.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.267 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.9 pt -124.54 145.97 50.93 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.548 -0.72 . . . . 0.0 109.193 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.1 143.87 99.05 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.026 1.817 . . . . 0.0 112.573 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -63.81 -20.98 66.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.754 -0.591 . . . . 0.0 109.909 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.5 -35.51 74.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.993 . . . . 0.0 110.165 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -64.69 -41.85 95.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 0.0 110.94 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.463 ' CD1' HD12 ' A' ' 53' ' ' ILE . 5.0 pt -81.82 20.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 109.893 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.22 -4.89 53.29 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.282 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.617 ' HB ' ' HB1' ' A' ' 48' ' ' ALA . 79.4 mt -78.92 134.03 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.939 -1.33 . . . . 0.0 110.075 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 55' ' ' GLY . 92.6 m-20 -61.38 -39.35 90.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.74 -0.6 . . . . 0.0 110.101 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.828 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -37.06 109.48 0.08 OUTLIER Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -80.81 4.35 19.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.517 -0.99 . . . . 0.0 109.007 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -84.12 161.55 20.59 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.654 0.74 . . . . 0.0 110.148 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.01 146.91 33.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.65 -0.656 . . . . 0.0 110.186 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 m -135.26 159.6 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.493 -0.754 . . . . 0.0 109.543 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.691 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 45.1 m-20 -102.05 135.77 43.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.362 -0.836 . . . . 0.0 109.681 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.45 155.94 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.395 -0.816 . . . . 0.0 110.057 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.498 HG23 HD11 ' A' ' 96' ' ' LEU . 25.2 pt -133.83 146.71 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -84.39 142.56 30.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.842 . . . . 0.0 109.825 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -136.71 121.67 18.85 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.592 ' N ' HD13 ' A' ' 64' ' ' LEU . 21.5 ptmt -84.98 136.71 33.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 110.115 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.442 HG11 HD13 ' A' ' 74' ' ' LEU . 28.6 m -142.52 165.93 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.253 -0.904 . . . . 0.0 109.88 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -78.01 149.25 76.48 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 0.0 109.669 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.639 ' O ' HG12 ' A' ' 71' ' ' VAL . 51.3 Cg_exo -50.2 -39.31 52.14 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.963 1.776 . . . . 0.0 111.639 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 69' ' ' GLU . 2.4 pt-20 -70.7 -33.79 71.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.726 -0.609 . . . . 0.0 110.037 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -84.67 2.66 40.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 0.0 109.837 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 68' ' ' PRO . 8.0 p -64.34 -42.56 95.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.506 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -69.92 -40.22 74.28 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -62.36 -32.31 73.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.471 -1.017 . . . . 0.0 109.348 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.478 HD12 HD22 ' A' ' 108' ' ' LEU . 2.2 tt -84.85 -35.86 21.96 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.48 -0.762 . . . . 0.0 109.871 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -73.49 -8.16 54.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 110.003 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -2.96 58.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.193 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.573 ' HB2' HD12 ' A' ' 80' ' ' ILE . 31.0 mtpt -96.21 111.43 56.49 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.602 -0.686 . . . . 0.0 109.337 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.15 143.14 42.98 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.061 1.841 . . . . 0.0 113.551 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -19.97 52.02 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.573 HD12 ' HB2' ' A' ' 77' ' ' LYS . 69.2 mt -100.76 121.24 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.321 -1.105 . . . . 0.0 109.299 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -108.78 151.07 41.58 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.468 -0.77 . . . . 0.0 109.765 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.56 163.66 37.29 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.466 2.11 . . . . 0.0 112.512 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -47.5 148.81 1.29 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.565 -0.71 . . . . 0.0 110.302 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.575 ' CZ ' HG21 ' A' ' 93' ' ' THR . 12.1 m-85 -63.07 -43.86 97.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.613 -0.679 . . . . 0.0 109.882 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -160.13 -26.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 109.223 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.407 ' CG ' ' H ' ' A' ' 87' ' ' ASN . 5.8 tpt -61.61 -140.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.51 -0.744 . . . . 0.0 110.42 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.464 ' CG ' ' ND1' ' A' ' 90' ' ' HIS . 82.7 m-20 -72.75 131.3 42.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.631 -0.668 . . . . 0.0 110.009 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -94.53 -21.93 18.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.502 -0.749 . . . . 0.0 109.788 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -100.98 -43.49 6.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.477 -0.764 . . . . 0.0 109.678 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.491 ' CD2' ' N ' ' A' ' 90' ' ' HIS . 3.4 m170 -63.21 -67.18 0.45 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 110.421 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.823 ' O ' HD13 ' A' ' 92' ' ' ILE . 8.3 m0 -111.39 148.48 32.95 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.628 -0.67 . . . . 0.0 109.713 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.823 HD13 ' O ' ' A' ' 91' ' ' TRP . 3.0 mm -132.75 161.77 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.575 HG21 ' CZ ' ' A' ' 84' ' ' TYR . 38.3 p -107.07 133.02 52.32 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.533 HG22 HG23 ' A' ' 80' ' ' ILE . 48.8 t -118.11 133.77 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.5 tp -90.75 108.45 19.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.508 -0.745 . . . . 0.0 109.957 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 62' ' ' ILE . 88.6 mt -65.58 -40.22 92.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.589 -0.694 . . . . 0.0 109.542 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.691 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 75.8 m-20 -78.32 6.2 8.82 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.475 -0.766 . . . . 0.0 109.164 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.83 178.84 53.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 100' ' ' LEU . 47.2 Cg_endo -68.02 -79.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.85 2.367 . . . . 0.0 112.079 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.495 ' C ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 22.92 -122.03 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.221 0.534 . . . . 0.0 111.085 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.9 159.63 21.48 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.202 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.56 -37.23 86.84 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.64 -0.918 . . . . 0.0 109.489 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.68 -40.06 95.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.581 -0.699 . . . . 0.0 109.401 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.17 -42.72 99.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.537 -0.727 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.23 -43.24 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 109.638 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -56.33 -44.13 79.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.47 -0.769 . . . . 0.0 109.494 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 t -61.9 -43.96 97.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.577 -0.702 . . . . 0.0 109.621 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.478 HD22 HD12 ' A' ' 74' ' ' LEU . 95.7 mt -63.3 -40.95 98.78 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.482 -0.761 . . . . 0.0 109.363 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.37 -43.18 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.49 -0.756 . . . . 0.0 109.24 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -60.42 -39.3 86.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.258 -0.902 . . . . 0.0 108.855 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.44 -41.14 98.52 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 116' ' ' THR . 38.8 t -62.73 -40.43 97.2 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.21 -44.5 83.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.545 -0.722 . . . . 0.0 109.209 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.83 -29.15 70.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.418 -0.801 . . . . 0.0 109.537 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.9 mt -86.1 -18.14 33.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.263 -0.898 . . . . 0.0 110.025 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 112' ' ' SER . 68.0 p -102.88 15.02 30.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.385 -0.822 . . . . 0.0 109.224 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 110.209 -179.766 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpp . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.474 0.654 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -95.23 162.33 13.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.356 -0.84 . . . . 0.0 110.489 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -61.52 -42.72 99.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 109.847 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -60.88 -39.04 87.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 109.756 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -63.59 -36.63 84.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.814 . . . . 0.0 109.059 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 56.5 t80 -60.98 -43.76 98.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 108.919 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.1 mm -61.1 -48.48 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.485 -0.76 . . . . 0.0 109.822 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -65.52 -41.47 93.1 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 109.452 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -61.54 -47.61 84.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -0.775 . . . . 0.0 109.849 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.66 -46.18 90.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.157 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ASP . 86.2 mt-30 -63.64 -32.28 73.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 110.465 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.39 -47.91 77.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.99 -1.069 . . . . 0.0 109.729 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -90.03 -12.21 39.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.302 -0.873 . . . . 0.0 111.844 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 15' ' ' ASP . 97.7 m-85 -132.93 -18.04 2.39 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.839 -1.163 . . . . 0.0 110.915 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' GLN . 4.4 p-10 43.85 31.92 0.54 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.365 -0.834 . . . . 0.0 109.418 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.0 m -102.37 136.96 41.27 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.657 0.741 . . . . 0.0 110.069 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -83.04 148.79 57.57 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.58 -0.7 . . . . 0.0 109.275 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.2 145.39 72.45 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.403 2.069 . . . . 0.0 112.129 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -121.91 143.44 49.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.617 -0.677 . . . . 0.0 109.485 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.635 ' H ' ' CD2' ' A' ' 20' ' ' HIS . 0.3 OUTLIER -122.18 86.44 47.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.62 -40.68 82.97 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.269 1.979 . . . . 0.0 111.068 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -90.3 136.54 32.99 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.61 0.719 . . . . 0.0 109.811 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 16.4 pt-20 -86.98 -22.02 25.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.62 -0.675 . . . . 0.0 109.516 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -75.85 -5.13 44.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.411 -0.806 . . . . 0.0 109.03 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -136.33 72.82 58.16 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.536 -0.728 . . . . 0.0 109.114 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.37 -12.08 24.99 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.499 2.133 . . . . 0.0 111.055 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 17.7 p-10 -87.53 -1.9 58.25 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.521 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.2 m-85 -87.15 142.09 28.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.511 -0.743 . . . . 0.0 109.892 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.93 129.18 47.66 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.411 HG22 HD13 ' A' ' 42' ' ' LEU . 48.2 t -132.03 131.14 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.532 -0.73 . . . . 0.0 109.888 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -109.4 139.08 44.81 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.496 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . 11.9 ptp180 -142.93 130.51 21.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.141 -0.974 . . . . 0.0 109.853 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.405 ' H ' ' CB ' ' A' ' 39' ' ' TRP . 1.0 OUTLIER -102.87 110.21 22.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.552 -0.718 . . . . 0.0 109.129 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.6 p -70.94 -16.31 62.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -0.812 . . . . 0.0 110.065 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -89.05 -5.14 58.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.124 -0.985 . . . . 0.0 109.644 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 38' ' ' LYS . 9.1 t-20 -107.45 -4.36 18.57 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.496 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 66.7 t0 59.35 -68.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.357 0.599 . . . . 0.0 110.231 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 36' ' ' ASN . 33.5 pttt -88.12 87.15 7.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.382 -0.824 . . . . 0.0 108.924 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.509 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 24.5 p90 -113.83 143.59 44.41 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.403 0.621 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.509 ' CG ' ' O ' ' A' ' 39' ' ' TRP . 99.4 m-85 -156.68 120.85 4.39 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.491 ' C ' HD22 ' A' ' 42' ' ' LEU . . . -155.94 105.33 2.36 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.491 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.3 mm? -111.21 131.57 55.02 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.425 0.631 . . . . 0.0 109.694 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' CD1' ' CD2' ' A' ' 6' ' ' PHE . 7.8 tt -135.41 119.71 17.85 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.521 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.2 ptt? -162.5 163.29 27.56 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.082 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 33.0 p-10 -102.97 118.37 36.66 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.9 146.19 52.47 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.717 -0.614 . . . . 0.0 109.933 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -46.36 141.37 10.39 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.36 2.04 . . . . 0.0 112.765 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.45 -24.16 67.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.62 -0.675 . . . . 0.0 109.915 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.58 -29.29 69.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -0.863 . . . . 0.0 109.785 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -64.47 -35.63 81.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.244 -0.91 . . . . 0.0 110.379 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.436 ' CD1' HD12 ' A' ' 53' ' ' ILE . 14.2 pt -85.15 2.47 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.907 -1.12 . . . . 0.0 109.6 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.84 -7.43 62.94 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.436 HD12 ' CD1' ' A' ' 51' ' ' ILE . 66.1 mt -78.27 126.61 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.775 -1.426 . . . . 0.0 110.072 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -61.71 86.35 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.705 0.764 . . . . 0.0 109.539 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.52 137.29 3.38 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -95.17 5.71 51.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.408 -1.054 . . . . 0.0 108.204 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -71.71 143.25 49.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 110.477 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -78.76 140.55 38.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.563 -0.711 . . . . 0.0 110.117 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.7 159.98 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.468 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 91.5 m-20 -88.19 134.06 33.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.463 -0.773 . . . . 0.0 109.929 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -137.49 153.44 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.496 -0.752 . . . . 0.0 109.714 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.7 pt -141.59 145.01 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.535 0.683 . . . . 0.0 110.151 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -79.82 142.23 35.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.543 -0.723 . . . . 0.0 109.84 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.695 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -127.31 127.81 44.93 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.695 ' N ' HD13 ' A' ' 64' ' ' LEU . 18.0 ttmm -82.11 130.39 35.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.639 -0.663 . . . . 0.0 109.937 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -139.13 163.59 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -0.785 . . . . 0.0 109.879 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -85.96 150.94 53.92 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.425 -0.797 . . . . 0.0 109.65 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.473 ' O ' HG12 ' A' ' 71' ' ' VAL . 53.8 Cg_exo -45.94 -26.7 3.6 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.271 1.981 . . . . 0.0 111.598 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 57.2 mp0 -94.31 -31.37 14.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.549 -0.719 . . . . 0.0 109.881 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.7 mt -87.12 -3.63 59.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 109.742 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 72' ' ' GLY . 9.0 p -67.51 -44.41 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.066 -1.021 . . . . 0.0 109.642 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.565 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.63 -41.32 99.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -62.79 -53.63 51.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -1.19 . . . . 0.0 110.233 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.454 HD12 HD22 ' A' ' 108' ' ' LEU . 2.0 tt -67.71 -44.5 77.51 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.813 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.51 -30.66 71.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.542 -0.724 . . . . 0.0 109.656 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -32.34 72.53 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -58.99 114.96 10.25 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.42 -0.8 . . . . 0.0 109.705 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.31 149.31 23.04 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.195 1.93 . . . . 0.0 113.186 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.92 -14.65 64.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.3 mt -106.57 120.09 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.599 -0.942 . . . . 0.0 109.345 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -105.15 150.36 38.72 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.593 -0.692 . . . . 0.0 109.668 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.6 149.32 79.4 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.436 2.091 . . . . 0.0 112.324 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.55 142.77 56.41 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.781 0.8 . . . . 0.0 110.502 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -86.52 -4.93 59.25 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.537 ' CG ' ' H ' ' A' ' 86' ' ' MET . 71.1 t60 -93.34 175.06 6.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.316 -0.865 . . . . 0.0 110.447 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 88' ' ' LYS . 79.1 mtm -52.11 -172.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.626 -0.671 . . . . 0.0 111.26 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 56.26 -78.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 86' ' ' MET . 31.5 ttmt 69.76 -46.13 0.59 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.387 0.613 . . . . 0.0 109.786 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -68.98 -44.39 72.98 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.39 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -69.62 -45.52 68.34 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.391 -0.818 . . . . 0.0 110.439 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -112.36 142.34 44.99 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.47 -0.769 . . . . 0.0 110.869 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 mm -132.09 139.88 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.6 m -83.76 129.53 34.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 109.594 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.1 t -115.01 132.01 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.7 tp -87.75 104.02 16.16 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.641 0.734 . . . . 0.0 110.019 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -66.36 -39.48 89.18 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.571 0.7 . . . . 0.0 109.123 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.468 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 98.6 m-20 -77.28 8.08 4.49 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -85.76 -161.39 34.85 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.49 -3.77 12.66 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.958 2.439 . . . . 0.0 111.874 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 100' ' ' LEU . 4.4 mm? -59.6 132.31 53.58 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.926 0.87 . . . . 0.0 110.052 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.98 161.52 38.07 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.11 97.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.807 -0.819 . . . . 0.0 109.514 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -72.04 -35.4 69.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.436 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.23 -42.55 93.27 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.352 -0.843 . . . . 0.0 109.31 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 93.0 mt -64.74 -43.02 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -56.67 -45.16 81.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 109.943 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.3 m -61.43 -43.73 98.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 109.715 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.454 HD22 HD12 ' A' ' 74' ' ' LEU . 95.2 mt -63.97 -40.97 97.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 109.547 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.95 -42.43 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 108.78 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -52.09 -42.87 63.59 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.446 -0.784 . . . . 0.0 108.991 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -62.2 -40.98 97.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 108.969 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 t -64.31 -36.83 85.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 109.358 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' ARG . 80.4 t80 -58.18 -43.09 87.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.543 -0.723 . . . . 0.0 109.52 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -54.29 -45.13 72.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.234 -0.916 . . . . 0.0 109.924 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.7 mp -66.75 -39.28 87.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.18 -0.95 . . . . 0.0 109.782 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.504 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 32.1 p -92.99 7.22 44.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.25 -0.906 . . . . 0.0 109.19 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 113' ' ' PHE . 42.2 ttm180 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.479 -0.763 . . . . 0.0 109.591 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 tpp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.358 0.599 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -101.1 162.84 12.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.435 -0.791 . . . . 0.0 110.17 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -61.53 -43.62 98.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.501 -0.75 . . . . 0.0 109.573 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.8 tp60 -65.9 -42.83 89.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.41 -41.87 96.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 0.0 109.482 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.431 ' CE1' HD13 ' A' ' 62' ' ' ILE . 87.3 t80 -62.26 -46.26 89.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 109.908 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.94 -43.71 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.252 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.01 -41.41 99.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.563 -0.71 . . . . 0.0 109.617 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -68.25 -36.61 79.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.49 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.44 73.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.433 -0.792 . . . . 0.0 110.344 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ASP . 2.8 pt20 -64.49 -37.53 87.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.601 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -61.42 -41.48 97.23 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.893 -1.129 . . . . 0.0 109.948 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -87.4 -33.8 18.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 111.503 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 16' ' ' THR . 88.3 m-85 -105.95 6.98 31.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.129 -0.982 . . . . 0.0 110.732 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 11' ' ' GLN . 2.1 p-10 39.91 29.74 0.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.427 -0.795 . . . . 0.0 109.643 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 14' ' ' TYR . 58.3 m -120.67 131.25 54.48 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.51 0.671 . . . . 0.0 109.915 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -87.35 156.82 53.84 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.556 -0.715 . . . . 0.0 109.374 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.66 133.29 26.66 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.077 1.851 . . . . 0.0 112.392 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -118.36 143.43 46.64 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.454 0.645 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.482 ' O ' ' CG ' ' A' ' 20' ' ' HIS . 20.0 p-80 -146.29 85.8 7.24 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.405 -0.809 . . . . 0.0 109.137 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.74 -10.71 9.41 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.737 2.291 . . . . 0.0 110.346 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -85.96 104.72 15.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.801 0.81 . . . . 0.0 109.647 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -68.08 -34.24 76.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.734 -0.604 . . . . 0.0 109.746 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -75.22 -6.08 47.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.857 . . . . 0.0 109.501 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.76 71.1 30.31 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.425 -0.797 . . . . 0.0 109.002 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.0 -17.59 40.97 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.458 2.106 . . . . 0.0 111.735 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -85.07 -4.41 59.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.386 -0.821 . . . . 0.0 109.328 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.3 m-85 -85.41 148.04 26.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 109.911 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.17 134.32 46.4 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.554 ' CG1' ' HE ' ' A' ' 32' ' ' ARG . 2.9 t -118.21 129.65 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.92 113.33 22.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.797 -0.565 . . . . 0.0 109.523 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.554 ' HE ' ' CG1' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -135.58 159.55 41.27 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.42 -0.8 . . . . 0.0 109.407 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.742 ' N ' ' HE1' ' A' ' 39' ' ' TRP . 0.5 OUTLIER -77.51 153.94 32.95 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.929 0.871 . . . . 0.0 110.516 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.8 p -88.37 -50.53 6.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -96.41 -25.66 15.62 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.326 -0.859 . . . . 0.0 111.247 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -105.07 30.02 5.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.096 -1.002 . . . . 0.0 110.037 -178.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 33' ' ' HIS . 10.4 m-20 -42.48 86.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.572 -0.705 . . . . 0.0 110.522 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.7 tttt -144.58 -29.02 0.48 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.742 ' HE1' ' N ' ' A' ' 33' ' ' HIS . 1.5 p-90 -95.89 159.27 15.06 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.384 -0.823 . . . . 0.0 109.368 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -138.58 126.2 22.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.617 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.75 150.48 31.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.495 -0.753 . . . . 0.0 109.421 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.51 152.85 33.53 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.494 -0.754 . . . . 0.0 109.089 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 43' ' ' LEU . 9.1 tt -119.9 128.18 53.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.592 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 8.0 ptt? -148.21 156.32 42.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 109.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -95.89 114.54 26.27 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.18 147.27 41.2 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.589 . . . . 0.0 109.662 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.1 145.33 98.69 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.545 2.163 . . . . 0.0 112.453 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.17 63.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.602 -0.686 . . . . 0.0 109.904 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.419 ' OE2' ' OD1' ' A' ' 56' ' ' ASP . 96.0 mt-10 -71.23 -19.39 62.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 110.254 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -84.72 -12.24 54.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.015 -1.053 . . . . 0.0 110.271 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 53' ' ' ILE . 5.0 pt -106.79 -0.32 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.287 -0.883 . . . . 0.0 109.245 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.11 -1.16 82.59 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.254 -0.974 . . . . 0.0 110.685 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 51' ' ' ILE . 75.3 mt -81.9 132.17 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.823 -1.398 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -85.44 96.99 9.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.553 -0.717 . . . . 0.0 109.858 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.9 -21.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.419 ' OD1' ' OE2' ' A' ' 49' ' ' GLU . 90.0 m-20 54.36 20.02 2.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.683 -0.893 . . . . 0.0 109.466 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -109.5 159.28 17.18 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.557 0.694 . . . . 0.0 110.082 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -84.38 142.26 30.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.648 -0.658 . . . . 0.0 109.662 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.56 159.18 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.494 -0.754 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.23 136.88 40.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.485 -0.759 . . . . 0.0 109.183 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.23 157.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.538 -0.726 . . . . 0.0 110.162 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.431 HD13 ' CE1' ' A' ' 6' ' ' PHE . 31.8 pt -137.0 145.24 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.48 0.657 . . . . 0.0 109.853 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -81.32 142.9 32.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.387 -0.82 . . . . 0.0 109.985 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -132.85 125.22 29.51 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.624 ' N ' HD13 ' A' ' 64' ' ' LEU . 88.1 tttt -82.02 130.33 35.05 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.394 -0.816 . . . . 0.0 110.414 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.69 163.73 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.456 -0.777 . . . . 0.0 109.609 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HG3' HD22 ' A' ' 115' ' ' LEU . 20.1 mt-30 -85.97 154.77 58.23 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 109.824 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.529 ' O ' HG12 ' A' ' 71' ' ' VAL . 75.9 Cg_exo -46.43 -35.0 15.45 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.511 2.141 . . . . 0.0 112.307 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -89.65 -21.72 22.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.171 -0.955 . . . . 0.0 110.157 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.1 mt -94.74 -6.06 43.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.096 -1.002 . . . . 0.0 109.334 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 68' ' ' PRO . 8.6 p -67.5 -41.46 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.339 -0.851 . . . . 0.0 109.544 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.522 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.43 -39.54 97.84 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.7 t -61.2 -47.23 87.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -1.099 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.483 HD12 HD22 ' A' ' 108' ' ' LEU . 3.2 tt -75.02 -42.16 57.91 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.445 -0.784 . . . . 0.0 109.809 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -69.91 -37.64 76.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.67 -0.644 . . . . 0.0 111.217 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -73.63 -3.41 27.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.922 -1.111 . . . . 0.0 109.762 -178.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -83.92 150.75 59.43 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.102 -0.999 . . . . 0.0 109.526 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.58 150.92 75.35 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.65 2.234 . . . . 0.0 113.1 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.96 2.89 79.46 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.0 127.74 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -1.049 . . . . 0.0 109.667 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -121.09 152.56 56.96 Favored Pre-proline 0 N--CA 1.494 1.733 0 CA-C-O 121.239 0.542 . . . . 0.0 109.786 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.423 ' O ' ' OG1' ' A' ' 93' ' ' THR . 43.4 Cg_endo -65.5 154.74 72.34 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.758 2.306 . . . . 0.0 112.322 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' HA ' HG23 ' A' ' 93' ' ' THR . . . -53.2 147.14 10.45 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.379 -0.826 . . . . 0.0 110.464 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 54.9 t80 -85.64 12.86 7.92 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -154.43 -169.54 3.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 0.0 109.811 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.6 mmm -60.41 -176.6 0.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.432 -0.792 . . . . 0.0 110.893 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.7 m120 57.46 35.11 25.52 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.781 0.8 . . . . 0.0 109.186 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -63.13 -42.68 99.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.568 -0.708 . . . . 0.0 109.824 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.89 -44.02 81.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.348 -0.845 . . . . 0.0 110.081 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -70.05 -46.68 64.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 110.425 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -116.67 146.03 43.03 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.547 -0.72 . . . . 0.0 110.246 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.442 HG21 ' CD2' ' A' ' 74' ' ' LEU . 9.4 mm -130.16 146.25 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.426 HG23 ' HA ' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -91.36 137.78 32.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.755 . . . . 0.0 109.249 -179.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.7 t -118.05 133.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 tp -84.25 103.74 13.7 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.517 0.675 . . . . 0.0 110.122 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.04 -39.92 87.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.525 -0.734 . . . . 0.0 109.172 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -68.82 -4.8 17.58 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -76.44 -166.34 22.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -79.48 -3.14 12.78 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 123.106 2.538 . . . . 0.0 111.399 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.4 mm? -55.2 125.78 22.06 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.908 0.861 . . . . 0.0 109.912 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.61 161.34 35.12 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.91 95.92 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.642 -0.916 . . . . 0.0 109.173 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mtmm -64.42 -41.96 96.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 109.201 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.56 -43.58 89.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.402 -0.811 . . . . 0.0 109.21 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.22 -43.29 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 109.198 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -58.77 -41.64 87.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.828 . . . . 0.0 109.38 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.6 m -61.19 -43.38 98.98 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 109.229 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.483 HD22 HD12 ' A' ' 74' ' ' LEU . 91.8 mt -64.47 -41.66 96.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 109.592 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.73 -42.97 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.121 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -59.47 -39.41 83.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.383 -0.823 . . . . 0.0 108.989 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -65.19 -37.83 88.56 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.3 t -61.51 -42.12 98.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.845 . . . . 0.0 109.179 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 117' ' ' ARG . 77.4 t80 -61.13 -44.24 97.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.07 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.62 -43.28 99.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 108.83 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.436 HD22 ' HG3' ' A' ' 67' ' ' GLN . 91.4 mt -64.78 -39.98 94.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.561 -0.712 . . . . 0.0 109.372 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.1 p -99.14 14.97 27.47 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 113' ' ' PHE . 9.1 ptm180 . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 121.796 0.808 . . . . 0.0 111.414 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.492 ' O ' ' NH2' ' A' ' 3' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.92 163.94 12.15 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.822 0.82 . . . . 0.0 110.24 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 1' ' ' MET . 13.8 mmp_? -59.91 -47.91 83.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.574 -0.704 . . . . 0.0 109.522 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -43.42 -43.15 5.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.558 -0.714 . . . . 0.0 109.962 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.03 -44.91 83.31 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 109.217 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -62.89 -46.03 89.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.35 -0.843 . . . . 0.0 109.635 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.7 mm -64.34 -45.0 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.361 -0.837 . . . . 0.0 109.722 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.08 -41.71 99.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.322 -0.862 . . . . 0.0 110.075 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.458 ' CE1' HG21 ' A' ' 109' ' ' ILE . 33.9 t80 -60.81 -44.56 96.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.531 -0.731 . . . . 0.0 109.988 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.41 84.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.485 -0.759 . . . . 0.0 110.117 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 15' ' ' ASP . 94.9 mt-30 -67.51 -35.92 80.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.844 -1.16 . . . . 0.0 109.603 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -64.9 -43.36 93.12 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.689 -1.257 . . . . 0.0 109.657 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -88.25 -11.84 45.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.378 -0.826 . . . . 0.0 111.346 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.606 ' CE1' ' NE2' ' A' ' 33' ' ' HIS . 91.4 m-85 -139.98 -20.34 0.89 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.837 -1.164 . . . . 0.0 111.139 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 11' ' ' GLN . 72.1 m-20 53.64 30.16 10.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.049 -1.032 . . . . 0.0 109.475 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -103.2 156.21 17.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.353 -0.842 . . . . 0.0 109.33 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -97.37 139.76 21.63 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.342 -0.849 . . . . 0.0 109.615 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -50.34 142.28 29.86 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.825 1.684 . . . . 0.0 112.906 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -125.97 121.68 33.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -89.55 146.44 35.75 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.184 -0.947 . . . . 0.0 109.867 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.32 -81.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.161 1.908 . . . . 0.0 111.561 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -87.2 137.03 32.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.448 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -61.51 -20.1 62.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.392 -0.817 . . . . 0.0 109.733 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -76.7 -5.19 46.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.0 109.629 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -129.8 70.12 81.87 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.469 -0.77 . . . . 0.0 109.286 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.92 -18.14 46.64 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.368 2.045 . . . . 0.0 112.015 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -79.78 -5.05 54.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.62 140.87 29.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.362 -0.836 . . . . 0.0 109.527 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.05 130.78 43.7 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.659 -0.65 . . . . 0.0 109.309 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 78.5 t -128.09 131.44 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -103.17 147.88 26.47 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.539 -0.726 . . . . 0.0 109.574 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -134.24 139.88 46.07 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.48 -0.762 . . . . 0.0 109.749 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.606 ' NE2' ' CE1' ' A' ' 14' ' ' TYR . 30.5 m170 -100.21 131.49 46.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.626 -0.671 . . . . 0.0 109.337 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -87.18 -32.11 19.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 0.0 110.59 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 31.4 p-10 -92.02 -1.6 57.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.092 -1.005 . . . . 0.0 111.491 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' LYS . 14.7 t-20 -118.66 29.1 7.92 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.027 -1.046 . . . . 0.0 110.16 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.412 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 98.7 m-20 37.23 -86.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.425 0.631 . . . . 0.0 111.215 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 17.9 ptpt -77.53 157.58 30.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.501 -0.749 . . . . 0.0 110.325 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.432 ' CE3' ' O ' ' A' ' 39' ' ' TRP . 12.0 p-90 -177.44 153.13 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.534 -0.729 . . . . 0.0 109.421 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -149.17 118.8 6.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.58 124.53 5.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -150.91 143.02 24.08 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.75 -1.219 . . . . 0.0 110.235 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.498 HD21 ' OD1' ' A' ' 60' ' ' ASP . 9.5 tt -121.03 125.45 47.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -156.99 162.11 39.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.04 114.89 26.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.582 -0.699 . . . . 0.0 109.157 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.7 pt -121.19 145.5 42.19 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.515 -0.741 . . . . 0.0 109.45 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -45.34 135.86 11.67 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.903 1.735 . . . . 0.0 112.787 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.25 -25.64 65.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.589 -0.695 . . . . 0.0 110.162 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -17.7 63.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.296 -0.877 . . . . 0.0 110.346 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -84.64 -12.84 53.15 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.971 -1.08 . . . . 0.0 110.991 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 pt -102.67 6.35 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.188 -0.945 . . . . 0.0 109.465 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.03 -4.61 67.98 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.682 HD11 ' CZ ' ' A' ' 81' ' ' TYR . 77.2 mt -79.7 135.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.886 -1.361 . . . . 0.0 109.882 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -74.42 92.36 2.32 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.568 -0.707 . . . . 0.0 110.083 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.2 139.63 3.23 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 37.5 p-10 -88.99 4.55 47.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 108.394 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -80.62 152.94 28.27 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.642 -0.661 . . . . 0.0 110.023 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -97.6 150.01 21.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.563 -0.711 . . . . 0.0 109.814 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.33 163.05 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.715 -0.616 . . . . 0.0 109.642 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.498 ' OD1' HD21 ' A' ' 43' ' ' LEU . 8.3 t70 -91.57 128.81 37.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.583 -0.698 . . . . 0.0 109.39 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.83 160.18 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.0 110.348 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.15 150.97 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -84.96 127.27 34.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.466 -0.771 . . . . 0.0 109.975 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.584 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -118.99 121.31 39.61 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.584 ' N ' HD13 ' A' ' 64' ' ' LEU . 37.4 ttmt -82.93 132.2 35.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.855 . . . . 0.0 110.159 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 m -142.5 165.08 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.347 -0.846 . . . . 0.0 108.879 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.496 HE21 HD12 ' A' ' 70' ' ' LEU . 6.5 mt-30 -84.71 156.9 61.4 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 108.725 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 71' ' ' VAL . 20.3 Cg_endo -60.66 -22.84 74.26 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.382 2.055 . . . . 0.0 111.405 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -90.48 -29.64 17.81 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.441 -0.787 . . . . 0.0 109.352 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.496 HD12 HE21 ' A' ' 67' ' ' GLN . 80.9 mt -95.2 1.93 54.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.326 -0.859 . . . . 0.0 109.763 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 68' ' ' PRO . 10.0 p -64.33 -34.47 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.0 109.52 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.56 -14.59 67.33 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.453 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 55.9 p -68.27 -60.56 2.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -1.163 . . . . 0.0 111.101 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.629 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.7 pt? -88.24 -23.9 23.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.796 -1.19 . . . . 0.0 110.934 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.445 HH21 ' NZ ' ' A' ' 88' ' ' LYS . 78.9 ttt-85 -65.76 -22.8 66.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 110.097 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.453 ' CD ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -94.28 -9.34 36.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.205 -0.934 . . . . 0.0 108.833 179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -73.81 151.28 88.81 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.097 -1.002 . . . . 0.0 109.357 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.09 143.34 71.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.612 2.208 . . . . 0.0 112.53 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.15 -5.26 63.54 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.9 mm -98.41 125.18 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -1.157 . . . . 0.0 109.174 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.682 ' CZ ' HD11 ' A' ' 53' ' ' ILE . 77.3 m-85 -119.87 147.91 45.29 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.733 -0.604 . . . . 0.0 109.598 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HB3' ' HZ1' ' A' ' 88' ' ' LYS . 52.0 Cg_endo -69.95 153.68 67.8 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.054 1.836 . . . . 0.0 111.837 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.68 50.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 109.834 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 85' ' ' HIS . 32.1 p90 -66.2 179.31 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.261 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.509 ' O ' ' CG ' ' A' ' 85' ' ' HIS . 54.5 p-80 -40.85 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.471 0.653 . . . . 0.0 110.545 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.1 ttm -167.67 -78.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.526 -0.734 . . . . 0.0 109.193 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.622 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 98.9 m-20 -139.92 -31.84 0.64 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.445 ' NZ ' HH21 ' A' ' 75' ' ' ARG . 49.9 tttp 58.77 -68.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.238 0.542 . . . . 0.0 111.417 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 87' ' ' ASN . 74.2 mt-10 -60.92 -52.21 66.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.868 . . . . 0.0 112.001 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -66.54 -46.77 75.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.935 -1.103 . . . . 0.0 111.251 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.622 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 8.9 m0 -115.51 140.99 48.66 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.439 -0.788 . . . . 0.0 110.317 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mm -128.87 138.41 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 p -86.84 133.35 33.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.876 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.9 t -112.91 132.58 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.3 tp -87.02 104.07 15.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.518 0.675 . . . . 0.0 110.488 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.64 -39.75 84.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.567 -0.708 . . . . 0.0 109.482 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.87 1.78 6.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.529 -0.732 . . . . 0.0 109.386 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.83 -162.47 30.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.44 -3.39 11.4 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.892 2.394 . . . . 0.0 111.242 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -49.6 126.63 13.99 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.618 0.723 . . . . 0.0 110.0 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.21 169.29 34.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.84 94.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -1.133 . . . . 0.0 109.232 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -64.85 -42.02 95.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.692 . . . . 0.0 109.612 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.74 -42.69 94.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.28 -43.3 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -56.94 -43.84 81.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.387 -0.82 . . . . 0.0 109.564 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.3 m -61.16 -43.99 98.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.897 . . . . 0.0 109.654 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.87 -42.46 97.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.201 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.458 HG21 ' CE1' ' A' ' 9' ' ' TYR . 97.0 mt -63.8 -42.78 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 108.652 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -53.07 -40.9 64.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.475 -0.766 . . . . 0.0 108.936 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.64 -39.61 94.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 108.702 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 t -65.02 -40.34 94.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.836 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -57.99 -48.97 78.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.417 -0.802 . . . . 0.0 110.076 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -67.75 -32.12 72.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.087 -1.008 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.476 HD21 ' HG3' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -61.88 -41.12 97.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.7 p -90.78 14.93 12.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.49 -0.756 . . . . 0.0 109.395 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 . . . . . 0 N--CA 1.494 1.766 0 O-C-N 121.467 -0.771 . . . . 0.0 110.319 -179.533 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -104.56 156.23 18.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.458 -0.776 . . . . 0.0 110.001 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.493 ' NH1' ' OD2' ' A' ' 45' ' ' ASP . 61.6 ttp180 -61.29 -42.9 99.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.54 -0.725 . . . . 0.0 109.336 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -63.56 -39.77 95.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.368 -0.832 . . . . 0.0 109.773 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.526 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -62.75 -42.44 99.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.013 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.404 ' CD1' HD12 ' A' ' 43' ' ' LEU . 60.2 t80 -61.08 -45.55 94.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.526 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.35 -44.51 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.487 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.12 -45.79 90.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.185 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -62.61 -43.19 99.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.782 . . . . 0.0 109.258 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.94 97.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.414 -0.803 . . . . 0.0 110.002 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 81.0 mt-30 -65.65 -45.0 84.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 110.123 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.37 -35.8 80.27 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.09 -1.006 . . . . 0.0 109.514 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -85.07 -37.24 20.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.398 -0.814 . . . . 0.0 111.686 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.543 ' CZ ' ' CE2' ' A' ' 39' ' ' TRP . 93.2 m-85 -114.55 6.63 15.88 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.015 -1.053 . . . . 0.0 111.698 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 2.4 p-10 39.04 29.12 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.162 -0.961 . . . . 0.0 110.434 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 14' ' ' TYR . 33.0 m -109.94 126.17 53.61 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 109.147 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 157.68 63.21 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.0 109.221 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.59 135.74 33.79 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.842 1.695 . . . . 0.0 112.316 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.433 ' C ' ' CD2' ' A' ' 20' ' ' HIS . 97.1 m-20 -118.27 140.22 50.14 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 20' ' ' HIS . 2.1 m-70 -136.99 85.43 22.76 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.365 -0.834 . . . . 0.0 109.165 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -54.83 -40.31 85.75 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.241 1.961 . . . . 0.0 111.626 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -91.92 130.7 37.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.677 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -84.44 -17.13 40.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.468 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -81.78 -5.16 57.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 109.391 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -128.81 62.04 59.18 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.57 -0.706 . . . . 0.0 109.405 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.93 -19.38 52.29 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.348 2.032 . . . . 0.0 111.828 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.35 -5.11 57.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.116 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.475 ' O ' ' ND1' ' A' ' 20' ' ' HIS . 21.8 m-85 -99.27 134.01 42.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.472 -0.768 . . . . 0.0 109.602 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.72 132.94 54.9 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.61 127.46 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -112.77 122.78 48.67 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.367 0.603 . . . . 0.0 109.862 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -151.57 143.98 24.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 109.106 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.82 124.11 42.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.266 -0.896 . . . . 0.0 109.769 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -80.0 -12.08 59.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.516 -0.74 . . . . 0.0 109.811 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -62.88 -45.23 93.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.095 -1.003 . . . . 0.0 110.528 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 54.3 p30 -123.6 -13.15 7.58 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.29 -0.881 . . . . 0.0 109.919 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 36' ' ' ASN . 45.8 t0 59.24 5.05 0.53 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.446 -0.784 . . . . 0.0 109.799 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 36' ' ' ASN . 28.6 mmtp -94.21 -8.95 37.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.055 -1.028 . . . . 0.0 109.086 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.543 ' CE2' ' CZ ' ' A' ' 14' ' ' TYR . 63.0 t-105 -90.35 108.36 19.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.461 -0.775 . . . . 0.0 109.298 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -107.88 128.62 54.78 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.554 -0.716 . . . . 0.0 109.171 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.33 123.92 8.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.495 -0.753 . . . . 0.0 108.98 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.8 tp -124.34 130.36 52.35 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.64 -0.663 . . . . 0.0 109.274 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.502 HD23 ' C ' ' A' ' 43' ' ' LEU . 9.4 tt -126.82 128.38 46.47 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.412 ' N ' HD23 ' A' ' 43' ' ' LEU . 6.2 ptt? -160.39 162.78 33.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 110.025 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.493 ' OD2' ' NH1' ' A' ' 3' ' ' ARG . 99.3 m-20 -100.28 117.37 34.35 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.7 pt -134.44 145.57 55.75 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.85 151.32 85.7 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.538 2.158 . . . . 0.0 112.917 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.82 64.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.593 -0.692 . . . . 0.0 109.761 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -66.22 -17.94 65.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.121 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -84.28 -14.67 49.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.064 -1.023 . . . . 0.0 111.253 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.64 10.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.174 -0.954 . . . . 0.0 109.885 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.34 -9.26 72.08 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.105 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.5 mt -79.96 135.12 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.802 -1.41 . . . . 0.0 109.722 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -74.61 95.67 2.85 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.14 133.52 1.75 Allowed Glycine 0 N--CA 1.482 1.717 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -91.1 11.72 22.23 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -64.96 157.63 27.64 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.1 mtp85 -100.35 135.98 40.95 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.3 m -137.55 157.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.695 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 96.6 m-20 -99.07 140.3 33.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.95 151.01 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.399 -0.813 . . . . 0.0 110.109 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 pt -131.32 161.07 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 66.8 t0 -133.73 140.76 47.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.236 -0.915 . . . . 0.0 109.732 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.519 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -132.9 159.19 40.62 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.444 0.64 . . . . 0.0 109.336 -179.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -88.36 138.93 31.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.491 -0.755 . . . . 0.0 110.629 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.1 161.92 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.56 -0.712 . . . . 0.0 109.298 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HG3' HD22 ' A' ' 115' ' ' LEU . 7.1 mt-30 -80.72 157.96 71.38 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.411 -0.805 . . . . 0.0 109.344 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.492 ' O ' HG12 ' A' ' 71' ' ' VAL . 29.3 Cg_endo -61.92 -23.85 76.35 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.532 2.155 . . . . 0.0 111.592 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -88.88 -30.81 18.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.279 -0.888 . . . . 0.0 109.574 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.5 mt -93.13 -0.16 57.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -0.84 . . . . 0.0 109.415 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 68' ' ' PRO . 11.3 p -63.95 -31.54 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.464 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.51 -15.44 78.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 p -69.01 -54.32 15.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 110.527 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.701 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.2 pt? -85.38 -28.04 25.43 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.0 -1.062 . . . . 0.0 110.499 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.3 ttt-85 -69.51 -21.96 63.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.192 -0.942 . . . . 0.0 110.585 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.25 -7.94 52.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.939 -1.101 . . . . 0.0 109.502 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -82.22 150.26 63.96 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.894 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.05 144.32 63.29 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.549 2.166 . . . . 0.0 112.293 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.78 -16.36 54.81 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.72 ' N ' HD12 ' A' ' 80' ' ' ILE . 2.0 mp -90.16 127.14 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.044 -1.268 . . . . 0.0 108.905 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -115.55 126.16 28.03 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.394 -0.816 . . . . 0.0 110.212 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -52.28 146.51 31.47 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.41 1.406 . . . . 0.0 111.79 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.24 140.26 57.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.375 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -98.03 1.45 47.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.384 -0.823 . . . . 0.0 108.933 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -65.77 -176.91 0.41 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.458 -0.776 . . . . 0.0 110.374 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 74.4 mtm -64.29 -41.17 97.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.531 -0.731 . . . . 0.0 109.938 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -97.62 138.02 35.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.263 -0.898 . . . . 0.0 109.784 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -141.32 70.27 1.34 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.409 -0.807 . . . . 0.0 109.342 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -143.83 -54.29 0.36 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.46 -0.775 . . . . 0.0 109.07 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -99.31 -15.68 18.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -108.26 122.41 46.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.368 -0.833 . . . . 0.0 110.011 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.7 mm -125.9 137.04 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.5 m -95.01 144.22 25.86 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -120.59 136.67 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.1 tp -87.22 113.63 23.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.975 . . . . 0.0 110.276 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 98' ' ' GLY . 12.8 mt -64.62 -40.72 95.97 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.695 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 58.8 m-80 -70.78 4.29 2.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.416 -0.802 . . . . 0.0 109.063 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -68.06 171.99 34.44 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.96 -4.97 15.5 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 123.445 2.763 . . . . 0.0 112.327 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.487 HD23 ' H ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -72.14 150.06 44.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.144 -179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.09 171.53 42.62 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 120.489 -0.863 . . . . 0.0 111.04 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.42 83.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.95 . . . . 0.0 109.715 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.9 pttm -61.11 -36.32 79.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.219 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -65.87 -38.84 89.86 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.415 -0.803 . . . . 0.0 109.126 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.92 -44.18 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -58.94 -42.54 90.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.388 -0.82 . . . . 0.0 109.786 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.7 m -60.71 -45.09 95.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 110.172 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.78 -44.1 94.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.752 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.03 -43.12 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.501 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -51.9 -42.06 62.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 108.875 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.37 -43.92 97.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.226 -0.921 . . . . 0.0 109.061 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 t -63.67 -41.76 98.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.0 110.69 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -58.96 -45.3 90.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.257 -0.902 . . . . 0.0 110.893 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -60.8 -38.83 86.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.028 -1.045 . . . . 0.0 110.418 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.433 HD22 ' HG3' ' A' ' 67' ' ' GLN . 96.7 mt -63.01 -40.71 98.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.695 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.4 p -93.78 14.32 19.67 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.437 -0.789 . . . . 0.0 109.693 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.7 ttm . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.509 0.671 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -93.48 166.05 12.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.361 -0.837 . . . . 0.0 110.727 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -63.22 -42.76 99.31 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.348 0.594 . . . . 0.0 109.76 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -65.48 -39.45 91.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.3 -0.875 . . . . 0.0 109.673 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.02 -38.75 92.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.327 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.75 -45.53 93.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -0.815 . . . . 0.0 109.439 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.59 -43.77 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.409 -0.807 . . . . 0.0 109.412 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.14 -41.61 97.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.446 -0.784 . . . . 0.0 109.794 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -62.2 -42.66 99.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.415 -0.803 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.38 82.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.432 -0.793 . . . . 0.0 109.719 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 15' ' ' ASP . 25.9 mt-30 -63.45 -48.42 77.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.062 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -64.48 -37.45 87.59 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.721 -1.237 . . . . 0.0 109.466 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -68.79 -46.3 69.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.522 -0.736 . . . . 0.0 111.942 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.17 -20.43 4.13 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.0 110.677 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 25.4 t0 65.31 42.1 4.07 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.266 -0.896 . . . . 0.0 108.855 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.7 m -104.19 133.35 49.27 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.609 0.718 . . . . 0.0 109.595 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -83.75 151.4 61.23 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.725 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.21 153.55 71.3 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.818 2.345 . . . . 0.0 112.533 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 61.6 t0 -140.76 138.92 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 108.96 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.467 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 13.7 p-80 -132.64 86.94 42.99 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.505 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -54.54 -37.92 90.28 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.502 2.135 . . . . 0.0 110.653 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -87.51 82.06 7.59 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -55.2 -14.45 1.71 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -65.18 -2.33 2.84 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.503 -0.748 . . . . 0.0 109.073 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -147.95 76.15 10.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.394 -0.817 . . . . 0.0 109.325 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.08 -19.22 65.61 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.635 2.224 . . . . 0.0 110.764 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 12.5 p-10 -81.19 -2.48 48.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -100.38 139.48 36.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.435 -0.791 . . . . 0.0 109.255 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.0 128.17 45.94 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -113.66 124.51 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.657 -0.652 . . . . 0.0 109.561 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.88 136.5 51.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.688 -0.632 . . . . 0.0 109.295 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -157.18 139.37 14.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -101.0 126.65 47.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.528 -0.733 . . . . 0.0 109.635 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 m -80.79 -10.62 59.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.473 -0.767 . . . . 0.0 109.168 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -64.03 -40.84 97.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.396 -0.815 . . . . 0.0 109.95 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 38' ' ' LYS . 2.1 m120 -113.16 -24.6 9.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.324 -0.86 . . . . 0.0 109.252 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.8 t0 63.36 -8.88 0.13 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.589 -0.694 . . . . 0.0 109.855 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 36' ' ' ASN . 64.5 mttp -97.64 -6.29 33.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.205 -0.934 . . . . 0.0 108.863 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.501 ' CE3' HG21 ' A' ' 116' ' ' THR . 15.0 t-105 -84.82 109.88 18.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 109.683 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -109.3 125.92 52.82 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB2' ' HE1' ' A' ' 39' ' ' TRP . . . -138.82 136.72 35.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.5 tp -145.1 122.95 11.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.4 tt -120.23 124.48 45.78 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.558 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.68 164.76 26.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 0.0 109.689 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 88.9 m-20 -96.42 114.05 25.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.565 -0.71 . . . . 0.0 109.721 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.469 HG23 ' SD ' ' A' ' 44' ' ' MET . 16.2 pt -116.83 144.99 34.48 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -48.78 141.38 21.19 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.985 1.79 . . . . 0.0 112.421 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -63.08 -21.09 65.94 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.382 0.61 . . . . 0.0 109.972 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.29 -13.99 59.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.123 -0.986 . . . . 0.0 109.608 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -84.32 -10.85 57.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.412 ' CD1' HD12 ' A' ' 53' ' ' ILE . 11.3 pt -103.19 1.73 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.301 -0.874 . . . . 0.0 109.345 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.43 -14.39 59.43 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.565 ' C ' ' H ' ' A' ' 55' ' ' GLY . 76.4 mt -78.55 130.55 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.956 -1.32 . . . . 0.0 109.498 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -63.28 14.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.585 -0.697 . . . . 0.0 110.539 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -86.11 140.78 17.96 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -101.27 5.77 42.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.503 -0.998 . . . . 0.0 109.628 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 88.4 tttt -88.44 144.81 26.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -71.73 145.8 48.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.63 -0.669 . . . . 0.0 110.359 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.46 157.46 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.528 -0.732 . . . . 0.0 109.633 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 12.9 m-20 -93.81 131.63 39.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.495 -0.753 . . . . 0.0 109.355 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.95 156.89 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.42 -0.8 . . . . 0.0 110.292 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 pt -134.96 149.88 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.474 0.654 . . . . 0.0 109.739 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -81.68 146.64 29.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.11 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.657 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -132.95 127.08 33.46 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.657 ' N ' HD13 ' A' ' 64' ' ' LEU . 63.1 tttp -82.21 131.69 35.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.556 -0.715 . . . . 0.0 110.147 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.37 161.32 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 109.677 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -85.62 158.71 56.64 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 71' ' ' VAL . 19.2 Cg_endo -59.87 -19.79 56.44 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.61 2.207 . . . . 0.0 111.544 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -95.88 -28.24 14.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.346 -0.846 . . . . 0.0 109.116 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.04 -2.56 56.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.415 -0.803 . . . . 0.0 109.493 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 72' ' ' GLY . 7.1 p -63.7 -41.08 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.946 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.475 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.12 -40.66 99.44 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.7 m -62.13 -36.03 80.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.208 -1.172 . . . . 0.0 110.419 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.526 ' CD2' HG21 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -77.98 -39.07 43.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.079 . . . . 0.0 111.011 -179.254 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.575 HH21 ' CD1' ' A' ' 92' ' ' ILE . 95.9 mtt180 -76.71 -6.54 52.57 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.069 -1.019 . . . . 0.0 110.125 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -11.41 58.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.084 -1.01 . . . . 0.0 109.171 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -90.83 148.07 37.46 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 109.266 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' HD21 ' A' ' 100' ' ' LEU . 56.2 Cg_endo -69.07 144.73 58.74 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.716 2.278 . . . . 0.0 113.09 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.15 -5.0 85.92 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.81 122.87 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -1.109 . . . . 0.0 109.782 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -124.6 145.52 49.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.26 150.08 81.45 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.454 2.103 . . . . 0.0 112.387 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.1 138.88 58.06 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.708 0.766 . . . . 0.0 110.257 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 13.0 p90 -95.32 1.02 54.27 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 86' ' ' MET . 8.9 m170 -148.47 159.36 44.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.112 -0.993 . . . . 0.0 110.793 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.443 ' O ' ' O ' ' A' ' 87' ' ' ASN . 79.5 mtp 48.61 105.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.892 0.853 . . . . 0.0 111.023 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 86' ' ' MET . 99.2 m-20 44.01 -171.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.642 0.734 . . . . 0.0 110.751 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -144.92 -57.78 0.35 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.49 -0.756 . . . . 0.0 109.308 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.0 -37.75 84.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.212 -0.93 . . . . 0.0 109.125 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -57.01 -67.13 0.34 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.44 -0.788 . . . . 0.0 109.801 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -105.04 144.53 31.71 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.525 0.679 . . . . 0.0 110.094 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.575 ' CD1' HH21 ' A' ' 75' ' ' ARG . 7.1 mm -130.54 144.07 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.8 m -87.48 131.18 34.43 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.394 -0.816 . . . . 0.0 109.82 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.1 t -118.52 132.39 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.5 tp -87.9 101.98 14.26 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.622 0.725 . . . . 0.0 110.24 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 98' ' ' GLY . 84.1 mt -66.04 -40.39 90.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -71.96 5.49 2.63 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -84.63 -166.33 41.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.8 7.86 4.34 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.023 2.482 . . . . 0.0 111.611 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.3 mm? -62.24 130.55 45.9 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.973 0.892 . . . . 0.0 110.578 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.5 158.43 31.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.463 ' O ' ' ND1' ' A' ' 106' ' ' HIS . . . -60.16 -47.02 87.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.695 -0.885 . . . . 0.0 109.552 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -65.18 -40.52 94.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.511 -0.743 . . . . 0.0 109.447 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.0 -44.89 96.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.509 -0.744 . . . . 0.0 109.522 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.43 -43.32 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.554 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 102' ' ' ALA . 31.8 m80 -58.74 -42.62 89.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.368 -0.833 . . . . 0.0 109.888 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.9 m -61.43 -43.6 98.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.54 -40.7 96.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.454 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.92 -43.2 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.215 -0.928 . . . . 0.0 109.337 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -60.48 -37.8 82.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.66 -42.04 99.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.493 -0.754 . . . . 0.0 108.987 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 116' ' ' THR . 96.6 p -62.61 -36.24 82.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.363 -0.836 . . . . 0.0 109.155 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.69 -45.21 95.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.385 -0.822 . . . . 0.0 109.594 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -65.65 -27.63 68.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.009 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.2 mt -82.37 -13.15 57.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.536 -0.727 . . . . 0.0 109.317 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 112' ' ' SER . 79.4 p -110.64 14.66 22.32 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.863 0.84 . . . . 0.0 110.308 -179.322 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.6 ttp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.155 0.503 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -94.96 155.64 16.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.176 -0.952 . . . . 0.0 110.373 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.512 ' NH2' ' OD1' ' A' ' 45' ' ' ASP . 40.8 ttm180 -62.09 -42.63 99.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.549 -0.719 . . . . 0.0 109.546 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -53.99 -42.32 68.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 109.817 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.65 -35.54 80.4 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.129 -0.982 . . . . 0.0 109.49 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -60.89 -44.65 96.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.123 -0.985 . . . . 0.0 109.161 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.9 mm -64.0 -44.66 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.288 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.15 -41.13 99.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.519 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -60.32 -49.86 75.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.3 -35.25 75.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 17.4 tt0 -59.34 -49.91 76.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.385 -0.822 . . . . 0.0 110.28 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -64.26 -40.21 95.51 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.637 -1.289 . . . . 0.0 109.465 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -68.34 -44.29 75.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 112.259 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 113' ' ' PHE . 97.0 m-85 -127.64 -18.49 4.34 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.993 -1.067 . . . . 0.0 110.902 -178.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 24.9 t0 63.68 45.81 4.39 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.0 . . . . 0.0 109.084 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.0 m -113.72 127.9 56.21 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -83.95 155.19 64.51 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.12 -0.987 . . . . 0.0 109.759 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.55 140.54 64.79 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.77 1.647 . . . . 0.0 112.607 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -116.28 121.31 41.63 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 20' ' ' HIS . 11.8 m-70 -114.87 85.32 11.61 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.499 -0.751 . . . . 0.0 109.19 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.43 -12.82 16.91 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.928 1.752 . . . . 0.0 110.878 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -100.7 93.97 5.85 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -63.34 -17.57 62.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 0.0 109.848 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -83.87 -3.07 57.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.681 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -143.43 69.35 17.5 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.128 -0.983 . . . . 0.0 109.792 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.98 -29.53 89.55 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.55 2.167 . . . . 0.0 111.191 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.91 -6.94 45.53 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.429 -0.795 . . . . 0.0 109.366 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -102.72 135.41 44.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.457 -0.777 . . . . 0.0 109.13 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -123.35 146.78 47.67 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.6 t -125.62 130.49 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.559 -0.713 . . . . 0.0 109.209 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.48 112.03 22.91 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.69 -0.631 . . . . 0.0 109.319 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -134.24 138.45 45.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.306 -0.871 . . . . 0.0 108.665 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.594 ' ND1' ' CD1' ' A' ' 39' ' ' TRP . 35.9 m170 -100.87 118.2 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -0.852 . . . . 0.0 109.765 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.1 m -63.28 -36.73 84.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.351 -0.843 . . . . 0.0 109.342 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.03 -43.42 98.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 110.134 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 38' ' ' LYS . 15.9 m120 -91.99 5.45 50.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.067 -1.021 . . . . 0.0 108.882 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' LYS . 66.9 t0 51.25 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.778 -0.576 . . . . 0.0 110.712 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' ASN . 60.3 mttp -55.88 -110.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 110.582 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.594 ' CD1' ' ND1' ' A' ' 33' ' ' HIS . 48.5 t-105 40.8 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.756 -0.59 . . . . 0.0 109.831 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -107.97 125.77 51.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.459 -0.776 . . . . 0.0 109.325 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.89 128.25 10.61 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.95 146.0 40.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 109.388 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 tt -116.84 128.26 55.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -152.08 163.17 39.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.994 . . . . 0.0 109.392 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.512 ' OD1' ' NH2' ' A' ' 3' ' ' ARG . 98.5 m-20 -98.89 136.56 38.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -0.795 . . . . 0.0 108.858 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -139.95 145.73 43.68 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.208 -0.932 . . . . 0.0 109.767 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.17 135.73 30.65 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.844 1.696 . . . . 0.0 113.089 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 57' ' ' LYS . . . -65.83 -29.52 70.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 109.902 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 55' ' ' GLY . 15.7 pt-20 -55.57 -29.89 59.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.076 -1.015 . . . . 0.0 110.22 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -63.79 -34.94 79.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.977 -1.077 . . . . 0.0 110.322 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 53' ' ' ILE . 4.6 pt -96.41 -1.55 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.16 -0.963 . . . . 0.0 109.708 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.96 34.75 32.92 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.874 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 51' ' ' ILE . 35.0 mt -110.16 136.51 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.349 -1.089 . . . . 0.0 110.059 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.401 ' C ' ' OD1' ' A' ' 54' ' ' ASN . 49.1 t-20 43.03 -89.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.396 0.617 . . . . 0.0 110.252 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . -158.73 -110.87 0.29 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -108.76 47.82 0.89 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.628 -0.925 . . . . 0.0 109.517 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 88.1 tttt -91.8 129.67 37.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.224 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -71.87 136.4 46.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.58 164.22 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.346 -0.846 . . . . 0.0 109.233 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.696 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 83.4 m-20 -92.01 134.34 34.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.189 -0.945 . . . . 0.0 110.04 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -137.02 158.93 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.234 -0.916 . . . . 0.0 109.69 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.3 pt -135.04 146.74 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -110.59 140.15 45.17 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.553 -0.717 . . . . 0.0 109.621 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.27 164.28 28.45 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 132.08 52.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.483 -0.761 . . . . 0.0 109.877 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.22 162.78 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.342 -0.848 . . . . 0.0 110.144 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -72.03 133.96 83.51 Favored Pre-proline 0 C--N 1.298 -1.643 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.46 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.607 ' O ' HG12 ' A' ' 71' ' ' VAL . 71.1 Cg_exo -44.69 -38.18 12.27 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.962 1.775 . . . . 0.0 112.302 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.43 -32.21 66.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.054 -1.029 . . . . 0.0 110.442 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.7 mt -92.1 5.02 51.86 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.085 -1.01 . . . . 0.0 110.111 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 68' ' ' PRO . 12.7 p -61.47 -28.21 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.047 -1.033 . . . . 0.0 109.015 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.461 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -58.46 -39.46 93.0 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -59.5 -41.11 89.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.15 -1.206 . . . . 0.0 109.668 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 2.5 mm? -68.99 -44.9 71.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 110.781 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -78.2 -36.92 46.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.0 111.299 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.461 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -72.98 -1.72 18.2 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.066 -1.053 . . . . 0.0 109.654 -178.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.403 ' CB ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -96.49 139.99 21.96 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 109.157 179.47 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.99 143.69 45.56 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.124 1.883 . . . . 0.0 112.969 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.09 -17.42 56.98 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 80' ' ' ILE . 3.7 mp -93.92 127.44 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -1.178 . . . . 0.0 109.401 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -114.35 133.55 22.43 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.699 -0.625 . . . . 0.0 110.133 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -54.32 149.26 38.11 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.278 1.319 . . . . 0.0 111.352 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.23 143.42 55.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.832 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -92.45 21.96 4.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 109.404 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' MET . 7.5 p80 -148.0 167.89 23.73 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.017 -1.052 . . . . 0.0 110.409 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' HIS . 65.5 mtt -43.68 173.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.539 0.685 . . . . 0.0 111.497 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 57.83 34.12 24.01 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.618 0.723 . . . . 0.0 109.459 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.7 -43.0 99.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.458 -0.776 . . . . 0.0 109.832 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.05 -44.52 84.34 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.102 -0.999 . . . . 0.0 109.858 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -68.78 -46.7 68.05 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.114 -0.991 . . . . 0.0 110.857 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -115.7 145.78 42.45 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.419 -0.801 . . . . 0.0 110.291 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.502 HD11 HG23 ' A' ' 71' ' ' VAL . 8.0 mm -130.61 152.32 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.9 m -101.92 135.49 43.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.406 -0.809 . . . . 0.0 109.508 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.37 136.41 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 63.2 tp -90.66 116.26 28.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 110.085 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 mt -65.96 -40.22 91.12 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.696 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 65.3 m-80 -72.28 3.58 4.52 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -56.56 164.94 5.22 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.74 -8.5 18.07 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.109 2.539 . . . . 0.0 111.576 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -75.93 162.29 28.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.217 -0.927 . . . . 0.0 110.66 -178.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.58 163.59 50.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.47 80.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.509 -0.995 . . . . 0.0 109.089 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.11 -39.55 92.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -0.858 . . . . 0.0 109.419 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -62.48 -42.12 99.27 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.114 -0.991 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.58 -43.89 96.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.213 -0.93 . . . . 0.0 109.354 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -66.03 -38.51 88.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.297 -0.877 . . . . 0.0 109.577 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.7 m -59.48 -44.57 93.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.116 -0.99 . . . . 0.0 109.809 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.37 -42.13 96.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 109.261 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.61 -42.94 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.061 -1.024 . . . . 0.0 109.058 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -53.09 -40.63 64.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.225 -0.922 . . . . 0.0 108.637 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.75 -40.89 98.66 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.3 -0.875 . . . . 0.0 108.724 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -60.2 -38.91 84.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.454 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 14' ' ' TYR . 74.8 t80 -61.39 -43.52 98.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.68 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -47.81 -39.55 18.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.194 -0.941 . . . . 0.0 109.68 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.9 mp -65.01 -39.19 93.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 109.684 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.5 p -90.94 9.68 29.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.149 -0.969 . . . . 0.0 109.172 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.864 -179.541 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.41 ' H1 ' HD12 ' A' ' 105' ' ' ILE . 21.4 ptp . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.271 0.558 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.441 HD22 HE21 ' A' ' 5' ' ' GLN . 95.6 m-20 -94.17 165.45 12.6 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.411 -0.806 . . . . 0.0 109.993 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 42.6 ttm180 -62.31 -44.72 95.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.506 -0.746 . . . . 0.0 109.433 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -63.68 -39.72 95.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.843 . . . . 0.0 109.095 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.441 HE21 HD22 ' A' ' 2' ' ' ASN . 73.2 mt-30 -63.63 -37.26 86.67 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.399 -0.813 . . . . 0.0 109.264 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.436 ' CD2' HD12 ' A' ' 43' ' ' LEU . 63.4 t80 -60.63 -46.94 88.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.488 -0.757 . . . . 0.0 109.74 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.59 -45.41 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.262 -0.899 . . . . 0.0 108.605 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -62.32 -41.8 98.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 0.0 109.558 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.72 -49.6 76.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.201 -0.937 . . . . 0.0 109.074 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.25 -36.1 78.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.729 . . . . 0.0 109.608 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -61.8 -42.6 99.21 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.501 -0.75 . . . . 0.0 110.006 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -83.98 -20.87 32.1 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.096 -1.003 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.4 tptt -87.2 -51.31 6.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.256 -0.902 . . . . 0.0 111.321 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -118.05 -15.05 9.94 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.204 -0.935 . . . . 0.0 110.312 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.0 t0 58.11 41.71 23.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.359 -0.838 . . . . 0.0 109.933 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.6 m -99.85 134.22 43.07 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.174 -0.954 . . . . 0.0 108.704 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -84.4 132.69 46.48 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.031 -1.043 . . . . 0.0 109.244 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.86 151.07 56.54 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.832 1.688 . . . . 0.0 112.295 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -132.94 149.26 52.26 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.542 -0.724 . . . . 0.0 109.352 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.49 ' O ' ' CG ' ' A' ' 20' ' ' HIS . 13.9 p-80 -132.6 85.38 47.89 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.39 -0.819 . . . . 0.0 109.222 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -55.7 -37.05 95.9 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.312 2.008 . . . . 0.0 111.233 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -79.76 98.67 7.11 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.651 0.739 . . . . 0.0 109.43 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.95 -23.32 65.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.438 -0.789 . . . . 0.0 109.744 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -74.49 -3.9 33.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.675 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -145.16 76.56 13.41 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.23 -0.918 . . . . 0.0 109.705 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.77 -20.0 63.94 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.617 2.211 . . . . 0.0 110.768 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 12.8 p-10 -76.5 -2.4 32.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.722 -0.611 . . . . 0.0 109.65 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 6.6 m-85 -99.54 134.87 41.78 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.45 129.86 29.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.288 -0.882 . . . . 0.0 109.405 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.78 128.37 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.682 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 73.5 m-85 -100.34 124.06 45.34 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.366 -0.834 . . . . 0.0 109.849 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.7 mtm-85 -137.02 135.68 37.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.297 -0.877 . . . . 0.0 109.284 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.98 112.77 25.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.458 -0.776 . . . . 0.0 109.725 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.2 t -69.72 -26.56 64.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.437 -0.79 . . . . 0.0 109.406 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -64.25 -39.34 93.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.51 -0.744 . . . . 0.0 109.559 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.71 -11.03 22.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.323 -0.86 . . . . 0.0 108.887 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 61.41 38.41 16.07 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.426 0.631 . . . . 0.0 109.626 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 39' ' ' TRP . 17.8 ptmt -167.65 -120.33 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.453 -0.779 . . . . 0.0 109.55 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.41 ' N ' ' HG3' ' A' ' 38' ' ' LYS . 62.6 t-105 56.16 91.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.489 -0.757 . . . . 0.0 109.318 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -105.21 126.64 52.31 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.945 0.879 . . . . 0.0 110.041 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . . . -149.5 146.71 27.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.4 tp -140.53 120.55 13.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.951 -1.093 . . . . 0.0 110.268 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 43' ' ' LEU . 8.1 tt -113.08 126.43 55.47 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.51 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.3 ptt? -153.27 165.18 36.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.997 -1.064 . . . . 0.0 109.843 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 92.9 m-20 -97.03 116.17 28.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 pt -127.55 145.55 55.1 Favored Pre-proline 0 N--CA 1.504 2.257 0 O-C-N 121.385 -0.822 . . . . 0.0 109.368 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.31 145.53 88.59 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.095 1.864 . . . . 0.0 112.116 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.43 -21.78 66.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.613 -0.679 . . . . 0.0 109.998 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 56' ' ' ASP . 9.8 pt-20 -56.62 -20.42 21.11 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 110.232 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.81 -13.0 59.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.107 -0.995 . . . . 0.0 110.705 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 53' ' ' ILE . 7.7 pt -116.43 -5.7 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.302 -0.874 . . . . 0.0 109.79 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.22 -2.29 81.05 Favored Glycine 0 N--CA 1.499 2.874 0 O-C-N 121.184 -0.947 . . . . 0.0 111.12 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 51' ' ' ILE . 39.3 mt -79.36 146.51 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.902 -1.352 . . . . 0.0 110.066 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 53' ' ' ILE . 18.2 m120 37.16 -88.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.493 0.664 . . . . 0.0 110.603 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . 143.94 116.43 1.11 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.48 ' H ' ' HB3' ' A' ' 49' ' ' GLU . 47.3 t0 60.26 41.44 16.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.946 . . . . 0.0 110.569 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -112.42 124.76 53.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.41 -0.806 . . . . 0.0 108.988 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -71.27 127.84 33.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 109.953 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 m -137.97 161.06 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.338 -0.851 . . . . 0.0 109.017 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -98.86 130.95 45.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.404 -0.81 . . . . 0.0 109.226 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.25 158.28 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.481 -0.762 . . . . 0.0 109.531 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 96' ' ' LEU . 37.5 pt -131.66 146.83 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -110.83 136.62 49.61 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 pp -137.88 156.79 47.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.287 -0.883 . . . . 0.0 109.48 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -90.65 144.72 25.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.815 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.07 162.1 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 0.0 109.621 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.446 HE21 HD12 ' A' ' 70' ' ' LEU . 19.2 mt-30 -70.25 155.64 93.12 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 71' ' ' VAL . 28.8 Cg_endo -64.17 -18.28 62.84 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.075 1.85 . . . . 0.0 110.953 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -94.28 -28.76 15.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.544 -0.722 . . . . 0.0 109.226 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.446 HD12 HE21 ' A' ' 67' ' ' GLN . 89.1 mt -94.32 -3.03 51.2 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.177 -0.952 . . . . 0.0 110.039 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 68' ' ' PRO . 7.6 p -63.45 -31.72 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.137 -0.977 . . . . 0.0 109.919 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.53 -14.72 81.83 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.44 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 34.7 t -70.41 -55.44 9.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -1.099 . . . . 0.0 111.483 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.586 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.8 pt? -84.28 -23.09 30.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.119 -0.988 . . . . 0.0 111.106 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -66.38 -41.42 89.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.106 -0.997 . . . . 0.0 111.264 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CD ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -76.29 -7.57 55.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.869 -1.145 . . . . 0.0 110.108 -178.502 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -77.69 149.22 77.5 Favored Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.799 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 80' ' ' ILE . 40.2 Cg_endo -66.34 155.37 70.3 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.12 2.547 . . . . 0.0 112.462 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.47 -25.77 0.9 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 78' ' ' PRO . 78.9 mt -93.7 115.35 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -1.216 . . . . 0.0 108.951 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.8 150.34 42.63 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.619 -0.675 . . . . 0.0 110.036 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.04 150.94 85.01 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.156 1.904 . . . . 0.0 111.809 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.4 143.88 56.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.345 -0.847 . . . . 0.0 109.625 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 52.4 p90 -92.08 126.9 37.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.119 -0.988 . . . . 0.0 109.899 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.485 ' O ' ' CG ' ' A' ' 85' ' ' HIS . 85.5 t60 41.53 43.51 2.28 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.561 -0.712 . . . . 0.0 110.405 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.0 mmm -143.46 65.32 1.32 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.234 -0.916 . . . . 0.0 109.044 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.612 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 22.2 m-20 68.39 -50.14 0.56 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.166 -0.334 . . . . 0.0 110.42 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 63.91 -37.63 0.19 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 120.979 0.419 . . . . 0.0 110.24 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 87' ' ' ASN . 83.1 tt0 -88.66 -20.19 25.23 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.903 -1.123 . . . . 0.0 109.817 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -96.88 -59.84 1.72 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.266 -0.896 . . . . 0.0 110.336 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . 0.612 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 5.4 m0 -105.96 140.96 38.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.494 -0.754 . . . . 0.0 109.912 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.0 mm -121.14 138.55 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.1 m -85.43 134.46 34.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.707 -0.62 . . . . 0.0 109.834 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.4 t -119.63 134.82 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.596 -0.69 . . . . 0.0 109.157 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.2 tp -89.55 107.2 18.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.199 -0.938 . . . . 0.0 110.058 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.431 HD11 HG23 ' A' ' 62' ' ' ILE . 81.2 mt -66.23 -39.33 89.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.497 -0.752 . . . . 0.0 109.71 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -74.28 2.88 8.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.477 -0.765 . . . . 0.0 109.61 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.93 -166.05 30.28 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 100' ' ' LEU . 83.8 Cg_endo -85.34 10.63 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.396 2.731 . . . . 0.0 111.54 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.8 mm? -52.55 -107.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.629 0.728 . . . . 0.0 109.63 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.11 154.38 6.15 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.48 -46.3 86.93 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.303 -1.116 . . . . 0.0 109.357 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.65 -42.67 98.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.501 -0.749 . . . . 0.0 109.84 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -66.06 -42.73 89.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.397 -0.814 . . . . 0.0 109.743 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.41 HD12 ' H1 ' ' A' ' 1' ' ' MET . 94.9 mt -64.15 -43.25 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -55.16 -43.98 74.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.318 -0.864 . . . . 0.0 109.263 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 56.0 m -60.83 -42.37 97.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.855 . . . . 0.0 109.46 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.07 -42.95 99.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.432 -0.793 . . . . 0.0 109.323 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.06 -43.08 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.369 -0.832 . . . . 0.0 109.097 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -58.52 -37.71 76.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 108.593 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.446 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 92.4 m-20 -62.57 -35.77 80.56 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.8 p -81.51 -23.55 37.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 109.306 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -61.65 -44.43 96.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.427 -0.796 . . . . 0.0 109.885 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.462 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 5.4 pt20 -50.9 -41.25 58.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.337 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.462 ' N ' ' CG ' ' A' ' 114' ' ' GLN . 84.6 mt -64.77 -39.71 94.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.526 -0.733 . . . . 0.0 109.745 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.3 p -92.99 14.83 16.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.135 -0.978 . . . . 0.0 109.522 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 121.145 -0.972 . . . . 0.0 109.58 -179.569 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.511 ' O ' ' ND2' ' A' ' 2' ' ' ASN . 6.3 ttt . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 1' ' ' MET . 15.2 m120 -146.73 -178.33 6.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.104 -0.998 . . . . 0.0 110.116 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.53 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 40.8 ttm180 -62.25 -44.61 96.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.593 -0.692 . . . . 0.0 109.81 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -61.83 -37.33 84.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.898 . . . . 0.0 109.521 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -59.98 -40.44 89.13 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.346 -0.846 . . . . 0.0 109.04 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -62.65 -41.63 99.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.696 -0.628 . . . . 0.0 110.363 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.5 mm -59.24 -47.7 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.059 -1.025 . . . . 0.0 110.018 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 9' ' ' TYR . 0.6 OUTLIER -63.8 -43.86 95.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.914 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.622 ' CE2' ' CD2' ' A' ' 106' ' ' HIS . 43.4 t80 -62.53 -48.29 80.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.562 -0.711 . . . . 0.0 109.872 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.01 86.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.4 -0.813 . . . . 0.0 110.102 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 15' ' ' ASP . 11.6 tp-100 -64.75 -48.95 72.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.384 -0.822 . . . . 0.0 109.896 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -66.71 -33.63 76.07 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.931 -1.106 . . . . 0.0 110.599 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -87.05 -12.09 48.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.118 -0.989 . . . . 0.0 111.83 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.609 ' CD1' ' NE2' ' A' ' 33' ' ' HIS . 95.8 m-85 -141.62 -0.22 1.39 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.653 -1.279 . . . . 0.0 110.446 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER 41.06 35.18 0.34 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -109.76 138.06 46.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.507 0.67 . . . . 0.0 109.653 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HA ' HE22 ' A' ' 11' ' ' GLN . 86.5 mttt -91.1 151.13 42.81 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.504 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.65 149.05 73.32 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.596 2.198 . . . . 0.0 112.186 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -123.83 134.36 53.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.623 -0.673 . . . . 0.0 109.343 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 20' ' ' HIS . 18.6 p80 -128.78 85.4 60.33 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.37 -12.76 11.36 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.452 2.101 . . . . 0.0 110.973 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -92.38 97.52 10.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -70.15 -18.59 63.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.507 -0.746 . . . . 0.0 109.934 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 10.0 mtpm? -76.56 -4.65 43.93 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.142 -0.974 . . . . 0.0 109.14 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 24' ' ' LYS . 53.3 m-85 -156.85 79.47 3.71 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.433 -0.792 . . . . 0.0 108.903 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.3 -19.48 50.71 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.723 2.282 . . . . 0.0 111.294 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -73.13 -5.96 42.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.521 -0.737 . . . . 0.0 109.183 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.586 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 4.9 m-85 -87.55 137.95 31.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.573 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.88 141.38 34.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 0.0 109.156 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.09 126.44 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -106.66 120.08 41.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.54 -0.725 . . . . 0.0 109.5 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.449 ' NH2' ' O ' ' A' ' 37' ' ' ASP . 17.5 ptm180 -150.61 158.3 43.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.135 -0.978 . . . . 0.0 109.61 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.609 ' NE2' ' CD1' ' A' ' 14' ' ' TYR . 4.4 m170 -97.94 126.52 43.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 109.713 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.4 p -66.45 -34.26 77.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.469 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.76 -39.54 94.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.36 -0.838 . . . . 0.0 109.86 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 38' ' ' LYS . 53.0 t-20 -93.23 -12.26 30.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.409 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.449 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 37.7 t70 57.93 -71.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.695 -0.628 . . . . 0.0 110.713 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.6 tttt -63.61 124.66 21.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 110.506 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.428 ' CZ2' HG21 ' A' ' 116' ' ' THR . 0.0 OUTLIER -178.86 126.46 0.1 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.345 -0.847 . . . . 0.0 108.975 179.075 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -115.09 123.29 48.61 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.553 0.692 . . . . 0.0 109.524 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.469 ' C ' HD22 ' A' ' 42' ' ' LEU . . . -153.8 106.23 2.85 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.469 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.2 mm? -107.59 128.25 54.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.524 -0.735 . . . . 0.0 109.788 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.1 tt -122.61 118.19 27.59 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.586 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -162.82 166.67 23.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.968 . . . . 0.0 109.92 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.53 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 91.5 m-20 -93.6 143.5 26.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.56 -0.713 . . . . 0.0 109.33 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.9 pt -150.67 146.23 19.31 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.254 -0.904 . . . . 0.0 109.435 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.62 145.82 6.02 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.127 1.885 . . . . 0.0 112.697 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.6 -20.98 62.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.48 -0.763 . . . . 0.0 109.959 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.61 -17.59 63.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.887 . . . . 0.0 110.135 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.95 -10.45 57.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.05 -1.031 . . . . 0.0 111.042 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 51' ' ' ILE . 7.2 pt -105.82 7.12 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.142 -0.974 . . . . 0.0 109.428 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 -13.83 63.24 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.59 129.01 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.845 -1.386 . . . . 0.0 110.028 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -88.52 100.84 13.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.454 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.06 -22.48 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 56.76 31.53 19.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.795 -0.827 . . . . 0.0 109.708 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -102.8 144.98 30.44 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.323 -0.861 . . . . 0.0 109.775 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -74.15 128.19 34.88 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.326 -0.858 . . . . 0.0 109.278 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.25 161.19 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.482 -0.761 . . . . 0.0 109.769 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.418 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 28.3 m-20 -93.28 132.32 37.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.795 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.11 155.95 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.39 -0.818 . . . . 0.0 110.249 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 96' ' ' LEU . 44.0 pt -130.93 155.3 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 42' ' ' LEU . 53.0 t0 -92.86 119.74 32.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 110.2 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.583 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -115.7 119.81 37.31 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.583 ' N ' HD13 ' A' ' 64' ' ' LEU . 9.9 ptmm? -86.71 135.86 33.23 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.461 -0.774 . . . . 0.0 110.588 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.462 HG11 HD13 ' A' ' 74' ' ' LEU . 31.3 m -140.66 165.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.426 -0.796 . . . . 0.0 109.946 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -75.31 152.78 85.98 Favored Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 121.362 -0.836 . . . . 0.0 110.176 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.552 ' O ' HG12 ' A' ' 71' ' ' VAL . 61.7 Cg_exo -48.93 -34.01 27.54 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.13 1.887 . . . . 0.0 111.77 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -85.51 -29.21 24.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.393 -0.817 . . . . 0.0 110.087 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.0 mt -88.25 1.03 55.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.985 -1.072 . . . . 0.0 109.847 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 68' ' ' PRO . 14.8 p -66.13 -42.5 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.136 -0.977 . . . . 0.0 109.516 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.549 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -66.05 -40.61 95.23 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -60.75 -36.75 79.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -1.217 . . . . 0.0 109.524 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.543 ' CD2' HG21 ' A' ' 92' ' ' ILE . 1.6 tt -85.75 -37.39 19.37 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.553 -0.717 . . . . 0.0 109.825 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 ttp85 -73.92 -16.98 61.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.794 . . . . 0.0 110.644 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -7.65 58.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.95 -1.094 . . . . 0.0 109.081 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.75 ' NZ ' HD21 ' A' ' 108' ' ' LEU . 40.9 mtmt -85.32 122.83 73.68 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.181 -0.95 . . . . 0.0 109.397 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.24 146.28 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.216 1.944 . . . . 0.0 113.137 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.71 -21.29 39.76 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.4 mt -104.45 122.97 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.296 -1.12 . . . . 0.0 109.307 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -118.8 149.3 46.25 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.69 -0.631 . . . . 0.0 109.858 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -40.56 165.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.564 2.176 . . . . 0.0 112.619 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.07 147.08 50.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.353 -0.842 . . . . 0.0 110.603 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.453 ' OH ' ' CE ' ' A' ' 44' ' ' MET . 5.9 p90 -76.64 167.39 21.92 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.731 0.777 . . . . 0.0 110.759 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 73.8 m80 53.29 -94.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.622 -0.674 . . . . 0.0 110.147 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 93.7 mtp -138.48 -151.79 0.4 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.389 -0.819 . . . . 0.0 109.747 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 59.35 34.96 23.04 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -88.62 62.47 6.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.471 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -146.16 -67.01 0.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 108.889 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -96.36 -19.13 19.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.391 -0.818 . . . . 0.0 109.668 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 -110.51 138.15 47.27 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.461 -0.775 . . . . 0.0 110.085 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.543 HG21 ' CD2' ' A' ' 74' ' ' LEU . 19.8 mm -136.27 154.31 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.462 -0.774 . . . . 0.0 108.938 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.4 m -98.85 131.28 45.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.853 . . . . 0.0 110.814 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.5 t -113.16 133.84 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.6 tp -93.71 112.76 24.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.432 -0.793 . . . . 0.0 110.256 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.444 HD11 HG23 ' A' ' 62' ' ' ILE . 84.3 mt -66.03 -39.54 90.28 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.637 0.732 . . . . 0.0 109.432 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -71.89 -6.21 40.15 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.285 -0.884 . . . . 0.0 109.245 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.02 177.65 1.52 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.72 -12.73 24.46 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 123.038 2.492 . . . . 0.0 111.404 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.82 136.9 54.86 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.562 0.696 . . . . 0.0 110.684 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.96 -178.73 46.03 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.49 81.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.618 -0.931 . . . . 0.0 109.671 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 104' ' ' GLU . 25.1 pttm -56.55 -42.07 77.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.887 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 103' ' ' LYS . 46.0 tp10 -69.09 -40.05 78.66 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.013 -1.054 . . . . 0.0 109.443 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.468 HD12 ' SD ' ' A' ' 1' ' ' MET . 97.2 mt -64.77 -43.13 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.351 -0.843 . . . . 0.0 109.484 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.622 ' CD2' ' CE2' ' A' ' 9' ' ' TYR . 62.7 m170 -56.89 -44.33 82.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 109.487 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.5 t -62.72 -43.45 98.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.37 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.75 HD21 ' NZ ' ' A' ' 77' ' ' LYS . 88.9 mt -63.39 -41.02 98.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.362 -0.836 . . . . 0.0 109.209 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.0 -42.45 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -56.3 -42.26 77.28 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.256 -0.903 . . . . 0.0 108.781 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.23 -37.69 88.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . 0.56 ' OG ' HD21 ' A' ' 64' ' ' LEU . 2.4 m -60.75 -39.66 89.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.46 -0.775 . . . . 0.0 109.29 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -59.89 -42.9 94.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.573 -0.704 . . . . 0.0 109.688 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -52.62 -46.36 67.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 110.091 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.521 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.1 mm? -65.9 -40.11 91.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.413 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.428 HG21 ' CZ2' ' A' ' 39' ' ' TRP . 15.9 p -93.94 15.46 16.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.978 . . . . 0.0 109.147 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 . . . . . 0 N--CA 1.496 1.847 0 CA-C-O 121.687 0.756 . . . . 0.0 110.673 -179.724 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.9 ttp . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.711 0.767 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.8 p30 -92.17 170.32 9.91 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.997 0.903 . . . . 0.0 110.408 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -63.5 -42.07 98.51 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.567 0.699 . . . . 0.0 109.607 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -51.33 -43.02 61.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.759 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -66.83 -37.78 85.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 109.457 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -61.21 -44.22 97.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.337 -0.852 . . . . 0.0 109.889 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.44 -46.66 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.184 -0.947 . . . . 0.0 109.726 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -63.9 -45.62 88.52 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 110.001 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.448 ' CD2' ' NE2' ' A' ' 106' ' ' HIS . 56.0 t80 -66.25 -42.16 88.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 110.195 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.41 98.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.208 -0.932 . . . . 0.0 109.99 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ASP . 84.6 mt-30 -65.75 -41.72 91.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.287 -0.883 . . . . 0.0 110.031 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -62.76 -31.49 72.45 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.889 -1.132 . . . . 0.0 109.185 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -87.93 -45.29 10.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 111.69 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -107.4 -13.85 15.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.013 -1.054 . . . . 0.0 111.251 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 11' ' ' GLN . 99.3 m-20 54.52 34.16 20.52 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.08 -1.012 . . . . 0.0 108.776 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.9 m -121.64 132.09 54.47 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.857 0.836 . . . . 0.0 110.273 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -83.04 152.25 65.05 Favored Pre-proline 0 N--CA 1.486 1.367 0 O-C-N 121.595 -0.69 . . . . 0.0 109.166 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.61 134.58 27.15 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.172 1.915 . . . . 0.0 112.481 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -106.03 121.61 44.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.478 -0.763 . . . . 0.0 109.232 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -85.37 116.88 67.4 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.42 -0.8 . . . . 0.0 109.825 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 22' ' ' TRP . 72.4 Cg_endo -80.19 -90.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.52 2.147 . . . . 0.0 111.999 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.411 ' H ' ' HG2' ' A' ' 21' ' ' PRO . 5.5 m-90 -81.18 137.5 35.89 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.855 0.836 . . . . 0.0 110.055 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -65.77 -30.69 71.38 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.542 0.686 . . . . 0.0 110.066 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -67.84 -0.56 4.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.808 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -143.77 73.02 17.04 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.039 -1.038 . . . . 0.0 109.61 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.61 -19.0 25.01 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.363 2.042 . . . . 0.0 110.881 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -81.18 -4.23 54.77 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.631 0.729 . . . . 0.0 109.209 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -96.11 139.1 32.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.468 -0.77 . . . . 0.0 109.222 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.97 146.37 47.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.697 . . . . 0.0 109.398 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.4 t -127.87 129.58 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.396 0.617 . . . . 0.0 109.395 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -118.24 113.87 22.14 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -146.49 161.36 40.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.15 -0.969 . . . . 0.0 110.086 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 37' ' ' ASP . 53.1 m170 -96.68 129.34 44.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.527 -0.733 . . . . 0.0 109.784 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.6 m -69.6 -20.66 63.63 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.58 0.705 . . . . 0.0 109.673 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.39 -45.64 90.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.09 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 37' ' ' ASP . 93.8 m-20 -125.58 -30.73 3.05 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.403 -0.81 . . . . 0.0 109.838 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 33' ' ' HIS . 1.2 p30 50.68 25.19 1.96 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.564 0.697 . . . . 0.0 110.04 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.24 -8.53 45.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.138 -0.977 . . . . 0.0 108.777 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -91.19 146.52 23.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.378 -0.826 . . . . 0.0 110.02 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.8 124.35 43.1 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.698 0.761 . . . . 0.0 109.493 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.61 105.71 2.84 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -132.86 149.36 52.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.267 -0.895 . . . . 0.0 109.457 -179.417 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.55 HD23 ' C ' ' A' ' 43' ' ' LEU . 9.6 tt -118.91 128.04 54.05 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.413 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.98 163.97 39.55 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.875 0.845 . . . . 0.0 110.211 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 46' ' ' ILE . 51.9 p-10 -93.52 145.61 24.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.537 0.684 . . . . 0.0 110.016 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 45' ' ' ASP . 22.6 pt -155.75 146.96 16.63 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.606 -0.684 . . . . 0.0 109.467 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.44 141.67 97.83 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.099 1.866 . . . . 0.0 111.619 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' A' ' 53' ' ' ILE . . . -64.53 -20.26 66.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.484 -0.76 . . . . 0.0 109.902 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -54.76 -16.59 2.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.431 -0.793 . . . . 0.0 110.214 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -85.5 -23.72 27.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.253 -0.905 . . . . 0.0 111.171 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 pt -95.64 10.69 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.892 -1.13 . . . . 0.0 109.726 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.13 -8.27 75.82 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.532 ' HB ' ' HB1' ' A' ' 48' ' ' ALA . 81.3 mt -78.77 129.98 36.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.806 -1.408 . . . . 0.0 109.996 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -62.23 -39.9 94.34 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.591 0.71 . . . . 0.0 109.34 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -42.07 133.23 4.12 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.8 p30 -89.6 3.08 53.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.462 -1.022 . . . . 0.0 108.93 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.8 144.65 56.18 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.731 0.777 . . . . 0.0 110.485 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -87.11 145.57 26.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.52 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.51 160.42 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.658 0.742 . . . . 0.0 110.321 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.77 132.89 34.99 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.305 0.574 . . . . 0.0 110.019 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.41 156.16 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.659 0.743 . . . . 0.0 110.017 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.8 pt -136.09 146.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.596 0.713 . . . . 0.0 109.963 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -81.87 143.34 31.77 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.524 0.678 . . . . 0.0 110.308 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -133.26 125.97 30.48 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.624 ' N ' HD13 ' A' ' 64' ' ' LEU . 63.3 tttm -82.95 131.28 35.19 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.689 0.757 . . . . 0.0 110.67 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.83 161.8 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.739 0.78 . . . . 0.0 109.726 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.473 ' H ' ' HB2' ' A' ' 70' ' ' LEU . 39.7 mt-30 -87.11 153.14 54.03 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.529 -0.732 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.505 ' O ' HG12 ' A' ' 71' ' ' VAL . 51.6 Cg_exo -47.5 -26.18 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.159 1.906 . . . . 0.0 111.577 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -94.78 -29.17 14.89 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.708 0.766 . . . . 0.0 109.345 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.473 ' HB2' ' H ' ' A' ' 67' ' ' GLN . 93.5 mt -86.77 -6.51 58.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 0.0 109.644 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 68' ' ' PRO . 12.1 p -67.29 -39.58 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 109.553 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.482 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -61.32 -47.04 93.03 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.6 m -59.59 -42.49 92.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.295 -1.121 . . . . 0.0 110.532 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.2 tt -84.65 -24.37 29.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 110.576 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.605 ' NH1' ' NZ ' ' A' ' 88' ' ' LYS . 69.7 ttt180 -82.72 -40.56 20.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.868 -1.145 . . . . 0.0 109.173 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -69.02 1.22 3.66 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.784 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -88.01 116.03 64.94 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.473 -0.767 . . . . 0.0 109.459 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.26 144.92 37.3 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.331 2.02 . . . . 0.0 113.045 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.61 -20.76 46.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.01 125.67 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.477 -1.013 . . . . 0.0 109.396 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -106.0 151.65 40.11 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.593 -0.692 . . . . 0.0 109.996 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.22 146.62 81.87 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.5 2.133 . . . . 0.0 112.194 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.525 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -67.09 153.23 44.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.546 -0.721 . . . . 0.0 110.592 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.09 -143.02 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.916 0.865 . . . . 0.0 110.52 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 46.16 -113.54 0.44 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.443 0.639 . . . . 0.0 109.954 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 98.2 mmm -141.07 0.89 1.59 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 89' ' ' GLU . 81.8 m-20 -59.64 -85.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 109.691 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.605 ' NZ ' ' NH1' ' A' ' 75' ' ' ARG . 62.7 tttm 56.86 -76.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.648 -0.657 . . . . 0.0 110.222 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' ASN . 97.5 mt-10 -65.35 -38.7 90.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 0.0 109.673 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -68.51 -68.12 0.42 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.584 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -120.57 159.4 25.33 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.525 -0.734 . . . . 0.0 109.634 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 mm -129.6 147.69 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.919 0.866 . . . . 0.0 109.826 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 p -90.59 134.6 34.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.683 -0.636 . . . . 0.0 110.076 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -115.48 129.87 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 34.0 tp -86.77 104.84 16.53 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.669 0.747 . . . . 0.0 109.976 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.76 -38.4 88.96 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.788 0.804 . . . . 0.0 109.237 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.39 -5.88 44.97 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.897 0.856 . . . . 0.0 109.113 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.92 -175.41 8.96 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.514 ' O ' ' C ' ' A' ' 100' ' ' LEU . 44.5 Cg_endo -71.63 -81.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.633 2.222 . . . . 0.0 112.226 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.514 ' C ' ' O ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER 19.2 -120.7 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 121.158 0.504 . . . . 0.0 111.689 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.95 165.61 30.19 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.22 -39.07 86.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.528 -0.984 . . . . 0.0 109.461 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -64.91 -35.5 81.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.447 -0.783 . . . . 0.0 109.611 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -67.09 -40.7 87.01 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.201 -0.937 . . . . 0.0 109.411 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.71 -43.3 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 109.273 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' HIS . . . . . 0.448 ' NE2' ' CD2' ' A' ' 9' ' ' TYR . 52.1 m170 -56.65 -44.95 81.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 109.76 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.2 m -62.25 -42.44 99.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.744 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.52 -41.03 96.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 109.194 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.1 -42.7 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.339 -0.85 . . . . 0.0 108.988 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -53.77 -46.55 71.0 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.502 -0.749 . . . . 0.0 109.438 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -64.43 -38.53 91.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.075 -1.016 . . . . 0.0 108.851 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.6 p -62.18 -36.24 81.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 0.0 109.226 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -61.75 -44.6 96.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.413 -0.805 . . . . 0.0 109.664 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.16 -41.86 89.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.296 -0.877 . . . . 0.0 109.612 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.8 mt -66.53 -38.7 87.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.341 -0.849 . . . . 0.0 109.798 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.8 p -89.09 5.84 42.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.216 -0.927 . . . . 0.0 109.372 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 108.903 179.624 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -100.41 156.79 17.06 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.821 0.82 . . . . 0.0 110.367 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 37.0 mtp-105 -60.6 -46.58 89.74 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.64 -0.662 . . . . 0.0 110.171 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -47.73 -40.51 20.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.992 . . . . 0.0 109.677 -179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -66.77 -41.6 87.43 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.344 -0.848 . . . . 0.0 109.366 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -63.72 -45.43 89.95 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.458 -0.777 . . . . 0.0 110.095 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 40.2 mm -63.84 -46.02 95.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 0.0 109.79 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -67.38 -39.04 85.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.925 . . . . 0.0 108.925 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -61.78 -46.14 90.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.456 -0.778 . . . . 0.0 109.936 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.3 -47.28 86.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.477 -0.765 . . . . 0.0 109.914 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -65.95 -21.71 66.44 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.337 -0.852 . . . . 0.0 109.467 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -84.42 -53.22 5.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 109.914 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -88.87 -44.02 10.78 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.446 -0.784 . . . . 0.0 111.601 -178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 15' ' ' ASP . 45.6 m-85 -93.45 -6.16 47.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.785 -1.197 . . . . 0.0 110.071 -178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 14' ' ' TYR . 0.7 OUTLIER 37.4 34.55 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.622 0.725 . . . . 0.0 109.796 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 14' ' ' TYR . 7.8 t -104.45 145.74 29.85 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.564 0.697 . . . . 0.0 110.085 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -98.47 151.28 37.4 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.66 149.35 73.51 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.712 2.275 . . . . 0.0 112.659 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -136.33 151.16 49.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.673 -0.642 . . . . 0.0 109.354 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -139.64 86.0 14.3 Favored Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -55.17 -38.1 93.8 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.566 2.178 . . . . 0.0 110.758 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -94.71 116.44 28.75 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.373 0.606 . . . . 0.0 109.509 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' C ' ' H ' ' A' ' 25' ' ' PHE . 17.4 pt-20 -69.49 -31.31 69.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.493 -0.754 . . . . 0.0 109.405 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -64.78 -0.66 1.55 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.564 -0.71 . . . . 0.0 109.464 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 23' ' ' GLU . 73.2 m-85 -137.05 71.75 54.95 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.524 -0.735 . . . . 0.0 109.333 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -70.7 -20.58 30.26 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 122.471 2.114 . . . . 0.0 111.615 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -82.18 -6.0 58.89 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.477 -0.764 . . . . 0.0 109.306 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -88.76 140.19 29.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.415 -0.803 . . . . 0.0 109.65 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.11 133.15 50.44 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 55.3 t -123.73 129.97 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.682 -0.636 . . . . 0.0 109.348 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -113.62 134.15 54.88 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -158.41 149.48 20.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.18 -0.95 . . . . 0.0 109.945 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.533 ' O ' ' NE1' ' A' ' 39' ' ' TRP . 81.2 m-70 -99.57 118.04 35.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.538 -0.726 . . . . 0.0 109.604 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.1 m -76.52 -15.09 59.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.534 -0.728 . . . . 0.0 109.149 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -92.59 -5.34 51.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.441 -0.787 . . . . 0.0 109.899 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' ND2' ' O ' ' A' ' 116' ' ' THR . 45.8 t-20 -115.24 -30.9 6.16 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.541 -0.724 . . . . 0.0 109.469 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 38' ' ' LYS . 65.1 t0 57.73 134.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.851 0.834 . . . . 0.0 111.018 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 6.3 tmtt? 82.41 102.2 0.05 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.515 0.674 . . . . 0.0 109.739 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -171.01 175.19 4.45 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.45 -0.781 . . . . 0.0 109.618 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.511 ' CG ' ' O ' ' A' ' 39' ' ' TRP . 80.3 m-85 -158.44 119.14 3.34 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.45 105.39 2.07 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.3 OUTLIER -133.93 138.64 45.62 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 0.0 109.091 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.629 HD21 ' OD1' ' A' ' 60' ' ' ASP . 9.1 tt -116.4 124.76 50.83 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.8 ptt? -152.39 156.01 38.71 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.815 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.413 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 98.3 m-20 -94.4 114.49 26.53 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.6 pt -118.03 145.29 36.51 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.766 -0.583 . . . . 0.0 109.998 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -46.81 143.26 9.46 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.144 1.896 . . . . 0.0 112.431 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 57' ' ' LYS . . . -64.09 -21.78 66.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -77.36 -14.23 59.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 109.783 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 26.5 mmtp -84.57 -10.7 57.15 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.197 -0.939 . . . . 0.0 110.158 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.493 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 13.7 pt -105.08 1.45 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.2 -8.36 60.71 Favored Glycine 0 N--CA 1.497 2.764 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.475 HG22 ' H ' ' A' ' 55' ' ' GLY . 77.0 mt -79.72 139.2 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 120.848 -1.383 . . . . 0.0 110.14 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.37 -38.22 88.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.742 -0.599 . . . . 0.0 110.746 -178.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -49.66 145.36 8.32 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.862 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -101.8 9.19 41.02 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.596 -0.943 . . . . 0.0 108.929 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.546 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 62.5 pttt -76.5 146.28 38.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.369 -0.832 . . . . 0.0 110.305 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -77.6 144.0 37.85 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.563 -0.711 . . . . 0.0 109.77 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.93 161.89 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.417 -0.802 . . . . 0.0 110.407 -179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.629 ' OD1' HD21 ' A' ' 43' ' ' LEU . 24.1 t70 -100.73 128.17 46.88 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.845 -0.534 . . . . 0.0 109.934 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -131.07 157.69 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.604 -0.685 . . . . 0.0 109.771 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 13.4 pt -132.61 150.15 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.48 0.657 . . . . 0.0 109.706 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 64.5 t0 -80.13 134.65 36.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.67 -0.644 . . . . 0.0 109.864 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.654 HD12 HG13 ' A' ' 66' ' ' VAL . 0.4 OUTLIER -125.82 124.0 39.98 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.643 ' N ' HD13 ' A' ' 64' ' ' LEU . 36.2 ttmt -89.91 129.47 36.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.394 -0.816 . . . . 0.0 109.943 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.654 HG13 HD12 ' A' ' 64' ' ' LEU . 15.0 m -138.64 164.68 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.895 0.855 . . . . 0.0 110.663 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -73.3 155.1 90.08 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.433 ' O ' HG12 ' A' ' 71' ' ' VAL . 31.3 Cg_endo -62.55 -24.62 75.3 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 C-N-CA 122.752 2.302 . . . . 0.0 112.402 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -91.16 -23.59 20.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.151 -0.968 . . . . 0.0 110.161 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 90.4 mt -92.68 1.18 57.41 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.03 -1.044 . . . . 0.0 109.469 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.511 HG13 ' N ' ' A' ' 72' ' ' GLY . 10.6 p -63.98 -41.56 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 108.831 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.511 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -61.94 -40.52 98.98 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.2 t -65.34 -54.79 23.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -1.133 . . . . 0.0 110.281 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.533 HD13 HG11 ' A' ' 66' ' ' VAL . 2.3 tt -68.25 -43.89 76.84 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 110.638 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -69.93 -18.29 63.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.457 -0.777 . . . . 0.0 110.214 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -71.66 -32.86 68.34 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.828 -1.17 . . . . 0.0 108.868 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -66.63 139.98 96.22 Favored Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.807 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.06 157.84 53.54 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.191 1.927 . . . . 0.0 112.562 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.44 -18.49 49.03 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.8 mt -103.23 117.11 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.549 -0.971 . . . . 0.0 109.209 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.493 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 63.0 m-85 -105.82 151.2 39.89 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.694 -0.629 . . . . 0.0 109.445 -179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.583 ' CB ' ' HZ1' ' A' ' 88' ' ' LYS . 57.9 Cg_endo -68.75 153.17 73.61 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.608 2.205 . . . . 0.0 112.648 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.53 139.73 58.8 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.356 -0.84 . . . . 0.0 110.059 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.52 ' CZ ' ' CE1' ' A' ' 85' ' ' HIS . 54.2 p90 -90.13 2.76 54.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.557 -0.714 . . . . 0.0 109.207 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.52 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 78.5 m80 -79.9 -168.34 1.58 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.393 -0.817 . . . . 0.0 110.65 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.0 mtt -63.38 -40.37 97.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.518 -0.739 . . . . 0.0 109.574 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -81.31 -172.79 3.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.258 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.583 ' HZ1' ' CB ' ' A' ' 82' ' ' PRO . 48.8 tttp -165.31 -61.06 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -67.87 -38.7 83.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.567 -0.708 . . . . 0.0 109.455 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -64.86 -50.07 68.05 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.486 -0.759 . . . . 0.0 109.988 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -115.96 137.01 52.5 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.675 -0.64 . . . . 0.0 109.732 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.46 HG21 ' CD2' ' A' ' 74' ' ' LEU . 6.8 mm -129.16 133.39 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-O 121.569 0.699 . . . . 0.0 109.189 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 53.9 m -81.58 130.82 35.19 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.634 -0.666 . . . . 0.0 109.702 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 44.5 t -115.18 132.98 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.598 -0.689 . . . . 0.0 109.245 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.5 tp -87.54 103.84 15.93 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 121.509 0.671 . . . . 0.0 110.095 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 98' ' ' GLY . 72.2 mt -65.73 -40.08 91.82 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.607 0.717 . . . . 0.0 109.218 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -76.83 11.12 1.85 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -89.66 -164.5 40.13 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.89 0.41 10.02 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 123.226 2.617 . . . . 0.0 111.697 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.3 mm? -61.25 135.22 57.66 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.95 0.881 . . . . 0.0 110.985 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.68 157.43 28.7 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.08 97.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.561 -0.964 . . . . 0.0 109.538 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -70.26 -34.87 73.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.444 -0.785 . . . . 0.0 109.337 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.06 -43.25 92.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.457 -0.777 . . . . 0.0 109.267 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.6 mt -64.73 -42.91 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.511 -0.743 . . . . 0.0 109.37 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 59.6 m170 -56.49 -43.76 79.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.406 -0.809 . . . . 0.0 109.673 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.5 t -61.93 -44.82 95.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.395 -0.816 . . . . 0.0 109.963 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.65 -41.0 98.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.0 109.48 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.56 -42.64 96.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.273 -0.892 . . . . 0.0 109.018 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -51.7 -43.86 62.95 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -62.71 -43.23 99.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.618 -0.676 . . . . 0.0 109.324 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.2 p -70.02 -30.86 68.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 0.0 109.433 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -58.16 -43.91 87.63 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.441 -0.787 . . . . 0.0 109.179 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -49.84 -31.01 10.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.541 -0.724 . . . . 0.0 109.698 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.2 mp -84.25 -17.43 39.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.328 -0.857 . . . . 0.0 109.617 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.534 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 32.3 p -102.92 15.23 29.95 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.453 -0.78 . . . . 0.0 109.211 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.452 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 18.2 mmm180 -63.77 141.51 58.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.227 -0.92 . . . . 0.0 109.973 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 118' ' ' LEU . 10.6 mp -77.31 152.1 34.7 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.564 0.697 . . . . 0.0 110.821 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 56.99 75.69 0.35 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.654 0.74 . . . . 0.0 110.118 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.642 ' ND1' ' N ' ' A' ' 120' ' ' HIS . 0.0 OUTLIER -66.51 -39.69 88.8 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.629 -0.669 . . . . 0.0 109.404 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.416 ' N ' ' ND1' ' A' ' 120' ' ' HIS . 19.3 p80 -154.54 146.4 23.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.913 . . . . 0.0 110.23 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -174.37 83.78 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 18.9 p-80 -157.51 123.76 4.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.407 -0.808 . . . . 0.0 109.466 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -66.77 -39.98 88.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.49 -0.756 . . . . 0.0 109.617 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.191 179.921 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 tpp . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.02 165.96 12.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.394 -0.817 . . . . 0.0 110.446 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -63.09 -42.52 99.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.75 -0.594 . . . . 0.0 109.731 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.549 HE22 ' CG ' ' A' ' 8' ' ' ASP . 2.2 tm0? -64.04 -38.59 91.64 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.146 -0.972 . . . . 0.0 109.471 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -63.57 -39.64 94.93 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.524 -0.735 . . . . 0.0 109.415 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -61.94 -46.86 87.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.438 -0.789 . . . . 0.0 109.83 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 85.7 mt -64.66 -44.36 96.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.31 -0.869 . . . . 0.0 109.615 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.549 ' CG ' HE22 ' A' ' 4' ' ' GLN . 54.3 m-20 -65.87 -38.26 88.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.387 -0.82 . . . . 0.0 109.023 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.462 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 91.6 t80 -61.58 -44.52 96.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.853 . . . . 0.0 109.803 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 14' ' ' TYR . . . -64.13 -36.65 84.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.396 -0.815 . . . . 0.0 110.312 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.567 ' O ' ' N ' ' A' ' 15' ' ' ASP . 58.3 mm-40 -61.88 -44.27 97.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -0.89 . . . . 0.0 110.147 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -66.78 -38.44 86.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.893 -1.129 . . . . 0.0 109.552 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 29.9 mmtp -88.19 -11.73 45.93 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.491 -0.756 . . . . 0.0 111.302 -178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.404 ' N ' ' O ' ' A' ' 10' ' ' ALA . 80.7 m-85 -144.61 -21.68 0.52 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.821 -1.174 . . . . 0.0 110.818 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 11' ' ' GLN . 65.0 m-20 53.83 32.94 15.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.124 -0.985 . . . . 0.0 109.063 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.533 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 12.3 t -103.15 134.91 45.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.499 -0.75 . . . . 0.0 109.674 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -82.52 149.14 60.35 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.611 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.33 151.98 71.5 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.44 2.093 . . . . 0.0 112.346 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -132.77 130.21 39.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.646 -0.659 . . . . 0.0 109.288 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.424 ' CD2' ' O ' ' A' ' 20' ' ' HIS . 31.5 p-80 -132.4 86.33 45.94 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.72 -35.85 93.99 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.515 2.143 . . . . 0.0 111.381 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.7 m0 -81.35 104.06 11.54 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.588 -0.695 . . . . 0.0 109.977 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -68.07 -34.99 77.48 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.501 0.667 . . . . 0.0 109.359 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -67.24 -3.13 7.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.402 -0.811 . . . . 0.0 109.708 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -135.08 71.51 68.6 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.493 -0.754 . . . . 0.0 109.463 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.75 -17.54 42.25 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 122.323 2.015 . . . . 0.0 111.126 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -80.16 -5.92 56.88 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.495 -0.753 . . . . 0.0 109.221 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -104.68 135.91 45.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.505 -0.747 . . . . 0.0 109.471 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.67 147.87 47.06 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.583 -0.698 . . . . 0.0 109.318 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.3 t -120.86 126.4 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.759 -0.588 . . . . 0.0 109.682 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -108.92 117.75 35.0 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -149.45 153.17 36.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.066 -1.021 . . . . 0.0 109.792 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.689 ' N ' ' HE1' ' A' ' 39' ' ' TRP . 28.1 m80 -83.76 132.07 34.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.495 -0.753 . . . . 0.0 110.379 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.0 m -67.8 -40.19 83.93 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.521 -0.737 . . . . 0.0 109.828 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -92.68 -42.4 9.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.401 -0.812 . . . . 0.0 109.756 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' N ' ' A' ' 38' ' ' LYS . 1.4 m-20 -95.01 31.76 1.81 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.412 ' O ' ' OD1' ' A' ' 37' ' ' ASP . 52.9 p-10 -48.38 83.5 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.541 0.686 . . . . 0.0 110.444 -179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 36' ' ' ASN . 6.1 tmtt? -147.32 -22.87 0.39 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.689 ' HE1' ' N ' ' A' ' 33' ' ' HIS . 4.4 p-90 -101.52 127.94 47.98 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.559 -0.713 . . . . 0.0 109.32 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -112.43 129.77 56.21 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.599 0.714 . . . . 0.0 109.354 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.9 121.11 7.25 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.19 147.98 45.51 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.72 -0.612 . . . . 0.0 109.595 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tt -115.27 126.08 54.07 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.468 ' O ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -157.67 161.25 38.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.953 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.51 ' OD2' ' NH1' ' A' ' 58' ' ' ARG . 92.6 m-20 -99.67 142.57 30.98 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.9 pt -149.27 146.46 21.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.897 . . . . 0.0 109.306 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -49.74 144.02 21.27 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 121.869 1.713 . . . . 0.0 112.849 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -64.49 -21.81 66.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.594 -0.691 . . . . 0.0 109.802 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.18 -16.27 59.17 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.254 -0.903 . . . . 0.0 110.103 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -84.87 -10.08 57.49 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.169 -0.957 . . . . 0.0 110.093 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.481 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 12.6 pt -103.57 3.32 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.285 -0.884 . . . . 0.0 109.206 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 99.15 -8.7 60.98 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.5 mt -83.93 129.98 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.81 -1.406 . . . . 0.0 110.334 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -65.77 87.0 0.09 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.622 -0.674 . . . . 0.0 109.335 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -176.29 136.32 3.21 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -95.81 11.94 31.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.368 -1.078 . . . . 0.0 108.993 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -74.86 144.85 43.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.277 -0.89 . . . . 0.0 110.64 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.51 ' NH1' ' OD2' ' A' ' 45' ' ' ASP . 72.4 ttp85 -76.48 137.06 39.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.504 -0.747 . . . . 0.0 109.806 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.7 m -134.14 161.54 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.463 -0.773 . . . . 0.0 110.02 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -100.66 127.58 47.01 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.519 -0.738 . . . . 0.0 109.464 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -132.98 158.4 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.443 -0.785 . . . . 0.0 110.353 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 pt -135.02 152.8 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.546 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.6 OUTLIER -116.14 145.27 43.2 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.437 0.637 . . . . 0.0 109.875 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.44 157.78 45.26 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -87.81 137.58 32.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.343 -0.848 . . . . 0.0 110.882 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.9 m -143.58 163.35 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.514 -0.741 . . . . 0.0 109.862 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.444 ' CD ' HD22 ' A' ' 115' ' ' LEU . 57.7 mt-30 -77.92 154.78 80.51 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.512 -0.743 . . . . 0.0 109.664 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.507 ' O ' HG12 ' A' ' 71' ' ' VAL . 27.9 Cg_endo -65.14 -21.5 62.57 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.411 2.074 . . . . 0.0 111.151 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -87.48 -26.92 22.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 0.0 109.131 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.3 mt -96.69 6.51 48.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.414 -0.803 . . . . 0.0 109.334 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 68' ' ' PRO . 7.5 p -63.09 -36.49 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.319 -0.863 . . . . 0.0 109.513 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.72 -21.45 79.33 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 38.0 m -62.27 -59.07 5.56 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.18 -1.188 . . . . 0.0 110.914 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.835 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -85.49 -29.25 24.42 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.057 -1.027 . . . . 0.0 110.698 -178.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.405 ' HE ' ' HB3' ' A' ' 82' ' ' PRO . 78.1 ttt-85 -67.73 -21.53 65.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.987 -1.07 . . . . 0.0 110.231 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.74 -8.14 55.01 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.051 -1.031 . . . . 0.0 109.229 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.4 mmtp -75.92 149.09 82.55 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.283 -0.886 . . . . 0.0 110.081 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.402 ' O ' HD12 ' A' ' 80' ' ' ILE . 47.7 Cg_endo -68.5 140.87 49.03 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.435 2.09 . . . . 0.0 112.533 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.32 -21.1 18.56 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.746 ' N ' HD12 ' A' ' 80' ' ' ILE . 2.7 mp -89.06 124.39 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -1.137 . . . . 0.0 109.388 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.481 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 55.5 m-85 -123.84 151.14 64.06 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.751 -0.593 . . . . 0.0 109.588 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 84' ' ' TYR . 41.2 Cg_endo -67.95 158.57 56.77 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.412 2.075 . . . . 0.0 112.16 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 85' ' ' HIS . . . -66.17 65.18 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.451 -0.78 . . . . 0.0 109.423 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.501 ' N ' ' O ' ' A' ' 82' ' ' PRO . 0.0 OUTLIER 50.84 -83.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.696 -0.627 . . . . 0.0 109.719 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.574 ' N ' ' O ' ' A' ' 83' ' ' ALA . 60.8 t-80 -174.97 -7.66 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.406 ' H ' ' H ' ' A' ' 85' ' ' HIS . 65.2 mtt -63.92 -41.27 97.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.394 -0.816 . . . . 0.0 109.702 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 88' ' ' LYS . 36.0 m120 -119.61 -74.65 0.6 Allowed 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.509 -0.744 . . . . 0.0 109.492 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.509 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 84.9 tttt 57.9 150.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.611 0.72 . . . . 0.0 110.264 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.419 ' CB ' ' O ' ' A' ' 88' ' ' LYS . 31.7 tt0 75.51 -67.42 0.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -65.53 -52.61 51.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.468 -0.77 . . . . 0.0 109.825 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.401 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 7.3 m0 -119.0 132.94 56.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.698 -0.626 . . . . 0.0 109.858 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.9 mm -117.19 133.95 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.8 p -87.42 143.14 27.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.773 -0.579 . . . . 0.0 110.152 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.4 t -122.29 134.91 64.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 49.6 tp -84.68 108.11 17.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.465 -0.772 . . . . 0.0 109.877 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.03 -39.58 93.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.656 -0.652 . . . . 0.0 109.353 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -75.25 1.18 14.21 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.276 -0.89 . . . . 0.0 109.092 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.0 177.14 20.26 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -74.71 -10.05 21.5 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 123.065 2.51 . . . . 0.0 111.844 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -66.61 143.32 57.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 0.0 110.403 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.78 170.52 48.04 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 120.604 -0.808 . . . . 0.0 111.153 -178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.64 -34.67 78.84 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.727 -0.867 . . . . 0.0 109.13 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -62.21 -39.14 91.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -65.08 -37.61 88.07 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.336 -0.853 . . . . 0.0 108.904 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 91.6 mt -63.42 -43.75 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.352 -0.842 . . . . 0.0 109.035 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -61.1 -45.46 94.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.426 -0.796 . . . . 0.0 109.762 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.9 m -61.39 -44.0 97.91 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.402 -0.811 . . . . 0.0 109.815 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 89.8 mt -64.34 -44.52 91.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 0.0 109.58 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.16 -42.76 91.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.399 -0.813 . . . . 0.0 108.939 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -55.03 -40.63 70.44 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -63.64 -42.19 98.16 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 48.6 m -61.21 -41.94 97.73 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -62.11 -45.3 94.07 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.602 -0.686 . . . . 0.0 110.224 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -59.9 -29.03 68.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.153 -0.967 . . . . 0.0 109.493 -179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.444 HD22 ' CD ' ' A' ' 67' ' ' GLN . 88.1 mt -79.53 -15.7 57.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.723 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.7 p -120.43 14.45 11.98 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.492 -0.755 . . . . 0.0 109.081 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -56.78 138.85 52.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.294 -0.878 . . . . 0.0 109.862 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HB2' ' ND2' ' A' ' 36' ' ' ASN . 6.1 tp -90.88 136.71 32.89 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.428 -0.795 . . . . 0.0 110.507 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -112.92 76.52 0.98 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.577 ' ND1' ' N ' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -67.67 -37.97 83.11 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.536 -0.727 . . . . 0.0 109.719 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 73.7 m80 -135.0 149.54 50.2 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.629 0.728 . . . . 0.0 110.221 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -67.01 -39.22 87.02 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.794 -0.566 . . . . 0.0 109.853 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 35.8 p-80 -147.68 155.4 41.72 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.083 -1.011 . . . . 0.0 109.944 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.423 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 6.5 p80 -152.27 165.7 34.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.423 -0.798 . . . . 0.0 109.845 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.423 ' CG ' ' O ' ' A' ' 124' ' ' HIS . 77.9 m80 . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 117.907 -1.044 . . . . 0.0 108.858 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.3 ttm . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.297 0.57 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -93.78 168.13 11.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -0.794 . . . . 0.0 110.511 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -62.08 -43.38 98.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.692 -0.63 . . . . 0.0 109.8 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -65.72 -37.55 86.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 0.0 109.612 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -63.9 -42.38 97.46 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.543 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -61.93 -45.41 93.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 109.741 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.8 -43.78 98.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.391 -0.818 . . . . 0.0 109.448 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.495 ' OD2' ' NZ ' ' A' ' 12' ' ' LYS . 45.6 t0 -65.26 -37.64 87.82 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.381 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.472 ' OH ' ' NZ ' ' A' ' 13' ' ' LYS . 83.4 t80 -59.97 -48.52 81.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.295 -0.878 . . . . 0.0 109.196 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.54 -30.69 71.06 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.478 -0.764 . . . . 0.0 109.115 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.56 ' O ' ' N ' ' A' ' 15' ' ' ASP . 36.0 tt0 -64.55 -42.26 95.8 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.46 -0.775 . . . . 0.0 109.404 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' NZ ' ' OD2' ' A' ' 8' ' ' ASP . 60.0 mttp -69.11 -36.8 77.93 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.882 -1.136 . . . . 0.0 109.814 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.472 ' NZ ' ' OH ' ' A' ' 9' ' ' TYR . 30.3 mmtp -88.17 -12.37 44.11 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 111.292 -178.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.496 ' CG ' ' CE1' ' A' ' 33' ' ' HIS . 94.2 m-85 -145.24 -22.11 0.49 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.869 -1.144 . . . . 0.0 110.46 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 11' ' ' GLN . 43.0 t0 54.82 34.58 22.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.143 -0.973 . . . . 0.0 109.011 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.7 m -102.01 130.1 48.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.404 -0.81 . . . . 0.0 109.402 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -87.02 156.71 54.82 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.445 -0.785 . . . . 0.0 109.985 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -51.54 140.16 45.49 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.188 1.925 . . . . 0.0 112.85 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -120.86 139.71 52.79 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -122.89 85.96 50.34 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.528 -0.732 . . . . 0.0 109.931 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -56.14 -39.55 90.5 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.65 2.233 . . . . 0.0 110.804 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.0 m-90 -96.34 131.78 42.51 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-O 121.709 0.766 . . . . 0.0 110.137 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.657 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 1.1 pm0 -73.53 -36.06 65.64 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.695 -0.628 . . . . 0.0 109.772 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.418 ' C ' ' CD1' ' A' ' 25' ' ' PHE . 18.8 mtpp -67.95 10.45 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.439 -0.788 . . . . 0.0 111.16 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 24' ' ' LYS . 81.2 m-85 -145.43 67.25 12.82 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 120.837 -1.164 . . . . 0.0 109.981 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.22 -20.37 32.74 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.571 2.18 . . . . 0.0 111.777 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -84.93 -4.11 58.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.068 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -88.42 150.8 22.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.788 . . . . 0.0 109.949 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.71 132.47 48.0 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.2 t -125.14 127.03 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.568 -0.707 . . . . 0.0 109.523 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.534 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 97.7 m-85 -111.11 119.52 39.26 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -142.12 135.09 28.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.224 -0.922 . . . . 0.0 109.572 179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.685 ' CD2' ' HE1' ' A' ' 39' ' ' TRP . 32.0 m-70 -100.1 127.52 46.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.572 -0.705 . . . . 0.0 109.818 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.7 p -69.76 -25.06 63.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.49 -0.756 . . . . 0.0 109.506 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -78.15 -7.19 56.73 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.373 -0.829 . . . . 0.0 109.797 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.442 ' ND2' ' O ' ' A' ' 116' ' ' THR . 13.4 t-20 -117.43 30.19 7.44 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 38' ' ' LYS . 53.2 t0 60.97 29.19 18.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.34 0.59 . . . . 0.0 110.212 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' O ' ' A' ' 37' ' ' ASP . 57.4 mttp 53.17 106.05 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.357 -0.839 . . . . 0.0 110.053 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.685 ' HE1' ' CD2' ' A' ' 33' ' ' HIS . 7.9 p-90 -101.53 -177.47 3.44 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.523 -0.736 . . . . 0.0 110.202 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -100.31 129.21 46.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.572 -0.705 . . . . 0.0 110.252 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.668 ' HB2' ' CZ3' ' A' ' 39' ' ' TRP . . . -151.03 105.75 3.28 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.409 ' H ' ' HB3' ' A' ' 63' ' ' ASP . 1.3 mm? -111.43 125.72 54.18 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.577 0.703 . . . . 0.0 109.57 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.642 HD23 ' C ' ' A' ' 43' ' ' LEU . 8.6 tt -129.66 112.91 14.15 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.402 ' C ' ' SD ' ' A' ' 44' ' ' MET . 0.0 OUTLIER -162.88 174.13 12.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.41 -0.806 . . . . 0.0 109.568 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 87.7 m-20 -101.57 141.43 34.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.684 -0.635 . . . . 0.0 109.716 179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.3 pt -143.34 145.54 32.56 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.565 -0.709 . . . . 0.0 109.464 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -48.5 144.28 14.18 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 121.989 1.792 . . . . 0.0 112.63 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.05 -24.06 67.74 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.6 -0.688 . . . . 0.0 110.191 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.86 -14.71 62.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 109.605 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -82.98 -12.58 57.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.399 -0.813 . . . . 0.0 110.501 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.471 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 11.2 pt -109.59 4.56 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.408 -0.808 . . . . 0.0 109.244 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.08 -17.19 59.06 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.0 mt -81.75 130.82 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 120.864 -1.374 . . . . 0.0 110.39 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -86.05 99.18 11.29 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.534 -0.729 . . . . 0.0 109.362 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.535 ' O ' ' N ' ' A' ' 57' ' ' LYS . . . -156.27 -8.17 0.07 OUTLIER Glycine 0 N--CA 1.486 1.975 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 55' ' ' GLY . 7.5 p-10 41.79 20.62 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.995 -0.709 . . . . 0.0 109.647 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.535 ' N ' ' O ' ' A' ' 55' ' ' GLY . 26.2 pttm -101.51 145.33 29.14 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.521 -0.737 . . . . 0.0 109.671 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -75.83 138.39 41.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.517 -0.739 . . . . 0.0 109.81 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.52 161.11 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.69 -0.631 . . . . 0.0 109.699 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.402 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 96.3 m-20 -88.79 132.42 34.64 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.559 -0.713 . . . . 0.0 109.433 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 26.8 m -137.01 149.23 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.35 -0.844 . . . . 0.0 109.836 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.2 pt -131.55 151.98 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-O 121.414 0.626 . . . . 0.0 109.823 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 67.9 t0 -86.05 142.54 28.66 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.456 -0.778 . . . . 0.0 109.457 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.63 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -133.01 126.71 32.51 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.63 ' N ' HD13 ' A' ' 64' ' ' LEU . 65.6 tttm -88.96 126.72 35.53 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.642 -0.661 . . . . 0.0 110.038 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.6 m -137.91 163.88 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.541 -0.724 . . . . 0.0 109.588 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -80.74 157.31 72.11 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.083 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' O ' HG12 ' A' ' 71' ' ' VAL . 17.7 Cg_endo -60.88 -18.02 54.37 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.6 2.2 . . . . 0.0 110.987 179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -95.44 -27.83 15.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.534 -0.729 . . . . 0.0 109.597 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.7 mt -89.89 -2.96 58.29 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.262 -0.898 . . . . 0.0 109.852 -179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.559 HG23 HD11 ' A' ' 92' ' ' ILE . 7.5 p -64.87 -38.87 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 109.867 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.45 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -59.32 -42.79 97.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 -178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 58.0 m -68.58 -56.26 8.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.329 . . . . 0.0 110.639 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.56 HD12 HD22 ' A' ' 108' ' ' LEU . 2.9 tt -65.56 -43.5 89.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.077 -1.014 . . . . 0.0 110.811 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.41 ' HE ' ' HB3' ' A' ' 82' ' ' PRO . 69.0 ttt-85 -67.81 -17.15 64.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.022 -1.049 . . . . 0.0 110.033 -178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.4 tmmm? -78.59 -31.52 47.22 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.032 -1.043 . . . . 0.0 108.94 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.8 mmtm -58.24 146.11 71.81 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.241 -0.912 . . . . 0.0 110.264 -177.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.71 148.31 58.63 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 122.332 2.021 . . . . 0.0 112.612 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.53 -17.89 46.01 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.726 ' N ' HD12 ' A' ' 80' ' ' ILE . 2.0 mp -87.72 123.15 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.353 -1.087 . . . . 0.0 109.526 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.471 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 65.7 m-85 -116.79 149.38 43.9 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.82 -0.55 . . . . 0.0 109.696 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HB3' ' HE ' ' A' ' 75' ' ' ARG . 51.7 Cg_endo -67.8 144.52 65.58 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.575 2.183 . . . . 0.0 112.15 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.83 144.9 55.12 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 0.0 109.989 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.485 ' CE1' ' CE1' ' A' ' 85' ' ' HIS . 43.9 p90 -78.1 9.0 4.05 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.438 -0.789 . . . . 0.0 109.334 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.485 ' CE1' ' CE1' ' A' ' 84' ' ' TYR . 96.3 m-70 -88.03 165.64 15.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 110.043 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 89.8 mtp -68.55 -8.39 41.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.415 -0.803 . . . . 0.0 109.681 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.621 ' C ' ' H ' ' A' ' 89' ' ' GLU . 60.6 m-80 -77.73 -67.47 0.72 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.32 -0.862 . . . . 0.0 109.549 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 63.3 -26.76 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.95 -0.468 . . . . 0.0 109.77 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 87' ' ' ASN . 97.6 mt-10 -98.67 -63.86 1.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.396 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.1 m170 -59.35 -46.52 88.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.318 -0.863 . . . . 0.0 110.338 -179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.609 ' CE3' ' ND2' ' A' ' 87' ' ' ASN . 9.3 m0 -116.41 138.55 51.27 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.618 0.723 . . . . 0.0 110.006 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.559 HD11 HG23 ' A' ' 71' ' ' VAL . 88.8 mt -138.56 153.51 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.6 m -97.56 138.4 35.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 110.036 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.6 t -120.34 133.44 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.4 tp -88.63 109.43 20.1 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.594 0.712 . . . . 0.0 110.408 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.63 -39.32 88.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -69.17 -8.65 47.55 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -57.25 178.26 0.96 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.29 -12.75 25.44 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.976 2.451 . . . . 0.0 111.686 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 pp -68.28 137.18 54.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.347 -0.846 . . . . 0.0 110.266 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.7 176.02 47.53 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.158 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.0 77.35 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.789 -0.83 . . . . 0.0 109.459 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 103' ' ' LYS . 13.5 mptt -62.0 -40.49 95.82 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.406 -0.808 . . . . 0.0 108.82 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -64.9 -41.99 95.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.34 -0.85 . . . . 0.0 108.869 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.4 -43.06 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.441 -0.787 . . . . 0.0 109.482 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -56.15 -43.57 78.42 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.703 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.2 p -64.22 -41.92 96.81 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.222 -0.924 . . . . 0.0 109.719 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.56 HD22 HD12 ' A' ' 74' ' ' LEU . 94.7 mt -64.81 -39.75 94.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.846 . . . . 0.0 109.602 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.73 -42.6 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.385 -0.822 . . . . 0.0 109.182 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -57.95 -39.26 77.64 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.212 -0.93 . . . . 0.0 109.083 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.45 -42.91 98.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.303 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 99.6 p -63.94 -34.74 78.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.355 -0.841 . . . . 0.0 109.36 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 117' ' ' ARG . 88.9 t80 -60.14 -44.78 94.69 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.404 -0.81 . . . . 0.0 109.306 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -60.37 -43.54 96.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.294 -0.879 . . . . 0.0 109.483 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.2 mt -64.5 -41.26 96.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.445 -0.784 . . . . 0.0 110.14 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.442 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 67.2 p -99.41 14.71 28.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.366 -0.834 . . . . 0.0 109.275 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.5 ' HG2' ' H ' ' A' ' 119' ' ' GLU . 38.6 ttp-105 -43.06 122.8 2.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.526 -0.734 . . . . 0.0 110.166 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.1 11.42 39.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.521 -0.737 . . . . 0.0 109.088 -179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.5 ' H ' ' HG2' ' A' ' 117' ' ' ARG . 72.6 mm-40 -63.65 140.6 58.89 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.466 -0.771 . . . . 0.0 109.755 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.562 ' ND1' ' N ' ' A' ' 121' ' ' HIS . 60.4 t-80 -153.85 173.53 15.79 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.922 . . . . 0.0 109.981 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.562 ' N ' ' ND1' ' A' ' 120' ' ' HIS . 58.5 m170 -67.77 8.1 0.42 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.508 -0.745 . . . . 0.0 109.621 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' A' ' 120' ' ' HIS . 99.5 m-70 56.26 109.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 121.64 0.733 . . . . 0.0 110.382 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -66.95 -38.66 86.54 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.489 -0.757 . . . . 0.0 109.443 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 36.0 p-80 -148.79 159.44 44.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.207 -0.933 . . . . 0.0 110.171 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.023 -179.509 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -93.57 -177.98 4.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.243 -0.911 . . . . 0.0 110.08 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.458 ' NH2' ' OD1' ' A' ' 60' ' ' ASP . 12.0 ptp85 -63.2 -32.9 74.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.481 -0.762 . . . . 0.0 109.541 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -56.44 -43.39 79.41 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.329 -0.857 . . . . 0.0 109.127 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.03 -42.44 84.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.067 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -62.05 -45.37 93.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.52 -0.737 . . . . 0.0 109.752 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.36 -43.09 98.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.408 -0.808 . . . . 0.0 109.36 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.72 -39.32 91.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.372 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -60.58 -44.46 96.18 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 109.818 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.06 86.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.521 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' A' ' 16' ' ' THR . 98.9 mm-40 -65.19 -45.89 82.98 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 110.021 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -66.99 -37.27 83.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -0.871 . . . . 0.0 110.207 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -63.71 -50.51 68.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.105 -0.997 . . . . 0.0 111.94 -177.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -147.02 17.53 1.23 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.53 -1.357 . . . . 0.0 110.225 -179.343 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 55.05 47.53 21.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.149 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.537 ' O ' ' NE2' ' A' ' 11' ' ' GLN . 88.3 m -101.07 123.74 45.7 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.294 -0.879 . . . . 0.0 109.7 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' HB3' ' HZ3' ' A' ' 17' ' ' LYS . 0.3 OUTLIER -93.67 148.83 36.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.7 157.36 60.77 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.206 1.937 . . . . 0.0 112.672 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -108.71 155.15 21.06 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -136.85 86.56 21.15 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.478 -0.764 . . . . 0.0 110.047 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -86.78 -10.99 5.87 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.782 2.322 . . . . 0.0 110.393 178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -102.04 98.66 8.83 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.5 0.667 . . . . 0.0 109.816 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 24' ' ' LYS . 14.9 pt-20 -68.55 -37.35 79.86 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 121.545 0.688 . . . . 0.0 109.658 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 23' ' ' GLU . 9.8 mtpm? -70.79 -3.54 19.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.479 -0.763 . . . . 0.0 110.788 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -142.95 77.38 16.25 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.078 -1.014 . . . . 0.0 110.018 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.66 -14.84 33.56 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.562 2.175 . . . . 0.0 112.099 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -78.72 -4.94 51.71 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.252 -0.905 . . . . 0.0 109.521 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -94.72 142.73 27.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.255 -0.903 . . . . 0.0 110.102 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -128.93 139.57 52.06 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -124.48 128.32 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.516 -0.74 . . . . 0.0 110.245 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -110.37 114.44 27.88 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' NH2' ' O ' ' A' ' 37' ' ' ASP . 77.8 ttt-85 -145.35 138.64 26.45 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.196 -0.94 . . . . 0.0 109.459 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.458 ' ND1' ' CD1' ' A' ' 39' ' ' TRP . 32.5 m170 -100.58 124.63 46.41 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.472 -0.767 . . . . 0.0 109.951 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.2 m -75.79 -22.71 56.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.428 -0.795 . . . . 0.0 109.983 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.64 -41.86 99.28 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.124 -0.985 . . . . 0.0 110.208 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 38' ' ' LYS . 12.3 m120 -93.49 4.07 54.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 0.0 108.531 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 98.8 m-20 47.56 11.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.77 . . . . 0.0 110.182 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 36' ' ' ASN . 8.4 mtmp? -139.99 -121.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.258 -0.901 . . . . 0.0 109.532 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.458 ' CD1' ' ND1' ' A' ' 33' ' ' HIS . 56.7 t-105 46.53 96.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.659 -0.651 . . . . 0.0 109.321 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -106.63 126.28 52.07 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.707 0.765 . . . . 0.0 109.981 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.06 128.53 10.68 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.73 140.55 27.29 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.943 -1.098 . . . . 0.0 109.812 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.6 130.74 55.49 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 7.6 ptt? -157.19 157.88 35.2 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.943 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 33.6 p-10 -98.98 116.6 31.58 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.2 pt -125.74 145.8 52.85 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.688 -0.633 . . . . 0.0 109.722 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -48.2 139.05 22.02 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.811 1.674 . . . . 0.0 112.304 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.5 -22.03 65.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 110.191 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -62.67 -29.76 70.89 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.142 -0.974 . . . . 0.0 109.641 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.71 -40.55 95.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 110.802 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.472 HD12 HD12 ' A' ' 53' ' ' ILE . 12.2 pt -79.08 16.0 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.758 -1.214 . . . . 0.0 109.739 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 81.19 -8.24 58.36 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 120.443 -0.884 . . . . 0.0 110.927 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.472 HD12 HD12 ' A' ' 51' ' ' ILE . 80.9 mt -82.7 129.01 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.638 -1.507 . . . . 0.0 109.81 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -85.39 97.12 9.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.494 -0.754 . . . . 0.0 110.276 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.59 -16.96 0.09 OUTLIER Glycine 0 N--CA 1.492 2.386 0 N-CA-C 108.516 -1.833 . . . . 0.0 108.516 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.424 ' O ' ' OD1' ' A' ' 56' ' ' ASP . 57.6 t0 51.19 19.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -1.032 . . . . 0.0 109.069 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -107.9 146.3 32.55 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.583 -0.698 . . . . 0.0 110.138 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -73.91 139.3 44.85 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.493 -0.754 . . . . 0.0 109.7 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m -135.44 157.88 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.424 -0.797 . . . . 0.0 109.464 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.458 ' OD1' ' NH2' ' A' ' 3' ' ' ARG . 90.2 m-20 -91.21 131.32 36.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.466 -0.771 . . . . 0.0 109.755 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 29.1 m -134.26 158.6 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.535 -0.728 . . . . 0.0 109.446 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.5 pt -134.53 146.49 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 CA-C-O 121.421 0.629 . . . . 0.0 109.614 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 64.4 t0 -79.29 134.78 36.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.407 -0.808 . . . . 0.0 110.229 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -127.14 121.82 32.45 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.589 ' N ' HD13 ' A' ' 64' ' ' LEU . 7.3 tmtm? -83.89 134.83 34.67 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.418 -0.801 . . . . 0.0 110.114 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.0 m -143.84 164.28 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.228 -0.92 . . . . 0.0 109.649 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -93.32 155.34 41.04 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.24 -0.912 . . . . 0.0 109.521 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.507 ' O ' HG12 ' A' ' 71' ' ' VAL . 47.6 Cg_exo -48.75 -28.9 13.55 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.167 1.911 . . . . 0.0 111.26 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -90.02 -32.11 16.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.459 -0.776 . . . . 0.0 109.376 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.1 mt -88.59 -5.25 58.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.89 . . . . 0.0 109.466 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 68' ' ' PRO . 9.2 p -68.53 -40.44 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -0.909 . . . . 0.0 109.863 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.482 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.87 -44.0 96.75 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.5 t -64.73 -26.32 68.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.938 -1.331 . . . . 0.0 110.21 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.537 HD12 HD22 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -86.98 -33.89 19.47 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.866 -1.146 . . . . 0.0 109.829 179.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -76.21 -7.49 54.97 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.375 -0.828 . . . . 0.0 109.105 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -7.33 59.68 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.476 ' HB2' HD12 ' A' ' 80' ' ' ILE . 61.2 mttm -94.14 113.76 61.53 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.634 -0.667 . . . . 0.0 109.474 -179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.94 147.05 19.95 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.303 2.002 . . . . 0.0 113.282 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.07 -13.28 67.31 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 77' ' ' LYS . 15.4 mt -107.28 124.43 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.529 -0.983 . . . . 0.0 109.085 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.404 ' O ' ' OG1' ' A' ' 93' ' ' THR . 56.1 m-85 -119.47 150.07 49.04 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.76 -0.588 . . . . 0.0 110.01 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 83' ' ' ALA . 37.1 Cg_exo -56.13 149.45 53.66 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.124 1.882 . . . . 0.0 112.576 178.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 88' ' ' LYS . . . -45.99 174.19 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.825 0.822 . . . . 0.0 111.129 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -72.62 -71.73 0.28 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -137.97 140.95 40.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.551 -0.718 . . . . 0.0 109.934 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.0 mmm 57.59 154.05 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.738 0.78 . . . . 0.0 111.231 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.546 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 85.1 m-20 56.56 33.21 22.27 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.51 0.672 . . . . 0.0 109.388 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.463 ' O ' HD13 ' A' ' 92' ' ' ILE . 37.8 ttpt -63.27 -46.96 84.38 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.454 -0.779 . . . . 0.0 109.262 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -79.37 -35.87 40.15 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.122 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -66.35 -50.71 62.65 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.339 -0.851 . . . . 0.0 110.243 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.546 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 11.1 m0 -117.5 152.08 35.8 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.587 -0.696 . . . . 0.0 109.753 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.463 HD13 ' O ' ' A' ' 88' ' ' LYS . 6.4 mm -136.22 157.68 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.567 -0.708 . . . . 0.0 109.451 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 7.6 p -105.85 123.68 48.35 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 41.8 t -108.46 131.06 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.5 tp -89.91 104.18 16.77 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.206 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.06 -39.49 86.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.539 -0.725 . . . . 0.0 109.264 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -69.28 -6.1 27.2 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.41 -0.806 . . . . 0.0 109.047 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -77.83 -162.26 18.12 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.72 6.26 5.89 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.348 2.699 . . . . 0.0 111.564 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -61.71 130.94 48.2 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 110.254 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.91 154.79 24.91 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.38 95.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.543 -0.975 . . . . 0.0 109.297 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -64.71 -42.08 95.51 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -0.943 . . . . 0.0 109.074 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -66.03 -43.95 86.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.446 -0.784 . . . . 0.0 109.198 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 93.8 mt -64.58 -43.48 96.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 109.069 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 49.6 m170 -60.43 -43.57 96.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.462 -0.774 . . . . 0.0 109.654 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -62.77 -42.72 99.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.819 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.537 HD22 HD12 ' A' ' 74' ' ' LEU . 95.1 mt -64.79 -41.92 95.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.931 . . . . 0.0 109.584 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.79 -43.17 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.304 -0.872 . . . . 0.0 108.919 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -61.19 -41.99 97.79 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -64.04 -41.58 97.36 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 90.7 p -66.07 -33.91 76.87 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.79 . . . . 0.0 109.304 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.25 -47.93 83.79 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 0.0 109.633 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -72.49 -29.03 63.27 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.273 -0.892 . . . . 0.0 109.451 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.7 tp -63.94 -42.23 97.39 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.185 -0.947 . . . . 0.0 109.511 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' ' 117' ' ' ARG . 62.2 p -97.11 14.73 24.75 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.569 -0.707 . . . . 0.0 109.1 -178.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.475 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 77.7 ttt-85 -40.78 -95.57 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.881 -0.512 . . . . 0.0 110.167 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.51 93.04 1.17 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -137.86 82.86 1.94 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -152.59 -59.99 0.15 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -84.08 138.69 32.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.649 -0.657 . . . . 0.0 110.22 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -148.55 -25.81 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -67.37 -39.35 85.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.476 -0.765 . . . . 0.0 109.664 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -65.79 -41.7 91.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.36 -0.838 . . . . 0.0 109.705 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.527 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.326 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 tpp . . . . . 0 N--CA 1.492 1.662 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -105.77 163.85 12.39 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.553 -0.717 . . . . 0.0 110.019 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -61.48 -43.25 99.2 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.622 -0.674 . . . . 0.0 109.585 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -64.26 -40.91 96.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.452 -0.78 . . . . 0.0 109.754 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -64.89 -42.27 94.91 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.0 109.572 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -61.42 -45.03 96.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.767 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.3 mt -62.29 -44.67 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.26 -0.9 . . . . 0.0 109.153 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.63 -44.13 94.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.395 -0.816 . . . . 0.0 109.487 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -64.15 -42.1 96.91 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.483 -0.76 . . . . 0.0 109.872 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.5 -54.31 48.29 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.379 -0.826 . . . . 0.0 110.698 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -64.9 -33.1 75.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.244 -0.91 . . . . 0.0 109.756 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -60.57 -46.59 89.65 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.026 -1.046 . . . . 0.0 109.791 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -87.2 -37.61 17.13 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.348 -0.845 . . . . 0.0 111.416 -178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.452 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 77.2 m-85 -94.57 -0.73 54.32 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.924 -1.11 . . . . 0.0 111.115 -178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 14' ' ' TYR . 3.4 p30 40.97 35.61 0.36 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.379 -0.825 . . . . 0.0 109.907 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.6 t -118.64 143.88 46.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.566 -0.709 . . . . 0.0 109.359 -179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -96.23 151.81 38.4 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.308 -0.87 . . . . 0.0 109.564 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.22 149.55 85.32 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.469 2.112 . . . . 0.0 112.162 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 66.1 t0 -132.8 138.51 47.14 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.517 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 5.5 p80 -131.24 85.58 53.43 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -79.29 -10.52 14.87 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 121.943 1.762 . . . . 0.0 111.14 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.4 m-90 -89.15 102.87 15.52 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.456 0.646 . . . . 0.0 109.555 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.86 -33.84 74.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.475 -0.766 . . . . 0.0 109.592 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' C ' ' CD1' ' A' ' 25' ' ' PHE . 60.1 mttp -68.06 -5.75 19.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.348 -0.845 . . . . 0.0 109.849 -179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' CD1' ' C ' ' A' ' 24' ' ' LYS . 64.1 m-85 -153.29 83.84 4.49 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.202 -0.936 . . . . 0.0 109.463 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.4 -15.61 31.15 Favored 'Trans proline' 0 N--CA 1.489 1.228 0 C-N-CA 121.565 1.51 . . . . 0.0 111.209 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -75.63 -5.92 47.84 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.4 m-85 -86.08 141.68 29.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 109.106 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.98 135.93 38.08 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.4 HG11 ' NH1' ' A' ' 32' ' ' ARG . 3.1 t -117.44 126.01 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 93.9 m-85 -110.26 122.66 48.2 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.4 ' NH1' HG11 ' A' ' 30' ' ' VAL . 95.6 mtm-85 -134.3 155.22 50.6 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.051 -1.031 . . . . 0.0 109.267 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 37' ' ' ASP . 1.4 t-160 -85.42 113.84 22.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.273 -0.892 . . . . 0.0 109.317 -179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.1 t -65.35 -23.43 66.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.525 -0.735 . . . . 0.0 109.799 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.8 -44.57 92.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.377 -0.827 . . . . 0.0 110.639 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.541 ' N ' ' OD1' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -122.48 -26.73 4.53 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.377 -0.827 . . . . 0.0 109.63 -178.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.523 ' N ' ' O ' ' A' ' 33' ' ' HIS . 54.4 m-20 58.49 -159.12 0.29 Allowed 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.438 0.637 . . . . 0.0 109.938 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.8 mttp 59.9 24.51 13.59 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.934 -0.479 . . . . 0.0 110.274 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.405 ' HE1' ' HB2' ' A' ' 36' ' ' ASN . 44.0 m95 -112.25 149.02 32.91 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.396 -0.815 . . . . 0.0 109.553 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -113.71 131.53 56.14 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.676 0.75 . . . . 0.0 110.239 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 31' ' ' PHE . . . -151.15 105.62 3.24 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.2 mm? -107.58 131.89 53.87 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.724 0.773 . . . . 0.0 110.417 -178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.0 tt -126.76 120.29 28.99 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.592 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 3.7 ptt? -160.41 164.19 32.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.01 . . . . 0.0 109.507 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 96.9 m-20 -98.38 118.78 35.81 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.2 pt -120.73 145.95 42.36 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.44 -0.788 . . . . 0.0 109.45 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -60.21 141.74 96.67 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.902 1.735 . . . . 0.0 112.719 -178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.19 -20.74 65.69 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.493 0.663 . . . . 0.0 109.263 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.436 ' OE2' ' OD1' ' A' ' 56' ' ' ASP . 95.6 mt-10 -53.69 -36.0 61.72 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.625 -0.672 . . . . 0.0 109.899 -178.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.05 -39.01 93.46 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 110.317 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.9 HD12 HD12 ' A' ' 53' ' ' ILE . 5.2 pt -92.94 -0.94 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.105 -0.997 . . . . 0.0 109.558 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.08 36.44 85.73 Favored Glycine 0 N--CA 1.495 2.6 0 C-N-CA 120.16 -1.019 . . . . 0.0 111.153 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.9 HD12 HD12 ' A' ' 51' ' ' ILE . 6.0 mt -104.46 133.63 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.182 -1.187 . . . . 0.0 109.713 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 52.77 -83.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.707 -0.621 . . . . 0.0 109.806 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . 143.46 114.65 1.0 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 0.6 OUTLIER 61.47 39.35 15.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.623 -0.928 . . . . 0.0 110.67 178.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -113.46 118.63 35.04 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -72.39 133.35 44.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.181 -0.949 . . . . 0.0 109.516 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.11 161.66 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.494 -0.754 . . . . 0.0 109.418 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 20.3 m-20 -99.43 138.07 37.03 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.29 -0.881 . . . . 0.0 109.444 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.75 156.59 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.304 -0.872 . . . . 0.0 109.344 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.8 pt -133.74 157.98 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.549 0.69 . . . . 0.0 109.702 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 42' ' ' LEU . 44.5 t0 -90.48 122.07 32.99 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.539 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -115.85 120.47 39.36 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.539 ' N ' HD13 ' A' ' 64' ' ' LEU . 37.9 ttmt -84.23 135.55 34.3 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.321 -0.862 . . . . 0.0 109.849 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.604 HG11 HD13 ' A' ' 74' ' ' LEU . 30.0 m -143.29 169.65 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.287 -0.883 . . . . 0.0 109.63 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -78.11 153.59 79.86 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.583 -0.698 . . . . 0.0 109.489 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' O ' HG12 ' A' ' 71' ' ' VAL . 28.8 Cg_endo -63.77 -19.26 66.81 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.256 1.97 . . . . 0.0 111.313 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -91.42 -27.56 18.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.48 -0.763 . . . . 0.0 109.395 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 79.1 mt -94.21 7.62 44.63 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.322 -0.861 . . . . 0.0 109.221 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 72' ' ' GLY . 7.1 p -63.26 -37.53 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.465 -0.772 . . . . 0.0 109.981 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -78.3 -15.1 81.47 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.904 -1.141 . . . . 0.0 110.522 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -71.25 -60.6 2.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.014 -1.286 . . . . 0.0 110.737 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.737 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.5 pt? -75.49 -37.23 60.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.184 -0.947 . . . . 0.0 110.537 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.432 ' HE ' ' HB3' ' A' ' 82' ' ' PRO . 79.0 ttt-85 -60.61 -33.07 72.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.389 -0.819 . . . . 0.0 109.475 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -32.84 73.69 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.315 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -68.09 120.36 73.78 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.176 -0.952 . . . . 0.0 110.059 -178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.05 147.28 20.06 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 121.938 1.759 . . . . 0.0 112.61 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.88 -22.56 34.97 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 83.8 mt -105.85 120.89 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.535 -0.98 . . . . 0.0 109.279 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -107.08 150.76 40.27 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.497 -0.752 . . . . 0.0 109.923 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.502 ' CB ' ' HZ2' ' A' ' 88' ' ' LYS . 53.6 Cg_endo -69.41 159.15 54.8 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.223 1.949 . . . . 0.0 111.92 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.03 142.37 58.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 109.984 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -79.29 12.9 2.12 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.355 -0.841 . . . . 0.0 109.843 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.9 p-80 -156.63 -161.5 1.11 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.23 -0.919 . . . . 0.0 110.176 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 78.9 mtm -52.77 -175.25 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.571 0.701 . . . . 0.0 111.078 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 19.9 m120 59.1 33.19 22.74 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.514 0.673 . . . . 0.0 109.687 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.502 ' HZ2' ' CB ' ' A' ' 82' ' ' PRO . 64.4 tttp -64.65 -39.22 93.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.556 -0.715 . . . . 0.0 109.605 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -89.28 -16.99 29.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.116 -0.99 . . . . 0.0 109.934 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -94.48 -53.33 3.94 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.24 -0.913 . . . . 0.0 110.358 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -111.19 131.32 55.21 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.389 -0.819 . . . . 0.0 109.781 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.7 mm -117.98 141.12 38.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.4 m -86.77 129.46 34.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.24 -0.913 . . . . 0.0 109.218 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.1 t -114.16 133.17 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.1 tp -91.05 108.51 19.92 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.648 -0.657 . . . . 0.0 109.923 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.34 -39.46 92.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.53 -0.731 . . . . 0.0 109.086 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -76.03 5.56 6.48 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.5 -0.75 . . . . 0.0 109.034 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -70.51 -176.44 20.43 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.117 -1.193 . . . . 0.0 110.117 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -79.42 -6.59 14.7 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.113 2.542 . . . . 0.0 111.701 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -71.83 145.84 48.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.646 -0.659 . . . . 0.0 109.794 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -95.08 173.01 31.28 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 -179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.55 -29.1 70.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.653 -0.91 . . . . 0.0 109.332 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.18 -41.31 98.21 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.456 -0.778 . . . . 0.0 109.234 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 104' ' ' GLU . 58.2 mp0 -65.69 -41.61 92.21 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.407 -0.808 . . . . 0.0 109.19 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.38 -43.42 97.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.418 -0.801 . . . . 0.0 109.931 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 44.7 m170 -56.03 -45.75 79.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.83 . . . . 0.0 109.589 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.6 t -61.94 -44.27 97.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.4 -0.812 . . . . 0.0 109.935 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.9 -41.32 99.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.427 -0.796 . . . . 0.0 109.658 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.77 -43.18 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 0.0 109.747 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -56.29 -43.69 79.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 0.0 109.089 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 47.7 t0 -60.06 -44.75 94.51 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.365 -0.835 . . . . 0.0 109.09 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.7 p -70.38 -27.18 64.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.258 -0.902 . . . . 0.0 109.983 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -59.07 -44.85 91.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.331 -0.856 . . . . 0.0 109.382 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -58.46 -43.31 88.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.893 . . . . 0.0 109.653 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.9 mp -63.33 -39.59 94.96 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.262 -0.899 . . . . 0.0 109.512 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.0 p -88.98 4.94 46.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.461 -0.774 . . . . 0.0 109.62 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -74.06 145.77 44.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.404 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 56.2 tp -67.11 136.07 54.57 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.212 -0.93 . . . . 0.0 109.337 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -77.75 110.37 12.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 109.709 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.429 ' CG ' ' O ' ' A' ' 120' ' ' HIS . 85.8 t60 -96.52 10.33 38.7 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.427 -0.796 . . . . 0.0 108.898 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 50.3 m80 54.5 175.44 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.367 0.603 . . . . 0.0 110.524 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -144.49 141.11 29.33 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.388 -0.82 . . . . 0.0 109.783 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.445 ' CD2' ' O ' ' A' ' 124' ' ' HIS . 80.3 t60 -79.01 144.52 34.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.394 -0.816 . . . . 0.0 110.192 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.445 ' O ' ' CD2' ' A' ' 123' ' ' HIS . 63.4 t-80 -65.05 145.77 55.88 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.494 -0.754 . . . . 0.0 110.024 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.526 ' OXT' ' CG ' ' A' ' 125' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.413 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.438 ' OD1' ' OE1' ' A' ' 5' ' ' GLN . 28.7 p30 -152.77 -179.03 7.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.22 -0.925 . . . . 0.0 109.536 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.615 ' HE ' HD21 ' A' ' 43' ' ' LEU . 12.6 ptm180 -61.53 -33.0 73.08 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.456 -0.778 . . . . 0.0 109.369 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.587 HE22 ' CG ' ' A' ' 8' ' ' ASP . 4.5 tm0? -61.36 -44.12 97.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 110.001 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.438 ' OE1' ' OD1' ' A' ' 2' ' ' ASN . 4.3 mp0 -64.44 -38.42 90.95 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.245 -0.909 . . . . 0.0 108.733 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 39.5 t80 -60.2 -45.12 94.25 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.206 -0.934 . . . . 0.0 109.309 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.74 -44.83 98.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.3 -0.875 . . . . 0.0 109.547 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.587 ' CG ' HE22 ' A' ' 4' ' ' GLN . 54.4 m-20 -64.73 -46.11 83.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 108.727 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -63.48 -39.91 95.69 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.383 -0.823 . . . . 0.0 109.093 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.09 -43.56 70.47 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.461 -0.774 . . . . 0.0 109.679 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 86.0 mt-30 -67.21 -40.63 86.45 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.156 -0.965 . . . . 0.0 109.651 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -63.4 -38.17 90.13 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.852 -1.155 . . . . 0.0 109.265 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.9 tptp -86.76 -35.84 18.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.279 -0.888 . . . . 0.0 111.691 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -118.74 -20.8 8.12 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.134 -0.978 . . . . 0.0 111.032 -177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 44.2 t0 59.0 38.66 24.12 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.949 -1.094 . . . . 0.0 109.118 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.2 m -107.07 135.79 48.03 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.558 -0.714 . . . . 0.0 109.334 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -82.15 131.21 57.06 Favored Pre-proline 0 C--N 1.304 -1.398 0 O-C-N 121.158 -0.964 . . . . 0.0 109.837 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.52 143.11 22.04 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.17 1.914 . . . . 0.0 112.982 179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -127.72 121.89 31.47 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.634 -0.666 . . . . 0.0 109.276 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.48 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -119.62 86.83 35.64 Favored Pre-proline 0 N--CA 1.496 1.83 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.2 -37.13 87.66 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.462 2.108 . . . . 0.0 111.146 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.476 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -87.81 83.87 7.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.337 -0.852 . . . . 0.0 109.064 179.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -54.59 -14.43 1.31 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.458 -0.776 . . . . 0.0 109.564 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -76.18 -2.62 32.06 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -141.25 75.63 22.92 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.287 -0.883 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.65 -31.42 91.86 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.723 2.282 . . . . 0.0 111.327 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.472 ' O ' ' NH2' ' A' ' 3' ' ' ARG . 98.9 m-20 -68.22 -16.04 63.82 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.401 -0.812 . . . . 0.0 109.347 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -92.56 132.16 37.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 0.0 109.213 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.09 141.07 50.12 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.15 133.55 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.521 -0.737 . . . . 0.0 109.043 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -107.95 143.81 36.08 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.56 -0.712 . . . . 0.0 109.217 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -132.85 129.68 38.77 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.34 -0.85 . . . . 0.0 110.051 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.467 ' H ' ' HB2' ' A' ' 39' ' ' TRP . 80.2 m80 -103.28 111.99 24.65 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.0 p -88.21 -16.66 32.7 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -94.39 -0.73 54.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.183 -0.948 . . . . 0.0 110.337 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.561 ' O ' ' N ' ' A' ' 38' ' ' LYS . 20.3 t-20 -115.99 29.8 7.75 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.382 -0.823 . . . . 0.0 109.854 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 67.9 t0 46.68 -86.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.575 -0.703 . . . . 0.0 110.511 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.1 tttt -79.98 136.15 36.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.603 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.54 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 7.8 p90 -141.96 141.38 32.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.281 -0.887 . . . . 0.0 110.607 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.525 ' CD2' ' O ' ' A' ' 39' ' ' TRP . 29.0 m-85 -159.51 119.96 3.1 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.517 ' C ' HD22 ' A' ' 42' ' ' LEU . . . -156.83 105.4 2.19 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 108.769 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.517 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.2 mm? -113.09 125.01 53.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.537 -0.727 . . . . 0.0 109.286 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.634 HD23 ' C ' ' A' ' 43' ' ' LEU . 8.8 tt -123.59 116.71 23.58 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 8.2 ptt? -162.74 167.46 22.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.026 -1.046 . . . . 0.0 109.499 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.523 ' OD2' ' NH2' ' A' ' 58' ' ' ARG . 34.7 p-10 -106.95 116.75 32.47 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.6 pt -118.71 146.65 40.44 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.837 -0.539 . . . . 0.0 110.248 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.27 145.33 11.5 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.104 1.869 . . . . 0.0 112.846 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -61.44 -21.48 64.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.402 -0.811 . . . . 0.0 109.948 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' OE2' ' O ' ' A' ' 54' ' ' ASN . 61.9 mm-40 -70.31 -15.41 62.88 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.917 -1.114 . . . . 0.0 110.28 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -84.67 -10.99 56.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.982 -1.074 . . . . 0.0 110.605 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.445 ' CD1' HD12 ' A' ' 53' ' ' ILE . 4.7 pt -104.53 2.82 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.216 -0.927 . . . . 0.0 109.027 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.69 -5.0 69.53 Favored Glycine 0 N--CA 1.496 2.662 0 O-C-N 121.245 -0.91 . . . . 0.0 110.854 178.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 55' ' ' GLY . 86.6 mt -81.47 138.09 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.912 -1.346 . . . . 0.0 110.235 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.425 ' O ' ' OE2' ' A' ' 49' ' ' GLU . 56.4 m-80 -61.58 -39.34 90.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.603 -0.686 . . . . 0.0 109.397 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 53' ' ' ILE . . . -42.59 139.8 2.4 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 110.561 -1.015 . . . . 0.0 110.561 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 36.9 p-10 -103.33 14.0 32.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.546 -0.973 . . . . 0.0 109.065 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 78.5 tttt -82.15 143.06 31.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.337 -0.852 . . . . 0.0 110.366 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.523 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 84.9 mtp180 -72.48 144.28 48.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.51 -0.744 . . . . 0.0 109.99 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HB ' HD11 ' A' ' 95' ' ' LEU . 27.3 m -136.36 162.89 34.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.495 -0.753 . . . . 0.0 110.003 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -97.37 136.93 37.12 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.474 -0.766 . . . . 0.0 109.789 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 m -134.37 155.59 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.39 -0.819 . . . . 0.0 110.374 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 35.2 pt -138.32 150.51 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -81.98 152.38 26.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.398 -0.814 . . . . 0.0 110.065 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.622 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -141.1 125.06 17.13 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.622 ' N ' HD13 ' A' ' 64' ' ' LEU . 3.5 pttm -84.84 131.06 34.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.197 -0.94 . . . . 0.0 109.359 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.97 165.31 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.269 -0.894 . . . . 0.0 109.445 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -87.41 157.99 52.36 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.494 -0.754 . . . . 0.0 109.086 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.71 -21.03 68.19 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.577 2.185 . . . . 0.0 111.352 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -95.01 -29.39 14.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 109.063 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.47 -3.47 49.95 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.264 -0.897 . . . . 0.0 109.81 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.1 p -65.08 -36.14 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.058 -1.027 . . . . 0.0 109.591 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.45 -42.45 99.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.5 m -61.7 -42.7 99.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.041 -1.27 . . . . 0.0 110.47 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.484 HD12 HD22 ' A' ' 108' ' ' LEU . 3.5 tt -85.0 -31.82 23.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.059 -1.026 . . . . 0.0 110.376 -179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.6 ttt-85 -77.02 -21.87 53.93 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.114 -0.991 . . . . 0.0 110.401 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.2 pptp? -85.61 -2.86 58.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.923 -1.111 . . . . 0.0 109.21 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.614 ' HB2' HD12 ' A' ' 80' ' ' ILE . 50.3 mttm -77.41 151.56 80.78 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 80' ' ' ILE . 73.7 Cg_endo -72.28 151.64 54.67 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.864 2.376 . . . . 0.0 112.565 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.04 -20.12 2.59 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 77' ' ' LYS . 72.2 mt -97.43 116.12 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -1.117 . . . . 0.0 108.363 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.408 ' O ' ' OG1' ' A' ' 93' ' ' THR . 18.1 m-85 -123.08 161.22 46.0 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.887 -0.508 . . . . 0.0 110.087 -178.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.61 153.07 69.51 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 122.006 1.804 . . . . 0.0 111.961 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.33 140.37 33.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.877 . . . . 0.0 110.585 -179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -74.77 7.62 2.97 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.473 -0.767 . . . . 0.0 109.125 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.406 ' O ' ' C ' ' A' ' 86' ' ' MET . 51.6 p-80 -157.7 -172.73 4.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 0.0 110.219 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.406 ' C ' ' O ' ' A' ' 85' ' ' HIS . 79.0 mtm -38.06 158.92 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.457 0.646 . . . . 0.0 111.623 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.6 m120 72.96 79.96 0.14 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 121.426 0.631 . . . . 0.0 110.339 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -114.16 -36.3 4.76 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.591 -0.693 . . . . 0.0 109.547 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.81 -85.13 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 O-C-N 120.946 -1.096 . . . . 0.0 111.087 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -67.92 -33.38 74.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.387 -0.821 . . . . 0.0 110.677 -178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.439 ' HE1' ' CB ' ' A' ' 40' ' ' TYR . 24.8 m-90 -93.93 130.62 39.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.014 . . . . 0.0 110.542 -178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.0 mm -134.89 143.8 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.437 -0.79 . . . . 0.0 109.021 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 81' ' ' TYR . 1.1 p -91.51 134.57 34.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.254 -0.904 . . . . 0.0 109.485 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 45.5 t -114.82 133.82 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.411 HD11 ' HB ' ' A' ' 59' ' ' VAL . 46.6 tp -91.47 123.74 35.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.688 -0.633 . . . . 0.0 109.897 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.6 mt -87.64 -13.93 41.36 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -94.39 0.21 55.3 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.416 ' C ' ' H ' ' A' ' 100' ' ' LEU . . . -89.14 -165.45 41.2 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.62 9.01 0.36 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 123.225 2.617 . . . . 0.0 111.259 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.565 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.7 mm? -70.35 124.86 25.2 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.252 -0.905 . . . . 0.0 109.981 -178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -98.16 161.47 20.8 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.28 89.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.567 -0.961 . . . . 0.0 109.364 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -64.72 -41.7 95.79 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -65.07 -44.93 87.34 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -0.806 . . . . 0.0 109.595 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.21 -43.4 97.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.276 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -58.98 -42.68 90.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.4 m -61.34 -44.02 97.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.936 . . . . 0.0 109.95 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.484 HD22 HD12 ' A' ' 74' ' ' LEU . 96.2 mt -63.99 -41.81 97.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -0.887 . . . . 0.0 109.348 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.9 mt -63.66 -42.77 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 O-C-N 121.388 -0.82 . . . . 0.0 109.187 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -55.54 -42.42 74.58 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.203 -0.935 . . . . 0.0 109.09 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.423 ' HA ' HE21 ' A' ' 114' ' ' GLN . 64.8 t0 -63.36 -40.65 97.85 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.343 -0.848 . . . . 0.0 109.19 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.454 ' OG ' HD11 ' A' ' 64' ' ' LEU . 1.4 m -63.24 -36.86 85.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.434 -0.791 . . . . 0.0 109.325 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -60.54 -47.27 86.92 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.426 -0.796 . . . . 0.0 110.409 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.423 HE21 ' HA ' ' A' ' 111' ' ' ASP . 17.4 pt20 -77.0 -20.59 55.86 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 0.0 109.856 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.3 tp -61.68 -42.01 98.35 Favored 'General case' 0 C--N 1.306 -1.318 0 O-C-N 121.16 -0.962 . . . . 0.0 109.951 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.487 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 6.2 p -101.21 16.77 24.39 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.453 -0.779 . . . . 0.0 109.364 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -37.84 138.94 0.35 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-O 121.726 0.774 . . . . 0.0 110.844 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 67.7 mt -73.98 150.49 40.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.631 -0.668 . . . . 0.0 110.569 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 56.15 27.95 12.32 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.579 0.704 . . . . 0.0 109.769 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -67.18 -40.14 86.51 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.403 -0.811 . . . . 0.0 109.68 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -68.44 119.4 12.87 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -84.77 136.12 33.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.466 -0.771 . . . . 0.0 109.945 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -144.95 143.37 30.51 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.168 -0.957 . . . . 0.0 109.424 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -60.14 -40.96 91.63 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.38 -0.825 . . . . 0.0 109.823 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 85.7 t60 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.196 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptp . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.317 0.579 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -95.72 165.34 12.35 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.301 -0.874 . . . . 0.0 110.189 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -60.63 -43.83 97.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.464 -0.773 . . . . 0.0 109.675 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.563 HE22 ' CG ' ' A' ' 8' ' ' ASP . 9.6 tm0? -62.65 -39.47 93.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.328 -0.857 . . . . 0.0 109.909 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -63.34 -37.5 87.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.94 . . . . 0.0 109.545 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -60.52 -44.31 96.18 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.0 109.441 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.0 mm -62.46 -45.06 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.158 -0.963 . . . . 0.0 109.43 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.563 ' CG ' HE22 ' A' ' 4' ' ' GLN . 95.8 m-20 -61.82 -44.29 97.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.968 . . . . 0.0 109.64 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.518 ' CD1' ' NE2' ' A' ' 106' ' ' HIS . 80.3 t80 -61.66 -47.18 86.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.837 . . . . 0.0 109.668 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.47 -37.62 87.38 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.294 -0.879 . . . . 0.0 109.868 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.543 ' O ' ' N ' ' A' ' 15' ' ' ASP . 7.2 tp-100 -64.34 -48.59 74.97 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.453 -0.78 . . . . 0.0 109.932 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -65.44 -35.18 80.14 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 120.997 -1.064 . . . . 0.0 109.674 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.5 tttp -82.08 -35.8 28.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.349 -0.844 . . . . 0.0 111.737 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CG ' ' NE2' ' A' ' 33' ' ' HIS . 78.1 m-85 -124.2 -20.71 5.19 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.033 -1.042 . . . . 0.0 110.998 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 11' ' ' GLN . 56.2 t0 56.92 36.31 27.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.028 -1.045 . . . . 0.0 109.026 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.8 t -108.4 148.64 29.84 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.54 -0.725 . . . . 0.0 109.371 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.435 ' CD ' ' N ' ' A' ' 17' ' ' LYS . 13.0 mptt -91.84 153.15 43.61 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.201 -0.937 . . . . 0.0 109.298 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.0 154.78 73.52 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.474 2.116 . . . . 0.0 111.66 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -139.72 142.05 36.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.35 -0.844 . . . . 0.0 109.118 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 -127.54 86.14 59.2 Favored Pre-proline 0 N--CA 1.496 1.867 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -55.56 -36.75 95.08 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 122.273 1.982 . . . . 0.0 110.708 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.9 m-90 -81.24 106.31 13.12 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.466 0.65 . . . . 0.0 109.53 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -66.42 -21.26 66.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.417 -0.802 . . . . 0.0 109.613 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -78.6 -3.88 46.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.316 -0.865 . . . . 0.0 109.49 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -137.74 66.46 48.95 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.35 -19.25 49.92 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.301 2.001 . . . . 0.0 111.616 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -81.19 -5.79 58.12 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -90.18 147.58 23.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.24 -0.912 . . . . 0.0 109.215 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.03 131.65 53.58 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.53 -0.731 . . . . 0.0 109.363 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.78 132.04 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -111.97 137.53 49.85 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.356 -0.84 . . . . 0.0 109.488 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.456 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . 13.3 ptp180 -139.44 132.23 29.13 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.203 -0.936 . . . . 0.0 109.33 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.592 ' NE2' ' CG ' ' A' ' 14' ' ' TYR . 70.2 m80 -100.76 110.16 22.23 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.294 -0.879 . . . . 0.0 109.363 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 79.4 p -78.4 -12.29 60.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.83 -1.66 58.04 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 0.0 110.02 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' LYS . 33.8 m120 -119.79 19.57 12.44 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.506 -0.747 . . . . 0.0 109.217 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.403 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 67.0 t0 56.82 -76.84 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.814 -0.554 . . . . 0.0 109.879 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 54.0 mtmt -83.81 152.71 24.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.88 . . . . 0.0 109.958 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.561 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 8.1 p90 -168.19 140.23 2.92 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.264 -0.897 . . . . 0.0 109.587 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -150.86 121.46 7.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.996 -1.065 . . . . 0.0 108.582 178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -154.54 104.86 2.59 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.546 HD13 ' N ' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -114.47 116.19 28.46 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.546 ' N ' HD13 ' A' ' 42' ' ' LEU . 7.4 tt -120.15 126.45 50.72 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 18.2 ptt? -157.9 150.96 23.04 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.143 -0.973 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -97.75 117.21 31.55 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 23.3 pt -125.01 147.01 55.45 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.388 -0.82 . . . . 0.0 110.295 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -48.37 144.12 13.99 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 121.873 1.715 . . . . 0.0 112.262 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -63.84 -22.73 67.05 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -0.837 . . . . 0.0 110.258 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 49' ' ' GLU . 10.7 pt-20 -71.99 -13.5 61.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.064 -1.022 . . . . 0.0 109.94 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -84.61 -10.66 57.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.148 -0.97 . . . . 0.0 110.677 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.456 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 8.5 pt -104.89 5.17 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.101 -0.999 . . . . 0.0 109.56 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.95 -7.42 60.64 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 121.186 -0.946 . . . . 0.0 111.018 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.564 HG22 ' H ' ' A' ' 55' ' ' GLY . 88.2 mt -79.04 142.05 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.874 -1.369 . . . . 0.0 110.448 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.88 -39.95 93.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 110.048 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.564 ' H ' HG22 ' A' ' 53' ' ' ILE . . . -58.75 142.82 45.58 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.039 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 34.8 p30 -101.94 7.49 41.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.557 -0.966 . . . . 0.0 108.709 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -63.52 139.75 58.8 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.308 -0.87 . . . . 0.0 110.303 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -69.53 136.34 51.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.585 -0.697 . . . . 0.0 110.274 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -133.07 161.27 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.522 -0.736 . . . . 0.0 109.313 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -101.55 133.23 46.54 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 0.0 109.806 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 m -132.59 157.91 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.446 -0.783 . . . . 0.0 110.111 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 34.8 pt -136.66 153.4 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -118.45 126.98 53.2 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.451 -0.781 . . . . 0.0 109.656 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.4 160.31 30.83 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-O 121.851 0.834 . . . . 0.0 109.259 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -84.09 136.51 33.98 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.844 -0.535 . . . . 0.0 109.803 -178.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.654 HG11 HD13 ' A' ' 74' ' ' LEU . 4.2 m -133.23 163.72 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -73.78 145.49 84.31 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.044 -1.035 . . . . 0.0 109.814 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.61 ' O ' HG12 ' A' ' 71' ' ' VAL . 49.7 Cg_exo -49.24 -30.23 18.95 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.268 1.979 . . . . 0.0 111.966 178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -85.32 -28.0 25.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.416 -0.802 . . . . 0.0 110.238 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.58 0.94 55.84 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.108 -0.995 . . . . 0.0 109.968 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 68' ' ' PRO . 7.4 p -63.45 -43.7 98.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.919 -1.113 . . . . 0.0 109.281 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.548 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -66.18 -48.46 64.55 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 t -61.33 -49.55 76.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.167 -1.196 . . . . 0.0 110.693 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.654 HD13 HG11 ' A' ' 66' ' ' VAL . 2.0 tt -67.24 -42.7 83.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.813 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -75.29 -7.38 53.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.342 -0.849 . . . . 0.0 109.391 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -28.61 16.79 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -61.79 149.72 84.33 Favored Pre-proline 0 C--N 1.303 -1.454 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.402 -178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' O ' HD12 ' A' ' 80' ' ' ILE . 24.7 Cg_exo -62.77 146.02 95.01 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 122.215 1.943 . . . . 0.0 113.058 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.06 -28.92 5.33 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.774 ' N ' HD12 ' A' ' 80' ' ' ILE . 2.7 mp -83.65 128.41 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.135 -1.215 . . . . 0.0 109.402 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.456 ' CD1' ' O ' ' A' ' 51' ' ' ILE . 49.3 m-85 -124.07 153.03 67.86 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.801 -0.562 . . . . 0.0 109.773 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.406 ' O ' ' OG1' ' A' ' 93' ' ' THR . 53.9 Cg_exo -45.15 159.52 0.15 Allowed 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 122.115 1.876 . . . . 0.0 112.089 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.72 144.05 56.8 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 110.144 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 88.0 t80 -89.28 4.27 49.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.805 . . . . 0.0 109.246 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.613 ' CG ' ' H ' ' A' ' 86' ' ' MET . 81.8 t60 -105.7 177.91 4.71 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.45 -0.781 . . . . 0.0 110.265 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.613 ' H ' ' CG ' ' A' ' 85' ' ' HIS . 91.7 mtp -64.69 -39.71 94.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.55 -0.719 . . . . 0.0 110.143 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -74.99 130.65 39.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.202 -0.936 . . . . 0.0 110.519 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -146.55 96.23 2.73 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -178.77 -43.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -111.9 -23.9 10.28 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.552 -0.717 . . . . 0.0 109.378 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.85 ' C ' HD12 ' A' ' 92' ' ' ILE . 2.0 m-90 -111.76 132.91 54.33 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.43 -0.794 . . . . 0.0 109.495 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.85 HD12 ' C ' ' A' ' 91' ' ' TRP . 3.0 mp -137.06 147.56 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.218 -0.926 . . . . 0.0 109.006 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' A' ' 82' ' ' PRO . 3.2 p -87.49 147.6 25.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.602 -0.686 . . . . 0.0 110.051 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 66.4 t -124.43 134.72 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 51.4 tp -87.04 112.44 21.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 0.0 110.104 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.7 mt -67.93 -38.68 83.19 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.44 -0.788 . . . . 0.0 108.996 178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -73.81 -0.1 14.81 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -64.35 171.56 19.24 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.79 -16.03 33.23 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 123.365 2.71 . . . . 0.0 111.972 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 pp -62.22 138.7 58.46 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.434 -0.791 . . . . 0.0 110.243 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -76.95 169.29 54.98 Favored Glycine 0 N--CA 1.493 2.439 0 CA-C-O 122.079 0.822 . . . . 0.0 111.222 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.63 -36.11 83.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.691 -0.887 . . . . 0.0 109.716 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -61.44 -38.75 88.29 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.356 -0.84 . . . . 0.0 108.986 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.09 -37.66 88.22 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.432 -0.792 . . . . 0.0 109.431 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.2 mt -62.94 -43.87 99.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.968 . . . . 0.0 109.527 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.518 ' NE2' ' CD1' ' A' ' 9' ' ' TYR . 48.4 m170 -61.47 -42.76 99.27 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.153 -0.967 . . . . 0.0 109.659 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.3 p -62.21 -44.66 96.09 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.7 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.66 -44.05 91.64 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.706 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -64.39 -42.83 96.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.309 -0.869 . . . . 0.0 109.476 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -53.9 -41.33 67.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.273 -0.892 . . . . 0.0 109.137 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -61.97 -44.74 96.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.259 -0.901 . . . . 0.0 109.445 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.5 m -60.64 -37.54 81.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 109.786 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -60.57 -43.4 97.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.349 -0.844 . . . . 0.0 110.221 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -51.45 -40.05 58.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.19 -0.944 . . . . 0.0 110.049 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 115' ' ' LEU . 9.0 mp -63.49 -40.06 96.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.878 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.416 ' O ' ' O ' ' A' ' 117' ' ' ARG . 5.6 p -92.19 6.53 46.3 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -0.964 . . . . 0.0 109.538 -179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.416 ' O ' ' O ' ' A' ' 116' ' ' THR . 53.3 ptt85 -40.16 162.14 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.566 0.698 . . . . 0.0 110.922 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.509 ' CD2' HD22 ' A' ' 36' ' ' ASN . 26.0 mt -83.75 136.14 34.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.467 -0.771 . . . . 0.0 110.327 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -78.44 163.61 25.48 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.613 0.721 . . . . 0.0 110.283 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 54.25 -92.74 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.546 -0.721 . . . . 0.0 110.632 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -75.32 119.13 19.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 110.389 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -96.5 -7.28 35.1 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.5 m170 53.18 84.82 0.05 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.596 -0.69 . . . . 0.0 109.92 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -75.28 141.54 43.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.53 -0.731 . . . . 0.0 109.993 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.841 179.833 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 ttm . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -100.23 161.66 13.46 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.26 -0.9 . . . . 0.0 110.221 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -61.54 -42.99 99.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.467 -0.771 . . . . 0.0 109.689 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -61.38 -39.22 89.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.228 -0.92 . . . . 0.0 109.791 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.46 -37.08 85.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.456 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -60.7 -44.23 96.81 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.32 -0.863 . . . . 0.0 109.547 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.4 mm -61.72 -46.45 96.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.261 -0.899 . . . . 0.0 109.653 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -63.41 -41.34 98.73 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 109.488 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -60.64 -49.9 75.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.193 -0.942 . . . . 0.0 109.446 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.39 -37.38 80.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.535 ' O ' ' N ' ' A' ' 15' ' ' ASP . 35.3 tt0 -62.83 -50.39 71.15 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.271 -0.893 . . . . 0.0 109.979 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.48 -40.49 97.25 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 120.628 -1.295 . . . . 0.0 109.132 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -70.33 -46.42 64.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.864 . . . . 0.0 112.129 -178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CE1' ' CE1' ' A' ' 33' ' ' HIS . 86.4 m-85 -120.43 -17.97 8.02 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 121.026 -1.046 . . . . 0.0 111.547 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 11' ' ' GLN . 30.1 t0 60.94 42.38 12.94 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.927 -1.108 . . . . 0.0 109.457 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.4 t -108.41 136.4 48.11 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -92.9 157.34 39.53 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.094 -1.004 . . . . 0.0 109.779 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.88 143.7 90.64 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.761 1.641 . . . . 0.0 112.775 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -132.28 135.67 46.4 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -133.72 85.1 42.81 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.184 -0.948 . . . . 0.0 109.376 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.77 -34.94 97.51 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.499 2.133 . . . . 0.0 111.394 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -85.87 110.88 19.71 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.572 -0.705 . . . . 0.0 109.625 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -68.56 -31.09 70.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.434 -0.791 . . . . 0.0 109.838 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -67.2 -4.35 10.17 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.282 -0.886 . . . . 0.0 109.923 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -133.33 70.49 77.16 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.433 -0.792 . . . . 0.0 108.939 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.68 -16.34 33.68 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.229 1.952 . . . . 0.0 111.883 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 22.7 p-10 -88.68 0.27 56.59 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.336 -0.853 . . . . 0.0 109.258 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.573 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.0 m-85 -92.71 139.19 30.81 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.197 -0.939 . . . . 0.0 109.186 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.46 114.92 21.36 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 18.3 t -103.75 128.28 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.419 -0.801 . . . . 0.0 109.012 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -111.47 134.19 53.22 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.66 -0.65 . . . . 0.0 109.262 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -145.19 150.67 37.15 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.235 -0.916 . . . . 0.0 109.291 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.538 ' CE1' ' CE1' ' A' ' 14' ' ' TYR . 64.1 m170 -100.08 160.99 13.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.339 -0.851 . . . . 0.0 109.926 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.3 t -102.91 -50.91 3.4 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.226 -0.921 . . . . 0.0 110.132 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -96.86 -0.82 47.2 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.097 -1.002 . . . . 0.0 110.83 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.472 ' ND2' ' O ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -104.99 31.82 4.58 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.162 -0.961 . . . . 0.0 109.129 -179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.456 ' O ' ' C ' ' A' ' 38' ' ' LYS . 98.9 m-20 59.38 40.05 21.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.972 -0.455 . . . . 0.0 110.066 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.471 ' HA ' ' H ' ' A' ' 33' ' ' HIS . 6.3 ptpp? 31.23 76.22 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.134 0 CA-C-O 121.676 0.75 . . . . 0.0 110.958 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.404 ' CZ2' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -55.59 -170.52 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.635 -0.666 . . . . 0.0 109.909 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CE2' ' OD2' ' A' ' 63' ' ' ASP . 63.0 t80 -115.04 122.69 46.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.611 -0.681 . . . . 0.0 109.167 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 39' ' ' TRP . . . -154.79 129.99 9.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.503 -0.748 . . . . 0.0 109.209 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 30.2 tp -140.86 129.05 22.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 109.349 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.576 HD23 ' C ' ' A' ' 43' ' ' LEU . 8.7 tt -122.09 125.97 47.38 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.573 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.9 ptt? -159.05 157.35 30.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 59' ' ' VAL . 46.6 t0 -96.19 114.03 25.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.537 -0.727 . . . . 0.0 109.143 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.9 pt -116.67 144.79 33.97 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.616 -0.678 . . . . 0.0 109.206 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -48.3 143.77 14.37 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.58 1.52 . . . . 0.0 112.412 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -61.39 -22.08 64.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.394 -0.816 . . . . 0.0 109.458 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.62 -16.83 62.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.89 -1.132 . . . . 0.0 110.278 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -84.72 -11.67 55.35 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.003 -1.061 . . . . 0.0 111.092 -178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.477 ' O ' ' CD2' ' A' ' 81' ' ' TYR . 11.4 pt -100.97 4.96 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 120.953 -1.092 . . . . 0.0 109.398 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.06 -11.07 65.91 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.515 ' C ' ' H ' ' A' ' 55' ' ' GLY . 61.6 mt -81.64 132.56 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.848 -1.383 . . . . 0.0 109.414 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -67.02 13.51 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.571 -0.706 . . . . 0.0 109.944 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.551 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -83.97 141.44 20.08 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 32.0 p-10 -101.04 8.9 42.71 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.452 -1.028 . . . . 0.0 109.019 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 64.1 tttp -84.03 141.39 31.21 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.494 -0.754 . . . . 0.0 109.556 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -72.52 145.44 47.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.303 -0.873 . . . . 0.0 109.867 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.435 ' HB ' HD11 ' A' ' 95' ' ' LEU . 31.6 m -136.13 161.3 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.486 -0.758 . . . . 0.0 109.721 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.684 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 95.7 m-20 -102.3 139.0 38.5 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.374 -0.829 . . . . 0.0 109.69 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.1 153.53 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.397 -0.815 . . . . 0.0 109.519 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.5 pt -137.01 148.31 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.694 -0.629 . . . . 0.0 109.446 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.538 ' OD2' ' CE2' ' A' ' 40' ' ' TYR . 86.5 m-20 -74.61 144.63 43.83 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.279 -0.888 . . . . 0.0 109.305 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.666 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -133.11 131.92 41.08 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -179.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.666 ' N ' HD13 ' A' ' 64' ' ' LEU . 10.0 mtpm? -97.73 130.3 44.71 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.223 -0.923 . . . . 0.0 109.912 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.5 m -141.11 165.6 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.369 -0.832 . . . . 0.0 110.316 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -70.61 152.9 95.23 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.512 -0.742 . . . . 0.0 109.129 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.461 ' O ' HG12 ' A' ' 71' ' ' VAL . 37.3 Cg_endo -65.57 -22.2 58.69 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.23 1.953 . . . . 0.0 111.353 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -86.47 -30.64 21.87 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 0.0 109.659 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 76.2 mt -97.38 10.62 39.17 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.244 -0.91 . . . . 0.0 109.291 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.532 HG13 ' N ' ' A' ' 72' ' ' GLY . 5.4 p -60.38 -46.74 94.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.186 -0.946 . . . . 0.0 110.1 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.532 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -75.92 -14.74 81.9 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.907 -1.139 . . . . 0.0 110.416 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.483 ' O ' ' NZ ' ' A' ' 76' ' ' LYS . 5.0 t -59.34 -55.46 34.54 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.015 -1.285 . . . . 0.0 110.898 -178.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.004 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.9 pt? -86.3 -21.57 27.24 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.874 . . . . 0.0 110.864 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.847 ' CZ ' HG21 ' A' ' 92' ' ' ILE . 0.0 OUTLIER -57.77 -42.27 83.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.772 -1.205 . . . . 0.0 111.275 -177.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.483 ' NZ ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -79.91 0.43 31.35 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.465 -1.397 . . . . 0.0 110.594 -178.525 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.2 mmtt -83.82 125.34 73.41 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 120.693 -1.254 . . . . 0.0 109.256 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.42 144.34 18.49 Favored 'Trans proline' 0 N--CA 1.498 1.79 0 C-N-CA 121.942 1.761 . . . . 0.0 113.141 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.57 -6.08 67.62 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.62 ' CG2' HH21 ' A' ' 75' ' ' ARG . 96.4 mt -122.47 128.77 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.208 -1.172 . . . . 0.0 109.805 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.477 ' CD2' ' O ' ' A' ' 51' ' ' ILE . 31.7 m-85 -120.46 152.6 55.45 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.498 -0.751 . . . . 0.0 109.934 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.83 154.77 67.09 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.471 2.114 . . . . 0.0 111.895 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.81 147.22 53.53 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.204 -0.935 . . . . 0.0 110.127 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.511 ' C ' ' H ' ' A' ' 86' ' ' MET . 0.8 OUTLIER -98.6 119.47 37.37 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.391 -0.818 . . . . 0.0 109.481 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 25.5 t60 66.74 -33.42 0.2 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.628 -0.67 . . . . 0.0 110.736 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.511 ' H ' ' C ' ' A' ' 84' ' ' TYR . 90.4 mmm -84.32 159.55 20.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.076 -1.015 . . . . 0.0 110.598 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 91' ' ' TRP . 57.9 t-20 -40.52 122.05 1.55 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.666 0.746 . . . . 0.0 110.939 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.1 ttmp? -94.41 -15.05 24.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.644 -0.66 . . . . 0.0 109.734 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.426 ' N ' ' OD1' ' A' ' 87' ' ' ASN . 98.1 mt-10 -80.87 -85.2 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.187 -0.946 . . . . 0.0 110.66 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 69.3 m80 -60.6 -44.18 96.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.286 -0.884 . . . . 0.0 110.739 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.439 ' N ' ' CD1' ' A' ' 91' ' ' TRP . 16.5 m0 -101.56 138.15 38.94 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.49 -0.756 . . . . 0.0 109.684 -178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.847 HG21 ' CZ ' ' A' ' 75' ' ' ARG . 9.3 mt -143.51 165.84 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.322 -0.861 . . . . 0.0 109.519 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 81' ' ' TYR . 6.3 p -107.77 138.58 43.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.301 -0.874 . . . . 0.0 109.928 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.9 t -121.1 133.97 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.435 HD11 ' HB ' ' A' ' 59' ' ' VAL . 31.0 tp -90.82 109.64 20.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.298 -0.876 . . . . 0.0 109.817 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.8 mt -64.95 -39.21 93.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.684 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 66.1 m-80 -74.41 5.76 4.34 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.4 -0.813 . . . . 0.0 109.66 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -60.85 165.18 15.33 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.52 -16.88 30.51 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.937 2.425 . . . . 0.0 111.293 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.542 ' C ' HD12 ' A' ' 100' ' ' LEU . 1.9 pp -60.22 169.3 1.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.648 -0.658 . . . . 0.0 110.46 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -99.99 169.13 21.71 Favored Glycine 0 N--CA 1.498 2.781 0 O-C-N 121.231 -0.918 . . . . 0.0 110.913 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.74 -35.88 82.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.629 -0.924 . . . . 0.0 109.365 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.497 ' NZ ' ' OE2' ' A' ' 104' ' ' GLU . 22.7 pttp -60.29 -37.05 79.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.329 -0.857 . . . . 0.0 108.973 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' A' ' 103' ' ' LYS . 72.9 mm-40 -65.33 -44.62 87.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.311 -0.868 . . . . 0.0 109.12 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 91.9 mt -64.05 -43.83 97.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.0 109.548 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -58.0 -44.29 87.14 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.273 -0.892 . . . . 0.0 109.911 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.0 p -61.15 -43.39 98.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.079 -1.013 . . . . 0.0 109.689 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.61 -42.05 98.24 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.252 -0.905 . . . . 0.0 109.034 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.68 -43.0 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.177 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -51.64 -44.83 63.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.109 -0.994 . . . . 0.0 108.879 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -61.21 -42.28 98.32 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.158 -0.964 . . . . 0.0 108.573 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 t -62.72 -38.75 91.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.351 -0.843 . . . . 0.0 109.581 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.2 -43.33 74.31 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.259 -0.901 . . . . 0.0 108.973 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -54.5 -31.81 56.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.913 . . . . 0.0 109.773 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 115' ' ' LEU . 9.0 mp -83.55 -13.48 54.39 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.084 -1.01 . . . . 0.0 109.974 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.472 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 45.0 p -102.04 13.87 33.55 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.297 -0.877 . . . . 0.0 109.306 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.34 148.51 51.55 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 110.168 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 68.8 mt -71.42 145.82 49.06 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.535 -0.728 . . . . 0.0 110.109 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -71.56 146.24 48.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.53 -0.731 . . . . 0.0 110.293 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 -154.1 150.62 28.37 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.433 -0.792 . . . . 0.0 109.264 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -100.72 3.14 42.05 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -99.36 120.5 39.68 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.547 -0.72 . . . . 0.0 109.393 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -80.36 128.74 33.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.32 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.65 146.47 42.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 0.0 110.187 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.545 ' OXT' ' CG ' ' A' ' 125' ' ' HIS . 51.5 p-80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 117.79 -1.1 . . . . 0.0 109.845 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.4 ttp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.284 0.564 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -87.2 159.29 18.89 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.313 -0.867 . . . . 0.0 110.495 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -64.27 -42.89 96.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.646 -0.659 . . . . 0.0 109.588 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -59.24 -43.22 92.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.349 -0.845 . . . . 0.0 109.497 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.86 -32.36 73.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.222 -0.923 . . . . 0.0 109.468 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -60.9 -47.66 85.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 0.0 109.664 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 7' ' ' ILE . 2.0 mp -64.98 -46.77 90.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.207 -0.933 . . . . 0.0 109.184 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.75 -43.22 99.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.333 -0.854 . . . . 0.0 109.819 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.417 ' CE1' ' CE1' ' A' ' 106' ' ' HIS . 89.8 t80 -64.12 -44.15 93.09 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.868 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.86 -51.49 69.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.3 -0.875 . . . . 0.0 110.625 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 15' ' ' ASP . 3.5 pt20 -70.11 -38.17 75.54 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.033 -1.042 . . . . 0.0 110.255 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -60.01 -43.45 95.22 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 120.626 -1.296 . . . . 0.0 109.35 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -88.2 -32.06 18.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.145 -0.972 . . . . 0.0 111.698 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.525 ' CE1' ' CD1' ' A' ' 113' ' ' PHE . 73.5 m-85 -121.25 -8.56 9.21 Favored 'General case' 0 N--CA 1.508 2.474 0 O-C-N 121.065 -1.022 . . . . 0.0 111.654 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 11' ' ' GLN . 91.4 m-20 54.97 37.48 28.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.025 -1.047 . . . . 0.0 109.54 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 17' ' ' LYS . 96.7 m -79.69 162.2 25.36 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.512 -0.742 . . . . 0.0 109.152 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.516 ' N ' HG22 ' A' ' 16' ' ' THR . 37.1 tptt -123.01 93.12 48.66 Favored Pre-proline 0 N--CA 1.497 1.895 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -56.49 146.5 74.24 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.405 2.07 . . . . 0.0 112.365 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 60.4 t0 -132.15 152.25 51.36 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.605 ' N ' ' ND1' ' A' ' 20' ' ' HIS . 0.8 OUTLIER -118.93 86.26 30.73 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 0.0 109.497 179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.78 -36.84 83.73 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.235 1.956 . . . . 0.0 111.469 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -87.4 126.99 35.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.575 -0.703 . . . . 0.0 109.357 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -87.51 -28.84 21.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.371 -0.83 . . . . 0.0 109.715 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -81.84 -7.56 59.61 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.326 -0.859 . . . . 0.0 110.0 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -123.57 75.35 54.38 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.449 -0.782 . . . . 0.0 109.518 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -68.86 -17.66 41.63 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.985 1.79 . . . . 0.0 111.634 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -80.64 -5.04 56.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.472 -0.768 . . . . 0.0 109.573 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -100.39 135.09 42.36 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.414 -0.804 . . . . 0.0 109.333 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.91 147.54 44.47 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 95.7 t -121.16 129.47 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.47 -0.769 . . . . 0.0 109.394 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 43.6 m-85 -108.45 109.92 21.31 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.0 ttp85 -142.21 146.15 34.89 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.145 -0.972 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.505 ' NE2' ' OG1' ' A' ' 16' ' ' THR . 63.8 m170 -99.86 113.56 26.16 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.417 -0.802 . . . . 0.0 109.521 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.3 p -69.79 -17.89 63.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.307 -0.87 . . . . 0.0 109.585 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -62.74 -44.12 97.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.378 -0.826 . . . . 0.0 109.808 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 38' ' ' LYS . 56.7 p30 -112.4 -1.49 15.02 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.425 -0.797 . . . . 0.0 109.133 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.4 t0 58.4 0.94 0.15 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.731 . . . . 0.0 109.925 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.481 ' H ' ' C ' ' A' ' 36' ' ' ASN . 53.6 mtmt -101.3 -156.91 0.58 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.242 -0.911 . . . . 0.0 109.69 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 46.9 t-105 57.15 94.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.644 -0.66 . . . . 0.0 109.491 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -112.59 125.2 54.02 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.54 143.93 24.13 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.42 144.01 32.9 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.193 -0.942 . . . . 0.0 109.014 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.615 HD23 ' C ' ' A' ' 43' ' ' LEU . 8.1 tt -117.61 127.11 53.63 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.528 ' N ' HD23 ' A' ' 43' ' ' LEU . 6.6 ptt? -146.63 158.09 43.84 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.097 -1.002 . . . . 0.0 109.485 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 45' ' ' ASP . 34.6 p-10 -95.59 115.6 27.66 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.366 -0.834 . . . . 0.0 109.265 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 15.2 pt -126.31 145.73 53.71 Favored Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.478 -0.764 . . . . 0.0 109.231 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -60.67 144.03 99.49 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.075 1.85 . . . . 0.0 112.78 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -62.82 -20.99 65.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.692 -0.63 . . . . 0.0 109.64 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.76 -36.54 76.86 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.051 -1.03 . . . . 0.0 110.465 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' A' ' 52' ' ' GLY . 97.2 mttt -63.74 -43.49 96.33 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.97 -1.081 . . . . 0.0 111.239 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.456 ' CD1' HD12 ' A' ' 53' ' ' ILE . 9.4 pt -71.57 15.22 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.958 -1.089 . . . . 0.0 110.145 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 50' ' ' LYS . . . 80.75 -7.49 58.57 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.161 -1.019 . . . . 0.0 111.088 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.582 ' C ' ' H ' ' A' ' 55' ' ' GLY . 71.0 mt -79.4 133.06 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.775 -1.427 . . . . 0.0 109.335 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -68.91 26.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.374 -0.829 . . . . 0.0 109.447 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -91.97 132.8 11.44 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 56' ' ' ASP . 32.2 p-10 -101.79 8.86 41.26 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.333 -1.098 . . . . 0.0 108.962 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.0 mtmp? -83.89 154.92 23.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.388 -0.82 . . . . 0.0 109.767 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -82.28 130.38 35.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 108.667 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.446 ' HA ' HD22 ' A' ' 97' ' ' ASN . 16.3 m -125.79 143.61 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.535 -0.728 . . . . 0.0 109.615 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -89.57 141.62 28.42 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.265 -0.897 . . . . 0.0 109.927 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.401 HG12 HD12 ' A' ' 95' ' ' LEU . 3.8 m -135.8 158.96 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.416 -0.802 . . . . 0.0 109.468 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.1 pt -134.24 151.38 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -112.16 140.35 46.93 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.471 -0.768 . . . . 0.0 110.126 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -138.33 157.22 46.68 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.656 -0.653 . . . . 0.0 109.362 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -92.73 139.92 30.05 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 0.0 110.867 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 17.3 m -141.39 164.68 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.41 -0.806 . . . . 0.0 109.547 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -74.78 156.74 86.39 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.527 -0.733 . . . . 0.0 109.628 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 71' ' ' VAL . 31.2 Cg_endo -64.47 -23.39 64.77 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.327 2.018 . . . . 0.0 111.207 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -86.57 -25.8 24.8 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.38 -0.825 . . . . 0.0 109.429 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.22 5.67 49.69 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.21 -0.931 . . . . 0.0 109.38 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.499 HG13 ' N ' ' A' ' 72' ' ' GLY . 11.6 p -63.28 -39.93 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.499 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -77.47 -15.42 81.44 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.5 t -68.17 -55.96 10.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.123 -1.222 . . . . 0.0 110.753 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.592 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.0 pt? -86.48 -25.26 25.25 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.962 -1.086 . . . . 0.0 110.614 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -71.08 -21.63 62.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.947 -1.096 . . . . 0.0 109.627 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.22 -6.68 57.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 108.727 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.42 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 9.0 mtpm? -84.54 152.65 60.78 Favored Pre-proline 0 N--CA 1.492 1.675 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.1 148.45 69.34 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.957 2.438 . . . . 0.0 113.19 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.47 -23.69 11.81 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.306 -1.117 . . . . 0.0 110.306 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 98.2 mt -96.02 121.14 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -1.189 . . . . 0.0 110.066 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -117.56 157.28 48.05 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.793 -0.567 . . . . 0.0 109.979 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -60.34 152.55 66.18 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.848 1.698 . . . . 0.0 112.36 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.87 151.37 39.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.399 -0.813 . . . . 0.0 109.962 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -90.48 1.24 56.86 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.344 -0.847 . . . . 0.0 109.259 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -100.17 -174.02 2.57 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.405 -0.809 . . . . 0.0 110.047 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.4 ttm -63.82 -39.39 94.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.558 -0.714 . . . . 0.0 110.148 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -67.9 153.55 43.48 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.922 . . . . 0.0 110.532 -179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -148.59 -54.97 0.19 Allowed 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.75 -17.6 59.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.364 -0.835 . . . . 0.0 109.257 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.41 ' CD2' ' N ' ' A' ' 90' ' ' HIS . 4.0 m170 -82.13 -62.84 1.51 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.891 . . . . 0.0 109.949 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -109.79 148.08 32.1 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.658 -0.651 . . . . 0.0 109.903 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.3 mm -130.9 137.25 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 94.1 m -87.19 131.03 34.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.671 -0.643 . . . . 0.0 110.147 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 64' ' ' LEU . 72.6 t -113.22 134.81 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.435 HD11 ' HB ' ' A' ' 59' ' ' VAL . 46.1 tp -89.22 108.73 19.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.941 . . . . 0.0 110.273 -178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.7 mt -64.64 -41.06 96.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.44 -0.788 . . . . 0.0 109.129 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.446 HD22 ' HA ' ' A' ' 59' ' ' VAL . 97.0 m-20 -84.51 20.22 1.76 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.508 -0.745 . . . . 0.0 109.009 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -93.78 -176.43 39.76 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.26 -37.24 94.55 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 123.047 2.498 . . . . 0.0 112.774 179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -57.97 138.22 56.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.272 -0.892 . . . . 0.0 110.418 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -93.92 -174.15 39.45 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.82 -38.94 92.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.683 -0.892 . . . . 0.0 109.882 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -62.79 -40.93 98.86 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 109.389 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -63.27 -40.21 96.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.507 -0.746 . . . . 0.0 109.775 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 88.0 mt -63.41 -43.61 98.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.296 -0.878 . . . . 0.0 109.771 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.417 ' CE1' ' CE1' ' A' ' 9' ' ' TYR . 55.9 m170 -59.59 -47.3 86.09 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.756 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.3 m -62.35 -43.93 97.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.256 -0.903 . . . . 0.0 109.957 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 64.3 mt -63.31 -44.96 93.49 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.39 -0.819 . . . . 0.0 109.732 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.5 mt -65.32 -43.02 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.353 -0.842 . . . . 0.0 109.337 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -52.2 -43.68 64.35 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.025 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 49.0 t0 -61.95 -44.18 97.3 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.255 -0.903 . . . . 0.0 109.273 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 78.0 p -67.34 -39.24 85.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.79 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 14' ' ' TYR . 87.6 t80 -61.62 -45.52 93.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 109.911 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -54.24 -42.07 69.47 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.371 -0.83 . . . . 0.0 109.578 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.56 -39.83 92.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.378 -0.826 . . . . 0.0 110.113 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.8 p -99.99 14.54 30.2 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.157 -0.964 . . . . 0.0 109.835 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.439 ' N ' ' O ' ' A' ' 113' ' ' PHE . 35.7 ptt180 -50.58 156.86 0.83 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.345 -0.847 . . . . 0.0 110.092 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.7 mp -92.26 -145.88 0.21 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.595 -0.691 . . . . 0.0 109.728 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 58.15 -148.81 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.73 -0.606 . . . . 0.0 110.215 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.0 t60 54.75 78.17 0.18 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.609 -0.682 . . . . 0.0 109.384 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 63.1 m170 -79.74 155.15 28.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.599 -0.688 . . . . 0.0 109.628 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -61.85 -40.58 95.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.547 -0.72 . . . . 0.0 110.152 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -71.5 130.78 42.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.266 -0.896 . . . . 0.0 110.159 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -83.81 144.87 29.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.388 -0.82 . . . . 0.0 110.138 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.487 ' CD2' ' H ' ' A' ' 125' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.641 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.7 ttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.603 0.716 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -102.14 163.22 12.36 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.733 0.777 . . . . 0.0 110.183 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.408 HH21 ' CG ' ' A' ' 60' ' ' ASP . 41.3 ttm180 -61.29 -43.82 98.24 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.586 0.708 . . . . 0.0 109.6 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -58.89 -40.06 83.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.454 -0.779 . . . . 0.0 109.842 -179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.14 -37.6 88.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.441 -0.787 . . . . 0.0 109.817 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -60.94 -43.8 98.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.317 -0.864 . . . . 0.0 109.397 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.42 -44.26 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -0.783 . . . . 0.0 109.474 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.76 -44.32 96.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.22 -0.925 . . . . 0.0 109.741 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.634 ' CE1' ' CD2' ' A' ' 106' ' ' HIS . 63.9 t80 -63.46 -48.58 77.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.443 -0.786 . . . . 0.0 109.696 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.4 -39.2 85.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.492 -0.755 . . . . 0.0 109.811 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.553 HE22 ' C ' ' A' ' 16' ' ' THR . 40.6 tp60 -68.53 -49.91 56.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.824 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.84 -31.67 73.01 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.957 -1.089 . . . . 0.0 109.087 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.484 ' NZ ' ' CZ ' ' A' ' 14' ' ' TYR . 65.8 tttm -83.44 -38.36 21.98 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.478 -0.764 . . . . 0.0 111.74 -178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.484 ' CZ ' ' NZ ' ' A' ' 13' ' ' LYS . 74.9 m-85 -116.63 -21.41 9.14 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.824 -1.173 . . . . 0.0 111.148 -178.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 49.7 t0 62.8 36.79 12.83 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.27 -0.894 . . . . 0.0 109.466 -179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.553 ' C ' HE22 ' A' ' 11' ' ' GLN . 14.5 t -114.88 134.75 54.89 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.593 0.711 . . . . 0.0 109.707 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -84.69 151.66 58.7 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.613 -0.679 . . . . 0.0 109.332 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -66.54 146.44 79.69 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.786 2.324 . . . . 0.0 112.477 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -115.38 155.17 27.87 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 121.693 0.759 . . . . 0.0 109.3 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -143.41 88.2 8.1 Favored Pre-proline 0 C--N 1.303 -1.419 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.89 -15.28 21.12 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.339 2.026 . . . . 0.0 110.617 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.403 ' CD1' ' N ' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -100.72 110.5 22.61 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.498 0.666 . . . . 0.0 109.335 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -68.32 -33.61 74.63 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.797 0.808 . . . . 0.0 109.186 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -67.76 -2.41 7.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.404 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -143.68 74.72 16.63 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.296 -0.878 . . . . 0.0 109.372 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -71.86 -15.8 29.63 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.605 2.203 . . . . 0.0 111.301 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -86.46 -4.96 59.26 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.494 -0.754 . . . . 0.0 109.391 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -84.57 142.38 30.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.373 -0.829 . . . . 0.0 109.611 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.07 140.77 50.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.589 -0.694 . . . . 0.0 109.69 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 73.2 t -125.78 132.66 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -109.07 136.47 48.52 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.394 0.616 . . . . 0.0 109.699 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -156.12 149.23 24.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.342 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.5 ' O ' ' NE1' ' A' ' 39' ' ' TRP . 80.3 m80 -100.75 128.95 46.6 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.611 0.719 . . . . 0.0 109.443 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 80.4 p -75.92 -6.89 53.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.471 -0.768 . . . . 0.0 109.518 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -94.33 -9.84 34.64 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.262 -0.899 . . . . 0.0 109.815 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -109.78 -30.23 7.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.147 -0.971 . . . . 0.0 108.783 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.8 t0 54.18 28.04 8.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.468 -0.77 . . . . 0.0 109.699 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.505 ' C ' ' CG ' ' A' ' 39' ' ' TRP . 50.8 tptt -170.11 112.03 0.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.0 110.143 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.614 ' CD2' ' N ' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -173.22 -174.48 1.05 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 122.207 1.003 . . . . 0.0 109.75 179.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.432 ' CE2' ' CD2' ' A' ' 42' ' ' LEU . 9.7 t80 -160.18 118.93 2.69 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.199 -0.938 . . . . 0.0 109.137 177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.12 121.72 4.42 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.432 ' CD2' ' CE2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -138.34 149.28 45.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.462 -0.774 . . . . 0.0 109.163 -179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.663 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.4 tt -129.31 122.56 29.81 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.547 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -152.43 162.23 41.48 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.688 0.756 . . . . 0.0 109.928 -179.44 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 42.5 p-10 -97.25 114.82 26.61 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.289 0.566 . . . . 0.0 109.518 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.7 pt -117.56 146.19 38.01 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.38 143.6 99.66 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.692 2.262 . . . . 0.0 112.495 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.77 -19.89 64.45 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.578 0.704 . . . . 0.0 109.794 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -60.91 -38.85 87.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.235 -0.915 . . . . 0.0 110.238 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.87 -43.76 95.1 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.23 -0.918 . . . . 0.0 111.174 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.669 HD12 HD12 ' A' ' 53' ' ' ILE . 2.8 pt -76.95 12.17 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.036 -1.04 . . . . 0.0 109.834 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 62.1 31.16 77.83 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.365 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.669 HD12 HD12 ' A' ' 51' ' ' ILE . 47.9 mt -101.23 128.57 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.111 -1.229 . . . . 0.0 109.737 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 41.8 p30 -55.93 81.83 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 121.644 0.735 . . . . 0.0 110.458 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . -176.98 151.48 11.19 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.71 15.35 18.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.513 -0.992 . . . . 0.0 108.446 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -88.45 155.04 19.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.36 -0.838 . . . . 0.0 110.256 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -86.36 141.83 28.91 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.526 0.679 . . . . 0.0 110.095 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.415 ' HB ' HD11 ' A' ' 95' ' ' LEU . 29.6 m -134.04 153.32 35.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.575 -0.703 . . . . 0.0 109.548 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.408 ' CG ' HH21 ' A' ' 3' ' ' ARG . 96.4 m-20 -90.47 139.4 30.72 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.696 -0.628 . . . . 0.0 110.167 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.465 ' CG2' ' SD ' ' A' ' 44' ' ' MET . 33.4 m -137.87 154.88 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 121.707 0.765 . . . . 0.0 109.987 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 18.6 pt -135.2 147.92 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 121.493 0.663 . . . . 0.0 109.871 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.76 143.37 34.54 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.419 0.628 . . . . 0.0 110.389 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.667 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -133.33 126.91 32.42 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.667 ' N ' HD13 ' A' ' 64' ' ' LEU . 64.8 tttm -82.81 135.88 34.83 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.671 0.748 . . . . 0.0 110.569 -179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.4 m -146.76 158.35 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.597 0.713 . . . . 0.0 109.782 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' H ' ' HB2' ' A' ' 70' ' ' LEU . 15.8 mt-30 -89.83 154.45 47.82 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.529 -0.732 . . . . 0.0 109.319 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.485 ' O ' HG12 ' A' ' 71' ' ' VAL . 52.6 Cg_exo -45.67 -28.86 4.84 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 122.252 1.968 . . . . 0.0 111.563 179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -91.48 -29.11 17.19 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 0.0 109.54 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.433 ' HB2' ' H ' ' A' ' 67' ' ' GLN . 89.2 mt -91.53 -8.33 47.82 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.269 -0.894 . . . . 0.0 109.668 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 68' ' ' PRO . 10.5 p -66.68 -40.01 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.126 -0.984 . . . . 0.0 109.652 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -62.88 -42.37 99.69 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.3 t -61.1 -48.76 80.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.353 -1.087 . . . . 0.0 110.073 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 tt -74.07 -39.1 63.7 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.419 -0.8 . . . . 0.0 110.189 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.426 ' HE ' ' HG3' ' A' ' 82' ' ' PRO . 72.9 ttt180 -72.17 -38.99 69.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.554 -0.716 . . . . 0.0 111.308 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.42 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -73.73 -5.06 38.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.909 -1.12 . . . . 0.0 110.051 -178.565 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -78.95 147.67 70.61 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.126 -0.984 . . . . 0.0 109.714 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.416 ' O ' HD12 ' A' ' 80' ' ' ILE . 55.2 Cg_endo -69.95 145.66 56.71 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 122.473 2.116 . . . . 0.0 112.542 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.31 -20.9 19.48 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.701 ' N ' HD12 ' A' ' 80' ' ' ILE . 3.0 mp -91.83 122.59 43.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.323 -1.104 . . . . 0.0 109.449 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.533 ' CZ ' HD11 ' A' ' 53' ' ' ILE . 82.8 m-85 -115.06 154.94 47.17 Favored Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.23 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HG3' ' HE ' ' A' ' 75' ' ' ARG . 31.4 Cg_exo -60.44 146.81 96.04 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.841 2.361 . . . . 0.0 112.869 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.89 140.47 43.83 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.389 -0.819 . . . . 0.0 110.515 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.63 ' CZ ' ' CE1' ' A' ' 85' ' ' HIS . 45.7 p90 -96.13 3.86 52.93 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.63 ' CE1' ' CZ ' ' A' ' 84' ' ' TYR . 71.9 m80 -87.93 -162.83 0.86 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.461 -0.774 . . . . 0.0 110.294 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 87' ' ' ASN . 42.0 ttp -55.32 160.86 2.08 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.56 0.695 . . . . 0.0 110.71 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 86' ' ' MET . 13.2 p30 42.32 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.864 0.84 . . . . 0.0 110.735 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.454 ' O ' HD11 ' A' ' 92' ' ' ILE . 81.9 tttt -151.83 -22.94 0.19 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 109.108 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 57.3 mp0 -96.02 -19.69 19.27 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.162 -0.962 . . . . 0.0 110.027 -179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -75.0 -69.82 0.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 110.633 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -110.39 138.81 46.29 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.392 -0.818 . . . . 0.0 110.026 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.454 HD11 ' O ' ' A' ' 88' ' ' LYS . 49.5 mm -120.13 157.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.429 ' N ' HG22 ' A' ' 92' ' ' ILE . 2.0 p -98.92 138.44 36.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.504 -0.747 . . . . 0.0 110.006 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 59.0 t -120.55 134.52 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.415 HD11 ' HB ' ' A' ' 59' ' ' VAL . 38.4 tp -86.3 105.89 16.98 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.585 0.707 . . . . 0.0 110.097 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.6 mt -66.51 -39.67 88.79 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.805 0.812 . . . . 0.0 109.012 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -68.57 -7.55 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.77 -169.04 13.18 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.78 18.83 1.21 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.239 2.626 . . . . 0.0 111.425 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.573 HD11 HD11 ' A' ' 80' ' ' ILE . 3.9 mm? -66.06 132.9 49.62 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.95 0.881 . . . . 0.0 110.38 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -92.74 155.79 22.76 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.01 -48.67 79.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.804 -0.821 . . . . 0.0 109.898 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -65.55 -40.06 92.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.386 -0.821 . . . . 0.0 109.207 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.99 -44.78 96.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.582 -0.699 . . . . 0.0 109.498 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.81 -43.4 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.243 -0.91 . . . . 0.0 109.583 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.634 ' CD2' ' CE1' ' A' ' 9' ' ' TYR . 54.2 m170 -58.94 -42.34 89.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.377 -0.827 . . . . 0.0 109.849 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.1 p -63.99 -42.14 97.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 109.853 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.8 -41.22 95.98 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.361 -0.837 . . . . 0.0 109.515 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.76 -42.88 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -55.75 -42.34 75.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.381 -0.824 . . . . 0.0 109.202 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.26 -41.03 98.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.23 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 7.4 t -60.19 -40.08 88.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.827 . . . . 0.0 109.649 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -58.36 -44.18 88.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.482 -0.761 . . . . 0.0 109.227 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -57.91 -46.1 85.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.359 -0.838 . . . . 0.0 109.844 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 9.6 mp -65.29 -37.77 88.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 0.0 109.623 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.3 p -88.08 13.19 11.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.276 -0.89 . . . . 0.0 109.157 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 59.4 ttm-85 -72.37 48.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.8 0.809 . . . . 0.0 109.022 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 118' ' ' LEU . 10.3 mp 52.67 173.66 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.868 0.842 . . . . 0.0 110.543 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -96.75 -151.6 0.36 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.748 0.785 . . . . 0.0 109.924 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.3 t60 53.3 92.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.89 0.852 . . . . 0.0 109.618 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -79.83 138.85 37.32 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.591 0.71 . . . . 0.0 109.965 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.48 ' CD2' ' H ' ' A' ' 122' ' ' HIS . 4.4 p80 -51.45 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.61 0.719 . . . . 0.0 110.287 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -152.56 142.79 22.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.379 -0.825 . . . . 0.0 109.751 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.445 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 85.4 t60 42.89 -101.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.411 0.624 . . . . 0.0 110.361 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' A' ' 124' ' ' HIS . 80.3 m80 . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 117.838 -1.077 . . . . 0.0 109.277 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.6 ttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -104.62 155.08 19.16 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.67 -0.643 . . . . 0.0 109.884 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -61.6 -43.54 98.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.571 -0.706 . . . . 0.0 109.73 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -58.09 -41.79 84.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.596 -0.69 . . . . 0.0 110.019 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.36 -35.71 81.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.448 -0.783 . . . . 0.0 110.122 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -60.16 -45.57 92.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.749 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.65 -45.46 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -62.82 -38.27 90.04 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.593 0.711 . . . . 0.0 109.506 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.516 ' CE2' ' NZ ' ' A' ' 13' ' ' LYS . 59.9 t80 -69.5 -43.89 72.19 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 110.141 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.13 -49.78 75.89 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.434 -0.791 . . . . 0.0 110.5 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.549 ' O ' ' N ' ' A' ' 15' ' ' ASP . 4.8 pt20 -66.53 -30.41 70.72 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.329 -0.857 . . . . 0.0 109.984 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.4 -48.54 80.75 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.047 -1.033 . . . . 0.0 110.225 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.516 ' NZ ' ' CE2' ' A' ' 9' ' ' TYR . 63.3 mttp -90.34 -12.4 37.82 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.217 -0.927 . . . . 0.0 111.875 -178.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -134.65 -20.38 1.79 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.981 -1.075 . . . . 0.0 111.012 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 11' ' ' GLN . 43.0 t0 58.42 39.45 25.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.119 -0.988 . . . . 0.0 109.263 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.5 m -106.93 127.1 53.14 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -89.34 156.04 48.61 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 0.0 109.715 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.66 141.3 43.98 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.981 1.787 . . . . 0.0 112.359 179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -125.88 121.73 34.04 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.508 ' O ' ' CG ' ' A' ' 20' ' ' HIS . 25.2 p-80 -125.39 86.17 57.47 Favored Pre-proline 0 N--CA 1.498 1.96 0 O-C-N 121.562 -0.711 . . . . 0.0 109.425 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.86 -32.3 91.62 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.537 2.158 . . . . 0.0 111.201 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -83.45 135.59 34.62 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.589 0.709 . . . . 0.0 110.161 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.661 ' H ' ' CD ' ' A' ' 23' ' ' GLU . 1.4 pm0 -89.41 -24.26 21.95 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 40.0 mtmt -78.11 -3.1 40.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.488 -0.757 . . . . 0.0 109.825 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -137.18 66.04 52.1 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.4 -0.812 . . . . 0.0 109.458 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.47 -20.2 36.51 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.433 2.088 . . . . 0.0 111.425 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -81.94 -5.61 58.44 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.53 -0.731 . . . . 0.0 109.063 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -90.96 140.35 29.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.497 -0.752 . . . . 0.0 109.117 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -124.72 121.52 34.87 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.9 t -109.44 125.49 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -108.76 116.55 32.19 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -145.07 135.31 24.03 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.092 -1.005 . . . . 0.0 109.285 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -99.95 115.0 28.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.486 -0.759 . . . . 0.0 109.716 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.7 m -63.69 -35.78 81.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.605 -0.684 . . . . 0.0 110.42 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 40.2 p30 -71.68 -5.37 33.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.961 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 38' ' ' LYS . 10.7 t-20 -113.74 -30.8 6.66 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 42.66 18.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.766 -0.584 . . . . 0.0 109.96 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.558 ' N ' ' O ' ' A' ' 36' ' ' ASN . 63.6 tttp -136.53 -19.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.411 ' CD1' ' C ' ' A' ' 39' ' ' TRP . 18.1 t-105 -78.01 117.99 19.87 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.514 -0.741 . . . . 0.0 109.491 -179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -115.26 125.72 53.65 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.614 -0.679 . . . . 0.0 109.274 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.42 129.01 11.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.359 -0.838 . . . . 0.0 108.739 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.3 tp -132.29 123.68 27.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.511 -0.743 . . . . 0.0 109.112 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.4 tt -117.58 124.66 49.2 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.52 ' N ' HD23 ' A' ' 43' ' ' LEU . 7.5 ptt? -153.95 161.38 42.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.0 109.212 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.446 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 38.1 p-10 -98.05 114.53 26.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.267 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 14.9 pt -124.54 145.97 50.93 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.548 -0.72 . . . . 0.0 109.193 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -61.1 143.87 99.05 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.026 1.817 . . . . 0.0 112.573 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -63.81 -20.98 66.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.754 -0.591 . . . . 0.0 109.909 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.5 -35.51 74.28 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.112 -0.993 . . . . 0.0 110.165 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -64.69 -41.85 95.74 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.343 -0.848 . . . . 0.0 110.94 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.463 ' CD1' HD12 ' A' ' 53' ' ' ILE . 5.0 pt -81.82 20.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.18 -0.95 . . . . 0.0 109.893 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.22 -4.89 53.29 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.646 -0.788 . . . . 0.0 111.282 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.617 ' HB ' ' HB1' ' A' ' 48' ' ' ALA . 79.4 mt -78.92 134.03 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.939 -1.33 . . . . 0.0 110.075 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.441 ' O ' ' C ' ' A' ' 55' ' ' GLY . 92.6 m-20 -61.38 -39.35 90.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.74 -0.6 . . . . 0.0 110.101 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.828 ' O ' ' HB3' ' A' ' 48' ' ' ALA . . . -37.06 109.48 0.08 OUTLIER Glycine 0 N--CA 1.496 2.647 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.7 p30 -80.81 4.35 19.42 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.517 -0.99 . . . . 0.0 109.007 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -84.12 161.55 20.59 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.654 0.74 . . . . 0.0 110.148 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -79.01 146.91 33.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.65 -0.656 . . . . 0.0 110.186 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.0 m -135.26 159.6 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.493 -0.754 . . . . 0.0 109.543 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.691 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 45.1 m-20 -102.05 135.77 43.05 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.362 -0.836 . . . . 0.0 109.681 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 m -135.45 155.94 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.395 -0.816 . . . . 0.0 110.057 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.498 HG23 HD11 ' A' ' 96' ' ' LEU . 25.2 pt -133.83 146.71 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -84.39 142.56 30.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.842 . . . . 0.0 109.825 -179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -136.71 121.67 18.85 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.592 ' N ' HD13 ' A' ' 64' ' ' LEU . 21.5 ptmt -84.98 136.71 33.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.204 -0.935 . . . . 0.0 110.115 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.442 HG11 HD13 ' A' ' 74' ' ' LEU . 28.6 m -142.52 165.93 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.253 -0.904 . . . . 0.0 109.88 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -78.01 149.25 76.48 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.459 -0.776 . . . . 0.0 109.669 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.639 ' O ' HG12 ' A' ' 71' ' ' VAL . 51.3 Cg_exo -50.2 -39.31 52.14 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 121.963 1.776 . . . . 0.0 111.639 178.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 69' ' ' GLU . 2.4 pt-20 -70.7 -33.79 71.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.726 -0.609 . . . . 0.0 110.037 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 94.6 mt -84.67 2.66 40.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.87 . . . . 0.0 109.837 -179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.639 HG12 ' O ' ' A' ' 68' ' ' PRO . 8.0 p -64.34 -42.56 95.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.271 -0.893 . . . . 0.0 109.571 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.506 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -69.92 -40.22 74.28 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -62.36 -32.31 73.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.471 -1.017 . . . . 0.0 109.348 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.478 HD12 HD22 ' A' ' 108' ' ' LEU . 2.2 tt -84.85 -35.86 21.96 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.48 -0.762 . . . . 0.0 109.871 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -73.49 -8.16 54.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 110.003 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.93 -2.96 58.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.314 -0.866 . . . . 0.0 109.193 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.573 ' HB2' HD12 ' A' ' 80' ' ' ILE . 31.0 mtpt -96.21 111.43 56.49 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.602 -0.686 . . . . 0.0 109.337 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -52.15 143.14 42.98 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.061 1.841 . . . . 0.0 113.551 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -19.97 52.02 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.573 HD12 ' HB2' ' A' ' 77' ' ' LYS . 69.2 mt -100.76 121.24 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.321 -1.105 . . . . 0.0 109.299 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -108.78 151.07 41.58 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.468 -0.77 . . . . 0.0 109.765 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.56 163.66 37.29 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.466 2.11 . . . . 0.0 112.512 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -47.5 148.81 1.29 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.565 -0.71 . . . . 0.0 110.302 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.575 ' CZ ' HG21 ' A' ' 93' ' ' THR . 12.1 m-85 -63.07 -43.86 97.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.613 -0.679 . . . . 0.0 109.882 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -160.13 -26.58 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.217 -0.927 . . . . 0.0 109.223 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.407 ' CG ' ' H ' ' A' ' 87' ' ' ASN . 5.8 tpt -61.61 -140.92 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.51 -0.744 . . . . 0.0 110.42 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.464 ' CG ' ' ND1' ' A' ' 90' ' ' HIS . 82.7 m-20 -72.75 131.3 42.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.631 -0.668 . . . . 0.0 110.009 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -94.53 -21.93 18.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.502 -0.749 . . . . 0.0 109.788 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -100.98 -43.49 6.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.477 -0.764 . . . . 0.0 109.678 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.491 ' CD2' ' N ' ' A' ' 90' ' ' HIS . 3.4 m170 -63.21 -67.18 0.45 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 110.421 -179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.823 ' O ' HD13 ' A' ' 92' ' ' ILE . 8.3 m0 -111.39 148.48 32.95 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.628 -0.67 . . . . 0.0 109.713 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.823 HD13 ' O ' ' A' ' 91' ' ' TRP . 3.0 mm -132.75 161.77 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.575 HG21 ' CZ ' ' A' ' 84' ' ' TYR . 38.3 p -107.07 133.02 52.32 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.292 -0.88 . . . . 0.0 110.409 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.533 HG22 HG23 ' A' ' 80' ' ' ILE . 48.8 t -118.11 133.77 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 46.5 tp -90.75 108.45 19.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.508 -0.745 . . . . 0.0 109.957 -179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 62' ' ' ILE . 88.6 mt -65.58 -40.22 92.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.589 -0.694 . . . . 0.0 109.542 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.691 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 75.8 m-20 -78.32 6.2 8.82 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.475 -0.766 . . . . 0.0 109.164 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.83 178.84 53.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' O ' ' C ' ' A' ' 100' ' ' LEU . 47.2 Cg_endo -68.02 -79.93 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.85 2.367 . . . . 0.0 112.079 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.495 ' C ' ' O ' ' A' ' 99' ' ' PRO . 0.4 OUTLIER 22.92 -122.03 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.221 0.534 . . . . 0.0 111.085 -179.795 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 174.9 159.63 21.48 Favored Glycine 0 N--CA 1.487 2.088 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.202 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.56 -37.23 86.84 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.64 -0.918 . . . . 0.0 109.489 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.68 -40.06 95.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.581 -0.699 . . . . 0.0 109.401 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.17 -42.72 99.54 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.537 -0.727 . . . . 0.0 109.49 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.6 mt -64.23 -43.24 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.412 -0.805 . . . . 0.0 109.638 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.7 m170 -56.33 -44.13 79.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.47 -0.769 . . . . 0.0 109.494 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.8 t -61.9 -43.96 97.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.577 -0.702 . . . . 0.0 109.621 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.478 HD22 HD12 ' A' ' 74' ' ' LEU . 95.7 mt -63.3 -40.95 98.78 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.482 -0.761 . . . . 0.0 109.363 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 92.8 mt -63.37 -43.18 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.49 -0.756 . . . . 0.0 109.24 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -60.42 -39.3 86.94 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.258 -0.902 . . . . 0.0 108.855 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.44 -41.14 98.52 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.404 ' O ' HG23 ' A' ' 116' ' ' THR . 38.8 t -62.73 -40.43 97.2 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -57.21 -44.5 83.76 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.545 -0.722 . . . . 0.0 109.209 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.83 -29.15 70.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.418 -0.801 . . . . 0.0 109.537 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 56.9 mt -86.1 -18.14 33.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.263 -0.898 . . . . 0.0 110.025 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 112' ' ' SER . 68.0 p -102.88 15.02 30.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.385 -0.822 . . . . 0.0 109.224 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.0 mtp85 -48.67 143.87 4.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.406 -0.809 . . . . 0.0 110.209 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.0 mt -78.06 142.96 37.82 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.53 0.681 . . . . 0.0 110.668 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 57.58 68.12 0.88 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.393 0.616 . . . . 0.0 109.632 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -82.63 -72.26 0.45 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.453 -0.78 . . . . 0.0 110.027 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -87.58 5.12 40.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -0.751 . . . . 0.0 109.226 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -80.57 142.27 34.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.654 -0.654 . . . . 0.0 110.054 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -82.83 136.7 34.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -0.771 . . . . 0.0 110.37 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 125' ' ' HIS . 0.1 OUTLIER -67.75 -40.98 84.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.608 -0.683 . . . . 0.0 109.73 179.566 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.612 ' CD2' ' CD2' ' A' ' 124' ' ' HIS . 3.1 p80 . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.303 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 tpp . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.474 0.654 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -95.23 162.33 13.74 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.356 -0.84 . . . . 0.0 110.489 -179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -61.52 -42.72 99.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 109.847 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tm0? -60.88 -39.04 87.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.214 -0.929 . . . . 0.0 109.756 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -63.59 -36.63 84.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.398 -0.814 . . . . 0.0 109.059 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.406 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 56.5 t80 -60.98 -43.76 98.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 108.919 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 47.1 mm -61.1 -48.48 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.485 -0.76 . . . . 0.0 109.822 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -65.52 -41.47 93.1 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.329 -0.857 . . . . 0.0 109.452 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -61.54 -47.61 84.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.46 -0.775 . . . . 0.0 109.849 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.66 -46.18 90.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.294 -0.879 . . . . 0.0 110.157 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' ASP . 86.2 mt-30 -63.64 -32.28 73.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.839 . . . . 0.0 110.465 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.39 -47.91 77.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.99 -1.069 . . . . 0.0 109.729 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -90.03 -12.21 39.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.302 -0.873 . . . . 0.0 111.844 -178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.423 ' O ' ' CG ' ' A' ' 15' ' ' ASP . 97.7 m-85 -132.93 -18.04 2.39 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.839 -1.163 . . . . 0.0 110.915 -178.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' GLN . 4.4 p-10 43.85 31.92 0.54 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.365 -0.834 . . . . 0.0 109.418 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.0 m -102.37 136.96 41.27 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.657 0.741 . . . . 0.0 110.069 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -83.04 148.79 57.57 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.58 -0.7 . . . . 0.0 109.275 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.2 145.39 72.45 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.403 2.069 . . . . 0.0 112.129 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -121.91 143.44 49.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.617 -0.677 . . . . 0.0 109.485 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.635 ' H ' ' CD2' ' A' ' 20' ' ' HIS . 0.3 OUTLIER -122.18 86.44 47.31 Favored Pre-proline 0 N--CA 1.493 1.698 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.589 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -54.62 -40.68 82.97 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.269 1.979 . . . . 0.0 111.068 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 13.9 m-90 -90.3 136.54 32.99 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 121.61 0.719 . . . . 0.0 109.811 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' H ' ' HG2' ' A' ' 23' ' ' GLU . 16.4 pt-20 -86.98 -22.02 25.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.62 -0.675 . . . . 0.0 109.516 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -75.85 -5.13 44.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.411 -0.806 . . . . 0.0 109.03 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -136.33 72.82 58.16 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.536 -0.728 . . . . 0.0 109.114 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.37 -12.08 24.99 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.499 2.133 . . . . 0.0 111.055 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 17.7 p-10 -87.53 -1.9 58.25 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.521 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.2 m-85 -87.15 142.09 28.17 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.511 -0.743 . . . . 0.0 109.892 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -126.93 129.18 47.66 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.411 HG22 HD13 ' A' ' 42' ' ' LEU . 48.2 t -132.03 131.14 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.532 -0.73 . . . . 0.0 109.888 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -109.4 139.08 44.81 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.496 ' CB ' ' CD1' ' A' ' 39' ' ' TRP . 11.9 ptp180 -142.93 130.51 21.28 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.141 -0.974 . . . . 0.0 109.853 179.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.405 ' H ' ' CB ' ' A' ' 39' ' ' TRP . 1.0 OUTLIER -102.87 110.21 22.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.552 -0.718 . . . . 0.0 109.129 179.105 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.6 p -70.94 -16.31 62.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -0.812 . . . . 0.0 110.065 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -89.05 -5.14 58.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.124 -0.985 . . . . 0.0 109.644 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.577 ' O ' ' N ' ' A' ' 38' ' ' LYS . 9.1 t-20 -107.45 -4.36 18.57 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.496 ' O ' ' CE3' ' A' ' 39' ' ' TRP . 66.7 t0 59.35 -68.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.357 0.599 . . . . 0.0 110.231 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.577 ' N ' ' O ' ' A' ' 36' ' ' ASN . 33.5 pttt -88.12 87.15 7.23 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.382 -0.824 . . . . 0.0 108.924 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.509 ' O ' ' CG ' ' A' ' 40' ' ' TYR . 24.5 p90 -113.83 143.59 44.41 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.403 0.621 . . . . 0.0 109.937 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.509 ' CG ' ' O ' ' A' ' 39' ' ' TRP . 99.4 m-85 -156.68 120.85 4.39 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.491 ' C ' HD22 ' A' ' 42' ' ' LEU . . . -155.94 105.33 2.36 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.3 mm? -111.21 131.57 55.02 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.425 0.631 . . . . 0.0 109.694 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' CD1' ' CD2' ' A' ' 6' ' ' PHE . 7.8 tt -135.41 119.71 17.85 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.521 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.2 ptt? -162.5 163.29 27.56 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.082 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.402 ' O ' ' OD1' ' A' ' 45' ' ' ASP . 33.0 p-10 -102.97 118.37 36.66 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.9 146.19 52.47 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.717 -0.614 . . . . 0.0 109.933 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -46.36 141.37 10.39 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 122.36 2.04 . . . . 0.0 112.765 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.45 -24.16 67.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.62 -0.675 . . . . 0.0 109.915 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.58 -29.29 69.31 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.319 -0.863 . . . . 0.0 109.785 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -64.47 -35.63 81.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.244 -0.91 . . . . 0.0 110.379 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.436 ' CD1' HD12 ' A' ' 53' ' ' ILE . 14.2 pt -85.15 2.47 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 120.907 -1.12 . . . . 0.0 109.6 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.84 -7.43 62.94 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.436 HD12 ' CD1' ' A' ' 51' ' ' ILE . 66.1 mt -78.27 126.61 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.775 -1.426 . . . . 0.0 110.072 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -61.71 86.35 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.705 0.764 . . . . 0.0 109.539 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.52 137.29 3.38 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -95.17 5.71 51.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.408 -1.054 . . . . 0.0 108.204 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -71.71 143.25 49.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.673 . . . . 0.0 110.477 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -78.76 140.55 38.25 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.563 -0.711 . . . . 0.0 110.117 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.7 159.98 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.468 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 91.5 m-20 -88.19 134.06 33.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.463 -0.773 . . . . 0.0 109.929 -178.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.9 m -137.49 153.44 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.496 -0.752 . . . . 0.0 109.714 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.7 pt -141.59 145.01 25.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 121.535 0.683 . . . . 0.0 110.151 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -79.82 142.23 35.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.543 -0.723 . . . . 0.0 109.84 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.695 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -127.31 127.81 44.93 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.695 ' N ' HD13 ' A' ' 64' ' ' LEU . 18.0 ttmm -82.11 130.39 35.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.639 -0.663 . . . . 0.0 109.937 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -139.13 163.59 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.444 -0.785 . . . . 0.0 109.879 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -85.96 150.94 53.92 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.425 -0.797 . . . . 0.0 109.65 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.473 ' O ' HG12 ' A' ' 71' ' ' VAL . 53.8 Cg_exo -45.94 -26.7 3.6 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.271 1.981 . . . . 0.0 111.598 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.541 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 57.2 mp0 -94.31 -31.37 14.08 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.549 -0.719 . . . . 0.0 109.881 -179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.7 mt -87.12 -3.63 59.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 109.742 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 72' ' ' GLY . 9.0 p -67.51 -44.41 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.066 -1.021 . . . . 0.0 109.642 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.565 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.63 -41.32 99.11 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.7 t -62.79 -53.63 51.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.177 -1.19 . . . . 0.0 110.233 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.454 HD12 HD22 ' A' ' 108' ' ' LEU . 2.0 tt -67.71 -44.5 77.51 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.217 -0.927 . . . . 0.0 109.813 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -62.51 -30.66 71.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.542 -0.724 . . . . 0.0 109.656 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.15 -32.34 72.53 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.4 mmmt -58.99 114.96 10.25 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.42 -0.8 . . . . 0.0 109.705 -178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -52.31 149.31 23.04 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.195 1.93 . . . . 0.0 113.186 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.92 -14.65 64.36 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 71.3 mt -106.57 120.09 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.599 -0.942 . . . . 0.0 109.345 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -105.15 150.36 38.72 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.593 -0.692 . . . . 0.0 109.668 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.6 149.32 79.4 Favored 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 122.436 2.091 . . . . 0.0 112.324 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.55 142.77 56.41 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.781 0.8 . . . . 0.0 110.502 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -86.52 -4.93 59.25 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.537 ' CG ' ' H ' ' A' ' 86' ' ' MET . 71.1 t60 -93.34 175.06 6.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.316 -0.865 . . . . 0.0 110.447 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 88' ' ' LYS . 79.1 mtm -52.11 -172.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.626 -0.671 . . . . 0.0 111.26 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 56.26 -78.7 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' N ' ' O ' ' A' ' 86' ' ' MET . 31.5 ttmt 69.76 -46.13 0.59 Allowed 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.387 0.613 . . . . 0.0 109.786 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -68.98 -44.39 72.98 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.39 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -69.62 -45.52 68.34 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.391 -0.818 . . . . 0.0 110.439 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -112.36 142.34 44.99 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.47 -0.769 . . . . 0.0 110.869 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.7 mm -132.09 139.88 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.6 m -83.76 129.53 34.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 0.0 109.594 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.1 t -115.01 132.01 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.7 tp -87.75 104.02 16.16 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-O 121.641 0.734 . . . . 0.0 110.019 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -66.36 -39.48 89.18 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.571 0.7 . . . . 0.0 109.123 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.468 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 98.6 m-20 -77.28 8.08 4.49 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -85.76 -161.39 34.85 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.49 -3.77 12.66 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.958 2.439 . . . . 0.0 111.874 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 100' ' ' LEU . 4.4 mm? -59.6 132.31 53.58 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.926 0.87 . . . . 0.0 110.052 -179.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -83.98 161.52 38.07 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.11 97.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.807 -0.819 . . . . 0.0 109.514 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -72.04 -35.4 69.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.396 -0.815 . . . . 0.0 109.436 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.23 -42.55 93.27 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.352 -0.843 . . . . 0.0 109.31 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 93.0 mt -64.74 -43.02 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.683 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -56.67 -45.16 81.87 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 0.0 109.943 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 60.3 m -61.43 -43.73 98.35 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.094 -1.004 . . . . 0.0 109.715 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.454 HD22 HD12 ' A' ' 74' ' ' LEU . 95.2 mt -63.97 -40.97 97.6 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 109.547 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 90.5 mt -62.95 -42.43 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.359 -0.838 . . . . 0.0 108.78 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -52.09 -42.87 63.59 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.446 -0.784 . . . . 0.0 108.991 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -62.2 -40.98 97.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 108.969 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.1 t -64.31 -36.83 85.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.436 -0.79 . . . . 0.0 109.358 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.478 ' O ' ' N ' ' A' ' 117' ' ' ARG . 80.4 t80 -58.18 -43.09 87.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.543 -0.723 . . . . 0.0 109.52 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -54.29 -45.13 72.44 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.234 -0.916 . . . . 0.0 109.924 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.518 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.7 mp -66.75 -39.28 87.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.18 -0.95 . . . . 0.0 109.782 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.504 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 32.1 p -92.99 7.22 44.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.25 -0.906 . . . . 0.0 109.19 -178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 113' ' ' PHE . 42.2 ttm180 -59.85 144.53 48.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.479 -0.763 . . . . 0.0 109.591 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mt -73.26 144.48 46.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.363 -0.836 . . . . 0.0 110.736 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -171.77 96.76 0.17 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -137.87 145.08 41.75 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.308 -0.87 . . . . 0.0 109.514 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -121.79 156.64 32.75 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.603 0.716 . . . . 0.0 110.084 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -61.61 -45.16 95.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.553 -0.717 . . . . 0.0 109.787 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.49 ' ND1' ' NE2' ' A' ' 124' ' ' HIS . 56.1 t-80 -67.22 -44.55 79.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.278 -0.888 . . . . 0.0 109.711 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.49 ' NE2' ' ND1' ' A' ' 123' ' ' HIS . 32.6 m170 -109.35 117.57 34.41 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.536 -0.728 . . . . 0.0 109.885 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.542 ' OXT' ' CG ' ' A' ' 125' ' ' HIS . 49.3 p-80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.894 -1.05 . . . . 0.0 108.95 179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 tpp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.358 0.599 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -101.1 162.84 12.61 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.435 -0.791 . . . . 0.0 110.17 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -61.53 -43.62 98.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.501 -0.75 . . . . 0.0 109.573 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 73.8 tp60 -65.9 -42.83 89.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.524 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -64.41 -41.87 96.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.84 . . . . 0.0 109.482 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.431 ' CE1' HD13 ' A' ' 62' ' ' ILE . 87.3 t80 -62.26 -46.26 89.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.28 -0.887 . . . . 0.0 109.908 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.94 -43.71 97.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.302 -0.874 . . . . 0.0 109.252 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.01 -41.41 99.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.563 -0.71 . . . . 0.0 109.617 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -68.25 -36.61 79.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.242 -0.911 . . . . 0.0 109.49 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 -50.44 73.67 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.433 -0.792 . . . . 0.0 110.344 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.475 ' O ' ' N ' ' A' ' 15' ' ' ASP . 2.8 pt20 -64.49 -37.53 87.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.601 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -61.42 -41.48 97.23 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.893 -1.129 . . . . 0.0 109.948 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -87.4 -33.8 18.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.237 -0.914 . . . . 0.0 111.503 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 16' ' ' THR . 88.3 m-85 -105.95 6.98 31.85 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.129 -0.982 . . . . 0.0 110.732 -178.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.475 ' N ' ' O ' ' A' ' 11' ' ' GLN . 2.1 p-10 39.91 29.74 0.05 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.427 -0.795 . . . . 0.0 109.643 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 14' ' ' TYR . 58.3 m -120.67 131.25 54.48 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.51 0.671 . . . . 0.0 109.915 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.0 ptmm? -87.35 156.82 53.84 Favored Pre-proline 0 C--N 1.303 -1.446 0 O-C-N 121.556 -0.715 . . . . 0.0 109.374 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -48.66 133.29 26.66 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.077 1.851 . . . . 0.0 112.392 179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -118.36 143.43 46.64 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.454 0.645 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.482 ' O ' ' CG ' ' A' ' 20' ' ' HIS . 20.0 p-80 -146.29 85.8 7.24 Favored Pre-proline 0 N--CA 1.486 1.362 0 O-C-N 121.405 -0.809 . . . . 0.0 109.137 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -83.74 -10.71 9.41 Favored 'Trans proline' 0 C--N 1.314 -1.285 0 C-N-CA 122.737 2.291 . . . . 0.0 110.346 179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -85.96 104.72 15.86 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.801 0.81 . . . . 0.0 109.647 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -68.08 -34.24 76.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.734 -0.604 . . . . 0.0 109.746 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -75.22 -6.08 47.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.33 -0.857 . . . . 0.0 109.501 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.76 71.1 30.31 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.425 -0.797 . . . . 0.0 109.002 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -69.0 -17.59 40.97 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.458 2.106 . . . . 0.0 111.735 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -85.07 -4.41 59.14 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.386 -0.821 . . . . 0.0 109.328 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.592 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 3.3 m-85 -85.41 148.04 26.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 109.911 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.17 134.32 46.4 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.554 ' CG1' ' HE ' ' A' ' 32' ' ' ARG . 2.9 t -118.21 129.65 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -116.92 113.33 22.28 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.797 -0.565 . . . . 0.0 109.523 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.554 ' HE ' ' CG1' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -135.58 159.55 41.27 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.42 -0.8 . . . . 0.0 109.407 179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.742 ' N ' ' HE1' ' A' ' 39' ' ' TRP . 0.5 OUTLIER -77.51 153.94 32.95 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.929 0.871 . . . . 0.0 110.516 -179.628 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.8 p -88.37 -50.53 6.27 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -96.41 -25.66 15.62 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.326 -0.859 . . . . 0.0 111.247 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.594 ' O ' ' N ' ' A' ' 38' ' ' LYS . 0.8 OUTLIER -105.07 30.02 5.9 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.096 -1.002 . . . . 0.0 110.037 -178.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 33' ' ' HIS . 10.4 m-20 -42.48 86.99 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.572 -0.705 . . . . 0.0 110.522 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.7 tttt -144.58 -29.02 0.48 Allowed 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.742 ' HE1' ' N ' ' A' ' 33' ' ' HIS . 1.5 p-90 -95.89 159.27 15.06 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.384 -0.823 . . . . 0.0 109.368 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -138.58 126.2 22.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.297 -0.877 . . . . 0.0 109.617 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -150.75 150.48 31.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.495 -0.753 . . . . 0.0 109.421 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.51 152.85 33.53 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.494 -0.754 . . . . 0.0 109.089 179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.51 HD23 ' C ' ' A' ' 43' ' ' LEU . 9.1 tt -119.9 128.18 53.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.592 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 8.0 ptt? -148.21 156.32 42.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.906 . . . . 0.0 109.907 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -95.89 114.54 26.27 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 11.1 pt -118.18 147.27 41.2 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 121.757 -0.589 . . . . 0.0 109.662 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.1 145.33 98.69 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.545 2.163 . . . . 0.0 112.453 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.33 -21.17 63.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.602 -0.686 . . . . 0.0 109.904 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' OE2' ' OD1' ' A' ' 56' ' ' ASP . 96.0 mt-10 -71.23 -19.39 62.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 110.254 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -84.72 -12.24 54.21 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.015 -1.053 . . . . 0.0 110.271 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 53' ' ' ILE . 5.0 pt -106.79 -0.32 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.287 -0.883 . . . . 0.0 109.245 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.11 -1.16 82.59 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 120.254 -0.974 . . . . 0.0 110.685 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.549 HD12 HD12 ' A' ' 51' ' ' ILE . 75.3 mt -81.9 132.17 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.823 -1.398 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -85.44 96.99 9.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.553 -0.717 . . . . 0.0 109.858 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -156.9 -21.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.666 -1.774 . . . . 0.0 108.666 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.419 ' OD1' ' OE2' ' A' ' 49' ' ' GLU . 90.0 m-20 54.36 20.02 2.52 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.683 -0.893 . . . . 0.0 109.466 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -109.5 159.28 17.18 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.557 0.694 . . . . 0.0 110.082 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -84.38 142.26 30.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.648 -0.658 . . . . 0.0 109.662 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.7 m -133.56 159.18 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.494 -0.754 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -101.23 136.88 40.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.485 -0.759 . . . . 0.0 109.183 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 m -136.23 157.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.538 -0.726 . . . . 0.0 110.162 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.431 HD13 ' CE1' ' A' ' 6' ' ' PHE . 31.8 pt -137.0 145.24 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 121.48 0.657 . . . . 0.0 109.853 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -81.32 142.9 32.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.387 -0.82 . . . . 0.0 109.985 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -132.85 125.22 29.51 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.624 ' N ' HD13 ' A' ' 64' ' ' LEU . 88.1 tttt -82.02 130.33 35.05 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.394 -0.816 . . . . 0.0 110.414 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.69 163.73 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.456 -0.777 . . . . 0.0 109.609 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.436 ' HG3' HD22 ' A' ' 115' ' ' LEU . 20.1 mt-30 -85.97 154.77 58.23 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.38 -0.825 . . . . 0.0 109.824 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.529 ' O ' HG12 ' A' ' 71' ' ' VAL . 75.9 Cg_exo -46.43 -35.0 15.45 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.511 2.141 . . . . 0.0 112.307 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -89.65 -21.72 22.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.171 -0.955 . . . . 0.0 110.157 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 88.1 mt -94.74 -6.06 43.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.096 -1.002 . . . . 0.0 109.334 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.529 HG12 ' O ' ' A' ' 68' ' ' PRO . 8.6 p -67.5 -41.46 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.339 -0.851 . . . . 0.0 109.544 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.522 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.43 -39.54 97.84 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 43.7 t -61.2 -47.23 87.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.331 -1.099 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.483 HD12 HD22 ' A' ' 108' ' ' LEU . 3.2 tt -75.02 -42.16 57.91 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.445 -0.784 . . . . 0.0 109.809 179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 65.2 ttt180 -69.91 -37.64 76.02 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.67 -0.644 . . . . 0.0 111.217 -178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -73.63 -3.41 27.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.922 -1.111 . . . . 0.0 109.762 -178.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -83.92 150.75 59.43 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.102 -0.999 . . . . 0.0 109.526 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.58 150.92 75.35 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 122.65 2.234 . . . . 0.0 113.1 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 76.96 2.89 79.46 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 26.5 mm -105.0 127.74 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -1.049 . . . . 0.0 109.667 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -121.09 152.56 56.96 Favored Pre-proline 0 N--CA 1.494 1.733 0 CA-C-O 121.239 0.542 . . . . 0.0 109.786 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.423 ' O ' ' OG1' ' A' ' 93' ' ' THR . 43.4 Cg_endo -65.5 154.74 72.34 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.758 2.306 . . . . 0.0 112.322 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' HA ' HG23 ' A' ' 93' ' ' THR . . . -53.2 147.14 10.45 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.379 -0.826 . . . . 0.0 110.464 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 84' ' ' TYR . 54.9 t80 -85.64 12.86 7.92 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -154.43 -169.54 3.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.437 -0.789 . . . . 0.0 109.811 179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 97.6 mmm -60.41 -176.6 0.05 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.432 -0.792 . . . . 0.0 110.893 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 9.7 m120 57.46 35.11 25.52 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.781 0.8 . . . . 0.0 109.186 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -63.13 -42.68 99.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.568 -0.708 . . . . 0.0 109.824 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.89 -44.02 81.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.348 -0.845 . . . . 0.0 110.081 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -70.05 -46.68 64.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 110.425 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -116.67 146.03 43.03 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.547 -0.72 . . . . 0.0 110.246 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.442 HG21 ' CD2' ' A' ' 74' ' ' LEU . 9.4 mm -130.16 146.25 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.426 HG23 ' HA ' ' A' ' 83' ' ' ALA . 0.9 OUTLIER -91.36 137.78 32.1 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.491 -0.755 . . . . 0.0 109.249 -179.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 73.7 t -118.05 133.23 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 40.1 tp -84.25 103.74 13.7 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.517 0.675 . . . . 0.0 110.122 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.3 mt -67.04 -39.92 87.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.525 -0.734 . . . . 0.0 109.172 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -68.82 -4.8 17.58 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -76.44 -166.34 22.97 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -79.48 -3.14 12.78 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 123.106 2.538 . . . . 0.0 111.399 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.4 mm? -55.2 125.78 22.06 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.908 0.861 . . . . 0.0 109.912 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -85.61 161.34 35.12 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.91 95.92 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.642 -0.916 . . . . 0.0 109.173 179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 24.5 mtmm -64.42 -41.96 96.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 109.201 179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.56 -43.58 89.4 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.402 -0.811 . . . . 0.0 109.21 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 95.4 mt -64.22 -43.29 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.465 -0.772 . . . . 0.0 109.198 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 26.0 m170 -58.77 -41.64 87.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.376 -0.828 . . . . 0.0 109.38 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.6 m -61.19 -43.38 98.98 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.295 -0.878 . . . . 0.0 109.229 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.483 HD22 HD12 ' A' ' 74' ' ' LEU . 91.8 mt -64.47 -41.66 96.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.772 . . . . 0.0 109.592 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.73 -42.97 97.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.859 . . . . 0.0 109.121 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -59.47 -39.41 83.6 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.383 -0.823 . . . . 0.0 108.989 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -65.19 -37.83 88.56 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 39.3 t -61.51 -42.12 98.33 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -0.845 . . . . 0.0 109.179 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 117' ' ' ARG . 77.4 t80 -61.13 -44.24 97.64 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.433 -0.792 . . . . 0.0 109.07 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -61.62 -43.28 99.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 0.0 108.83 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.436 HD22 ' HG3' ' A' ' 67' ' ' GLN . 91.4 mt -64.78 -39.98 94.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.561 -0.712 . . . . 0.0 109.372 179.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.1 p -99.14 14.97 27.47 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.521 ' N ' ' O ' ' A' ' 113' ' ' PHE . 9.1 ptm180 -38.57 144.27 0.12 Allowed 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.796 0.808 . . . . 0.0 111.414 -178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 63.3 tp -74.72 142.86 44.35 Favored 'General case' 0 C--N 1.307 -1.251 0 O-C-N 121.567 -0.708 . . . . 0.0 109.813 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -137.78 22.52 2.88 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -150.35 97.25 2.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.433 -0.792 . . . . 0.0 109.257 179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -86.57 112.93 22.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.412 -0.805 . . . . 0.0 109.846 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -69.93 -35.95 74.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.533 -0.729 . . . . 0.0 109.583 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 57.59 68.19 0.88 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.608 0.718 . . . . 0.0 109.845 -179.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -66.96 -42.89 84.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.595 -0.691 . . . . 0.0 109.589 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.461 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 56.5 p-80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.298 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.492 ' O ' ' NH2' ' A' ' 3' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -104.92 163.94 12.15 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.822 0.82 . . . . 0.0 110.24 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.492 ' NH2' ' O ' ' A' ' 1' ' ' MET . 13.8 mmp_? -59.91 -47.91 83.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.574 -0.704 . . . . 0.0 109.522 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -43.42 -43.15 5.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.558 -0.714 . . . . 0.0 109.962 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.03 -44.91 83.31 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.186 -0.946 . . . . 0.0 109.217 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -62.89 -46.03 89.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.35 -0.843 . . . . 0.0 109.635 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 39.7 mm -64.34 -45.0 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.361 -0.837 . . . . 0.0 109.722 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.08 -41.71 99.48 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.322 -0.862 . . . . 0.0 110.075 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.458 ' CE1' HG21 ' A' ' 109' ' ' ILE . 33.9 t80 -60.81 -44.56 96.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.531 -0.731 . . . . 0.0 109.988 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.89 -37.41 84.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.485 -0.759 . . . . 0.0 110.117 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.571 ' O ' ' N ' ' A' ' 15' ' ' ASP . 94.9 mt-30 -67.51 -35.92 80.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.844 -1.16 . . . . 0.0 109.603 179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -64.9 -43.36 93.12 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.689 -1.257 . . . . 0.0 109.657 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -88.25 -11.84 45.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.378 -0.826 . . . . 0.0 111.346 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.606 ' CE1' ' NE2' ' A' ' 33' ' ' HIS . 91.4 m-85 -139.98 -20.34 0.89 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 120.837 -1.164 . . . . 0.0 111.139 -179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.571 ' N ' ' O ' ' A' ' 11' ' ' GLN . 72.1 m-20 53.64 30.16 10.49 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.049 -1.032 . . . . 0.0 109.475 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 t -103.2 156.21 17.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.353 -0.842 . . . . 0.0 109.33 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -97.37 139.76 21.63 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.342 -0.849 . . . . 0.0 109.615 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -50.34 142.28 29.86 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.825 1.684 . . . . 0.0 112.906 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -125.97 121.68 33.76 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -89.55 146.44 35.75 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.184 -0.947 . . . . 0.0 109.867 -179.576 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.32 -81.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.161 1.908 . . . . 0.0 111.561 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -87.2 137.03 32.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.448 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -61.51 -20.1 62.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.392 -0.817 . . . . 0.0 109.733 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -76.7 -5.19 46.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.392 -0.818 . . . . 0.0 109.629 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -129.8 70.12 81.87 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.469 -0.77 . . . . 0.0 109.286 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -67.92 -18.14 46.64 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.368 2.045 . . . . 0.0 112.015 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -79.78 -5.05 54.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.342 -0.849 . . . . 0.0 109.435 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.62 140.87 29.12 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.362 -0.836 . . . . 0.0 109.527 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.05 130.78 43.7 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.659 -0.65 . . . . 0.0 109.309 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 78.5 t -128.09 131.44 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -103.17 147.88 26.47 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.539 -0.726 . . . . 0.0 109.574 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -134.24 139.88 46.07 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.48 -0.762 . . . . 0.0 109.749 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.606 ' NE2' ' CE1' ' A' ' 14' ' ' TYR . 30.5 m170 -100.21 131.49 46.11 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.626 -0.671 . . . . 0.0 109.337 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.3 m -87.18 -32.11 19.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 0.0 110.59 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 31.4 p-10 -92.02 -1.6 57.15 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.092 -1.005 . . . . 0.0 111.491 -178.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.573 ' O ' ' N ' ' A' ' 38' ' ' LYS . 14.7 t-20 -118.66 29.1 7.92 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.027 -1.046 . . . . 0.0 110.16 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.412 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 98.7 m-20 37.23 -86.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.425 0.631 . . . . 0.0 111.215 179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 36' ' ' ASN . 17.9 ptpt -77.53 157.58 30.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.501 -0.749 . . . . 0.0 110.325 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.432 ' CE3' ' O ' ' A' ' 39' ' ' TRP . 12.0 p-90 -177.44 153.13 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.534 -0.729 . . . . 0.0 109.421 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -149.17 118.8 6.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.177 -0.952 . . . . 0.0 109.364 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -157.58 124.53 5.05 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.431 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -150.91 143.02 24.08 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.75 -1.219 . . . . 0.0 110.235 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.498 HD21 ' OD1' ' A' ' 60' ' ' ASP . 9.5 tt -121.03 125.45 47.36 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -156.99 162.11 39.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.311 -0.868 . . . . 0.0 109.906 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.04 114.89 26.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.582 -0.699 . . . . 0.0 109.157 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.7 pt -121.19 145.5 42.19 Favored Pre-proline 0 N--CA 1.502 2.173 0 O-C-N 121.515 -0.741 . . . . 0.0 109.45 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -45.34 135.86 11.67 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 C-N-CA 121.903 1.735 . . . . 0.0 112.787 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.25 -25.64 65.28 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.589 -0.695 . . . . 0.0 110.162 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.22 -17.7 63.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.296 -0.877 . . . . 0.0 110.346 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -84.64 -12.84 53.15 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.971 -1.08 . . . . 0.0 110.991 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.5 pt -102.67 6.35 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 O-C-N 121.188 -0.945 . . . . 0.0 109.465 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.03 -4.61 67.98 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 178.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.682 HD11 ' CZ ' ' A' ' 81' ' ' TYR . 77.2 mt -79.7 135.43 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.886 -1.361 . . . . 0.0 109.882 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -74.42 92.36 2.32 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.568 -0.707 . . . . 0.0 110.083 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.2 139.63 3.23 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 56' ' ' ASP . 37.5 p-10 -88.99 4.55 47.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.345 -1.091 . . . . 0.0 108.394 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -80.62 152.94 28.27 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.642 -0.661 . . . . 0.0 110.023 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -97.6 150.01 21.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.563 -0.711 . . . . 0.0 109.814 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.33 163.05 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.715 -0.616 . . . . 0.0 109.642 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.498 ' OD1' HD21 ' A' ' 43' ' ' LEU . 8.3 t70 -91.57 128.81 37.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.583 -0.698 . . . . 0.0 109.39 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.8 m -131.83 160.18 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.43 -0.794 . . . . 0.0 110.348 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.15 150.97 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -84.96 127.27 34.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.466 -0.771 . . . . 0.0 109.975 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.584 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -118.99 121.31 39.61 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.584 ' N ' HD13 ' A' ' 64' ' ' LEU . 37.4 ttmt -82.93 132.2 35.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.333 -0.855 . . . . 0.0 110.159 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 m -142.5 165.08 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.347 -0.846 . . . . 0.0 108.879 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.496 HE21 HD12 ' A' ' 70' ' ' LEU . 6.5 mt-30 -84.71 156.9 61.4 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 108.725 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 71' ' ' VAL . 20.3 Cg_endo -60.66 -22.84 74.26 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 C-N-CA 122.382 2.055 . . . . 0.0 111.405 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -90.48 -29.64 17.81 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.441 -0.787 . . . . 0.0 109.352 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.496 HD12 HE21 ' A' ' 67' ' ' GLN . 80.9 mt -95.2 1.93 54.81 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.326 -0.859 . . . . 0.0 109.763 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.444 HG12 ' O ' ' A' ' 68' ' ' PRO . 10.0 p -64.33 -34.47 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.105 -0.997 . . . . 0.0 109.52 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -68.56 -14.59 67.33 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.453 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 55.9 p -68.27 -60.56 2.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.223 -1.163 . . . . 0.0 111.101 -178.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.629 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.7 pt? -88.24 -23.9 23.4 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.796 -1.19 . . . . 0.0 110.934 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.445 HH21 ' NZ ' ' A' ' 88' ' ' LYS . 78.9 ttt-85 -65.76 -22.8 66.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 110.097 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.453 ' CD ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -94.28 -9.34 36.33 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.205 -0.934 . . . . 0.0 108.833 179.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -73.81 151.28 88.81 Favored Pre-proline 0 C--N 1.307 -1.246 0 O-C-N 121.097 -1.002 . . . . 0.0 109.357 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.09 143.34 71.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.612 2.208 . . . . 0.0 112.53 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.15 -5.26 63.54 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.9 mm -98.41 125.18 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.234 -1.157 . . . . 0.0 109.174 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.682 ' CZ ' HD11 ' A' ' 53' ' ' ILE . 77.3 m-85 -119.87 147.91 45.29 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.733 -0.604 . . . . 0.0 109.598 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HB3' ' HZ1' ' A' ' 88' ' ' LYS . 52.0 Cg_endo -69.95 153.68 67.8 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.054 1.836 . . . . 0.0 111.837 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.67 148.68 50.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.343 -0.848 . . . . 0.0 109.834 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.403 ' O ' ' C ' ' A' ' 85' ' ' HIS . 32.1 p90 -66.2 179.31 0.97 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.391 -0.818 . . . . 0.0 110.261 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.509 ' O ' ' CG ' ' A' ' 85' ' ' HIS . 54.5 p-80 -40.85 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.471 0.653 . . . . 0.0 110.545 -179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 36.1 ttm -167.67 -78.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.526 -0.734 . . . . 0.0 109.193 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.622 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 98.9 m-20 -139.92 -31.84 0.64 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.363 -0.836 . . . . 0.0 109.317 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.445 ' NZ ' HH21 ' A' ' 75' ' ' ARG . 49.9 tttp 58.77 -68.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.238 0.542 . . . . 0.0 111.417 179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.553 ' N ' ' O ' ' A' ' 87' ' ' ASN . 74.2 mt-10 -60.92 -52.21 66.01 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.312 -0.868 . . . . 0.0 112.001 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -66.54 -46.77 75.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.935 -1.103 . . . . 0.0 111.251 -177.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.622 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 8.9 m0 -115.51 140.99 48.66 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.439 -0.788 . . . . 0.0 110.317 -178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.5 mm -128.87 138.41 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.8 p -86.84 133.35 33.64 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.554 -0.716 . . . . 0.0 109.876 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 87.9 t -112.91 132.58 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 47.3 tp -87.02 104.07 15.96 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.518 0.675 . . . . 0.0 110.488 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.5 mt -67.64 -39.75 84.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.567 -0.708 . . . . 0.0 109.482 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -71.87 1.78 6.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.529 -0.732 . . . . 0.0 109.386 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.83 -162.47 30.09 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.44 -3.39 11.4 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.892 2.394 . . . . 0.0 111.242 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -49.6 126.63 13.99 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.618 0.723 . . . . 0.0 110.0 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -90.21 169.29 34.59 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.84 94.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.274 -1.133 . . . . 0.0 109.232 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -64.85 -42.02 95.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.592 -0.692 . . . . 0.0 109.612 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.74 -42.69 94.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 94.8 mt -64.28 -43.3 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.48 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -56.94 -43.84 81.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.387 -0.82 . . . . 0.0 109.564 -179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 59.3 m -61.16 -43.99 98.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.897 . . . . 0.0 109.654 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.0 mt -63.87 -42.46 97.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.328 -0.858 . . . . 0.0 109.201 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.458 HG21 ' CE1' ' A' ' 9' ' ' TYR . 97.0 mt -63.8 -42.78 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 108.652 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -53.07 -40.9 64.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.475 -0.766 . . . . 0.0 108.936 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.64 -39.61 94.4 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 108.702 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.2 t -65.02 -40.34 94.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.836 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -57.99 -48.97 78.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.417 -0.802 . . . . 0.0 110.076 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -67.75 -32.12 72.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.087 -1.008 . . . . 0.0 109.408 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.476 HD21 ' HG3' ' A' ' 67' ' ' GLN . 0.1 OUTLIER -61.88 -41.12 97.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.301 -0.874 . . . . 0.0 109.701 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 43.7 p -90.78 14.93 12.2 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.49 -0.756 . . . . 0.0 109.395 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -53.93 145.69 15.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.467 -0.771 . . . . 0.0 110.319 -179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.429 HD22 ' O ' ' A' ' 35' ' ' ASP . 57.2 mt -71.51 141.19 50.16 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.642 0.734 . . . . 0.0 110.547 -179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -97.09 21.95 9.14 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.662 -0.649 . . . . 0.0 109.551 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -150.04 162.93 39.43 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.897 . . . . 0.0 109.937 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -80.5 155.63 26.92 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.545 -0.722 . . . . 0.0 110.175 -179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -60.44 -41.28 93.72 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.553 -0.717 . . . . 0.0 109.678 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -73.92 129.12 37.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.582 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -76.32 135.12 39.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.469 -0.769 . . . . 0.0 110.261 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.501 ' O ' ' CG ' ' A' ' 125' ' ' HIS . 86.8 t60 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.346 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.5 ttm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -104.56 156.23 18.14 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.458 -0.776 . . . . 0.0 110.001 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.493 ' NH1' ' OD2' ' A' ' 45' ' ' ASP . 61.6 ttp180 -61.29 -42.9 99.43 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.54 -0.725 . . . . 0.0 109.336 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 tm0? -63.56 -39.77 95.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.368 -0.832 . . . . 0.0 109.773 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' N ' ' OE1' ' A' ' 5' ' ' GLN . 0.4 OUTLIER -62.75 -42.44 99.68 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 109.013 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.404 ' CD1' HD12 ' A' ' 43' ' ' LEU . 60.2 t80 -61.08 -45.55 94.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.297 -0.877 . . . . 0.0 109.526 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.35 -44.51 99.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.336 -0.853 . . . . 0.0 109.487 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -63.12 -45.79 90.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 0.0 109.185 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -62.61 -43.19 99.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.782 . . . . 0.0 109.258 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.46 -42.94 97.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.414 -0.803 . . . . 0.0 110.002 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 81.0 mt-30 -65.65 -45.0 84.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 110.123 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.37 -35.8 80.27 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.09 -1.006 . . . . 0.0 109.514 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -85.07 -37.24 20.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.398 -0.814 . . . . 0.0 111.686 -178.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.543 ' CZ ' ' CE2' ' A' ' 39' ' ' TRP . 93.2 m-85 -114.55 6.63 15.88 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.015 -1.053 . . . . 0.0 111.698 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 2.4 p-10 39.04 29.12 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.162 -0.961 . . . . 0.0 110.434 179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 14' ' ' TYR . 33.0 m -109.94 126.17 53.61 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.508 -0.745 . . . . 0.0 109.147 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 157.68 63.21 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.468 -0.77 . . . . 0.0 109.221 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.59 135.74 33.79 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.842 1.695 . . . . 0.0 112.316 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.433 ' C ' ' CD2' ' A' ' 20' ' ' HIS . 97.1 m-20 -118.27 140.22 50.14 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 20' ' ' HIS . 2.1 m-70 -136.99 85.43 22.76 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.365 -0.834 . . . . 0.0 109.165 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -54.83 -40.31 85.75 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.241 1.961 . . . . 0.0 111.626 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -91.92 130.7 37.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.42 -0.8 . . . . 0.0 109.677 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -84.44 -17.13 40.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.42 -0.8 . . . . 0.0 109.468 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -81.78 -5.16 57.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.0 109.391 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -128.81 62.04 59.18 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.57 -0.706 . . . . 0.0 109.405 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.93 -19.38 52.29 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.348 2.032 . . . . 0.0 111.828 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.35 -5.11 57.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.116 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.475 ' O ' ' ND1' ' A' ' 20' ' ' HIS . 21.8 m-85 -99.27 134.01 42.74 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.472 -0.768 . . . . 0.0 109.602 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -121.72 132.94 54.9 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.6 t -113.61 127.46 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -112.77 122.78 48.67 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.367 0.603 . . . . 0.0 109.862 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -151.57 143.98 24.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 109.106 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.82 124.11 42.07 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.266 -0.896 . . . . 0.0 109.769 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.8 p -80.0 -12.08 59.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.516 -0.74 . . . . 0.0 109.811 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -62.88 -45.23 93.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.095 -1.003 . . . . 0.0 110.528 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 54.3 p30 -123.6 -13.15 7.58 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.29 -0.881 . . . . 0.0 109.919 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 36' ' ' ASN . 45.8 t0 59.24 5.05 0.53 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.446 -0.784 . . . . 0.0 109.799 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 36' ' ' ASN . 28.6 mmtp -94.21 -8.95 37.82 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.055 -1.028 . . . . 0.0 109.086 179.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.543 ' CE2' ' CZ ' ' A' ' 14' ' ' TYR . 63.0 t-105 -90.35 108.36 19.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.461 -0.775 . . . . 0.0 109.298 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -107.88 128.62 54.78 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.554 -0.716 . . . . 0.0 109.171 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.33 123.92 8.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.495 -0.753 . . . . 0.0 108.98 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.8 tp -124.34 130.36 52.35 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.64 -0.663 . . . . 0.0 109.274 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.502 HD23 ' C ' ' A' ' 43' ' ' LEU . 9.4 tt -126.82 128.38 46.47 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.412 ' N ' HD23 ' A' ' 43' ' ' LEU . 6.2 ptt? -160.39 162.78 33.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.076 -1.015 . . . . 0.0 110.025 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.493 ' OD2' ' NH1' ' A' ' 3' ' ' ARG . 99.3 m-20 -100.28 117.37 34.35 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.7 pt -134.44 145.57 55.75 Favored Pre-proline 0 N--CA 1.503 2.189 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 -179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.85 151.32 85.7 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.538 2.158 . . . . 0.0 112.917 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.82 64.99 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.593 -0.692 . . . . 0.0 109.761 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -66.22 -17.94 65.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 110.121 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -84.28 -14.67 49.18 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.064 -1.023 . . . . 0.0 111.253 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.64 10.89 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.174 -0.954 . . . . 0.0 109.885 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.34 -9.26 72.08 Favored Glycine 0 N--CA 1.497 2.711 0 C-N-CA 120.426 -0.893 . . . . 0.0 111.105 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.5 mt -79.96 135.12 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.802 -1.41 . . . . 0.0 109.722 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 50.6 t30 -74.61 95.67 2.85 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.14 133.52 1.75 Allowed Glycine 0 N--CA 1.482 1.717 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 p-10 -91.1 11.72 22.23 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -64.96 157.63 27.64 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 11.1 mtp85 -100.35 135.98 40.95 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.3 m -137.55 157.23 33.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.695 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 96.6 m-20 -99.07 140.3 33.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.95 151.01 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.399 -0.813 . . . . 0.0 110.109 -179.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 17.8 pt -131.32 161.07 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' LEU . 66.8 t0 -133.73 140.76 47.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.236 -0.915 . . . . 0.0 109.732 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.519 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 0.8 OUTLIER -132.9 159.19 40.62 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.444 0.64 . . . . 0.0 109.336 -179.718 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -88.36 138.93 31.0 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.491 -0.755 . . . . 0.0 110.629 -178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.9 m -140.1 161.92 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.56 -0.712 . . . . 0.0 109.298 178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.433 ' HG3' HD22 ' A' ' 115' ' ' LEU . 7.1 mt-30 -80.72 157.96 71.38 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.411 -0.805 . . . . 0.0 109.344 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.492 ' O ' HG12 ' A' ' 71' ' ' VAL . 29.3 Cg_endo -61.92 -23.85 76.35 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 C-N-CA 122.532 2.155 . . . . 0.0 111.592 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -88.88 -30.81 18.61 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.279 -0.888 . . . . 0.0 109.574 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.5 mt -93.13 -0.16 57.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -0.84 . . . . 0.0 109.415 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 68' ' ' PRO . 11.3 p -63.95 -31.54 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.464 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -80.51 -15.44 78.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.9 p -69.01 -54.32 15.82 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 110.527 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.701 ' H ' HD23 ' A' ' 74' ' ' LEU . 2.2 pt? -85.38 -28.04 25.43 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.0 -1.062 . . . . 0.0 110.499 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.3 ttt-85 -69.51 -21.96 63.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.192 -0.942 . . . . 0.0 110.585 -178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.25 -7.94 52.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.939 -1.101 . . . . 0.0 109.502 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -82.22 150.26 63.96 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.894 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.05 144.32 63.29 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 C-N-CA 122.549 2.166 . . . . 0.0 112.293 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.78 -16.36 54.81 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.72 ' N ' HD12 ' A' ' 80' ' ' ILE . 2.0 mp -90.16 127.14 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.044 -1.268 . . . . 0.0 108.905 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -115.55 126.16 28.03 Favored Pre-proline 0 N--CA 1.499 1.998 0 O-C-N 121.394 -0.816 . . . . 0.0 110.212 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -52.28 146.51 31.47 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.41 1.406 . . . . 0.0 111.79 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.24 140.26 57.98 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.3 -0.875 . . . . 0.0 110.375 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -98.03 1.45 47.79 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.384 -0.823 . . . . 0.0 108.933 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -65.77 -176.91 0.41 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.458 -0.776 . . . . 0.0 110.374 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 74.4 mtm -64.29 -41.17 97.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.531 -0.731 . . . . 0.0 109.938 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -97.62 138.02 35.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.263 -0.898 . . . . 0.0 109.784 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -141.32 70.27 1.34 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.409 -0.807 . . . . 0.0 109.342 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -143.83 -54.29 0.36 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.46 -0.775 . . . . 0.0 109.07 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -99.31 -15.68 18.74 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.427 -0.796 . . . . 0.0 109.947 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 -108.26 122.41 46.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.368 -0.833 . . . . 0.0 110.011 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 46.7 mm -125.9 137.04 59.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.5 m -95.01 144.22 25.86 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.228 -0.92 . . . . 0.0 110.207 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.6 t -120.59 136.67 56.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 54.1 tp -87.22 113.63 23.12 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.975 . . . . 0.0 110.276 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 98' ' ' GLY . 12.8 mt -64.62 -40.72 95.97 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.695 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 58.8 m-80 -70.78 4.29 2.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.416 -0.802 . . . . 0.0 109.063 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -68.06 171.99 34.44 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.96 -4.97 15.5 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 123.445 2.763 . . . . 0.0 112.327 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.487 HD23 ' H ' ' A' ' 100' ' ' LEU . 0.4 OUTLIER -72.14 150.06 44.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.144 -179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -87.09 171.53 42.62 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 120.489 -0.863 . . . . 0.0 111.04 -178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.42 83.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.95 . . . . 0.0 109.715 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 26.9 pttm -61.11 -36.32 79.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.323 -0.861 . . . . 0.0 109.219 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -65.87 -38.84 89.86 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.415 -0.803 . . . . 0.0 109.126 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -62.92 -44.18 99.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.225 -0.922 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 61.9 m170 -58.94 -42.54 90.02 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.388 -0.82 . . . . 0.0 109.786 -179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.7 m -60.71 -45.09 95.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.193 -0.942 . . . . 0.0 110.172 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.78 -44.1 94.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.752 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.03 -43.12 96.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -0.833 . . . . 0.0 109.501 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -51.9 -42.06 62.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 108.875 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -62.37 -43.92 97.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.226 -0.921 . . . . 0.0 109.061 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 11.7 t -63.67 -41.76 98.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.548 -0.72 . . . . 0.0 110.69 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -58.96 -45.3 90.84 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.257 -0.902 . . . . 0.0 110.893 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -60.8 -38.83 86.67 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.028 -1.045 . . . . 0.0 110.418 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.433 HD22 ' HG3' ' A' ' 67' ' ' GLN . 96.7 mt -63.01 -40.71 98.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 109.695 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 19.4 p -93.78 14.32 19.67 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.25 -0.906 . . . . 0.0 109.394 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -45.71 142.48 2.42 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.437 -0.789 . . . . 0.0 109.693 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 76.1 mt -68.69 147.57 51.66 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.33 -0.857 . . . . 0.0 109.941 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.67 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 1.3 pm0 -74.66 43.98 0.2 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.537 -0.727 . . . . 0.0 109.756 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.539 ' ND1' ' N ' ' A' ' 121' ' ' HIS . 63.3 t-80 60.35 167.14 0.08 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.536 0.684 . . . . 0.0 110.636 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.539 ' N ' ' ND1' ' A' ' 120' ' ' HIS . 75.7 m80 -82.31 150.59 27.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.555 -0.716 . . . . 0.0 110.058 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -84.44 167.56 16.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.23 -0.919 . . . . 0.0 109.965 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -76.34 123.41 25.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.33 -0.856 . . . . 0.0 110.425 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -68.29 -37.99 81.22 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.572 -0.705 . . . . 0.0 109.946 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.564 -179.421 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.7 ttm . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.509 0.671 . . . . 0.0 109.298 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -93.48 166.05 12.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.361 -0.837 . . . . 0.0 110.727 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -63.22 -42.76 99.31 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.348 0.594 . . . . 0.0 109.76 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 tp60 -65.48 -39.45 91.94 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.3 -0.875 . . . . 0.0 109.673 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.02 -38.75 92.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.212 -0.93 . . . . 0.0 109.327 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -60.75 -45.53 93.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -0.815 . . . . 0.0 109.439 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.59 -43.77 98.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.409 -0.807 . . . . 0.0 109.412 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -64.14 -41.61 97.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.446 -0.784 . . . . 0.0 109.794 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -62.2 -42.66 99.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.415 -0.803 . . . . 0.0 109.501 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.0 -37.38 82.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.432 -0.793 . . . . 0.0 109.719 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.528 ' O ' ' N ' ' A' ' 15' ' ' ASP . 25.9 mt-30 -63.45 -48.42 77.78 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.228 -0.92 . . . . 0.0 110.062 -179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -64.48 -37.45 87.59 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.721 -1.237 . . . . 0.0 109.466 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.3 tptt -68.79 -46.3 69.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.522 -0.736 . . . . 0.0 111.942 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -127.17 -20.43 4.13 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.0 110.677 -177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 11' ' ' GLN . 25.4 t0 65.31 42.1 4.07 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.266 -0.896 . . . . 0.0 108.855 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.7 m -104.19 133.35 49.27 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.609 0.718 . . . . 0.0 109.595 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.6 mttm -83.75 151.4 61.23 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.455 -0.778 . . . . 0.0 109.725 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.21 153.55 71.3 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.818 2.345 . . . . 0.0 112.533 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' OD1' ' N ' ' A' ' 20' ' ' HIS . 61.6 t0 -140.76 138.92 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.399 -0.813 . . . . 0.0 108.96 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.467 ' N ' ' OD1' ' A' ' 19' ' ' ASP . 13.7 p-80 -132.64 86.94 42.99 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.55 -0.719 . . . . 0.0 109.505 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -54.54 -37.92 90.28 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.502 2.135 . . . . 0.0 110.653 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.432 ' N ' ' CD1' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -87.51 82.06 7.59 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -55.2 -14.45 1.71 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -65.18 -2.33 2.84 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.503 -0.748 . . . . 0.0 109.073 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -147.95 76.15 10.61 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.394 -0.817 . . . . 0.0 109.325 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -62.08 -19.22 65.61 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.635 2.224 . . . . 0.0 110.764 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 12.5 p-10 -81.19 -2.48 48.79 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -100.38 139.48 36.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.435 -0.791 . . . . 0.0 109.255 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.0 128.17 45.94 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t -113.66 124.51 70.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.657 -0.652 . . . . 0.0 109.561 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.88 136.5 51.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.688 -0.632 . . . . 0.0 109.295 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -157.18 139.37 14.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -101.0 126.65 47.69 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.528 -0.733 . . . . 0.0 109.635 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.6 m -80.79 -10.62 59.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.473 -0.767 . . . . 0.0 109.168 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -64.03 -40.84 97.21 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.396 -0.815 . . . . 0.0 109.95 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.705 ' ND2' HD21 ' A' ' 118' ' ' LEU . 2.1 m120 -113.16 -24.6 9.33 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.324 -0.86 . . . . 0.0 109.252 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 44.8 t0 63.36 -8.88 0.13 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.589 -0.694 . . . . 0.0 109.855 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.543 ' H ' ' C ' ' A' ' 36' ' ' ASN . 64.5 mttp -97.64 -6.29 33.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.205 -0.934 . . . . 0.0 108.863 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.501 ' CE3' HG21 ' A' ' 116' ' ' THR . 15.0 t-105 -84.82 109.88 18.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 109.683 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -109.3 125.92 52.82 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.435 ' HB2' ' HE1' ' A' ' 39' ' ' TRP . . . -138.82 136.72 35.93 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.5 tp -145.1 122.95 11.94 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.518 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.4 tt -120.23 124.48 45.78 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.558 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -162.68 164.76 26.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.152 -0.968 . . . . 0.0 109.689 179.495 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 88.9 m-20 -96.42 114.05 25.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.565 -0.71 . . . . 0.0 109.721 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.469 HG23 ' SD ' ' A' ' 44' ' ' MET . 16.2 pt -116.83 144.99 34.48 Favored Pre-proline 0 N--CA 1.495 1.825 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -48.78 141.38 21.19 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.985 1.79 . . . . 0.0 112.421 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.559 ' HB3' ' O ' ' A' ' 55' ' ' GLY . . . -63.08 -21.09 65.94 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.382 0.61 . . . . 0.0 109.972 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -77.29 -13.99 59.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.123 -0.986 . . . . 0.0 109.608 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -84.32 -10.85 57.26 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.284 -0.885 . . . . 0.0 110.268 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.412 ' CD1' HD12 ' A' ' 53' ' ' ILE . 11.3 pt -103.19 1.73 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.301 -0.874 . . . . 0.0 109.345 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.43 -14.39 59.43 Favored Glycine 0 N--CA 1.499 2.89 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.565 ' C ' ' H ' ' A' ' 55' ' ' GLY . 76.4 mt -78.55 130.55 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.956 -1.32 . . . . 0.0 109.498 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -63.28 14.39 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.585 -0.697 . . . . 0.0 110.539 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.565 ' H ' ' C ' ' A' ' 53' ' ' ILE . . . -86.11 140.78 17.96 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -101.27 5.77 42.58 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.503 -0.998 . . . . 0.0 109.628 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 88.4 tttt -88.44 144.81 26.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 0.0 110.279 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 87.7 mtm180 -71.73 145.8 48.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.63 -0.669 . . . . 0.0 110.359 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.1 m -133.46 157.46 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.528 -0.732 . . . . 0.0 109.633 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 12.9 m-20 -93.81 131.63 39.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.495 -0.753 . . . . 0.0 109.355 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.95 156.89 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.42 -0.8 . . . . 0.0 110.292 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 16.8 pt -134.96 149.88 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.474 0.654 . . . . 0.0 109.739 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -81.68 146.64 29.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.343 -0.848 . . . . 0.0 110.11 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.657 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -132.95 127.08 33.46 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.657 ' N ' HD13 ' A' ' 64' ' ' LEU . 63.1 tttp -82.21 131.69 35.23 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.556 -0.715 . . . . 0.0 110.147 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.4 m -144.37 161.32 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.46 -0.775 . . . . 0.0 109.677 178.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -85.62 158.71 56.64 Favored Pre-proline 0 C--N 1.304 -1.411 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.444 ' O ' HG12 ' A' ' 71' ' ' VAL . 19.2 Cg_endo -59.87 -19.79 56.44 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.61 2.207 . . . . 0.0 111.544 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -95.88 -28.24 14.8 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.346 -0.846 . . . . 0.0 109.116 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 96.0 mt -92.04 -2.56 56.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.415 -0.803 . . . . 0.0 109.493 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.475 HG13 ' N ' ' A' ' 72' ' ' GLY . 7.1 p -63.7 -41.08 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.29 -0.881 . . . . 0.0 109.946 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.475 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -63.12 -40.66 99.44 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.7 m -62.13 -36.03 80.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.208 -1.172 . . . . 0.0 110.419 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.526 ' CD2' HG21 ' A' ' 92' ' ' ILE . 0.7 OUTLIER -77.98 -39.07 43.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.973 -1.079 . . . . 0.0 111.011 -179.254 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.575 HH21 ' CD1' ' A' ' 92' ' ' ILE . 95.9 mtt180 -76.71 -6.54 52.57 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.069 -1.019 . . . . 0.0 110.125 -178.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.65 -11.41 58.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.084 -1.01 . . . . 0.0 109.171 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -90.83 148.07 37.46 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.863 . . . . 0.0 109.266 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.409 ' O ' HD21 ' A' ' 100' ' ' LEU . 56.2 Cg_endo -69.07 144.73 58.74 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.716 2.278 . . . . 0.0 113.09 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 87.15 -5.0 85.92 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.81 122.87 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.315 -1.109 . . . . 0.0 109.782 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -124.6 145.52 49.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.26 150.08 81.45 Favored 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 122.454 2.103 . . . . 0.0 112.387 179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.1 138.88 58.06 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.708 0.766 . . . . 0.0 110.257 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' A' ' 84' ' ' TYR . 13.0 p90 -95.32 1.02 54.27 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.432 ' O ' ' O ' ' A' ' 86' ' ' MET . 8.9 m170 -148.47 159.36 44.12 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.112 -0.993 . . . . 0.0 110.793 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.443 ' O ' ' O ' ' A' ' 87' ' ' ASN . 79.5 mtp 48.61 105.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.892 0.853 . . . . 0.0 111.023 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.443 ' O ' ' O ' ' A' ' 86' ' ' MET . 99.2 m-20 44.01 -171.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.642 0.734 . . . . 0.0 110.751 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -144.92 -57.78 0.35 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.49 -0.756 . . . . 0.0 109.308 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.0 -37.75 84.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.212 -0.93 . . . . 0.0 109.125 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -57.01 -67.13 0.34 Allowed 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.44 -0.788 . . . . 0.0 109.801 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -105.04 144.53 31.71 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.525 0.679 . . . . 0.0 110.094 -178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.575 ' CD1' HH21 ' A' ' 75' ' ' ARG . 7.1 mm -130.54 144.07 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 86.8 m -87.48 131.18 34.43 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.394 -0.816 . . . . 0.0 109.82 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 82.1 t -118.52 132.39 68.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 43.5 tp -87.9 101.98 14.26 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.622 0.725 . . . . 0.0 110.24 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' A' ' 98' ' ' GLY . 84.1 mt -66.04 -40.39 90.95 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -71.96 5.49 2.63 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 96' ' ' LEU . . . -84.63 -166.33 41.15 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -79.8 7.86 4.34 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 123.023 2.482 . . . . 0.0 111.611 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 100' ' ' LEU . 4.3 mm? -62.24 130.55 45.9 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.973 0.892 . . . . 0.0 110.578 -178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -86.5 158.43 31.11 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.8 -0.92 . . . . 0.0 110.8 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.463 ' O ' ' ND1' ' A' ' 106' ' ' HIS . . . -60.16 -47.02 87.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.695 -0.885 . . . . 0.0 109.552 179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -65.18 -40.52 94.37 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.511 -0.743 . . . . 0.0 109.447 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.0 -44.89 96.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.509 -0.744 . . . . 0.0 109.522 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.0 mt -64.43 -43.32 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.325 -0.859 . . . . 0.0 109.554 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 102' ' ' ALA . 31.8 m80 -58.74 -42.62 89.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.368 -0.833 . . . . 0.0 109.888 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 64.9 m -61.43 -43.6 98.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.68 -179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 95.9 mt -64.54 -40.7 96.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.454 -0.779 . . . . 0.0 109.454 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.92 -43.2 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.215 -0.928 . . . . 0.0 109.337 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -60.48 -37.8 82.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 108.803 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -62.66 -42.04 99.39 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.493 -0.754 . . . . 0.0 108.987 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.516 ' O ' HG23 ' A' ' 116' ' ' THR . 96.6 p -62.61 -36.24 82.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.363 -0.836 . . . . 0.0 109.155 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -60.69 -45.21 95.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.385 -0.822 . . . . 0.0 109.594 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -65.65 -27.63 68.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.009 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 88.2 mt -82.37 -13.15 57.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.536 -0.727 . . . . 0.0 109.317 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 112' ' ' SER . 79.4 p -110.64 14.66 22.32 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.2 ptt180 -68.15 140.06 56.14 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.863 0.84 . . . . 0.0 110.308 -179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.705 HD21 ' ND2' ' A' ' 36' ' ' ASN . 88.3 mt -81.9 177.02 9.09 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.668 0.747 . . . . 0.0 110.912 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 56.94 108.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.64 0.734 . . . . 0.0 109.984 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.525 ' O ' ' N ' ' A' ' 122' ' ' HIS . 54.7 t-80 -84.47 90.37 7.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.436 -0.79 . . . . 0.0 109.681 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 74.6 m80 46.61 13.01 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.692 -0.63 . . . . 0.0 110.308 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 120' ' ' HIS . 61.8 m170 -110.98 149.93 29.98 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.906 0.86 . . . . 0.0 109.988 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 53.18 90.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.74 0.781 . . . . 0.0 110.187 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.9 m80 46.87 83.82 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.717 0.77 . . . . 0.0 110.021 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.937 179.638 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.6 ttp . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.155 0.503 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -94.96 155.64 16.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.176 -0.952 . . . . 0.0 110.373 -179.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.512 ' NH2' ' OD1' ' A' ' 45' ' ' ASP . 40.8 ttm180 -62.09 -42.63 99.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.549 -0.719 . . . . 0.0 109.546 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -53.99 -42.32 68.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.119 -0.988 . . . . 0.0 109.817 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.65 -35.54 80.4 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.129 -0.982 . . . . 0.0 109.49 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -60.89 -44.65 96.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.123 -0.985 . . . . 0.0 109.161 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 38.9 mm -64.0 -44.66 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.288 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.15 -41.13 99.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.0 109.519 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -60.32 -49.86 75.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.222 -0.924 . . . . 0.0 109.503 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.3 -35.25 75.81 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.719 179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 15' ' ' ASP . 17.4 tt0 -59.34 -49.91 76.01 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.385 -0.822 . . . . 0.0 110.28 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -64.26 -40.21 95.51 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.637 -1.289 . . . . 0.0 109.465 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm -68.34 -44.29 75.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.397 -0.815 . . . . 0.0 112.259 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.521 ' OH ' ' CD1' ' A' ' 113' ' ' PHE . 97.0 m-85 -127.64 -18.49 4.34 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 120.993 -1.067 . . . . 0.0 110.902 -178.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 11' ' ' GLN . 24.9 t0 63.68 45.81 4.39 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.1 -1.0 . . . . 0.0 109.084 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.0 m -113.72 127.9 56.21 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -83.95 155.19 64.51 Favored Pre-proline 0 C--N 1.302 -1.472 0 O-C-N 121.12 -0.987 . . . . 0.0 109.759 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.55 140.54 64.79 Favored 'Trans proline' 0 N--CA 1.499 1.808 0 C-N-CA 121.77 1.647 . . . . 0.0 112.607 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -116.28 121.31 41.63 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.454 ' CD2' ' N ' ' A' ' 20' ' ' HIS . 11.8 m-70 -114.87 85.32 11.61 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.499 -0.751 . . . . 0.0 109.19 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.43 -12.82 16.91 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.928 1.752 . . . . 0.0 110.878 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 7.0 m0 -100.7 93.97 5.85 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -63.34 -17.57 62.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 0.0 109.848 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -83.87 -3.07 57.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.256 -0.903 . . . . 0.0 109.681 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -143.43 69.35 17.5 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.128 -0.983 . . . . 0.0 109.792 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.98 -29.53 89.55 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.55 2.167 . . . . 0.0 111.191 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -71.91 -6.94 45.53 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.429 -0.795 . . . . 0.0 109.366 -179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -102.72 135.41 44.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.457 -0.777 . . . . 0.0 109.13 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -123.35 146.78 47.67 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 51.6 t -125.62 130.49 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.559 -0.713 . . . . 0.0 109.209 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -113.48 112.03 22.91 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.69 -0.631 . . . . 0.0 109.319 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -134.24 138.45 45.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.306 -0.871 . . . . 0.0 108.665 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.594 ' ND1' ' CD1' ' A' ' 39' ' ' TRP . 35.9 m170 -100.87 118.2 36.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.337 -0.852 . . . . 0.0 109.765 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.1 m -63.28 -36.73 84.64 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.351 -0.843 . . . . 0.0 109.342 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.03 -43.42 98.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 110.134 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.645 ' ND2' HD21 ' A' ' 118' ' ' LEU . 15.9 m120 -91.99 5.45 50.09 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.067 -1.021 . . . . 0.0 108.882 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 38' ' ' LYS . 66.9 t0 51.25 -81.41 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.778 -0.576 . . . . 0.0 110.712 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.561 ' N ' ' O ' ' A' ' 36' ' ' ASN . 60.3 mttp -55.88 -110.15 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -0.928 . . . . 0.0 110.582 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.594 ' CD1' ' ND1' ' A' ' 33' ' ' HIS . 48.5 t-105 40.8 92.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.756 -0.59 . . . . 0.0 109.831 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -107.97 125.77 51.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.459 -0.776 . . . . 0.0 109.325 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.89 128.25 10.61 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.95 146.0 40.46 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 109.388 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 tt -116.84 128.26 55.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 4.2 ptt? -152.08 163.17 39.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.109 -0.994 . . . . 0.0 109.392 -179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.512 ' OD1' ' NH2' ' A' ' 3' ' ' ARG . 98.5 m-20 -98.89 136.56 38.72 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -0.795 . . . . 0.0 108.858 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 19.6 pt -139.95 145.73 43.68 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.208 -0.932 . . . . 0.0 109.767 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -49.17 135.73 30.65 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 121.844 1.696 . . . . 0.0 113.089 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 57' ' ' LYS . . . -65.83 -29.52 70.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 109.902 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 55' ' ' GLY . 15.7 pt-20 -55.57 -29.89 59.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.076 -1.015 . . . . 0.0 110.22 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -63.79 -34.94 79.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.977 -1.077 . . . . 0.0 110.322 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 53' ' ' ILE . 4.6 pt -96.41 -1.55 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.16 -0.963 . . . . 0.0 109.708 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.96 34.75 32.92 Favored Glycine 0 N--CA 1.491 2.358 0 C-N-CA 119.952 -1.118 . . . . 0.0 110.874 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.601 HD12 HD12 ' A' ' 51' ' ' ILE . 35.0 mt -110.16 136.51 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 121.349 -1.089 . . . . 0.0 110.059 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.401 ' C ' ' OD1' ' A' ' 54' ' ' ASN . 49.1 t-20 43.03 -89.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.396 0.617 . . . . 0.0 110.252 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . -158.73 -110.87 0.29 Allowed Glycine 0 N--CA 1.484 1.886 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -108.76 47.82 0.89 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.628 -0.925 . . . . 0.0 109.517 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.527 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 88.1 tttt -91.8 129.67 37.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.276 -0.89 . . . . 0.0 109.224 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -71.87 136.4 46.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.197 -0.939 . . . . 0.0 110.219 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.58 164.22 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.346 -0.846 . . . . 0.0 109.233 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.696 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 83.4 m-20 -92.01 134.34 34.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.189 -0.945 . . . . 0.0 110.04 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -137.02 158.93 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.234 -0.916 . . . . 0.0 109.69 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.3 pt -135.04 146.74 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -110.59 140.15 45.17 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.553 -0.717 . . . . 0.0 109.621 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.27 164.28 28.45 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.87 132.08 52.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.483 -0.761 . . . . 0.0 109.877 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.8 m -136.22 162.78 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.342 -0.848 . . . . 0.0 110.144 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -72.03 133.96 83.51 Favored Pre-proline 0 C--N 1.298 -1.643 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.46 -179.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.607 ' O ' HG12 ' A' ' 71' ' ' VAL . 71.1 Cg_exo -44.69 -38.18 12.27 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 C-N-CA 121.962 1.775 . . . . 0.0 112.302 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.43 -32.21 66.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.054 -1.029 . . . . 0.0 110.442 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 83.7 mt -92.1 5.02 51.86 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.085 -1.01 . . . . 0.0 110.111 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 68' ' ' PRO . 12.7 p -61.47 -28.21 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.047 -1.033 . . . . 0.0 109.015 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.461 ' O ' ' CG ' ' A' ' 76' ' ' LYS . . . -58.46 -39.46 93.0 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -59.5 -41.11 89.14 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.15 -1.206 . . . . 0.0 109.668 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.534 ' CD2' ' N ' ' A' ' 74' ' ' LEU . 2.5 mm? -68.99 -44.9 71.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 110.781 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -78.2 -36.92 46.7 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.0 111.299 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.461 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -72.98 -1.72 18.2 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.066 -1.053 . . . . 0.0 109.654 -178.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.403 ' CB ' HD13 ' A' ' 80' ' ' ILE . 0.3 OUTLIER -96.49 139.99 21.96 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.252 -0.905 . . . . 0.0 109.157 179.47 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.99 143.69 45.56 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.124 1.883 . . . . 0.0 112.969 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.09 -17.42 56.98 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.619 ' N ' HD12 ' A' ' 80' ' ' ILE . 3.7 mp -93.92 127.44 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -1.178 . . . . 0.0 109.401 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -114.35 133.55 22.43 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.699 -0.625 . . . . 0.0 110.133 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -54.32 149.26 38.11 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.278 1.319 . . . . 0.0 111.352 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.23 143.42 55.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.054 -1.029 . . . . 0.0 110.832 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -92.45 21.96 4.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.513 -0.742 . . . . 0.0 109.404 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 86' ' ' MET . 7.5 p80 -148.0 167.89 23.73 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.017 -1.052 . . . . 0.0 110.409 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 85' ' ' HIS . 65.5 mtt -43.68 173.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.539 0.685 . . . . 0.0 111.497 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 57.83 34.12 24.01 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.618 0.723 . . . . 0.0 109.459 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.7 -43.0 99.93 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.458 -0.776 . . . . 0.0 109.832 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.05 -44.52 84.34 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.102 -0.999 . . . . 0.0 109.858 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -68.78 -46.7 68.05 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.114 -0.991 . . . . 0.0 110.857 -179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -115.7 145.78 42.45 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.419 -0.801 . . . . 0.0 110.291 -178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.502 HD11 HG23 ' A' ' 71' ' ' VAL . 8.0 mm -130.61 152.32 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.9 m -101.92 135.49 43.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.406 -0.809 . . . . 0.0 109.508 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.37 136.41 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 63.2 tp -90.66 116.26 28.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.337 -0.852 . . . . 0.0 110.085 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 mt -65.96 -40.22 91.12 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.696 ' ND2' ' H ' ' A' ' 60' ' ' ASP . 65.3 m-80 -72.28 3.58 4.52 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -56.56 164.94 5.22 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.74 -8.5 18.07 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 123.109 2.539 . . . . 0.0 111.576 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.537 ' O ' HD12 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -75.93 162.29 28.23 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.217 -0.927 . . . . 0.0 110.66 -178.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -78.58 163.59 50.09 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.47 80.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.509 -0.995 . . . . 0.0 109.089 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -62.11 -39.55 92.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.327 -0.858 . . . . 0.0 109.419 179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -62.48 -42.12 99.27 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.114 -0.991 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.5 mt -64.58 -43.89 96.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.213 -0.93 . . . . 0.0 109.354 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -66.03 -38.51 88.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.297 -0.877 . . . . 0.0 109.577 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.7 m -59.48 -44.57 93.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.116 -0.99 . . . . 0.0 109.809 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.1 mt -64.37 -42.13 96.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 109.261 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.61 -42.94 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.061 -1.024 . . . . 0.0 109.058 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -53.09 -40.63 64.23 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.225 -0.922 . . . . 0.0 108.637 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.75 -40.89 98.66 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.3 -0.875 . . . . 0.0 108.724 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.0 m -60.2 -38.91 84.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.317 -0.864 . . . . 0.0 109.454 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.521 ' CD1' ' OH ' ' A' ' 14' ' ' TYR . 74.8 t80 -61.39 -43.52 98.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.68 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -47.81 -39.55 18.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.194 -0.941 . . . . 0.0 109.68 -179.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 115' ' ' LEU . 10.9 mp -65.01 -39.19 93.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 109.684 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.5 p -90.94 9.68 29.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.149 -0.969 . . . . 0.0 109.172 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -49.57 136.68 16.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.884 . . . . 0.0 109.864 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.645 HD21 ' ND2' ' A' ' 36' ' ' ASN . 92.9 mt -80.81 -133.54 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.417 -0.802 . . . . 0.0 109.881 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 118' ' ' LEU . 16.1 pt-20 38.84 -160.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.376 0.608 . . . . 0.0 110.942 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.564 ' CD2' ' H ' ' A' ' 121' ' ' HIS . 13.9 t-80 -156.81 170.57 22.16 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.265 -0.897 . . . . 0.0 109.541 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . 0.564 ' H ' ' CD2' ' A' ' 120' ' ' HIS . 45.9 p-80 -148.54 167.18 26.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 0.0 109.462 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -69.83 142.08 53.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.282 -0.887 . . . . 0.0 110.448 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -90.86 164.19 14.14 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.284 -0.885 . . . . 0.0 110.302 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -113.31 145.54 40.9 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.525 -0.734 . . . . 0.0 110.124 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 117.716 -1.135 . . . . 0.0 108.704 179.539 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' H1 ' HD12 ' A' ' 105' ' ' ILE . 21.4 ptp . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.271 0.558 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.441 HD22 HE21 ' A' ' 5' ' ' GLN . 95.6 m-20 -94.17 165.45 12.6 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.411 -0.806 . . . . 0.0 109.993 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 42.6 ttm180 -62.31 -44.72 95.87 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.506 -0.746 . . . . 0.0 109.433 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -63.68 -39.72 95.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.843 . . . . 0.0 109.095 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.441 HE21 HD22 ' A' ' 2' ' ' ASN . 73.2 mt-30 -63.63 -37.26 86.67 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.399 -0.813 . . . . 0.0 109.264 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.436 ' CD2' HD12 ' A' ' 43' ' ' LEU . 63.4 t80 -60.63 -46.94 88.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.488 -0.757 . . . . 0.0 109.74 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.59 -45.41 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.262 -0.899 . . . . 0.0 108.605 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -62.32 -41.8 98.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.424 -0.797 . . . . 0.0 109.558 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -60.72 -49.6 76.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.201 -0.937 . . . . 0.0 109.074 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.25 -36.1 78.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.533 -0.729 . . . . 0.0 109.608 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -61.8 -42.6 99.21 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.501 -0.75 . . . . 0.0 110.006 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -83.98 -20.87 32.1 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.096 -1.003 . . . . 0.0 110.085 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 37.4 tptt -87.2 -51.31 6.05 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.256 -0.902 . . . . 0.0 111.321 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -118.05 -15.05 9.94 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.204 -0.935 . . . . 0.0 110.312 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 53.0 t0 58.11 41.71 23.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.359 -0.838 . . . . 0.0 109.933 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.6 m -99.85 134.22 43.07 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.174 -0.954 . . . . 0.0 108.704 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -84.4 132.69 46.48 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.031 -1.043 . . . . 0.0 109.244 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.86 151.07 56.54 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.832 1.688 . . . . 0.0 112.295 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -132.94 149.26 52.26 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.542 -0.724 . . . . 0.0 109.352 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.49 ' O ' ' CG ' ' A' ' 20' ' ' HIS . 13.9 p-80 -132.6 85.38 47.89 Favored Pre-proline 0 N--CA 1.497 1.884 0 O-C-N 121.39 -0.819 . . . . 0.0 109.222 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -55.7 -37.05 95.9 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.312 2.008 . . . . 0.0 111.233 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 6.3 m0 -79.76 98.67 7.11 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.651 0.739 . . . . 0.0 109.43 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -67.95 -23.32 65.05 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.438 -0.789 . . . . 0.0 109.744 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -74.49 -3.9 33.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.439 -0.788 . . . . 0.0 109.675 -179.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -145.16 76.56 13.41 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.23 -0.918 . . . . 0.0 109.705 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -60.77 -20.0 63.94 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.617 2.211 . . . . 0.0 110.768 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' A' ' 27' ' ' ASP . 12.8 p-10 -76.5 -2.4 32.05 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.722 -0.611 . . . . 0.0 109.65 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.51 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 6.6 m-85 -99.54 134.87 41.78 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -137.45 129.86 29.63 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.288 -0.882 . . . . 0.0 109.405 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 t -108.78 128.37 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.682 ' HB2' ' HB3' ' A' ' 41' ' ' ALA . 73.5 m-85 -100.34 124.06 45.34 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.366 -0.834 . . . . 0.0 109.849 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.7 mtm-85 -137.02 135.68 37.79 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.297 -0.877 . . . . 0.0 109.284 179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.98 112.77 25.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.458 -0.776 . . . . 0.0 109.725 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.2 t -69.72 -26.56 64.39 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.437 -0.79 . . . . 0.0 109.406 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -64.25 -39.34 93.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.51 -0.744 . . . . 0.0 109.559 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -98.71 -11.03 22.34 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.323 -0.86 . . . . 0.0 108.887 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 61.41 38.41 16.07 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.426 0.631 . . . . 0.0 109.626 -179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.41 ' HG3' ' N ' ' A' ' 39' ' ' TRP . 17.8 ptmt -167.65 -120.33 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.453 -0.779 . . . . 0.0 109.55 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.41 ' N ' ' HG3' ' A' ' 38' ' ' LYS . 62.6 t-105 56.16 91.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.489 -0.757 . . . . 0.0 109.318 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -105.21 126.64 52.31 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.945 0.879 . . . . 0.0 110.041 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB3' ' HB2' ' A' ' 31' ' ' PHE . . . -149.5 146.71 27.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 21.4 tp -140.53 120.55 13.68 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.951 -1.093 . . . . 0.0 110.268 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.539 HD23 ' C ' ' A' ' 43' ' ' LEU . 8.1 tt -113.08 126.43 55.47 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.51 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 7.3 ptt? -153.27 165.18 36.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.997 -1.064 . . . . 0.0 109.843 -179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 92.9 m-20 -97.03 116.17 28.75 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 26.9 pt -127.55 145.55 55.1 Favored Pre-proline 0 N--CA 1.504 2.257 0 O-C-N 121.385 -0.822 . . . . 0.0 109.368 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.31 145.53 88.59 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.095 1.864 . . . . 0.0 112.116 -178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.43 -21.78 66.7 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.613 -0.679 . . . . 0.0 109.998 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HB3' ' H ' ' A' ' 56' ' ' ASP . 9.8 pt-20 -56.62 -20.42 21.11 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.337 -0.852 . . . . 0.0 110.232 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -80.81 -13.0 59.34 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.107 -0.995 . . . . 0.0 110.705 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 53' ' ' ILE . 7.7 pt -116.43 -5.7 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.302 -0.874 . . . . 0.0 109.79 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.22 -2.29 81.05 Favored Glycine 0 N--CA 1.499 2.874 0 O-C-N 121.184 -0.947 . . . . 0.0 111.12 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.78 HD12 HD12 ' A' ' 51' ' ' ILE . 39.3 mt -79.36 146.51 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.902 -1.352 . . . . 0.0 110.066 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 53' ' ' ILE . 18.2 m120 37.16 -88.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.493 0.664 . . . . 0.0 110.603 179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 53' ' ' ILE . . . 143.94 116.43 1.11 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.48 ' H ' ' HB3' ' A' ' 49' ' ' GLU . 47.3 t0 60.26 41.44 16.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.591 -0.946 . . . . 0.0 110.569 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.8 tttp -112.42 124.76 53.21 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.41 -0.806 . . . . 0.0 108.988 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -71.27 127.84 33.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.204 -0.935 . . . . 0.0 109.953 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.2 m -137.97 161.06 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.338 -0.851 . . . . 0.0 109.017 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -98.86 130.95 45.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.404 -0.81 . . . . 0.0 109.226 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.0 m -134.25 158.28 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.481 -0.762 . . . . 0.0 109.531 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 96' ' ' LEU . 37.5 pt -131.66 146.83 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -110.83 136.62 49.61 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 pp -137.88 156.79 47.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.287 -0.883 . . . . 0.0 109.48 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -90.65 144.72 25.47 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.503 -0.748 . . . . 0.0 110.815 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.1 m -139.07 162.1 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.588 -0.695 . . . . 0.0 109.621 179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.446 HE21 HD12 ' A' ' 70' ' ' LEU . 19.2 mt-30 -70.25 155.64 93.12 Favored Pre-proline 0 C--N 1.3 -1.555 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 71' ' ' VAL . 28.8 Cg_endo -64.17 -18.28 62.84 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.075 1.85 . . . . 0.0 110.953 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -94.28 -28.76 15.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.544 -0.722 . . . . 0.0 109.226 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.446 HD12 HE21 ' A' ' 67' ' ' GLN . 89.1 mt -94.32 -3.03 51.2 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.177 -0.952 . . . . 0.0 110.039 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 68' ' ' PRO . 7.6 p -63.45 -31.72 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.137 -0.977 . . . . 0.0 109.919 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.53 -14.72 81.83 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.44 ' O ' ' CD ' ' A' ' 76' ' ' LYS . 34.7 t -70.41 -55.44 9.06 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -1.099 . . . . 0.0 111.483 -178.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.586 ' H ' HD23 ' A' ' 74' ' ' LEU . 1.8 pt? -84.28 -23.09 30.48 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.119 -0.988 . . . . 0.0 111.106 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 79.9 ttt-85 -66.38 -41.42 89.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.106 -0.997 . . . . 0.0 111.264 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.44 ' CD ' ' O ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -76.29 -7.57 55.21 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.869 -1.145 . . . . 0.0 110.108 -178.502 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.598 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 0.1 OUTLIER -77.69 149.22 77.5 Favored Pre-proline 0 C--N 1.3 -1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.799 -178.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.478 ' C ' ' H ' ' A' ' 80' ' ' ILE . 40.2 Cg_endo -66.34 155.37 70.3 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 123.12 2.547 . . . . 0.0 112.462 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.47 -25.77 0.9 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 78' ' ' PRO . 78.9 mt -93.7 115.35 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.133 -1.216 . . . . 0.0 108.951 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -112.8 150.34 42.63 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.619 -0.675 . . . . 0.0 110.036 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.04 150.94 85.01 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.156 1.904 . . . . 0.0 111.809 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.4 143.88 56.87 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.345 -0.847 . . . . 0.0 109.625 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 52.4 p90 -92.08 126.9 37.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.119 -0.988 . . . . 0.0 109.899 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.485 ' O ' ' CG ' ' A' ' 85' ' ' HIS . 85.5 t60 41.53 43.51 2.28 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.561 -0.712 . . . . 0.0 110.405 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 67.0 mmm -143.46 65.32 1.32 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.234 -0.916 . . . . 0.0 109.044 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.612 ' ND2' ' CZ3' ' A' ' 91' ' ' TRP . 22.2 m-20 68.39 -50.14 0.56 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.166 -0.334 . . . . 0.0 110.42 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 87.4 tttt 63.91 -37.63 0.19 Allowed 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 120.979 0.419 . . . . 0.0 110.24 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 87' ' ' ASN . 83.1 tt0 -88.66 -20.19 25.23 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.903 -1.123 . . . . 0.0 109.817 -179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 75.8 m80 -96.88 -59.84 1.72 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.266 -0.896 . . . . 0.0 110.336 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.612 ' CZ3' ' ND2' ' A' ' 87' ' ' ASN . 5.4 m0 -105.96 140.96 38.16 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.494 -0.754 . . . . 0.0 109.912 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.0 mm -121.14 138.55 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 62.1 m -85.43 134.46 34.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.707 -0.62 . . . . 0.0 109.834 -179.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 65.4 t -119.63 134.82 61.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.596 -0.69 . . . . 0.0 109.157 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 56.2 tp -89.55 107.2 18.94 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.199 -0.938 . . . . 0.0 110.058 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.431 HD11 HG23 ' A' ' 62' ' ' ILE . 81.2 mt -66.23 -39.33 89.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.497 -0.752 . . . . 0.0 109.71 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -74.28 2.88 8.23 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.477 -0.765 . . . . 0.0 109.61 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -78.93 -166.05 30.28 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 100' ' ' LEU . 83.8 Cg_endo -85.34 10.63 3.64 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.396 2.731 . . . . 0.0 111.54 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 100' ' ' LEU . 3.8 mm? -52.55 -107.95 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.629 0.728 . . . . 0.0 109.63 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 142.11 154.38 6.15 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.48 -46.3 86.93 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.303 -1.116 . . . . 0.0 109.357 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.65 -42.67 98.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.501 -0.749 . . . . 0.0 109.84 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -66.06 -42.73 89.07 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.397 -0.814 . . . . 0.0 109.743 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.41 HD12 ' H1 ' ' A' ' 1' ' ' MET . 94.9 mt -64.15 -43.25 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.311 -0.868 . . . . 0.0 109.447 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -55.16 -43.98 74.77 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.318 -0.864 . . . . 0.0 109.263 -179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 56.0 m -60.83 -42.37 97.59 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.855 . . . . 0.0 109.46 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 97.4 mt -63.07 -42.95 99.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.432 -0.793 . . . . 0.0 109.323 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.06 -43.08 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.369 -0.832 . . . . 0.0 109.097 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -58.52 -37.71 76.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 108.593 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.446 ' O ' ' NE2' ' A' ' 114' ' ' GLN . 92.4 m-20 -62.57 -35.77 80.56 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 67.8 p -81.51 -23.55 37.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.337 -0.852 . . . . 0.0 109.306 179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -61.65 -44.43 96.99 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.427 -0.796 . . . . 0.0 109.885 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.462 ' CG ' ' N ' ' A' ' 115' ' ' LEU . 5.4 pt20 -50.9 -41.25 58.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.404 -0.81 . . . . 0.0 109.337 -179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.462 ' N ' ' CG ' ' A' ' 114' ' ' GLN . 84.6 mt -64.77 -39.71 94.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.526 -0.733 . . . . 0.0 109.745 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.3 p -92.99 14.83 16.49 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.135 -0.978 . . . . 0.0 109.522 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -58.09 141.22 50.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.145 -0.972 . . . . 0.0 109.58 -179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mt -75.83 147.92 38.77 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.739 0.781 . . . . 0.0 110.409 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.09 136.47 56.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.619 -0.676 . . . . 0.0 109.816 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -154.01 137.95 16.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.395 -0.816 . . . . 0.0 108.966 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -82.38 146.02 29.58 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.233 -0.917 . . . . 0.0 110.639 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -61.36 -42.89 99.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.699 -0.626 . . . . 0.0 110.025 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' A' ' 123' ' ' HIS . 56.8 p-80 -98.28 108.04 20.65 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.364 -0.835 . . . . 0.0 109.874 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -133.0 124.01 26.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.485 -0.759 . . . . 0.0 108.998 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 40.3 p-80 . . . . . 0 N--CA 1.5 2.059 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.436 -179.963 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.511 ' O ' ' ND2' ' A' ' 2' ' ' ASN . 6.3 ttt . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 1' ' ' MET . 15.2 m120 -146.73 -178.33 6.12 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.104 -0.998 . . . . 0.0 110.116 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.53 ' NH2' ' OD2' ' A' ' 45' ' ' ASP . 40.8 ttm180 -62.25 -44.61 96.16 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.593 -0.692 . . . . 0.0 109.81 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -61.83 -37.33 84.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.264 -0.898 . . . . 0.0 109.521 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -59.98 -40.44 89.13 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.346 -0.846 . . . . 0.0 109.04 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -62.65 -41.63 99.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.696 -0.628 . . . . 0.0 110.363 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.5 mm -59.24 -47.7 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.059 -1.025 . . . . 0.0 110.018 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 9' ' ' TYR . 0.6 OUTLIER -63.8 -43.86 95.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.218 -0.926 . . . . 0.0 109.914 -179.228 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.622 ' CE2' ' CD2' ' A' ' 106' ' ' HIS . 43.4 t80 -62.53 -48.29 80.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.562 -0.711 . . . . 0.0 109.872 -178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.28 -41.01 86.17 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.4 -0.813 . . . . 0.0 110.102 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.556 ' O ' ' N ' ' A' ' 15' ' ' ASP . 11.6 tp-100 -64.75 -48.95 72.69 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.384 -0.822 . . . . 0.0 109.896 -179.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 53.6 mtmt -66.71 -33.63 76.07 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.931 -1.106 . . . . 0.0 110.599 -179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -87.05 -12.09 48.32 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.118 -0.989 . . . . 0.0 111.83 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.609 ' CD1' ' NE2' ' A' ' 33' ' ' HIS . 95.8 m-85 -141.62 -0.22 1.39 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.653 -1.279 . . . . 0.0 110.446 -179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 11' ' ' GLN . 0.5 OUTLIER 41.06 35.18 0.34 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.287 -0.883 . . . . 0.0 109.438 -179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.2 t -109.76 138.06 46.67 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.507 0.67 . . . . 0.0 109.653 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.4 ' HA ' HE22 ' A' ' 11' ' ' GLN . 86.5 mttt -91.1 151.13 42.81 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.304 -0.873 . . . . 0.0 109.504 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.65 149.05 73.32 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.596 2.198 . . . . 0.0 112.186 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -123.83 134.36 53.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.623 -0.673 . . . . 0.0 109.343 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.512 ' O ' ' ND1' ' A' ' 20' ' ' HIS . 18.6 p80 -128.78 85.4 60.33 Favored Pre-proline 0 N--CA 1.493 1.708 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.37 -12.76 11.36 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 C-N-CA 122.452 2.101 . . . . 0.0 110.973 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 4.6 m-90 -92.38 97.52 10.91 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -70.15 -18.59 63.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.507 -0.746 . . . . 0.0 109.934 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' O ' ' CD1' ' A' ' 25' ' ' PHE . 10.0 mtpm? -76.56 -4.65 43.93 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.142 -0.974 . . . . 0.0 109.14 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 24' ' ' LYS . 53.3 m-85 -156.85 79.47 3.71 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.433 -0.792 . . . . 0.0 108.903 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.3 -19.48 50.71 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.723 2.282 . . . . 0.0 111.294 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -73.13 -5.96 42.55 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.521 -0.737 . . . . 0.0 109.183 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.586 ' CE2' ' SD ' ' A' ' 44' ' ' MET . 4.9 m-85 -87.55 137.95 31.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.233 -0.917 . . . . 0.0 109.573 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.88 141.38 34.62 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.479 -0.763 . . . . 0.0 109.156 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.2 t -118.09 126.44 74.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -106.66 120.08 41.01 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.54 -0.725 . . . . 0.0 109.5 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.449 ' NH2' ' O ' ' A' ' 37' ' ' ASP . 17.5 ptm180 -150.61 158.3 43.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.135 -0.978 . . . . 0.0 109.61 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.609 ' NE2' ' CD1' ' A' ' 14' ' ' TYR . 4.4 m170 -97.94 126.52 43.38 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.371 -0.831 . . . . 0.0 109.713 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 74.4 p -66.45 -34.26 77.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.534 -0.729 . . . . 0.0 109.469 179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.76 -39.54 94.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.36 -0.838 . . . . 0.0 109.86 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.571 ' O ' ' N ' ' A' ' 38' ' ' LYS . 53.0 t-20 -93.23 -12.26 30.63 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.226 -0.921 . . . . 0.0 109.409 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.449 ' O ' ' NH2' ' A' ' 32' ' ' ARG . 37.7 t70 57.93 -71.42 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.695 -0.628 . . . . 0.0 110.713 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.571 ' N ' ' O ' ' A' ' 36' ' ' ASN . 88.6 tttt -63.61 124.66 21.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.105 -0.997 . . . . 0.0 110.506 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.428 ' CZ2' HG21 ' A' ' 116' ' ' THR . 0.0 OUTLIER -178.86 126.46 0.1 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.345 -0.847 . . . . 0.0 108.975 179.075 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -115.09 123.29 48.61 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.553 0.692 . . . . 0.0 109.524 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.469 ' C ' HD22 ' A' ' 42' ' ' LEU . . . -153.8 106.23 2.85 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.469 HD22 ' C ' ' A' ' 41' ' ' ALA . 4.2 mm? -107.59 128.25 54.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.524 -0.735 . . . . 0.0 109.788 -179.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.572 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.1 tt -122.61 118.19 27.59 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.586 ' SD ' ' CE2' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -162.82 166.67 23.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.968 . . . . 0.0 109.92 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.53 ' OD2' ' NH2' ' A' ' 3' ' ' ARG . 91.5 m-20 -93.6 143.5 26.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.56 -0.713 . . . . 0.0 109.33 179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.9 pt -150.67 146.23 19.31 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.254 -0.904 . . . . 0.0 109.435 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -46.62 145.82 6.02 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.127 1.885 . . . . 0.0 112.697 179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.6 -20.98 62.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.48 -0.763 . . . . 0.0 109.959 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -69.61 -17.59 63.54 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.887 . . . . 0.0 110.135 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -84.95 -10.45 57.05 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.05 -1.031 . . . . 0.0 111.042 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 51' ' ' ILE . 7.2 pt -105.82 7.12 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 121.142 -0.974 . . . . 0.0 109.428 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.96 -13.83 63.24 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.7 mt -86.59 129.01 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 120.845 -1.386 . . . . 0.0 110.028 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -88.52 100.84 13.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.365 -0.834 . . . . 0.0 109.454 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.06 -22.48 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 56.76 31.53 19.62 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.795 -0.827 . . . . 0.0 109.708 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -102.8 144.98 30.44 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.323 -0.861 . . . . 0.0 109.775 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 88.9 mtm180 -74.15 128.19 34.88 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.326 -0.858 . . . . 0.0 109.278 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.25 161.19 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.482 -0.761 . . . . 0.0 109.769 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.418 ' OD1' ' OD1' ' A' ' 45' ' ' ASP . 28.3 m-20 -93.28 132.32 37.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 109.795 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.11 155.95 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.39 -0.818 . . . . 0.0 110.249 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.444 HG23 HD11 ' A' ' 96' ' ' LEU . 44.0 pt -130.93 155.3 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 42' ' ' LEU . 53.0 t0 -92.86 119.74 32.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.374 -0.829 . . . . 0.0 110.2 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.583 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -115.7 119.81 37.31 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.279 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.583 ' N ' HD13 ' A' ' 64' ' ' LEU . 9.9 ptmm? -86.71 135.86 33.23 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.461 -0.774 . . . . 0.0 110.588 -178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.462 HG11 HD13 ' A' ' 74' ' ' LEU . 31.3 m -140.66 165.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.426 -0.796 . . . . 0.0 109.946 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -75.31 152.78 85.98 Favored Pre-proline 0 C--N 1.304 -1.385 0 O-C-N 121.362 -0.836 . . . . 0.0 110.176 -179.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.552 ' O ' HG12 ' A' ' 71' ' ' VAL . 61.7 Cg_exo -48.93 -34.01 27.54 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.13 1.887 . . . . 0.0 111.77 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -85.51 -29.21 24.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.393 -0.817 . . . . 0.0 110.087 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.0 mt -88.25 1.03 55.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.985 -1.072 . . . . 0.0 109.847 -179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 68' ' ' PRO . 14.8 p -66.13 -42.5 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.136 -0.977 . . . . 0.0 109.516 178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.549 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -66.05 -40.61 95.23 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 78.2 p -60.75 -36.75 79.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.131 -1.217 . . . . 0.0 109.524 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.543 ' CD2' HG21 ' A' ' 92' ' ' ILE . 1.6 tt -85.75 -37.39 19.37 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.553 -0.717 . . . . 0.0 109.825 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 ttp85 -73.92 -16.98 61.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.429 -0.794 . . . . 0.0 110.644 -178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.29 -7.65 58.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.95 -1.094 . . . . 0.0 109.081 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.75 ' NZ ' HD21 ' A' ' 108' ' ' LEU . 40.9 mtmt -85.32 122.83 73.68 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 121.181 -0.95 . . . . 0.0 109.397 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -50.24 146.28 18.61 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.216 1.944 . . . . 0.0 113.137 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 92.71 -21.29 39.76 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 67.4 mt -104.45 122.97 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.296 -1.12 . . . . 0.0 109.307 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -118.8 149.3 46.25 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.69 -0.631 . . . . 0.0 109.858 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -40.56 165.19 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.564 2.176 . . . . 0.0 112.619 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.07 147.08 50.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.353 -0.842 . . . . 0.0 110.603 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.453 ' OH ' ' CE ' ' A' ' 44' ' ' MET . 5.9 p90 -76.64 167.39 21.92 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.731 0.777 . . . . 0.0 110.759 -179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 73.8 m80 53.29 -94.01 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.622 -0.674 . . . . 0.0 110.147 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 93.7 mtp -138.48 -151.79 0.4 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.389 -0.819 . . . . 0.0 109.747 -179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 59.35 34.96 23.04 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -88.62 62.47 6.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.405 -0.81 . . . . 0.0 109.471 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -146.16 -67.01 0.29 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.861 . . . . 0.0 108.889 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 75.6 m80 -96.36 -19.13 19.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.391 -0.818 . . . . 0.0 109.668 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 -110.51 138.15 47.27 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.461 -0.775 . . . . 0.0 110.085 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.543 HG21 ' CD2' ' A' ' 74' ' ' LEU . 19.8 mm -136.27 154.31 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.462 -0.774 . . . . 0.0 108.938 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 32.4 m -98.85 131.28 45.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.853 . . . . 0.0 110.814 -178.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 50.5 t -113.16 133.84 57.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.6 tp -93.71 112.76 24.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.432 -0.793 . . . . 0.0 110.256 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD11 HG23 ' A' ' 62' ' ' ILE . 84.3 mt -66.03 -39.54 90.28 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 121.637 0.732 . . . . 0.0 109.432 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -71.89 -6.21 40.15 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.285 -0.884 . . . . 0.0 109.245 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -58.02 177.65 1.52 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.72 -12.73 24.46 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 123.038 2.492 . . . . 0.0 111.404 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 pp -67.82 136.9 54.86 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.562 0.696 . . . . 0.0 110.684 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -88.96 -178.73 46.03 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -64.5 -35.49 81.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.618 -0.931 . . . . 0.0 109.671 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 104' ' ' GLU . 25.1 pttm -56.55 -42.07 77.9 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.267 -0.896 . . . . 0.0 109.887 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.402 ' N ' ' HG3' ' A' ' 103' ' ' LYS . 46.0 tp10 -69.09 -40.05 78.66 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.013 -1.054 . . . . 0.0 109.443 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.468 HD12 ' SD ' ' A' ' 1' ' ' MET . 97.2 mt -64.77 -43.13 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.351 -0.843 . . . . 0.0 109.484 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.622 ' CD2' ' CE2' ' A' ' 9' ' ' TYR . 62.7 m170 -56.89 -44.33 82.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 109.487 -179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.5 t -62.72 -43.45 98.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.847 . . . . 0.0 109.37 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.75 HD21 ' NZ ' ' A' ' 77' ' ' LYS . 88.9 mt -63.39 -41.02 98.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.362 -0.836 . . . . 0.0 109.209 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.6 mt -63.0 -42.45 96.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -56.3 -42.26 77.28 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.256 -0.903 . . . . 0.0 108.781 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.23 -37.69 88.23 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.56 ' OG ' HD21 ' A' ' 64' ' ' LEU . 2.4 m -60.75 -39.66 89.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.46 -0.775 . . . . 0.0 109.29 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -59.89 -42.9 94.8 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.573 -0.704 . . . . 0.0 109.688 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -52.62 -46.36 67.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 110.091 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.521 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.1 mm? -65.9 -40.11 91.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.413 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.428 HG21 ' CZ2' ' A' ' 39' ' ' TRP . 15.9 p -93.94 15.46 16.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.978 . . . . 0.0 109.147 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -60.96 143.0 56.02 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.687 0.756 . . . . 0.0 110.673 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.07 157.98 32.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.54 -0.725 . . . . 0.0 110.702 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 57.23 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.55 0.691 . . . . 0.0 110.031 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -87.22 138.1 31.78 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.559 0.695 . . . . 0.0 109.937 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -70.3 149.72 47.1 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.448 -0.783 . . . . 0.0 109.989 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 124' ' ' HIS . 23.9 p80 -144.48 161.83 38.07 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.247 -0.908 . . . . 0.0 109.922 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -88.64 -13.24 40.32 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.529 ' C ' ' HD1' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -151.81 164.52 36.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.285 -0.884 . . . . 0.0 109.868 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 76.0 m80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.859 -1.067 . . . . 0.0 109.996 -179.682 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.9 ttp . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 121.711 0.767 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.8 p30 -92.17 170.32 9.91 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.997 0.903 . . . . 0.0 110.408 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -63.5 -42.07 98.51 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.567 0.699 . . . . 0.0 109.607 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -51.33 -43.02 61.63 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.33 -0.856 . . . . 0.0 109.759 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -66.83 -37.78 85.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 109.457 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -61.21 -44.22 97.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.337 -0.852 . . . . 0.0 109.889 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.44 -46.66 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.184 -0.947 . . . . 0.0 109.726 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -63.9 -45.62 88.52 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 110.001 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.448 ' CD2' ' NE2' ' A' ' 106' ' ' HIS . 56.0 t80 -66.25 -42.16 88.93 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -0.819 . . . . 0.0 110.195 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.41 98.7 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.208 -0.932 . . . . 0.0 109.99 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 15' ' ' ASP . 84.6 mt-30 -65.75 -41.72 91.78 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.287 -0.883 . . . . 0.0 110.031 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -62.76 -31.49 72.45 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.889 -1.132 . . . . 0.0 109.185 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -87.93 -45.29 10.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 111.69 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -107.4 -13.85 15.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.013 -1.054 . . . . 0.0 111.251 -177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.499 ' N ' ' O ' ' A' ' 11' ' ' GLN . 99.3 m-20 54.52 34.16 20.52 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.08 -1.012 . . . . 0.0 108.776 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.9 m -121.64 132.09 54.47 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.857 0.836 . . . . 0.0 110.273 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 23.4 mtmm -83.04 152.25 65.05 Favored Pre-proline 0 N--CA 1.486 1.367 0 O-C-N 121.595 -0.69 . . . . 0.0 109.166 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.61 134.58 27.15 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.172 1.915 . . . . 0.0 112.481 179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -106.03 121.61 44.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.478 -0.763 . . . . 0.0 109.232 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -85.37 116.88 67.4 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.42 -0.8 . . . . 0.0 109.825 -179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 22' ' ' TRP . 72.4 Cg_endo -80.19 -90.23 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 122.52 2.147 . . . . 0.0 111.999 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.411 ' H ' ' HG2' ' A' ' 21' ' ' PRO . 5.5 m-90 -81.18 137.5 35.89 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.855 0.836 . . . . 0.0 110.055 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -65.77 -30.69 71.38 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.542 0.686 . . . . 0.0 110.066 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -67.84 -0.56 4.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.891 . . . . 0.0 109.808 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -143.77 73.02 17.04 Favored Pre-proline 0 N--CA 1.495 1.805 0 O-C-N 121.039 -1.038 . . . . 0.0 109.61 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -72.61 -19.0 25.01 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.363 2.042 . . . . 0.0 110.881 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -81.18 -4.23 54.77 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.631 0.729 . . . . 0.0 109.209 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -96.11 139.1 32.77 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.468 -0.77 . . . . 0.0 109.222 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -122.97 146.37 47.68 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.585 -0.697 . . . . 0.0 109.398 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 52.4 t -127.87 129.58 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-O 121.396 0.617 . . . . 0.0 109.395 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -118.24 113.87 22.14 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.0 ptp180 -146.49 161.36 40.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.15 -0.969 . . . . 0.0 110.086 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.516 ' O ' ' N ' ' A' ' 37' ' ' ASP . 53.1 m170 -96.68 129.34 44.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.527 -0.733 . . . . 0.0 109.784 -179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.6 m -69.6 -20.66 63.63 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.58 0.705 . . . . 0.0 109.673 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.39 -45.64 90.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -0.928 . . . . 0.0 110.09 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.438 ' O ' ' CG ' ' A' ' 37' ' ' ASP . 93.8 m-20 -125.58 -30.73 3.05 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.403 -0.81 . . . . 0.0 109.838 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 33' ' ' HIS . 1.2 p30 50.68 25.19 1.96 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.564 0.697 . . . . 0.0 110.04 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -92.24 -8.53 45.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.138 -0.977 . . . . 0.0 108.777 179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 4.7 m95 -91.19 146.52 23.76 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.378 -0.826 . . . . 0.0 110.02 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -122.8 124.35 43.1 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.698 0.761 . . . . 0.0 109.493 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.61 105.71 2.84 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -132.86 149.36 52.27 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.267 -0.895 . . . . 0.0 109.457 -179.417 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.55 HD23 ' C ' ' A' ' 43' ' ' LEU . 9.6 tt -118.91 128.04 54.05 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.413 ' N ' HD23 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -154.98 163.97 39.55 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.875 0.845 . . . . 0.0 110.211 -179.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 46' ' ' ILE . 51.9 p-10 -93.52 145.61 24.39 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.537 0.684 . . . . 0.0 110.016 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 45' ' ' ASP . 22.6 pt -155.75 146.96 16.63 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.606 -0.684 . . . . 0.0 109.467 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.44 141.67 97.83 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.099 1.866 . . . . 0.0 111.619 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' A' ' 53' ' ' ILE . . . -64.53 -20.26 66.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.484 -0.76 . . . . 0.0 109.902 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -54.76 -16.59 2.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.431 -0.793 . . . . 0.0 110.214 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -85.5 -23.72 27.63 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.253 -0.905 . . . . 0.0 111.171 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.2 pt -95.64 10.69 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.892 -1.13 . . . . 0.0 109.726 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.13 -8.27 75.82 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.532 ' HB ' ' HB1' ' A' ' 48' ' ' ALA . 81.3 mt -78.77 129.98 36.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.806 -1.408 . . . . 0.0 109.996 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -62.23 -39.9 94.34 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.591 0.71 . . . . 0.0 109.34 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -42.07 133.23 4.12 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 36.8 p30 -89.6 3.08 53.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.462 -1.022 . . . . 0.0 108.93 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.8 144.65 56.18 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.731 0.777 . . . . 0.0 110.485 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -87.11 145.57 26.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.577 -0.702 . . . . 0.0 109.52 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.51 160.42 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 CA-C-O 121.658 0.742 . . . . 0.0 110.321 -179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -89.77 132.89 34.99 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.305 0.574 . . . . 0.0 110.019 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 33.7 m -136.41 156.16 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 CA-C-O 121.659 0.743 . . . . 0.0 110.017 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 39.8 pt -136.09 146.84 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.596 0.713 . . . . 0.0 109.963 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -81.87 143.34 31.77 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.524 0.678 . . . . 0.0 110.308 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.624 HD13 ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -133.26 125.97 30.48 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.624 ' N ' HD13 ' A' ' 64' ' ' LEU . 63.3 tttm -82.95 131.28 35.19 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.689 0.757 . . . . 0.0 110.67 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 28.1 m -143.83 161.8 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.739 0.78 . . . . 0.0 109.726 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.473 ' H ' ' HB2' ' A' ' 70' ' ' LEU . 39.7 mt-30 -87.11 153.14 54.03 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 121.529 -0.732 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.505 ' O ' HG12 ' A' ' 71' ' ' VAL . 51.6 Cg_exo -47.5 -26.18 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.159 1.906 . . . . 0.0 111.577 179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -94.78 -29.17 14.89 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.708 0.766 . . . . 0.0 109.345 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.473 ' HB2' ' H ' ' A' ' 67' ' ' GLN . 93.5 mt -86.77 -6.51 58.8 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.439 -0.788 . . . . 0.0 109.644 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 68' ' ' PRO . 12.1 p -67.29 -39.58 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.229 -0.919 . . . . 0.0 109.553 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.482 ' N ' HG13 ' A' ' 71' ' ' VAL . . . -61.32 -47.04 93.03 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 56.6 m -59.59 -42.49 92.65 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.295 -1.121 . . . . 0.0 110.532 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.2 tt -84.65 -24.37 29.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.031 -1.043 . . . . 0.0 110.576 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.605 ' NH1' ' NZ ' ' A' ' 88' ' ' LYS . 69.7 ttt180 -82.72 -40.56 20.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.868 -1.145 . . . . 0.0 109.173 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.448 ' CG ' ' O ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -69.02 1.22 3.66 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.784 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.8 mmtt -88.01 116.03 64.94 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.473 -0.767 . . . . 0.0 109.459 179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.26 144.92 37.3 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.331 2.02 . . . . 0.0 113.045 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 94.61 -20.76 46.82 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.7 mt -103.01 125.67 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.477 -1.013 . . . . 0.0 109.396 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -106.0 151.65 40.11 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.593 -0.692 . . . . 0.0 109.996 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.22 146.62 81.87 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.5 2.133 . . . . 0.0 112.194 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.525 ' HB3' ' H ' ' A' ' 88' ' ' LYS . . . -67.09 153.23 44.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.546 -0.721 . . . . 0.0 110.592 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -85.09 -143.02 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.916 0.865 . . . . 0.0 110.52 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 46.16 -113.54 0.44 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.443 0.639 . . . . 0.0 109.954 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 98.2 mmm -141.07 0.89 1.59 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.555 ' O ' ' N ' ' A' ' 89' ' ' GLU . 81.8 m-20 -59.64 -85.87 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.417 -0.802 . . . . 0.0 109.691 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.605 ' NZ ' ' NH1' ' A' ' 75' ' ' ARG . 62.7 tttm 56.86 -76.71 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.648 -0.657 . . . . 0.0 110.222 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.555 ' N ' ' O ' ' A' ' 87' ' ' ASN . 97.5 mt-10 -65.35 -38.7 90.88 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.288 -0.882 . . . . 0.0 109.673 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -68.51 -68.12 0.42 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.364 -0.835 . . . . 0.0 109.584 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -120.57 159.4 25.33 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.525 -0.734 . . . . 0.0 109.634 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 6.2 mm -129.6 147.69 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.919 0.866 . . . . 0.0 109.826 179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.1 p -90.59 134.6 34.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.683 -0.636 . . . . 0.0 110.076 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 54.5 t -115.48 129.87 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 34.0 tp -86.77 104.84 16.53 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.669 0.747 . . . . 0.0 109.976 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.76 -38.4 88.96 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.788 0.804 . . . . 0.0 109.237 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -74.39 -5.88 44.97 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.897 0.856 . . . . 0.0 109.113 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.92 -175.41 8.96 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.514 ' O ' ' C ' ' A' ' 100' ' ' LEU . 44.5 Cg_endo -71.63 -81.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.633 2.222 . . . . 0.0 112.226 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.514 ' C ' ' O ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER 19.2 -120.7 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.417 0 CA-C-O 121.158 0.504 . . . . 0.0 111.689 -179.346 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 172.95 165.61 30.19 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.22 -39.07 86.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.528 -0.984 . . . . 0.0 109.461 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -64.91 -35.5 81.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.447 -0.783 . . . . 0.0 109.611 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -67.09 -40.7 87.01 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.201 -0.937 . . . . 0.0 109.411 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.71 -43.3 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.228 -0.92 . . . . 0.0 109.273 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.448 ' NE2' ' CD2' ' A' ' 9' ' ' TYR . 52.1 m170 -56.65 -44.95 81.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 109.76 -179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.2 m -62.25 -42.44 99.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.265 -0.897 . . . . 0.0 109.744 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 94.5 mt -64.52 -41.03 96.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.234 -0.916 . . . . 0.0 109.194 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 86.7 mt -63.1 -42.7 97.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.339 -0.85 . . . . 0.0 108.988 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -53.77 -46.55 71.0 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.502 -0.749 . . . . 0.0 109.438 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -64.43 -38.53 91.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.075 -1.016 . . . . 0.0 108.851 179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.6 p -62.18 -36.24 81.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 0.0 109.226 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -61.75 -44.6 96.59 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.413 -0.805 . . . . 0.0 109.664 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -59.16 -41.86 89.38 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.296 -0.877 . . . . 0.0 109.612 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.8 mt -66.53 -38.7 87.73 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.341 -0.849 . . . . 0.0 109.798 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 44.8 p -89.09 5.84 42.63 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.216 -0.927 . . . . 0.0 109.372 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 118' ' ' LEU . 34.4 ttm180 -73.86 51.47 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 108.903 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 117' ' ' ARG . 5.3 mp 40.03 -161.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.532 0.682 . . . . 0.0 110.833 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -94.14 -122.25 0.1 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.247 -0.908 . . . . 0.0 109.813 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.491 ' CG ' ' O ' ' A' ' 120' ' ' HIS . 52.5 p-80 -146.55 59.9 1.21 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.579 -0.701 . . . . 0.0 109.537 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -84.76 156.98 21.16 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.451 -0.781 . . . . 0.0 110.633 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 122' ' ' HIS . 86.3 t60 56.03 10.76 0.63 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.556 0.693 . . . . 0.0 109.439 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -81.48 62.24 5.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.421 -0.799 . . . . 0.0 109.209 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -67.33 -39.87 85.88 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 0.0 109.425 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 80.7 m80 . . . . . 0 N--CA 1.495 1.793 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.935 -179.425 . . . . . . . . 0 0 . 1 stop_ save_